Sentence,class,file
2006. http://otp.unesco-ci.org/training-resource/community-empowerment-general/antiretroviral-drugs-all-obstacles-access-hivaids-tr 13.,Non-OADS,/arxiv_data1/oa_pdf/30/c9/bmjopen-2016-012537.PMC5168604.pdf
2014. http://www.chp.gov.hk/ en/data/4/10/27/111.html (accessed Dec 2015).,OADS,/arxiv_data1/oa_pdf/7b/27/bmjopen-2016-013259.PMC5168605.pdf
http://www.bycensus2006.gov.hk/ FileManager/EN/Content_962/06bc_op.pdf (accessed Sep 2016).,OADS,/arxiv_data1/oa_pdf/7b/27/bmjopen-2016-013259.PMC5168605.pdf
2011 Population Census: Thematic Report:Older Persons http://www.census2011.gov.hk/pdf/older-persons.pdf 21.,Non-OADS,/arxiv_data1/oa_pdf/7b/27/bmjopen-2016-013259.PMC5168605.pdf
26. http://www.statistics.gov.hk/pub/B11302262006XXXXB0100.pdf (accessed Sep 2016).,OADS,/arxiv_data1/oa_pdf/7b/27/bmjopen-2016-013259.PMC5168605.pdf
30.2007. http://www.statistics.gov.hk/pub/B11302302007XXXXB0100.pdf (accessed Sep 2016).,OADS,/arxiv_data1/oa_pdf/7b/27/bmjopen-2016-013259.PMC5168605.pdf
2010. http://www.statistics.gov.hk/pub/B11302452010XXXXB0100.pdf (accessed Sep 2016).,OADS,/arxiv_data1/oa_pdf/7b/27/bmjopen-2016-013259.PMC5168605.pdf
48.2011. http://www.statistics.gov.hk/pub/B11302482011XXXXB0100.pdf (accessed Sep 2016).25.,OADS,/arxiv_data1/oa_pdf/7b/27/bmjopen-2016-013259.PMC5168605.pdf
2014. http://www.statistics.gov.hk/pub/B10100032014AN14B0100.pdf (accessed Dec 2015).,OADS,/arxiv_data1/oa_pdf/7b/27/bmjopen-2016-013259.PMC5168605.pdf
http://www.statistics.gov.hk/pub/B11301622014XXXXB0100.pdf (accessed Sep 2016).,OADS,/arxiv_data1/oa_pdf/7b/27/bmjopen-2016-013259.PMC5168605.pdf
63 of the Director of Audit(Chapter 1 Provision of long-term care services for the elderly).2014. http://www.legco.gov.hk/yr14-15/english/counmtg/papers/cm20141120-sp030-e.pdf (accessed Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/7b/27/bmjopen-2016-013259.PMC5168605.pdf
http://www.elsa-project.,Non-OADS,/arxiv_data1/oa_pdf/7b/27/bmjopen-2016-013259.PMC5168605.pdf
40.2010. http://www.statistics.gov.hk/pub/B11302402009XXXXB0100.pdf (accessed Sep 2016).,OADS,/arxiv_data1/oa_pdf/7b/27/bmjopen-2016-013259.PMC5168605.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ BMJ Open 2016; 6:e012894corr1.,Non-OADS,/arxiv_data1/oa_pdf/dc/7c/bmjopen-2016-012894corr1.PMC5168606.pdf
between the ages of 20 –24 years (http://www.healthdata.,Non-OADS,/arxiv_data1/oa_pdf/7b/6e/bmjopen-2016-014007.PMC5168607.pdf
youngandwellcrc.org.au/ and the Young Female Health Initiative Research Program: https://www.yfhi.org/useful-links/.,Non-OADS,/arxiv_data1/oa_pdf/7b/6e/bmjopen-2016-014007.PMC5168607.pdf
"Initial eligibility screening was undertaken through an online survey platform Qualtrics (Provo, Utah, USA;https://www.qualtrics.com/research-suite/), which allows tailored survey design, data capture and analysis.",Non-OADS,/arxiv_data1/oa_pdf/7b/6e/bmjopen-2016-014007.PMC5168607.pdf
32 RESULTSThis paper is drawn from a broader mixed methods study of persistent pain in young people (see http://www.move.org.au/Research/Funded-Research/Completed/Painful- Transitions).,Non-OADS,/arxiv_data1/oa_pdf/7b/6e/bmjopen-2016-014007.PMC5168607.pdf
"Melbourne, Western Australia: Arthritis andOsteoporosis Victoria and Arthritis and Osteoporosis WesternAustralia, 2016. http://www.move.org.au/Research/Funded-Research/Completed/Painful-Transitions.",Non-OADS,/arxiv_data1/oa_pdf/7b/6e/bmjopen-2016-014007.PMC5168607.pdf
"Sydney, Australia, 2011. http://apo.org.",Non-OADS,/arxiv_data1/oa_pdf/7b/6e/bmjopen-2016-014007.PMC5168607.pdf
"Washington, DC: The National Academies Press, 2011. http://www.nap.edu/ catalog/13172/relieving-pain-in-america-a-blueprint-for-transforming-prevention-care (accessed 8 Feb 2015).",Non-OADS,/arxiv_data1/oa_pdf/7b/6e/bmjopen-2016-014007.PMC5168607.pdf
"Melbourne, Australia: Health Promotion ResearchCentre National University of Ireland Galway and Inspire IrelandFoundation in collaboration with the Young and Well CooperativeResearch Centre, 2014. http://ie.reachout.com/wp-content/uploads/2013/10/Bridging-the-digital-disconnect.pdf (accessed 16 Jul 2016) 19.",Non-OADS,/arxiv_data1/oa_pdf/7b/6e/bmjopen-2016-014007.PMC5168607.pdf
"Canberra: Australian Instituteof Health and Welfare, 2011. http://www.aihw.gov.au/publication-detail/?id=10737419261 (accessed 18 Feb 2016).",Non-OADS,/arxiv_data1/oa_pdf/7b/6e/bmjopen-2016-014007.PMC5168607.pdf
"Arthritis Series.Canberra: Australian Institute of Health and Welfare, 2014. http://www.aihw.gov.au/publication-detail/?id=60129547059 (accessed 15Oct 2016).",Non-OADS,/arxiv_data1/oa_pdf/7b/6e/bmjopen-2016-014007.PMC5168607.pdf
http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=6442452993 (accessed 18 Aug 2014).,OADS,/arxiv_data1/oa_pdf/7b/6e/bmjopen-2016-014007.PMC5168607.pdf
"Melbourne: Young and Well CooperativeResearch Centre, 2014. http://www.youngandwellcrc.org.au/(accessed Nov 2015).",Non-OADS,/arxiv_data1/oa_pdf/7b/6e/bmjopen-2016-014007.PMC5168607.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-012576).,Non-OADS,/arxiv_data1/oa_pdf/ba/67/bmjopen-2016-012576.PMC5168608.pdf
"Competing interests All authors MIB, LZ, MA, SD have completed the Unified Competing Interest form (http://www.icmje.org/coi_disclosure.pdf available onrequest from the corresponding author) and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous 3 years, no other relationships or activities that could appear to have influenced the submitted work.",Non-OADS,/arxiv_data1/oa_pdf/ba/67/bmjopen-2016-012576.PMC5168608.pdf
http://www.pssru.ac.uk/publication-details.php?id=4962 24.,Non-OADS,/arxiv_data1/oa_pdf/ba/67/bmjopen-2016-012576.PMC5168608.pdf
"http://www.endoflifecare-intelligence.org.uk/view?rid=803 6 Bennett MI, et al.BMJ Open 2016; 6:e012576.",Non-OADS,/arxiv_data1/oa_pdf/ba/67/bmjopen-2016-012576.PMC5168608.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-012870).,Non-OADS,/arxiv_data1/oa_pdf/f0/5c/bmjopen-2016-012870.PMC5168609.pdf
http://www.vanderbilt.edu/lapop/guyana/2006-politicalculture.pdf 49.,Non-OADS,/arxiv_data1/oa_pdf/f0/5c/bmjopen-2016-012870.PMC5168609.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-012623).,Non-OADS,/arxiv_data1/oa_pdf/ca/e3/bmjopen-2016-012623.PMC5168610.pdf
In collaboration with theCanadian Critical Care Trials Group (http://www.ccctg.,Non-OADS,/arxiv_data1/oa_pdf/ca/e3/bmjopen-2016-012623.PMC5168610.pdf
"Köln, 2011. https://publikationen.sexualaufklaerung.de/cgi-sub/fetch.php?id=701 (accessed 12 Jun 2016).",Non-OADS,/arxiv_data1/oa_pdf/0e/d8/bmjopen-2016-012592.PMC5168611.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 011034).,Non-OADS,/arxiv_data1/oa_pdf/87/5b/bmjopen-2016-011034.PMC5168614.pdf
"Boston: University School ofPublic Health: Compliance Advisor Ombudman, 2012. http://www.cao-ombudsman.org/documents/Biological_Sampling_Report_April_ 2012.pdf (accessed 2 Jan 2016).",Non-OADS,/arxiv_data1/oa_pdf/87/5b/bmjopen-2016-011034.PMC5168614.pdf
http://ndb.nal.usda.gov/ndb/foods/show/6216?,Non-OADS,/arxiv_data1/oa_pdf/87/5b/bmjopen-2016-011034.PMC5168614.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-013742).,Non-OADS,/arxiv_data1/oa_pdf/cc/48/bmjopen-2016-013742.PMC5168615.pdf
http://www.nice.org.uk/CG56 10.,Non-OADS,/arxiv_data1/oa_pdf/cc/48/bmjopen-2016-013742.PMC5168615.pdf
2014. http://www.nice.org.uk/CG176 11.,Non-OADS,/arxiv_data1/oa_pdf/cc/48/bmjopen-2016-013742.PMC5168615.pdf
http://www.pssru.ac.uk/project-pages/unit-costs/2015 12.,Non-OADS,/arxiv_data1/oa_pdf/cc/48/bmjopen-2016-013742.PMC5168615.pdf
http://www.gov.uk/government/publications/ nhs-reference-costs-2014-to-2015 14.,Non-OADS,/arxiv_data1/oa_pdf/cc/48/bmjopen-2016-013742.PMC5168615.pdf
http://www.ons.gov.uk/ons/publications/re-reference-tables.html?edition=tcm%3A77-352834.,Non-OADS,/arxiv_data1/oa_pdf/cc/48/bmjopen-2016-013742.PMC5168615.pdf
http://www.nice.org.uk/article/pmg9/resources/non-guidance-guide-to-the-methods-of-technology-appraisal-2013-pdf 18.,Non-OADS,/arxiv_data1/oa_pdf/cc/48/bmjopen-2016-013742.PMC5168615.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-013220).,Non-OADS,/arxiv_data1/oa_pdf/3f/35/bmjopen-2016-013220.PMC5168617.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/3f/35/bmjopen-2016-013220.PMC5168617.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-011458).,Non-OADS,/arxiv_data1/oa_pdf/33/08/bmjopen-2016-011458.PMC5168618.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/33/08/bmjopen-2016-011458.PMC5168618.pdf
2009. http://bestbets.org/links/BET-CA-worksheets.php 22.,Non-OADS,/arxiv_data1/oa_pdf/33/08/bmjopen-2016-011458.PMC5168618.pdf
"Questions to assist with the critical appraisal of an observational study eg cohort, case-control, cross-sectional, 2004. http://hebw.cf.ac.uk/projectmethod/appendix8.htm 27.",Non-OADS,/arxiv_data1/oa_pdf/33/08/bmjopen-2016-011458.PMC5168618.pdf
2014. http://joannabriggs.org/assets/docs/sumari/ ReviewersManual-2014.pdf 30.,Non-OADS,/arxiv_data1/oa_pdf/33/08/bmjopen-2016-011458.PMC5168618.pdf
2000. http://www.medicine.mcgill.ca/rtamblyn/Readings/The%20Newcastle%20-%20Scale%20for%20assessing %20the%20quality%20of%20nonrandomised%20studies%20in% 20meta-analyses.pdf 37.,Non-OADS,/arxiv_data1/oa_pdf/33/08/bmjopen-2016-011458.PMC5168618.pdf
@ERSpublications Sympathetic heart activity is increased in children with obstructive sleep apnoea and obesity http://ow.ly/iSVc305AZRv Copyright ©ERS 2016.,Non-OADS,/arxiv_data1/oa_pdf/76/af/00038-2016.PMC5168620.pdf
Sleep Med 2015; in press [https://doi.org/10.1016/j.sleep.2015.11.014].,OADS,/arxiv_data1/oa_pdf/76/af/00038-2016.PMC5168620.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 013755).,Non-OADS,/arxiv_data1/oa_pdf/2e/c0/bmjopen-2016-013755.PMC5168622.pdf
"The search for guidelines will include searches at the National Guideline Clearinghouse, http://www.cari.org, http://www.kdigo.org, the National Kidney Foundation (NKF-DOQI), Kidney Health Australia, the RenalPhysicians Association, ERA-EDTA and national specialty organisations (USA, UK, Australia, European).",Non-OADS,/arxiv_data1/oa_pdf/2e/c0/bmjopen-2016-013755.PMC5168622.pdf
http://www.who.int/dietphysicalactivity/childhood/en/(accessed 15 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/0e/49/bmjopen-2016-012536.PMC5168623.pdf
"Melbourne: NHMRC, 2013. https://www.nhmrc.gov.au/guidelines-publications/n57 8.",Non-OADS,/arxiv_data1/oa_pdf/0e/49/bmjopen-2016-012536.PMC5168623.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 013361).,Non-OADS,/arxiv_data1/oa_pdf/bd/af/bmjopen-2016-013361.PMC5168625.pdf
2011 (cited 1 June 2016) http://www.cancerresearchuk.,Non-OADS,/arxiv_data1/oa_pdf/bd/af/bmjopen-2016-013361.PMC5168625.pdf
"We will provide local (to each site) mental health crisis line numbers and access to online psychologicalinterventions (http://www.ecouch.com.au, http://www.",Non-OADS,/arxiv_data1/oa_pdf/be/d8/bmjopen-2016-015009.PMC5168627.pdf
There is provi- sion for up to 10 sessions per year as part of a GPmental health treatment plan http://www.health.gov.,Non-OADS,/arxiv_data1/oa_pdf/be/d8/bmjopen-2016-015009.PMC5168627.pdf
"If you feel that antidepressant medication is neces- sary, then either yourself or their treating doctor might consider the attached guidelines, https://www.nice.org.uk/guidance/cg90.",Non-OADS,/arxiv_data1/oa_pdf/be/d8/bmjopen-2016-015009.PMC5168627.pdf
2016. https://www.nice.org.uk/guidance/cg90 24.,Non-OADS,/arxiv_data1/oa_pdf/be/d8/bmjopen-2016-015009.PMC5168627.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-013336).,Non-OADS,/arxiv_data1/oa_pdf/e8/04/bmjopen-2016-013336.PMC5168628.pdf
https://rapidminer.com/wp-content/uploads/ 2013/10/RapidMiner_OperatorReference_en.pdf (accessed 12 Feb 2015).,OADS,/arxiv_data1/oa_pdf/e8/04/bmjopen-2016-013336.PMC5168628.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-013885).,Non-OADS,/arxiv_data1/oa_pdf/12/36/bmjopen-2016-013885.PMC5168629.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/12/36/bmjopen-2016-013885.PMC5168629.pdf
2016. http://www.rea.or.jp/chutou/koukai_jyosen/H27nen/English/honbun_jyosen-h27-English.html (accessed 17 Oct 2016).,Non-OADS,/arxiv_data1/oa_pdf/12/36/bmjopen-2016-013885.PMC5168629.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-011941).,Non-OADS,/arxiv_data1/oa_pdf/c9/32/bmjopen-2016-011941.PMC5168630.pdf
"Competing interests All authors have completed the ICMJE uniform disclosure form at http://www.icmje.org/coi_disclosure.pdf and declare no support from any organisation for the submitted work; SP, VS, MD, GB haveno competing interests.",Non-OADS,/arxiv_data1/oa_pdf/c9/32/bmjopen-2016-011941.PMC5168630.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-011555).,Non-OADS,/arxiv_data1/oa_pdf/96/57/bmjopen-2016-011555.PMC5168631.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1. WHO.,Non-OADS,/arxiv_data1/oa_pdf/96/57/bmjopen-2016-011555.PMC5168631.pdf
http://www.who.int/respiratory/copd/burden/en/ 2.,Non-OADS,/arxiv_data1/oa_pdf/96/57/bmjopen-2016-011555.PMC5168631.pdf
https://www.destatis.de/DE/ZahlenFakten/GesellschaftStaat/Gesundheit/Todesursachen/Tabellen/SterbefaelleInsgesamt.html 3.,Non-OADS,/arxiv_data1/oa_pdf/96/57/bmjopen-2016-011555.PMC5168631.pdf
2010. http://www.goldcopd.,Non-OADS,/arxiv_data1/oa_pdf/96/57/bmjopen-2016-011555.PMC5168631.pdf
http://www.who.int/cancer/palliative/definition/en/ 34.,Non-OADS,/arxiv_data1/oa_pdf/96/57/bmjopen-2016-011555.PMC5168631.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 012548).,Non-OADS,/arxiv_data1/oa_pdf/e0/bd/bmjopen-2016-012548.PMC5168632.pdf
Funding The research was funded by the Australian Capital Territory Health Directorate (http://www.health.act.gov.au).,Non-OADS,/arxiv_data1/oa_pdf/e0/bd/bmjopen-2016-012548.PMC5168632.pdf
https://www.walkscore.com/ cities-and-neighborhoods/australia 8.,Non-OADS,/arxiv_data1/oa_pdf/e0/bd/bmjopen-2016-012548.PMC5168632.pdf
http://www.cancer.gov/ about-cancer/causes-prevention/risk/obesity/physical-activity-fact-sheet 33.,Non-OADS,/arxiv_data1/oa_pdf/e0/bd/bmjopen-2016-012548.PMC5168632.pdf
http://www.abs.gov.au/websitedbs/D3310114.nsf/home/Correspondences 34.,Non-OADS,/arxiv_data1/oa_pdf/e0/bd/bmjopen-2016-012548.PMC5168632.pdf
https://www.walkscore.com/AU-ACT/Canberra 39.,Non-OADS,/arxiv_data1/oa_pdf/e0/bd/bmjopen-2016-012548.PMC5168632.pdf
http://www.accesscanberra.act.gov.au/app/answers/detail/a_id/1654#!,Non-OADS,/arxiv_data1/oa_pdf/e0/bd/bmjopen-2016-012548.PMC5168632.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-013897).,Non-OADS,/arxiv_data1/oa_pdf/7e/31/bmjopen-2016-013897.PMC5168633.pdf
"Prepared for the General Medical Council, 2016. http://www.gmc-uk.org/about/ research/23658.asp 22.",Non-OADS,/arxiv_data1/oa_pdf/7e/31/bmjopen-2016-013897.PMC5168633.pdf
http://www.dailymail.co.uk/debate/article-2532461/Why-having-women-doctors-hurting-NHS-A-provovcative-powerful-argument-leading-surgeon.html34.,Non-OADS,/arxiv_data1/oa_pdf/7e/31/bmjopen-2016-013897.PMC5168633.pdf
2015. https://www.gov.uk/government/publications/7-day-nhs-services-a-factsheet/7-day-nhs-services-a-factsheet 45.,Non-OADS,/arxiv_data1/oa_pdf/7e/31/bmjopen-2016-013897.PMC5168633.pdf
2016. https://www.gov.,Non-OADS,/arxiv_data1/oa_pdf/7e/31/bmjopen-2016-013897.PMC5168633.pdf
2015. http://www.pulsetoday.co.uk/your-practice/regulation/doctors-need-resilience-training-like-soldiers-in-afghanistan-gmc-head-says/20008855.fullarticle 49.,Non-OADS,/arxiv_data1/oa_pdf/7e/31/bmjopen-2016-013897.PMC5168633.pdf
"http://www.gmc-uk.org/GMC_Understanding_Differential_Attainment.pdf_63533431.pdf Rich A, et al.BMJ Open 2016; 6:e013897.",Non-OADS,/arxiv_data1/oa_pdf/7e/31/bmjopen-2016-013897.PMC5168633.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 011504).,Non-OADS,/arxiv_data1/oa_pdf/f6/ff/bmjopen-2016-011504.PMC5168634.pdf
"The Cochrane Collaboration, 2011. http://www.cochrane-handbook.org 16.",OADS,/arxiv_data1/oa_pdf/f6/ff/bmjopen-2016-011504.PMC5168634.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-011925).,Non-OADS,/arxiv_data1/oa_pdf/85/7f/bmjopen-2016-011925.PMC5168635.pdf
Available from: http://unstats.un.org/unsd/demographic/products/dyb/dyb2005.htm.,Non-OADS,/arxiv_data1/oa_pdf/85/7f/bmjopen-2016-011925.PMC5168635.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-012890).,Non-OADS,/arxiv_data1/oa_pdf/e2/1a/bmjopen-2016-012890.PMC5168637.pdf
"We created questionnaires based on ‘Section 4 Hospital Self-Appraisal and Monitoring ’by the WHO and UNICEF (http://www.who.int/nutrition /publications/infantfeeding/ bfhi_trainingcourse_s4 accessed 14 October 2015) to beadministered prenatally and at 1, 3 and 6 months postnatal and a separate questionnaire for administration and staff.",Non-OADS,/arxiv_data1/oa_pdf/e2/1a/bmjopen-2016-012890.PMC5168637.pdf
http://apps.who.int/gb/archive/pdf_files/WHA55/ea5515.pdf 4.,OADS,/arxiv_data1/oa_pdf/e2/1a/bmjopen-2016-012890.PMC5168637.pdf
2009. http://www.who.int/nutrition/publications/infantfeeding/bfhi_trainingcourse_s3/en/ 5.,Non-OADS,/arxiv_data1/oa_pdf/e2/1a/bmjopen-2016-012890.PMC5168637.pdf
http://www.smj.org.sa/ PDFFiles/Mar08/18Patterns20070902.pdf\nhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed8&NEWS=N&AN=2008490369 12.,Non-OADS,/arxiv_data1/oa_pdf/e2/1a/bmjopen-2016-012890.PMC5168637.pdf
"Dissemination was undertaken overFebruary –May 2014 via the BMA list servers for GP members, partner organisations of Cambridge and Ulster Universities (using http://www.SurveyMonkey.com) and at GP conferences (completed hard copies of the questionnaire).",OADS,/arxiv_data1/oa_pdf/9b/e5/bmjopen-2016-012004.PMC5168638.pdf
21 April 2013. http://www.europeanhydrationinstitute.org/dehydration.html 2.,Non-OADS,/arxiv_data1/oa_pdf/9b/e5/bmjopen-2016-012004.PMC5168638.pdf
2005. http://www.elderabuse.org.uk/Documents/Other%20Orgs/Water%20UK%20-%20Hydration%20kit%20for%20Care%20Homes.pdf 11.,Non-OADS,/arxiv_data1/oa_pdf/9b/e5/bmjopen-2016-012004.PMC5168638.pdf
2016. http://www.rcgp.org.uk/training-exams/gp-curriculum-overview.aspx 31.,Non-OADS,/arxiv_data1/oa_pdf/9b/e5/bmjopen-2016-012004.PMC5168638.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-013183).,Non-OADS,/arxiv_data1/oa_pdf/c9/9a/bmjopen-2016-013183.PMC5168639.pdf
"Achtste (8e) Volks- en Woningtelling in Suriname (Volume I),Demografische en Socale karakteristieken en Migratie, 2013.http://unstats.un.org/unsd/demographic/sources/census/wphc/Suriname/SUR-Census2012-vol1.pdf 17.",Non-OADS,/arxiv_data1/oa_pdf/c9/9a/bmjopen-2016-013183.PMC5168639.pdf
http://www.iccp-portal.org/sites/default/files/plans/national_action_ plan_for_the_prevention_and_control_of_noncommunicable_ diseases_2012-2016.pdf 18.,Non-OADS,/arxiv_data1/oa_pdf/c9/9a/bmjopen-2016-013183.PMC5168639.pdf
[updated 14 November 2008. http://www.who.int/chp/steps/manual/en/ 22.,Non-OADS,/arxiv_data1/oa_pdf/c9/9a/bmjopen-2016-013183.PMC5168639.pdf
http://www.who.int/chp/steps/resources/GPAQ_Analysis_Guide.pdf 25.,OADS,/arxiv_data1/oa_pdf/c9/9a/bmjopen-2016-013183.PMC5168639.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-012824).,Non-OADS,/arxiv_data1/oa_pdf/2c/e0/bmjopen-2016-012824.PMC5168640.pdf
"Retrieved from: http://www.statcan.gc.ca/pub/89 –503-x/89 –503- x2010001-eng.htm.†Defined as parenting a child living in the home who is either under the age of 16 (one study), or 18 (four studies).",Non-OADS,/arxiv_data1/oa_pdf/2c/e0/bmjopen-2016-012824.PMC5168640.pdf
Retrieved from: http://www12.statcan.gc.ca/datasets/Rp-eng.cfm?LANG=E&APATH=3&DETAIL=0& DIM=0&FL=A&FREE=0&GC=0&GID=0&GK=0&GRP=1&PID=89022&PRID=0&PTYPE=88971&S=0&SHOWALL=0&SUB=0&Temporal=2006&THEME=68&VID=0&VNAMEE=&VNAMEF.§These ‘identity ’data are combined because the largest study in the data pool did not disaggregate data according to Aboriginal status.,OADS,/arxiv_data1/oa_pdf/2c/e0/bmjopen-2016-012824.PMC5168640.pdf
Retrieved from: http://www.swc-cfc.gc.ca/initiatives/wnc-fcn/profile-eng.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2c/e0/bmjopen-2016-012824.PMC5168640.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-013666).,Non-OADS,/arxiv_data1/oa_pdf/82/1d/bmjopen-2016-013666.PMC5168641.pdf
RESPECT will be implemented as a web tool and access- ible to the public from http://www.projectbiglife.ca.,Non-OADS,/arxiv_data1/oa_pdf/82/1d/bmjopen-2016-013666.PMC5168641.pdf
"Third, we will present mea- sures of functional performance (eg, scores on the ADLHierarchy Scale or the CPS) in our web report on http://www.projectbiglife.ca to aid the interpretation of the predicted mortality risk, since these are commonlyused indicators for determining the need for support in the community.",Non-OADS,/arxiv_data1/oa_pdf/82/1d/bmjopen-2016-013666.PMC5168641.pdf
"We anticipate that RESPECT-lite will take <1 min to com- plete, based on our experience with other calculatorsimplemented on http://www.projectbiglife.ca.",Non-OADS,/arxiv_data1/oa_pdf/82/1d/bmjopen-2016-013666.PMC5168641.pdf
http://www.spict.org.uk/the-spict/ (accessed 25 Nov 2016).,Non-OADS,/arxiv_data1/oa_pdf/82/1d/bmjopen-2016-013666.PMC5168641.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-013441).,Non-OADS,/arxiv_data1/oa_pdf/a2/eb/bmjopen-2016-013441.PMC5168642.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 012864).,Non-OADS,/arxiv_data1/oa_pdf/d0/da/bmjopen-2016-012864.PMC5168644.pdf
Data sharing statement Additional data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.0s0n6.,OADS,/arxiv_data1/oa_pdf/c4/25/bmjopen-2016-012563.PMC5168647.pdf
http://hdl.handle.net/11245/1.,Non-OADS,/arxiv_data1/oa_pdf/c4/25/bmjopen-2016-012563.PMC5168647.pdf
2010. http://onlineqda.hud.ac.uk/Intro_QDA/how_what_to_code.php 52.,Non-OADS,/arxiv_data1/oa_pdf/9d/e6/bmjopen-2016-012762.PMC5168650.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-012749).,Non-OADS,/arxiv_data1/oa_pdf/ae/29/bmjopen-2016-012749.PMC5168652.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-011174).,Non-OADS,/arxiv_data1/oa_pdf/cb/c8/bmjopen-2016-011174.PMC5168653.pdf
Competing interests CBT and RWe are coordinators of the Dutch-Flemish PROMIS group (http://www.dutchflemishpromis.nl).,Non-OADS,/arxiv_data1/oa_pdf/cb/c8/bmjopen-2016-011174.PMC5168653.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/10/c3/bmjopen-2016-013837.PMC5168655.pdf
http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/CounterfeitMedicine/ 2.,Non-OADS,/arxiv_data1/oa_pdf/10/c3/bmjopen-2016-013837.PMC5168655.pdf
http://www.ema.europa.eu/ema/index.jsp?curl=pages/special_topics/general/general_content_000186.jsp 3.,Non-OADS,/arxiv_data1/oa_pdf/10/c3/bmjopen-2016-013837.PMC5168655.pdf
http://www.psi-inc.org/incidentTrends.,OADS,/arxiv_data1/oa_pdf/10/c3/bmjopen-2016-013837.PMC5168655.pdf
http://www.fda.gov/Drugs/DrugSafety/ ucm291960.htm 6.,Non-OADS,/arxiv_data1/oa_pdf/10/c3/bmjopen-2016-013837.PMC5168655.pdf
http://www.fda.gov/Drugs/DrugSafety/ucm291960.htm 7.,Non-OADS,/arxiv_data1/oa_pdf/10/c3/bmjopen-2016-013837.PMC5168655.pdf
https://www.gov.uk/ drug-safety-update/counterfeit-medicines-what-pharmacists-should-know8.,Non-OADS,/arxiv_data1/oa_pdf/10/c3/bmjopen-2016-013837.PMC5168655.pdf
http://www.who.int/bulletin/volumes/88/4/10-020410/en/ 10.,Non-OADS,/arxiv_data1/oa_pdf/10/c3/bmjopen-2016-013837.PMC5168655.pdf
http://www.ncbi.nlm.nih.gov/books/NBK202526/#ref_000225 12.,Non-OADS,/arxiv_data1/oa_pdf/10/c3/bmjopen-2016-013837.PMC5168655.pdf
http://www.ipedr.com/vol17/65-CHHSS%202011-H10119.pdf 14.,Non-OADS,/arxiv_data1/oa_pdf/10/c3/bmjopen-2016-013837.PMC5168655.pdf
http://ec.europa.eu/health/files/eudralex/vol-1/dir_2011_62/dir_2011_62_en.pdf 16.,Non-OADS,/arxiv_data1/oa_pdf/10/c3/bmjopen-2016-013837.PMC5168655.pdf
http://eur-lex.europa.eu/legal-content/ EN/TXT/PDF/?uri=OJ:JOL_2016_032_R_0001&from=EN 17.,Non-OADS,/arxiv_data1/oa_pdf/10/c3/bmjopen-2016-013837.PMC5168655.pdf
https://www.congress.gov/bill/113th-congress/house-bill/3204 20.,Non-OADS,/arxiv_data1/oa_pdf/10/c3/bmjopen-2016-013837.PMC5168655.pdf
http://www.who.int/medicines/services/counterfeit/impact/TheNewEstimatesCounterfeit.pdf 22.,Non-OADS,/arxiv_data1/oa_pdf/10/c3/bmjopen-2016-013837.PMC5168655.pdf
http://www.surveysystem.,Non-OADS,/arxiv_data1/oa_pdf/10/c3/bmjopen-2016-013837.PMC5168655.pdf
https://www.mccallum-layton.co.uk/tools/statistic-calculators/z-test-for-proportions-independent-groups-calculator/ 25.,Non-OADS,/arxiv_data1/oa_pdf/10/c3/bmjopen-2016-013837.PMC5168655.pdf
2007 [cited 2016 Jun 9]; http://www2.comm.virginia.edu/cmit/Research/MISQE%206-07.pdf 26.,OADS,/arxiv_data1/oa_pdf/10/c3/bmjopen-2016-013837.PMC5168655.pdf
http://ecdc.europa.eu/en/publications/_layouts/forms/Publication_DispForm.aspx?ID=487&List=4f55ad51-4aed-4d32-b960-af70113dbb90 (accessed 25 Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/34/be/bmjopen-2016-013359.PMC5168657.pdf
http://ecdc.europa.eu/en/publications/_layouts/forms/Publication_DispForm.aspx?List=4f55ad51-4aed-4d32-b960-af70113dbb90&ID=712 (accessed25 Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/34/be/bmjopen-2016-013359.PMC5168657.pdf
2012. http://eco.iarc.fr/EUCAN/CancerOne.aspx?Cancer=25&Gender=2 (accessed 11 Aug2015).,Non-OADS,/arxiv_data1/oa_pdf/34/be/bmjopen-2016-013359.PMC5168657.pdf
http://www.who.int/whr/2008/en/ (accessed 19 Jun 2015).,OADS,/arxiv_data1/oa_pdf/34/be/bmjopen-2016-013359.PMC5168657.pdf
http://www.mz.gov.pl/ leczenie/poz (accessed 13 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/34/be/bmjopen-2016-013359.PMC5168657.pdf
http://www.rcgp.org.uk/news/2015/april/new-film-putshep-c-in-the-primary-care-spotlight.aspx (accessed 13Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/34/be/bmjopen-2016-013359.PMC5168657.pdf
http://www.euro.who.int/en/publications/abstracts/ building-primary-care-in-a-changing-europe (accessed 11 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/34/be/bmjopen-2016-013359.PMC5168657.pdf
http://www.who.int/hiv/pub/hepatitis/hepatitis-c-guidelines/en/ (accessed 25 Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/34/be/bmjopen-2016-013359.PMC5168657.pdf
http://ecdc.europa.eu/en/healthtopics/hepatitis_c/Pages/Annual-Epidemiological-Report.aspx (accessed 1Sep 2016).,Non-OADS,/arxiv_data1/oa_pdf/34/be/bmjopen-2016-013359.PMC5168657.pdf
2009. http://hints.cancer.gov/docs/2009/wingfield-trust.pdf (accessed 25 Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/34/be/bmjopen-2016-013359.PMC5168657.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-014058).,Non-OADS,/arxiv_data1/oa_pdf/a2/c5/bmjopen-2016-014058.PMC5168658.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ BMJ Open 2016; 6:e010756corr1.,Non-OADS,/arxiv_data1/oa_pdf/54/2e/bmjopen-2015-010756corr1.PMC5168659.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-011420).,Non-OADS,/arxiv_data1/oa_pdf/96/c8/bmjopen-2016-011420.PMC5168660.pdf
"For a certificate, please see: http://www.textcheck.com/certificate/IUo2OsContributors J-HK, E-CP, carried out the acquisition of data, performed the experiments and participated in drafting the manuscript.",Non-OADS,/arxiv_data1/oa_pdf/96/c8/bmjopen-2016-011420.PMC5168660.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-011028).,Non-OADS,/arxiv_data1/oa_pdf/22/eb/bmjopen-2016-011028.PMC5168661.pdf
"Geneva: World Health Organization, 2014. http://www.who.int/choice/en/ (accessedNovember 2016) 12 Calderone A, et al.BMJ Open 2016; 6:e011028.",Non-OADS,/arxiv_data1/oa_pdf/22/eb/bmjopen-2016-011028.PMC5168661.pdf
"All data were entered into Epidata V .3.1 (EpiData Association, Odense, Denmark, http://www.epidata.",OADS,/arxiv_data1/oa_pdf/fa/a6/bmjopen-2016-012817.PMC5168662.pdf
http://www.regioner.dk/om+regionerne/ statistik+opdateret+dec+2014 (accessed 14 Oct 2015).,OADS,/arxiv_data1/oa_pdf/fa/a6/bmjopen-2016-012817.PMC5168662.pdf
http://www.drg.dk (accessed 12Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/fa/a6/bmjopen-2016-012817.PMC5168662.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/05/fc/bmjopen-2016-013376.PMC5168663.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-012847).,Non-OADS,/arxiv_data1/oa_pdf/18/81/bmjopen-2016-012847.PMC5168664.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 013781).,Non-OADS,/arxiv_data1/oa_pdf/66/79/bmjopen-2016-013781.PMC5168665.pdf
Data sharing statement Extra data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.1n6c4.,OADS,/arxiv_data1/oa_pdf/66/79/bmjopen-2016-013781.PMC5168665.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 012903).,Non-OADS,/arxiv_data1/oa_pdf/83/69/bmjopen-2016-012903.PMC5168666.pdf
http://www.agenas.it/images/ agenas/In%20primo%20piano/Matrice/Progetto_MATRICE_Scheda_informativa.pdf (accessed Aug 2016) [Italian].,Non-OADS,/arxiv_data1/oa_pdf/66/19/bmjopen-2016-012413.PMC5168667.pdf
https://www.ars.toscana.it/en/project/chronic-diseases/ 2460-matrice-project.html (accessed Aug 2016).,Non-OADS,/arxiv_data1/oa_pdf/66/19/bmjopen-2016-012413.PMC5168667.pdf
https://www.healthsearch.it/?lang=en (accessed Aug 2016).,Non-OADS,/arxiv_data1/oa_pdf/66/19/bmjopen-2016-012413.PMC5168667.pdf
30 September 2014. https://ama.com.au/ausmed/mandatory-reporting-laws-backfire (accessed Mar 2016).,Non-OADS,/arxiv_data1/oa_pdf/36/71/bmjopen-2016-011988.PMC5168668.pdf
http://www.coaghealthcouncil.gov.au/DesktopModules/EasyDNNNews/ DocumentDownload.ashx?portalid=0&moduleid=514&articleid= 68&documentid=74 (accessed Mar 2016).,OADS,/arxiv_data1/oa_pdf/36/71/bmjopen-2016-011988.PMC5168668.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/71/bmjopen-2016-011988.PMC5168668.pdf
http://www.medicalboard.gov.au/Codes-Guidelines-Policies/Guidelines-for-mandatory-notifications.aspx (accessed Mar 2016).,Non-OADS,/arxiv_data1/oa_pdf/36/71/bmjopen-2016-011988.PMC5168668.pdf
http://lsbc.vic.,Non-OADS,/arxiv_data1/oa_pdf/36/71/bmjopen-2016-011988.PMC5168668.pdf
http://www.phac-aspc.gc.ca/chn-rcs/cah-acps-eng.php 2.,Non-OADS,/arxiv_data1/oa_pdf/2c/a3/bmjopen-2016-014028.PMC5168671.pdf
https://www.fraserinstitute.org/sites/default/files/ComplementaryAlternativeMedicine.pdf 3.,Non-OADS,/arxiv_data1/oa_pdf/2c/a3/bmjopen-2016-014028.PMC5168671.pdf
https://www.mja.,Non-OADS,/arxiv_data1/oa_pdf/2c/a3/bmjopen-2016-014028.PMC5168671.pdf
https://ajp.com.au/news/integrative-medicine-health-fraud-quackery/ 11.,Non-OADS,/arxiv_data1/oa_pdf/2c/a3/bmjopen-2016-014028.PMC5168671.pdf
7 March 2016. http://www.theguardian.com/ australia-news/2016/mar/07/chiropractors-using-unacceptable-false-advertising-says-board 12.,Non-OADS,/arxiv_data1/oa_pdf/2c/a3/bmjopen-2016-014028.PMC5168671.pdf
28 April 2016. http://www.smh.,Non-OADS,/arxiv_data1/oa_pdf/2c/a3/bmjopen-2016-014028.PMC5168671.pdf
28 April 2016. http://www.theglobeandmail.com/life/health-and-fitness/health/canadian-naturopaths-need-to-follow-the-rules-if-they-want-regulation/article29785140/ 14.,Non-OADS,/arxiv_data1/oa_pdf/2c/a3/bmjopen-2016-014028.PMC5168671.pdf
17 February 2014. http://www.nytimes.com/2014/02/18/business/food-industry-wagers-big-on-gluten-free.html 22.,Non-OADS,/arxiv_data1/oa_pdf/2c/a3/bmjopen-2016-014028.PMC5168671.pdf
2016. http://www.nhmrc.gov.au/guidelines-publications/cam02 30.,Non-OADS,/arxiv_data1/oa_pdf/2c/a3/bmjopen-2016-014028.PMC5168671.pdf
"10 June 2016. http://news.nationalpost.com/news/canada/different-spin-on-health-inside-tragic-death-ezekiel-stephan 8 Murdoch B, et al.BMJ Open 2016; 6:e014028.",Non-OADS,/arxiv_data1/oa_pdf/2c/a3/bmjopen-2016-014028.PMC5168671.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-012387).,Non-OADS,/arxiv_data1/oa_pdf/82/67/bmjopen-2016-012387.PMC5168675.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-012876).,Non-OADS,/arxiv_data1/oa_pdf/b6/2c/bmjopen-2016-012876.PMC5168676.pdf
Find instructions for installation and use at https://github.com/josie-hughes/EmpiricTherapyIndices/blob/master/ Example.R.,Non-OADS,/arxiv_data1/oa_pdf/ef/d9/bmjopen-2016-012040.PMC5168677.pdf
2013. http://www.cdc.gov/drugresistance/threat-report-2013/ (accessed 26 May 2015).,OADS,/arxiv_data1/oa_pdf/ef/d9/bmjopen-2016-012040.PMC5168677.pdf
2014. http://www.who.int/drugresistance/documents/surveillancereport/en/ (accessed 26 May 2015).,OADS,/arxiv_data1/oa_pdf/ef/d9/bmjopen-2016-012040.PMC5168677.pdf
2015. http://www.cddep.org/ publications/state_worlds_antibiotics_2015 (accessed 30 Sep 2015).,Non-OADS,/arxiv_data1/oa_pdf/ef/d9/bmjopen-2016-012040.PMC5168677.pdf
2016. http://www.publichealthontario.ca/en/BrowseByTopic/InfectiousDiseases/AntimicrobialStewardshipProgram/Documents/ASP_Strategy_Formulary_Restriction.pdf (accessed 01 Jul 2016).,Non-OADS,/arxiv_data1/oa_pdf/ef/d9/bmjopen-2016-012040.PMC5168677.pdf
2013. http://www.mountsinai.on.ca/education/staff-professionals/microbiology 39.,Non-OADS,/arxiv_data1/oa_pdf/ef/d9/bmjopen-2016-012040.PMC5168677.pdf
2014. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMateri Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM426700.pdf (accessed 11 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/ef/d9/bmjopen-2016-012040.PMC5168677.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/bc/00/bmjopen-2016-013042.PMC5168679.pdf
http://www.fda.gov/downloads/Drugs/DrugSafety/UCM394286.pdf (accessed 22 Mar 2016).,Non-OADS,/arxiv_data1/oa_pdf/bc/00/bmjopen-2016-013042.PMC5168679.pdf
http://www.fda.gov/downloads/AdvisoryCommittees/ CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM422692.pdf (accessed 22 Mar2016).,Non-OADS,/arxiv_data1/oa_pdf/bc/00/bmjopen-2016-013042.PMC5168679.pdf
http://www.cms.hhs.gov/ (accessed 22 Mar2016).,Non-OADS,/arxiv_data1/oa_pdf/bc/00/bmjopen-2016-013042.PMC5168679.pdf
August 2010. http://oig.hhs.gov/oei/reports/oei-05-09-00030.pdf (accessed 22 Mar 2016).,OADS,/arxiv_data1/oa_pdf/bc/00/bmjopen-2016-013042.PMC5168679.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e1/97/bmjopen-2016-012515.PMC5168680.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-014662).,Non-OADS,/arxiv_data1/oa_pdf/60/ac/bmjopen-2016-014662.PMC5168681.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-013060).,Non-OADS,/arxiv_data1/oa_pdf/c1/99/bmjopen-2016-013060.PMC5168682.pdf
METHODS Data source Study data were collected in clinic as part of the Inter-professional Spine Assessment and EducationClinics (ISAEC) pilot programme (http://www.isaec.,OADS,/arxiv_data1/oa_pdf/c1/99/bmjopen-2016-013060.PMC5168682.pdf
2014. http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/c1/99/bmjopen-2016-013060.PMC5168682.pdf
2016. http://www.ISAEC.org 31.,Non-OADS,/arxiv_data1/oa_pdf/c1/99/bmjopen-2016-013060.PMC5168682.pdf
2016. http://spinepathwaysk.ca/ 32.,Non-OADS,/arxiv_data1/oa_pdf/c1/99/bmjopen-2016-013060.PMC5168682.pdf
2015. http://www.gpscbc.ca/what-we-do/professional-development/psp/modules/musculoskeletal-msk/tools-resources 33.,Non-OADS,/arxiv_data1/oa_pdf/c1/99/bmjopen-2016-013060.PMC5168682.pdf
2013. ontario.ca/lowbackpain and http://www.effectivepractice.org/lowbackpain 34.,Non-OADS,/arxiv_data1/oa_pdf/c1/99/bmjopen-2016-013060.PMC5168682.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-012730).,Non-OADS,/arxiv_data1/oa_pdf/49/12/bmjopen-2016-012730.PMC5168683.pdf
"CMDh annotated QRD template for MC/DC procedures (based on version 8 of the QRD template for CP), 2011. http://www.hma.eu/uploa 4.",OADS,/arxiv_data1/oa_pdf/cf/8a/bmjopen-2016-012000.PMC5168685.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1. WHO.,Non-OADS,/arxiv_data1/oa_pdf/8c/02/bmjopen-2016-013409.PMC5168686.pdf
http://www.who.int/ hiv/pub/sti/sex_worker_implementation/swit_chpt2.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/8c/02/bmjopen-2016-013409.PMC5168686.pdf
http://apps.who.int/iris/bitstream/10665/112325/1/WHO_RHR_14.11_eng.pdf 5.,OADS,/arxiv_data1/oa_pdf/8c/02/bmjopen-2016-013409.PMC5168686.pdf
http://www.cdc.gov/violenceprevention/pdf/sv-datasheet-a.pdf 6.,Non-OADS,/arxiv_data1/oa_pdf/8c/02/bmjopen-2016-013409.PMC5168686.pdf
World population prospects: the 2015 revision.https://esa.un.org/unpd/wpp 17.,Non-OADS,/arxiv_data1/oa_pdf/8c/02/bmjopen-2016-013409.PMC5168686.pdf
http://aidsdatahub.org/ dmdocuments/sex_work_hiv_china.pdf 27.,Non-OADS,/arxiv_data1/oa_pdf/8c/02/bmjopen-2016-013409.PMC5168686.pdf
http://www.stats.yn.gov.cn/TJJMH_Model/newsview.aspx?,Non-OADS,/arxiv_data1/oa_pdf/8c/02/bmjopen-2016-013409.PMC5168686.pdf
http://www.who.int/reproductive-health/adolescent/Adolescent_core_instruments.en.html 39.,Non-OADS,/arxiv_data1/oa_pdf/8c/02/bmjopen-2016-013409.PMC5168686.pdf
http://dhsprogram.com/pubs/pdf/FR219/FR219.pdf 40.,Non-OADS,/arxiv_data1/oa_pdf/8c/02/bmjopen-2016-013409.PMC5168686.pdf
1993. http://www.un.org/documents/ga/res/ 48/a48r104.htm 44.,Non-OADS,/arxiv_data1/oa_pdf/8c/02/bmjopen-2016-013409.PMC5168686.pdf
1999. http://www.un.org/womenwatch/daw/cedaw/ recommendations/recomm.htm 45.,Non-OADS,/arxiv_data1/oa_pdf/8c/02/bmjopen-2016-013409.PMC5168686.pdf
http://www.un.org/en/women/endviolence/about.shtml 59.,Non-OADS,/arxiv_data1/oa_pdf/8c/02/bmjopen-2016-013409.PMC5168686.pdf
http://www.un.org/ sustainabledevelopment/blog/2015/02/un-launches-initiative-end-adolescent-aids/ 60.,Non-OADS,/arxiv_data1/oa_pdf/8c/02/bmjopen-2016-013409.PMC5168686.pdf
http://www.globalmigrationgroup.org/sites/default/files/7._Chapter_4.pdf 61.,Non-OADS,/arxiv_data1/oa_pdf/8c/02/bmjopen-2016-013409.PMC5168686.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-013835).,Non-OADS,/arxiv_data1/oa_pdf/cf/8b/bmjopen-2016-013835.PMC5168687.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/cf/8b/bmjopen-2016-013835.PMC5168687.pdf
http://www.who.int/diabetes/publications/Definition%20and%20diagnosis%20of%20diabetes_new.pdf 2006.,Non-OADS,/arxiv_data1/oa_pdf/cf/8b/bmjopen-2016-013835.PMC5168687.pdf
2011. http://www.nice.org.uk/guidance/cg130/resources/ guidance-hyperglycaemia-in-acute-coronary-syndromes-pdf VIsited:20150510.,Non-OADS,/arxiv_data1/oa_pdf/cf/8b/bmjopen-2016-013835.PMC5168687.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-011798).,Non-OADS,/arxiv_data1/oa_pdf/a9/d9/bmjopen-2016-011798.PMC5168689.pdf
http://www2.sas.com/proceedings/sugi30/203-30.pdf (accessed 22 Jul 2016).,Non-OADS,/arxiv_data1/oa_pdf/a9/d9/bmjopen-2016-011798.PMC5168689.pdf
"UNICEF UK, 2012. http://www.unicef.",Non-OADS,/arxiv_data1/oa_pdf/44/a7/bmjopen-2016-012900.PMC5168690.pdf
2012. http://www.hscic.gov.uk/catalogue/PUB08694/Infant-Feeding-Survey-2010-Consolidated-Report.pdf (accessed 12Oct 2016).,Non-OADS,/arxiv_data1/oa_pdf/44/a7/bmjopen-2016-012900.PMC5168690.pdf
2014. http://www.cdc.gov/breastfeeding/data/reportcard.htm(accessed 11 Oct 2016).,Non-OADS,/arxiv_data1/oa_pdf/44/a7/bmjopen-2016-012900.PMC5168690.pdf
2015. http://www.socialstyrelsen.se/publikationer2015/2015-10-9 (accessed 11 Oct 2016).,Non-OADS,/arxiv_data1/oa_pdf/44/a7/bmjopen-2016-012900.PMC5168690.pdf
2001. http://www.who.int/nutrition/topics/infantfeeding_recommendation/en/ (accessed 11 Oct 2016).,Non-OADS,/arxiv_data1/oa_pdf/44/a7/bmjopen-2016-012900.PMC5168690.pdf
2014. http://www.socialstyrelsen.se/ Lists/Artikelkatalog/Attachments/19627/2014-12-19.pdf (accessed 11Oct 2016).,Non-OADS,/arxiv_data1/oa_pdf/44/a7/bmjopen-2016-012900.PMC5168690.pdf
2014. http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/19727/2015-2-33.pdf (accessed 11 Oct 2016).33.,Non-OADS,/arxiv_data1/oa_pdf/44/a7/bmjopen-2016-012900.PMC5168690.pdf
2009. http://www.who.int/nutrition/publications/infantfeeding/bfhi_ trainingcourse/en/ (accessed 11 Oct 2016).,Non-OADS,/arxiv_data1/oa_pdf/44/a7/bmjopen-2016-012900.PMC5168690.pdf
2014.http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/19562/2014-10-24.pdf (accessed 11 Oct 2016).,Non-OADS,/arxiv_data1/oa_pdf/44/a7/bmjopen-2016-012900.PMC5168690.pdf
2014. http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/19549/2014-12-3.pdf (accessed11 Oct 2016).,Non-OADS,/arxiv_data1/oa_pdf/44/a7/bmjopen-2016-012900.PMC5168690.pdf
2013. http://www.abs.gov.au/AUSSTATS/ abs@.nsf/DetailsPage/1270.0.55.005July%202011?OpenDocument 23.,Non-OADS,/arxiv_data1/oa_pdf/e4/30/bmjopen-2016-013266.PMC5168691.pdf
2015. https://www.nice.org.uk/guidance/ng11 2.,Non-OADS,/arxiv_data1/oa_pdf/ee/7f/bmjopen-2016-013116.PMC5168692.pdf
"University of Birmingham, 2006. http://www.ld-medication.bham.ac.uk/ 11.",Non-OADS,/arxiv_data1/oa_pdf/ee/7f/bmjopen-2016-013116.PMC5168692.pdf
"NICE Guideline (CG178), 2014. https://www.nice.org.uk/guidance/cg178 13.",Non-OADS,/arxiv_data1/oa_pdf/ee/7f/bmjopen-2016-013116.PMC5168692.pdf
2015. http://apps.who.int/ classifications/icd10/browse/2015/en#/V14.,OADS,/arxiv_data1/oa_pdf/ee/7f/bmjopen-2016-013116.PMC5168692.pdf
http://www.formic.com/survey-software/ 15.,OADS,/arxiv_data1/oa_pdf/ee/7f/bmjopen-2016-013116.PMC5168692.pdf
PHE publications gateway number:2015105. http://www.improvinghealthandlives.org.uk/securefiles/160131_1129//Psychotropic%20medication%20and%20people%20with%20learning%20disabilities%20or%20autism.pdf 17.,Non-OADS,/arxiv_data1/oa_pdf/ee/7f/bmjopen-2016-013116.PMC5168692.pdf
"Department of Health, 2009. http://www.rcpsych.ac.uk/pdf/Antipsychotic%20Bannerjee%20Report.pdf 21.",Non-OADS,/arxiv_data1/oa_pdf/ee/7f/bmjopen-2016-013116.PMC5168692.pdf
"NICE Guideline (CG185), 2014. https://www.nice.org.uk/guidance/cg185 22.",Non-OADS,/arxiv_data1/oa_pdf/ee/7f/bmjopen-2016-013116.PMC5168692.pdf
2009. https://www.nice.org.uk/guidance/cg178 23.,Non-OADS,/arxiv_data1/oa_pdf/ee/7f/bmjopen-2016-013116.PMC5168692.pdf
"NICE Guideline (NG10), 2015. http://www.nice.",Non-OADS,/arxiv_data1/oa_pdf/ee/7f/bmjopen-2016-013116.PMC5168692.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-012617).,Non-OADS,/arxiv_data1/oa_pdf/3a/bb/bmjopen-2016-012617.PMC5168693.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-012307).,Non-OADS,/arxiv_data1/oa_pdf/da/2e/bmjopen-2016-012307.PMC5168694.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 012255).,Non-OADS,/arxiv_data1/oa_pdf/1d/64/bmjopen-2016-012255.PMC5168695.pdf
2015; http://www.R-project.org/ (accessed 30 Mar 2016)) and apply- ing the appropriate variance stabilising transformations.,Non-OADS,/arxiv_data1/oa_pdf/1d/64/bmjopen-2016-012255.PMC5168695.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/1d/64/bmjopen-2016-012255.PMC5168695.pdf
2015. https://www.idf.org/sites/default/files/EN_6E_Atlas_Full_0.pdf(accessed 07 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/1d/64/bmjopen-2016-012255.PMC5168695.pdf
2015. http://www.who.int/reproductivehealth/topics/infertility/definitions/en/ (accessed 13 Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/1d/64/bmjopen-2016-012255.PMC5168695.pdf
2015. http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/prostate-cancer/incidence 2.,Non-OADS,/arxiv_data1/oa_pdf/d9/13/bmjopen-2016-013555.PMC5168696.pdf
https://www.gov.uk/government/ uploads/system/uploads/attachment_data/file/213789/dh_123138.pdf 25.,Non-OADS,/arxiv_data1/oa_pdf/d9/13/bmjopen-2016-013555.PMC5168696.pdf
"London, 2010. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/213789/dh_123138.pdf, 2013.",Non-OADS,/arxiv_data1/oa_pdf/d9/13/bmjopen-2016-013555.PMC5168696.pdf
"Edinburgh, 2016. http://www.gov.scot/Resource/0049/00496709.pdf 28.",Non-OADS,/arxiv_data1/oa_pdf/d9/13/bmjopen-2016-013555.PMC5168696.pdf
"London: Department of Health, 2013. http://www.ncsi.org.",Non-OADS,/arxiv_data1/oa_pdf/d9/13/bmjopen-2016-013555.PMC5168696.pdf
2013. https://www.quality-health.co.uk/resources/surveys/cancer-survivorship-survey 35. International Consortium for Health Outcomes Measurement (ICHOM).,Non-OADS,/arxiv_data1/oa_pdf/d9/13/bmjopen-2016-013555.PMC5168696.pdf
"Boston, 2014. http://www.ichom.org/medical-conditions/localized-prostate-cancer/ 36.",Non-OADS,/arxiv_data1/oa_pdf/d9/13/bmjopen-2016-013555.PMC5168696.pdf
http://www.crd.york.ac.uk/PROSPERO_REBRANDING/display_record.asp?ID=CRD42015017836 58.,Non-OADS,/arxiv_data1/oa_pdf/d9/13/bmjopen-2016-013555.PMC5168696.pdf
2015. http://www.quality-health.co.uk/surveys/national-cancer-patient-experience-survey 59.,Non-OADS,/arxiv_data1/oa_pdf/d9/13/bmjopen-2016-013555.PMC5168696.pdf
2013. http://www.endoflifecare-intelligence.org.uk/home 60.,Non-OADS,/arxiv_data1/oa_pdf/d9/13/bmjopen-2016-013555.PMC5168696.pdf
2014. http://www.nihr.ac.uk/funding/how-we-can-help-you/RDS-PPI-Handbook-2014-v8-FINAL.pdf 65.,Non-OADS,/arxiv_data1/oa_pdf/d9/13/bmjopen-2016-013555.PMC5168696.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-012299).,Non-OADS,/arxiv_data1/oa_pdf/ea/82/bmjopen-2016-012299.PMC5168697.pdf
Competing interests All authors have completed the ICMJE uniform disclosure form at http://www.icmje.org/coi_disclosure.pdf and declare: SC was supported by NHMRC Career Development Fellowship number 1032963 when this work was completed; they have no financial relationships with any organisations that might have an interest in the submitted work in theprevious 3 years; they have no other relationships or activities that could appear to have influenced the submitted work.,Non-OADS,/arxiv_data1/oa_pdf/42/7d/bmjopen-2016-011932.PMC5168698.pdf
"World Health Organisation, 2012. http://globocan.iarc.fr/ Pages/fact_sheets_cancer.aspx 4.",Non-OADS,/arxiv_data1/oa_pdf/42/7d/bmjopen-2016-011932.PMC5168698.pdf
http://wiki.cancer.org.au/australia/Guidelines:PSA_Testing/Introduction#cite_note-Citation: Australian_Government_Department_of_Health_2014-16 7.,Non-OADS,/arxiv_data1/oa_pdf/42/7d/bmjopen-2016-011932.PMC5168698.pdf
Sydney: Cancer Council Australia.http://wiki.cancer.org.au/australiawiki/index.php?oldid=122816(accessed 24 Nov 2016).,Non-OADS,/arxiv_data1/oa_pdf/42/7d/bmjopen-2016-011932.PMC5168698.pdf
https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=274 28.,OADS,/arxiv_data1/oa_pdf/42/7d/bmjopen-2016-011932.PMC5168698.pdf
"Beck M. Doctors could be penalized for ordering prostate tests: The Wall Street Journal , 2015. http://www.wsj.com/article_email/doctors- could-be-penalized-for-ordering-prostate-tests-1447993920-lMyQjAxMTE1MzI3MDkyNDA1Wj 29.",Non-OADS,/arxiv_data1/oa_pdf/42/7d/bmjopen-2016-011932.PMC5168698.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 013530).,Non-OADS,/arxiv_data1/oa_pdf/57/74/bmjopen-2016-013530.PMC5168699.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 012952).,Non-OADS,/arxiv_data1/oa_pdf/e5/a7/bmjopen-2016-012952.PMC5168701.pdf
16. http://www.eortc.be/qol/files/SCManualQLQ-C30.pdf 17.,Non-OADS,/arxiv_data1/oa_pdf/e5/a7/bmjopen-2016-012952.PMC5168701.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-012194).,Non-OADS,/arxiv_data1/oa_pdf/61/13/bmjopen-2016-012194.PMC5168703.pdf
2007:03. https://database.yomiuri.co.jp/rekishikan/ 4.,OADS,/arxiv_data1/oa_pdf/61/13/bmjopen-2016-012194.PMC5168703.pdf
2015:67. http://www.fdma.go.jp/neuter/ topics/fieldList9_3.html (accessed 23 Mar 2016).,OADS,/arxiv_data1/oa_pdf/61/13/bmjopen-2016-012194.PMC5168703.pdf
http://esa.un.org/unpd/wpp/Publications/ (accessed 19 Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/61/13/bmjopen-2016-012194.PMC5168703.pdf
http://www.stat.go.jp/english/data/jinsui/tsuki/index.htm (accessed 19Jan 2016).,OADS,/arxiv_data1/oa_pdf/61/13/bmjopen-2016-012194.PMC5168703.pdf
http://www8.cao.go.jp/kourei/english/annualreport/2014/2014pdf_e.html (accessed 19 Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/61/13/bmjopen-2016-012194.PMC5168703.pdf
2016. http://www.stat.go.jp/english/data/kokusei/index.htm(accessed 6 Jun 2016).,OADS,/arxiv_data1/oa_pdf/61/13/bmjopen-2016-012194.PMC5168703.pdf
2012. http://www.mhlw.go.jp/english/policy/health-medical/health/index.html (accessed 6 Jun 2016).,Non-OADS,/arxiv_data1/oa_pdf/61/13/bmjopen-2016-012194.PMC5168703.pdf
2015. http://www.e-stat.go.jp/SG1/estat/GL32010201.do?method=searchTop&andKeyword=hospital 17.,Non-OADS,/arxiv_data1/oa_pdf/61/13/bmjopen-2016-012194.PMC5168703.pdf
http://www.mhlw.go.jp/english/policy/health-medical/medical-care/index.html (accessed 25 Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/61/13/bmjopen-2016-012194.PMC5168703.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: COPD StrokePrevalenceMortality 1.,Non-OADS,/arxiv_data1/oa_pdf/7c/0c/main.PMC5168723.pdf
http://dx.doi.org/10.1016/j.ensci.2016.11.007 2405-6502/Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/7c/0c/main.PMC5168723.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7c/0c/main.PMC5168723.pdf
Contents lists available at ScienceDirect eNeurologicalSci journal homepage: http://ees.elsevier.com/ensci/,Non-OADS,/arxiv_data1/oa_pdf/7c/0c/main.PMC5168723.pdf
Available from: http://ucsc.genome.edu  23.,Non-OADS,/arxiv_data1/oa_pdf/03/b4/yjbm_89_4_441.PMC5168824.pdf
Avail - able from: http://genome.ucsc.edu/cgi-  bin/hgTrackui?hgsid=492885615_Yg1tPNyBQ5YaWPbdn  AAZoOA4y03u&c=chr10&g=hub_24125_roadmapCon - solidatedAssaya27004.,OADS,/arxiv_data1/oa_pdf/03/b4/yjbm_89_4_441.PMC5168824.pdf
Available from:  http://www.genecards.org/.,Non-OADS,/arxiv_data1/oa_pdf/03/b4/yjbm_89_4_441.PMC5168824.pdf
"Due to complicated phylogenetic rela - tionships, subfamilies of TEs are not  depicted here; for complete informa - tion, see RepBase online:  http://www.girinst.org/repbase/",Non-OADS,/arxiv_data1/oa_pdf/ba/a0/yjbm_89_4_487.PMC5168827.pdf
MSA was performed  using MUSCLE (http://www.ebi.ac.uk/Tools/msa/muscle/).,OADS,/arxiv_data1/oa_pdf/ba/a0/yjbm_89_4_487.PMC5168827.pdf
"In Figure 1, we identify the fastest evolving compo - nents of the piRNA machinery in a comparison between  D. melanogaster and D. simulans using results provided  from the flyDIVAS database (http://igem.temple.edu/fly - divas/index.html) [81].",OADS,/arxiv_data1/oa_pdf/8e/6b/yjbm_89_4_499.PMC5168828.pdf
"In this analysis, we utilized the Evolutionary Covariation  Rate webserver (http://csb.pitt.edu/erc_analysis/) to de - termine the level of evolutionary covariation of the piRNA  machinery within the 12 well sequenced species of the  Drosophila genus.",OADS,/arxiv_data1/oa_pdf/8e/6b/yjbm_89_4_499.PMC5168828.pdf
Available September 2015 at http://www.nei.nih.gov.,Non-OADS,/arxiv_data1/oa_pdf/76/3c/yjbm_89_4_597.PMC5168835.pdf
Available from: http://www.airwaycam.com/ cricothyrotomy.,Non-OADS,/arxiv_data1/oa_pdf/73/0e/IJA-60-885.PMC5168891.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/73/0e/IJA-60-885.PMC5168891.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/73/0e/IJA-60-885.PMC5168891.pdf
" Eligibility: Best anaesthesia, critical care and pain rela ted original articles  published between October previous year to September of Current year      The publications are assessed  as per the guidelines of the IJA, ICMJE and  Consolidated Standards of Reporting Trials (CONSORT)      For greater chances of winning, please update your self before submitting  articles  at   http://www.ijaweb.org , www.ijaweb .in  http://www.icmje.org                              http://www.consort- statemen t.org      A team of editorial board would decide on the winner!",Non-OADS,/arxiv_data1/oa_pdf/3b/85/IJA-60-906.PMC5168893.pdf
Visit http://www.cjisa.org for details.,Non-OADS,/arxiv_data1/oa_pdf/0f/47/IJA-60-915.PMC5168894.pdf
Visit http://www.njisa.org for details.,Non-OADS,/arxiv_data1/oa_pdf/84/95/IJA-60-958.PMC5168901.pdf
94Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/21/58/IJA-60-965.PMC5168905.pdf
Available from: http://www.aios.org/aioc13abstractbook.pdf.,Non-OADS,/arxiv_data1/oa_pdf/be/d8/IJO-64-715.PMC5168910.pdf
Available from: http://www.apglaucomasociety.,Non-OADS,/arxiv_data1/oa_pdf/be/d8/IJO-64-715.PMC5168910.pdf
"10 authors to submit their work for the AIOC and accept the best  papers most likely to advance our scientific knowledge using  international checklists such as the STROBE, RECORD, and  CONSORT (available at the http://www.equator‑network.org/,  last accessed April 30, 2016).",Non-OADS,/arxiv_data1/oa_pdf/46/92/IJO-64-722.PMC5168911.pdf
Statistical analysis Deviation from the Hardy–Weinberg equilibrium  (HWE)  among the controls was evaluated for each single study  using online calculator named HWE calculator for 2  alleles (http://www.had2know.com).,OADS,/arxiv_data1/oa_pdf/25/92/IJO-64-756.PMC5168918.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Corresponding author:  Gangning Liang     http://orcid.org/0000-0001-8664-922X Department of Urology, Norris Comprehensive Cancer Center, Keck School of  Medicine, University of Southern California, Los Angeles, CA 90089, USA E-mail: gliang@usc.edu / Tel: +1-323-865-0470 / Fax: +1-323-865-0102 *Current Address: DxTerity, Rancho Dominguez, CA 90220, USA Submitted:  October 20, 2016 / Accepted after revision:  October 27, 2016INTRODUCTION Bladder cancer is the fifth most common malignancy in the  United States, with an estimated 76,960 new cases and 16,390  deaths in 2016 [1,2].",Non-OADS,/arxiv_data1/oa_pdf/b0/a4/inj-1632752-376.PMC5169086.pdf
"Keywords:  Epigenetics, Genetic; Urinary Bladder Neoplasms; DNA Methylation; Epigenetic Therapy • Conflict of Interest: No potential conflict of interest relevant to this article was reported.Genetic and Epigenetic Alterations in Bladder Cancer Hong-Tao Li1, Christopher E. Duymich1,*, Daniel J. Weisenberger1,2, Gangning Liang1,3  1Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA 2Department of Biochemistry and Molecular Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA 3Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA https://doi.org/10.5213/inj.1632752.376 pISSN 2093-4777 · eISSN 2093-6931Int Neurourol J 2016;20 Suppl 2:S84-94",Non-OADS,/arxiv_data1/oa_pdf/b0/a4/inj-1632752-376.PMC5169086.pdf
Available from: http://seer.cancer.,Non-OADS,/arxiv_data1/oa_pdf/b0/a4/inj-1632752-376.PMC5169086.pdf
http://doi.org/10.1016/j.eururo.2016.05.041.,OADS,/arxiv_data1/oa_pdf/b0/a4/inj-1632752-376.PMC5169086.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Corresponding author:  Samuel J. Klempner     http://orcid.org/0000-0002-4062-0808 The Angeles Clinic and Research Institute, 11818 Wilshire Blvd, Los Angeles, CA  90025, USA E-mail: sklempner@theangelesclinic.org /  Tel: +1-310-231-2167 / Fax: +1-310-231-2172 Submitted:  September 26, 2016 / Accepted after revision:  October 17, 2016INTRODUCTION Gastric adenocarcinoma (GC) is the fifth most common cancer  in the world, with approximately one million new cases and  730,000 deaths occurring annually [1].",Non-OADS,/arxiv_data1/oa_pdf/a8/97/inj-1632740-370.PMC5169087.pdf
"Phu Tran1, Cham Nguyen2, Samuel J. Klempner3,4  1Division of Hematology-Oncology, University of California Irvine, Orange, CA, USA 2Department of Pharmacy, University of California Irvine, Orange, CA, USA 3The Angeles Clinic and Research Institute, Los Angeles, CA, USA 4Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA https://doi.org/10.5213/inj.1632740.370 pISSN 2093-4777 · eISSN 2093-6931Int Neurourol J 2016;20 Suppl 2:S131-140",Non-OADS,/arxiv_data1/oa_pdf/a8/97/inj-1632740-370.PMC5169087.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Corresponding author:  Liyan Zhuang     http://orcid.org/0000-0003-2258-0176 Department of Urology, Lahey Hospital and Medical Center, Tufts University  School of Medicine, 41 Mall Road, Burlington, MA 01805, USA E-mail: liyanzhuang@yahoo.com / Tel: +1-603-594-0800 / Fax: +1-603-879-9329 Submitted:  September 23, 2016 / Accepted after revision:  October 17, 2016INTRODUCTION Precision medicine is an emerging approach for disease man - agement that focuses on individual variability at the genomic,  transcriptomic, proteomic, and metabolomic levels.",Non-OADS,/arxiv_data1/oa_pdf/6a/9b/inj-1632724-362.PMC5169088.pdf
"Liyan Zhuang1, Matthew T. Johnson2  1Department of Urology, Lahey Hospital and Medical Center, Tufts University School of Medicine, Burlington, MA, USA 2Urology Consultants, Ltd., St. Louis, MO, USA https://doi.org/10.5213/inj.1632724.362 pISSN 2093-4777 · eISSN 2093-6931Int Neurourol J 2016;20 Suppl 2:S120-130",Non-OADS,/arxiv_data1/oa_pdf/6a/9b/inj-1632724-362.PMC5169088.pdf
http://doi.org/10.1097/CEJ.0000000000000248.,Non-OADS,/arxiv_data1/oa_pdf/6a/9b/inj-1632724-362.PMC5169088.pdf
"Jayoung Kim      http://orcid.org/0000-0002-3683-4627 Guest Editor Cedars-Sinai Medical Center, University of California, Los Angeles, CA, USA E-mail: Jayoung.Kim@csmc.edu https://doi.org/10.5213/inj.1620edi007 pISSN 2093-4777 · eISSN 2093-6931Int Neurourol J 2016;20 Suppl 2:S65-67",Non-OADS,/arxiv_data1/oa_pdf/a7/2c/inj-1620edi007.PMC5169089.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Corresponding author:  Ashley Beasley-Green     http://orcid.org/0000-0002-2065-4218 Material Measurement Laboratory, Biomolecular Measurement Division, National  Institute of Standards and Technology, 100 Bureau Drive, MS 8314, Gaithersburg,  MD 20899-8390, USA E-mail: ashley.beasley@nist.gov / Tel: +1-301-975-4026 / Fax: +1-301- 977-0685 Submitted:  September 23, 2016 / Accepted after revision:  October 6, 2016INTRODUCTION The goal of this article is to provide a summary of the advance - ment of urine proteomics in clinical applications with the emer - gence of sophisticated mass spectrometry (MS)-based pro - teomic platforms.",Non-OADS,/arxiv_data1/oa_pdf/da/76/inj-1612720-360.PMC5169090.pdf
"Urine Proteomics in the Era of Mass Spectrometry Ashley Beasley-Green  Material Measurement Laboratory, Biomolecular Measurement Division, National Institute of Standards and Technology, Gaithersburg, MD, USA https://doi.org/10.5213/inj.1612720.360 pISSN 2093-4777 · eISSN 2093-6931Int Neurourol J 2016;20 Suppl 2:S70-75",Non-OADS,/arxiv_data1/oa_pdf/da/76/inj-1612720-360.PMC5169090.pdf
http://doi.org/10.1007/ s12020-016-1091-6 .,Non-OADS,/arxiv_data1/oa_pdf/da/76/inj-1612720-360.PMC5169090.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Corresponding author:  Sang Tae Park     http://orcid.org/0000-0003-0790-7302 Macrogen Clinical Laboratory, Macrogen Corporation, 1330 Piccard Drive, Suite  103, Rockville, MD 20850, USA E-mail: stpark@macrogenlab.com / Tel: +1-301-251-1007 / Fax: +1-301-251-4006 Submitted:  October 12, 2016 / Accepted after revision:  October 18, 2016NGS TECHNOLOGIES AND PLATFORMS Next-generation sequencing (NGS) technologies are methods  that sequence nucleotides faster and cheaper than Sanger se - quencing.",Non-OADS,/arxiv_data1/oa_pdf/3f/c0/inj-1632742-371.PMC5169091.pdf
"Trends in Next-Generation Sequencing and a New Era for Whole  Genome Sequencing Sang Tae Park1, Jayoung Kim2,3  1Macrogen Corporation, Rockville, MD, 2Departments of Surgery and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA,  3Department of Medicine, University of California Los Angeles, Los Angeles, CA, USA https://doi.org/10.5213/inj.1632742.371 pISSN 2093-4777 · eISSN 2093-6931Int Neurourol J 2016;20 Suppl 2:S76-83",Non-OADS,/arxiv_data1/oa_pdf/3f/c0/inj-1632742-371.PMC5169091.pdf
Available from:  https://www.thermofisher.com/us/en/home/life-science/sequenc - ing/next-generation-sequencing/ion-torrent-next-generation-se - quencing-workflow/ion-torrent-next-generation-sequencing-run- sequence/ion-proton-system-for-next-generation-sequencing/ion- proton-system-specifications.html.,Non-OADS,/arxiv_data1/oa_pdf/3f/c0/inj-1632742-371.PMC5169091.pdf
Available from: http://www.illu - mina.com/systems/hiseq-x-sequencing-system/performance-spec - ifications.html.,OADS,/arxiv_data1/oa_pdf/3f/c0/inj-1632742-371.PMC5169091.pdf
Avail - able from: https://www.genome.gov/sequencingcostsdata/.,OADS,/arxiv_data1/oa_pdf/3f/c0/inj-1632742-371.PMC5169091.pdf
Available from:  http://www.pacb.com/products-and-services/pacbio-systems/rsii/.,OADS,/arxiv_data1/oa_pdf/3f/c0/inj-1632742-371.PMC5169091.pdf
Available from:  http://www.ncbi.nlm.nih.gov/genbank/.,Non-OADS,/arxiv_data1/oa_pdf/3f/c0/inj-1632742-371.PMC5169091.pdf
Available from: http://useast.ensembl.org/ index.html.,OADS,/arxiv_data1/oa_pdf/3f/c0/inj-1632742-371.PMC5169091.pdf
Available from: https://www.nhlbi.nih.gov/ research/resources/nhlbi-precision-medicine-initiative/topmed.,Non-OADS,/arxiv_data1/oa_pdf/3f/c0/inj-1632742-371.PMC5169091.pdf
Available from: https://www.genomic - sengland.co.uk/the-100000-genomes-project/.,Non-OADS,/arxiv_data1/oa_pdf/3f/c0/inj-1632742-371.PMC5169091.pdf
Available from: http://www.genomeasia100k.com/.,Non-OADS,/arxiv_data1/oa_pdf/3f/c0/inj-1632742-371.PMC5169091.pdf
Available from: https://www.genomeweb.com/molec - ular-diagnostics/white-house-announces-efforts-accelerate-preci - sion-medicine-initiative.,Non-OADS,/arxiv_data1/oa_pdf/3f/c0/inj-1632742-371.PMC5169091.pdf
Available from: http://www.pacb.com/litera - ture/case-study-assembling-high-quality-human-genomes-be - yond-the-%C2%911000-genome%C2%92/.,Non-OADS,/arxiv_data1/oa_pdf/3f/c0/inj-1632742-371.PMC5169091.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Corresponding author:  Kyung Jin Chung     http://orcid.org/0000-0003-0153-7814 Department of Urology, Gachon University Gil Medical Center, Gachon University  School of Medicine, 21 Namdong-daero 774beon-gil, Namdong-gu, Incheon  21565, Korea E-mail: Kjchung@gilhospital.com / Tel: +82-32-460-3334 / Fax: +82-32-460-8414 Submitted:  October 3, 2016 / Accepted after revision:  November 4, 2016Original Article Volume 19 | Number 2 | June 2015   pages 131-210 INJ INTERNATIONAL  NEUROUROLOGY JOURNAL Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNAL Purpose:  Overactive bladder (OAB) causes urinary urgency, usually accompanied by frequency and nocturia.",Non-OADS,/arxiv_data1/oa_pdf/35/3c/inj-1632768-384.PMC5169092.pdf
"• Conflict of Interest: No potential conflict of interest relevant to this article was reported.Effects of Combination Treatment of Alpha 1-Adrenergic  Receptor Antagonists on Voiding Dysfunction: Study on Target  Organs in Overactive Bladder Rats  Il Gyu Ko1, Bo Min Moon2, Sung Eun Kim1, Jun Jang Jin1, Lakkyong Hwang1, Eun Sang Ji1, Chang Ju Kim1, Tai Hyung Kim3,  Hyun Hee Choi4, Kyung Jin Chung2  1Department of Physiology, College of Medicine, Kyung Hee University, Seoul, Korea 2Department of Urology, Gachon University Gil Medical Center, Gachon University School of Medicine, Incheon, Korea 3Graduate School of Technology Management, Kyung Hee University, Y ongin, Korea 4Division of Leisure & Sports Science, Department of Exercise Prescription, Dongseo University, Busan, Korea https://doi.org/10.5213/inj.1632768.384 pISSN 2093-4777 · eISSN 2093-6931Int Neurourol J 2016;20 Suppl 2:S150-158",Non-OADS,/arxiv_data1/oa_pdf/35/3c/inj-1632768-384.PMC5169092.pdf
"Effects  of tamsulosin on urinary bladder function and neuronal activity in Editorial Volume 19 | Number 2 | June 2015   pages 131-210 INJ INTERNATIONAL  NEUROUROLOGY JOURNAL Official Journal of  Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence  and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web pISSN 2093-4777 eISSN 2093-6931 INTERNATIONAL  NEUROUROLOGY  JOURNAL New Attempts to Overcome the Urinary Tract Disorders Khae Hawn Kim      http://orcid.org/0000-0002-7045-8004 Department of Urology, Gachon University Gil Hospital, Gachon University of Medicine and Science, Incheon, Korea E-mail: kimcho99@gilhospital.com https://doi.org/10.5213/inj.1620edi008 pISSN 2093-4777 · eISSN 2093-6931Int Neurourol J 2016;20 Suppl 2:S68-69",Non-OADS,/arxiv_data1/oa_pdf/c8/ca/inj-1620edi008.PMC5169093.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Corresponding author:  Jong Y Park     http://orcid.org/0000-0002-6384-6447 Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and  Research Institute, Tampa, FL 33612, USA   E-mail: jong.park@moffitt.org / Tel: +1-813-745-1703 / Fax: +1-813-745-1720 Submitted:  September 23, 2016 / Accepted after revision:  October 14, 2016INTRODUCTION Prostate cancer (PCa), the most common malignancy in adult  men, is the second most common cancer and the fifth-highest  cause of cancer mortality in the United States (US).",Non-OADS,/arxiv_data1/oa_pdf/4a/b1/inj-1632722-361.PMC5169094.pdf
"Park2  1Department of Pharmacy, Federal University of Sergipe, Brazil 2Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA https://doi.org/10.5213/inj.1632722.361 pISSN 2093-4777 · eISSN 2093-6931Int Neurourol J 2016;20 Seppl 2:S112-119",Non-OADS,/arxiv_data1/oa_pdf/4a/b1/inj-1632722-361.PMC5169094.pdf
Available from:  https://cancerstatisticscenter.cancer.org/#/.,Non-OADS,/arxiv_data1/oa_pdf/4a/b1/inj-1632722-361.PMC5169094.pdf
Available from: http://www.nccn.,Non-OADS,/arxiv_data1/oa_pdf/4a/b1/inj-1632722-361.PMC5169094.pdf
Available from: http://www.cdc.gov/ cancer/prostate/statistics/race.htm.,Non-OADS,/arxiv_data1/oa_pdf/4a/b1/inj-1632722-361.PMC5169094.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Corresponding author:  Akihiro Kanematsu     http://orcid.org/0000-0002-0669-8986 Department of Urology, Hyogo College of Medicine, Mukogawacho,  Nishinomiya, Hyogo 663-8501, Japan  E-mail: aqui@hyo-med.ac.jp / Tel: +81-798-45-6366 / Fax: +81-798-45-6368 Submitted:  September 24, 2016 / Accepted after revision:  October 17, 2016INTRODUCTION Pediatric lower urinary tract dysfunction (LUTD) involves a  broad spectrum of conditions.",Non-OADS,/arxiv_data1/oa_pdf/6b/fd/inj-1632726-363.PMC5169095.pdf
"Translational Research for Pediatric Lower Urinary Tract Dysfunction Akihiro Kanematsu  Department of Urology, Hyogo College of Medicine, Nishinomiya, Japan https://doi.org/10.5213/inj.1632726.363 pISSN 2093-4777 · eISSN 2093-6931Int Neurourol J 2016;20 Suppl 2:S105-111",Non-OADS,/arxiv_data1/oa_pdf/6b/fd/inj-1632726-363.PMC5169095.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Corresponding author:  Oh Y oung Kwon     http://orcid.org/0000-0003-0817-2256 Department of Medical Education and Medical Humanities, College of Medicine,  Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Korea E-mail: koy0004@hotmail.com / Tel: +82-2-961-9102 / Fax: +82-2-961-9573  * Dong Sup Hwang and Hyo Bum Kwak contributed equally to this study as co-first authors.",Non-OADS,/arxiv_data1/oa_pdf/fa/27/inj-1632738-369.PMC5169096.pdf
"• Conflict of Interest: No potential conflict of interest relevant to this article was reported.Treadmill Exercise Improves Memory Function Depending on  Circadian Rhythm Changes in Mice Dong Sup Hwang1,*, Hyo Bum Kwak2,*, Il Gyu Ko1, Sung Eun Kim1, Jun Jang Jin1, Eun Sang Ji1, Hyun Hee Choi3, Oh Y oung Kwon4 1Department of Physiology, College of Medicine, Kyung Hee University, Seoul, Korea 2Department of Kinesiology, Inha University, Incheon, Korea 3Division of Leisure & Sports Science, Department of Exercise Prescription, Dongseo University, Busan, Korea 4Department of Medical Education and Medical Humanities, College of Medicine, Kyung Hee University, Seoul, Korea https://doi.org/10.5213/inj.1632738.369 pISSN 2093-4777 · eISSN 2093-6931Int Neurourol J 2016;20 Suppl 2:S141-149",Non-OADS,/arxiv_data1/oa_pdf/fa/27/inj-1632738-369.PMC5169096.pdf
"www.einj.org Copyright © 2016 Korean Continence SocietyThis is an Open Access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial License (http://creative - commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distri - bution, and reproduction in any medium, provided the original work is properly cited.Corresponding author:  Hann-Chorng Kuo     http://orcid.org/0000-0001-7165-4771 Department of Urology, Buddhist Tzu Chi General Hospital, 707, Section 3, Chung  Y ang Road, Hualien, Taiwan E-mail: hck@tzuchi.com.tw / Tel: +886-3-8561825, ext.",Non-OADS,/arxiv_data1/oa_pdf/cd/e4/inj-1632712-356.PMC5169097.pdf
"Keywords:  Lower Urinary Tract Symptoms; Cystitis; Bladder Pain; Biomarkers; Urotheliuim • Conflict of Interest: No potential conflict of interest relevant to this article was reported.Pathomechanism of Interstitial Cystitis/Bladder Pain Syndrome  and Mapping the Heterogeneity of Disease Jia-Fong Jhang, Hann-Chorng Kuo  Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan https://doi.org/10.5213/inj.1632712.356 pISSN 2093-4777 · eISSN 2093-6931Int Neurourol J 2016;20 Suppl 2:S95-104",Non-OADS,/arxiv_data1/oa_pdf/cd/e4/inj-1632712-356.PMC5169097.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licens - es/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9a/ed/ofw234.PMC5170490.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/57/2f/ofw217.PMC5170492.pdf
2012; Available at: http://www.wwarn.org/tools-resources/toolkit/ana- lyse/parasite-clearance-estimator-pce .,OADS,/arxiv_data1/oa_pdf/57/2f/ofw217.PMC5170492.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licens- es/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in  any medium, provided the original work is not altered or transformed in any way, and that the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/48/50/ofw232.PMC5170494.pdf
2016. http://www.cdc.gov/nhsn/PDFs/pscManual/17pscNosInfDef_current.pdf.,OADS,/arxiv_data1/oa_pdf/48/50/ofw232.PMC5170494.pdf
http://www.idsociety.org/IDSA_Practice_Guidelines/.,Non-OADS,/arxiv_data1/oa_pdf/48/50/ofw232.PMC5170494.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licens - es/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/49/f2/ofw233.PMC5170495.pdf
All sequences were checked for quality assurance analysis using the HIVdb Program (http://sierra2.stanford.edu/sierra/serv- let/JSierra) before further analyses.,OADS,/arxiv_data1/oa_pdf/49/f2/ofw233.PMC5170495.pdf
Available at:  http://sgreport.unaids.org/pdf/20160423_SGreport_HLM_en.pdf .,Non-OADS,/arxiv_data1/oa_pdf/49/f2/ofw233.PMC5170495.pdf
Available at: http://www.unaids.org/sites/default/files/media_asset/JC2686_W AD2014report_ en.pdf .,Non-OADS,/arxiv_data1/oa_pdf/49/f2/ofw233.PMC5170495.pdf
Available at: http://www.unaids.org/sites/default/ files/media_asset/global-AIDS-update-2016_en.pdf .,Non-OADS,/arxiv_data1/oa_pdf/49/f2/ofw233.PMC5170495.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licens - es/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/57/fb/ofw214.PMC5170496.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attri-bution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/),  which permits non-commercial reproduction and distribution of the work, in anymedium, pro- vided the original work is not altered or transformed in any way, and that the work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/c5/37/ofw228.PMC5170497.pdf
Available at: https://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadoles- centgl.pdf .,Non-OADS,/arxiv_data1/oa_pdf/c5/37/ofw228.PMC5170497.pdf
Available at: http://www.hcsp.fr/Explore.cgi/AvisRapports.,Non-OADS,/arxiv_data1/oa_pdf/c5/37/ofw228.PMC5170497.pdf
[Epibac] Available at: http://www.invs.sante.fr/Dossiers-thematiques/Maladies-infectieuses/Maladies-a-prevention- vaccinale/Infections-invasives-d-origine-bacterienne-Reseau-EPIBAC/Bulletin-du-reseau-de-surveillance-des-infections-invasives-bacteriennes.,Non-OADS,/arxiv_data1/oa_pdf/c5/37/ofw228.PMC5170497.pdf
"[Prise en Charge Médicale des PVVIH, Recommandations du Groupe d’Expert] Available at: http://www.sante.gouv.fr/IMG/pdf/Rapport_ Morlat_2013_Mise_en_ligne.pdf .",Non-OADS,/arxiv_data1/oa_pdf/c5/37/ofw228.PMC5170497.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/d1/5c/3687.PMC5170552.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/40/c0/3695.PMC5170553.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/e6/14/3705.PMC5170554.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/29/3d/3717.PMC5170555.pdf
We obtained the  CDSes from ftp://ftp.sanger.ac.uk/pub2/wormbase/releases/WS245/   species/c_elegans/PRJNA13758/c_elegans.PRJNA13758.WS245   .mRNA_transcripts.fa.gz  and ftp://ftp.sanger.ac.uk/pub2/wormbase   /releases/WS245/species/c_elegans/PRJNA13758/c_elegans   .PRJNA13758.WS245.ncRNA_transcripts.fa.gz .,OADS,/arxiv_data1/oa_pdf/29/3d/3717.PMC5170555.pdf
Two months after publication  it is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/8a/26/3729.PMC5170556.pdf
"The  partial specific volume was set to 0.73 ml/g for all measurements,  and the solvent density and viscosity of the buffers used were calcu - lated using SEDNTERP (http://bitcwiki.sr.unh.edu).",OADS,/arxiv_data1/oa_pdf/8a/26/3729.PMC5170556.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/45/50/3746.PMC5170557.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0 Un - ported Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/b8/67/3757.PMC5170558.pdf
Two months after publica - tion it is available to the public under an Attribution–Noncommercial–Share Alike  3.0 Unported Creative Commons License (http://creativecommons.org/licenses/ by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/d3/10/3771.PMC5170559.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/8b/b2/3780.PMC5170560.pdf
https://www.ncbi.nlm.nih.gov/ books/NBK1325/ .,Non-OADS,/arxiv_data1/oa_pdf/8b/b2/3780.PMC5170560.pdf
http://doi.org/10.5281/   zenodo.44678 .,Non-OADS,/arxiv_data1/oa_pdf/8b/b2/3780.PMC5170560.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/04/96/ndt-12-3243.PMC5170599.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 3243–3247Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  3243OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S11875 9 association between the high-dose use of  benzodiazepines and rehospitalization in patients  with schizophrenia: a 2-year naturalistic study Yukika Takita1 Y oshikazu Takaesu1 Kotaro Ono1 Kunihiro Futenma1 akiyoshi shimura1 akiko Murakoshi1 Y oko Komada2 Yuichi inoue1,2 Takeshi inoue1 1Department of Psychiatry,   2Department of somnology, Tokyo  Medical University, T okyo, JapanBackground:  High-dose use of benzodiazepines (BZPs) reportedly causes adverse effects on  cognitive function and quality of life in patients with schizophrenia.",Non-OADS,/arxiv_data1/oa_pdf/04/96/ndt-12-3243.PMC5170599.pdf
jp Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Takita et al Running head recto: Association between BZPs and rehospitalization in schizophrenia patients DOI: http://dx.doi.org/10.2147/NDT.S118759,Non-OADS,/arxiv_data1/oa_pdf/04/96/ndt-12-3243.PMC5170599.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/04/96/ndt-12-3243.PMC5170599.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/04/96/ndt-12-3243.PMC5170599.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/17/5d/imcrj-9-389.PMC5170600.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/17/5d/imcrj-9-389.PMC5170600.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Medical Case Reports Journal 2016:9 389–389International Medical Case Reports Journal Dovepress submit your manuscript | www.dovepress.com Dovepress International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/international-medical-case-reports-journal-journalThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/17/5d/imcrj-9-389.PMC5170600.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 389 CORRIGENDUM open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IMCRJ.S123214Retropupillary iris claw intraocular lens implantation in aphakia for  dislocated intraocular lens [Corrigendum] Faria MY , Ferreira NP , Pinto JM.",Non-OADS,/arxiv_data1/oa_pdf/17/5d/imcrj-9-389.PMC5170600.pdf
The incorrect author list was: Mun Yueh Faria1–3 Nuno Pinto Ferreira1–3 Joana Medeiros Pinto1–3 David Cordeiro Sousa1–3 Ines Leal1–3 Eliana Neto1–3 Carlos Marques-Neves1–3 The correct author list should have been: Mun Yueh Faria1–3 Nuno Pinto Ferreira1–3 Joana Medeiros Pinto1–3 Ivo Gama1–3 David Cordeiro Sousa1–3 Ines Leal1–3 Eliana Neto1–3 Carlos Marques-Neves1–3Journal name: International Medical Case Reports Journal Article Designation: CORRIGENDUMY ear: 2016V olume: 9Running head verso: Faria et alRunning head recto: Short TitleDOI: http://dx.doi.org/10.2147/IMCRJ.S123214,Non-OADS,/arxiv_data1/oa_pdf/17/5d/imcrj-9-389.PMC5170600.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/65/a9/jir-9-231.PMC5170601.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/65/a9/jir-9-231.PMC5170601.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Inflammation Research 2016:9 231–240Journal of Inflammation Research Dovepress submit your manuscript | www.dovepress.com Dovepress 231 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JIR.S121994 Activation, homing, and role of the mesenchymal  stem cells in the inflammatory environment Lukáš Zachar Darina Bačenková Ján Rosocha Associated Tissue Bank of Faculty  of Medicine of P .",Non-OADS,/arxiv_data1/oa_pdf/65/a9/jir-9-231.PMC5170601.pdf
"8Correspondence: Lukáš Zachar Associated Tissue Bank of Faculty of Medicine of P. J. Šafárik University and University Hospital of L. Pasteur, Trieda SNP 1, Košice 040 11, Slovak RepublicEmail lukas.zachar@upjs.skJournal name: Journal of Inflammation Research Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Zachar et alRunning head recto: Role of the activated MSCs in the inflammatory environmentDOI: http://dx.doi.org/10.2147/JIR.S121994",Non-OADS,/arxiv_data1/oa_pdf/65/a9/jir-9-231.PMC5170601.pdf
"Journal of Inflammation Research 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Inflammation Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-inflammation-research-journalThe Journal of Inflammation Research is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings on the molecular basis, cell biology and pharmacology of inflammation including original research, reviews, symposium reports, hypothesis for - mation and commentaries on: acute/chronic inflammation; mediators of inflammation; cellular processes; molecular mechanisms; pharmacology and novel anti-inflammatory drugs; clinical conditions involving inflam-mation.",Non-OADS,/arxiv_data1/oa_pdf/65/a9/jir-9-231.PMC5170601.pdf
Visit http://www.dove   press.com/testimonials.php to read real quotes from published authors.Dovepress 240 Zachar et al  86.,Non-OADS,/arxiv_data1/oa_pdf/65/a9/jir-9-231.PMC5170601.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/44/4e/mder-9-429.PMC5170602.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/44/4e/mder-9-429.PMC5170602.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Medical Devices: Evidence and Research 2016:9 429–439Medical Devices: Evidence and Research Dovepress submit your manuscript | www.dovepress.com Dovepress 429 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S116633 In situ gelation properties of a collagen–genipin  sol with a potential for the treatment of  gastrointestinal ulcers Takefumi Narita1  Shunji Yunoki1  Y oshimi Ohyabu1  Naohisa Yahagi2  T oshio Uraoka3 1Biotechnology Group, T okyo  Metropolitan Industrial T echnology  Research Institute, Koto-ku, 2Division  of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine, Shinjuku-ku,  3Department of  Gastroenterology, National Hospital Organization T okyo Medical Center,  Meguro-ku, T okyo, JapanAbstract:  We investigated the potential of collagen–genipin sols as biomaterials for treating  artificial ulcers following endoscopic submucosal dissection.",Non-OADS,/arxiv_data1/oa_pdf/44/4e/mder-9-429.PMC5170602.pdf
"Tissue-engineered cell sheets have been proposed for prophylactic treatments of  intractable cancers.10,11 In these studies, tissue-engineered autologous oral mucosal Correspondence: Takefumi Narita   Biotechnology Group, Tokyo  Metropolitan Industrial Technology Research Institute, 2-4-10 Aomi, Koto-ku, Tokyo 135-0064, Japan   Tel +81 3 5530 2671   Fax +81 3 5530 2629   Email narita.takefumi@iri-tokyo.jpJournal name: Medical Devices: Evidence and Research Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Narita et alRunning head recto: Collagen–genipin sol for treating gastrointestinal ulcersDOI: http://dx.doi.org/10.2147/MDER.S116633",Non-OADS,/arxiv_data1/oa_pdf/44/4e/mder-9-429.PMC5170602.pdf
"Medical Devices: Evidence and Research 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/medical-devices-evidence-and-research-journalMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology, research, and expert opinion supporting the use and application of   medical devices in the diagnosis, monitoring, treatment and management of clinical conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/44/4e/mder-9-429.PMC5170602.pdf
Two months after publication  it is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/9e/b7/3791.PMC5170603.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unport - ed Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/c1/70/3800.PMC5170604.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/b9/bb/3813.PMC5170605.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/96/53/3828.PMC5170606.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0 Un - ported Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/5c/31/3841.PMC5170607.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/fe/e2/3855.PMC5170608.pdf
"More importantly, searches in the KEGG database (www.genome.jp/ kegg) showed that SMA-5 orthologues are conserved throughout the (https://transgeneome.mpi-cbg.de/transgeneomics/index.html).",OADS,/arxiv_data1/oa_pdf/fe/e2/3855.PMC5170608.pdf
Protein domain anal - ysis using the SMART-server (http://smart.embl-heidelberg.de)  identified SMA-5 as a serine–threonine kinase with a typical cata - lytic domain located between amino acids 81 and 388 in isoform a.,Non-OADS,/arxiv_data1/oa_pdf/fe/e2/3855.PMC5170608.pdf
", 2006; Transgene Ome  Project, https://transgeneome.mpi-cbg   .de/transgeneomics/index.html).",Non-OADS,/arxiv_data1/oa_pdf/fe/e2/3855.PMC5170608.pdf
Two months after publica - tion it is available to the public under an Attribution–Noncommercial–Share Alike  3.0 Unported Creative Commons License (http://creativecommons.org/licenses/ by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/cb/17/3869.PMC5170609.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0 Un - ported Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/4e/ce/3883.PMC5170610.pdf
Target sequences for ATP9A  gene were designed using the CRISPR  Design Tool from the Zhang lab (http://crispr.mit.edu).,OADS,/arxiv_data1/oa_pdf/4e/ce/3883.PMC5170610.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/c9/fc/3894.PMC5170611.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Un - ported Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/72/eb/3903.PMC5170612.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/77/ac/3913.PMC5170613.pdf
Two months after publication  it is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by- nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/90/3e/3926.PMC5170614.pdf
Two months after publi - cation it is available to the public under an Attribution–Noncommercial–Share  Alike 3.0 Unported Creative Commons License (http://creativecommons.org/   licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/30/da/3937.PMC5170615.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9b/1e/dddt-10-4073.PMC5170616.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 4073–4078Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4073LeTTeropen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S11708 0 Efficacy and safety of iron-chelation therapy  with deferoxamine, deferiprone, and deferasirox  for the treatment of iron-loaded patients with  nontransfusion-dependent thalassemia syndromes Ali T Taher1 John B Porter2 Antonis Kattamis3 Vip Viprakasit4 M Domenica Cappellini5 1Department of Internal Medicine,   American University of Beirut,   Beirut, Lebanon; 2Department  of Haematology, University  College London, London, UK;   3First Department of Pediatrics,   University of Athens, Athens, Greece;   4Department of Pediatrics and  Thalassemia Center, Siriraj Hospital,   Mahidol University, Bangkok, Thailand;   5Department of Internal Medicine,   Università di Milano, Ca Granda  Foundation IrCCS,  Milan, ItalyDear editor As the scientific steering committee for THALASSA (an assessment of Exjade in  nontransfusion-dependent thalassemia [NTDT]), we read with interest the review by  Kontoghiorghe and Kontoghiorghes entitled “Efficacy and safety of iron-chelation  therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded  patients with non-transfusion-dependent thalassemia syndromes” published in January  2016.1 While this review provides a detailed overview of available iron chelators for  the treatment of NTDT patients, there remain some factual inaccuracies and misrepre - sentations of data related to deferasirox.",Non-OADS,/arxiv_data1/oa_pdf/9b/1e/dddt-10-4073.PMC5170616.pdf
"These data were neither  discussed nor cited.Correspondence: Ali T Taher Department of Internal Medicine,  American University of Beirut, riad el  Solh 1107 2020, Beirut, Lebanon email ataher@aub.edu.l bJournal name: Drug Design, Development and Therapy Article Designation: Letter Y ear: 2016 Volume: 10 Running head verso: Taher et al Running head recto: Efficacy and safety of iron chelation therapy in NTDT DOI: http://dx.doi.org/10.2147/DDDT.S117080",Non-OADS,/arxiv_data1/oa_pdf/9b/1e/dddt-10-4073.PMC5170616.pdf
"Available from: https://www.fbi.gov/newyork/press-releases/2015/ manhattan-u.s.-attorney-announces-60-million-civil-fraud-settlement- with-accredo-health-group-over-kickback-scheme-involving-prescrip - tion-dru g. Accessed August 4, 2016.",Non-OADS,/arxiv_data1/oa_pdf/9b/1e/dddt-10-4073.PMC5170616.pdf
Available from: http://www.lexisnexis.,Non-OADS,/arxiv_data1/oa_pdf/9b/1e/dddt-10-4073.PMC5170616.pdf
"Available from: http://www.accessdata.fda.gov/drugsatfda_docs/ label/2010/021882s010lbl.pd f. Accessed August 4, 2016.",Non-OADS,/arxiv_data1/oa_pdf/9b/1e/dddt-10-4073.PMC5170616.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/9b/1e/dddt-10-4073.PMC5170616.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/1e/dddt-10-4073.PMC5170616.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c1/8d/dddt-10-4079.PMC5170617.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 4079–4089Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4079Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11720 7 Protective effects of vitamin c and vitamin e   against hysterosalpingography-induced epithelial  degeneration and proliferation in rat endometrium Şehmus Pala1 remzi atilgan1 T uncay Kulog ˘lu2 Murat Kara3 Melike Başpinar1 Behzat can1 Gökhan Artaş4 1Department of Obstetrics and  gynecology, 2Department of  histology and embriology, Firat  University school of Medicine, elazig,   3Department of Medical Biology  and Genetics, Mug ˘la Sıtkı Koçman  University school of Medicine,   Mug ˘la, 4Department of Pathology,   Firat University school of Medicine,   elazig, T urkeyAim:  The aim of this study was to examine the protective effects of vitamin C (VC) and  vitamin  E (VE) against hysterosalpingography (HSG)-induced epithelial degeneration and  proliferation in rat endometrium.",Non-OADS,/arxiv_data1/oa_pdf/c1/8d/dddt-10-4079.PMC5170617.pdf
"Radiation damage is caused by either a direct correspondence: remzi atilgan Department of Obstetrics and  gynecology, Firat University school  of Medicine, University street,  Yunus emre Boulevard, number 20,  elazig 23100, Turkey Tel +90 53 3629 5981 email remzi_atilgan@hotmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Pala et al Running head recto: The antioxidant vitamins and HSG DOI: http://dx.doi.org/10.2147/DDDT.S117207",Non-OADS,/arxiv_data1/oa_pdf/c1/8d/dddt-10-4079.PMC5170617.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/c1/8d/dddt-10-4079.PMC5170617.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/8d/dddt-10-4079.PMC5170617.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/09/af/ndt-12-3221.PMC5170618.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 3221–3236Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  3221OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12536 7 Efficacy and tolerability of topiramate-augmentation  therapy for schizophrenia: a systematic review and  meta-analysis of randomized controlled trials Yuji Okuyama* Kazuto Oya* Shinji Matsunaga Taro Kishi Nakao iwata Department of Psychiatry, Fujita  health University school of Medicine,   T oyoake, Japan *These authors contributed equally  to this workAbstract:  This study aimed to perform a comprehensive meta-analysis of topiramate-augmen- tation therapy in patients with schizophrenia receiving antipsychotic agents.",Non-OADS,/arxiv_data1/oa_pdf/09/af/ndt-12-3221.PMC5170618.pdf
"Of those patients, one in six failed  to recover fully and one in ten committed suicide.2 A previous meta-analysis that  compared relapse rates between antipsychotic and placebo groups at 7–12 months  found that antipsychotics significantly reduced relapse rates at 1 year over placebo,  measured by the number needed to treat to benefit, which was three.3 Nonethe - less, it appears difficult to maintain drug adherence by outpatients, which leads to  relapse and readmission to hospital.4 In an anonymous online-survey study (n =113),  patients with schizophrenia reported discontinuing medication for the following correspondence: Taro Kishi Department of Psychiatry, Fujita  health University school of Medicine,  1-98 Dengakugakubo, Kutsukake-cho,  Toyoake, Aichi 470-1192, Japan Tel +81 562 939 250 Fax +81 562 931 831 email tarok@fujita-hu.ac.j p Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Okuyama et al Running head recto: Topiramate for schizophrenia DOI: http://dx.doi.org/10.2147/NDT.S125367",Non-OADS,/arxiv_data1/oa_pdf/09/af/ndt-12-3221.PMC5170618.pdf
Available at: http://cdmd.cnki.com.cn/Article/CDMD-10631- 2008176780.htm.dissertatio n.  27.,Non-OADS,/arxiv_data1/oa_pdf/09/af/ndt-12-3221.PMC5170618.pdf
Available at: http://cdmd.cnki.com.cn/Article/CDMD-10631- 2008176780.htm.dissertatio n.,Non-OADS,/arxiv_data1/oa_pdf/09/af/ndt-12-3221.PMC5170618.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/09/af/ndt-12-3221.PMC5170618.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/09/af/ndt-12-3221.PMC5170618.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/27/22/dddt-10-4091.PMC5170619.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 4091–4100Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4091Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11845 7 structure-based virtual screening and  characterization of a novel il-6 antagonistic  compound from synthetic compound database Jing Wang1,* chunxia Qiao1,* he Xiao1 Zhou lin1 Yan li1 Jiyan Zhang1 Beifen shen1 Tinghuan Fu2 Jiannan Feng1 1Department of Molecular  immunology, Beijing institute of Basic  Medical sciences, 2First affiliated  hospital of P la general hospital,   Beijing, People’s republic of china *These authors contributed equally  to this workAbstract:  According to the three-dimensional (3D) complex structure of (hIL-6 ⋅hIL-6R ⋅gp  130)2 and the binding orientation of hIL-6, three compounds with high affinity to hIL-6R and  bioactivity to block hIL-6 in vitro were screened theoretically from the chemical databases,  including 3D-Available Chemicals Directory (ACD) and MDL Drug Data Report (MDDR), by  means of the computer-guided virtual screening method.",Non-OADS,/arxiv_data1/oa_pdf/27/22/dddt-10-4091.PMC5170619.pdf
"D1 on the N-terminus correspondence: Tinghuan Fu; Jiannan  Feng Department of Molecular immunology,  Beijing institute of Basic Medical sciences,   Taiping road #27, Beijing 100850,  People’s republic of china   Tel/fax +86 10 6815 9436   email f utinghuan@hotmail.co m;  fengjiannan1970@qq.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Wang et al Running head recto: A novel IL-6 antagonistic compound from synthetic compound database DOI: http://dx.doi.org/10.2147/DDDT.S118457",Non-OADS,/arxiv_data1/oa_pdf/27/22/dddt-10-4091.PMC5170619.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/27/22/dddt-10-4091.PMC5170619.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/27/22/dddt-10-4091.PMC5170619.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d5/f2/ijwh-8-731.PMC5170621.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2016:8 731–742International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  731OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S11975 7 searching for sex- and gender-sensitive tuberculosis  research in public health: finding a needle in a  haystack Bilkis Vissandjee1 assia Mourid2 christina a greenaway3 Wendy e short4 Jodi a Proctor5 1Faculty of nursing, Public Health  research Institute, Université de  Montréal, Montréal, Montréal, Qc ,   canada; 2allied Health library,   Université de Montréal, Montréal,   Qc, canada; 3Department of  Medicine, Mcgill University, Division  of Infectious Diseases, Jewish general  Hospital, Montréal, Qc , canada;   4Faculty of Humanities and social  sciences, school of social sciences,   University of Queensland, st lucia,   QlD, australia; 5school of social  Work, Mcgill University, Montréal,   Qc, canadaAbstract:  Despite broadening consideration of sex- and gender-based issues in health research,  when seeking information on how sex and gender contribute to disease contexts for specific  health or public health topics, a lack of consistent or systematic use of terminology in health  literature means that it remains difficult to identify research with a sex or gender focus.",Non-OADS,/arxiv_data1/oa_pdf/d5/f2/ijwh-8-731.PMC5170621.pdf
"Keywords:  sex, gender, tuberculosis, literature search, indexing, databases, terminological  accuracy, keywords search Introduction It is well documented that different social notions of sex and gender mean that different  individuals are impacted (positively or detrimentally) and experience varied vulner - abilities, symptoms, and responses to particular disease conditions and treatments.1–3  Today, multinational groups such as the World Health Organization (WHO) advocate  that good public health science accounts for social determinants of health such as sex  and gender whenever possible.4 Johnson et al5 recommended that “all health fields and  disciplines incorporate sex and gender as a matter of ethics and science”, that is, that  researchers should always critically consider the influence of sex and gender on health correspondence: Bilkis Vissandjee Faculty of nursing, Université de  Montréal, PO Box 6128, station centre- Ville, Montréal, Qc H3c 3J7, canada Tel +1 514 343 6837 email bilkis.vissandjee@umontreal.c a Journal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2016 Volume: 8 Running head verso: Vissandjee et al Running head recto: Searching for sex and gender in health databases DOI: http://dx.doi.org/10.2147/IJWH.S119757",Non-OADS,/arxiv_data1/oa_pdf/d5/f2/ijwh-8-731.PMC5170621.pdf
Avail - able from: http://www.who.int/tb/publications/global_report/en/(2014a ).,Non-OADS,/arxiv_data1/oa_pdf/d5/f2/ijwh-8-731.PMC5170621.pdf
"Available from: http://www.phac- aspc.gc.c a/cphorsphc-respcacsp/2012/chap-4-eng.ph p. Accessed  November 10, 2014.",Non-OADS,/arxiv_data1/oa_pdf/d5/f2/ijwh-8-731.PMC5170621.pdf
Avail - able from: http://www.who.int/tb/challenges/gender/page_1/en/(2014b ).,Non-OADS,/arxiv_data1/oa_pdf/d5/f2/ijwh-8-731.PMC5170621.pdf
Available from: http://www.who.int/tb/dots/whatisdots/en /.,OADS,/arxiv_data1/oa_pdf/d5/f2/ijwh-8-731.PMC5170621.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/d5/f2/ijwh-8-731.PMC5170621.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d5/f2/ijwh-8-731.PMC5170621.pdf
Available from: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/d5/f2/ijwh-8-731.PMC5170621.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/12/e0/copd-11-3207.PMC5170673.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 3207–3217International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  3207OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11948 5 The administration of a high refined carbohydrate  diet promoted an increase in pulmonary  inflammation and oxidative stress in mice  exposed to cigarette smoke Karina Braga Pena1 Camila de Oliveira ramos1 nícia Pedreira soares1 Pamela Félix da silva1 ana Carla Balthar Bandeira2 guilherme de Paula Costa3 sílvia Dantas Cangussú1 andré Talvani3 Frank silva Bezerra1 1Laboratory of Experimental  Pathophysiology (LAFEx), 2Laboratory  of Metabolic Biochemistry (LBM),   3Laboratory of Immunobiology of  Inflammation (LABIIN), Department  of Biological Sciences (DECBI),   Center of research in Biological  Sciences (NUPEB), Federal University  of Ouro Preto (UFOP), Ouro Preto,   MG, BrazilAbstract:  This study aimed to evaluate the effects of a high refined carbohydrate diet and  pulmonary inflammatory response in C57BL/6 mice exposed to cigarette smoke (CS).",Non-OADS,/arxiv_data1/oa_pdf/12/e0/copd-11-3207.PMC5170673.pdf
"Its etiology has genetic contributions, which  can be mitigated or exacerbated by factors such as the external environment and  psychosocial interactions that interfere in physiological mediators of energy control.3  Studies on obesity have intensified due to increased prevalence of this disease in recent  decades, becoming a worldwide epidemic.4 The World Health Organization estimates  that 2.8 million people die each year as a result of overweight or obesity.5 Obesity, Correspondence: Frank silva Bezerra Laboratory of Experimental  Pathophysiology (LAFEx), Department of  Biological Sciences (DECBI), Center of  Research in Biological Sciences (NUPEB),  Federal University of Ouro Preto  (UFOP), Campus Universitário s/n, Morro  do Cruzeiro, Ouro Preto, MG, Brazil Tel +55 31 3559 1672 Fax +55 31 3559 1352 email franksbezerra@hotmail.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Pena et al Running head recto: High carbohydrate diet in pulmonary disorders DOI: http://dx.doi.org/10.2147/COPD.S119485",Non-OADS,/arxiv_data1/oa_pdf/12/e0/copd-11-3207.PMC5170673.pdf
Available from: http://www.who.int/mediacentre/factsheets/ fs311/en /.,Non-OADS,/arxiv_data1/oa_pdf/12/e0/copd-11-3207.PMC5170673.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/12/e0/copd-11-3207.PMC5170673.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/12/e0/copd-11-3207.PMC5170673.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/ed/22/cpaa-8-203.PMC5170674.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/ed/22/cpaa-8-203.PMC5170674.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Pharmacology: Advances and Applications 2016:8 203–212Clinical Pharmacology: Advances and Applications Dovepress submit your manuscript | www.dovepress.com Dovepress  203 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CPAA.S98437A Phase I study evaluating the effect of age and  weight on the pharmacokinetics of an injectable  formulation of diclofenac solubilized with  hydroxypropyl-β-cyclodextrin Ronald Goldwater1 William G Kramer2 Douglas A Hamilton3,4 Eric Lang4,5 Jianyuan Wang4 Donna E Madden4 Peter G Lacouture6,7 Atulkumar Ramaiya8 Daniel B Carr4,9 1PAREXEL International, Baltimore,   MD, 2Kramer Consulting, LLC,   North Potomac, MD, 3New Biology  Ventures, LLC, San Mateo, CA, 4Javelin  Pharmaceuticals, Cambridge, MA  (now Hospira, a Pfizer company, Lake Forest, IL, USA),  5Covance, Princeton,   NJ, 6Magidom Discovery, LLC,   Lindenhurst, IL, 7Brown University  School of Medicine, Providence, RI,   8Global Medical Affairs, Hospira,   a Pfizer company, Lake Forest, IL,   9Department of Anesthesiology, T ufts  Medical Center, Boston, MA, USAPurpose: The analgesic and opioid-sparing effects of nonsteroidal anti-inflammatory drugs can  be beneficial in postoperative populations.",Non-OADS,/arxiv_data1/oa_pdf/ed/22/cpaa-8-203.PMC5170674.pdf
"1,2 There are, however, relatively few available options in the  United States for fast-acting injectable NSAIDs that are appropriate for management Correspondence: Daniel B Carr Department of Anesthesiology, Tufts Medical Center, #298, 800 Washington Street, Boston, MA 02111, USA.Tel +1 617 636 9710Fax +1 617 636 9709Email daniel.carr@tufts.eduJournal name: Clinical Pharmacology: Advances and Applications Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Goldwater et alRunning head recto: Age and weight effects on HPβCD-diclofenac pharmacokineticsDOI: http://dx.doi.org/10.2147/CPAA.S98437",Non-OADS,/arxiv_data1/oa_pdf/ed/22/cpaa-8-203.PMC5170674.pdf
"Clinical Pharmacology: Advances and Applications 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Pharmacology: Advances and Applications Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-pharmacology-advances-and-applications-journalClinical Pharmacology: Advances and Applications is an international,  peer-reviewed, open access journal publishing original research, reports, reviews and commentaries on all areas of drug experience in humans.",Non-OADS,/arxiv_data1/oa_pdf/ed/22/cpaa-8-203.PMC5170674.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 212 Goldwater et al  13.,Non-OADS,/arxiv_data1/oa_pdf/ed/22/cpaa-8-203.PMC5170674.pdf
Available from: http://www.nrls.npsa.nhs.uk/resources/?entryid45=59812.,Non-OADS,/arxiv_data1/oa_pdf/ed/22/cpaa-8-203.PMC5170674.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/82/5c/ijn-11-6809.PMC5170675.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6809–6824International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6809OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12344 2 rescuing cholinergic neurons from apoptotic  degeneration by targeting of serotonin modulator-  and apolipoprotein e-conjugated liposomes to the  hippocampus Yung-chih Kuo Yin-Jung lee Department of chemical engineering,   National chung cheng University,   chia-Yi, Taiwan, republic of chinaAbstract:  β-Amyloid (A β)-targeting liposomes (LIP) with surface serotonin modulator (SM)  and apolipoprotein E (ApoE) were utilized to facilitate the delivery of nerve growth factor (NGF)  across the blood–brain barrier (BBB) for neuroprotection in the hippocampus.",Non-OADS,/arxiv_data1/oa_pdf/82/5c/ijn-11-6809.PMC5170675.pdf
"In fact, NGF can stimulate distal neurites and upregulate neurotrophic tyrosine  kinase receptor type 1 (TrkA) for neuronal survival, growth, and differentiation in  nervous system.3 TrkA evokes subsequent intracellular signaling cascades, includ - ing Ras/Raf/mitogen-activated protein kinase, phosphoinositide phospholipase C- γ,  and phosphatidylinositol-4,5-bisphosphate 3-kinase/protein kinase B, to improve  neuroprotective and neural repair functions.4 In an organotypic brain slice model, the  application of NGF protected cholinergic basal nuclei of Meynert neurons against correspondence: Yung-chih Kuo Department of chemical engineering,  National chung cheng University,  chia-Yi, Taiwan 62102, republic of china Tel +886 5 272 0411 ext 33459 Fax +886 5 272 1206 email chmyck@ccu.edu.t w Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Kuo and Lee Running head recto: Rescuing cholinergic neurons from degeneration with SM-ApoE-LIP DOI: http://dx.doi.org/10.2147/IJN.S123442",Non-OADS,/arxiv_data1/oa_pdf/82/5c/ijn-11-6809.PMC5170675.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/82/5c/ijn-11-6809.PMC5170675.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/82/5c/ijn-11-6809.PMC5170675.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a5/d9/ijn-11-6561.PMC5170787.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6561–6574International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6561OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11774 5 New silver nanoparticles induce apoptosis-like  process in E. coli  and interfere with mammalian  copper metabolism Iurii a Orlov1,2 Tatiana P sankova1,2 Polina s Babich3 Ilya M sosnin1,4 ekaterina Yu Ilyechova1,5 Demid a Kirilenko1,6 Pavel N Brunkov1,6 gennadii l ataev3 alexey e romanov1,4,6 ludmila V Puchkova1,2,5 1International research and education  center “Functional materials and  devices of optoelectronics and  microelectronics”, ITMO University,   2Department of Biophysics, Peter  the great st Petersburg Polytechnic  University, 3Department of  Zoology, herzen state Pedagogical  University of russia, st Petersburg,   4Nanocatalysts and Functional  Materials laboratory, Togliatti state  University, T ogliatti, 5Department  of Molecular genetics, research  Institute of experimental Medicine,   6Ioffe Institute, st Petersburg, russiaAbstract:  Silver nanoparticles (SNPs) are new functional materials that are widely used in  biomedical and industrial technologies.",Non-OADS,/arxiv_data1/oa_pdf/a5/d9/ijn-11-6561.PMC5170787.pdf
"Therefore, in many cases, SNPs may potentially substitute for antibiotics correspondence: Iurii a Orlov International research and education  center “Functional materials and devices  of optoelectronics and microelectronics”,  ITMO University, Kronverksky av,  49, st Petersburg, 197101, russia Tel +7 921 409 5168 email orlov239@gmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Orlov et al Running head recto: Silver nanoparticles interfere with copper metabolism DOI: http://dx.doi.org/10.2147/IJN.S117745",Non-OADS,/arxiv_data1/oa_pdf/a5/d9/ijn-11-6561.PMC5170787.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/a5/d9/ijn-11-6561.PMC5170787.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a5/d9/ijn-11-6561.PMC5170787.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/88/16/opth-10-2505.PMC5170788.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 2505–2513Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2505Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S12080 3 Physician, patient, and caregiver experience of  different wet age-related macular degeneration  anti-VegF treatment regimens in Japan:  a qualitative assessment T omohiro iida1 Keirei ishii2 1Department of Ophthalmology, T okyo  Women’s Medical University, T okyo,   2health economics and Outcomes  research, Bayer Yakuhin ltd.,   Osaka,  JapanPurpose:  The purpose of this study was to monitor anti-vascular endothelial growth factor  (anti-VEGF) treatment regimens for wet age-related macular degeneration (wAMD) in clinical  practice and to determine how they impact the physician, patient, and caregiver treatment  experience.",Non-OADS,/arxiv_data1/oa_pdf/88/16/opth-10-2505.PMC5170788.pdf
"Keywords:  wet age-related macular degeneration, anti-vascular growth factor, anti-VEGF  as-needed, anti-VEGF treat-and-extend, wAMD patient experience Introduction Wet age-related macular degeneration (wAMD) is a chronic disease and a leading  cause of blindness in older patients.1–3 Following the recent introduction of anti-vascular  endothelial growth factor (anti-VEGF) therapy, wAMD treatment has changed dramati - cally, with a switch to improving rather than maintaining visual acuity.4 In Japan, after the launch of ranibizumab (Lucentis®; Novartis International AG)  in 2009, the pro re nata (PRN) method of administration became the standard approach Correspondence: Tomohiro iida Department of Ophthalmology, Tokyo  Women’s Medical University, Tokyo  162-8666, Japan Tel +81 3 3353 8111 Fax +81 3 5269 8059 email iida@oph.twmu.ac.j p Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Iida and Ishii Running head recto: Physician and patient experience of wAMD treatment regimens DOI: http://dx.doi.org/10.2147/OPTH.S120803",Non-OADS,/arxiv_data1/oa_pdf/88/16/opth-10-2505.PMC5170788.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/88/16/opth-10-2505.PMC5170788.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/88/16/opth-10-2505.PMC5170788.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/61/0c/dddt-10-4101.PMC5170841.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 4101–4110Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4101Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S12338 6 Folic acid-conjugated amphiphilic alternating  copolymer as a new active tumor targeting drug  delivery platform Xia li1 Myron r szewczuk2 cecile Malardier-Jugroot1 1Department of chemistry and  chemical engineering, royal Military  college of canada, 2Department of  Biomedical and Molecular sciences,   Queen’s University, Kingston, On ,   canadaAbstract:  Targeted drug delivery using polymeric nanostructures is an emerging cancer  research area, engineered for safer, more efficient, and effective use of chemotherapeutic drugs.",Non-OADS,/arxiv_data1/oa_pdf/61/0c/dddt-10-4101.PMC5170841.pdf
"Passive  targeting, also known as enhanced permeability and retention (EPR) effect, takes correspondence: cecile Malardier- Jugroot Department of chemistry and chemical  engineering, sawyer Mod 5, rm 5512,  royal Military college of canada, PO Box  17000, station Forces Kingston, On K7K  7B4, canada Tel +1 613 541 6000 ext 6046 Fax +1 613 542 9489 email c ecile.malardier-jugroot@rmc.c a  Myron r szewczuk Department of Biomedical and Molecular  sciences, 18 stuart st, Botterell hall rm  827, Kingston, On K7l3n6, canada Tel +1 613 533 2457 Fax +1 613 533 6796 email szewczuk@queensu.c a Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Li et al Running head recto: Functionalized alternating copolymers for targeted drug delivery DOI: http://dx.doi.org/10.2147/DDDT.S123386",Non-OADS,/arxiv_data1/oa_pdf/61/0c/dddt-10-4101.PMC5170841.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/61/0c/dddt-10-4101.PMC5170841.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/61/0c/dddt-10-4101.PMC5170841.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/9e/9f/3181.PMC5170845.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/9e/70/3183.PMC5170846.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/c8/a5/3185.PMC5170847.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/31/97/3189.PMC5170848.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f4/1e/3192.PMC5170849.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/a0/29/3194.PMC5170850.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/44/a2/3197.PMC5170851.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/a6/fe/3202.PMC5170852.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/0a/24/3205.PMC5170853.pdf
"There are also scores of write-ups on our publi - cations and press releases in the Lawrence Berkeley National Labo - ratory archives (Today at Berkeley Lab, https://today.lbl.gov), and  then there are more than 400 publications from our laboratory (also  on the website).",Non-OADS,/arxiv_data1/oa_pdf/0a/24/3205.PMC5170853.pdf
Two months after publi - cation it is available to the public under an Attribution–Noncommercial–Share  Alike 3.0 Unported Creative Commons License (http://creativecommons.org/   licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/06/89/3210.PMC5170854.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Creative  Commons License.(http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/62/49/3214.PMC5170855.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/10/41/3221.PMC5170856.pdf
Quantitative assay of antigen expression was based  on density measurements of protein bands using ImageJ software  (http://rsb.info.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/10/41/3221.PMC5170856.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unport - ed Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/ad/a6/3233.PMC5170857.pdf
http://tronolab.epfl.ch/lentivectors  (accessed  2013).,OADS,/arxiv_data1/oa_pdf/ad/a6/3233.PMC5170857.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/ef/8d/3245.PMC5170858.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f4/0d/3257.PMC5170859.pdf
Two months after publication it is available to the  public under an Attribution–Noncommercial–Share Alike 3.0 Unported Creative  Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).).,Non-OADS,/arxiv_data1/oa_pdf/70/9f/3273.PMC5170860.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/42/10/3284.PMC5170861.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/89/48/3293.PMC5170862.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unport - ed Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/53/f8/3305.PMC5170863.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0 Un - ported Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/c7/92/3317.PMC5170864.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/64/2a/3329.PMC5170865.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/0c/11/3342.PMC5170866.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/03/67/3357.PMC5170867.pdf
http://bio3d.colorado.edu/PEET/  (accessed 18 January 2016).,OADS,/arxiv_data1/oa_pdf/03/67/3357.PMC5170867.pdf
Two months after publication  it is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/84/a1/3369.PMC5170868.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/bf/6b/ott-9-7583.PMC5171196.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7583–7590OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7583Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S12224 1 Non-secretory multiple myeloma: from biology  to clinical management Megan Murray Dupuis1 Sascha A T uchman2 1Department of Medicine, Duke  University, Durham, 2Division of  Hematology/Oncology, Lineberger  Comprehensive Cancer Center,   University of North Carolina at  Chapel Hill, Chapel Hill, NC, USAAbstract:  Multiple myeloma (MM) is the second most common hematologic malignancy in the  US.",Non-OADS,/arxiv_data1/oa_pdf/bf/6b/ott-9-7583.PMC5171196.pdf
"A fourth entity exists, which is production of free heavy  chain in the absence of bound light chain, but this is very rare.Correspondence: Sascha A Tuchman Division of Hematology/Oncology,  Lineberger Comprehensive Cancer  Center, University of North Carolina  at Chapel Hill, 170 Manning Drive,  CB#7305, Chapel Hill, NC 27599, USA Tel +1 919 966 3856 Fax +1 919 966 6735 email sascha_tuchman@med.unc.ed uJournal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Dupuis and Tuchman Running head recto: Non-secretory multiple myeloma DOI: http://dx.doi.org/10.2147/OTT.S122241",Non-OADS,/arxiv_data1/oa_pdf/bf/6b/ott-9-7583.PMC5171196.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/bf/6b/ott-9-7583.PMC5171196.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/6b/ott-9-7583.PMC5171196.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ed/91/ppa-10-2519.PMC5171197.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 2519–2529Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  2519OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S12346 8 improving doctor–patient communication: content  validity examination of a novel urinary system- simulating physical model Wengang hu  YaJun song  Xiao Zhong  JiaYu Feng  PingXian Wang chiBing huang Department of Urology, second  Affiliated hospital, Third Military  Medical University, chongqing,   People’s republic of chinaAbstract:  Effective doctor–patient communication is essential for establishing a successful  doctor–patient relationship and implementing high-quality health care.",Non-OADS,/arxiv_data1/oa_pdf/ed/91/ppa-10-2519.PMC5171197.pdf
"Keywords:  doctor–patient communication, doctor–patient relationship, model, urology Introduction Doctor–patient communication has been shown to be fundamental in clinical practice,  and the main goals of communication have been to create good interpersonal relation - ships, to facilitate the exchange of information, and to include patients in decision- making.1–4 In contemporary medicine, communication has been gaining increasing  attention as more health care providers have recognized that it is essential to health.5  Studies have shown that good doctor–patient communication can enhance the doctor– patient relationship, improve patient satisfaction with medical encounters, and decrease  patients’ psychological stress and symptoms and was associated with improved trust  in health care providers, increased satisfaction with care, greater patient confidence  in and adherence to treatment plans, and improved medical outcomes.6–10 Inversely,  poor communication and attitudes between the doctor and patient constitute the most  frequent underlying cause of malpractice litigation, complaints against doctors, and correspondence: chiBing huang Department of Urology, second  Affiliated Hospital, Third Military Medical  University, no 183, XinQiao street,  shaPingBa District, chongqing, 400037,  People’s republic of china Tel +86 023 68755141 Fax +86 023 68755306 email huangchibing@medmail.com.c n Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Hu et al Running head recto: Improving doctor–patient communication DOI: http://dx.doi.org/10.2147/PPA.S123468",Non-OADS,/arxiv_data1/oa_pdf/ed/91/ppa-10-2519.PMC5171197.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/ed/91/ppa-10-2519.PMC5171197.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ce/5b/ppa-10-2491.PMC5171198.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 2491–2500Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  2491OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S12231 9 importance of hemodialysis-related outcomes:  comparison of ratings by a self-help group, clinicians,  and health technology assessment authors with  those by a large reference group of patients inger M Janssen1 Fueloep scheibler2 Ansgar gerhardus3,4 1Department of epidemiology and  international Public health, University  of Bielefeld, Bielefeld, 2Department  of non-Drug interventions, institute  for Quality and efficiency in health  care, cologne, 3Department for  health services research, institute  for Public health and nursing  research, University of Bremen,   4health sciences Bremen, University  of Bremen, Bremen, germanyBackground:  The selection of important outcomes is a crucial decision for clinical research  and health technology assessment (HTA), and there is ongoing debate about which stakeholders  should be involved.",Non-OADS,/arxiv_data1/oa_pdf/ce/5b/ppa-10-2491.PMC5171198.pdf
"Keywords:  patient preferences, hemodialysis patients, patient-centered outcomes, preference  elicitation, rating scale Background For some years now, more and more emphasis has been placed on patient-centered  health care as well as on active patient involvement in clinical research and health  technology assessment (HTA).1–4 The Institute of Medicine (IOM) defined patient-centered care as “Providing care  that is respectful of and responsive to individual patient preferences, needs, and values,  and ensuring that patient values guide all clinical decisions.”5correspondence: inger M Janssen Department of epidemiology and  international Public health, University  of Bielefeld, PO Box 10 01 31, 33501  Bielefeld, germany Tel +49 221 3568 5358 email inger.scheike@uni-bielefeld.d e Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Janssen et al Running head recto: Importance of hemodialysis-related outcomes DOI: http://dx.doi.org/10.2147/PPA.S122319",Non-OADS,/arxiv_data1/oa_pdf/ce/5b/ppa-10-2491.PMC5171198.pdf
Available  from: http://www.cc-ims.net/gradepro.,Non-OADS,/arxiv_data1/oa_pdf/ce/5b/ppa-10-2491.PMC5171198.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/ce/5b/ppa-10-2491.PMC5171198.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/86/01/ott-9-7573.PMC5171199.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7573–7582OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7573Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S10138 5 Sunitinib in the treatment of gastrointestinal  stromal tumor: patient selection and perspectives Nuria Mulet-Margalef Xavier Garcia-del-Muro Sarcoma Multidisciplinary Unit and  Medical Oncology Department,   institut Català d’Oncologia Hospitalet,   iDiBeLL, Barcelona, SpainAbstract:  Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor  of the gastrointestinal tract.",Non-OADS,/arxiv_data1/oa_pdf/86/01/ott-9-7573.PMC5171199.pdf
"Imatinib was approved by Food and Drug Administration  (FDA) after the results of a phase II trial in which .60% of patients experimented Correspondence: Xavier Garcia-del-Muro Sarcoma Multidisciplinary Unit and  Medical Oncology Department,  institut Català d’Oncologia Hospitalet,  Avda Gran via de L’Hospitalet 199,  Barcelona 08908, Spain Tel +34 93 260 7744 Fax +34 93 260 7741 email garciadelmuro@iconcologia.ne t Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Mulet-Margalef and Garcia-del-Muro Running head recto: Sunitinib in GIST treatment DOI: http://dx.doi.org/10.2147/OTT.S101385",Non-OADS,/arxiv_data1/oa_pdf/86/01/ott-9-7573.PMC5171199.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/86/01/ott-9-7573.PMC5171199.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/86/01/ott-9-7573.PMC5171199.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f9/af/ppa-10-2501.PMC5171200.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 2501–2517Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  2501OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10439 6 communicating laboratory test results for  rheumatoid factor: what do patients and  physicians want?",Non-OADS,/arxiv_data1/oa_pdf/f9/af/ppa-10-2501.PMC5171200.pdf
"Similar efforts are being made in Europe, such as are  described under the Digital Agenda for Europe.2 In a recent EU-commissioned study  of the country-level policies on interoperability and sharing of electronic health records  among health care providers and patients, it was found that each EU member state has  policy or policies to provide patients with access to their electronic health records, with  around half of EU countries granting patients full access to their health data, without  exemptions and/or restrictions.3correspondence: Ariella Kelman genentech, 1 DnA Way, south san  Francisco 94080, cA, UsA Tel +1 415 509 1310 Fax +1 650 222 8641 email k elman.ariella@gene.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Kelman et al Running head recto: Communicating laboratory test results for rheumatoid factor DOI: http://dx.doi.org/10.2147/PPA.S104396",Non-OADS,/arxiv_data1/oa_pdf/f9/af/ppa-10-2501.PMC5171200.pdf
"Available from:  http://ec.europa.eu/digital-agenda/en/pillar-vii-ict-enabled-benefits- eu-society/action-75-give-europeans-secure-online-access-thei r.  Accessed July 29, 2015.",Non-OADS,/arxiv_data1/oa_pdf/f9/af/ppa-10-2501.PMC5171200.pdf
"Available from: http://ec.europa.eu/health/ehealth/projects/nation - allaws_electronichealthrecords_en.ht m. Accessed March 15, 2016.",Non-OADS,/arxiv_data1/oa_pdf/f9/af/ppa-10-2501.PMC5171200.pdf
Available at: http://www.wired.com/2013/01/ medical-record-redesign /.,Non-OADS,/arxiv_data1/oa_pdf/f9/af/ppa-10-2501.PMC5171200.pdf
Available from: http://www.mayoclinic.org/ tests-procedures/rheumatoid-factor/basics/definition/prc-2001348 4.,Non-OADS,/arxiv_data1/oa_pdf/f9/af/ppa-10-2501.PMC5171200.pdf
Available from: http://blog.sermo.com/.,Non-OADS,/arxiv_data1/oa_pdf/f9/af/ppa-10-2501.PMC5171200.pdf
Available  from: https://labtestsonline.org/understanding/analytes/rheumatoid /.,Non-OADS,/arxiv_data1/oa_pdf/f9/af/ppa-10-2501.PMC5171200.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/f9/af/ppa-10-2501.PMC5171200.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d9/d9/ppa-10-2479.PMC5171201.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 2479–2489Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  2479OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S11775 7 The Australasian hepatology Association  consensus guidelines for the provision of  adherence support to patients with hepatitis c  on direct acting antivirals Jacqueline A richmond1,2 suzanne sheppard-law3,4 susan Mason5 sherryne l Warner6,7 1Australian research centre in  sex, health and society, la Trobe  University, 2Victorian infectious  Diseases service, The royal  Melbourne hospital, Melbourne,   Vic, 3Faculty of health, University  of T echnology, 4sydney children’s  hospital network, 5AW Morrow  gastroenterology and liver centre,   royal Prince Alfred hospital,   sydney, nsW, 6Department of  gastroenterology, Monash health,   7Department of Medicine, Monash  University, Melbourne, Vic , AustraliaBackground:  Hepatitis C is a blood-borne virus primarily spread through sharing of  drug-injecting equipment.",Non-OADS,/arxiv_data1/oa_pdf/d9/d9/ppa-10-2479.PMC5171201.pdf
"Keywords:  nursing, adherence, best practice, nursing support, hepatitis C treatment Introduction Infection with hepatitis C virus and the resultant liver disease is a global public  health issue affecting approximately 150 million people worldwide and an estimated  230,470 Australians.1 Australia is in the unique position, globally, to have diagnosed  approximately 75% of people affected by hepatitis C; however, treatment rates remain correspondence: Jacqueline A richmond Viral hepatitis research Program,  Australian research centre in sex,  health and society, la Trobe University,  215 Franklin street, Melbourne,  Vic 3000, Australia Tel +61 488 662 268 email j .richmond@latrobe.edu.a u Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Richmond et al Running head recto: AHA consensus guidelines on adherence support DOI: http://dx.doi.org/10.2147/PPA.S117757",Non-OADS,/arxiv_data1/oa_pdf/d9/d9/ppa-10-2479.PMC5171201.pdf
Available from: http://www.hepatologyassociation.com.au/about-us/ consensus-based-nursing-guidelines /.,Non-OADS,/arxiv_data1/oa_pdf/d9/d9/ppa-10-2479.PMC5171201.pdf
Available  from: http://www.hepatologyassociation.com.au/about-us/practice- standards /.,Non-OADS,/arxiv_data1/oa_pdf/d9/d9/ppa-10-2479.PMC5171201.pdf
"Available from: http://www.ahrq.gov/literac y.  Accessed March 23, 2016.",Non-OADS,/arxiv_data1/oa_pdf/d9/d9/ppa-10-2479.PMC5171201.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/d9/d9/ppa-10-2479.PMC5171201.pdf
"Additional Information Supplementary information accompanies this paper at http://www.nature.com/srep Competing financial interests: The authors declare no competing financial interests.How to cite this article: Bono, R. K. et al.",Non-OADS,/arxiv_data1/oa_pdf/1a/fa/srep38876.PMC5171645.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/   © The Author(s) 2016",Non-OADS,/arxiv_data1/oa_pdf/1a/fa/srep38876.PMC5171645.pdf
"To quantifythe bands obtained via western blot analysis, an ImageJ software-based analysis was applied (http://rsb.info.nih.gov/ij/).",OADS,/arxiv_data1/oa_pdf/a8/8c/AkinciMCS001339.PMC5171694.pdf
ADDITIONAL INFORMATION Data Deposition and Access The raw proteomics data have been deposited in the Mass Spectrometry Interactive Virtual Environment (MassIVE) repository (https://massive.ucsd.edu/) under accession number MSV000080191 and are in ProteomeXchange (http://www.proteomexchange.org/) under ac- cession number PXD005037.Treating MAD and RD patients with rapamycin and DMSOCOLD SPRING HARBOR Molecular Case Studies Akinci et al.,OADS,/arxiv_data1/oa_pdf/a8/8c/AkinciMCS001339.PMC5171694.pdf
ALK COPY-NUMBER VARIANTS ALK gene amplification has been detected in variety of tumors (http://cancergenome.nih.,Non-OADS,/arxiv_data1/oa_pdf/9d/f4/HollaMCS001115.PMC5171696.pdf
"Allele frequency of this var- iant is assumed to be very low, as it is absent from the 1000 Genomes Project, the ExomeVariant Server, National Heart, Lung, and Blood Institute (NHLBI) GO Exome Sequencing Project (ESP), and Exome Aggregation Consortium (ExAC) databases (http://evs.gs.",Non-OADS,/arxiv_data1/oa_pdf/59/ed/ZastrowMCS001388.PMC5171698.pdf
"Echocardiogram performed during the UDN evaluation, but after WES results were avail-able, revealed mild aortic root dilation ( Z-score = 3.24), aortic annulus ( Z-score = 4.13), and sinotubular junction ( Z-score = 3.03) (The Marfan Foundation; https://www.marfan.org/dx/ zscore).",Non-OADS,/arxiv_data1/oa_pdf/59/ed/ZastrowMCS001388.PMC5171698.pdf
"Therefore, the likelihood of a co-occurrence of MFS and TRPS1 is 1/5,000,000,000 –1/10,000,000,000, indicating our patient may be unique among the world ’s population (7.4 billion) (World Population Clock; http://www.worldometers.info/world-population/, accessed July 7, 2016); the likeli- hood of de novo mutations causing these specific phenotypes would be even lower.",Non-OADS,/arxiv_data1/oa_pdf/59/ed/ZastrowMCS001388.PMC5171698.pdf
ADDITIONAL INFORMATION Data Deposition and Access Whole-exome sequencing data have been submitted to the Database of Genotypes and Phenotypes (dbGaP; https://www.ncbi.nlm.nih.gov/gap) per NIH study protocol and patient consent (accession number phs001232.v1.p1).,OADS,/arxiv_data1/oa_pdf/59/ed/ZastrowMCS001388.PMC5171698.pdf
The FBN1 and TRPS1 variants have been submitted to ClinVar (http://www.ncbi.nlm.nih.gov/clinvar/) under accession numbers SCV000328213.1 and SCV000328214.1.,Non-OADS,/arxiv_data1/oa_pdf/59/ed/ZastrowMCS001388.PMC5171698.pdf
http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/59/ed/ZastrowMCS001388.PMC5171698.pdf
http://www.orpha.net/orphacom/cahiers/docs/GB/ Prevalence_of_rare_diseases_by_diseases.pdf.,Non-OADS,/arxiv_data1/oa_pdf/59/ed/ZastrowMCS001388.PMC5171698.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/74/9c/CG-CGCR160104.PMC5171925.pdf
Watch the video: http://s3.gi.org/media/links/ 16-0185Video.mp4.,Non-OADS,/arxiv_data1/oa_pdf/74/9c/CG-CGCR160104.PMC5171925.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/60/c3/CG-CGCR160121.PMC5171926.pdf
Available: https://clinicaltrials.gov/ct2/show/NCT02463305 NLM Identi ﬁer: NCT02463305.,Non-OADS,/arxiv_data1/oa_pdf/60/c3/CG-CGCR160121.PMC5171926.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/78/c4/CG-CGCR160129.PMC5171927.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/ba/77/CG-CGCR160105.PMC5171928.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/f4/16/CG-CGCR160127.PMC5171929.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/60/f1/CG-CGCR160144.PMC5171930.pdf
"FDA Brie ﬁng Document: NDA 202293, Dapagli ﬂozin Oral Tablets, 5 and 10 mg; Advisory Committee Meeting December 12, 2013. http://www.fda.gov/ downloads/advisorycommittees/committeesmeetingmaterials/drugs/endocrinologicandmetabolicdrugsadvisorycommittee/ucm378076.pdf.Accessed November 2, 2016.",Non-OADS,/arxiv_data1/oa_pdf/60/f1/CG-CGCR160144.PMC5171930.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/89/26/CG-CGCR160142.PMC5171931.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/8e/a5/CG-CGCR160134.PMC5171932.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/19/a0/CG-CGCR160123.PMC5171933.pdf
Watch the video: http://s3.gi.org/media/ links/16-0136Video.mp4.,Non-OADS,/arxiv_data1/oa_pdf/03/66/CG-CGCR160098.PMC5171934.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/03/66/CG-CGCR160098.PMC5171934.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/2c/b9/CG-CGCR160141.PMC5171935.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/6c/a5/CG-CGCR160078.PMC5171936.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/79/f3/CG-CGCR160133.PMC5171937.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/5a/bc/CG-CGCR160120.PMC5171938.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/59/52/CG-CGCR160124.PMC5171939.pdf
/CA/CT/DA/CX/CT/DB/BT/D6/CT /BZ/CT/D2/CT /BX/DC/D4/D6/CT/D7/D7/CX/D3/D2 /C5/CX/CR/D6/D3/CP/D6/D6/CP /DD /BT/D2/CP/D0/DD/D7/CT/D7 /CA/CT/D0/CX/CP/CQ/D0/CT/BR/BT /CA/CT/DA/CX/CT/DB /D3/CU /CB/D8/D9/CS/CX/CT/D7 /D3/CU /CA/CT/D8/CX/D2/D3/CX/CR /BT/CR/CX/CS /CA/CT/D7/D4 /D3/D2/D7/CX/DA /CT /BZ/CT/D2/CT/D7/C8 /CT/D8/CT/D6 /C2/BA /DA /CP/D2 /CS/CT/D6 /CB/D4 /CT/CZ /BD/B8 /BT/D2/CS/D6/CT/CP/D7 /C3/D6/CT/D1/CT/D6 /BD/B8 /C4/DD/D2/D2 /C5/D9/D6/D6/DD /BE/B8 /CP/D2/CS /C5/CX/CR /CW/CP/CT/D0 /BZ/BA /CF /CP/D0/CZ /CT/D6 /BE/B6/BD/C2/CP/D2/D7/D7/CT/D2 /C8/CW/CP/D6/D1/CP/CR /CT/D9/D8/CX/CR /CP/B8 /BU/CT /CT/D6/D7/CT/B8 /BU/CT/D0/CV/CX/D9/D1/BN /BE/C1/D2/CR/DD/D8/CT /BZ/CT/D2/D3/D1/CX/CR/D7/B8 /C1/D2/CR/BA/B8 /BV/BT /BL/BG/BC/BK/BJ/B8 /CD/CB/BT/C5/CX/CR/D6/D3/CP/D6/D6/CP /DD /CP/D2/CP/D0/DD/D7/CT/D7 /D3/CU /CV/CT/D2/CT /CT/DC/D4/D6/CT/D7/D7/CX/D3/D2 /CP/D6/CT /DB/CX/CS/CT/D0/DD /D9/D7/CT/CS/B8 /CQ/D9/D8 /D6/CT/D4 /D3/D6/D8/D7 /D3/CU /D8/CW/CT /D7/CP/D1/CT/CP/D2/CP/D0/DD/D7/CT/D7 /CQ /DD /CS/CX/AB/CT/D6/CT/D2 /D8 /CV/D6/D3/D9/D4/D7 /CV/CX/DA /CT /DB/CX/CS/CT/D0/DD /CS/CX/DA /CT/D6/CV/CT/D2 /D8 /D6/CT/D7/D9/D0/D8/D7/B8 /CP/D2/CS /D6/CP/CX/D7/CT /D5/D9/CT/D7/D8/CX/D3/D2/D7 /D6/CT/B9/CV/CP/D6/CS/CX/D2/CV /D6/CT/D4/D6/D3 /CS/D9/CR/CX/CQ/CX/D0/CX/D8 /DD /CP/D2/CS /D6/CT/D0/CX/CP/CQ/CX/D0/CX/D8 /DD /BA /CF /CT /D8/CP/CZ /CT /CP/D7 /CP/D2 /CT/DC/CP/D1/D4/D0/CT /D6/CT/CR/CT/D2 /D8 /D4/D9/CQ/D0/CX/D7/CW/CT/CS/D6/CT/D4 /D3/D6/D8/D7 /D3/D2 /D1/CX/CR/D6/D3/CP/D6/D6/CP /DD /CT/DC/D4 /CT/D6/CX/D1/CT/D2 /D8/D7 /D8/CW/CP/D8 /DB /CT/D6/CT /CS/CT/D7/CX/CV/D2/CT/CS /D8/D3 /CX/CS/CT/D2 /D8/CX/CU/DD /D6/CT/D8/CX/D2/D3/CX/CR /CP/CR/CX/CS/D6/CT/D7/D4 /D3/D2/D7/CX/DA /CT /CV/CT/D2/CT/D7/BA /CC/CW/CT/D7/CT /D6/CT/D4 /D3/D6/D8/D7 /D7/CW/D3 /DB /D7/D9/CQ/D7/D8/CP/D2 /D8/CX/CP/D0 /CS/CX/AB/CT/D6/CT/D2/CR/CT/D7 /CX/D2 /D8/CW/CT/CX/D6 /D6/CT/D7/D9/D0/D8/D7/BA /C1/D2/D8/CW/CX/D7 /CP/D6/D8/CX/CR/D0/CT/B8 /DB /CT /D6/CT/DA/CX/CT/DB /D8/CW/CT /D1/CT/D8/CW/D3 /CS/D3/D0/D3/CV/DD /B8 /D6/CT/D7/D9/D0/D8/D7/B8 /CP/D2/CS /D4 /D3/D8/CT/D2 /D8/CX/CP/D0 /CR/CP/D9/D7/CT/D7 /D3/CU /CS/CX/AB/CT/D6/CT/D2/CR/CT/D7/CX/D2 /D8/CW/CT/D7/CT /CP/D4/D4/D0/CX/CR/CP/D8/CX/D3/D2/D7 /D3/CU /D1/CX/CR/D6/D3/CP/D6/D6/CP /DD/D7/BA /BY/CX/D2/CP/D0/D0/DD /B8 /DB /CT /D7/D9/CV/CV/CT/D7/D8 /D4/D6/CP/CR/D8/CX/CR/CT/D7 /D8/D3 /CX/D1/D4/D6/D3 /DA /CT /D8/CW/CT/D6/CT/D0/CX/CP/CQ/CX/D0/CX/D8 /DD /CP/D2/CS /D6/CT/D4/D6/D3 /CS/D9/CR/CX/CQ/CX/D0/CX/D8 /DD /D3/CU /D1/CX/CR/D6/D3/CP/D6/D6/CP /DD /CT/DC/D4 /CT/D6/CX/D1/CT/D2 /D8/D7/BA/C3/CT/DD /DB /D3/D6/CS/D7/BM /D1/CX/CR/D6/D3/CP/D6/D6/CP /DD/D7/B8 /D6/CT/D8/CX/D2/D3/CX/CR /CP/CR/CX/CS /D6/CT/D7/D4 /D3/D2/D7/CT /CV/CT/D2/CT/B8 /D6/CT/D0/CX/CP/CQ/CX/D0/CX/D8 /DD /CR/CP/D7/CT /D7/D8/D9/CS/CX/CT/D7/C1/D2 /D8/D6/D3 /CS/D9/CR/D8/CX/D3/D2/C5/CX/CR/D6/D3/CP/D6/D6/CP /DD/D7 /CP/D6/CT /DB/CX/CS/CT/D0/DD /D9/D7/CT/CS /D8/D3 /CX/CS/CT/D2 /D8/CX/CU/DD /CV/CT/D2/CT/D7 /D3/CU /D4/D9/B9/D8/CP/D8/CX/DA /CT /D1/CT/CS/CX/CR/CP/D0 /D3/D6 /CX/D2/CS/D9/D7/D8/D6/CX/CP/D0 /DA /CP/D0/D9/CT/B8 /D8/D3 /CR /CW/CP/D6/CP/CR/D8/CT/D6/CX/DE/CT /D8/CW/CT/D4 /D3/D7/D7/CX/CQ/D0/CT /D1/D3 /CS/CT /D3/CU /CP/CR/D8/CX/D3/D2 /D3/CU /CS/D6/D9/CV/D7/B8 /CP/D2/CS /CX/D2 /D1/CP/D2 /DD /D3/D8/CW/CT/D6/CP/D4/D4/D0/CX/CR/CP/D8/CX/D3/D2/D7/BA /C0/D3 /DB /CT/DA /CT/D6/B8 /CS/CX/D7/CX/D2 /D8/CT/D6/CT/D7/D8/CT/CS /D6/CT/D7/CT/CP/D6/CR /CW/CT/D6/D7 /CW/CP /DA /CT/D6/CP/D6/CT/D0/DD /CT/DA /CP/D0/D9/CP/D8/CT/CS /D8/CW/CT /D6/CT/D4/D6/D3 /CS/D9/CR/CX/CQ/CX/D0/CX/D8 /DD /CP/D2/CS /D6/CT/D0/CX/CP/CQ/CX/D0/CX/D8 /DD /D3/CU/D1/CX/CR/D6/D3/CP/D6/D6/CP /DD /D6/CT/D7/D9/D0/D8/D7/BA /C8/D9/CQ/D0/CX/D7/CW/CT/CS /D6/CT/D4 /D3/D6/D8/D7 /D3/CU /D8/CW/CT /D7/CP/D1/CT/CP/D2/CP/D0/DD/D7/CT/D7 /CQ /DD /CS/CX/AB/CT/D6/CT/D2 /D8 /D6/CT/D7/CT/CP/D6/CR /CW/CT/D6/D7 /D3/CU/D8/CT/D2 /CV/CX/DA /CT /DB/CX/CS/CT/D0/DD /CS/CX/B9/DA /CT/D6/CV/CT/D2 /D8 /D6/CT/D7/D9/D0/D8/D7/BA /CF /CT /DB/CX/D7/CW /D8/D3 /D9/D2/CS/CT/D6/D7/D8/CP/D2/CS /D8/CW/CT /D4 /D3/D7/D7/CX/CQ/D0/CT/D7/D3/D9/D6/CR/CT/D7 /D3/CU /D8/CW/CT/D7/CT /CS/CX/AB/CT/D6/CT/D2/CR/CT/D7/B8 /CP/D2/CS /D8/D3 /CX/CS/CT/D2 /D8/CX/CU/DD /D4/D6/CP/CR/D8/CX/CR/CT/D7/D8/CW/CP/D8 /D1/CP /DD /CX/D1/D4/D6/D3 /DA /CT /D8/CW/CT /D5/D9/CP/D0/CX/D8 /DD /D3/CU /D1/CX/CR/D6/D3/CP/D6/D6/CP /DD /D7/D8/D9/CS/CX/CT/D7/BA/CF /CT /D8/CP/CZ /CT /CP/D7 /CP/D2 /CT/DC/CP/D1/D4/D0/CT /D6/CT/CR/CT/D2 /D8 /D4/D9/CQ/D0/CX/D7/CW/CT/CS /D6/CT/D4 /D3/D6/D8/D7 /D3/D2/D1/CX/CR/D6/D3/CP/D6/D6/CP /DD /CT/DC/D4 /CT/D6/CX/D1/CT/D2 /D8/D7 /D8/CW/CP/D8 /DB /CT/D6/CT /CS/CT/D7/CX/CV/D2/CT/CS /D8/D3 /CX/CS/CT/D2/B9/D8/CX/CU/DD /D6/CT/D8/CX/D2/D3/CX/CR /CP/CR/CX/CS /D6/CT/D7/D4 /D3/D2/D7/CX/DA /CT /CV/CT/D2/CT/D7/BA /CA/CT/D8/CX/D2/D3/CX/CR /CP/CR/CX/CS /B4/CA/BT/B5/CX/D7 /CP/D2 /CP/D2 /D8/CX/B9/D8/D9/D1/D3/D6 /CP/CV/CT/D2 /D8 /D8/CW/CP/D8 /CX/D2/CS/D9/CR/CT/D7 /CS/CX/AB/CT/D6/CT/D2 /D8/CX/CP/D8/CX/D3/D2 /D3/D6/CP/D4 /D3/D4/D8/D3/D7/CX/D7 /B4/BD /A0 /BJ /B5/BA /CB/CT/DA /CT/D6/CP/D0 /D6/CT/D8/CX/D2/D3/CX/CR /CP/CR/CX/CS /D6/CT/D0/CP/D8/CT/CS /CR/D3/D1/B9/D4/D3 /D9 /D2 /CS /D7 /CW/CP /DA /CT /CS/CT/D1/D3/D2/D7/D8/D6/CP/D8/CT/CS /CP/D2 /D8/CX/B9/D8/D9/D1/D3/D6 /CT/AB/CT/CR/D8/D7/B8 /CP/D2/CS/D7/D3/D1/CT /CP/D6/CT /CX/D2 /CR/D0/CX/D2/CX/CR/CP/D0 /D9/D7/CT /D3/D6 /CX/D2 /D8/D6/CX/CP/D0/D7 /CU/D3/D6 /CW /D9/D1/CP/D2 /D8/CW/CT/D6/CP/D4 /DD/B4/BJ /A0 /BD/BG /B5/BA /CC/CW /D9/D7/B8 /D8/CW/CT/D6/CT /CX/D7 /CV /D3/D3/CS /D6/CT/CP/D7/D3/D2 /CU/D3/D6 /DB/CX/D7/CW/CX/D2/CV /CU/D3/D6/D6/CT/D0/CX/CP/CQ/D0/CT /CX/CS/CT/D2 /D8/CX/AC/CR/CP/D8/CX/D3/D2 /D3/CU /D8/CW/CT /CV/CT/D2/CT/D7 /CX/D2 /DA /D3/D0/DA /CT/CS/BA/C1/D2 /D8/CW/CT /D2/CT/DC/D8 /D7/CT/CR/D8/CX/D3/D2/B8 /DB /CT /CV/CX/DA /CT /CP /CR /CW/D6/D3/D2/D3/D0/D3/CV/CX/CR/CP/D0 /D6/CT/B9/DA/CX/CT/DB /D3/CU /D1/CX/CR/D6/D3/CP/D6/D6/CP /DD /CT/DC/D4/D6/CT/D7/D7/CX/D3/D2 /CT/DC/D4 /CT/D6/CX/D1/CT/D2 /D8/D7 /D8/D3 /CX/CS/CT/D2/B9/D8/CX/CU/DD /D6/CT/D8/CX/D2/D3/CX/CR /CP/CR/CX/CS /D6/CT/D7/D4 /D3/D2/D7/CX/DA /CT /CV/CT/D2/CT/D7/BA /C1/D2 /D8/CW/CT /CS/CX/D7/CR/D9/D7/D7/CX/D3/D2/D7/CT/CR/D8/CX/D3/D2/B8 /DB /CT /CT/DC/CP/D1/CX/D2/CT /D8/CW/CT /D1/CT/D8/CW/D3 /CS/D3/D0/D3/CV/DD /D3/CU /D1/CX/CR/D6/D3/CP/D6/D6/CP /DD/CT/DC/D4 /CT/D6/CX/D1/CT/D2 /D8/D7 /CT/DC/CT/D1/D4/D0/CX/AC/CT/CS /CQ /DD /D8/CW/CT/D7/CT /D7/D8/D9/CS/CX/CT/D7/BA/BX/DC/D4/D6/CT/D7/D7/CX/D3/D2 /BT/D2/CP/D0/DD/D7/CT/D7 /D3/CU /CA/BT/B9/D6/CT/D7/D4 /D3/D2/D7/CX/DA /CT /BZ/CT/D2/CT/D7/CC /CP/D1/CP /DD /D3 /CP/D2/CS /CR/D3/D0/D0/CT/CP/CV/D9/CT/D7 /B4/BD/BH /B5 /D7/D8/D9/CS/CX/CT/CS /CP/CR/D9/D8/CT /D4/D6/D3/D1 /DD /CT/D0/B9/A3/BV/D3/D6/D6/CT/D7/D4 /D3/D2/CS/CX/D2/CV /CP/D9/D8/CW/D3/D6/BA/BX/B9/D1/CP/CX/D0/BM /D1 /DB /CP/D0/CZ /CT/D6/BS/D7/D8/CP/D2/CU/D3/D6/CS/CP/D0/D9/D1/D2/CX/BA/D3/D6/CV /D3 /CR/DD/D8/CX/CR /D0/CT/D9/CZ /CT/D1/CX/CP /C6/BU/BG /CR/CT/D0/D0/D7 /D7/D8/CX/D1 /D9/D0/CP/D8/CT/CS /DB/CX/D8/CW /BD /AM/C5 /CA/BT/CU/D3/D6 /BC/B8 /BI/B8 /BE/BG/B8 /BG/BK/B8 /D3/D6 /BJ/BE /CW/BA /CC/CW/CT/CX/D6 /D7/D8/D9/CS/DD /CP/D0/D7/D3 /CX/D2/CR/D0/D9/CS/CT/CS/CR/D3/D1/D4/CP/D6/CP/D8/CX/DA /CT /CP/D2/CP/D0/DD/D7/CX/D7 /D3/CU /D8/CW/D6/CT/CT /D3/D8/CW/CT/D6 /CR/CT/D0/D0 /D8 /DD/D4 /CT/D7 /B4/C0/C4/B9/BI/BC/B8 /CD/BL/BF/BJ/B8 /CP/D2/CS /C2/D9/D6/CZ /CP/D8/B5 /D8/D6/CT/CP/D8/CT/CS /DB/CX/D8/CW /C8/C5/BT /CP/D8 /BC/B8 /BC/BA/BH/B8/BI/B8 /D3/D6 /BE/BG /CW/BA /CC/CW/CT/DD /D9/D7/CT/CS /D8/CW/CT /BT/AB/DD/D1/CT/D8/D6/CX/DC /C0/CD/BI/BC/BC/BC /CP/D6/D6/CP /DD /B8/DB/CW/CX/CR /CW /CR/D3/D2 /D8/CP/CX/D2/D7 /D4/D6/D3/CQ /CT/D7 /CU/D3/D6 /BI/B8/BG/BD/BI /CV/CT/D2/CT/D7/B8 /CP/D2/CS /CX/CS/CT/D2 /D8/CX/AC/CT/CS/CV/CT/D2/CT/D7 /D8/CW/CP/D8 /D7/CW/D3 /DB /CT/CS /CP /D8/CW/D6/CT/CT/B9/CU/D3/D0/CS /D6/CT/D0/CP/D8/CX/DA /CT /CR /CW/CP/D2/CV/CT /CX/D2 /CT/DC/B9/D4/D6/CT/D7/D7/CX/D3/D2 /CP/D2/CS /CP /BD/BC/BC/B9/D9/D2/CX/D8 /CP/CQ/D7/D3/D0/D9/D8/CT /CR /CW/CP/D2/CV/CT /CX/D2 /CT/DC/D4/D6/CT/D7/B9/D7/CX/D3/D2/BA /CC/CW/CT/DD /CR/D3/D2/AC/D6/D1/CT/CS /D6/CT/D7/D9/D0/D8/D7 /DB/CX/D8/CW /C6/D3/D6/D8/CW/CT/D6/D2 /CQ/D0/D3/D8/D7/BA/C1/D2 /CP /CR/D0/D9/D7/D8/CT/D6 /CP/D2/CP/D0/DD/D7/CX/D7/B8 /D8/CW/CT/DD /CX/CS/CT/D2 /D8/CX/AC/CT/CS /CP /CV/D6/D3/D9/D4 /D3/CU /BD/BH/BG/CV/CT/D2/CT/D7 /CX/D2/CS/D9/CR/CT/CS /CQ /DD /CA/BT /CX/D2 /C6/BU/BG /CR/CT/D0/D0/D7 /D8/CW/CP/D8 /DB /CT/D6/CT /D2/D3/D8 /D6/CT/CV/B9/D9/D0/CP/D8/CT/CS /CX/D2 /D8/CW/CT /D3/D8/CW/CT/D6 /D8/CW/D6/CT/CT /CR/CT/D0/D0 /D0/CX/D2/CT/D7/BA /CC/CW/CT /CS/CX/AB/CT/D6/CT/D2/B9/D8/CX/CP/D0/D0/DD /CT/DC/D4/D6/CT/D7/D7/CT/CS /CV/CT/D2/CT/D7 /CX/D2/CR/D0/D9/CS/CT/CS /D2/CT/D9/D8/D6/D3/D4/CW/CX/D0 /CS/CX/AB/CT/D6/CT/D2 /D8/CX/B9/CP/D8/CX/D3/D2 /D1/CP/D6/CZ /CT/D6/D7 /B4/CV/D6/CP/D2 /D9/D0/D3 /CR/DD/D8/CT /CR/D3/D0/D3/D2 /DD /D7/D8/CX/D1 /D9/D0/CP/D8/CX/D2/CV /CU/CP/CR/D8/D3/D6/D6/CT/CR/CT/D4/D8/D3/D6/B8 /BV/BW/BH/BL/B8 /CP/D2/CS /CS/CT/CU/CT/D2/D7/CX/D2 /CP/D0/D4/CW/CP /BG/B5/B8 /D7/D3/D1/CT /D4/D6/D3/D8/CT/CX/D2/D7/CZ/D2/D3 /DB/D2 /D8/D3 /CQ/CT /CA/BT/B9/CX/D2/CS/D9/CR/CT/CS /B4/CA/C1/BZ/B9/BX /CP/D2/CS /D8/CW/CT /CX/D2 /D8/CT/D6/CU/CT/D6/D3/D2/B9/CX/D2/CS/D9/CR/CX/CQ/D0/CT /CV/CT/D2/CT/D7 /C1/BY/C1/BH/BI/B8 /C1/C6/C8/BD/BC/B8 /CP/D2/CS /C1/CA/BY/BD/B5/B8 /CP/D2/CS /CV/CT/D2/CT/D7/D2/D3/D8 /D4/D6/CT/DA/CX/D3/D9/D7/D0/DD /D0/CX/D2/CZ /CT/CS /D8/D3 /CA/BT/B8 /CX/D2/CR/D0/D9/CS/CX/D2/CV /BZ/BC/CB/BE/B8 /CP/D2/CS /D8 /DB /D3/D4/D6/D3/D8/CT/D3/D0/DD/D7/CX/D7/B9/D6/CT/D0/CP/D8/CT/CS /CV/CT/D2/CT/D7/B8 /C4/C5/C8/BJ /CP/D2/CS /CD/BU/BX/BD/C4/BA/C4/CX/D9 /CP/D2/CS /CR/D3/D0/D0/CT/CP/CV/D9/CT/D7 /B4/BD/BI /B5 /CT/DC/CP/D1/CX/D2/CT/CS /CA/BT/B9/CX/D2/CS/D9/CR/CT/CS/CV/CT/D2/CT/D7 /CX/D2 /D8/CW/CT /D7/CP/D1/CT /C6/BU/BG /CR/CT/D0/D0 /D0/CX/D2/CT /CP/D7 /CS/CX/CS /CC /CP/D1/CP /DD /D3 /CP/D2/CS /CR/D3/D0/B9/D0/CT/CP/CV/D9/CT/D7/BA /CC/CW/CT/DD /CX/CS/CT/D2 /D8/CX/AC/CT/CS /CS/CX/AB/CT/D6/CT/D2 /D8/CX/CP/D0/D0/DD /CT/DC/D4/D6/CT/D7/D7/CT/CS /CV/CT/D2/CT/D7/D9/D7/CX/D2/CV /D1/CX/CR/D6/D3/CP/D6/D6/CP /DD/D7/B8 /D7/D9/CQ/D8/D6/CP/CR/D8/CX/DA /CT /CW /DD/CQ/D6/CX/CS/CX/DE/CP/D8/CX/D3/D2/B8 /CP/D2/CS/CS/CX/AB/CT/D6/CT/D2 /D8/CX/CP/D0/B9/CS/CX/D7/D4/D0/CP /DD/B9/D4 /D3/D0/DD/D1/CT/D6/CP/D7/CT /CR /CW/CP/CX/D2 /D6/CT/CP/CR/D8/CX/D3/D2/BA /BY /D3/D6/D8/CW/CT/CX/D6 /CP/D2/CP/D0/DD/D7/CX/D7/B8 /D8/CW/CT/DD /D9/D7/CT/CS /BV/D0/D3/D2 /D8/CT/CR /CW /D1/CT/D1 /CQ/D6/CP/D2/CT/D7 /CR/D3/D2/B9/D8/CP/CX/D2/CX/D2/CV /BH/BK/BK /CV/CT/D2/CT/D7 /CX/D2 /D8/D6/CX/D4/D0/CX/CR/CP/D8/CT /CT/DC/D4 /CT/D6/CX/D1/CT/D2 /D8/D7/BA /CC/CW/CT/DD/CU/D3/D9/D2/CS /BL/BL /D3/CU /D8/CW/CT /BH/BK/BK /CV/CT/D2/CT/D7 /CW/CP/CS /CV/D6/CT/CP/D8/CT/D6 /D8/CW/CP/D2 /D8 /DB /D3/B9/CU/D3/D0/CS/CR /CW/CP/D2/CV/CT/D7 /CX/D2 /CT/DC/D4/D6/CT/D7/D7/CX/D3/D2/BN /BF/BJ /DB /CT/D6/CT /D9/D4/B9/D6/CT/CV/D9/D0/CP/D8/CT/CS/B8 /CP/D2/CS /BI/BE/DB /CT/D6/CT /CS/D3 /DB/D2/D6/CT/CV/D9/D0/CP/D8/CT/CS/BA /CC/CW/CT/DD /CR/D3/D2/AC/D6/D1/CT/CS /CT/DC/D4/D6/CT/D7/D7/CX/D3/D2 /D3/CU /BK/D9/D4/B9/D6/CT/CV/D9/D0/CP/D8/CT/CS /CP/D2/CS /BE/CS /D3 /DB/D2/B9/D6/CT/CV/D9/D0/CP/D8/CT/CS /CV/CT/D2/CT/D7 /CQ /DD/CA /CC/B9/C8/BV/CA/BA/CB/D9/CQ/D8/D6/CP/CR/D8/CX/DA /CT /CW /DD/CQ/D6/CX/CS/CX/DE/CP/D8/CX/D3/D2 /DD/CX/CT/D0/CS/CT/CS /BJ/BC/BF /CR/D0/D3/D2/CT/D7/B8 /DB/CW/CX/CR /CW/CP/D7/D7/CT/D1 /CQ/D0/CT/CS /CX/D2 /D8/D3 /BF/BD/BI /CR/D3/D2 /D8/CX/CV/D7/BA /BD/BH/BL /DB /CT/D6/CT /CZ/D2/D3 /DB/D2 /CV/CT/D2/CT/D7/B8 /BE/BH/DB /CT/D6/CT /D1/CX/D8/D3 /CR /CW/D3/D2/CS/D6/CX/CP/D0/B8 /D6/CX/CQ /D3/D7/D3/D1/CP/D0 /D3/D6 /BT/C4/CD /D6/CT/D4 /CT/CP/D8/D7/B8 /CP/D2/CS/BZ/CT/D2/D3/BA/B8 /C8/D6/D3/D8/BA /B2 /BU/CX/D3/CX/D2/CU/D3/BA /CE /D3/D0/BA /BD/BA /C6/D3/BA /BD /BY /CT/CQ/D6/D9/CP/D6/DD /BE/BC/BC/BF /BLThis is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e4/5d/main.PMC5171945.pdf
3 August 2003This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bf/6e/main.PMC5172238.pdf
"We analyzed the possible recombination between the SARS-CoV and other viruses, especially other coronaviruses by using the software of SIMPLOT (version 2.5, http://sray.med.som.jhmi.edu/RaySoft/ SimPlot/), but didn't ¯nd any hint of recombinations between the SARS-CoV and other viruses.",OADS,/arxiv_data1/oa_pdf/bf/6e/main.PMC5172238.pdf
"Supporting Online Material http://www.gpbjournal.org/journal/pdf/ GPB1(3)-06.pdf Table S1 Geno., Prot.",Non-OADS,/arxiv_data1/oa_pdf/bf/6e/main.PMC5172238.pdf
3 August 2003This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9d/60/main.PMC5172239.pdf
"FGENESV, a program for gene predic- tion provided by Softberry Inc. (Mount Kisco, USA) through a web-based interface, has been spe- cially modi¯ed and trained with parameters for virus (http://www.softberry.com/berry.phtml?topic=g¯n dv).",OADS,/arxiv_data1/oa_pdf/9d/60/main.PMC5172239.pdf
"BGFV is a program developed by Beijing Ge- nomics Institute, based on the self-organizing theory (http://arxiv.org/abs/physics/0102048).",Non-OADS,/arxiv_data1/oa_pdf/9d/60/main.PMC5172239.pdf
3 August 2003This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ef/99/main.PMC5172240.pdf
"CROSSMATCH (Phil Green, unpublished, http://bozeman.mbt.washington.edu/phrap.docs/ phrap.html) is used to mask vector sequences into \X"".",OADS,/arxiv_data1/oa_pdf/ef/99/main.PMC5172240.pdf
"Sequence assembly The AssembleStat module calls PHRAP (Phil Green, unpublished, http://bozeman.mbt.washington.edu/ phrap.docs/phrap.html) or CAP3 to assemble the EST sequences into consensi (contigs) according to the user preference, and distills the assembly infor- mation.",OADS,/arxiv_data1/oa_pdf/ef/99/main.PMC5172240.pdf
4 November 2003 243This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9c/b4/main.PMC5172241.pdf
/C1/D2 /DA/CX/D8/CT/CS /BT/D6/D8/CX/CR/D0/CT/CC/CW/CT /C5 /C8/D6/D3/D8/CT/CX/D2 /D3/CU /CB/BT/CA/CB/B9/BV/D3/CE/BM /BU/CP/D7/CX/CR /CB/D8/D6/D9/CR/D8/D9/D6/CP/D0 /CP/D2/CS /C1/D1/D1 /D9/D2/D3/D0/D3/CV/CX/CR/CP/D0/C8/D6/D3/D4 /CT/D6/D8/CX/CT/D7/CH /D3/D2/CV/DB/D9 /C0/D9 /BD/BN/BE/B6/B8 /C2/CX/CT /CF /CT/D2 /BD/B6/B8 /C4/CX/D2 /CC /CP/D2/CV /BD/B6/B8 /C0/CP/CX/CY/D9/D2 /CI/CW/CP/D2/CV /BD/B6/B8 /CG/CX/CP/D3 /DB /CT/CX /CI/CW/CP/D2/CV /BD/B8 /CH /CP/D2 /C4/CX /BD/B8 /C2/CX/D2/CV /CF /CP/D2/CV /BD/BN/BF/B8 /CH /D9/CY/D9/D2/C0/CP/D2 /BD/B8 /BZ/D9/D3 /D5/CX/D2/CV /C4/CX /BD/B8 /C2/CX/CP/D2/D4/CX/D2/CV /CB/CW/CX /BD/B8 /CG/CX/CP/D2/CV /CY/D9/D2 /CC/CX/CP/D2 /BD/BN/BE/B8 /BY /CT/D2/CV /C2/CX/CP/D2/CV /BD/B8 /CG/CX/CP/D3 /D5/CX/CP/D2 /CI/CW/CP/D3 /BD/B8 /C2/D9/D2 /CF /CP/D2/CV /BD/B8 /CB/CX/D5/CX /C4/CX/D9 /BD/B8/BV/CW/CP/D2/CV/D5/CX/D2/CV /CI/CT/D2/CV /BD/B8 /C2/CX/CP/D2 /CF /CP/D2/CV /BD/BN/BE/B8 /CP/D2/CS /C0/D9/CP/D2/D1/CX/D2/CV /CH /CP/D2/CV /BD/BN/BE/AZ/BD/BU/CT/CX/CY/CX/D2/CV /BZ/CT/D2/D3/D1/CX/CR/D7 /C1/D2/D7/D8/CX/D8/D9/D8/CT/B8 /BV/CW/CX/D2/CT/D7/CT /BT /CR /CP/CS/CT/D1/DD /D3/CU /CB/CR/CX/CT/D2/CR /CT/D7/B8 /BU/CT/CX/CY/CX/D2/CV /BD/BC/BD/BF/BC/BC/B8 /BV/CW/CX/D2/CP/BN /BE/C2/CP/D1/CT/D7 /BW/BA /CF/CP/D8/D7/D3/D2 /C1/D2/D7/D8/CX/B9/D8/D9/D8/CT /D3/CU /BZ/CT/D2/D3/D1/CT /CB/CR/CX/CT/D2/CR /CT/D7/B8 /CI/CW/CX/CY/CX/CP/D2/CV /BV/CP/D1/D4/D9/D7/B8 /CI/CW/CT/CY/CX/CP/D2/CV /CD/D2/CX/DA/CT/D6/D7/CX/D8/DD /CP/D2/CS /C0/CP/D2/CV/DE/CW/D3/D9 /BZ/CT/D2/D3/D1/CX/CR/D7 /C1/D2/D7/D8/CX/D8/D9/D8/CT/B8 /C0/CP/D2/CV/DE/CW/D3/D9/BF/BD/BC/BC/BC/BK/B8 /BV/CW/CX/D2/CP/BN /BF/BV/D3/D0 /D0/CT /CV/CT /D3/CU /C4/CX/CU/CT /CB/CR/CX/CT/D2/CR /CT/D7/B8 /C8/CT/CZ/CX/D2/CV /CD/D2/CX/DA/CT/D6/D7/CX/D8/DD/B8 /BU/CT/CX/CY/CX/D2/CV /BD/BC/BC/BK/BJ/BD/B8 /BV/CW/CX/D2/CP/BA/CF /CT /D7/D8/D9/CS/CX/CT/CS /D7/D8/D6/D9/CR/D8/D9/D6/CP/D0 /CP/D2/CS /CX/D1/D1 /D9/D2/D3/D0/D3/CV/CX/CR/CP/D0 /D4/D6/D3/D4 /CT/D6/D8/CX/CT/D7 /D3/CU /D8/CW/CT /CB/BT/CA/CB/B9/BV/D3/CE /C5 /B4/D1/CT/D1/B9/CQ/D6/CP/D2/CT/B5 /D4/D6/D3/D8/CT/CX/D2/B8 /CQ/CP/D7/CT/CS /D3/D2 /CR/D3/D1/D4/CP/D6/CP/D8/CX/DA /CT /CP/D2/CP/D0/DD/D7/CT/D7 /D3/CU /D7/CT/D5/D9/CT/D2/CR/CT /CU/CT/CP/D8/D9/D6/CT/D7/B8 /D4/CW /DD/D0/D3/CV/CT/D2/CT/D8/CX/CR/CX/D2 /DA /CT/D7/D8/CX/CV/CP/D8/CX/D3/D2/B8 /CP/D2/CS /CT/DC/D4 /CT/D6/CX/D1/CT/D2 /D8/CP/D0 /D6/CT/D7/D9/D0/D8/D7/BA /CC/CW/CT /C5 /D4/D6/D3/D8/CT/CX/D2 /CX/D7 /D4/D6/CT/CS/CX/CR/D8/CT/CS /D8/D3 /CR/D3/D2 /D8/CP/CX/D2 /CP/D8/D6/CX/D4/D0/CT/B9/D7/D4/CP/D2/D2/CX/D2/CV /D8/D6/CP/D2/D7/D1/CT/D1 /CQ/D6/CP/D2/CT /B4/CC/C5/B5 /D6/CT/CV/CX/D3/D2/B8 /CP /D7/CX/D2/CV/D0/CT /C6/B9/CV/D0/DD/CR/D3/D7/DD/D0/CP/D8/CX/D3/D2 /D7/CX/D8/CT /D2/CT/CP/D6 /CX/D8/D7/C6/B9/D8/CT/D6/D1/CX/D2 /D9/D7 /D8/CW/CP/D8 /CX/D7 /CX/D2 /D8/CW/CT /CT/DC/D8/CT/D6/CX/D3/D6 /D3/CU /D8/CW/CT /DA/CX/D6/CX/D3/D2/B8 /CP/D2/CS /CP /D0/D3/D2/CV /BV/B9/D8/CT/D6/D1/CX/D2/CP/D0 /D6/CT/CV/CX/D3/D2 /CX/D2/D8/CW/CT /CX/D2 /D8/CT/D6/CX/D3/D6/BA /CC/CW/CT /C5 /D4/D6/D3/D8/CT/CX/D2 /CW/CP/D6/CQ /D3/D6/D7 /CP /CW/CX/CV/CW/CT/D6 /D7/D9/CQ/D7/D8/CX/D8/D9/D8/CX/D3/D2 /D6/CP/D8/CT /B4/BC/BA/BI/B1 /CR/D3/D6/D6/CT/D0/CP/D8/CT/CS /D8/D3/CX/D8/D7 /D7/CX/DE/CT/B5 /CP/D1/D3/D2/CV /DA/CX/D6/CP/D0 /D3/D4 /CT/D2 /D6/CT/CP/CS/CX/D2/CV /CU/D6/CP/D1/CT/D7 /B4/C7/CA/BY/D7/B5 /CU/D6/D3/D1 /D4/D9/CQ/D0/CX/D7/CW/CT/CS /CS/CP/D8/CP/BA /CC/CW/CT /CU/D3/D9/D6/D7/D9/CQ/D7/D8/CX/D8/D9/D8/CX/D3/D2/D7 /CS/CT/D8/CT/CR/D8/CT/CS /CX/D2 /D8/CW/CT /C5 /D4/D6/D3/D8/CT/CX/D2/B8 /DB/CW/CX/CR /CW /CR/CP/D9/D7/CT /D2/D3/D2/B9/D7/DD/D2/D3/D2 /DD/D1/D3/D9/D7 /CR /CW/CP/D2/CV/CT/D7/B8/CR/CP/D2 /CQ/CT /CR/D0/CP/D7/D7/CX/AC/CT/CS /CX/D2 /D8/D3 /D8/CW/D6/CT/CT /D8 /DD/D4 /CT/D7/BA /C7/D2/CT /D3/CU /D8/CW/CT/D1 /D6/CT/D7/D9/D0/D8/D7 /CX/D2 /CR /CW/CP/D2/CV/CT/D7 /D3/CU /D4/C1 /B4/CX/D7/D3 /CT/D0/CT/CR/D8/D6/CX/CR/D4/D3 /CX /D2 /D8/B5 /CP/D2/CS /CR /CW/CP/D6/CV/CT/B8 /CP/AB/CT/CR/D8/CX/D2/CV /CP/D2 /D8/CX/CV/CT/D2/CX/CR/CX/D8 /DD /BA /CC/CW/CT /D7/CT/CR/D3/D2/CS /CR /CW/CP/D2/CV/CT/D7 /CW /DD/CS/D6/D3/D4/CW/D3/CQ/CX/CR/CX/D8 /DD /D3/CU /D8/CW/CT/CC/C5 /D6/CT/CV/CX/D3/D2/B8 /CP/D2/CS /D8/CW/CT /D8/CW/CX/D6/CS /D3/D2/CT /D6/CT/D0/CP/D8/CT/D7 /D8/D3 /CW /DD/CS/D6/D3/D4/CW/CX/D0/CX/CR/CX/D8 /DD /D3/CU /D8/CW/CT /CX/D2 /D8/CT/D6/CX/D3/D6 /D7/D8/D6/D9/CR/D8/D9/D6/CT/BA/C8/CW /DD/D0/D3/CV/CT/D2/CT/D8/CX/CR /D8/D6/CT/CT /CQ/D9/CX/D0/CS/CX/D2/CV /CQ/CP/D7/CT/CS /D3/D2 /D8/CW/CT /DA /CP/D6/CX/CP/D8/CX/D3/D2/D7 /D3/CU /D8/CW/CT /C5 /D4/D6/D3/D8/CT/CX/D2 /CP/D4/D4 /CT/CP/D6/D7 /D8/D3/D7/D9/D4/D4 /D3/D6/D8 /D8/CW/CT /D2/D3/D2/B9/CW /D9/D1/CP/D2 /D3/D6/CX/CV/CX/D2 /D3/CU /CB/BT/CA/CB/B9/BV/D3/CE/BA /CC /D3 /CX/D2 /DA /CT/D7/D8/CX/CV/CP/D8/CT /CX/D8/D7 /CX/D1/D1 /D9/D2/D3/CV/CT/D2/CX/CR/CX/D8 /DD /B8/DB /CT /D7/DD/D2 /D8/CW/CT/D7/CX/DE/CT/CS /CT/CX/CV/CW /D8 /D3/D0/CX/CV/D3/D4 /CT/D4/D8/CX/CS/CT/D7 /CR/D3 /DA /CT/D6/CX/D2/CV /BI/BL/BA/BE/B1 /D3/CU /D8/CW/CT /CT/D2 /D8/CX/D6/CT /C7/CA/BY /CP/D2/CS /D7/CR/D6/CT/CT/D2/CT/CS/D8/CW/CT/D1 /CQ /DD /D9/D7/CX/D2/CV /BX/C4/C1/CB/BT /B4/CT/D2/DE/DD/D1/CT/B9/D0/CX/D2/CZ /CT/CS /CX/D1/D1 /D9/D2/D3/D7/D3/D6/CQ /CT/D2 /D8 /CP/D7/D7/CP /DD/B5 /DB/CX/D8/CW /D7/CT/D6/CP /CU/D6/D3/D1 /CB/BT/CA/CB/D4/CP/D8/CX/CT/D2 /D8/D7/BA /CC/CW/CT /D6/CT/D7/D9/D0/D8/D7 /CR/D3/D2/AC/D6/D1/CT/CS /D3/D9/D6 /D4/D6/CT/CS/CX/CR/D8/CX/D3/D2/D7 /D3/D2 /CP/D2 /D8/CX/CV/CT/D2/CX/CR /D7/CX/D8/CT/D7/BA/C3/CT/DD /DB /D3/D6/CS/D7/BM /CB/BT/CA/CB/B9/BV/D3/CE/B8 /D8/CW/CT /C5 /D4/D6/D3/D8/CT/CX/D2/B8 /CT/D2/DE/DD/D1/CT /CX/D1/D1 /D9/D2/D3/CP/D7/D7/CP /DD /B8 /CP/D2 /D8/CX/CV/CT/D2/CX/CR/CX/D8 /DD/C1/D2 /D8/D6/D3 /CS/D9/CR/D8/CX/D3/D2/C1/D2 /D8/CW/CT /CT/DC/D8/CT/D2/D7/CX/DA /CT /D4/D6/D3 /CR/CT/D7/D7/CT/D7 /D3/CU /CT/DA /D3/D0/D9/D8/CX/D3/D2/B8 /D1/CP/D2 /DD /DA/CX/D6/D9/D7/CT/D7/CP/CR/D5/D9/CX/D6/CT /CP /D0/CX/D4/CX/CS /CQ/CX/D0/CP /DD /CT/D6 /CU/D6/D3/D1 /D8/CW/CT/CX/D6 /CW/D3/D7/D8 /CR/CT/D0/D0/D7/BA /BT /D7/D4 /CT/CR/CX/CP/D0/D4/D6/D3/D8/CT/CR/D8/CX/DA /CT /CP/D2/CS /CU/D9/D2/CR/D8/CX/D3/D2/CP/D0 /D1/D3/D7/CP/CX/CR /D7/D8/D6/D9/CR/D8/D9/D6/CT /CX/D7 /D8/CW/CT/D6/CT/CQ /DD/CU/D3/D6/D1/CT/CS /DB/CX/D8/CW /D8/CW/CT /DA/CX/D6/CP/D0 /D7/D8/D6/D9/CR/D8/D9/D6/CP/D0 /D4/D6/D3/D8/CT/CX/D2/D7 /D8/CW/CP/D8 /CP/D6/CT /CX/D2/B9/D8/CT/CV/D6/CP/D8/CT/CS /CX/D2 /D8/D3 /D8/CW/CT /D1/CT/D1 /CQ/D6/CP/D2/D3/D9/D7 /CT/D2 /DA /CT/D0/D3/D4 /CT/BA /CC/CW/CT /DA/CX/D6/CP/D0/D1/CT/D1 /CQ/D6/CP/D2/CT /D4/D6/D3/D8/CT/CX/D2/D7 /D3/CU/D8/CT/D2 /D6/CT/D7/CT/D1 /CQ/D0/CT /D8/CW/CT/CX/D6 /CW/D3/D7/D8 /CR/D3/D9/D2 /D8/CT/D6/B9/D4/CP/D6/D8/D7 /CX/D2 /D8/CW/CT /D7/D8/D6/D9/CR/D8/D9/D6/CT /CP/D2/CS /CU/D9/D2/CR/D8/CX/D3/D2/D7 /B4/BD /B5/BA/CC/CW/CT /C5 /B4/D1/CT/D1 /CQ/D6/CP/D2/CT/B5 /D4/D6/D3/D8/CT/CX/D2 /B4/CP/D0/D7/D3 /CZ/D2/D3 /DB/D2 /CP/D7 /BX/BD/D1/CT/D1 /CQ/D6/CP/D2/CT /CV/D0/DD/CR/D3/D4/D6/D3/D8/CT/CX/D2 /D3/D6 /D1/CP/D8/D6/CX/DC /D4/D6/D3/D8/CT/CX/D2/B5 /CX/D7 /D3/D2/CT /D3/CU/D1/CP /CY/D3/D6 /D1/CT/D1 /CQ/D6/CP/D2/CT /D4/D6/D3/D8/CT/CX/D2/D7 /D3/CU /D8/CW/CT /CR/D3/D6/D3/D2/CP /DA/CX/D6/D9/D7 /D8/D3/CV/CT/D8/CW/CT/D6/B6 /CC/CW/CT/D7/CT /CP/D9/D8/CW/D3/D6/D7 /CR/D3/D2 /D8/D6/CX/CQ/D9/D8/CT/CS /CT/D5/D9/CP/D0/D0/DD /D8/D3 /D8/CW/CX/D7/DB /D3/D6/CZ/BA/AZ/BV/D3/D6/D6/CT/D7/D4 /D3/D2/CS/CX/D2/CV /CP/D9/D8/CW/D3/D6/BA/BX/B9/D1/CP/CX/D0/BM /DD /CP/D2/CV/CW/D1/BS/CV/CT/D2/D3/D1/CX/CR/D7/BA/D3/D6/CV/BA/CR/D2 /DB/CX/D8/CW /D8/CW/CT /CB /B4/D7/D4/CX/CZ /CT/B5 /CP/D2/CS /D8/CW/CT /BX /B4/CT/D2 /DA /CT/D0/D3/D4 /CT/B5 /D4/D6/D3/D8/CT/CX/D2/D7 /B4/BE /B5/BA/C1/D8 /CW/CP/D7 /CQ /CT/CT/D2 /D4 /D3/D7/D8/D9/D0/CP/D8/CT/CS /D8/CW/CP/D8 /D8/CW/CT /C5 /D4/D6/D3/D8/CT/CX/D2 /CX/D7 /D6/CT/D0/CP/D8/CT/CS/D8/D3 /DA/CX/D6/CP/D0 /CX/D2/CU/CT/CR/D8/CX/DA/CX/D8 /DD /D8/CW/D6/D3/D9/CV/CW /CQ/CX/D2/CS/CX/D2/CV /D8/D3 /D8/CW/CT /DA/CX/D6/CP/D0 /CB /D4/D6/D3/B9/D8/CT/CX/D2 /CP/D2/CS /D8/CW/CT /CW/D3/D7/D8 /D7/D9/D6/CU/CP/CR/CT /D6/CT/CR/CT/D4/D8/D3/D6/B4/D7/B5/B8 /D8/CW /D9/D7 /D4/D6/D3/D1/D3/D8/CX/D2/CV/D1/CT/D1 /CQ/D6/CP/D2/CT /CU/D9/D7/CX/D3/D2 /B4/BD /BN /BF /B5/BA /C1/D8 /CP/D4/D4 /CT/CP/D6/D7 /D8/D3 /CQ/CT /CX/D2 /DA /D3/D0/DA /CT/CS /CX/D2/D8/CW/CT /CP/D2 /D8/CX/CV/CT/D2/CX/CR/CX/D8 /DD /CS/CT/D1/D3/D2/D7/D8/D6/CP/D8/CT/CS /CQ /DD /D8/CW/CT /DA/CX/D6/D9/D7/B9/CX/D2/CS/D9/CR/CT/CS/CX/D1/D1 /D9/D2/CT /D6/CT/D7/D4 /D3/D2/D7/CT/D7 /D3/CU /D8/CW/CT /CW/D3/D7/D8/BA /BT/D7 /D8/CW/CT /D1/D3/D7/D8 /CP/CQ/D9/D2/CS/CP/D2 /D8/D4/D6/D3/D8/CT/CX/D2 /CX/D2 /D8/CW/CT /DA/CX/D6/CX/D3/D2 /D3/CU /CR/D3/D6/D3/D2/CP /DA/CX/D6/D9/D7/CT/D7/B8 /D8/CW/CT /C5 /D4/D6/D3/D8/CT/CX/D2/D1/CP /DD /CP/D0/D7/D3 /CQ/CT /D3/D2/CT /D3/CU /D8/CW/CT /CZ /CT/DD /CR/D3/D1/D4 /D3/D2/CT/D2 /D8/D7 /CX/D2 /DA/CX/D6/CP/D0 /CP/D7/B9/D7/CT/D1 /CQ/D0/DD /CP/D2/CS /D1/D3/D6/D4/CW/D3/CV/CT/D2/CT/D7/CX/D7/B8 /CX/D2 /DA /D3/D0/DA /CT/CS /CX/D2 /D6/CT/CV/D9/D0/CP/D8/CX/D3/D2 /D3/CU/D6/CT/D4/D0/CX/CR/CP/D8/CX/D3/D2 /CP/D2/CS /D4/CP/CR /CZ/CX/D2/CV /D8/CW/CT /CV/CT/D2/D3/D1/CX/CR /CA/C6/BT /CX/D2 /D8/D3 /DA/CX/D6/CP/D0/D4/CP/D6/D8/CX/CR/D0/CT/D7 /B4/BG /BN /BH /B5/BA/CF /CT /D6/CT/D4 /D3/D6/D8 /CW/CT/D6/CT/CX/D2 /D8/CW/CT /CR/D3/D1/D4/D6/CT/CW/CT/D2/D7/CX/DA /CT /CP/D2/CP/D0/DD/D7/CT/D7 /D3/CU/D8/CW/CT /C5 /D4/D6/D3/D8/CT/CX/D2 /CQ/CP/D7/CT/CS /D3/D2 /D8/CW/CT /D7/CX/DC/D8/CT/CT/D2 /AC/D6/D7/D8 /D6/CT/D4 /D3/D6/D8/CT/CS/CB/BT/CA/CB/B9/BV/D3/CE /CV/CT/D2/D3/D1/CT /D7/CT/D5/D9/CT/D2/CR/CT/D7/B8 /CP/D7 /DB /CT/D0/D0 /CP/D7 /D7/CT/DA /CT/D2 /D8/CT/CT/D2/D1/CT/D1 /CQ /CT/D6/D7 /D3/CU /BV/D3/D6 /D3/D2/CP/DA/CX/D6/CX/CS/CP/CT /CP/D2/CS /BF/BI/BD /D3/D8/CW/CT/D6 /D7/CX/D2/CV/D0/CT/B9/D7/D8/D6/CP/D2/CS /CA/C6/BT /B4/D7/D7/CA/C6/BT/B5 /DA/CX/D6/D9/D7/CT/D7/BA/BD/BD/BK /BZ/CT/D2/D3/BA/B8 /C8/D6/D3/D8/BA /B2 /BU/CX/D3/CX/D2/CU/D3/BA /CE /D3/D0/BA /BD /C6/D3/BA /BE /C5/CP /DD /BE/BC/BC/BFThis is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bc/2d/main.PMC5172243.pdf
/C1/D2 /DA/CX/D8/CT/CS /BT/D6/D8/CX/CR/D0/CT/CC/CW/CT /CA /C8/D6/D3/D8/CT/CX/D2 /D3/CU /CB/BT/CA/CB/B9/BV/D3/CE/BM /BT/D2/CP/D0/DD/D7/CT/D7 /D3/CU /CB/D8/D6/D9/CR/D8/D9/D6/CT /CP/D2/CS /BY /D9/D2/CR/D8/CX/D3/D2/BU/CP/D7/CT/CS /D3/D2 /BY /D3/D9/D6 /BV/D3/D1/D4/D0/CT/D8/CT /BZ/CT/D2/D3/D1/CT /CB/CT/D5/D9/CT/D2/CR/CT/D7 /D3/CU /C1/D7/D3/D0/CP/D8/CT/D7 /BU/C2/BC/BD/B9/BU/C2/BC/BG/CI/D9/DD/D9/CP/D2 /CG/D9 /BD/BN/BE/B6/B8 /C0/CP/CX/D5/CX/D2/CV /CI/CW/CP/D2/CV /BD/B6/B8 /CG/CX/CP/D2/CV /CY/D9/D2 /CC/CX/CP/D2 /BE/BN/BD/B6/B8 /C2/CX/CP /C2/CX /BD/B6/B8 /CF /CT/CX /C4/CX /BD/B8 /CH /CP/D2 /C4/CX /BD/B8 /CF /CT/CX /CC/CX/CP/D2 /BD/BN/BE/BN/BF/B8 /CH /D9/CY/D9/D2 /C0/CP/D2 /BD/B8/C4/CX/D0/CX /CF /CP/D2/CV /BD/B8 /CI/CX/DE/CW/CP/D2/CV /CI/CW/CP/D2/CV /BE/B8 /C2/CX/D2/CV /CG/D9 /BD/B8 /CF /CT/CX /CF /CT/CX /BE/B8 /C2/CX/D2/CV/D9/CX /CI/CW /D9 /BD/B8 /C0/CP/CX/DD /CP/D2 /CB/D9/D2 /BD/B8 /CG/CX/CP/D3 /DB /CT/CX /CI/CW/CP/D2/CV /BD/B8 /C2/D9/D2 /CI/CW/D3/D9 /BD/B8/CB/D3/D2/CV/CV/CP/D2/CV /C4/CX /BD/BN/BG/B8 /C2/D9/D2 /CF /CP/D2/CV /BD/B8 /C2/CX/CP/D2 /CF /CP/D2/CV /BD/BN/BE/B8 /CB/CW/CT/D2/CV/D0/CX /BU/CX /BH/B8 /CP/D2/CS /C0/D9/CP/D2/D1/CX/D2/CV /CH /CP/D2/CV /BD/BN/BE/AZ/BD/BU/CT/CX/CY/CX/D2/CV /BZ/CT/D2/D3/D1/CX/CR/D7 /C1/D2/D7/D8/CX/D8/D9/D8/CT/B8 /BV/CW/CX/D2/CT/D7/CT /BT /CR /CP/CS/CT/D1/DD /D3/CU /CB/CR/CX/CT/D2/CR /CT/D7/B8 /BU/CT/CX/CY/CX/D2/CV /BD/BC/BD/BF/BC/BC/B8 /BV/CW/CX/D2/CP/BN /BE/C2/CP/D1/CT/D7 /BW/BA /CF/CP/D8/D7/D3/D2/C1/D2/D7/D8/CX/D8/D9/D8/CT /D3/CU /BZ/CT/D2/D3/D1/CT /CB/CR/CX/CT/D2/CR /CT/D7/B8 /CI/CW/CX/CY/CX/CP/D2/CV /BV/CP/D1/D4/D9/D7/B8 /CI/CW/CT/CY/CX/CP/D2/CV /CD/D2/CX/DA/CT/D6/D7/CX/D8/DD/B8 /C0/CP/D2/CV/DE/CW/D3/D9 /BF/BD/BC/BC/BC/BK/B8 /BV/CW/CX/D2/CP/BN /BF/C5/CT /CS/CX/CR /CP/D0/BV/D3/D0 /D0/CT /CV/CT/B8 /CG/CX/B3/CP/D2 /C2/CX/CP/D3/D8/D3/D2/CV /CD/D2/CX/DA/CT/D6/D7/CX/D8/DD/B8 /CG/CX/B3/CP/D2 /BJ/BD/BC/BC/BG/BL/B8 /BV/CW/CX/D2/CP/BN /BG/BV/D3/D0 /D0/CT /CV/CT /D3/CU /C4/CX/CU/CT /CB/CR/CX/CT/D2/CR /CT/D7/B8 /C8/CT/CZ/CX/D2/CV /CD/D2/CX/DA/CT/D6/D7/CX/D8/DD/B8/BU/CT/CX/CY/CX/D2/CV /BD/BC/BC/BK/BJ/BD/B8 /BV/CW/CX/D2/CP/BN /BH/BV/CT/D2/D8/CT/D6 /D3/CU /BW/CX/D7/CT /CP/D7/CT /BV/D3/D2/D8/D6 /D3/D0 /CP/D2/CS /C8/D6 /CT/DA/CT/D2/D8/CX/D3/D2/B8 /BU/CT/CX/CY/CX/D2/CV /BD/BC/BC/BC/BH/BC/B8 /BV/CW/CX/D2/CP/BA/CC/CW/CT /CA /B4/D6/CT/D4/D0/CX/CR/CP/D7/CT/B5 /D4/D6/D3/D8/CT/CX/D2 /CX/D7 /D8/CW/CT /D9/D2/CX/D5/D9/CT/D0/DD /CS/CT/AC/D2/CT/CS /D2/D3/D2/B9/D7/D8/D6/D9/CR/D8/D9/D6/CP/D0 /D4/D6/D3/D8/CT/CX/D2 /B4/C6/CB/C8/B5/D6/CT/D7/D4 /D3/D2/D7/CX/CQ/D0/CT /CU/D3/D6 /CA/C6/BT /D6/CT/D4/D0/CX/CR/CP/D8/CX/D3/D2/B8 /D1 /D9/D8/CP/D8/CX/D3/D2 /D6/CP/D8/CT /D3/D6 /AC/CS/CT/D0/CX/D8 /DD /B8 /D6/CT/CV/D9/D0/CP/D8/CX/D3/D2 /D3/CU /D8/D6/CP/D2/D7/CR/D6/CX/D4/B9/D8/CX/D3/D2 /CX/D2 /CR/D3/D6/D3/D2/CP /DA/CX/D6/D9/D7/CT/D7 /CP/D2/CS /D1/CP/D2 /DD /D3/D8/CW/CT/D6 /D7/D7/CA/C6/BT /DA/CX/D6/D9/D7/CT/D7/BA /BU/CP/D7/CT/CS /D3/D2 /D3/D9/D6 /CR/D3/D1/D4/D0/CT/D8/CT/CV/CT/D2/D3/D1/CT /D7/CT/D5/D9/CT/D2/CR/CT/D7 /D3/CU /CU/D3/D9/D6 /CX/D7/D3/D0/CP/D8/CT/D7 /B4/BU/C2/BC/BD/B9/BU/C2/BC/BG/B5 /D3/CU /CB/BT/CA/CB/B9/BV/D3/CE /CU/D6/D3/D1 /BU/CT/CX/CY/CX/D2/CV/B8 /BV/CW/CX/D2/CP/B8/DB /CT /CP/D2/CP/D0/DD/DE/CT/CS /D8/CW/CT /D7/D8/D6/D9/CR/D8/D9/D6/CT /CP/D2/CS /D4/D6/CT/CS/CX/CR/D8/CT/CS /CU/D9/D2/CR/D8/CX/D3/D2/D7 /D3/CU /D8/CW/CT /CA /D4/D6/D3/D8/CT/CX/D2 /CX/D2 /CR/D3/D1/D4/CP/D6/CX/D7/D3/D2/DB/CX/D8/CW /BD/BF /D3/D8/CW/CT/D6 /CX/D7/D3/D0/CP/D8/CT/D7 /D3/CU /CB/BT/CA/CB/B9/BV/D3/CE /CP/D2/CS /BI /D3/D8/CW/CT/D6 /CR/D3/D6/D3/D2/CP /DA/CX/D6/D9/D7/CT/D7/BA /CC/CW/CT /CT/D2 /D8/CX/D6/CT /C7/CA/BY/B4/D3/D4 /CT/D2/B9/D6/CT/CP/CS/CX/D2/CV /CU/D6/CP/D1/CT/B5 /CT/D2/CR/D3 /CS/CT/D7 /CU/D3/D6 /D8 /DB /D3 /D1/CP /CY/D3/D6 /CT/D2/DE/DD/D1/CT /CP/CR/D8/CX/DA/CX/D8/CX/CT/D7/B8 /CA/C6/BT/B9/CS/CT/D4 /CT/D2/CS/CT/D2 /D8/CA/C6/BT /D4 /D3/D0/DD/D1/CT/D6/CP/D7/CT /B4/CA/CS/CA/D4/B5 /CP/D2/CS /D4/D6/D3/D8/CT/CX/D2/CP/D7/CT /CP/CR/D8/CX/DA/CX/D8/CX/CT/D7/BA /CC/CW/CT /CA /D4 /D3/D0/DD/D4/D6/D3/D8/CT/CX/D2 /D9/D2/CS/CT/D6/B9/CV/D3 /CT/D7 /CP /CR/D3/D1/D4/D0/CT/DC /D4/D6/D3/D8/CT/D3/D0/DD/D8/CX/CR /D4/D6/D3 /CR/CT/D7/D7 /D8/D3 /D4/D6/D3 /CS/D9/CR/CT /BD/BH /CU/D9/D2/CR/D8/CX/D3/D2/B9/D6/CT/D0/CP/D8/CT/CS /D4 /CT/D4/D8/CX/CS/CT/D7/BA /BT/CW /DD/CS/D6/D3/D4/CW/D3/CQ/CX/CR /CS/D3/D1/CP/CX/D2 /B4/C0/C7/BW/B5 /CP/D2/CS /CP /CW /DD/CS/D6/D3/D4/CW/CX/D0/CX/CR /CS/D3/D1/CP/CX/D2 /B4/C0/C1/BW/B5 /CP/D6/CT /D2/CT/DB/D0/DD /CX/CS/CT/D2 /D8/CX/AC/CT/CS/DB/CX/D8/CW/CX/D2 /C6/CB/C8/BD/BA /CC/CW/CT /D7/D9/CQ/D7/D8/CX/D8/D9/D8/CX/D3/D2 /D6/CP/D8/CT /D3/CU /D8/CW/CT /CA /D4/D6/D3/D8/CT/CX/D2 /CX/D7 /CR/D0/D3/D7/CT /D8/D3 /D8/CW/CT /CP /DA /CT/D6/CP/CV/CT /D3/CU/D8/CW/CT /CB/BT/CA/CB/B9/BV/D3/CE /CV/CT/D2/D3/D1/CT/BA /CC/CW/CT /CU/D9/D2/CR/D8/CX/D3/D2/CP/D0 /CS/D3/D1/CP/CX/D2/D7 /CX/D2 /CP/D0/D0 /C6/CB/C8/D7 /D3/CU /D8/CW/CT /CA /D4/D6/D3/D8/CT/CX/D2/CV/CX/DA /CT /CS/CX/AB/CT/D6/CT/D2 /D8 /D4/CW /DD/D0/D3/CV/CT/D2/CT/D8/CX/CR /D6/CT/D7/D9/D0/D8/D7 /D8/CW/CP/D8 /D7/D9/CV/CV/CT/D7/D8 /D8/CW/CT/CX/D6 /CS/CX/AB/CT/D6/CT/D2 /D8 /D1 /D9/D8/CP/D8/CX/D3/D2 /D6/CP/D8/CT /D9/D2/CS/CT/D6/D7/CT/D0/CT/CR/D8/CX/DA /CT /D4/D6/CT/D7/D7/D9/D6/CT/BA /BX/D0/CT/DA /CT/D2 /CW/CX/CV/CW/D0/DD /CR/D3/D2/D7/CT/D6/DA /CT/CS /D6/CT/CV/CX/D3/D2/D7 /CX/D2 /CA/CS/CA/D4 /CP/D2/CS /D8 /DB /CT/D0/DA /CT /CR/D0/CT/CP /DA /CP/CV/CT/D7/CX/D8/CT/D7 /CQ /DD /BF/BV/C4/C8 /B4/CR /CW /DD/D1/D3/D8/D6/DD/D4/D7/CX/D2/B9/D0/CX/CZ /CT /D4/D6/D3/D8/CT/CX/D2/B5 /CW/CP /DA/CT /CQ /CT/CT/D2 /CX/CS/CT/D2 /D8/CX/AC/CT/CS /CP/D7 /D4/D3 /D8 /CT /D2 /D8/CX/CP/D0 /CS/D6/D9/CV/D8/CP/D6/CV/CT/D8/D7/BA /BY/CX/D2/CS/CX/D2/CV/D7 /D7/D9/CV/CV/CT/D7/D8 /D8/CW/CP/D8 /CX/D8 /CX/D7 /D4 /D3/D7/D7/CX/CQ/D0/CT /D8/D3 /D3/CQ/D8/CP/CX/D2 /CX/D2/CU/D3/D6/D1/CP/D8/CX/D3/D2 /CP/CQ /D3/D9/D8 /D8/CW/CT /D4/CW /DD/B9/D0/D3/CV/CT/D2 /DD /D3/CU /CB/BT/CA/CB/B9/BV/D3/CE/B8 /CP/D7 /DB /CT/D0/D0 /CP/D7 /D4 /D3/D8/CT/D2 /D8/CX/CP/D0 /D8/D3 /D3/D0/D7 /CU/D3/D6 /CS/D6/D9/CV /CS/CT/D7/CX/CV/D2/B8 /CV/CT/D2/D3/D8 /DD/D4/CX/D2/CV /CP/D2/CS/CS/CX/CP/CV/D2/D3/D7/D8/CX/CR/D7 /D3/CU /CB/BT/CA/CB/BA/C3/CT/DD /DB /D3/D6/CS/D7/BM /CB/BT/CA/CB/B8 /CB/BT/CA/CB/B9/BV/D3/CE/B8 /CA/C6/BT/B9/CS/CT/D4 /CT/D2/CS/CT/D2 /D8 /CA/C6/BT /D4 /D3/D0/DD/D1/CT/D6/CP/D7/CT/B8 /CA/C6/BT /DA/CX/D6/D9/D7/CT/D7/B8 /D4/D6/D3/D8/CT/D3/D0/DD/D7/CX/D7/C1/D2 /D8/D6/D3 /CS/D9/CR/D8/CX/D3/D2/C1/D2 /D8/CW/CT /D0/CX/CU/CT /CR/DD/CR/D0/CT /D3/CU /CR/D3/D6/D3/D2/CP /DA/CX/D6/D9/D7/CT/D7/B8 /D8/CW/CT /CA /B4/D6/CT/D4/D0/CX/CR/CP/D7/CT/B5/D4/D6/D3/D8/CT/CX/D2/B8 /D8/CW/CT /D0/CP/D6/CV/CT/D7/D8 /D4/D6/D3/D8/CT/CX/D2 /D3/CU /D8/CW/CT /DA/CX/D6/D9/D7/B8 /CX/D7 /D8/CW/CT /AC/D6/D7/D8/D8/D6/CP/D2/D7/D0/CP/D8/CT/CS /D4/D6/D3 /CS/D9/CR/D8 /CU/D3/D0/D0/D3 /DB/CX/D2/CV /D8/CW/CT /CX/D2/CU/CT/CR/D8/CX/D3/D2 /D3/CU /CW/D3/D7/D8 /CR/CT/D0/D0/D7/CQ /DD /D8/CW/CT /DA/CX/D6/D9/D7/BA /C1/D8 /CX/D7 /CX/D1/D1/CT/CS/CX/CP/D8/CT/D0/DD /D8/D6/CP/D2/D7/D0/CP/D8/CT/CS /CQ /DD /CW/D3/D7/D8 /D6/CX/B9/CQ/D3 /D7 /D3 /D1 /CT /D7 /CX/D2 /D8/D3 /CP /D0/CP/D6/CV/CT /D4 /D3/D0/DD/D4/D6/D3/D8/CT/CX/D2/BA /CC/CW/CX/D7 /D4/D6/D3/D8/CT/CX/D2 /CX/D7 /D8/CW/CT/D2/D4 /D3/D7/D8/B9/D8/D6/CP/D2/D7/D0/CP/D8/CX/D3/D2/CP/D0/D0/DD /D1/D3 /CS/CX/AC/CT/CS /D8/D3 /CV/CT/D2/CT/D6/CP/D8/CT /D7/D8/D6/D9/CR/D8/D9/D6/CP/D0/D0/DD/CX/D2/CS/CT/D4 /CT/D2/CS/CT/D2 /D8 /D3/D6 /CP/D7/D7/D3 /CR/CX/CP/D8/CT/CS /CU/D9/D2/CR/D8/CX/D3/D2/CX/D2/CV /CR/D3/D1/D4 /D3/D2/CT/D2 /D8/D7/B8/D8/CW /D9/D7 /CX/D2/CX/D8/CX/CP/D8/CX/D2/CV /CA/C6/BT /D6/CT/D4/D0/CX/CR/CP/D8/CX/D3/D2 /D3/CU /D8/CW/CT /DA/CX/D6/CP/D0 /CV/CT/D2/D3/D1/CT/BA/CC/CW/CT /CA /D4/D6/D3/D8/CT/CX/D2 /D1/CP/CX/D2/D0/DD /CW/CP/D6/CQ /D3/D6/D7 /D8/CW/CT /CA/CS/CA/D4 /B4/CA/C6/BT/B9/B6 /CC/CW/CT/D7/CT /CP/D9/D8/CW/D3/D6/D7 /CR/D3/D2 /D8/D6/CX/CQ/D9/D8/CT/CS /CT/D5/D9/CP/D0/D0/DD /D8/D3 /D8/CW/CX/D7/DB /D3/D6/CZ/BA/AZ/BV/D3/D6/D6/CT/D7/D4 /D3/D2/CS/CX/D2/CV /CP/D9/D8/CW/D3/D6/BA/BX/B9/D1/CP/CX/D0/BM /DD /CP/D2/CV/CW/D1/BS/CV/CT/D2/D3/D1/CX/CR/D7/BA/D3/D6/CV/BA/CR/D2 /CS/CT/D4 /CT/D2/CS/CT/D2 /D8 /CA/C6/BT /D4 /D3/D0/DD/D1/CT/D6/CP/D7/CT/B5 /CP/CR/D8/CX/DA/CX/D8 /DD /CU/D3/D6 /D6/CT/D4/D0/CX/CR/CP/D8/CX/D3/D2/D3/CU /D8/CW/CT /CV/CT/D2/D3/D1/CX/CR /CA/C6/BT /CQ /DD /D4/D6/D3 /CS/D9/CR/CX/D2/CV /D8/CW/CT /B4/B9/B5 /CP/D2/CS /B4/B7/B5/D7/D8/D6/CP/D2/CS/CT/CS /CA/C6/BT /D1/D3/D0/CT/CR/D9/D0/CT/D7/B8 /CV/CT/D2/CT/D6/CP/D8/CX/D2/CV /D8/CW/CT /D7/D9/CQ/CV/CT/D2/D3/D1/CX/CR/B4/B7/B5 /D8/D6/CP/D2/D7/CR/D6/CX/D4/D8/D7 /D6/CT/D5/D9/CX/D6/CT/CS /CU/D3/D6 /D8/CW/CT /CU/D9/D2/CR/D8/CX/D3/D2 /D3/CU /CP/D0/D0 /D8/CW/CT /DA/CX/B9/D6/CP/D0 /D7/D8/D6/D9/CR/D8/D9/D6/CP/D0 /D4/D6/D3/D8/CT/CX/D2/D7 /CP/D2/CS /D3/D8/CW/CT/D6 /D9/D2/CR /CW/CP/D6/CP/CR/D8/CT/D6/CX/DE/CT/CS /D4/D6/D3/B9/D8/CT/CX/D2/D7 /B4/BD /BN /BE /B5/BA /C1/D2 /CP/CS/CS/CX/D8/CX/D3/D2/B8 /CX/D8 /CP/D0/D7/D3 /D7/D9/D4/D4 /D3/D6/D8/D7 /D8/CW/CT /D4/D6/D3/B9/D8/CT/CX/D2/CP/D7/CT /CP/CR/D8/CX/DA/CX/D8/CX/CT/D7/B8 /D2/CP/D1/CT/D0/DD /B8 /D8/CW/CT /D1/CP/CX/D2 /D4/D6/D3/D8/CT/CX/D2/CP/D7/CT /BF/BV/C4/C8/D8/CW/CP/D8 /D4/D6/CX/D1/CP/D6/CX/D0/DD /D1/CT/CS/CX/CP/D8/CT/D7 /CR/D0/CT/CP /DA /CP/CV/CT /D3/CU /CA/CS/CA/D4 /CP/D2/CS /C0/BX/C4/B4/CW/CT/D0/CX/CR/CP/D7/CT/B5/B8 /CP/D2/CS /CP/CR/CR/CT/D7/D7/D3/D6/DD /D4/D6/D3/D8/CT/CX/D2/CP/D7/CT/D7/B8 /D7/D9/CR /CW /CP/D7 /C8/C4/C8/B4/D4/CP/D4/CP/CX/D2/B9/D0/CX/CZ /CT /D4/D6/D3/D8/CT/CX/D2/B5/B8 /D8/CW/CP/D8 /CP/D6/CT /CX/D2 /DA /D3/D0/DA /CT/CS /CX/D2 /D8/CW/CT /D4 /D3/D7/D8/B9/D8/D6/CP/D2/D7/D0/CP/D8/CX/D3/D2/CP/D0/D0/DD /D4/D6/D3/D8/CT/D3/D0/DD/D8/CX/CR /D4/D6/D3 /CR/CT/D7/D7/CT/D7 /CU/D3/D6 /D3/D8/CW/CT/D6 /D7/D8/D6/D9/CR/B9/D8/D9/D6/CP/D0 /D3/D6 /D2/D3/D2/B9/D7/D8/D6/D9/CR/D8/D9/D6/CP/D0 /D4/D6/D3/D8/CT/CX/D2/D7 /B4/BF /B5/BA/BT/D2/CP/D0/DD/D7/CT/D7 /D3/CU /D8/CW/CT /D7/D8/D6/D9/CR/D8/D9/D6/CT /D3/CU /D8/CW/CT /CA /D4/D6/D3/D8/CT/CX/D2 /CP/D6/CT /CX/D1/B9/D4 /D3/D6/D8/CP/D2 /D8 /CQ /CT/CR/CP/D9/D7/CT /D8/CW/CT /CX/D2/CU/D3/D6/D1/CP/D8/CX/D3/D2 /CS/CT/D6/CX/DA /CT/CS /CU/D6/D3/D1 /D8/CW/CT /D4/D6/CX/B9/D1/CP/D6/DD /D7/D8/D6/D9/CR/D8/D9/D6/CT /CR/CP/D2 /CQ/CT /CS/CX/D6/CT/CR/D8/D0/DD /CP/D4/D4/D0/CX/CT/CS /D8/D3 /CS/D6/D9/CV /CS/CT/B9/D7/CX/CV/D2/BA /BT/D0/D0 /D3/CU /D8/CW/CT /DA/CX/D6/CP/D0 /D7/D8/D6/D9/CR/D8/D9/D6/CP/D0 /D4/D6/D3/D8/CT/CX/D2/D7 /CP/D6/CT /CQ/CT /D0 /CX /CT /DA /CT/CS/D8/D3 /CQ/CT /CX/D2/CS/CX/DA/CX/CS/D9/CP/D0/D0/DD /CT/DC/D4/D6/CT/D7/D7/CT/CS /CU/D6/D3/D1 /CP /D2/CT/D7/D8/CT/CS /D7/CT/D8 /D3/CU /CR/D3/B9/BZ/CT/D2/D3/BA/B8 /C8/D6/D3/D8/BA /B2 /BU/CX/D3/CX/D2/CU/D3/BA /CE /D3/D0/BA /BD /C6/D3/BA /BE /C5/CP /DD /BE/BC/BC/BF /BD/BH/BHThis is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/55/31/main.PMC5172245.pdf
4 November 2003This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1f/6f/main.PMC5172246.pdf
"B, and C have 24, 48, and 8 serogroups, respectively (http://www.ihwg.org).",Non-OADS,/arxiv_data1/oa_pdf/1f/6f/main.PMC5172246.pdf
HLA-A Polymorphism by SBT in Northern Han T able 1 HLA-A Alleles and Frequencies Detected by SBT and Serological Speci¯cities in Northern Chinese Han Population HLA-A allele Gene frequencies Serological Antigen frequencies (N=2£161) speci¯cities (N=2 £161) A*010101 0.0062 A1 0.0124 A*0103 0.0031 A*0104N 0.0031 A*020101 0.1553 A2 0.2702 A*0202 0.0031 A*0203 0.0280 A*0205 0.0124 A*0206 0.0280 A*0207 0.0311 A*0209 0.0031 A*0211 0.0031 A*0212 0.0031 A*0246 0.0031 A*030101 0.0093 A3 0.0124 A*030103 0.0031 A*110101 0.2360 A11 0.2484 A*110102 0.0031 A*1102 0.0062 A*1104 0.0031 A*2301 0.0031 A23 0.0031 A*24020101 0.1646 A24 0.1832 A*2407 0.0031 A*2409N 0.0031 A*2423 0.0093 A*2429 0.0031 A*2502 0.0031 A25 0.0031 A*2601 0.0156 A26 0.0217 A*2603 0.0031 A*2614 0.0031 A*3001 0.0590 A30 0.0594 A*310102 0.0404 A31 0.0404 A*3201 0.0093 A32 0.0093 A*3301 0.0093 A33 0.1273 A*3303 0.1180 A*680102 0.0062 A68 0.0062 A*6901 0.0031 A69 0.0031 T otal: 36 1.000 14 1.0002 IHW G reference cell panel The reference cell panel used in our research was supplied by International Histocompatibility Work- ing Group (IHWG; http://www.ihwg.org).,Non-OADS,/arxiv_data1/oa_pdf/1f/6f/main.PMC5172246.pdf
During the last few years HLA-A*02 family has rapidly grown to more than 70 members (http://www.anthonyloan.com/HIG/index.html).,Non-OADS,/arxiv_data1/oa_pdf/1f/6f/main.PMC5172246.pdf
V ol.1No.1e Fbrua ry2003 15This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ae/ec/main.PMC5172247.pdf
/BT/D6/D8/CX/CR/D0/CT/BT /CB/D8/CP/D8/CX/D7/D8/CX/CR/CP/D0 /BT/D4/D4/D6/D3/CP/CR /CW /BW/CT/D7/CX/CV/D2/CT/CS /CU/D3/D6 /BY/CX/D2/CS/CX/D2/CV /C5/CP/D8/CW/CT/D1/CP/D8/CX/CR/CP/D0/D0/DD /BW/CT/B9/AC/D2/CT/CS /CA/CT/D4 /CT/CP/D8/D7 /CX/D2 /CB/CW/D3/D8/CV/D9/D2 /BW/CP/D8/CP /CP/D2/CS /BW/CT/D8/CT/D6/D1/CX/D2/CX/D2/CV /D8/CW/CT /C4/CT/D2/CV/D8/CW /BW/CX/D7/D8/D6/CX/B9/CQ/D9/D8/CX/D3/D2 /D3/CU /BV/D0/D3/D2/CT/B9/C1/D2/D7/CT/D6/D8/D7/C4/CP/D2 /CI/CW/D3/D2/CV /BD/BN /BE/B8 /C3/D9/D2/D0/CX/D2 /CI/CW/CP/D2/CV /BD/B8 /CG/CX/CP/D2/CV/CP/D2/CV /C0/D9/CP/D2/CV /BE/B8 /C8 /CT/CX/DC/CX/CP/D2/CV /C6/CX /BE/B8 /CH /D9/CY/D9/D2 /C0/CP/D2 /BE/B8 /C3/CP/CX /CF /CP/D2/CV /BE/B8 /C2/D9/D2 /CF /CP/D2/CV /BD/BN/BE/B8 /CP/D2/CS/CB/D3/D2/CV/CV/CP/D2/CV /C4/CX /BD/BN /BE/B6/BD/BV/D3/D0 /D0/CT /CV/CT /D3/CU /C4/CX/CU/CT /CB/CR/CX/CT/D2/CR /CT/B8 /C8/CT/CZ/CX/D2/CV /CD/D2/CX/DA/CT/D6/D7/CX/D8/DD/B8 /BU/CT/CX/CY/CX/D2/CV /BD/BC/BC/BK/BJ/BD/B8 /BV/CW/CX/D2/CP/BN /BE/BU/CT/CX/CY/CX/D2/CV /BZ/CT/D2/D3/D1/CX/CR/D7 /C1/D2/D7/D8/CX/D8/D9/D8/CT/BB/BV/CT/D2/D8/CT/D6 /D3/CU/BZ/CT/D2/D3/D1/CX/CR/D7 /CP/D2/CS /BU/CX/D3/CX/D2/CU/D3/D6/D1/CP/D8/CX/CR/D7/B8 /BV/CW/CX/D2/CT/D7/CT /BT /CR /CP/CS/CT/D1/DD /D3/CU /CB/CR/CX/CT/D2/CR /CT/D7/B8 /BU/CT/CX/CY/CX/D2/CV /BD/BC/BD/BF/BC/BC/B8 /BV/CW/CX/D2/CP/CC/CW/CT /D0/CP/D6/CV/CT /CP/D1/D3/D9/D2 /D8 /D3/CU /D6/CT/D4 /CT/CP/D8/D7/B8 /CT/D7/D4 /CT/CR/CX/CP/D0/D0/DD /CW/CX/CV/CW /CR/D3/D4 /DD /D6/CT/D4 /CT/CP/D8/D7/B8 /CX/D2 /D8/CW/CT /CV/CT/D2/D3/D1/CT/D7 /D3/CU /CW/CX/CV/CW/CT/D6/CP/D2/CX/D1/CP/D0/D7 /CP/D2/CS /D4/D0/CP/D2 /D8/D7 /D1/CP/CZ /CT/D7 /DB/CW/D3/D0/CT /CV/CT/D2/D3/D1/CT /CP/D7/D7/CT/D1 /CQ/D0/DD /B4/CF /BZ/BT/B5 /D5/D9/CX/D8/CT /CS/CXÆ/CR/D9/D0/D8/BA /C1/D2 /D3/D6/B9/CS/CT/D6 /D8/D3 /D7/D3/D0/DA /CT /D8/CW/CX/D7 /D4/D6/D3/CQ/D0/CT/D1/B8 /DB /CT /D8/D6/CX/CT/CS /D8/D3 /CX/CS/CT/D2 /D8/CX/CU/DD /D6/CT/D4 /CT/CP/D8/D7 /CP/D2/CS /D1/CP/D7/CZ /D8/CW/CT/D1 /D4/D6/CX/D3/D6 /D8/D3/CP/D7/D7/CT/D1 /CQ/D0/DD /CT/DA /CT/D2 /CP/D8 /D8/CW/CT /D7/D8/CP/CV/CT /D3/CU /CV/CT/D2/D3/D1/CT /D7/D9/D6/DA /CT/DD /BA /C1/D8 /CX/D7 /CZ/D2/D3 /DB/D2 /D8/CW/CP/D8 /D6/CT/D4 /CT/CP/D8/D7 /D3/CU /CS/CX/AB/CT/D6/B9/CT/D2 /D8 /CR/D3/D4 /DD /D2 /D9/D1 /CQ/CT /D6 /CW/CP /DA /CT /CS/CX/AB/CT/D6/CT/D2 /D8 /D4/D6/D3/CQ/CP/CQ/CX/D0/CX/D8/CX/CT/D7 /D3/CU /CP/D4/D4 /CT/CP/D6/CP/D2/CR/CT /CX/D2 /D7/CW/D3/D8/CV/D9/D2 /CS/CP/D8/CP/B8 /D7/D3/CQ/CP/D7/CT/CS /D3/D2 /D8/CW/CX/D7 /D4/D6/CX/D2/CR/CX/D4/D0/CT/B8 /DB /CT /CR/D3/D2/D7/D8/D6/D9/CR/D8/CT/CS /CP /D7/D8/CP/D8/CX/D7/D8/CX/CR/CP/D0 /D1/D3 /CS/CT/D0 /CP/D2/CS /CX/D2/CU/CT/D6/D6/CT/CS /CR/D6/CX/D8/CT/D6/CX/CP/CU/D3/D6 /D1/CP/D8/CW/CT/D1/CP/D8/CX/CR/CP/D0/D0/DD /CS/CT/AC/D2/CT/CS /D6/CT/D4 /CT/CP/D8/D7 /B4/C5/BW/CA/D7/B5 /CP/D8 /CS/CX/AB/CT/D6/CT/D2 /D8 /D7/CW/D3/D8/CV/D9/D2 /CR/D3 /DA /CT/D6/CP/CV/CT/D7/BA /BT/CR/B9/CR/D3/D6/CS/CX/D2/CV /D8/D3 /D8/CW/CT/D7/CT /CR/D6/CX/D8/CT/D6/CX/CP/B8 /DB /CT /CS/CT/DA /CT/D0/D3/D4 /CT/CS /D7/D3/CU/D8 /DB /CP/D6/CT /C5/BW/CA/D1/CP/D7/CZ /CT/D6 /D8/D3 /CX/CS/CT/D2 /D8/CX/CU/DD /CP/D2/CS /D1/CP/D7/CZ/C5/BW/CA/D7 /CX/D2 /D7/CW/D3/D8/CV/D9/D2 /CS/CP/D8/CP/BA /CF/CX/D8/CW /D6/CT/D4 /CT/CP/D8/D7 /D1/CP/D7/CZ /CT/CS /D4/D6/CX/D3/D6 /D8/D3 /CP/D7/D7/CT/D1 /CQ/D0/DD /B8 /D8/CW/CT /D7/D4 /CT/CT/CS /D3/CU /CP/D7/B9/D7/CT/D1 /CQ/D0/DD /DB /CP/D7 /CX/D2/CR/D6/CT/CP/D7/CT/CS /DB/CX/D8/CW /D0/D3 /DB /CT/D6 /CT/D6/D6/D3/D6 /D4/D6/D3/CQ/CP/CQ/CX/D0/CX/D8 /DD /BA /C1/D2 /CP/CS/CS/CX/D8/CX/D3/D2/B8 /CR/D0/D3/D2/CT/B9/CX/D2/D7/CT/D6/D8 /D7/CX/DE/CT/CP/AB/CT/CR/D8/D7 /D8/CW/CT /CP/CR/CR/D9/D6/CP/CR/DD /D3/CU /D6/CT/D4 /CT/CP/D8 /CP/D7/D7/CT/D1 /CQ/D0/DD /CP/D2/CS /D7/CR/CP/AB/D3/D0/CS /CR/D3/D2/D7/D8/D6/D9/CR/D8/CX/D3/D2/BA /CF /CT /CP/D0/D7/D3 /CS/CT/D7/CX/CV/D2/CT/CS/D0/CT/D2/CV/D8/CW /CS/CX/D7/D8/D6/CX/CQ/D9/D8/CX/D3/D2 /D3/CU /CR/D0/D3/D2/CT/B9/CX/D2/D7/CT/D6/D8/D7 /D9/D7/CX/D2/CV /D3/D9/D6 /D1/D3 /CS/CT/D0/BA /C1/D2 /D3/D9/D6 /D7/CX/D1 /D9/D0/CP/D8/CT/CS /CV/CT/D2/D3/D1/CT/D7 /D3/CU/CW /D9/D1/CP/D2 /CP/D2/CS /D6/CX/CR/CT/B8 /D8/CW/CT /D0/CT/D2/CV/D8/CW /CS/CX/D7/D8/D6/CX/CQ/D9/D8/CX/D3/D2 /D3/CU /D6/CT/D4 /CT/CP/D8/D7 /CX/D7 /CS/CX/AB/CT/D6/CT/D2 /D8/B8 /D7/D3 /D8/CW/CT/CX/D6 /D3/D4/D8/CX/D1/CP/D0/D0/CT/D2/CV/D8/CW /CS/CX/D7/D8/D6/CX/CQ/D9/D8/CX/D3/D2/D7 /D3/CU /CR/D0/D3/D2/CT/B9/CX/D2/D7/CT/D6/D8/D7 /DB /CT/D6/CT /D2/D3/D8 /D8/CW/CT /D7/CP/D1/CT/BA /CC/CW /D9/D7 /DB/CX/D8/CW /D3/D4/D8/CX/D1/CP/D0 /D0/CT/D2/CV/D8/CW/CS/CX/D7/D8/D6/CX/CQ/D9/D8/CX/D3/D2 /D3/CU /CR/D0/D3/D2/CT/B9/CX/D2/D7/CT/D6/D8/D7/B8 /CP /CV/CX/DA /CT/D2 /CV/CT/D2/D3/D1/CT /CR/D3/D9/D0/CS /CQ/CT /CP/D7/D7/CT/D1 /CQ/D0/CT/CS /CQ /CT/D8/D8/CT/D6 /CP/D8 /D0/D3 /DB /CT/D6/CR/D3 /DA /CT/D6/CP/CV/CT/BA/C3/CT/DD /DB /D3/D6/CS/D7/BM /D1/CP/D8/CW/CT/D1/CP/D8/CX/CR/CP/D0/D0/DD /CS/CT/AC/D2/CT/CS /D6/CT/D4 /CT/CP/D8 /B4/C5/BW/CA/B5/B8 /CR/D0/D3/D2/CT/B9/CX/D2/D7/CT/D6/D8/D7/B8 /CP/D7/D7/CT/D1 /CQ/D0/DD/C1/D2 /D8/D6/D3 /CS/D9/CR/D8/CX/D3/D2/CB/CP/D2/CV/CT/D6 /CX/D2 /DA /CT/D2 /D8/CT/CS /D8/CW/CT /BW/C6/BT /D7/CT/D5/D9/CT/D2/CR/CX/D2/CV /D8/CT/CR /CW/D2/D3/D0/D3/CV/DD /D9/D7/B9/CX/D2/CV /CS/CX/CS/CT/D3 /DC/DD/D2 /D9/CR/D0/CT/D3/D8/CX/CS/CT /CR /CW/CP/CX/D2 /D8/CT/D6/D1/CX/D2/CP/D8/D3/D6/D7 /CX/D2 /BD/BL/BJ/BH /B4/BD /B5/BA/CC/CW/CT/D2 /D8/CW/CT /D7/CW/D3/D8/CV/D9/D2 /D7/CT/D5/D9/CT/D2/CR/CX/D2/CV /D7/D8/D6/CP/D8/CT/CV/DD /DB /CP/D7 /CS/CT/DA /CT/D0/D3/D4 /CT/CS/CX/D2 /D8/CW/CT /CT/CP/D6/D0/DD /BD/BL/BK/BC/D7 /B4/BE /A0 /BG /B5/BA /CB/CW/D3/D8/CV/D9/D2 /D7/CT/D5/D9/CT/D2/CR/CX/D2/CV /CW/CP/D7/CQ/CT /CT /D2 /D8/CW/CT /CU/D9/D2/CS/CP/D1/CT/D2 /D8/CP/D0 /D1/CT/D8/CW/D3 /CS /CU/D3/D6 /D0/CP/D6/CV/CT/B9/D7/CR/CP/D0/CT /BW/C6/BT /D7/CT/B9/D5/D9/CT/D2/CR/CX/D2/CV /CX/D2 /D8/CW/CT /D0/CP/D7/D8 /BE/BC /DD /CT/CP/D6/D7 /B4/BH /A0 /BJ /B5/BA /C0/D3 /DB /CT/DA /CT/D6 /DB/CW/D3/D0/CT/B9/CV/CT/D2/D3/D1/CT /D7/CW/D3/D8/CV/D9/D2 /D7/CT/D5/D9/CT/D2/CR/CX/D2/CV /B4/CF /BZ/BT/B5 /CW/CP/CS /CQ/CT /CT /D2 /D6/D3/D9/D8/CX/D2/CT/D3/D2/D0/DD /CX/D2 /D7/D1/CP/D0/D0 /D3/D6/CV/CP/D2/CX/D7/D1/D7 /D7/D9/CR /CW /CP/D7 /CQ/CP/CR/D8/CT/D6/CX/CP/D0 /CV/CT/D2/D3/D1/CT/D7/BA/C4/D3/D8/D7 /D3/CU /CW/CX/CV/CW /CR/D3/D4 /DD /D6/CT/D4 /CT/CP/D8/D7 /CX/D2 /D8/CW/CT /CV/CT/D2/D3/D1/CT/D7 /D3/CU /CW/CX/CV/CW/CT/D6/DA /CT/D6/D8/CT/CQ/D6/CP/D8/CT/D7 /D1/CP/CZ /CT /CF /BZ/BT /CP/D8 /CP/D2 /CT/D2/D0/CP/D6/CV/CT/CS /D6/CX/D7/CZ /D3/CU /D1/CX/D7/B9/CP/D7/D7/CT/D1 /CQ/D0/DD /BA /C1/D2 /D8/CW/CT /CX/D2/CX/D8/CX/CP/D0 /D7/D8/CP/CV/CT /D3/CU /D8/CW/CT /CW /D9/D1/CP/D2 /CV/CT/D2/D3/D1/CT/D4/D6/D3 /CY/CT/CR/D8/B8 /D8/CW/CT/D6/CT /DB /CT/D6/CT /D7/CR/CX/CT/D2 /D8/CX/AC/CR /CS/CT/CQ/CP/D8/CT/D7 /D3 /DA /CT/D6 /DB/CW/CT/D8/CW/CT/D6 /D8/D3/D9/D7/CT /CW/CX/CT/D6/CP/D6/CR /CW/CX/CR/CP/D0 /D7/CW/D3/D8/CV/D9/D2 /D7/CT/D5/D9/CT/D2/CR/CX/D2/CV /B4/BK /B5 /D3/D6 /CF /BZ/BT /B4/BL /B5/D8/D3 /D7/CT/D5/D9/CT/D2/CR/CT /D8/CW/CT /CW /D9/D1/CP/D2 /CV/CT/D2/D3/D1/CT/BA /CC/CW/CT /C1/D2 /D8/CT/D6/D2/CP/D8/CX/D3/D2/CP/D0/C0/D9/D1/CP/D2 /BZ/CT/D2/D3/D1/CT /CB/CT/D5/D9/CT/D2/CR/CX/D2/CV /BV/D3/D2/D7/D3/D6/D8/CX/D9/D1 /CR /CW/D3/D7/CT /D8/CW/CT/D0/CP/D8/D8/CT/D6 /B4/BD/BC /B5/BA /C1/D2 /D6/CT/CR/CT/D2 /D8 /DD /CT/CP/D6/D7/B8 /D8/CW/CT/D6/CT /CP/D6/CT /D7/D3/D1/CT /D7/D9/CR/CR/CT/D7/D7/B9/CU/D9/D0 /CT/DC/CP/D1/D4/D0/CT/D7 /D3/CU /CF /BZ/BT /D3/CU /CR/D3/D1/D4/D0/CT/DC /CT/D9/CZ /CP/D6/DD /D3/D8/CX/CR /CV/CT/D2/D3/D1/CT/D7/B8/A3/BV/D3/D6/D6/CT/D7/D4 /D3/D2/CS/CX/D2/CV /CP/D9/D8/CW/D3/D6/BA/BX/B9/D1/CP/CX/D0/BM /D0/CX/D7/CV/BS/CV/CT/D2/D3/D1/CX/CR/D7/BA/D3/D6/CV/BA/CR/D2 /D7/D9/CR /CW /CP/D7 /D8/CW/CP/D8 /D3/CU /BW/D6 /D3/D7/D3/D4/CW/CX/D0/CP /D1/CT/D0/CP/D2/CV/D3/D7/D8/CT/D6 /B4/BD/BD /B5 /CP/D2/CS/C0/D3/D1/D3 /D7/CP/D4/CX/CT/D2/D7 /B4/BD/BE /B5 /CP/D7/D7/CT/D1 /CQ/D0/CT/CS /CQ /DD /BV/CT/D0/CT/D6/CP /BZ/CT/D2/D3/D1/CX/CR/D7/B8/CP/D2/CS /D8/CW/CP/D8 /D3/CU /C7/D6/DD/DE/CP /D7/CP/D8/CX/DA/CP /CP/D7/D7/CT/D1 /CQ/CT /CS /CQ /DD /BU/CT/CX/CY/CX/D2/CV /BZ/CT/B9/D2/D3/D1/CX/CR/D7 /C1/D2/D7/D8/CX/D8/D9/D8/CT /B4/BD/BF /BN /BD/BG /B5/BA /CF/CX/D8/CW /CT/DC/D8/CT/D2/D7/CX/DA /CT /CP/D4/D4/D0/CX/CR/CP/B9/D8/CX/D3/D2/D7 /D3/CU /CR/CP/D4/CX/D0/D0/CP/D6/DD /D7/CT/D5/D9/CT/D2/CR/CT/D6/D7/B8 /D8/CW/CT /CR/D0/D3/D2/CT/B9/CT/D2/CS /D4/CP/CX/D6 /CX/D2/CU/D3/D6/B9/D1/CP/D8/CX/D3/D2 /CX/D7 /D0/CX/CZ /CT/D0/DD /D8/D3 /D6/CT/CS/D9/CR/CT /CP/D7/D7/CT/D1 /CQ/D0/DD /D8/D6/D3/D9/CQ/D0/CT /CS/D9/CT /D8/D3 /D6/CT/B9/D4 /CT/CP/D8/D7/BA /CC/CW/CT/D6/CT/CU/D3/D6/CT /CF /BZ/BT /DB/CX/D0/D0 /CQ /CT/CR/D3/D1/CT /D8/CW/CT /D1/CP /CY/D3/D6 /D1/CT/D8/CW/D3 /CS/CX/D2 /CV/CT/D2/D3/D1/CT /D6/CT/D7/CT/CP/D6/CR /CW /CX/D2 /D8/CW/CT /CU/D3/D0/D0/D3 /DB/CX/D2/CV /DD /CT/CP/D6/D7/BA /BV/D3/D1/D4/CP/D6/CT/CS/D8/D3 /CK/D6/CT/CV/CX/D3/D2/CP/D0 /CR /CW/D6/D3/D1/D3/D7/D3/D1/CT /CP/D7/D7/CT/D1 /CQ/D0/DDꜼ/B8 /CF /BZ/BT /CR/CP/D2 /CP/D7/D7/CT/D1/B9/CQ/D0/CT /D6/CP/D2/CS/D3/D1 /D7/CW/D3/D8/CV/D9/D2 /CS/CP/D8/CP /DB/CX/D8/CW/D3/D9/D8 /CP/D2 /DD /CW/CX/CV/CW/B9/CS/CT/D2/D7/CX/D8 /DD/CV/CT/D2/CT/D8/CX/CR /D3/D6 /D4/CW /DD/D7/CX/CR/CP/D0 /D1/CP/D4/D7/B8 /D7/D3 /CX/D8 /CW/CP/D7 /CP/CS/DA /CP/D2 /D8/CP/CV/CT/D7 /D3/CU /CW/CX/CV/CW/D7/D4 /CT/CT/CS/B8 /CT/CP/D7/DD /D4/CX/D4 /CT/D0/CX/D2/CX/D2/CV /CP/D2/CS /D0/CX/D8/D8/D0/CT /D0/CP/CQ /D3/D6/CX/D3/D9/D7 /CW/CT/CP/CS/DB /D3/D6/CZ/BA/C0/CT/D6/CT /DB /CT /D4/D6/CT/D7/CT/D2 /D8 /CP /D7/D8/CP/D8/CX/D7/D8/CX/CR/CP/D0 /D1/D3 /CS/CT/D0/B8 /DB/CW/CX/CR /CW /CX/D2/CU/CT/D6/D6/CT/CS/D7/D8/CP/D2/CS/CP/D6/CS/D7 /CU/D3/D6 /CX/CS/CT/D2 /D8/CX/CU/DD/CX/D2/CV /D1/CP/D8/CW/CT/D1/CP/D8/CX/CR/CP/D0/D0/DD /CS/CT/AC/D2/CT/CS /D6/CT/B9/D4 /CT/CP/D8/D7 /B4/C5/BW/CA/D7/B5/BA /CF/CX/D8/CW /C5/BW/CA/D7 /D1/CP/D7/CZ /CT/CS /CQ /CT/CU/D3/D6/CT /CP/D7/D7/CT/D1 /CQ/D0/DD /B8/D8/CW/CT /D6/CX/D7/CZ /D3/CU /D1/CX/D7/B9/CP/D7/D7/CT/D1 /CQ/D0/DD /DB /CP/D7 /D6/CT/CS/D9/CR/CT/CS /CP/D2/CS /D8/CW/CT /D7/D4 /CT/CT/CS/D3/CU /CP/D7/D7/CT/D1 /CQ/D0/DD /DB /CP/D7 /CX/D2/CR/D6/CT/CP/D7/CT/CS/BA/C1/D2 /D8/CW/CT /D7/D8/D6/CP/D8/CT/CV/DD /D3/CU /D6/CT/D4 /CT/CP/D8/B9/D1/CP/D7/CZ /CT/CS /CP/D7/D7/CT/D1 /CQ/D0/DD /B8 /CS/CT/B9/D8/CT/CR/D8/CT/CS /D6/CT/D4 /CT/CP/D8/D7 /DB /CT/D6/CT /D1/CP/D7/CZ /CT/CS /D4/D6/CX/D3/D6 /D8/D3 /D8/CW/CT /CP/D7/D7/CT/D1 /CQ/D0/DD /B8/D8/CW /D9/D7 /D0/CT/CP /DA/CX/D2/CV /D7/D3 /D1/CP/D2 /DD /CV/CP/D4/D7 /CX/D2 /D8/CW/CT /CV/CT/D2/D3/D1/CT/BA /BY /D3/D6 /D8/CW/CT/D4/D9/D6/D4 /D3/D7/CT /D3/CU /CV/CP/D4 /CR/D0/D3/D7/D9/D6/CT/B8 /CR/D0/D3/D2/CT/B9/CX/D2/D7/CT/D6/D8/D7 /D7/CW/D3/D9/D0/CS /CR/D3 /DA /CT/D6 /D6/CT/B9/BZ/CT/D2/D3/BA/B8 /C8/D6/D3/D8/BA /B2 /BU/CX/D3/CX/D2/CU/D3/BA /CE /D3/D0/BA /BD /C6/D3/BA /BD /BY /CT/CQ/D6/D9/CP/D6/DD /BE/BC/BC/BF /BG/BFThis is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ba/39/main.PMC5172250.pdf
/C4/CT/D8/D8/CT/D6/C8/D6/D3/D8/CT/D3/D1/CX/CR /BV/D3/D1/D4/CP/D6/CX/D7/D3/D2 /D3/CU /CC/DB /D3/B9/BW/CX/D1/CT/D2/D7/CX/D3/D2/CP/D0 /BZ/CT/D0 /BX/D0/CT/CR/D8/D6/D3/D4/CW/D3/D6/CT/D7/CX/D7 /C8/D6/D3/B9/AC/D0/CT/D7 /CU/D6/D3/D1 /C0/D9/D1/CP/D2 /C4/D9/D2/CV /CB/D5/D9/CP/D1/D3/D9/D7 /BV/CP/D6/CR/CX/D2/D3/D1/CP /CP/D2/CS /C6/D3/D6/D1/CP/D0 /BU/D6/D3/D2/CR /CW/CX/CP/D0/BX/D4/CX/D8/CW/CT/D0/CX/CP/D0 /CC/CX/D7/D7/D9/CT/D7/BV/D9/CX /C4/CX /BD/BN /BE/B8 /CG/CX/CP/D2/D5/D9/CP/D2 /CI/CW/CP/D2 /BD/BN /BE/B8 /C5/CP/D3 /DD/D9 /C4/CX /BE/B8 /CG/CX/CP/D3 /DD/CX/D2/CV /CF /D9 /BE/B8 /BY /CT/D2/CV /C4/CX /BE/B8 /C2/CX/CP/D2/D0/CX/D2/CV /C4/CX /BD/B8 /CI/CW/CX/D5/CX/CP/D2/CV /CG/CX/CP/D3 /BD/B8 /CI/CW /D9/CR /CW /D9/BV/CW/CT/D2 /BD/BN /BE/B6/B8 /CG/D9/CT/D4/CX/D2/CV /BY /CT/D2/CV /BE/B8 /C8/CX/D2/CV /BV/CW/CT/D2 /BF/B8 /C2/CX/D2/CV/DD/D9/D2 /CG/CX/CT /BF/B8 /CP/D2/CS /CB/D3/D2/CV/D4/CX/D2/CV /C4/CX/CP/D2/CV /BF/BD/C5/CT /CS/CX/CR /CP/D0 /CA /CT/D7/CT /CP/D6 /CR/CW /BV/CT/D2/D8/CT/D6/B8 /CG/CX/CP/D2/CV/DD/CP /CW/D3/D7/D4/CX/D8/CP/D0/B8 /BV/CT/D2/D8/D6 /CP/D0 /CB/D3/D9/D8/CW /CD/D2/CX/DA/CT/D6/D7/CX/D8/DD/B8 /BV/CW/CP/D2/CV/D7/CW/CP /BG/BD/BC/BC/BC/BK/B8 /BV/CW/CX/D2/CP/BN /BE/BV/CP/D2/CR /CT/D6/CA /CT/D7/CT /CP/D6 /CR/CW /C1/D2/D7/D8/CX/D8/D9/D8/CT/B8 /CG/CX/CP/D2/CV/DD/CP /CB/CR/CW/D3 /D3/D0 /D3/CU /C5/CT /CS/CX/CR/CX/D2/CT/B8 /BV/CT/D2/D8/D6 /CP/D0 /CB/D3/D9/D8/CW /CD/D2/CX/DA/CT/D6/D7/CX/D8/DD/B8 /BV/CW/CP/D2/CV/D7/CW/CP /BG/BD/BC/BC/BJ/BK/B8 /BV/CW/CX/D2/CP/BN /BF/BV/D3/D0 /D0/CT /CV/CT/D3/CU /C4/CX/CU/CT /CB/CR/CX/CT/D2/CR /CT/B8 /C0/D9/D2/CP/D2 /C6/D3/D6/D1/CP/D0 /CD/D2/CX/DA/CT/D6/D7/CX/D8/DD/B8 /BV/CW/CP/D2/CV/D7/CW/CP /BG/BD/BC/BC/BC/BI/B8 /BV/CW/CX/D2/CP/BW/CX/AB/CT/D6/CT/D2 /D8/CX/CP/D0 /D4/D6/D3/D8/CT/D3/D1/CT /D4/D6/D3/AC/D0/CT/D7 /D3/CU /CW /D9/D1/CP/D2 /D0/D9/D2/CV /D7/D5/D9/CP/D1/D3/D9/D7 /CR/CP/D6/CR/CX/D2/D3/D1/CP /D8/CX/D7/D7/D9/CT /CR/D3/D1/B9/D4/CP/D6/CT/CS /D8/D3 /D4/CP/CX/D6/CT/CS /D8/D9/D1/D3/D6/B9/CP/CS/CY/CP/CR/CT/D2 /D8 /D2/D3/D6/D1/CP/D0 /CQ/D6/D3/D2/CR /CW/CX/CP/D0 /CT/D4/CX/D8/CW/CT/D0/CX/CP/D0 /D8/CX/D7/D7/D9/CT /DB /CT/D6/CT /CT/D7/D8/CP/CQ/B9/D0/CX/D7/CW/CT/CS /CP/D2/CS /CP/D2/CP/D0/DD/DE/CT/CS /CQ /DD /D1/CT/CP/D2/D7 /D3/CU /CX/D1/D1/D3/CQ/CX/D0/CX/DE/CT/CS /D4/C0 /CV/D6/CP/CS/CX/CT/D2 /D8/B9/CQ/CP/D7/CT/CS /D8 /DB /D3/B9/CS/CX/D1/CT/D2/D7/CX/D3/D2/CP/D0/D4 /D3/D0/DD /CP/CR/D6/DD/D0/CP/D1/CX/CS/CT /CV/CT/D0 /CT/D0/CT/CR/D8/D6/D3/D4/CW/D3/D6/CT/D7/CX/D7 /B4/BE/B9/BW /C8 /BT /BZ/BX/B5 /CP/D2/CS /D1/CP/D8/D6/CX/DC/B9/CP/D7/D7/CX/D7/D8/CT/CS /D0/CP/D7/CT/D6 /CS/CT/D7/D3/D6/D4/B9/D8/CX/D3/D2/BB/CX/D3/D2/CX/DE/CP/D8/CX/D3/D2 /D8/CX/D1/CT /D3/CU /AD/CX/CV/CW /D8 /D1/CP/D7/D7 /D7/D4 /CT/CR/D8/D6/D3/D1/CT/D8/D6/DD /B4/C5/BT/C4/BW/C1/B9/CC/C7/BY/B9/C5/CB/B5/BA /CC/CW/CT /D6/CT/D7/D9/D0/D8/D7/D7/CW/D3 /DB /CT/CS /D8/CW/CP/D8 /DB /CT/D0/D0/B9/D6/CT/D7/D3/D0/DA /CT/CS/B8 /D6/CT/D4/D6/D3 /CS/D9/CR/CX/CQ/D0/CT /BE/B9/BW/BX /D4/CP/D8/D8/CT/D6/D2/D7 /D3/CU /CW /D9/D1/CP/D2 /D0/D9/D2/CV /D7/D5/D9/CP/D1/D3/D9/D7/CR/CP/D6/CR/CX/D2/D3/D1/CP /CP/D2/CS /CP/CS/CY/CP/CR/CT/D2 /D8 /D2/D3/D6/D1/CP/D0 /CQ/D6/D3/D2/CR /CW/CX/CP/D0 /CT/D4/CX/D8/CW/CT/D0/CX/CP/D0 /D8/CX/D7/D7/D9/CT/D7 /DB /CT/D6/CT /D3/CQ/D8/CP/CX/D2/CT/CS /D9/D2/CS/CT/D6/D8/CW/CT /CR/D3/D2/CS/CX/D8/CX/D3/D2 /D3/CU /BC/BA/BJ/BH/B9/D1/CV /D4/D6/D3/D8/CT/CX/D2/B9/D0/D3/CP/CS/BA /CC/CW/CT /CP /DA /CT/D6/CP/CV/CT /CS/CT/DA/CX/CP/D8/CX/D3/D2 /D3/CU /D7/D4 /D3/D8 /D4 /D3/D7/CX/D8/CX/D3/D2/DB /CP/D7 /BC/BA/BJ/BF/BF/A6/BC/BA/BD/BC/BD /D1/D1 /CX/D2 /C1/BX/BY /CS/CX/D6/CT/CR/D8/CX/D3/D2/B8 /CP/D2/CS /BC/BA/BL/BE/BH/A6/BC/BA/BE/BC/BJ /D1/D1 /CX/D2 /CB/BW/CB/B9/C8 /BT /BZ/BX /CS/CX/D6/CT/CR/B9/D8/CX/D3/D2/BA /BY /D3/D6 /D8/D9/D1/D3/D6 /D8/CX/D7/D7/D9/CT/B8 /CP /D8/D3/D8/CP/D0 /D3/CU /BD/BE/BG/BD/A6/BK/BK /D7/D4 /D3/D8/D7 /DB /CT/D6/CT /CS/CT/D8/CT/CR/D8/CT/CS/B8 /BL/BK/BJ/A6/BI/BH /D7/D4 /D3/D8/D7 /DB /CT/D6/CT/D1/CP/D8/CR /CW/CT/CS /DB/CX/D8/CW /CP/D2 /CP /DA /CT/D6/CP/CV/CT /D1/CP/D8/CR /CW/CX/D2/CV /D6/CP/D8/CT /D3/CU /BJ/BL/BA/BH/B1/BA /BY /D3/D6 /CR/D3/D2 /D8/D6/D3/D0/B8 /CP /D8/D3/D8/CP/D0 /D3/CU /BD/BD/BL/BC/A6/BJ/BE/D7/D4 /D3/D8/D7 /DB /CT/D6/CT /CS/CT/D8/CT/CR/D8/CT/CS/B8 /CP/D2/CS /BK/BJ/BH/A6/BG/BK /D7/D4 /D3/D8/D7 /DB /CT/D6/CT /D1/CP/D8/CR /CW/CT/CS /DB/CX/D8/CW /CP/D2 /CP /DA /CT/D6/CP/CV/CT /D1/CP/D8/CR /CW/CX/D2/CV/D6/CP/D8/CT /D3/CU /BJ/BF/BA/BH/B1/BA /BT /D8/D3/D8/CP/D0 /D3/CU /BK/BI/BG/A6/BF/BG /D7/D4 /D3/D8/D7 /DB /CT/D6/CT /D1/CP/D8/CR /CW/CT/CS /CQ/CT /D8 /DB /CT/CT/D2 /D8/D9/D1/D3/D6/D7 /CP/D2/CS /CR/D3/D2 /D8/D6/D3/D0/D7/BA/BY /D3/D6/D8 /DD/B9/D8/CW/D6/CT/CT /CS/CX/AB/CT/D6/CT/D2 /D8/CX/CP/D0 /D4/D6/D3/D8/CT/CX/D2/D7 /DB /CT/D6/CT /CR /CW/CP/D6/CP/CR/D8/CT/D6/CX/DE/CT/CS/BM /D7/D3/D1/CT /D4/D6/D3/D8/CT/CX/D2/D7 /DB /CT/D6/CT /D6/CT/D0/CP/D8/CT/CS /D8/D3/D3/D2/CR/D3/CV/CT/D2/CT/D7/B8 /CP/D2/CS /D3/D8/CW/CT/D6/D7 /CX/D2 /DA /D3/D0/DA /CT/CS /CX/D2 /D8/CW/CT /D6/CT/CV/D9/D0/CP/D8/CX/D3/D2 /D3/CU /CR/CT/D0/D0 /CR/DD/CR/D0/CT /CP/D2/CS /D7/CX/CV/D2/CP/D0 /D8/D6/CP/D2/D7/CS/D9/CR/B9/D8/CX/D3/D2/BA /C1/D8 /CX/D7 /D7/D9/CV/CV/CT/D7/D8/CT/CS /D8/CW/CP/D8 /D8/CW/CT /CS/CX/AB/CT/D6/CT/D2 /D8/CX/CP/D0 /D4/D6/D3/D8/CT/D3/D1/CX/CR /CP/D4/D4/D6/D3/CP/CR /CW /CX/D7 /DA /CP/D0/D9/CP/CQ/D0/CT /CU/D3/D6 /D1/CP/D7/D7/CX/CS/CT/D2 /D8/CX/AC/CR/CP/D8/CX/D3/D2 /D3/CU /CS/CX/AB/CT/D6/CT/D2 /D8/CX/CP/D0/D0/DD /CT/DC/D4/D6/CT/D7/D7/CT/CS /D4/D6/D3/D8/CT/CX/D2/D7 /CX/D2 /DA /D3/D0/DA /CT/CS /CX/D2 /D0/D9/D2/CV /CR/CP/D6/CR/CX/D2/D3/CV/CT/D2/CT/D7/CX/D7/BA/CC/CW/CT/D7/CT /CS/CP/D8/CP /DB/CX/D0/D0 /CQ/CT /D9/D7/CT/CS /D8/D3 /CT/D7/D8/CP/CQ/D0/CX/D7/CW /CW /D9/D1/CP/D2 /D0/D9/D2/CV /CR/CP/D2/CR/CT/D6 /D4/D6/D3/D8/CT/D3/D1/CT /CS/CP/D8/CP/CQ/CP/D7/CT /D8/D3/CU/D9/D6/D8/CW/CT/D6 /D7/D8/D9/CS/DD /CW /D9/D1/CP/D2 /D0/D9/D2/CV /D7/D5/D9/CP/D1/D3/D9/D7 /CR/CP/D6/CR/CX/D2/D3/D1/CP/BA/C3/CT/DD /DB /D3/D6/CS/D7/BM /CW /D9/D1/CP/D2 /D0/D9/D2/CV /D7/D5/D9/CP/D1/D3/D9/D7 /CR/CP/D6/CR/CX/D2/D3/D1/CP /D8/CX/D7/D7/D9/CT/B8 /D2/D3/D6/D1/CP/D0 /CQ/D6/D3/D2/CR /CW/CX/CP/D0 /CT/D4/CX/D8/CW/CT/D0/CX/CP/D0 /D8/CX/D7/D7/D9/CT/B8 /BE/B9/BW/C8 /BT /BZ/BX/B8 /C5/BT/C4/BW/C1/B9/CC/C7/BY/B9/C5/CB/B8 /D4/D6/D3/D8/CT/D3/D1/CT/C1/D2 /D8/D6/D3 /CS/D9/CR/D8/CX/D3/D2/C4/D9/D2/CV /CR/CP/D2/CR/CT/D6 /CX/D7 /CP /D1/CP/D0/CX/CV/D2/CP/D2 /D8 /D8/D9/D1/D3/D6 /DB/CX/D8/CW /CP /DA /CT/D6/DD /CW/CX/CV/CW/CX/D2/CR/CX/CS/CT/D2/CR/CT/BA /BT/CR/CR/D3/D6/CS/CX/D2/CV /D8/D3 /CW/CX/D7/D8/D3/D0/D3/CV/DD /CS/CX/CP/CV/D2/D3/D7/CX/D7/B8 /D0/D9/D2/CV /CR/CP/D2/B9/CR/CT/D6 /CX/D7 /CS/CX/DA/CX/CS/CT/CS /CX/D2 /D8/D3 /CU/D3/D9/D6 /D8 /DD/D4 /CT/D7/BM /D7/D5/D9/CP/D1/D3/D9/D7 /CR/CP/D6/CR/CX/D2/D3/D1/CP/B8/CP/CS/CT/D2/D3 /CR/CP/D6/CR/CX/D2/D3/D1/CP/B8 /D0/CP/D6/CV/CT/B9/CR/CT/D0/D0 /CR/CP/D6/CR/CX/D2/D3/D1/CP /CP/D2/CS /D7/D1/CP/D0/D0/B9/CR/CT/D0/D0/CR/CP/D6/CR/CX/D2/D3/D1/CP/BA /CB/D5/D9/CP/D1/D3/D9/D7 /CR/CP/D6/CR/CX/D2/D3/D1/CP /CX/D7 /D8/CW/CT /CR/D3/D1/D1/D3/D2/CT/D7/D8/D8 /DD/D4 /CT /DB/CX/D8/CW /CP /D6/CP/D8/CX/D3 /D3/CU /BF/BC/B9/BH/BC/B1 /D3/CU /CP/D0/D0 /D0/D9/D2/CV /CR/CP/D2/CR/CT/D6 /D4/CP/B9/D8/CX/CT/D2 /D8/D7/BA /BT /CR/D0/CX/D2/CX/CR/CP/D0 /D7/D8/CP/D8/CX/D7/D8/CX/CR/CP/D0 /D7/D8/D9/CS/DD /D7/CW/D3 /DB /CT/CS /D8/CW/CP/D8 /CX/D2/D9/D6/CQ/CP/D2 /BV/CW/CX/D2/CP/B8 /D8/CW/CT /D2 /D9/D1 /CQ/CT /D6 /D3/CU /D7/D5/D9/CP/D1/D3/D9/D7 /CR/CP/D6/CR/CX/D2/D3/D1/CP/D4/CP/D8/CX/CT/D2 /D8/D7 /DB /CP/D7 /D6/CP/D4/CX/CS/D0/DD /CX/D2/CR/D6/CT/CP/D7/CX/D2/CV/B8 /CP/D2/CS /CR/D3/D2/D7/D8/CX/D8/D9/D8/CT/CS /BH/BC/B9/BJ/BC/B1 /D3/CU /CP/D0/D0 /D0/D9/D2/CV /CR/CP/D2/CR/CT/D6 /D4/CP/D8/CX/CT/D2 /D8/D7 /B4/BD /B5/BA /CB/D3/D1/CT /D1/D3/D0/CT/CR/D9/D0/CP/D6/D4/CP/D8/CW/D3/CV/CT/D2/CT/D7/CX/D7 /D7/D8/D9/CS/CX/CT/D7 /D3/D2 /CW /D9/D1/CP/D2 /D0/D9/D2/CV /CR/CP/D2/CR/CT/D6 /CW/CP /DA /CT /CQ/CT /CT /D2/A3/BV/D3/D6/D6/CT/D7/D4 /D3/D2/CS/CX/D2/CV /CP/D9/D8/CW/D3/D6/BA/BX/B9/D1/CP/CX/D0/BM /D8/CR/CQ/D0/BS/D4/D9/CQ/D0/CX/CR/BA/CR/D7/BA/CW/D2/BA/CR/D2 /D9/D2/CS/CT/D6/D8/CP/CZ /CT/D2 /D7/D9/CR/CR/CT/D7/D7/CU/D9/D0/D0/DD /CP/D8 /D8/CW/CT /CV/CT/D2/CT /B4/BW/C6/BT/B5 /CP/D2/CS /D8/D6/CP/D2/B9/D7/CR/D6/CX/D4/D8/CX/D3/D2 /B4/D1/CA/C6/BT/B5 /D0/CT/DA /CT/D0/D7 /B4/BE /B5/BA /C0/D3 /DB /CT/DA /CT/D6/B8 /D7/CX/D2/CR/CT /D8/CW/CT /CU/D9/D2/CR/B9/D8/CX/D3/D2/D7 /D3/CU /CV/CT/D2/CT /CP/D6/CT /CS/CT/D8/CT/D6/D1/CX/D2/CT/CS /CQ /DD /D4/D6/D3/D8/CT/CX/D2/D7/B8 /D8/CW/CT /D4/D6/D3/B9/D8/CT/D3/D1/CX/CR /D7/D8/D9/CS/DD /D3/CU /D0/D9/D2/CV /CR/CP/D2/CR/CT/D6 /D1/CP /DD /CS/CX/D6/CT/CR/D8/D0/DD /CP/D2/CS /CR/D3/D1/B9/D4/D6/CT/CW/CT/D2/D7/CX/DA /CT/D0/DD /CT/DC/D4/D0/D3/D6/CT /D8/CW/CT /CR/CP/D6/CR/CX/D2/D3/CV/CT/D2/CT/D7/CX/CR /D1/CT/CR /CW/CP/D2/CX/D7/D1 /D3/CU/D0/D9/D2/CV /CR/CP/D2/CR/CT/D6/BA /CF/CX/D8/CW /D8/CW/CT /CS/CT/DA /CT/D0/D3/D4/D1/CT/D2 /D8 /D3/CU /D4/D6/D3/D8/CT/D3/D1/CX/CR/D8/CT/CR /CW/D2/D3/D0/D3/CV/CX/CT/D7 /CP/D2/CS /D8/CW/CT/CX/D6 /CP/D4/D4/D0/CX/CR/CP/D8/CX/D3/D2 /CX/D2 /D0/D9/D2/CV /CR/CP/D2/CR/CT/D6 /D6/CT/B9/D7/CT/CP/D6/CR /CW/B8 /D7/D3/D1/CT /D8/D9/D1/D3/D6/B9/D6/CT/D0/CP/D8/CT/CS /D1/CP/D6/CZ /CT/D6/D7 /CW/CP /DA /CT /CQ/CT /CT /D2 /CX/CS/CT/D2/B9/D8/CX/AC/CT/CS/B8 /CP/D2/CS /CP/D4/D4/D0/CX/CT/CS /CX/D2 /CR/D0/CX/D2/CX/CR /CS/CX/CP/CV/D2/D3/D7/CX/D7/BA /BY /D3/D6 /CT/DC/CP/D1/B9/D4/D0/CT/B8 /CC /BT /C7/BD /CP/D2/CS /CC /BT /C7/BE /DB /CT/D6/CT /D8/CW/CT /CT/AB/CT/CR/D8/CX/DA /CT /D1/CP/D6/CZ /CT/D6/D7 /D8/CW/CP/D8/CS/CX/D7/D8/CX/D2/CV/D9/CX/D7/CW /D3/D6/CX/CV/CX/D2/CP/D0 /CP/CS/CT/D2/D3 /CR/CP/D6/CR/CX/D2/D3/D1/CP /CU/D6/D3/D1 /D8/D6/CP/D2/D7/CU/CT/D6/D6/CT/CS/CP/CS/CT/D2/D3 /CR/CP/D6/CR/CX/D2/D3/D1/CP /B4/BF /BN /BG /B5/BA /CB/D3/D1/CT /D7/D8/D9/CS/CX/CT/D7 /CP/D0/D7/D3 /CX/D2/CS/CX/CR/CP/D8/CT/CS/D8/CW/CP/D8 /D8/CW/CT /D4/D6/D3/D8/CT/CX/D2/D7/B8 /CP/D2 /D8/CX/D3 /DC/CX/CS/CP/D2 /D8 /CT/D2/DE/DD/D1/CT /B4/BT /C7/BX/BF/BJ/BE/B5 /CP/D2/CS/BT /CC/C8 /D7/DD/D2 /D8/CW/CP/D7/CT /D7/D9/CQ/D9/D2/CX/D8 /B4/BT /CC/C8/BH/BW/B5 /DB /CT/D6/CT /D7/CX/CV/D2/CX/AC/CR/CP/D2 /D8/D0/DD/D3 /DA /CT/D6/B9/CT/DC/D4/D6/CT/D7/D7/CT/CS /CX/D2 /D0/D9/D2/CV /CP/CS/CT/D2/D3 /CR/CP/D6/CR/CX/D2/D3/D1/CP/B8 /DB/CW/CX/CR /CW /DB/CX/D0/D0/D1/CP/CZ /CT /D8/CW/CT/D1 /D4 /D3/D8/CT/D2 /D8/CX/CP/D0 /CS/CX/CP/CV/D2/D3/D7/D8/CX/CR /D1/CP/D6/CZ /CT/D6/D7 /D3/CU /D0/D9/D2/CV /CP/CS/CT/B9/BH/BK /BZ/CT/D2/D3/BA/B8 /C8/D6/D3/D8/BA /B2 /BU/CX/D3/CX/D2/CU/D3/BA /CE /D3/D0/BA /BD /C6/D3/BA /BD /BY /CT/CQ/D6/D9/CP/D6/DD /BE/BC/BC/BFThis is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e0/86/main.PMC5172349.pdf
3 August 2003 173This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,OADS,/arxiv_data1/oa_pdf/eb/b9/main.PMC5172350.pdf
3 August 2003This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/6f/c0/main.PMC5172353.pdf
The clinical diagnostic criteria for SARS followed the Clinical Description of SARS re- leased by WHO (http://www.who.int/csr/sars/guide lines/en/).,Non-OADS,/arxiv_data1/oa_pdf/6f/c0/main.PMC5172353.pdf
/C1/D2 /DA/CX/D8/CT/CS /BT/D6/D8/CX/CR/D0/CT/CC/CW/CT /CB/D8/D6/D9/CR/D8/D9/D6/CP/D0 /BV/CW/CP/D6/CP/CR/D8/CT/D6/CX/DE/CP/D8/CX/D3/D2 /CP/D2/CS /BT/D2 /D8/CX/CV/CT/D2/CX/CR/CX/D8 /DD /D3/CU /D8/CW/CT /CB /C8/D6/D3/D8/CT/CX/D2/D3/CU /CB/BT/CA/CB/B9/BV/D3/CE/C2/CX/D2/CV/DC/CX/CP/D2/CV /C4/CX /BD/B6/B8 /BV/CW /D9/D2/D5/CX/D2/CV /C4/D9/D3 /BD/B6/B8 /CH /CP/CY /D9 /D2 /BW/CT/D2/CV /BD/BN/BE/B6/B8 /CH /D9/CY/D9/D2 /C0/CP/D2 /BD/B6/B8 /C4/CX/D2 /CC /CP/D2/CV /BD/B8 /C2/CX/D2/CV /CF /CP/D2/CV /BD/BN/BF/B8 /C2/CX/CP /C2/CX /BD/B8 /C2/CX/CP /CH /CT /BD/BN/BG/B8/BY /CP/D2 /CQ/D3 /C2/CX/CP/D2/CV /BD/B8 /CI/CW/CP/D3 /CG/D9 /BG/B8 /CF /CT/CX /CC /D3/D2/CV /BD/B8 /CF /CT/CX /CF /CT/CX /BG/B8 /C9/CX/D2/CV/D6/D9/D2 /CI/CW/CP/D2/CV /BD/B8 /CB/CW/CT/D2/CV/CQ/CX/D2 /C4/CX /BD/BN/BE/B8 /CF /CT/CX /C4/CX /BD/B8 /C0/D3/D2/CV/DD /CP/D2 /C4/CX /BD/B8/CH /D9/CS/D3/D2/CV /C4/CX /BD/B8 /CF /CT/CX /BW/D3/D2/CV /BD/B8 /C2/CX/CP/D2 /CF /CP/D2/CV /BD/BN/BG/B8 /CB/CW/CT/D2/CV/D0/CX /BU/CX /BH/B8 /CP/D2/CS /C0/D9/CP/D2/D1/CX/D2/CV /CH /CP/D2/CV /BD/BN/BG/AZ/BD/BU/CT/CX/CY/CX/D2/CV /BZ/CT/D2/D3/D1/CX/CR/D7 /C1/D2/D7/D8/CX/D8/D9/D8/CT/B8 /BV/CW/CX/D2/CT/D7/CT /BT /CR /CP/CS/CT/D1/DD /D3/CU /CB/CR/CX/CT/D2/CR /CT/D7/B8 /BU/CT/CX/CY/CX/D2/CV /BD/BC/BD/BF/BC/BC/B8 /BV/CW/CX/D2/CP/BN /BE/C5/CT /CS/CX/CR /CP/D0 /BV/D3/D0 /D0/CT /CV/CT/B8 /CG/CX/B3/CP/D2/C2/CX/CP/D3/D8/D3/D2/CV /CD/D2/CX/DA/CT/D6/D7/CX/D8/DD/B8 /CG/CX/B3/CP/D2 /BJ/BD/BC/BC/BG/BL/B8 /BV/CW/CX/D2/CP/BN /BF/BV/D3/D0 /D0/CT /CV/CT /D3/CU /C4/CX/CU/CT /CB/CR/CX/CT/D2/CR /CT/D7/B8 /C8/CT/CZ/CX/D2/CV /CD/D2/CX/DA/CT/D6/D7/CX/D8/DD/B8 /BU/CT/CX/CY/CX/D2/CV /BD/BC/BC/BK/BJ/BD/B8/BV/CW/CX/D2/CP/BN /BG/C2/CP/D1/CT/D7 /BW/BA /CF/CP/D8/D7/D3/D2 /C1/D2/D7/D8/CX/D8/D9/D8/CT /D3/CU /BZ/CT/D2/D3/D1/CT /CB/CR/CX/CT/D2/CR /CT/D7/B8 /CI/CW/CX/CY/CX/CP/D2/CV /BV/CP/D1/D4/D9/D7/B8 /CI/CW/CT/CY/CX/CP/D2/CV /CD/D2/CX/DA/CT/D6/D7/CX/D8/DD/B8 /C0/CP/D2/CV/DE/CW/D3/D9/BF/BD/BC/BC/BC/BK/B8 /BV/CW/CX/D2/CP/BN /BH/BV/CT/D2/D8/CT/D6 /D3/CU /BW/CX/D7/CT /CP/D7/CT /BV/D3/D2/D8/D6 /D3/D0 /CP/D2/CS /C8/D6 /CT/DA/CT/D2/D8/CX/D3/D2/B8 /BU/CT/CX/CY/CX/D2/CV /BD/BC/BC/BC/BH/BC/B8 /BV/CW/CX/D2/CP/BA/CC/CW/CT /CR/D3/D6/D3/D2/CP/B9/D0/CX/CZ /CT /D7/D4/CX/CZ /CT/D7 /D3/D6 /D4 /CT/D4/D0/D3/D1/CT/D6/D7 /D3/D2 /D8/CW/CT /D7/D9/D6/CU/CP/CR/CT /D3/CU /D8/CW/CT /DA/CX/D6/CX/D3/D2 /D9/D2/CS/CT/D6 /CT/D0/CT/CR/D8/D6/D3/D2/CX/CR/D1/CX/CR/D6/D3/D7/CR/D3/D4 /CT /CP/D6/CT /D8/CW/CT /D1/D3/D7/D8 /D7/D8/D6/CX/CZ/CX/D2/CV /CU/CT/CP/D8/D9/D6/CT/D7 /D3/CU /CR/D3/D6/D3/D2/CP /DA/CX/D6/D9/D7/CT/D7/BA /CC/CW/CT /CB /B4/D7/D4/CX/CZ /CT/B5 /D4/D6/D3/D8/CT/CX/D2/CX/D7 /D8/CW/CT /D0/CP/D6/CV/CT/D7/D8 /D7/D8/D6/D9/CR/D8/D9/D6/CP/D0 /D4/D6/D3/D8/CT/CX/D2/B8 /DB/CX/D8/CW /BD/B8/BE/BH/BH /CP/D1/CX/D2/D3 /CP/CR/CX/CS/D7/B8 /CX/D2 /D8/CW/CT /DA/CX/D6/CP/D0 /CV/CT/D2/D3/D1/CT/BA /C1/D8/D7/D7/D8/D6/D9/CR/D8/D9/D6/CT /CR/CP/D2 /CQ/CT /CS/CX/DA/CX/CS/CT/CS /CX/D2 /D8/D3 /D8/CW/D6/CT/CT /D6/CT/CV/CX/D3/D2/D7/BM /CP /D0/D3/D2/CV /C6/B9/D8/CT/D6/D1/CX/D2/CP/D0 /D6/CT/CV/CX/D3/D2 /CX/D2 /D8/CW/CT /CT/DC/D8/CT/B9/D6/CX/D3/D6/B8 /CP /CR /CW/CP/D6/CP/CR/D8/CT/D6/CX/D7/D8/CX/CR /D8/D6/CP/D2/D7/D1/CT/D1 /CQ/D6/CP/D2/CT /B4/CC/C5/B5 /D6/CT/CV/CX/D3/D2/B8 /CP/D2/CS /CP /D7/CW/D3/D6/D8 /BV/B9/D8/CT/D6/D1/CX/D2 /D9/D7 /CX/D2 /D8/CW/CT/CX/D2 /D8/CT/D6/CX/D3/D6 /D3/CU /CP /DA/CX/D6/CX/D3/D2/BA /CF /CT /CS/CT/D8/CT/CR/D8/CT/CS /AC/CU/D8/CT/CT/D2 /D7/D9/CQ/D7/D8/CX/D8/D9/D8/CX/D3/D2/D7 /D3/CU /D2 /D9/CR/D0/CT/D3/D8/CX/CS/CT/D7 /CQ /DD /CR/D3/D1/D4/CP/D6/CX/D7/D3/D2/D7/DB/CX/D8/CW /D8/CW/CT /D7/CT/DA /CT/D2 /D8/CT/CT/D2 /D4/D9/CQ/D0/CX/D7/CW/CT/CS /CB/BT/CA/CB/B9/BV/D3/CE /CV/CT/D2/D3/D1/CT /D7/CT/D5/D9/CT/D2/CR/CT/D7/B8 /CT/CX/CV/CW /D8 /B4/BH/BF/BA/BF/B1/B5 /D3/CU /DB/CW/CX/CR /CW/CP/D6/CT /D2/D3/D2/B9/D7/DD/D2/D3/D2 /DD/D1/D3/D9/D7 /D1 /D9/D8/CP/D8/CX/D3/D2/D7 /D0/CT/CP/CS/CX/D2/CV /D8/D3 /CP/D1/CX/D2/D3 /CP/CR/CX/CS /CP/D0/D8/CT/D6/D2/CP/D8/CX/D3/D2/D7 /DB/CX/D8/CW /D4/D6/CT/CS/CX/CR/D8/CT/CS/D4/CW /DD/D7/CX/D3 /CR /CW/CT/D1/CX/CR/CP/D0 /CR /CW/CP/D2/CV/CT/D7/BA /CC/CW/CT /D4 /D3/D7/D7/CX/CQ/D0/CT /CP/D2 /D8/CX/CV/CT/D2/CX/CR /CS/CT/D8/CT/D6/D1/CX/D2/CP/D2 /D8/D7 /D3/CU /D8/CW/CT /CB /D4/D6/D3/D8/CT/CX/D2 /CP/D6/CT/D4/D6/CT/CS/CX/CR/D8/CT/CS/B8 /CP/D2/CS /D8/CW/CT /D6/CT/D7/D9/D0/D8 /CX/D7 /CR/D3/D2/AC/D6/D1/CT/CS /CQ /DD /BX/C4/C1/CB/BT /B4/CT/D2/DE/DD/D1/CT/B9/D0/CX/D2/CZ /CT/CS /CX/D1/D1 /D9/D2/D3/D7/D3/D6/CQ/CT/D2 /D8/CP/D7/D7/CP /DD/B5 /DB/CX/D8/CW /D7/DD/D2 /D8/CW/CT/D7/CX/DE/CT/CS /D4 /CT/D4/D8/CX/CS/CT/D7/BA /BT/D2/D3/D8/CW/CT/D6 /D4/D6/D3/CU/D3/D9/D2/CS /AC/D2/CS/CX/D2/CV /CX/D7 /D8/CW/CP/D8 /D8/CW/D6/CT/CT /CS/CX/D7/D9/D0/AC/CS/CT/CQ/D3/D2/CS/D7 /CP/D6/CT /CS/CT/AC/D2/CT/CS /CP/D8 /D8/CW/CT /BV/B9/D8/CT/D6/D1/CX/D2 /D9/D7 /DB/CX/D8/CW /D8/CW/CT /C6/B9/D8/CT/D6/D1/CX/D2 /D9/D7 /D3/CU /D8/CW/CT /BX /B4/CT/D2 /DA /CT/D0/D3/D4 /CT/B5 /D4/D6/D3/B9/D8/CT/CX/D2/B8 /CQ/CP/D7/CT/CS /D3/D2 /D8/CW/CT /D8 /DD/D4/CX/CR/CP/D0 /D7/CT/D5/D9/CT/D2/CR/CT /CP/D2/CS /D4 /D3/D7/CX/D8/CX/D3/D2/D7/B8 /D8/CW /D9/D7 /CT/D7/D8/CP/CQ/D0/CX/D7/CW/CX/D2/CV /D8/CW/CT /D7/D8/D6/D9/CR/D8/D9/D6/CP/D0/CR/D3/D2/D2/CT/CR/D8/CX/D3/D2 /DB/CX/D8/CW /D8/CW/CT/D7/CT /D8 /DB /D3 /CX/D1/D4 /D3/D6/D8/CP/D2 /D8 /D7/D8/D6/D9/CR/D8/D9/D6/CP/D0 /D4/D6/D3/D8/CT/CX/D2/D7/B8 /CX/CU /CR/D3/D2/AC/D6/D1/CT/CS/BA /C8/CW /DD/D0/D3/CV/CT/B9/D2/CT/D8/CX/CR /CP/D2/CP/D0/DD/D7/CX/D7 /D6/CT/DA /CT/CP/D0/D7 /D7/CT/DA /CT/D6/CP/D0 /CR/D3/D2/D7/CT/D6/DA /CT/CS /D6/CT/CV/CX/D3/D2/D7 /D8/CW/CP/D8 /D1/CX/CV/CW /D8 /CQ/CT /D4 /D3/D8/CT/D2 /D8 /CS/D6/D9/CV /D8/CP/D6/CV/CT/D8/D7/BA/C3/CT/DD /DB /D3/D6/CS/D7/BM /CB/BT/CA/CB/B8 /CR/D3/D6/D3/D2/CP /DA/CX/D6/D9/D7/B8 /D8/CW/CT /CB /D4/D6/D3/D8/CT/CX/D2/B8 /D7/D8/D6/D9/CR/D8/D9/D6/CT/B8 /CP/D2 /D8/CX/CV/CT/D2/CX/CR/CX/D8 /DD/C1/D2 /D8/D6/D3 /CS/D9/CR/D8/CX/D3/D2/CC/CW/CT /CB /B4/D7/D4/CX/CZ /CT/B8 /D3/D6 /BX/BE /CV/D0/DD/CR/D3/D4/D6/D3/D8/CT/CX/D2 /D4/D6/CT/CR/D9/D6/D7/D3/D6/B5 /D4/D6/D3/D8/CT/CX/D2/CX/D7 /D8/CW/CT /D0/CP/D6/CV/CT/D7/D8 /D7/D8/D6/D9/CR/D8/D9/D6/CP/D0 /D4/D6/D3/D8/CT/CX/D2 /D3/CU /CC /DD/D4 /CT /C1 /D1/CT/D1 /CQ/D6/CP/D2/CT/CV/D0/DD/CR/D3/D4/D6/D3/D8/CT/CX/D2/D7 /CP/D2/CS /CX/D7 /D8/CW/CT /D1/CP/CX/D2 /CR/D3/D1/D4 /D3/D2/CT/D2 /D8 /D3/CU /D8/CW/CT /CR /CW/CP/D6/B9/CP/CR/D8/CT/D6/CX/D7/D8/CX/CR /D7/D4/CX/CZ /CT/D7 /D3/D2 /D8/CW/CT /D7/D9/D6/CU/CP/CR/CT /D3/CU /CR/D3/D6/D3/D2/CP /DA/CX/D6/D9/D7/CT/D7/BA /C1/D8/CX/D7 /CR/D3/D1/D4 /D3/D7/CT/CS /D3/CU /CP /CZ/D2/D3/CQ /D6/CT/CV/CX/D3/D2 /B4/CB/BD/B5 /CP/D2/CS /CP /D7/D8/CT/D1 /D6/CT/CV/CX/D3/D2/B4/CB/BE/B5/B8 /CP/D2/CS /CX/D2 /D7/D3/D1/CT /D7/D4 /CT/CR/CX/CT/D7 /D3/CU /CR/D3/D6/D3/D2/CP /DA/CX/D6/D9/D7/CT/D7 /D8/CW/CT /D4/D6/CT/B9/CR/D9/D6/D7/D3/D6 /CB /D4/D6/D3/D8/CT/CX/D2 /DB/CX/D0/D0 /CQ/CT /CR/D0/CT/CP /DA /CT/CS /CX/D2 /D8/D3 /D8/CW/CT /C6/B9/D8/CT/D6/D1/CX/D2/CP/D0/CB/BD /CP/D2/CS /BV/B9/D8/CT/D6/D1/CX/D2/CP/D0 /CB/BE /CV/D0/DD/CR/D3/D4 /D3/D0/DD/D4 /CT/D4/D8/CX/CS/CT/D7 /CP/D8 /CP /D7/D4 /CT/CR/CX/CP/D0/D4/D6/D3/D8/CT/CP/D7/CT /CR/D0/CT/CP /DA /CP/CV/CT /D7/CX/D8/CT /B4/BD/B9/BG/B5/BA /CC/CW/CT /CB /D4/D6/D3/D8/CT/CX/D2 /CX/D7 /D4 /D3/D7/B9/D8/D9/D0/CP/D8/CT/CS /D8/D3 /CQ/CT /CX/D2/CR/D3/D6/D4 /D3/D6/CP/D8/CT/CS /CX/D2 /D8/D3 /D8/CW/CT /DA/CX/D6/CP/D0 /D1/CT/D1 /CQ/D6/CP/D2/CT/CQ /DD /CX/D2 /D8/CT/D6/CP/CR/D8/CX/D3/D2 /DB/CX/D8/CW /D8/CW/CT /C5 /B4/D1/CT/D1 /CQ/D6/CP/D2/CT/B5 /D4/D6/D3/D8/CT/CX/D2/B8 /CP/D2/CS/D7/D9/CQ/D7/CT/D5/D9/CT/D2 /D8 /D6/CT/D0/CT/CP/D7/CT /D3/CU /D1/CP/D8/D9/D6/CT /DA/CX/D6/CX/D3/D2/D7 /CU/D6/D3/D1 /D8/CW/CT /D7/D1/D3 /D3/D8/CW/DA /CT/D7/CX/CR/D0/CT/D7 /B4/BH/B5/BA /CC/CW/CT /CB /D4/D6/D3/D8/CT/CX/D2 /CX/D7 /D8/CW/D3/D9/CV/CW /D8 /D8/D3 /CQ/CT /CX/D1/D4 /D3/D6/B9/D8/CP/D2 /D8 /CU/D3/D6 /DA/CX/D6/CP/D0 /CP/D8/D8/CP/CR /CW/D1/CT/D2 /D8 /D8/CW/D6/D3/D9/CV/CW /CX/D8/D7 /CX/D2 /D8/CT/D6/CP/CR/D8/CX/D3/D2 /DB/CX/D8/CW/D8/CW/CT /CR/CT/D0/D0/D9/D0/CP/D6 /D6/CT/CR/CT/D4/D8/D3/D6/D7/BA /C8/D6/CT/DA/CX/D3/D9/D7 /D6/CT/D7/CT/CP/D6/CR /CW /CW/CP/D7 /D7/CW/D3 /DB/D2/D8/CW/CP/D8 /D8/CW/CT /CW/CP/D0/CU /D3/CU /D8/CW/CT /CB /D4/D6/D3/D8/CT/CX/D2 /D2/CT/CP/D6 /D8/CW/CT /BV/B9/D8/CT/D6/D1/CX/D2 /D9/D7 /CX/D7/B6 /CC/CW/CT/D7/CT /CP/D9/D8/CW/D3/D6/D7 /CR/D3/D2 /D8/D6/CX/CQ/D9/D8/CT/CS /CT/D5/D9/CP/D0/D0/DD /D8/D3 /D8/CW/CX/D7/DB /D3/D6/CZ/BA/AZ/BV/D3/D6/D6/CT/D7/D4 /D3/D2/CS/CX/D2/CV /CP/D9/D8/CW/D3/D6/BA/BX/B9/D1/CP/CX/D0/BM /DD /CP/D2/CV/CW/D1/BS/CV/CT/D2/D3/D1/CX/CR/D7/BA/D3/D6/CV/BA/CR/D2 /CR/D3/D0/D0/CP/D4/D7/CT/CS /CX/D2 /D8/D3 /CR/D3/CX/D0/CT/CS/B9/CR/D3/CX/D0/D7/B8 /D8/CW /D9/D7 /CQ/D6/CX/D2/CV/CX/D2/CV /CP /CU/D9/D7/CX/D3/D2 /D4/CT /D4 /B9/D8/CX/CS/CT /DB/CX/D8/CW /D8/CW/CT /D8/D6/CP/D2/D7/D1/CT/D1 /CQ/D6/CP/D2/CT /B4/CC/C5/B5 /D6/CT/CV/CX/D3/D2 /CU/D3/D6 /CR/CT/D0/D0/D9/D0/CP/D6/CP/D2/CS /DA/CX/D6/CP/D0 /D1/CT/D1 /CQ/D6/CP/D2/CT /CU/D9/D7/CX/D3/D2 /B4/BI/B8 /BJ/B5/BA /BY /D9/D6/D8/CW/CT/D6/D1/D3/D6/CT/B8 /CX/D8 /CW/CP/D7/CQ /CT/CT/D2 /D7/D9/CV/CV/CT/D7/D8/CT/CS /D8/CW/CP/D8 /D8/CW/CT /CB /D4/D6/D3/D8/CT/CX/D2 /CX/D2/CS/D9/CR/CT/D7 /D8/CW/CT /D4/D6/D3 /CS/D9/CR/B9/D8/CX/D3/D2 /D3/CU /DA/CX/D6/D9/D7/B9/D2/CT/D9/D8/D6/CP/D0/CX/DE/CX/D2/CV /CP/D2 /D8/CX/CQ /D3 /CS/CX/CT/D7 /CP/D2/CS /D8/CW/CP/D8 /CP/D1/CX/D2/D3/CP/CR/CX/CS /CR /CW/CP/D2/CV/CT/D7 /CX/D2 /D8/CW/CT /CB /D4/D6/D3/D8/CT/CX/D2 /D1/CP /DD /CS/D6/CP/D1/CP/D8/CX/CR/CP/D0/D0/DD /CP/AB/CT/CR/D8/D8/CW/CT /DA/CX/D6/D9/D0/CT/D2/CR/CT /CP/D0/D8/CT/D6/CT/CS /D4/CP/D8/CW/D3/CV/CT/D2/CT/D7/CX/D7 /CP/D2/CS /CX/D2 /DA/CX/D8/D6 /D3 /CW/D3/D7/D8/CR/CT/D0/D0 /D8/D6/D3/D4/CX/D7/D1 /CX/D2 /D3/D8/CW/CT/D6 /CR/D3/D6/D3/D2/CP /DA/CX/D6/D9/D7/CT/D7 /B4/BI/B8 /BK/B5/BA/CF /CT /D6/CT/D4 /D3/D6/D8/B8 /CX/D2 /D8/CW/CX/D7 /D4/CP/D4 /CT/D6/B8 /D8/CW/CT /D6/CT/D7/D9/D0/D8/D7 /D3/CU /D8/CW/CT /CR/D3/D1/B9/D4/CP/D6/CP/D8/CX/DA /CT /CP/D2/CP/D0/DD/D7/CT/D7 /D3/D2 /D8/CW/CT /CB /D4/D6/D3/D8/CT/CX/D2 /D3/CU /BU/C2 /BZ/D6/D3/D9/D4 /B4/BU/C2/BC/BD/B9/BU/C2/BC/BG/B5 /CP/D2/CS /BD/BF /D3/D8/CW/CT/D6 /D6/CT/D4 /D3/D6/D8/CT/CS /CB/BT/CA/CB/B9/BV/D3/CE /CV/CT/D2/D3/D1/CT /D7/CT/B9/D5/D9/CT/D2/CR/CT/D7 /B4/BL/B9/BD/BE/B5 /CP/D7 /DB /CT/D0/D0 /CP/D7 /BD/BF /D3/D9/D8 /D3/CU /BD/BJ /D1/CT/D1 /CQ /CT/D6/D7 /D3/CU/BV/D3/D6 /D3/D2/CP/DA/CX/D6/CX/CS/CP/CT /DB/CX/D8/CW /D8/CW/CT /CS/CP/D8/CP /D3/CU /D8/CW/CT /CB /D4/D6/D3/D8/CT/CX/D2 /CP /DA /CP/CX/D0/B9/CP/CQ/D0/CT/BA/CA/CT/D7/D9/D0/D8/D7 /CP/D2/CS /BW/CX/D7/CR/D9/D7/D7/CX/D3/D2/BZ/CT/D2/CT/D6/CP/D0 /CU/CT/CP/D8/D9/D6/CT/D7/CC/CW/CT /C7/CA/BY /B4/D3/D4 /CT/D2 /D6/CT/CP/CS/CX/D2/CV /CU/D6/CP/D1/CT/B5 /D3/CU /D8/CW/CT /CB /D4/D6/D3/D8/CT/CX/D2/B8 /D2 /D9/B9/CR/D0/CT/D3/D8/CX/CS/CT /B4/D2 /D8/B5 /D4 /D3/D7/CX/D8/CX/D3/D2 /BE/BD/B8/BG/BJ/BF/B9/BE/BH/B8/BE/BG/BC/B8 /D0/D3 /CR/CP/D8/CT/D7 /CQ/CT /D8 /DB /CT/CT/D2/D8/CW/CT /C7/CA/BY/D7 /CU/D3/D6 /D8/CW/CT /CA /B4/D6/CT/D4/D0/CX/CR/CP/D7/CT/B5 /D4/D6/D3/D8/CT/CX/D2 /B4/D2 /D8 /D4 /D3/D7/CX/D8/CX/D3/D2/BD/BC/BK /BZ/CT/D2/D3/BA/B8 /C8/D6/D3/D8/BA /B2 /BU/CX/D3/CX/D2/CU/D3/BA /CE /D3/D0/BA /BD /C6/D3/BA /BE /C5/CP /DD /BE/BC/BC/BFThis is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bd/d1/main.PMC5172354.pdf
/C4/CT/D8/D8/CT/D6/BZ/CT/D2/CT /BX/DC/D4/D6/CT/D7/D7/CX/D3/D2 /CE /CT/D6/D7/D9/D7 /CB/CT/D5/D9/CT/D2/CR/CT /CU/D3/D6 /C8/D6/CT/CS/CX/CR/D8/CX/D2/CV /BY /D9/D2/CR/D8/CX/D3/D2/BM /BZ/D0/CX/CP/C5/CP/D8/D9/D6/CP/D8/CX/D3/D2 /BY /CP/CR/D8/D3/D6 /BZ/CP/D1/D1/CP /C1/D7 /C6/D3/D8 /BT /BZ/D0/CX/CP /C5/CP/D8/D9/D6/CP/D8/CX/D3/D2 /BY /CP/CR/D8/D3/D6/C5/CX/CR /CW/CP/CT/D0 /BZ/BA /CF /CP/D0/CZ /CT/D6/C1/D2/CR/DD/D8/CT /BZ/CT/D2/D3/D1/CX/CR/D7/B8 /C1/D2/CR/BA/B8 /BV/BT /BL/BG/BC/BK/BJ/B8 /CD/CB/BT/C1/D8 /CX/D7 /D7/D8/CP/D2/CS/CP/D6/CS /D4/D6/CP/CR/D8/CX/CR/CT/B8 /DB/CW/CT/D2/CT/DA /CT/D6 /CP /D6/CT/D7/CT/CP/D6/CR /CW/CT/D6 /AC/D2/CS/D7 /CP /D2/CT/DB /CV/CT/D2/CT/B8 /D8/D3 /D7/CT/CP/D6/CR /CW /CS/CP/D8/CP/CQ/CP/D7/CT/D7/CU/D3/D6 /CV/CT/D2/CT/D7 /D8/CW/CP/D8 /CW/CP /DA /CT /CP /D7/CX/D1/CX/D0/CP/D6 /D7/CT/D5/D9/CT/D2/CR/CT/BA /C1/D8 /CX/D7 /D2/D3/D8 /D7/D8/CP/D2/CS/CP/D6/CS /D4/D6/CP/CR/D8/CX/CR/CT/B8 /DB/CW/CT/D2/CT/DA /CT/D6 /CP/D6/CT/D7/CT/CP/D6/CR /CW/CT/D6 /AC/D2/CS/D7 /CP /D2/CT/DB /CV/CT/D2/CT/B8 /D8/D3 /D7/CT/CP/D6/CR /CW /CU/D3/D6 /CV/CT/D2/CT/D7 /D8/CW/CP/D8 /CW/CP /DA /CT /D7/CX/D1/CX/D0/CP/D6 /CT/DC/D4/D6/CT/D7/D7/CX/D3/D2 /B4/CR/D3/B9/CT/DC/D4/D6/CT/D7/D7/CX/D3/D2/B5/BA /BY /CP/CX/D0/D9/D6/CT /D8/D3 /D4 /CT/D6/CU/D3/D6/D1 /CR/D3/B9/CT/DC/D4/D6/CT/D7/D7/CX/D3/D2 /D7/CT/CP/D6/CR /CW/CT/D7 /CW/CP/D7 /D0/CT/CP/CS /D8/D3 /CX/D2/CR/D3/D6/D6/CT/CR/D8 /CR/D3/D2/B9/CR/D0/D9/D7/CX/D3/D2/D7 /CP/CQ /D3/D9/D8 /D8/CW/CT /D0/CX/CZ /CT/D0/DD /CU/D9/D2/CR/D8/CX/D3/D2 /D3/CU /D2/CT/DB /CV/CT/D2/CT/D7/B8 /CP/D2/CS /CW/CP/D7 /D0/CT/CP/CS /D8/D3 /DB /CP/D7/D8/CT/CS /D0/CP/CQ /D3/D6/CP/D8/D3/D6/DD/CP/D8/D8/CT/D1/D4/D8/D7 /D8/D3 /CR/D3/D2/AC/D6/D1 /CU/D9/D2/CR/D8/CX/D3/D2/D7 /CX/D2/CR/D3/D6/D6/CT/CR/D8/D0/DD /D4/D6/CT/CS/CX/CR/D8/CT/CS/BA /CF /CT /D4/D6/CT/D7/CT/D2 /D8 /CW/CT/D6/CT /D8/CW/CT /CT/DC/CP/D1/D4/D0/CT/D3/CU /BZ/D0/CX/CP /C5/CP/D8/D9/D6/CP/D8/CX/D3/D2 /BY /CP/CR/D8/D3/D6 /CV/CP/D1/D1/CP /B4/BZ/C5/BY/B9/CV/CP/D1/D1/CP/B5/BA /BW/CT/D7/D4/CX/D8/CT /CX/D8/D7 /D2/CP/D1/CT/B8 /CX/D8 /CW/CP/D7 /D2/D3/D8/CQ /CT/CT/D2 /D7/CW/D3 /DB/D2 /D8/D3 /D4/CP/D6/D8/CX/CR/CX/D4/CP/D8/CT /CX/D2 /CV/D0/CX/CP /D1/CP/D8/D9/D6/CP/D8/CX/D3/D2/BA /C1/D8 /CX/D7 /CP /CV/CT/D2/CT /D3/CU /D9/D2/CZ/D2/D3 /DB/D2 /CU/D9/D2/CR/D8/CX/D3/D2/D8/CW/CP/D8 /CX/D7 /D7/CX/D1/CX/D0/CP/D6 /CX/D2 /D7/CT/D5/D9/CT/D2/CR/CT /D8/D3 /BZ/C5/BY/B9/CQ /CT/D8/CP/BA /CC/CW/CT /D7/CT/D5/D9/CT/D2/CR/CT /CW/D3/D1/D3/D0/D3/CV/DD /CP/D2/CS /CR /CW/D6/D3/D1/D3/D7/D3/B9/D1/CP/D0 /D0/D3 /CR/CP/D8/CX/D3/D2 /D0/CT/CS /D8/D3 /CP/D2 /D9/D2/D7/D9/CR/CR/CT/D7/D7/CU/D9/D0 /D7/CT/CP/D6/CR /CW /CU/D3/D6 /BZ/C5/BY/B9/CV/CP/D1/D1/CP /D1 /D9/D8/CP/D8/CX/D3/D2/D7 /CX/D2 /CV/D0/CX/D3/D1/CP/BA/CF /CT /CT/DC/CP/D1/CX/D2/CT/CS /BZ/C5/BY/B9/CV/CP/D1/D1/CP /CT/DC/D4/D6/CT/D7/D7/CX/D3/D2 /CX/D2 /BD/BG/BF/BE /CW /D9/D1/CP/D2 /CR/BW/C6/BT /D0/CX/CQ/D6/CP/D6/CX/CT/D7/BA /C0/CX/CV/CW/CT/D7/D8/CT/DC/D4/D6/CT/D7/D7/CX/D3/D2 /D3 /CR/CR/D9/D6/D7 /CX/D2 /D4/CW/CP/CV/D3 /CR/DD/D8/CX/CR/B8 /CP/D2 /D8/CX/CV/CT/D2/B9/D4/D6/CT/D7/CT/D2 /D8/CX/D2/CV /CP/D2/CS /D3/D8/CW/CT/D6 /CW/CT/D1/CP/D8/D3/D4 /D3/CX/CT/D8/CX/CR /CR/CT/D0/D0/D7/BA/CF /CT /CU/D3/D9/D2/CS /BZ/C5/BY/B9/CV/CP/D1/D1/CP /D1/CA/C6/BT /CX/D2 /CP/D0/D1/D3/D7/D8 /CT/DA /CT/D6/DD /D8/CX/D7/D7/D9/CT /CT/DC/CP/D1/CX/D2/CT/CS/B8 /DB/CX/D8/CW /CT/DC/D4/D6/CT/D7/D7/CX/D3/D2/CX/D2 /D2/CT/D6/DA /D3/D9/D7 /D8/CX/D7/D7/D9/CT /D2/D3 /CW/CX/CV/CW/CT/D6 /D8/CW/CP/D2 /CX/D2 /CP/D2 /DD /D3/D8/CW/CT/D6 /D8/CX/D7/D7/D9/CT/BA /C7/D9/D6 /CT/DA/CX/CS/CT/D2/CR/CT /CX/D2/CS/CX/CR/CP/D8/CT/D7 /D8/CW/CP/D8/BZ/C5/BY/B9/CV/CP/D1/D1/CP /D4/CP/D6/D8/CX/CR/CX/D4/CP/D8/CT/D7 /CX/D2 /D4/CW/CP/CV/D3 /CR/DD/D8/D3/D7/CX/D7 /CX/D2 /CP/D2 /D8/CX/CV/CT/D2 /D4/D6/CT/D7/CT/D2 /D8/CX/D2/CV /CR/CT/D0/D0/D7/BA /CB/CT/CP/D6/CR /CW/CT/D7 /CU/D3/D6/CV/CT/D2/CT/D7 /DB/CX/D8/CW /D7/CX/D1/CX/D0/CP/D6 /D7/CT/D5/D9/CT/D2/CR/CT/D7 /D7/CW/D3/D9/D0/CS /CQ/CT /D7/D9/D4/D4/D0/CT/D1/CT/D2 /D8/CT/CS /DB/CX/D8/CW /D7/CT/CP/D6/CR /CW/CT/D7 /CU/D3/D6 /CV/CT/D2/CT/D7 /DB/CX/D8/CW/D7/CX/D1/CX/D0/CP/D6 /CT/DC/D4/D6/CT/D7/D7/CX/D3/D2 /D8/D3 /CP /DA /D3/CX/CS /CX/D2/CR/D3/D6/D6/CT/CR/D8 /D4/D6/CT/CS/CX/CR/D8/CX/D3/D2/D7/BA/C3/CT/DD /DB /D3/D6/CS/D7/BM /CV/CT/D2/CT /CU/D9/D2/CR/D8/CX/D3/D2 /D4/D6/CT/CS/CX/CR/D8/CX/D3/D2/B8 /CT/DC/D4/D6/CT/D7/D7/CX/D3/D2 /CP/D2/CP/D0/DD/D7/CX/D7/B8 /D7/CT/D5/D9/CT/D2/CR/CT /CP/D2/CP/D0/DD/D7/CX/D7/B8 /BZ/C5/BY/B9/CV/CP/D1/D1/CP/C1/D2 /D8/D6/D3 /CS/D9/CR/D8/CX/D3/D2/CF/CW/CT/D2 /CP /D6/CT/D7/CT/CP/D6/CR /CW/CT/D6 /AC/D2/CS/D7 /CP /D2/CT/DB /CV/CT/D2/CT /D8/CW/CT/DD /D7/CT/CP/D6/CR /CW /BZ/CT/D2/B9/CQ/CP/D2/CZ /D3/D6 /D3/D8/CW/CT/D6 /CS/CP/D8/CP/CQ/CP/D7/CT/D7 /CU/D3/D6 /CV/CT/D2/CT/D7 /D8/CW/CP/D8 /CW/CP /DA /CT /CP /D7/CX/D1/CX/B9/D0/CP/D6 /D7/CT/D5/D9/CT/D2/CR/CT/BA /C1/D8 /CX/D7 /D2/D3/D8 /D7/D8/CP/D2/CS/CP/D6/CS /D4/D6/CP/CR/D8/CX/CR/CT/B8 /DB/CW/CT/D2 /CP /D6/CT/B9/D7/CT/CP/D6/CR /CW/CT/D6 /AC/D2/CS/D7 /CP /D2/CT/DB /CV/CT/D2/CT/B8 /D8/D3 /D7/CT/CP/D6/CR /CW /CU/D3/D6 /CV/CT/D2/CT/D7 /D8/CW/CP/D8/CW/CP /DA /CT /D7/CX/D1/CX/D0/CP/D6 /CT/DC/D4/D6/CT/D7/D7/CX/D3/D2 /B4/CR/D3/B9/CT/DC/D4/D6/CT/D7/D7/CX/D3/D2/B5/BA /BY /CP/CX/D0/D9/D6/CT /D8/D3/D4/CT /D6 /CU /D3 /D6 /D1 /CR/D3/B9/CT/DC/D4/D6/CT/D7/D7/CX/D3/D2 /D7/CT/CP/D6/CR /CW/CT/D7 /CW/CP/D7 /D0/CT/CS /D8/D3 /CX/D2/CR/D3/D6/D6/CT/CR/D8/CR/D3/D2/CR/D0/D9/D7/CX/D3/D2/D7 /CP/CQ /D3/D9/D8 /D8/CW/CT /D0/CX/CZ /CT/D0/DD /CU/D9/D2/CR/D8/CX/D3/D2/D7 /D3/CU /D2/CT/DB /CV/CT/D2/CT/D7/B8/CP/D2/CS /CW/CP/D7 /D0/CT/CS /D8/D3 /DB /CP/D7/D8/CT/CS /D0/CP/CQ /D3/D6/CP/D8/D3/D6/DD /CP/D8/D8/CT/D1/D4/D8/D7 /D8/D3 /CR/D3/D2/AC/D6/D1/CU/D9/D2/CR/D8/CX/D3/D2/D7 /CX/D2/CR/D3/D6/D6/CT/CR/D8/D0/DD /D4/D6/CT/CS/CX/CR/D8/CT/CS /CQ /DD /D7/CT/D5/D9/CT/D2/CR/CT /D7/CX/D1/CX/D0/CP/D6/CX/D8 /DD /BA/CF /CT /CS/CT/D7/CR/D6/CX/CQ /CT /CW/CT/D6/CT /D8/CW/CT /CR/CP/D7/CT /D3/CU /BZ/D0/CX/CP /C5/CP/D8/D9/D6/CP/D8/CX/D3/D2 /BY /CP/CR/B9/D8/D3/D6 /CV/CP/D1/D1/CP/BA /BW/CT/D7/D4/CX/D8/CT /CX/D8/D7 /D2/CP/D1/CT/B8 /BZ/D0/CX/CP /C5/CP/D8/D9/D6/CP/D8/CX/D3/D2 /BY /CP/CR/D8/D3/D6/CV/CP/D1/D1/CP /B4/BZ/C5/BY/B9/CV/CP/D1/D1/CP/B5 /CW/CP/D7 /D2/D3/D8 /CQ /CT/CT/D2 /D7/CW/D3 /DB/D2 /D8/D3 /D4/CP/D6/D8/CX/CR/CX/B9/D4/CP/D8/CT /CX/D2 /CV/D0/CX/CP /D1/CP/D8/D9/D6/CP/D8/CX/D3/D2/BA /C1/D8 /CX/D7 /CP /D6/CT/CR/CT/D2 /D8/D0/DD/B9/CX/CS/CT/D2 /D8/CX/AC/CT/CS /CV/CT/D2/CT/D3/CU /D9/D2/CZ/D2/D3 /DB/D2 /CU/D9/D2/CR/D8/CX/D3/D2/BA /C1/D8 /DB /CP/D7 /AC/D6/D7/D8 /CS/CT/D7/CR/D6/CX/CQ /CT/CS /CQ /DD /BT/D7/CP/CX/B4/BD /B5/B8 /DB/CW/D3 /D2/CP/D1/CT/CS /CX/D8 /CQ/CP/D7/CT/CS /D3/D2 /CX/D8/D7 /CW/D3/D1/D3/D0/D3/CV/DD /D8/D3 /BZ/C5/BY/B9/CQ/CT /D8 /CP /B4/BK/BE/B1 /CP/D1/CX/D2/D3 /CP/CR/CX/CS /CX/CS/CT/D2 /D8/CX/D8 /DD /B8 /BJ/BC/B1 /BW/C6/BT /CX/CS/CT/D2 /D8/CX/D8 /DD/B5/B8/CP /D2/CT/D9/D6/CP/D0 /CV/D6/D3 /DB/D8/CW /CP/D2/CS /D1/CP/D8/D9/D6/CP/D8/CX/D3/D2 /CU/CP/CR/D8/D3/D6/BA /BT/D7/CP/CX /CP/D2/CS/CR/D3/D0/D0/CT/CP/CV/D9/CT/D7 /CT/DC/CP/D1/CX/D2/CT/CS /BZ/C5/BY/B9/CV/CP/D1/D1/CP /CT/DC/D4/D6/CT/D7/D7/CX/D3/D2 /CX/D2 /CT/CX/CV/CW /D8/CW /D9/D1/CP/D2 /D8/CX/D7/D7/D9/CT/D7 /CP/D2/CS /CU/D3/D9/D2/CS /CX/D8 /D4/D6/CT/CS/D3/D1/CX/D2/CP/D2 /D8/D0/DD /CX/D2 /D0/D9/D2/CV/B8/CW/CT/CP/D6/D8 /CP/D2/CS /D4/D0/CP/CR/CT/D2 /D8/CP/B8 /DB/CX/D8/CW /D8/D6/CP/CR/CT /CT/DC/D4/D6/CT/D7/D7/CX/D3/D2 /CX/D2 /CQ/D6/CP/CX/D2/B8/BX/B9/D1/CP/CX/D0/BM /D1 /DB /CP/D0/CZ /CT/D6/BS/D7/D8/CP/D2/CU/D3/D6/CS/CP/D0/D9/D1/D2/CX/BA/D3/D6/CV /D0/CX/DA /CT/D6/B8 /D7/CZ /CT/D0/CT/D8/CP/D0 /D1 /D9/D7/CR/D0/CT/B8 /CZ/CX/CS/D2/CT/DD /B8 /CP/D2/CS /D4/CP/D2/CR/D6/CT/CP/D7/BA /B4/CC/CW/CT/CX/D6/D0/CX/CQ/D6/CP/D6/CX/CT/D7 /CS/CX/CS /D2/D3/D8 /CX/D2/CR/D0/D9/CS/CT /CW/CT/D1/CX/CR /D3/D6 /CX/D1/D1 /D9/D2/CT /D7/DD/D7/D8/CT/D1/D8/CX/D7/D7/D9/CT/D7/BA/B5 /C8 /CT/D8/CT/D6/D7 /CP/D2/CS /CR/D3/D0/D0/CT/CP/CV/D9/CT/D7 /B4/BE /B5 /CS/CT/D8/CT/D6/D1/CX/D2/CT/CS /D8/CW/CP/D8/BZ/C5/BY/B9/CV/CP/D1/D1/CP /CX/D7 /D0/D3 /CR/CP/D8/CT/CS /D3/D2 /CW /D9/D1/CP/D2 /CR /CW/D6/D3/D1/D3/D7/D3/D1/CT /BD/BL /CP/D8/CQ/CP/D2/CS /D5/BD/BF/BA/BE/B8 /CP /D6/CT/CV/CX/D3/D2 /D8/CW/CP/D8 /CX/D7 /CU/D6/CT/D5/D9/CT/D2 /D8/D0/DD /CS/CT/D0/CT/D8/CT/CS /CX/D2 /D1/CP/B9/D0/CX/CV/D2/CP/D2 /D8 /CV/D0/CX/D3/D1/CP/BA /CC/CW/CT /D4 /D3/D7/D7/CX/CQ/D0/CT /D6/D3/D0/CT /D3/CU /BZ/C5/BY/B9/CV/CP/D1/D1/CP /CX/D2/CV/D0/CX/CP/D0 /CS/CX/AB/CT/D6/CT/D2 /D8/CX/CP/D8/CX/D3/D2 /B4/CQ/CP/D7/CT/CS /D3/D2 /CX/D8/D7 /CW/D3/D1/D3/D0/D3/CV/DD /D8/D3 /BZ/C5/BY/B9/CQ /CT/D8/CP/B5 /CP/D2/CS /CX/D8/D7 /CR /CW/D6/D3/D1/D3/D7/D3/D1/CP/D0 /D0/D3 /CR/CP/D8/CX/D3/D2 /CX/D2 /CP /D6/CT/CV/CX/D3/D2 /D0/CX/D2/CZ /CT/CS/D8/D3 /D1/CP/D0/CX/CV/D2/CP/D2 /D8 /CV/D0/CX/D3/D1/CP /D0/CT/CS /C8 /CT/D8/CT/D6/D7 /D8/D3 /D7/D8/D9/CS/DD /CX/D8/D7 /D4 /D3/D8/CT/D2 /D8/CX/CP/D0/D6/D3/D0/CT /CX/D2 /D8/CW/CX/D7 /CS/CX/D7/CT/CP/D7/CT/BA /CC/CW/CT/DD /CT/DC/CP/D1/CX/D2/CT/CS /BG/BD /CV/D0/CX/D3/D1/CP/D7/B8 /CQ/D9/D8/CU/D3/D9/D2/CS /D2/D3 /D1 /D9/D8/CP/D8/CX/D3/D2/D7 /CX/D2 /BZ/C5/BY/B9/CV/CP/D1/D1/CP/B8 /CX/D2/CS/CX/CR/CP/D8/CX/D2/CV /D8/CW/CP/D8/CX/D8 /CX/D7 /D2/D3/D8 /D8/CW/CT /BD/BL/D5/BD/BF/BA/BE /CV/D0/CX/D3/D1/CP /CV/CT/D2/CT/BA /CC/CW /D9/D7/B8 /D8/CW/CT /CU/D9/D2/CR/D8/CX/D3/D2/D3/CU /BZ/C5/BY/B9/CV/CP/D1/D1/CP /CX/D7 /CR/D9/D6/D6/CT/D2 /D8/D0/DD /D9/D2/CZ/D2/D3 /DB/D2/BA/CA/CT/D7/D9/D0/D8/D7 /CP/D2/CS /BW/CX/D7/CR/D9/D7/D7/CX/D3/D2/CF /CT /CS/CT/D8/CT/CR/D8/CT/CS /BZ/C5/BY/B9/CV/CP/D1/D1/CP /D1/CA/C6/BT /CX/D2 /BE/BL/BE /D3/CU /BD/BG/BF/BE/CR/BW/C6/BT /D0/CX/CQ/D6/CP/D6/CX/CT/D7 /B4/CC /CP/CQ/D0/CT /BD/B5/B8 /CX/D2 /CT/DA /CT/D6/DD /D8/CX/D7/D7/D9/CT /CR/CP/D8/CT/CV/D3/D6/DD /CT/DC/B9/CR/CT/D4/D8 /D7/D8/D3/D1/CP/D8/D3/CV/D2/CP/D8/CW/CX/CR/BA /C1/D8 /CX/D7 /D1/D3/D7/D8 /CP/CQ/D9/D2/CS/CP/D2 /D8 /CX/D2 /CW/CT/D1/CX/CR/CP/D2/CS /CX/D1/D1 /D9/D2/CT /D8/CX/D7/D7/D9/CT/D7 /B4/BK/BJ /D3/CU /BD/BJ/BL /D0/CX/CQ/D6/CP/D6/CX/CT/D7/B5/BA /CC/CW/CT/D7/CT /BD/BJ/BL/CW/CT/D1/CX/CR /CP/D2/CS /CX/D1/D1 /D9/D2/CT /D0/CX/CQ/D6/CP/D6/CX/CT/D7 /DB /CT/D6/CT /CS/CT/D6/CX/DA /CT/CS /CU/D6/D3/D1 /D4/CT /B9/D6/CX/D4/CW/CT/D6/CP/D0 /CQ /D0 /D3/D3/CS /B8 /D9/D1 /CQ/CX/D0/CX/CR/CP/D0 /CR/D3/D6/CS /CQ/D0/D3 /D3 /CS/B8 /D0/DD/D1/D4/CW /D2/D3 /CS/CT/D7/B8/BH/BE /BZ/CT/D2/D3/BA/B8 /C8/D6/D3/D8/BA /B2 /BU/CX/D3/CX/D2/CU/D3/BA /CE /D3/D0/BA /BD /C6/D3/BA /BD /BY /CT/CQ/D6/D9/CP/D6/DD /BE/BC/BC/BFThis is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/84/56/main.PMC5172355.pdf
/C5/CT/D8/CW/D3 /CS/D7/BT /C6/D3 /DA /CT/D0 /BT/D4/D4/D6/D3/CP/CR /CW /CU/D3/D6 /C1/CS/CT/D2 /D8/CX/CU/DD/CX/D2/CV /D8/CW/CT /C0/CT/D1/CT/B9/BU/CX/D2/CS/CX/D2/CV /C8/D6/D3/D8/CT/CX/D2/D7 /CU/D6/D3/D1/C5/D3/D9/D7/CT /CC/CX/D7/D7/D9/CT/D7/CG/CX/CP/D3/D0/CT/CX /C4/CX/B8 /CG/CX/CP/D3/D7/CW/CP/D2 /CF /CP/D2/CV/B8 /C3/CP/D2/CV /CI/CW/CP/D3/B8 /CI/CW/CT/D2/CV/CU/CT/D2/CV /CI/CW/D3/D9/B8 /BV/CP/CX/CU/CT/D2/CV /CI/CW/CP/D3/B8 /CA/CT/D2 /CH /CP/D2/B8 /C4/CX/CP/D2/CV /C4/CX/D2/B8 /CC/CX/D2/CV/D8/CX/D2/CV /C4/CT/CX/B8/C2/CX/CP/D2/D2/CX/D2/CV /CH/CX/D2/B8 /CA/D3/D2/CV /CF /CP/D2/CV/B8 /CG/CX/CP/D3/D0/CX /BY /CT/D2/CV/B8 /CP/D2/CS /CB/CX/D5/CX /C4/CX/D9/B6/BU/CT/CX/CY/CX/D2/CV /BZ/CT/D2/D3/D1/CX/CR/D7 /C1/D2/D7/D8/CX/D8/D9/D8/CT/B8 /BV/CW/CX/D2/CT/D7/CT /BT /CR /CP/CS/CT/D1/DD /D3/CU /CB/CR/CX/CT/D2/CR /CT/D7 /BU/CT/CX/CY/CX/D2/CV /BD/BC/BD/BF/BC/BC/B8 /BV/CW/CX/D2/CP/C0/CT/D1/CT /CX/D7 /CP /CZ /CT/DD /CR/D3/CU/CP/CR/D8/D3/D6 /CX/D2 /CP/CT/D6/D3/CQ/CX/CR /D0/CX/CU/CT/B8 /CQ/D3 /D8 /CW /CX/D2 /CT/D9/CZ /CP/D6/DD /D3/D8/CT/D7 /CP/D2/CS /D4/D6/D3/CZ /CP/D6/DD /D3/D8/CT/D7/BA /BU/CT/CR/CP/D9/D7/CT/D3/CU /D8/CW/CT /CW/CX/CV/CW /D6/CT/CP/CR/D8/CX/DA/CX/D8 /DD /D3/CU /CU/CT/D6/D6/D3/D9/D7 /D4/D6/D3/D8/D3/D4 /D3/D6/D4/CW /DD/D6/CX/D2 /C1/CG/B8 /D8/CW/CT /D6/CT/CP/CR/D8/CX/D3/D2/D7 /D3/CU /CW/CT/D1/CT /CX/D2 /CR/CT/D0/D0/D7 /CP/D6/CT/D3/CU/D8/CT/D2 /CR/CP/D6/D6/CX/CT/CS /D3/D9/D8 /D8/CW/D6/D3/D9/CV/CW /CW/CT/D1/CT/B9/D4/D6/D3/D8/CT/CX/D2 /CR/D3/D1/D4/D0/CT/DC/CT/D7/BA /CC /D6/CP/CS/CX/D8/CX/D3/D2/CP/D0/D0/DD /D7/D8/D9/CS/CX/CT/D7 /D3/CU /CW/CT/D1/CT/B9/CQ/CX/D2/CS/CX/D2/CV /D4/D6/D3/D8/CT/CX/D2/D7 /CW/CP /DA /CT /CQ /CT/CT/D2 /CP/D4/D4/D6/D3/CP/CR /CW/CT/CS /D3/D2 /CP /CR/CP/D7/CT /CQ /DD /CR/CP/D7/CT /CQ/CP/D7/CX/D7/B8 /D8/CW /D9/D7 /D8/CW/CT/D6/CT /CX/D7 /CP/D0/CX/D1/CX/D8/CT/CS /CV/D0/D3/CQ/CP/D0 /DA/CX/CT/DB /D3/CU /D8/CW/CT /CS/CX/D7/D8/D6/CX/CQ/D9/D8/CX/D3/D2 /D3/CU /CW/CT/D1/CT/B9/CQ/CX/D2/CS/CX/D2/CV /D4/D6/D3/D8/CT/CX/D2/D7 /CX/D2 /CS/CX/AB/CT/D6/CT/D2 /D8 /CR/CT/D0/D0/D7 /D3/D6/D8/CX/D7/D7/D9/CT/D7/BA /CC/CW/CT /D4/D6/D3 /CR/CT/CS/D9/D6/CT /CS/CT/D7/CR/D6/CX/CQ /CT/CS /CW/CT/D6/CT /CX/D7 /CP/CX/D1/CT/CS /CP/D8 /D4/D6/D3/AC/D0/CX/D2/CV /CW/CT/D1/CT/B9/CQ/CX/D2/CS/CX/D2/CV /D4/D6/D3/D8/CT/CX/D2/D7/CX/D2 /D1/D3/D9/D7/CT /D8/CX/D7/D7/D9/CT/D7 /D7/CT/D5/D9/CT/D2 /D8/CX/CP/D0/D0/DD /CQ /DD /BD/B5 /D4/D9/D6/CX/AC/CR/CP/D8/CX/D3/D2 /D3/CU /CW/CT/D1/CT/B9/CQ/CX/D2/CS/CX/D2/CV /D4/D6/D3/D8/CT/CX/D2/D7 /CQ /DD /CW/CT/D1/CT/B9/CP/CV/CP/D6/D3/D7/CT/B8 /CP/D2 /CPÆ/D2/CX/D8 /DD /CR /CW/D6/D3/D1/CP/D8/D3/CV/D6/CP/D4/CW/CX/CR /D6/CT/D7/CX/D2/BN /BE/B5 /CX/D7/D3/D0/CP/D8/CX/D3/D2 /D3/CU /CW/CT/D1/CT/B9/CQ/CX/D2/CS/CX/D2/CV /D4/D6/D3/D8/CT/CX/D2/D7 /CQ /DD/CB/BW/CB/B9/C8 /BT /BZ/BX /D3/D6 /D8 /DB /D3/B9/CS/CX/D1/CT/D2/D7/CX/D3/D2/CP/D0 /CT/D0/CT/CR/D8/D6/D3/D4/CW/D3/D6/CT/D7/CX/D7/BN /BF/B5 /CX/CS/CT/D2 /D8/CX/AC/CR/CP/D8/CX/D3/D2 /D3/CU /CW/CT/D1/CT/B9/CQ/CX/D2/CS/CX/D2/CV/D4/D6/D3/D8/CT/CX/D2/D7 /CQ /DD /D1/CP/D7/D7 /D7/D4 /CT/CR/D8/D6/D3/D1/CT/D8/D6/DD /BA /C1/D2 /AC/DA /CT /D1/D3/D9/D7/CT /D8/CX/D7/D7/D9/CT/D7/B8 /D3 /DA /CT/D6 /BI/BC/BC /D4/D6/D3/D8/CT/CX/D2 /D7/D4 /D3/D8/D7 /DB /CT/D6/CT/DA/CX/D7/D9/CP/D0/CX/DE/CT/CS /D3/D2 /BE/BW/BX /CV/CT/D0 /D7/D8/CP/CX/D2/CT/CS /CQ /DD /BV/D3/D1/D1/CP/D7/D7/CX/CT /CQ/D0/D9/CT /CP/D2/CS /BD/BH/BG /D4/D6/D3/D8/CT/CX/D2/D7 /DB /CT/D6/CT /CX/CS/CT/D2 /D8/CX/AC/CT/CS/CQ /DD /C5/BT/C4/BW/C1/B9/CC/C7/BY/B8 /CX/D2 /DB/CW/CX/CR /CW /D1/D3/D7/D8 /D4/D6/D3/D8/CT/CX/D2/D7 /CQ/CT /D0 /D3 /D2 /CV /D8/D3 /CW/CT/D1/CT /D6/CT/D0/CP/D8/CT/CS/BA /CC/CW/CX/D7 /D1/CT/D8/CW/D3 /CS/D3/D0/D3/CV/DD/D1/CP/CZ /CT/D7 /CX/D8 /D4 /D3/D7/D7/CX/CQ/D0/CT /D8/D3 /CV/D0/D3/CQ/CP/D0/D0/DD /CR /CW/CP/D6/CP/CR/D8/CT/D6/CX/DE/CT /D8/CW/CT /CW/CT/D1/CT/B9/CQ/CX/D2/CS/CX/D2/CV /D4/D6/D3/D8/CT/CX/D2/D7 /CX/D2 /CP /CQ/CX/D3/D0/D3/CV/CX/CR/CP/D0/D7/DD/D7/D8/CT/D1/BA/C3/CT/DD /DB /D3/D6/CS/D7/BM /CW/CT/D1/CT/B8 /CW/CT/D1/CT/B9/CP/CV/CP/D6/D3/D7/CT/B8 /D4/D6/D3/D8/CT/D3/D1/CX/CR/D7/B8 /D1/D3/D9/D7/CT/C1/D2 /D8/D6/D3 /CS/D9/CR/D8/CX/D3/D2/C1/D2 /CP /CR/CT/D0/D0/D9/D0/CP/D6 /CT/D2 /DA/CX/D6/D3/D2/D1/CT/D2 /D8/B8 /CR/D3/CU/CP/CR/D8/D3/D6/D7 /CR/CP/D2 /CW/CP /DA /CT /D7/CX/CV/D2/CX/CU/B9/CX/CR/CP/D2 /D8 /CT/AB/CT/CR/D8/D7 /D3/D2 /D8/CW/CT/CX/D6 /CR/D3/D6/D6/CT/D7/D4 /D3/D2/CS/CX/D2/CV /D4/D6/D3/D8/CT/CX/D2/D7/B3 /CU/D3/D0/CS/CX/D2/CV/D7/D8/CP/D8/D9/D7 /B4/BD /B5/BA /C5/CP/D2 /DD /D4/D6/D3/D8/CT/CX/D2/D7 /CW/CT/D2/CR/CT /D6/CT/D5/D9/CX/D6/CT /CR/D3/CU/CP/CR/D8/D3/D6/D7/B8/D7/D9/CR /CW /CP/D7 /D1/CT/D8/CP/D0 /CX/D3/D2/D7 /CP/D2/CS /D3/D6/CV/CP/D2/CX/CR /D1/D3/CX/CT/D8/CX/CT/D7/B8 /D8/D3 /D4 /CT/D6/CU/D3/D6/D1/D8/CW/CT/CX/D6 /CQ/CX/D3/D0/D3/CV/CX/CR/CP/D0 /CP/CR/D8/CX/DA/CX/D8/CX/CT/D7/BA /CC/CW/CT /D7/D8/D9/CS/CX/CT/D7 /D3/D2 /CR/D3/CU/CP/CR/D8/D3/D6/B9/D4/D6/D3/D8/CT/CX/D2 /CX/D2 /D8/CT/D6/CP/CR/D8/CX/D3/D2/D7 /D9/D2/CS/CT/D6/D7/CR/D3/D6/CT /D8/CW/CT /CX/D1/D4 /D3/D6/D8/CP/D2/CR/CT /D3/CU /D9/D2/B9/CS/CT/D6/D7/D8/CP/D2/CS/CX/D2/CV /D4/D6/D3/D8/CT/CX/D2 /CU/D9/D2/CR/D8/CX/D3/D2/D7/BA/C0/CT/D1/CT /CX/D7 /CT/D7/D7/CT/D2 /D8/CX/CP/D0 /D8/D3 /CP/CT/D6/D3/CQ/CX/CR /D0/CX/CU/CT/B8 /CQ/D3 /D8 /CW /CX/D2 /CT/D9/CZ /CP/D6/DD/B9/D3/D8/CT/D7 /CP/D2/CS /D4/D6/D3/CZ /CP/D6/DD /D3/D8/CT/D7 /B4/BE /B5/BA /C1/D8 /CX/D7 /CP /CR/D3/D1/D4/D0/CT/DC /D3/CU /CX/D6/D3/D2 /DB/CX/D8/CW/D4/D6/D3/D8/D3/D4 /D3/D6/D4/CW /DD/D6/CX/D2 /C1/CG /CP/D2/CS /D7/CT/D6/DA /CT/D7 /CP/D7 /D8/CW/CT /D4/D6/D3/D7/D8/CW/CT/D8/CX/CR /CV/D6/D3/D9/D4/D3/CU /D2 /D9/D1/CT/D6/D3/D9/D7 /CW/CT/D1/CT/B9/CQ/CX/D2/CS/CX/D2/CV /D4/D6/D3/D8/CT/CX/D2/D7/B8 /CX/D2 /DB/CW/CX/CR /CW /CW/CT/D1/CT/D4/D0/CP /DD/D7 /CP /DA /CT/D6/D7/CP/D8/CX/D0/CT /CP/D2/CS /D9/CQ/CX/D5/D9/CX/D8/D3/D9/D7 /D6/D3/D0/CT /D8/D3 /CU/D3/D6/D1 /D8/CW/CT /CP/CR/B9/D8/CX/DA /CT /CR/CT/D2 /D8/CT/D6/D7 /B4/BF /B5/BA /BU/CP/D7/CX/CR/CP/D0/D0/DD /CW/CT/D1/CT /CX/D2 /D8/CT/D6/CP/CR/D8/D7 /DB/CX/D8/CW /D4/D6/D3/B9/D8/CT/CX/D2/D7 /CX/D2 /D8 /DB /D3 /CS/CX/AB/CT/D6/CT/D2 /D8 /DB /CP /DD/D7/BA /C1/D2 /CW/CT/D1/CT/B9/CR/D3/D2 /D8/CP/CX/D2/CX/D2/CV /D4/D6/D3/B9/D8/CT/CX/D2/D7/B8 /D4/D6/D3/D8/D3/D4 /D3/D6/D4/CW /DD/D6/CX/D2 /C1/CG /CR/D3 /DA /CP/D0/CT/D2 /D8/D0/DD /CR/D3/D1 /CQ/CX/D2/CT/D7 /DB/CX/D8/CW /D8/CW/CT/CP/D1/CX/D2/D3 /CP/CR/CX/CS /D6/CT/D7/CX/CS/D9/CT/B4/D7/B5 /CX/D2 /CP /D4/D6/D3/D8/CT/CX/D2/B8 /D7/D9/CR /CW /CP/D7 /CW/CT/D1/D3/CV/D0/D3/CQ/CX/D2/CP/D2/CS /CR/DD/D8/D3 /CR /CW/D6/D3/D1/CT/D7/BA /BT/D2/D3/D8/CW/CT/D6 /CZ/CX/D2/CS /CW/CT/D1/CT/B9/D6/CT/D0/CP/D8/CT/CS /D4/D6/D3/B9/D8/CT/CX/D2 /CX/D7 /CW/CT/D1/CT/B9/CQ/CX/D2/CS/CX/D2/CV /CX/D2 /DB/CW/CX/CR /CW /CW/CT/D1/CT /D3/D2/D0/DD /CX/D2 /D8/CT/D6/CP/CR/D8/D7/DB/CX/D8/CW /D4/D6/D3/D8/CT/CX/D2/D7 /D2/D3/D2/B9/CR/D3 /DA /CP/D0/CT/D2 /D8/D0/DD /CP/D2/CS /D6/CT/DA /CT/D6/D7/CX/CQ/D0/DD /B8 /D7/D9/CR /CW /CP/D7/CW/CT/D1/CT /CQ/CX/D2/CS/CX/D2/CV /D8/D3 /CP/D0/CS/CT/CW /DD/CS/CT /CS/CT/CW /DD/CS/D6/D3/CV/CT/D2/CP/D7/CT/BA /BU/D3/D8/CW /CW/CT/D1/CT/B9/D6/CT/D0/CP/D8/CT/CS /D4/D6/D3/D8/CT/CX/D2/D7 /CP/D6/CT /CX/D2 /DA /D3/D0/DA /CT/CS /CX/D2 /CP/D2 /CT/DC/D8/D6/CP/D3/D6/CS/CX/D2/CP/D6/DD /CP/D6/D6/CP /DD/A3/BV/D3/D6/D6/CT/D7/D4 /D3/D2/CS/CX/D2/CV /CP/D9/D8/CW/D3/D6/BA/BX/B9/D1/CP/CX/D0/BM /D7/CX/D5/CX/D0/CX/D9/BS/CV/CT/D2/D3/D1/CX/CR/D7/BA/D3/D6/CV/BA/CR/D2 /D3/CU /CQ/CX/D3/D0/D3/CV/CX/CR/CP/D0 /CU/D9/D2/CR/D8/CX/D3/D2/D7/B8 /D6/CP/D2/CV/CX/D2/CV /CU/D6/D3/D1 /CT/D0/CT/CR/D8/D6/D3/D2 /D8/D6/CP/D2/D7/B9/CU/CT/D6/B8 /CR/CP/D8/CP/D0/DD/D7/CX/D7/B8 /D3 /DC/DD/CV/CT/D2 /D8/D6/CP/D2/D7/D4 /D3/D6/D8 /CP/D2/CS /D7/D8/D3/D6/CP/CV/CT/B8 /D3 /DC/DD/CV/CT/D2/D1/CT/D8/CP/CQ /D3/D0/CX/D7/D1/B8 /D7/CX/CV/D2/CP/D0 /D8/D6/CP/D2/D7/CS/D9/CR/D8/CX/D3/D2/B8 /CP/D2/CS /CR/D3/D2 /D8/D6/D3/D0/D0/CX/D2/CV /CV/CT/D2/CT/CT/DC/D4/D6/CT/D7/D7/CX/D3/D2/BA /C5/D3/D6/CT/D3 /DA /CT/D6/B8 /D6/CT/CR/CT/D2 /D8/D0/DD /CW/CT/D1/CT/B9/D4/D6/D3/D8/CT/CX/D2 /CX/D2 /D8/CT/D6/CP/CR/B9/D8/CX/D3/D2/D7 /CW/CP /DA /CT /CQ /CT/CT/D2 /CU/D3/D9/D2/CS /D8/D3 /D6/CT/CV/D9/D0/CP/D8/CT /D8/CW/CT /CR/CT/D0/D0 /CR/DD/CR/D0/CT /CX/D2 /D4/CP/D6/D8/DA/CX/CP /CP /D7/D4 /CT/CR/CX/AC/CR /CW/CT/D1/CT/B9/BW/C6/BT /CQ/CX/D2/CS/CX/D2/CV /D4/D6/D3/D8/CT/CX/D2/B8 /CT/CX/D8/CW/CT/D6 /CU/D3/D6/CS/CX/AB/CT/D6/CT/D2 /D8/CX/CP/D8/CX/D3/D2 /D3/D6 /CU/D3/D6 /CP/D2 /D8/CX/CP/D4 /D3/D4/D8/D3/D7/CX/D7 /B4/BG /B5/BA /BV/D3/D1/D4/CP/D6/CT/CS /D8/D3/D8/CW/CT /D7/D8/CP/D2/CS/CP/D6/CS /D8 /CT /DC /D8 /CQ/D3/D3 /CZ /CT/DC/CP/D1/D4/D0/CT/D7 /D3/CU /CW/CT/D1/CT/B9/CR/D3/D2 /D8/CP/CX/D2/CX/D2/CV/D4/D6/D3/D8/CT/CX/D2/D7 /CX/D2 /D3 /DC/DD/CV/CT/D2 /D8/D6/CP/D2/D7/D4 /D3/D6/D8 /CQ /DD /AB /B9/CW/CT/D0/CX/CR/CP/D0 /D1 /DD /D3/CV/D0/D3/CQ/CX/D2/CP/D2/CS /CW/CT/D1/D3/CV/D0/D3/CQ/CX/D2/B8 /D8/D3 /CS/CP /DD /D3/D9/D6 /CZ/D2/D3 /DB/D0/CT/CS/CV/CT /D6/CT/CV/CP/D6/CS/CX/D2/CV /D8/CW/CT/D4 /D3/D8/CT/D2 /D8/CX/CP/D0 /CP/D2/CS /DA /CT/D6/D7/CP/D8/CX/D0/CT /CU/D9/D2/CR/D8/CX/D3/D2/D7 /D3/CU /CW/CT/D1/CT /CP/D2/CS /CW/CT/D1/CT/B9/D6/CT/D0/CP/D8/CT/CS /D4/D6/D3/D8/CT/CX/D2/D7 /CW/CP/D7 /D6/CT/CP/CR /CW/CT/CS /CP /D2/CT/DB /D0/CT/DA /CT/D0/B8 /CP/D8 /DB/CW/CX/CR /CW /CP/D2/CX/D2/D7/CX/CV/CW /D8 /CX/D2 /D8/D3 /D8/CW/CT /CV/D0/D3/CQ/CP/D0 /CP/D6/D6/CP /DD /D3/CU /CW/CT/D1/CT/B9/D6/CT/D0/CP/D8/CT/CS /D4/D6/D3/D8/CT/CX/D2/D7/CX/D2 /CP /CR/CT/D0/D0 /D3/D6 /CX/D2 /CP /D8/CX/D7/D7/D9/CT /DB /D3/D9/D0/CS /CQ/CT /CT/DC/D8/D6/CT/D1/CT/D0/DD /CQ /CT/D2/CT/AC/CR/CX/CP/D0/BA/CC/CW/CT /D3/D6/CV/CP/D2/CX/D7/D1/CP/D0 /CW/CT/D1/CT /CX/D7 /D1/CP/CX/D2/D0/DD /D7/DD/D2 /D8/CW/CT/D7/CX/DE/CT/CS /CX/D2 /CX/D1/B9/D1/CP/D8/D9/D6/CT /CT/D6/DD/D8/CW/D6/D3/CX/CS /CR/CT/D0/D0/D7/B8 /CP/D2/CS /D8/CW/CT /D1/D3/D0/CT/CR/D9/D0/CP/D6 /D1/CT/CR /CW/CP/D2/CX/D7/D1/CU/D3/D6 /CW/CT/D1/CT /D8/D6/CPÆ/CR /CZ/CX/D2/CV /CP/D2/CS /CP/D7/D7/CT/D1 /CQ/D0/DD /D3/CU /CW/CT/D1/CT/B9/CQ/CX/D2/CS/CX/D2/CV/D4/D6/D3/D8/CT/CX/D2/D7 /CX/D7 /CU/CP/D6 /D0/CT/D7/D7 /D8/CW/CP/D2 /CP/CS/CT/D5/D9/CP/D8/CT /B4/BH /B5/BA /C0/D3 /DB /CT/DA /CT/D6/B8 /D1/CP/D2 /DD/D0/CP/CQ /D3/D6/CP/D8/D3/D6/CX/CT/D7 /CW/CP /DA /CT /CR/D3/D2/AC/D6/D1/CT/CS /D8/CW/CP/D8 /CW/CT/D1/CT /D6/CT/D5/D9/CX/D6/CT/D1/CT/D2 /D8/D7/DA /CP/D6/DD /D7/CX/CV/D2/CX/AC/CR/CP/D2 /D8/D0/DD /CP/D1/D3/D2/CV /CS/CX/AB/CT/D6/CT/D2 /D8 /CR/CT/D0/D0/D7 /CP/D2/CS /D8/CX/D7/D7/D9/CT/D7 /B4/BI /B5/BA/BY /D3/D6 /CX/D2/D7/D8/CP/D2/CR/CT/B8 /CX/D2 /D6/CP/D8 /CW/CT/D4/CP/D8/D3 /CR/DD/D8/CT/D7 /BE/BC/B1 /D3/CU /D2/CT/DB/D0/DD /CU/D3/D6/D1/CT/CS/CW/CT/D1/CT /CX/D7 /CS/CX/D6/CT/CR/D8/D0/DD /CR/D3/D2 /DA /CT/D6/D8/CT/CS /D8/D3 /CQ/CX/D0/CT /D4/CX/CV/D1/CT/D2 /D8/B8 /DB/CW/CT/D6/CT/CP/D7/BK/BC/B1 /CX/D7 /D9/D7/CT/CS /CU/D3/D6 /D8/CW/CT /CU/D3/D6/D1/CP/D8/CX/D3/D2 /D3/CU /CW/CT/D1/CT/B9/D6/CT/D0/CP/D8/CT/CS /D4/D6/D3/D8/CT/CX/D2/D7/B4/BJ /B5/BA /CC/CW /D9/D7/B8 /CP /D0/D3/CV/CX/CR/CP/D0 /CP/D7/D7/D9/D1/D4/D8/CX/D3/D2 /CX/D7 /D8/CW/CT /CW/CT/D1/CT/B9/D6/CT/D0/CP/D8/CT/CS/D4/D6/D3/D8/CT/CX/D2/D7 /CR/D3/D9/D0/CS /CQ/CT /CX/D2 /CP /DB/CX/CS/CT /CR/D3/D2/CR/CT/D2 /D8/D6/CP/D8/CX/D3/D2 /D6/CP/D2/CV/CT /CX/D2/BJ/BK /BZ/CT/D2/D3/BA/B8 /C8/D6/D3/D8/BA /B2 /BU/CX/D3/CX/D2/CU/D3/BA /CE /D3/D0/BA /BD /C6/D3/BA /BD /BY /CT/CQ/D6/D9/CP/D6/DD /BE/BC/BC/BFThis is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/88/52/main.PMC5172403.pdf
/CA/CT/DA/CX/CT/DB/C8/D0/CP/D2 /D8 /C5/C1/CC/BX/D7/BM /CD/D7/CT/CU/D9/D0 /CC /D3 /D3/D0/D7 /CU/D3/D6 /C8/D0/CP/D2 /D8 /BZ/CT/D2/CT/D8/CX/CR/D7 /CP/D2/CS /BZ/CT/D2/D3/D1/CX/CR/D7/CH/CX/D2/CV /BY /CT/D2/CV/BT /CV/D6/CX/CR/D9/D0/D8/D9/D6 /CT /CP/D2/CS /BU/CX/D3/D8/CT /CR/CW/D2/D3/D0/D3 /CV/DD /BV/D3/D0 /D0/CT /CV/CT/B8 /CI/CW/CT/CY/CX/CP/D2/CV /CD/D2/CX/DA/CT/D6/D7/CX/D8/DD/B8 /C0/CP/D2/CV/DE/CW/D3/D9 /BF/BD/BC/BC/BE/BL/B8 /BV/CW/CX/D2/CP/C5/C1/CC/BX/D7 /B4/C5/CX/D2/CX/CP/D8/D9/D6/CT /CX/D2 /DA /CT/D6/D8/CT/CS/B9/D6/CT/D4 /CT/CP/D8 /D8/D6/CP/D2/D7/D4 /D3/D7/CP/CQ/D0/CT /CT/D0/CT/D1/CT/D2 /D8/D7/B5 /CP/D6/CT /D6/CT/D1/CX/D2/CX/D7/CR/CT/D2/CR/CT /D3/CU /D2/D3/D2/B9/CP/D9/D8/D3/D2/D3/D1/D3/D9/D7 /BW/C6/BT /B4/CR/D0/CP/D7/D7 /C1/C1 /B5 /CT/D0/CT/D1/CT/D2 /D8/D7/B8 /DB/CW/CX/CR /CW /CP/D6/CT /CS/CX/D7/D8/CX/D2/CV/D9/CX/D7/CW/CT/CS /CU/D6/D3/D1 /D3/D8/CW/CT/D6 /D8/D6/CP/D2/D7/D4 /D3/D7/B9/CP/CQ/D0/CT /CT/D0/CT/D1/CT/D2 /D8/D7 /CQ /DD /D8/CW/CT/CX/D6 /D7/D1/CP/D0/D0 /D7/CX/DE/CT/B8 /D7/CW/D3/D6/D8 /D8/CT/D6/D1/CX/D2/CP/D0 /CX/D2 /DA /CT/D6/D8/CT/CS /D6/CT/D4 /CT/CP/D8/D7 /B4/CC/C1/CA/D7/B5/B8 /CW/CX/CV/CW /CR/D3/D4 /DD/D2 /D9/D1 /CQ /CT/D6/D7/B8 /CV/CT/D2/CX/CR /D4/D6/CT/CU/CT/D6/CT/D2/CR/CT/B8 /CP/D2/CS /BW/C6/BT /D7/CT/D5/D9/CT/D2/CR/CT /CX/CS/CT/D2 /D8/CX/D8 /DD /CP/D1/D3/D2/CV /CU/CP/D1/CX/D0/DD /D1/CT/D1 /CQ /CT/D6/D7/BA /BT/D0/B9/D8/CW/D3/D9/CV/CW /C5/C1/CC/BX/D7 /DB /CT/D6/CT /AC/D6/D7/D8 /CS/CX/D7/CR/D3 /DA /CT/D6/CT/CS /CX/D2 /D4/D0/CP/D2 /D8/D7 /CP/D2/CS /D7/D8/CX/D0/D0 /CP/CR/D8/CX/DA /CT/D0/DD /D6/CT/D7/CW/CP/D4/CX/D2/CV /CV/CT/D2/D3/D1/CT/D7/B8/D8/CW/CT/DD /CW/CP /DA /CT /CQ/CT /CT /D2 /CX/D7/D3/D0/CP/D8/CT/CS /CU/D6/D3/D1 /CP /DB/CX/CS/CT /D6/CP/D2/CV/CT /D3/CU /CT/D9/CZ /CP/D6/DD /D3/D8/CX/CR /D3/D6/CV/CP/D2/CX/D7/D1/D7/BA /C5/C1/CC/BX/D7 /CR/CP/D2/CQ/CT /CS/CX/DA/CX/CS/CT/CS /CX/D2 /D8/D3 /CC /D3/D9/D6/CX/D7/D8 /B9/D0/CX/CZ /CT/B8 /CB/D8/D3/DB/CP/DB/CP/DD /B9/D0/CX/CZ /CT/B8 /CP/D2/CS /D4 /D3 /CV/D3 /B9/D0/CX/CZ /CT /CV/D6/D3/D9/D4/D7/B8 /CP/CR/CR/D3/D6/CS/CX/D2/CV /D8/D3/D7/CX/D1/CX/D0/CP/D6/CX/D8/CX/CT/D7 /D3/CU /D8/CW/CT/CX/D6 /CC/C1/CA/D7 /CP/D2/CS /CC/CB/BW/D7 /B4/D8/CP/D6/CV/CT/D8 /D7/CX/D8/CT /CS/D9/D4/D0/CX/CR/CP/D8/CX/D3/D2/D7/B5/BA /C1/D2 /CS/CT/D7/D4/CX/D8/CT /D3/CU /D7/CT/DA/B9/CT/D6/CP/D0 /D1/D3 /CS/CT/D0/D7 /D8/D3 /CT/DC/D4/D0/CP/CX/D2 /D8/CW/CT /D3/D6/CX/CV/CX/D2 /CP/D2/CS /CP/D1/D4/D0/CX/AC/CR/CP/D8/CX/D3/D2 /D3/CU /C5/C1/CC/BX/D7/B8 /D8/CW/CT/CX/D6 /D1/CT/CR /CW/CP/D2/CX/D7/D1/D7 /D3/CU/D8/D6/CP/D2/D7/D4 /D3/D7/CX/D8/CX/D3/D2 /CP/D2/CS /CP/CR/CR/D9/D1 /D9/D0/CP/D8/CX/D3/D2 /CX/D2 /CT/D9/CZ /CP/D6/DD /D3/D8/CX/CR /CV/CT/D2/D3/D1/CT/D7 /D6/CT/D1/CP/CX/D2 /D4/D3/D3 /D6 /D0 /DD /D9/D2/CS/CT/D6/D7/D8/D3 /D3 /CS/D3 /DB/CX/D2/CV /D8/D3 /CX/D2/D7/D9Æ/CR/CX/CT/D2 /D8 /CT/DC/D4 /CT/D6/CX/D1/CT/D2 /D8/CP/D0 /CS/CP/D8/CP/BA /CC/CW/CT /D9/D2/CX/D5/D9/CT /D4/D6/D3/D4 /CT/D6/D8/CX/CT/D7 /D3/CU /C5/C1/CC/BX/D7 /CW/CP /DA /CT /CQ/CT /CT /D2/CT/DC/D4/D0/D3/CX/D8/CT/CS /CP/D7 /D9/D7/CT/CU/D9/D0 /CV/CT/D2/CT/D8/CX/CR /D8/D3 /D3/D0/D7 /CU/D3/D6 /D4/D0/CP/D2 /D8 /CV/CT/D2/D3/D1/CT /CP/D2/CP/D0/DD/D7/CX/D7/BA /CD/D8/CX/D0/CX/DE/CP/D8/CX/D3/D2 /D3/CU /C5/C1/CC/BX/D7/CP/D7 /CT/AB/CT/CR/D8/CX/DA /CT /CP/D2/CS /CX/D2/CU/D3/D6/D1/CP/D8/CX/DA /CT /CV/CT/D2/D3/D1/CX/CR /D1/CP/D6/CZ /CT/D6/D7 /CP/D2/CS /D4 /D3/D8/CT/D2 /D8/CX/CP/D0 /CP/D4/D4/D0/CX/CR/CP/D8/CX/D3/D2 /D3/CU /C5/C1/CC/BX/D7/CX/D2 /D4/D0/CP/D2 /D8/D7 /D7/DD/D7/D8/CT/D1/CP/D8/CX/CR/B8 /D4/CW /DD/D0/D3/CV/CT/D2/CT/D8/CX/CR/B8 /CP/D2/CS /CV/CT/D2/CT/D8/CX/CR /D7/D8/D9/CS/CX/CT/D7 /CP/D6/CT /CS/CX/D7/CR/D9/D7/D7/CT/CS/BA/C3/CT/DD /DB /D3/D6/CS/D7/BM /D1/CX/D2/CX/CP/D8/D9/D6/CT /CX/D2 /DA /CT/D6/D8/CT/CS/B9/D6/CT/D4 /CT/CP/D8 /D8/D6/CP/D2/D7/D4 /D3/D7/CP/CQ/D0/CT /CT/D0/CT/D1/CT/D2 /D8/B8 /C5/C1/CC/BX/B8 /D8/D6/CP/D2/D7/D4 /D3/D7/CP/CQ/D0/CT /CT/D0/CT/D1/CT/D2 /D8/B8/D6/CT/D8/D6/D3/D8/D6/CP/D2/D7/D4 /D3/D7/D3/D2/B8 /CT/DA /D3/D0/D9/D8/CX/D3/D2/B8 /D4/D0/CP/D2 /D8/CC /D6/CP/D2/D7/D4 /D3/D7/CP/CQ/D0/CT /CT/D0/CT/D1/CT/D2 /D8/D7 /B4/CC/BX/D7/B5 /CP/D6/CT /BW/C6/BT /D7/CT/CV/D1/CT/D2 /D8/D7 /D8/CW/CP/D8/CR/CP/D2 /CX/D2/D7/CT/D6/D8 /CX/D2 /D8/D3 /D2/CT/DB /CR /CW/D6/D3/D1/D3/D7/D3/D1/CP/D0 /D0/D3 /CR/CP/D8/CX/D3/D2/D7 /CP/D2/CS /D3/CU/D8/CT/D2/D1/CP/CZ /CT /CS/D9/D4/D0/CX/CR/CP/D8/CT/CS /CR/D3/D4/CX/CT/D7 /D3/CU /D8/CW/CT/D1/D7/CT/D0/DA /CT/D7 /CX/D2 /D8/CW/CT /D4/D6/D3 /CR/CT/D7/D7/B4/BD /B5/BA /BU/CP/D6/CQ/CP/D6/CP /C5/CR/BV/D0/CX/D2 /D8/D3 /CR /CZ /CS/CX/D7/CR/D3 /DA /CT/D6/CT/CS /D8/CW/CT/D1 /CX/D2 /D1/CP/CX/DE/CT/D1/D3/D6/CT /D8/CW/CP/D2 /CP /CW/CP/D0/CU /CR/CT/D2 /D8/D9/D6/DD /CP/CV/D3 /CP/D7 /D8/CW/CT /CV/CT/D2/CT/D8/CX/CR /CP/CV/CT/D2 /D8/D7/D8/CW/CP/D8 /CP/D6/CT /D6/CT/D7/D4 /D3/D2/D7/CX/CQ/D0/CT /CU/D3/D6 /D8/CW/CT /D7/CT/CR/D8/D3/D6/D7 /D3/CU /CP/D0/D8/CT/D6/CT/CS /D4/CX/CV/D1/CT/D2/B9/D8/CP/D8/CX/D3/D2 /D3/D2 /D1 /D9/D8/CP/D2 /D8 /CZ /CT/D6/D2/CT/D0/D7 /B4/BE /B5/BA /CB/D9/CR /CW /CT/D0/CT/D1/CT/D2 /D8/D7 /D3/CU /DA /CP/D6/CX/B9/D3/D9/D7 /D8 /DD/D4 /CT/D7 /CW/CP /DA /CT /CQ/CT /CT /D2 /CU/D3/D9/D2/CS /CX/D2 /D1/CP/D2 /DD /CV/CT/D2/D3/D1/CT/D7/B8 /D7/D9/CR /CW /CP/D7/BW/D6 /D3/D7/D3/D4/CW/CX/D0/CP /D1/CT/D0/CP/D2/D3 /CV/CP/D7/D8/CT/D6/B8 /DD /CT/CP/D7/D8 /B4/CB/CP/CR /CR/CW/CP/D6 /D3/D1/DD/CR /CT/D7 /CR /CT/D6 /CT/B9/DA/CX/D7/CX/CP/CT /B5/B8 /BX/D7/CR/CW/CT/D6/CX/CR/CW/CX/CP /CR /D3/D0/CX/B8 /BV/CP/CT/D2/D3/D6/CW/CP/CQ /CS/CX/D8/CX/D7 /CT/D0/CT /CV/CP/D2/D7/B8 /CP/D2/CS/CW /D9/D1/CP/D2/D7 /B4/D6/CT/DA/CX/CT/DB /CT/CS /CX/D2 /D6/CT/CU/BA /BF /B5/BA/CF/CX/D8/CW /D8/CW/CT /D4/D6/D3/CV/D6/CT/D7/D7 /D3/CU /D0/CP/D6/CV/CT/B9/D7/CR/CP/D0/CT /BW/C6/BT /D7/CT/D5/D9/CT/D2/CR/CX/D2/CV/B8/CX/D8 /CW/CP/D7 /CQ /CT/CR/D3/D1/CT /CP/D4/D4/CP/D6/CT/D2 /D8 /D8/CW/CP/D8/B8 /CU/CP/D6 /CU/D6/D3/D1 /CQ /CT/CX/D2/CV /D6/CP/D6/CT /CR/D3/D1/B9/D4/D3 /D2 /CT /D2 /D8/D7 /D3/CU /D0/CP/D6/CV/CT /CV/CT/D2/D3/D1/CT/D7/B8 /CC/BX/D7 /CP/D6/CT /D8/CW/CT /D7/CX/D2/CV/D0/CT /D0/CP/D6/CV/CT/D7/D8/CR/D3/D1/D4 /D3/D2/CT/D2 /D8 /D3/CU /D8/CW/CT /CV/CT/D2/CT/D8/CX/CR /D1/CP/D8/CT/D6/CX/CP/D0 /D3/CU /D1/D3/D7/D8 /CT/D9/CZ /CP/D6/DD /D3/D8/CT/D7/B4/BD /B5/BA /CC/CW/CT/DD /CP/CR/CR/D3/D9/D2 /D8 /CU/D3/D6 /CP/D8 /D0/CT/CP/D7/D8 /BG/BH/B1 /D3/CU /D8/CW/CT /CW /D9/D1/CP/D2/CV/CT/D2/D3/D1/CT /B4/BG /B5 /CP/D2/CS /BH/BC/B9/BL/BC/B1 /D3/CU /D7/D3/D1/CT /CV/D6/CP/D7/D7 /CV/CT/D2/D3/D1/CT/D7 /B4/BH /B5/BA/CC/BX/D7 /CX/D2 /CV/CT/D2/CT/D6/CP/D0 /CP/D6/CT /CS/CX/DA/CX/CS/CT/CS /CX/D2 /D8/D3 /D8 /DB /D3 /D1/CP /CY/D3/D6 /CR/D0/CP/D7/D7/CT/D7/CP/CR/CR/D3/D6/CS/CX/D2/CV /D8/D3 /D8/CW/CT/CX/D6 /D1/D3 /CS/CT/D7 /D3/CU /D8/D6/CP/D2/D7/D4 /D3/D7/CX/D8/CX/D3/D2 /B4/BI /BN /BJ /B5/BA/BV/D0/CP/D7/D7 /C1 /CT/D0/CT/D1/CT/D2 /D8/D7 /B4/D6/CT/D8/D6/D3 /CT/D0/CT/D1/CT/D2 /D8/D7/B5/B8 /D3/D6 /D6/CT/D8/D6/D3/D8/D6/CP/D2/D7/D4 /D3/D7/D3/D2/D7/B8/D8/D6/CP/D2/D7/D4 /D3/D7/CT /CQ /DD /D1/CT/CP/D2/D7 /D3/CU /CP/D2 /CA/C6/BT /CX/D2 /D8/CT/D6/D1/CT/CS/CX/CP/D8/CT /CV/CT/D2/CT/D6/B9/CP/D8/CT/CS /CQ /DD /D6/CT/DA /CT/D6/D7/CT /D8/D6/CP/D2/D7/CR/D6/CX/D4/D8/CX/D3/D2 /B4/BK /BN /BL /B5/BA /C4 /CC/CA /D6/CT/D8/D6/D3/D8/D6/CP/D2/D7/B9/D4/D3 /D7 /D3 /D2 /D7 /CP/D6/CT /CR /CW/CP/D6/CP/CR/D8/CT/D6/CX/DE/CT/CS /CQ /DD /D8/CW/CT /D4/D6/CT/D7/CT/D2/CR/CT /D3/CU /D0/D3/D2/CV /D8/CT/D6/B9/D1/CX/D2/CP/D0 /D6/CT/D4 /CT/CP/D8/D7/BA /C6/D3/D2/B9/C4 /CC/CA /D6/CT/D8/D6/D3/D8/D6/CP/D2/D7/D4 /D3/D7/D3/D2/D7/B8 /D7/D9/CR /CW /CP/D7/BX/B9/D1/CP/CX/D0/BM /D5/DE/CW/DC/D9/CT/BS/DE/CY/D9/BA/CT/CS/D9/BA/CR/D2 /C4/C1/C6/BX/D7 /B4/D0/D3/D2/CV /CX/D2 /D8/CT/D6/D7/D4 /CT/D6/D7/CT/CS /D2 /D9/CR/D0/CT/CP/D6 /CT/D0/CT/D1/CT/D2 /D8/D7/B5 /CP/D2/CS/CB/C1/C6/BX/D7 /B4/D7/CW/D3/D6/D8 /CX/D2 /D8/CT/D6/D7/D4 /CT/D6/D7/CT/CS /D2 /D9/CR/D0/CT/CP/D6 /CT/D0/CT/D1/CT/D2 /D8/D7/B5/B8 /D0/CP/CR /CZ/D8/CW/CT/D7/CT /CR /CW/CP/D6/CP/CR/D8/CT/D6/CX/D7/D8/CX/CR /D7/CT/D5/D9/CT/D2/CR/CT/D7 /B4/BK /BN /BL /B5/BA /BV/D0/CP/D7/D7 /C1/C1 /CT/D0/CT/B9/D1/CT/D2 /D8/D7 /D8/D6/CP/D2/D7/D4 /D3/D7/CT /DA/CX/CP /CP /BW/C6/BT /CX/D2 /D8/CT/D6/D1/CT/CS/CX/CP/D8/CT /CP/D2/CS /CP/D6/CT/CR /CW/CP/D6/CP/CR/D8/CT/D6/CX/DE/CT/CS /CQ /DD /D8/CW/CT /D4/D6/CT/D7/CT/D2/CR/CT /D3/CU /D8/CT/D6/D1/CX/D2/CP/D0 /CX/D2 /DA /CT/D6/D8/CT/CS /D6/CT/B9/D4 /CT/CP/D8/D7/B8 /D3/D6 /CC/C1/CA/D7 /B4/BD/BC /BN /BD/BD /B5/B8 /D7/D9/CR /CW /CP/D7 /D8/CW/CT /BT /CR/B9/BW/D7 /CU/CP/D1/CX/D0/DD /CX/D2/D1/CP/CX/DE/CT /CP/D2/CS /D8/CW/CT /C8 /CT/D0/CT/D1/CT/D2 /D8 /CX/D2 /BW/D6 /D3/D7/D3/D4/CW/CX/D0/CP/BA /CB/CT/DA /CT/D6/CP/D0 /CT/D0/B9/CT/D1/CT/D2 /D8/D7 /CP/D6/CT /CS/CXÆ/CR/D9/D0/D8 /D8/D3 /CR/D0/CP/D7/D7/CX/CU/DD /B8 /D1/CP/CX/D2/D0/DD /CQ /CT/CR/CP/D9/D7/CT /D8/CW/CT/CX/D6/D1/CT/CR /CW/CP/D2/CX/D7/D1/D7 /D3/CU /D8/D6/CP/D2/D7/D4 /D3/D7/CX/D8/CX/D3/D2 /D6/CT/D1/CP/CX/D2 /D9/D2/CZ/D2/D3 /DB/D2 /B4/BD/BE /B5/BA/C1/D8 /CX/D7 /D8/CW/CT /CR/CP/D7/CT /CU/D3/D6 /D1/CX/D2/CX/CP/D8/D9/D6/CT /CX/D2 /DA /CT/D6/D8/CT/CS/B9/D6/CT/D4 /CT/CP/D8 /D8/D6/CP/D2/D7/D4 /D3/D7/B9/CP/CQ/D0/CT /CT/D0/CT/D1/CT/D2 /D8/D7 /B4/C5/C1/CC/BX/D7/B5/B8 /DB/CW/CX/CR /CW /DB /CT/D6/CT /AC/D6/D7/D8 /CS/CT/D7/CR/D6/CX/CQ /CT/CS /CX/D2/D4/D0/CP/D2 /D8/D7 /B4/BD/BF /B5 /CP/D2/CS /D0/CP/D8/CT/D6 /CX/D2 /D3/D8/CW/CT/D6 /D3/D6/CV/CP/D2/CX/D7/D1/D7 /B4/BD/BG /B5/BA/BY /CT/CP/D8/D9/D6/CT/D7 /D3/CU /C5/C1/CC/BX/D7/C5/C1/CC/BX/D7 /DB /CT/D6/CT /AC/D6/D7/D8 /CS/CT/D7/CR/D6/CX/CQ /CT/CS /CU/D3/D6 /CV/D6/CP/D7/D7 /CV/CT/D2/D3/D1/CT/D7 /B4/BD/BH /BN /BD/BI /B5/CP/D2/CS /CX/CS/CT/D2 /D8/CX/AC/CT/CS /CX/D2 /D7/CT/DA /CT/D6/CP/D0 /D4/D0/CP/D2 /D8 /D7/D4 /CT/CR/CX/CT/D7/B8 /CX/D2/CR/D0/D9/CS/CX/D2/CV /D1/CP/CX/DE/CT/B4/BD/BH/B8 /BD/BI/B8 /BD/BJ /B5/B8 /D6/CX/CR/CT /B4/BD/BH/B8 /BD/BI/B8 /BD/BK/B8 /BD/BL /B5/B8 /CV/D6/CT/CT/D2 /D4/CT /D4 /D4/CT /D6 /B4/BE/BC /B5/B8/CP/D2/CS /BT /D6 /CP/CQ/CX/CS/D3/D4/D7/CX/D7 /B4/BD/BC /BN /BD/BD /B5/B8 /CQ/D9/D8 /CW/CP /DA /CT /CP/D0/D7/D3 /CQ/CT /CT /D2 /CU/D3/D9/D2/CS/CX/D2 /CP /DB/CX/CS/CT /D6/CP/D2/CV/CT /D3/CU /D3/D8/CW/CT/D6 /CT/D9/CZ /CP/D6/DD /D3/D8/CX/CR /D3/D6/CV/CP/D2/CX/D7/D1/D7/B8 /CX/D2/B9/CR/D0/D9/CS/CX/D2/CV /BV/CP/CT/D2/D3/D6/CW/CP/CQ /CS/CX/D8/CX/D7 /CT/D0/CT /CV/CP/D2/D7 /B4/BE/BD /BN /BE/BE /B5/B8 /CU/D9/D2/CV/CX /B4/BE/BF /B5/B8/D1/D3/D7/D5/D9/CX/D8/D3 /CT/D7 /B4/BD/BE/B8 /BD/BG/B8 /BE/BG /B5/B8 /CQ /CT/CT/D8/D0/CT/D7 /B4/BE/BH /B5/B8 /CP/D2/CS /CR/CT/D6/D8/CP/CX/D2 /DA /CT/D6/B9/D8/CT/CQ/D6/CP/D8/CT/D7/B8 /D0/CX/CZ /CT /CG/CT/D2/D3/D4/D9/D7 /B4/BE/BI /B5/B8 /CW /D9/D1/CP/D2/D7 /B4/BE/BJ /B5/B8 /CP/D2/CS /D8/CT/D0/CT/D3/D7/D8/AC/D7/CW/CT/D7 /B4/BE/BK /B5/BA/CB/D8/D6/D9/CR/D8/D9/D6/CP/D0/D0/DD /B8 /C5/C1/CC/BX/D7 /CP/D6/CT /D6/CT/D1/CX/D2/CX/D7/CR/CT/D2/CR/CT /D3/CU /D2/D3/D2/B9/CP/D9/D8/D3/D2/D3/D1/D3/D9/D7 /BW/C6/BT /B4/CR/D0/CP/D7/D7 /C1/C1 /B5 /CT/D0/CT/D1/CT/D2 /D8/D7 /DB/CX/D8/CW /D8/CW/CT/CX/D6 /D7/D1/CP/D0/D0/D7/CX/DE/CT /B4/BD/BC/BC/B9/BI/BC/BC /CQ/D4/B5 /CP/D2/CS /D7/CW/D3/D6/D8 /CC/C1/CA/D7 /B4/BD/BC/B9/BF/BC /CQ/D4/B8 /D8/CW/CT/D7/CT/D5/D9/CT/D2/CR/CT /CQ/CT /D8 /DB /CT/CT/D2 /CC/C1/CA/D7 /CX/D7 /BT/B7/CC /D6/CX/CR /CW/B5/BA /C0/D3 /DB /CT/DA /CT/D6/B8/BL/BC /BZ/CT/D2/D3/BA/B8 /C8/D6/D3/D8/BA /B2 /BU/CX/D3/CX/D2/CU/D3/BA /CE /D3/D0/BA /BD /C6/D3/BA /BE /C5/CP /DD /BE/BC/BC/BFThis is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/72/71/main.PMC5172404.pdf
/CA/CT/DA/CX/CT/DB/BT/CS/DA /CP/D2/CR/CT/D7 /CX/D2 /D8/CW/CT /CB/D8/D9/CS/DD /D3/CU /CB/CA /C8/D6/D3/D8/CT/CX/D2 /BY /CP/D1/CX/D0/DD/CG/CX/CP/D3 /DD/D9/D2 /C5/CP /CP/D2/CS /BY /D9/CR /CW /D9 /C0/CT/B6/BU/CT/CX/CY/CX/D2/CV /C1/D2/D7/D8/CX/D8/D9/D8/CT /D3/CU /CA /CP/CS/CX/CP/D8/CX/D3/D2 /C5/CT /CS/CX/CR/CX/D2/CT/B8 /BU/CT/CX/CY/CX/D2/CV /BD/BC/BC/BK/BH/BC/B8 /BV/CW/CX/D2/CP/CC/CW/CT /D2/CP/D1/CT /D3/CU /CB/CA /D4/D6/D3/D8/CT/CX/D2/D7 /CX/D7 /CS/CT/D6/CX/DA /CT/CS /CU/D6/D3/D1 /D8/CW/CT/CX/D6 /D8 /DD/D4/CX/CR/CP/D0 /CA/CB /CS/D3/D1/CP/CX/D2 /D8/CW/CP/D8 /CX/D7 /D6/CX/CR /CW /CX/D2/D7/CT/D6/CX/D2/CT /B4/CB/CT/D6/B8 /CB/B5 /CP/D2/CS /CP/D6/CV/CX/D2/CX/D2/CT /B4/BT/D6/CV/B8 /CA/B5/BA /CC/CW/CT/DD /CP/D6/CT /CR/D3/D2/D7/CT/D6/DA /CT/CS /CX/D2 /CT/DA /D3/D0/D9/D8/CX/D3/D2/BA /CD/D4 /D8/D3/D2/D3 /DB/B8 /BD/BC /D1/CT/D1 /CQ/CT/D6/D7 /D3/CU /D8/CW/CT /CB/CA /D4/D6/D3/D8/CT/CX/D2 /CU/CP/D1/CX/D0/DD /CW/CP /DA /CT /CQ/CT/CT/D2 /CX/CS/CT/D2 /D8/CX/AC/CT/CS /CX/D2 /CW /D9/D1/CP/D2/D7/BA /CB/CA/D4/D6/D3/D8/CT/CX/D2/D7 /CR/D3/D2 /D8/CP/CX/D2 /D3/D2/CT /D3/D6 /D8 /DB /D3 /CA/C6/BT /CQ/CX/D2/CS/CX/D2/CV /D1/D3/D8/CX/CU/D7 /CP/D7/CX/CS/CT /CU/D6/D3/D1 /D8/CW/CT /CA/CB /CS/D3/D1/CP/CX/D2/B8 /CP/D2/CS/CP/D0/D7/D3 /D4 /D3/D7/D7/CT/D7/D7 /D7/D4 /CT/CR/CX/CP/D0 /CQ/CX/D3 /CR /CW/CT/D1/CX/CR/CP/D0 /CP/D2/CS /CX/D1/D1 /D9/D2/D3/D0/D3/CV/CX/CR/CP/D0 /CU/CT/CP/D8/D9/D6/CT/D7/BA /BT/D7 /D8/D3 /D8/CW/CT /CU/D9/D2/CR/D8/CX/D3/D2/D7/D3/CU /CB/CA /D4/D6/D3/D8/CT/CX/D2/D7/B8 /D8/CW/CT/DD /CU/CP/CR/CX/D0/CX/D8/CP/D8/CT /D8/CW/CT /D6/CT/CR/D6/D9/CX/D8/D1/CT/D2 /D8 /D3/CU /D8/CW/CT /CR/D3/D1/D4 /D3/D2/CT/D2 /D8/D7 /D3/CU /D7/D4/D0/CX/CR/CT/D7/D3/D1/CT /DA/CX/CP/D4/D6/D3/D8/CT/CX/D2/B9/D4/D6/D3/D8/CT/CX/D2 /CX/D2 /D8/CT/D6/CP/CR/D8/CX/D3/D2 /D8/D3 /D4/D6/D3/D1/D4/D8 /D8/CW/CT /CP/D7/D7/CT/D1 /CQ/D0/DD /D3/CU /CT/CP/D6/D0/DD /D7/D4/D0/CX/CR/CT/D7/D3/D1/CT/BN /DB/CW/CX/D0/CT /CX/D2/CP/D0/D8/CT/D6/D2/CP/D8/CX/DA /CT /D7/D4/D0/CX/CR/CX/D2/CV/B8 /D8/CX/D7/D7/D9/CT/B9/D7/D4 /CT/CR/CX/AC/CR/CP/D0/D0/DD /CT/DC/D4/D6/CT/D7/D7/CT/CS /CB/CA /D4/D6/D3/D8/CT/CX/D2 /CP/D0/D3/D2/CV /DB/CX/D8/CW /D8/CW/CT /D6/CT/D0/CP/B9/D8/CX/DA /CT /D6/CP/D8/CX/D3 /D3/CU /CB/CA /D4/D6/D3/D8/CT/CX/D2 /CP/D2/CS /CW/CT/D8/CT/D6/D3/CV/CT/D2/CT/D3/D9/D7 /D2 /D9/CR/D0/CT/CP/D6 /D6/CX/CQ/D3/D2 /D9/CR/D0/CT/D3/D4/D6/D3/D8/CT/CX/D2 /B4/CW/D2/CA/C6/C8/B5 /CX/D7/CR/D3/D1/D4 /D3/D7/CT/CS /D3/CU /D8 /DB /D3 /D1/CP/CX/D2 /D6/CT/CV/D9/D0/CP/D8/CX/DA /CT /D1/CT/CR /CW/CP/D2/CX/D7/D1/D7 /CU/D3/D6 /CP/D0/D8/CT/D6/D2/CP/D8/CX/DA /CT /D7/D4/D0/CX/CR/CX/D2/CV/BA /BT/D0/D1/D3/D7/D8 /CP/D0/D0/D3/CU /D8/CW/CT /CQ/CX/D3 /CR /CW/CT/D1/CX/CR/CP/D0 /CU/D9/D2/CR/D8/CX/D3/D2/D7 /CP/D6/CT /D6/CT/CV/D9/D0/CP/D8/CT/CS /CQ /DD /D6/CT/DA /CT/D6/D7/CX/CQ/D0/CT /D4/CW/D3/D7/D4/CW/D3/D6/DD/D0/CP/D8/CX/D3/D2/BA/C3/CT/DD /DB /D3/D6/CS/D7/BM /CB/CA /D4/D6/D3/D8/CT/CX/D2/D7/B8 /D7/D4/D0/CX/CR/CT/D7/D3/D1/CT/B8 /CW/D2/CA/C6/C8 /B8 /D4/CW/D3/D7/D4/CW/D3/D6/DD/D0/CP/D8/CX/D3/D2/C1/D2 /D8/D6/D3 /CS/D9/CR/D8/CX/D3/D2/CC/CW/CT /D7/D4/D0/CX/CR/CX/D2/CV /D3/CU /D4/D6/CT/B9/D1/CA/C6/BT /D8/CP/CZ /CT/D7 /D4/D0/CP/CR/CT /CX/D2 /D8/CW/CT /D7/D4/D0/CX/CR/CT/B9/D7/D3/D1/CT/BA /BX/DC/CR/CT/D4/D8 /CU/D3/D6 /D8/CW/CT /CR/D3/D1/D4 /D3/D2/CT/D2 /D8/D7 /D3/CU /CR/CP/D8/CP/D0/DD/D8/CX/CR /CR/D3/D6/CT/B8/D7/D4/D0/CX/CR/CT/D7/D3/D1/CT /CX/D7 /D1/CP/CX/D2/D0/DD /CR/D3/D1/D4 /D3/D7/CT/CS /D3/CU /D7/D1/CP/D0/D0 /D2 /D9/CR/D0/CT/CP/D6 /D6/CX/B9/CQ/D3 /D2 /D9/CR/D0/CT/D3/D4/D6/D3/D8/CT/CX/D2 /B4/D7/D2/CA/C6/C8/B5 /CP/D2/CS /D2/D3/D2/B9/D7/D2/CA/C6/C8 /CU/CP/CR/D8/D3/D6/D7/BA/BT/D1/D3/D2/CV /D8/CW/CT /D0/CP/D8/D8/CT/D6/B8 /CB/CA /D4/D6/D3/D8/CT/CX/D2/D7 /CP/D6/CT /D7/D8/D9/CS/CX/CT/CS /D1/D3/D6/CT/DB/CX/CS/CT/D0/DD /CP/D2/CS /D8/CW/D3/D6/D3/D9/CV/CW/D0/DD /BA /CB/CA /D4/D6/D3/D8/CT/CX/D2/D7 /CP/D6/CT /D2/CP/D1/CT/CS /CQ /DD/D8/CW/CT/CX/D6 /D8 /DD/D4/CX/CR/CP/D0 /CA/CB /CS/D3/D1/CP/CX/D2/B8 /DB/CW/CX/CR /CW /CX/D7 /CR/D3/D1/D4 /D3/D7/CT/CS /D3/CU /CP/CR/CT/D6/D8/CP/CX/D2 /D2 /D9/D1 /CQ/CT /D6 /D3/CU /D8/CP/D2/CS/CT/D1/D0/DD /D6/CT/D4 /CT/CP/D8/CT/CS /D7/CT/D6/CX/D2/CT/B9/CP/D6/CV/CX/D2/CX/D2/CT/B4/CB/CT/D6/B9/BT/D6/CV/B8 /CB/CA/B5 /CS/CX/D4 /CT/D4/D8/CX/CS/CT/BA /CC/CW/CT /D1/CT/CP/D2/CX/D2/CV /D3/CU /CB/CA /CP/D2/CS /CA/CB/CX/D7 /CX/CS/CT/D2 /D8/CX/CR/CP/D0/B8 /CP/D2/CS /CU/D3/D6 /D7/D3/D1/CT /CW/CX/D7/D8/D3/D6/CX/CR/CP/D0 /D6/CT/CP/D7/D3/D2/D7/B8 /D8/CW/CT /CS/CX/CU/B9/CU/CT/D6/CT/D2/CR/CT /CQ/CT /D8 /DB /CT/CT/D2 /D8/CW/CT /D2/CP/D1/CT/D7 /D3/CU /D8/CW/CT /D4/D6/D3/D8/CT/CX/D2/D7 /CP/D2/CS /D8/CW/CT/CX/D6/D7/CX/CV/D2/CP/D8/D9/D6/CT /CS/D3/D1/CP/CX/D2 /DB /CP/D7 /CU/D3/D6/D1/CT/CS/BA /BT/D7 /D8/D3 /D8/CW/CT /CU/D9/D2/CR/D8/CX/D3/D2 /D3/CU/CB/CA /D4/D6/D3/D8/CT/CX/D2/D7/B8 /D8/CW/CT/DD /CP/D6/CT /CX/D2 /DA /D3/D0/DA /CT/CS /CX/D2 /CP/D0/D1/D3/D7/D8 /CP/D0/D0 /D7/D8/CT/D4/D7 /D3/CU/D4/D6/CT/B9/D1/CA/C6/BT /D7/D4/D0/CX/CR/CX/D2/CV/BA /CC/CW/CT/DD /CP/D6/CT /D2/CT/CR/CT/D7/D7/CP/D6/DD /CU/D3/D6 /CR/D3/D2/D7/D8/CX/D8/D9/B9/D8/CX/DA /CT /D7/D4/D0/CX/CR/CX/D2/CV/B8 /CP/D2/CS /D8/CW/CT/CX/D6 /CU/D9/D2/CR/D8/CX/D3/D2 /CX/D7 /CP/D0/D7/D3 /DA /CT/D6/DD /CX/D1/D4 /D3/D6/B9/D8/CP/D2 /D8 /CX/D2 /D8/CW/CT /D6/CT/CV/D9/D0/CP/D8/CX/D3/D2 /D3/CU /CP/D0/D8/CT/D6/D2/CP/D8/CX/DA /CT /D7/D4/D0/CX/CR/CX/D2/CV/BA /CB/CX/D2/CR/CT/D8/CW/CT /BD/BL/BL/BC/B3/D7/B8 /D8/CW/CT /D7/D8/D9/CS/DD /D3/D2 /D8/CW/CT /CU/D9/D2/CR/D8/CX/D3/D2 /D3/CU /CB/CA /D4/D6/D3/D8/CT/CX/D2/D7/CW/CP/D7 /CQ /CT/CR/D3/D1/CT /CP /DA /CT/D6/DD /CP/CR/D8/CX/DA /CT /AC/CT/D0/CS/BA /CC/CW/CX/D7 /D6/CT/DA/CX/CT/DB /CU/D3 /CR/D9/D7/CT/D7 /D3/D2/D8/CW/CT /CQ/CP/D7/CX/CR /D7/D8/D6/D9/CR/D8/D9/D6/CP/D0 /CU/CT/CP/D8/D9/D6/CT/D7/B8 /CR/D0/CP/D7/D7/CX/AC/CR/CP/D8/CX/D3/D2 /CP/D2/CS /CX/CS/CT/D2/B9/D8/CX/AC/CR/CP/D8/CX/D3/D2/B8 /CP/D2/CS /CU/D9/D2/CR/D8/CX/D3/D2/D7 /CX/D2 /D4/D6/CT/B9/D1/CA/C6/BT /CP/D2/CS /D4/CW/D3/D7/D4/CW/D3/B9/D6/DD/D0/CP/D8/CX/D3/D2 /D3/CU /D8/CW/CT /CB/CA /D4/D6/D3/D8/CT/CX/D2 /CU/CP/D1/CX/D0/DD /BA/BW/CX/D7/CR/D3 /DA /CT/D6/DD /CP/D2/CS /C6/D3/D1/CT/D2/CR/D0/CP/D8/D9/D6/CT/CC/CW/CT /AC/D6/D7/D8 /D8 /DB /D3 /CB/CA /D4/D6/D3/D8/CT/CX/D2/D7 /DB /CT/D6/CT /CS/CX/D7/CR/D3 /DA /CT/D6/CT/CS /CX/D2 /D8/CW/CT /CQ/CX/D3/B9/CR /CW/CT/D1/CX/CR/CP/D0 /D7/D8/D9/CS/CX/CT/D7 /D3/D2 /D1/CP/D1/D1/CP/D0/CX/CP/D2 /D7/D4/D0/CX/CR/CX/D2/CV/BA /C1/D2 /BD/BL/BK/BH/B8/C3/D6/CP/CX/D2/CT/D6 /CP/D2/CS /C5/CP/D2/CX/CP/D8/CX/D7 /CX/CS/CT/D2 /D8/CX/AC/CT/CS /CP /D7/D4/D0/CX/CR/CX/D2/CV /CU/CP/CR/D8/D3/D6/A3/BV/D3/D6/D6/CT/D7/D4 /D3/D2/CS/CX/D2/CV /CP/D9/D8/CW/D3/D6/BA/BX/B9/D1/CP/CX/D0/BM /CW/CT/CU/CR/BS/D2/CX/CR/BA/CQ/D1/CX/BA/CP/CR/BA/CR/D2 /D6/CT/D5/D9/CX/D6/CT/CS /CU/D3/D6 /D7/D4/D0/CX/CR/CX/D2/CV /D3/CU /CP /AC /B9/CV/D0/D3/CQ/CX/D2 /D4/D6/CT/B9/D1/CA/C6/BT /CX/D2 /DA/CX/D8/D6 /D3/B8/CB/BY/BE /B4/D7/D4/D0/CX/CR/CX/D2/CV /CU/CP/CR/D8/D3/D6 /BE/B5/B8 /CP/D2/CS /D7/D9/CQ/D7/CT/D5/D9/CT/D2 /D8/D0/DD /CR/D3/D2/AC/D6/D1/CT/CS /CX/D8/CP/D7 /CP/D2 /CT/D7/D7/CT/D2 /D8/CX/CP/D0 /D7/D4/D0/CX/CR/CX/D2/CV /CU/CP/CR/D8/D3/D6/BA /C1/D2 /BD/BL/BL/BC/B8 /BZ/CT /CP/D2/CS /C5/CP/D2/D0/DD/CS/CX/D7/CR/D3 /DA /CT/D6/CT/CS /CP /D7/D4/D0/CX/CR/CX/D2/CV /CU/CP/CR/D8/D3/D6 /D8/CW/CP/D8 /CR/D3/D9/D0/CS /CX/D2/AD/D9/CT/D2/CR/CT /D7/CT/D0/CT/CR/B9/D8/CX/D3/D2 /D3/CU /BH /BC/CP/D0/D8/CT/D6/D2/CP/D8/CX/DA /CT /D7/D4/D0/CX/CR/CX/D2/CV /D7/CX/D8/CT/D7 /CX/D2 /CP/D2 /CB/CE/BG/BC /CT/CP/D6/D0/DD/D4/D6/CT/B9/D1/CA/C6/BT/B8 /CP/D2/CS /D2/CP/D1/CT/CS /CX/D8 /D8/CW/CT /CP/D0/D8/CT/D6/D2/CP/D8/CX/DA /CT /D7/D4/D0/CX/CR/CX/D2/CV /CU/CP/CR/B9/D8/D3/D6 /B4/BT/CB/BY/B5/BA /CC/CW/CT/D2/B8 /BT/CB/BY /CP/D2/CS /CB/BY/BE /DB /CT/D6/CT /CR/D3/D2/AC/D6/D1/CT/CS /CP/D7 /CP/D2/CX/CS/CT/D2 /D8/CX/CR/CP/D0 /D4/D6/D3/D8/CT/CX/D2 /CP/D2/CS /CR/CP/D0/D0/CT/CS /BT/CB/BY/BB/CB/BY/BE /D3/D6 /CB/BY/BE/BB /BT/CB/BY/B4/CP/D0/D7/D3 /D2/CP/D1/CT/CS /CB/CA/D4/BF/BC/CP/B5/BA /CC/CW/CP/D8 /CX/D7 /D8/CW/CT /D4/D6/D3/D8/D3/D8 /DD/D4 /CT /D3/CU /CB/CA/D4/D6/D3/D8/CT/CX/D2/BA /CB/BV/BF/BH /B4/CB/CA/D4/BF/BC/CQ/BB/C8/CA/BE/BI/BG/B5 /CX/D7 /D8/CW/CT /D7/CT/CR/D3/D2/CS /CX/CS/CT/D2 /D8/CX/B9/AC/CT/CS /CB/CA /D4/D6/D3/D8/CT/CX/D2/BA /CC/CW/CT/DD /DB /CT/D6/CT /D7/CW/D3 /DB/D2 /D8/D3 /CQ/CT /D1/CT/D1 /CQ/CT /D6 /D7 /D3/CU/CP /D0/CP/D6/CV/CT/D6/B8 /CT/DA /D3/D0/D9/D8/CX/D3/D2/CP/D6/CX/D0/DD /CR/D3/D2/D7/CT/D6/DA /CT/CS /CU/CP/D1/CX/D0/DD /D3/CU /D4/D6/D3/D8/CT/CX/D2/D7/BA/CD/D4 /D8/D3 /D2/D3 /DB/B8 /BD/BC /CB/CA /D4/D6/D3/D8/CT/CX/D2/D7 /CW/CP /DA /CT /CQ/CT /CT /D2 /CX/CS/CT/D2 /D8/CX/AC/CT/CS /CX/D2 /CW /D9/B9/D1/CP/D2/BA /C1/D2 /CP/CS/CS/CX/D8/CX/D3/D2 /D8/D3 /D8/CW/CT /D8 /DB /D3 /D4/D6/D3/D8/CT/CX/D2/D7 /CS/CX/D7/CR/D9/D7/D7/CT/CS /CP/CQ /D3 /DA /CT/B8/CB/CA/D4/BE/BC /B4/CG/BD/BI /CX/D2 /D1/D3/D9/D7/CT/B8 /CA/BU/C8/BD /CX/D2 /BW/D6 /D3/D7/D3/D4/CW/CX/D0/CP /B5/B8 /CB/CA/D4/BG/BC/B4/C0/CA/CB /CX/D2 /D1/D3/D9/D7/CT/B5/B8 /CB/CA/D4/BH/BH /B4/BU/BH/BE /CX/D2 /BW/D6 /D3/D7/D3/D4/CW/CX/D0/CP /B5/B8 /CW/BL/BZ/BK/B8/CB/CA/D4/BJ/BH/B8 /CB/CA/D4/BF/BC/CR/B8 /CB/CA/D4/BG/BI/B8 /CP/D2/CS /D4/BH/BG /DB /CT/D6/CT /CX/CS/CT/D2 /D8/CX/AC/CT/CS /D0/CP/D8/CT/D6/BA/CB/CA /D4/D6/D3/D8/CT/CX/D2/D7 /D3/D6 /D8/CW/CT/CX/D6 /CW/D3/D1/D3/D0/D3/CV/D9/CT/D7 /DB /CT/D6/CT /CP/D0/D7/D3 /CS/CX/D7/CR/D3 /DA /CT/D6/CT/CS/CX/D2 /D3/D8/CW/CT/D6 /D7/D4 /CT/CR/CX/CT/D7/BA /C5/D3/D6/CT/D3 /DA /CT/D6/B8 /D1/CP/D2 /DD /CB/CA/B9/D6/CT/D0/CP/D8/CT/CS /D3/D6 /B9/D0/CX/CZ /CT/D4/D6/D3/D8/CT/CX/D2/D7/B8 /DB/CW/CX/CR /CW /CP/D6/CT /CX/D2 /DA /D3/D0/DA /CT/CS /CX/D2 /D1 /D9/D0/D8/CX/D4/D0/CT /CU/D9/D2/CR/D8/CX/D3/D2/D7 /D7/D9/CR /CW/CP/D7 /D7/D4/D0/CX/CR/CX/D2/CV/B8 /D8/D6/CP/D2/D7/CR/D6/CX/D4/D8/CX/D3/D2/B8 /D4/D6/D3 /CR/CT/D7/D7/CX/D2/CV /CP/D2/CS /D8/D6/CP/D2/D7/D4 /D3/D6/D8/CX/D2/CV/D3/CU /D1/CA/C6/BT/B8 /CP/D0/D3/D2/CV /DB/CX/D8/CW /CB/CA /D4/D6/D3/D8/CT/CX/D2/D7 /D1/CP/CZ /CT /D9/D4 /D8/CW/CT /CB/CA/D4/D6/D3/D8/CT/CX/D2 /D7/D9/D4 /CT/D6/CU/CP/D1/CX/D0/DD /BA/CC/CW/CT /D2/D3/D1/CT/D2/CR/D0/CP/D8/D9/D6/CT /D3/CU /CB/CA /D4/D6/D3/D8/CT/CX/D2/D7 /CX/D7 /CQ/CP/D7/CT/CS /D3/D2 /D8/CW/CT/CX/D6/D1/D3/D0/CT/CR/D9/D0/CP/D6 /DB /CT/CX/CV/CW /D8 /CP/D2/CS /CR/CP/D4/D4 /CT/CS /DB/CX/D8/CW /CK/CB/CAꜼ /CP/CR/CR/D3/D6/CS/CX/D2/CV /D8/D3/D8/CW/CT /D6/D9/D0/CT /D3/CU /CI/CP/CW/D0/CT/D6/BA /BY /D3/D6 /CT/DC/CP/D1/D4/D0/CT/B8 /BT/CB/BY/BB/CB/BY/BE /DB /CP/D7 /D8/CT/D6/D1/CT/CS/CP/D7 /CB/CA/D4/BF/BC/CP /B4/CB/CX/D2/CR/CT /D8/CW/CT/D6/CT /CP/D6/CT /D1/D3/D6/CT /D8/CW/CP/D2 /D3/D2/CT /CB/CA /D4/D6/D3/D8/CT/CX/D2/DB/CX/D8/CW /D1/D3/D0/CT/CR/D9/D0/CP/D6 /DB /CT/CX/CV/CW /D8 /CX/D7 /BF/BC /CZ/BW/CP/B8 /D3/D2/D0/DD /D8/CW/CT /D0/CT/D8/D8/CT/D6 /CK/CPꜼ/CX/D7 /D9/D7/CT/CS /CX/D2 /D8/CW/CT /D2/CP/D1/CT /D3/CU /BT/CB/BY/BB/CB/BY/BE/B5/B8 /D0/CX/CZ /CT/DB/CX/D7/CT /CB/BV/BF/BH /CX/D7/CR/CP/D0/D0/CT/CS /CB/CA/D4/BF/BC/CQ/BA/BE /BZ/CT/D2/D3/BA/B8 /C8/D6/D3/D8/BA /B2 /BU/CX/D3/CX/D2/CU/D3/BA /CE /D3/D0/BA /BD /C6/D3/BA /BD /BY /CT/CQ/D6/D9/CP/D6/DD /BE/BC/BC/BFThis is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/39/b2/main.PMC5172405.pdf
/C4/CT/D8/D8/CT/D6/C8 /D3/D0/DD/D1/D3/D6/D4/CW/CX/D7/D1 /C8/D6/D3/AC/D0/CT /D3/CU /C6/CX/D2/CT /CB/CW/D3/D6/D8 /CC /CP/D2/CS/CT/D1 /CA/CT/D4 /CT/CP/D8 /C4/D3 /CR/CX /CX/D2 /D8/CW/CT /C0/CP/D2/BV/CW/CX/D2/CT/D7/CT/CB/CW /D9/CP/D2/CV/CS/CX/D2/CV /C4/CX /BD/BN/BF/B6/B8 /BV/CW /D9/D2/DC/CX/CP /CH /CP/D2 /BD/BN/BE/BN/BF/B6/B8 /CH /CP /CY/D9/D2 /BW/CT/D2/CV /BD/BN/BE/BN/BF/B8 /CA/D9/CX/D0/CX/D2 /CF /CP/D2/CV /BE/BN/BF/B8 /C2/CX/CP/D2 /CF /CP/D2/CV /BE/B8 /C0/D9/CP/D2/D1/CX/D2/CV /CH /CP/D2/CV /BE/B8 /CP/D2/CS/CB/CW/CT/D2/CV/CQ/CX/D2 /C4/CX /BD/BN/BE/BN/BF/AZ/BD/C3/CT/DD /C4 /CP/CQ /D3/D6 /CP/D8/D3/D6/DD /D3/CU /C6/CP/D8/CX/D3/D2/CP/D0 /C5/CX/D2/CX/D7/D8/D6/DD /D3/CU /C0/CT /CP/D0/D8/CW /CU/D3/D6 /BY /D3/D6 /CT/D2/D7/CX/CR /CB/CR/CX/CT/D2/CR /CT/D7/B8 /CG/CX/B3/CP/D2 /C2/CX/CP/D3/D8/D3/D2/CV /CD/D2/CX/DA/CT/D6/D7/CX/D8/DD/B8 /CG/CX/B3/CP/D2/BJ/BD/BC/BC/BI/BD/B8 /BV/CW/CX/D2/CP/BN /BE/BU/CT/CX/CY/CX/D2/CV /BZ/CT/D2/D3/D1/CX/CR/D7 /C1/D2/D7/D8/CX/D8/D9/D8/CT/B8 /BV/CW/CX/D2/CT/D7/CT /BT /CR /CP/CS/CT/D1/DD /D3/CU /CB/CR/CX/CT/D2/CR /CT/D7/B8 /BU/CT/CX/CY/CX/D2/CV /BD/BC/BD/BF/BC/BC/B8 /BV/CW/CX/D2/CP/BN /BF/BY /D3/D6 /CT/D2/D7/CX/CR/BV/CT/D2/D8/CT/D6 /CX/D2 /BU/CT/CX/CY/CX/D2/CV /BZ/CT/D2/D3/D1/CX/CR/D7 /C1/D2/D7/D8/CX/D8/D9/D8/CT/B8 /BU/CT/CX/CY/CX/D2/CV /BD/BC/BD/BF/BC/BC/B8 /BV/CW/CX/D2/CP/BA/C6/CX/D2/CT /D7/CW/D3/D6/D8 /D8/CP/D2/CS/CT/D1 /D6/CT/D4 /CT/CP/D8 /B4/CB/CC/CA/B5 /D1/CP/D6/CZ /CT/D6/D7 /B4/BW/BF/CB/BD/BF/BH/BK/B8 /CE/CF /BT/B8 /BY /BZ/BT/B8 /CC/C0/C7/BD/B8 /CC/C8/C7 /CG/B8/BV/CB/BY/C1/C8/C7/B8 /BW/BH/CB/BK/BD/BK/B8 /BW/BD/BF/CB/BF/BD/BJ/B8 /CP/D2/CS /BW/BJ/CB/BK/BE/BC/B5 /CP/D2/CS /CP /D7/CT/DC/B9/CX/CS/CT/D2 /D8/CX/AC/CR/CP/D8/CX/D3/D2 /D1/CP/D6/CZ /CT/D6 /B4/BT/D1/CT/D0/B9/D3/CV/CT/D2/CX/D2 /D0/D3 /CR/D9/D7/B5 /DB /CT/D6/CT /CP/D1/D4/D0/CX/AC/CT/CS /DB/CX/D8/CW /D1 /D9/D0/D8/CX/D4/D0/CT/DC /C8/BV/CA /CP/D2/CS /DB /CT/D6/CT /CV/CT/D2/D3/D8 /DD/D4 /CT/CS /DB/CX/D8/CW /CP/CU/D3/D9/D6/B9/CR/D3/D0/D3/D6 /AD/D9/D3/D6/CT/D7/CR/CT/D2/CR/CT /D1/CT/D8/CW/D3 /CS /CX/D2 /D7/CP/D1/D4/D0/CT/D7 /CU/D6/D3/D1 /BD/BJ/BG /D9/D2/D6/CT/D0/CP/D8/CT/CS /C0/CP/D2 /CX/D2/CS/CX/DA/CX/CS/D9/CP/D0/D7 /CX/D2/C6/D3/D6/D8/CW /BV/CW/CX/D2/CP/BA /CC/CW/CT /CP/D0/D0/CT/D0/CT /CU/D6/CT/D5/D9/CT/D2/CR/CX/CT/D7/B8 /CV/CT/D2/D3/D8 /DD/D4 /CT /CU/D6/CT/D5/D9/CT/D2/CR/CX/CT/D7/B8 /CW/CT/D8/CT/D6/D3/DE/DD/CV/D3/D7/CX/D8 /DD /B8 /D4/D6/D3/CQ/B9/CP/CQ/CX/D0/CX/D8 /DD /D3/CU /CS/CX/D7/CR/D6/CX/D1/CX/D2/CP/D8/CX/D3/D2 /D4/D3 /DB /CT/D6/D7/B8 /D4/D6/D3/CQ/CP/CQ/CX/D0/CX/D8 /DD /D3/CU /D4/CP/D8/CT/D6/D2/CX/D8 /DD /CT/DC/CR/D0/D9/D7/CX/D3/D2 /CP/D2/CS /C0/CP/D6/CS/DD/B9/CF /CT/CX/D2 /CQ /CT/D6/CV /CT/D5/D9/CX/D0/CX/CQ/D6/CX/D9/D1 /CT/DC/D4 /CT/CR/D8/CP/D8/CX/D3/D2/D7 /DB /CT/D6/CT /CS/CT/D8/CT/D6/D1/CX/D2/CT/CS/BA /CC/CW/CT /D6/CT/D7/D9/D0/D8/D7 /CS/CT/D1/D3/D2/D7/D8/D6/CP/D8/CT/CS/D8/CW/CP/D8 /D8/CW/CT /CV/CT/D2/D3/D8 /DD/D4 /CT/D7 /CP/D8 /CP/D0/D0 /D8/CW/CT/D7/CT /CB/CC/CA /D0/D3 /CR/CX /CX/D2 /C0/CP/D2 /D4 /D3/D4/D9/D0/CP/D8/CX/D3/D2 /CR/D3/D2/CU/D3/D6/D1 /D8/D3 /C0/CP/D6/CS/DD/B9/CF /CT/CX/D2 /CQ /CT/D6/CV /CT/D5/D9/CX/D0/CX/CQ/D6/CX/D9/D1 /CT/DC/D4 /CT/CR/D8/CP/D8/CX/D3/D2/D7/BA /CC/CW/CT /CR/D3/D1 /CQ/CX/D2/CT/CS /CS/CX/D7/CR/D6/CX/D1/CX/D2/CP/D8/CX/D3/D2 /D4/D3 /DB /CT/D6 /B4/BW/C8/B5 /DB /CP/D7/BD/BA/BC/BH/A2/BD/BC /A0/BD/BC/DB/CX/D8/CW/CX/D2 /D2/CX/D2/CT /CB/CC/CA /D0/D3 /CR/CX /CP/D2/CP/D0/DD/DE/CT/CS /CP/D2/CS /D8/CW/CT /D4/D6/D3/CQ/CP/CQ/CX/D0/CX/D8 /DD /D3/CU /D4/CP/D8/CT/D6/D2/CX/D8 /DD /CT/DC/CR/D0/D9/D7/CX/D3/D2/B4/BX/C8/C8/B5 /DB /CP/D7 /BC/BA/BL/BL/BL/BK/BA /CC/CW/CT /D6/CT/D7/D9/D0/D8/D7 /CX/D2/CS/CX/CR/CP/D8/CT /D8/CW/CP/D8 /D8/CW/CT/D7/CT /D2/CX/D2/CT /CB/CC/CA /D0/D3 /CR/CX /CP/D2/CS /D8/CW/CT /BT/D1/CT/D0/D3/B9/CV/CT/D2/CX/D2 /D0/D3 /CR/D9/D7 /CP/D6/CT /D9/D7/CT/CU/D9/D0 /D1/CP/D6/CZ /CT/D6/D7 /CU/D3/D6 /CW /D9/D1/CP/D2 /CX/CS/CT/D2 /D8/CX/AC/CR/CP/D8/CX/D3/D2/B8 /D4/CP/D8/CT/D6/D2/CX/D8 /DD /CP/D2/CS /D1/CP/D8/CT/D6/D2/CX/D8 /DD/D8/CT/D7/D8/CX/D2/CV /CP/D2/CS /D7/CT/DC /CS/CT/D8/CT/D6/D1/CX/D2/CP/D8/CX/D3/D2 /CX/D2 /CU/D3/D6/CT/D2/D7/CX/CR /D7/CR/CX/CT/D2/CR/CT/D7/BA/C3/CT/DD /DB /D3/D6/CS/D7/BM /D7/CW/D3/D6/D8 /D8/CP/D2/CS/CT/D1 /D6/CT/D4 /CT/CP/D8/D7/B8 /D4 /D3/D0/DD/D1/D3/D6/D4/CW/CX/D7/D1/B8 /C0/CP/D2 /D4 /D3/D4/D9/D0/CP/D8/CX/D3/D2/C1/D2 /D8/D6/D3 /CS/D9/CR/D8/CX/D3/D2/C5/D3/D7/D8 /BW/C6/BT /D4 /D3/D0/DD/D1/D3/D6/D4/CW/CX/D7/D1/D7 /CP/D6/CT /DA /CP/D6/CX/CP/D8/CX/D3/D2/D7 /CX/D2 /D8/CW/CT /BW/C6/BT/D7/CT/D5/D9/CT/D2/CR/CT /D8/CW/CP/D8 /D9/D7/D9/CP/D0/D0/DD /CW/CP /DA /CT /D2/D3 /D3/CQ /DA/CX/D3/D9/D7 /CT/AB/CT/CR/D8 /D3/D2/D8/CW/CT /D4/CW/CT/D2/D3/D8 /DD/D4/CT /D3/CU /CP/D2 /CX/D2/CS/CX/DA/CX/CS/D9/CP/D0 /CP/D2/CS /CP/D6/CT /CX/D2/CW/CT/D6/CX/D8/CT/CS/CU/D6/D3/D1 /CV/CT/D2/CT/D6/CP/D8/CX/D3/D2 /D8/D3 /CV/CT/D2/CT/D6/CP/D8/CX/D3/D2 /CP/CR/CR/D3/D6/CS/CX/D2/CV /D8/D3 /C5/CT/D2/CS/CT/D0/CX/CP/D2/D6/D9/D0/CT/D7/BA /CC/CW/CT/DD /CR/D3/D2 /D8/D6/CX/CQ/D9/D8/CT /D7/CX/CV/D2/CX/AC/CR/CP/D2 /D8/D0/DD /D8/D3 /D8/CW/CT /DA /CP/D6/CX/CP/CQ/CX/D0/B9/CX/D8 /DD /CX/D2 /D8/CW/CT /BW/C6/BT /D7/CT/D5/D9/CT/D2/CR/CT /D3/CU /CX/D2/CS/CX/DA/CX/CS/D9/CP/D0/D7 /D3/CU /CP /D7/D4 /CT/CR/CX/CT/D7/BA/BT/D1/D3/D2/CV /D8/CW/CT /DA /CP/D6/CX/CP/D8/CX/D3/D2/D7/B8 /D8/CW/CT/D6/CT /CP/D6/CT /D1/CP/D2 /DD /D7/CW/D3/D6/D8 /D8/CP/D2/CS/CT/D1/D6/CT/D4 /CT/CP/D8/D7 /B4/CB/CC/CA/D7/B5 /CX/D2 /D8/CW/CT /CW /D9/D1/CP/D2 /CV/CT/D2/D3/D1/CT/BA /CB/CC/CA/D7 /CP/D4/D4 /CT/CP/D6/D8/D3 /CQ/CT /CP/CQ/D9/D2/CS/CP/D2 /D8 /D8/CW/D6/D3/D9/CV/CW/D3/D9/D8 /D8/CW/CT /CW /D9/D1/CP/D2 /CV/CT/D2/D3/D1/CT/B8 /D3/CR /B9/CR/D9/D6/D6/CX/D2/CV /D3/D2 /CP /DA /CT/D6/CP/CV/CT /CT/DA /CT/D6/DD /BI/B9/BD/BC /C3/CQ /B4/BD /B5/BA /BT/D0/D8/CW/D3/D9/CV/CW /CV/CT/D2/B9/CT/D6/CP/D0/D0/DD /D7/D1/CP/D0/D0/B8 /BD/BC/BC/B9/BF/BH/BC /CQ/D4 /CX/D2 /D7/CX/DE/CT /CP/D2/CS /D7/CX/D1/D4/D0/CT /D6/CT/D4 /CT/CP/D8/CT/CS/D7/CT/D5/D9/CT/D2/CR/CT/D7 /D3/CU /BE/B9/BG /CQ/D4 /CX/D2 /D0/CT/D2/CV/D8/CW/B8 /CB/CC/CA/D7 /CT/DC/CW/CX/CQ/CX/D8 /CP /CW/CX/CV/CW /CS/CT/B9/CV/D6/CT/CT /D3/CU /D0/CT/D2/CV/D8/CW /CP/D2/CS /D7/CT/D5/D9/CT/D2/CR/CT /D4 /D3/D0/DD/D1/D3/D6/D4/CW/CX/D7/D1 /CP/D2/CS /D4/D6/D3/B9/DA/CX/CS/CT /CP /D7/D3/D9/D6/CR/CT /D3/CU /CW/CX/CV/CW/D0/DD /CX/D2/CU/D3/D6/D1/CP/D8/CX/DA /CT /D0/D3 /CR/CX /D8/CW/CP/D8 /CR/CP/D2 /CQ/CT/D9/D7/CT/CS /CU/D3/D6 /D8/CW/CT /CX/CS/CT/D2 /D8/CX/AC/CR/CP/D8/CX/D3/D2 /D3/CU /CX/D2/CS/CX/DA/CX/CS/D9/CP/D0/D7/BA /CC/CW/CT/D6/CT/CU/D3/D6/CT/B8/CB/CC/CA /D1/CP/D6/CZ /CT/D6/D7 /CP/D6/CT /D3/CU /CV/D6/CT/CP/D8 /DA /CP/D0/D9/CT /CU/D3/D6 /CV/CT/D2/CT/D8/CX/CR /D7/D8/D9/CS/CX/CT/D7 /CP/D2/CS/CU/D3/D6/CT/D2/D7/CX/CR /CX/CS/CT/D2 /D8/CX/AC/CR/CP/D8/CX/D3/D2 /B4/BE/B9/BI/B5/BA/B6 /CC/CW/CT/D7/CT /CP/D9/D8/CW/D3/D6/D7 /CR/D3/D2 /D8/D6/CX/CQ/D9/D8/CT/CS /CT/D5/D9/CP/D0/D0/DD /D8/D3 /D8/CW/CX/D7/DB /D3/D6/CZ/BA/AZ/BV/D3/D6/D6/CT/D7/D4 /D3/D2/CS/CX/D2/CV /CP/D9/D8/CW/D3/D6/BA/BX/B9/D1/CP/CX/D0/BM /D0/CX/D7/CW/CT/D2/CV/CQ/CX/D2/BS/CV/CT/D2/D3/D1/CX/CR/D7/BA/D3/D6/CV/BA/CR/D2 /BU/DD /D9/D7/CX/D2/CV /CU/D3/D9/D6/B9/CR/D3/D0/D3/D6 /AD/D9/D3/D6/CT/D7/CR/CT/D2/CR/CT /BW/C6/BT /D7/CT/D5/D9/CT/D2/CR/CX/D2/CV/D4/D0/CP/D8/CU/D3/D6/D1 /B4/BT/D4/D4/D0/CX/CT/CS /BU/CX/D3/D7/DD/D7/D8/CT/D1/D7 /BT/D9/D8/D3/D1/CP/D8/CT/CS /BW/C6/BT /CB/CT/B9/D5/D9/CT/D2/CR/CT/D6 /C5/D3 /CS/CT/D0 /BF/BJ/BJ/B5 /CP/D2/CS /D1 /D9/D0/D8/CX/D4/D0/CT/DC /C8/BV/CA/B8 /DB /CT /CP/D2/CP/D0/DD/DE/CT/CS/D2/CX/D2/CT /CB/CC/CA /D0/D3 /CR/CX /B4/BW/BF/CB/BD/BF/BH/BK/B8 /CE/CF /BT/B8 /BY /BZ/BT/B8 /CC/C0/C7/BD/B8 /CC/C8/C7 /CG/B8/BV/CB/BY/C1/C8/C7/B8 /BW/BH/CB/BK/BD/BK/B8 /BW/BD/BF/CB/BF/BD/BJ/B8 /CP/D2/CS /BW/BJ/CB/BK/BE/BC/B5 /CP/D2/CS /CP /D7/CT/DC/B9/D8 /DD/D4/CX/D2/CV /D0/D3 /CR/D9/D7 /B4/BT/D1/CT/D0/D3/CV/CT/D2/CX/D2/B5 /DB/CX/D8/CW /D7/CP/D1/D4/D0/CT/D7 /CR/D3/D0/D0/CT/CR/D8/CT/CS/CU/D6/D3/D1 /BD/BJ/BG /D9/D2/D6/CT/D0/CP/D8/CT/CS /C0/CP/D2 /CX/D2/CS/CX/DA/CX/CS/D9/CP/D0/D7 /CX/D2 /BV/CW/CP/D2/CV/B3/CP/D2/BV/D3/D9/D2 /D8 /DD /B8 /C6/D3/D6/D8/CW /BV/CW/CX/D2/CP/BA/CA/CT/D7/D9/D0/D8/D7 /CP/D2/CS /BW/CX/D7/CR/D9/D7/D7/CX/D3/D2/CC/CW/CT /CP/D0/D0/CT/D0/CX/CR /CU/D6/CT/D5/D9/CT/D2/CR/CX/CT/D7 /D3/CU /D8/CW/CT /D2/CX/D2/CT /CB/CC/CA /D0/D3 /CR/CX /CP/D2/CS /D8/CW/CT/BT/D1/CT/D0/D3/CV/CT/D2/CX/D2 /D0/D3 /CR/D9/D7 /CX/D2 /D8/CW/CT /C0/CP/D2 /BV/CW/CX/D2/CT/D7/CT /DB /CT/D6/CT /D7/D9/D1/B9/D1/CP/D6/CX/DE/CT/CS /CP/D2/CS /CR/D3/D1/D4/CP/D6/CT/CS /DB/CX/D8/CW /D8/CW/D3/D7/CT /CU/D6/D3/D1 /BT/CU/D6/CX/CR/CP/D2/B9/BT/D1/CT/D6/CX/CR/CP/D2 /CP/D2/CS /BV/CP/D9/CR/CP/D7/CX/CP/D2 /D4 /D3/D4/D9/D0/CP/D8/CX/D3/D2/D7 /B4/CC /CP/CQ/D0/CT /BD/B5/BA /CF /CT/D9/D7/CT/CS /D4 /CT/D6/D8/CX/D2/CT/D2 /D8 /CS/CP/D8/CP /D8/D3 /CS/CT/D8/CT/D6/D1/CX/D2/CT /D8/CW/CT /CS/CX/D7/CR/D6/CX/D1/CX/D2/CP/D8/CX/D3/D2/D4/D3 /DB /CT/D6 /B4/BW/C8/B5 /CP/D2/CS /D4/D6/D3/CQ/CP/CQ/CX/D0/CX/D8/CX/CT/D7 /D3/CU /D4/CP/D8/CT/D6/D2/CX/D8 /DD /CT/DC/CR/D0/D9/D7/CX/D3/D2/B4/BX/C8/C8/B5 /D3/CU /D8/CW/CT /C0/CP/D2 /BV/CW/CX/D2/CT/D7/CT /CU/D3/D6 /D2/CX/D2/CT /CB/CC/CA /D0/D3 /CR/CX /B4/CC /CP/CQ/D0/CT/BE/B5/BA /CC/CW/CT/D7/CT /CB/CC/CA /CS/CP/D8/CP /CR/D3/D2/CU/D3/D6/D1/CT/CS /D8/D3 /D8/CW/CT /D4/D6/CT/CS/CX/CR/D8/CX/D3/D2/D7 /D3/CU/C0/CP/D6/CS/DD/B9/CF /CT/CX/D2 /CQ/CT /D6 /CV /CT/D5/D9/CX/D0/CX/CQ/D6/CX/D9/D1/BA/CC/CW/D6/CT/CT /AD/D9/D3/D6/CT/D7/CR/CT/D2 /D8 /D0/CP/CQ /CT/D0/D7 /CP/D2/CS /D7/CX/DE/CT /D7/CT/D4/CP/D6/CP/D8/CX/D3/D2 /D4/D6/D3/B9/DA/CX/CS/CT/CS /CQ /DD /BW/C6/BT /D7/CT/D5/D9/CT/D2/CR/CT/D6 /C5/D3 /CS/CT/D0 /BF/BJ/BJ /CT/D2/CP/CQ/D0/CT/CS /D9/D7 /D8/D3/CS/CX/D7/D8/CX/D2/CV/D9/CX/D7/CW /D1/CP/D2 /DD /CX/D2/CS/CT/D4 /CT/D2/CS/CT/D2 /D8 /D0/D3 /CR/CX /CX/D2 /D8/CW/CT /D7/CP/D1/CT /D0/CP/D2/CT/BA/CC /D3 /CT/DC/D4/D0/D3/CX/D8 /D8/CW/CT /D4 /D3/D8/CT/D2 /D8/CX/CP/D0 /D8/D3 /CX/D2/CR/D6/CT/CP/D7/CT /D8/CW/D6/D3/D9/CV/CW/D4/D9/D8 /DB/CX/D8/CW/BD/BI/BI /BZ/CT/D2/D3/BA/B8 /C8/D6/D3/D8/BA /B2 /BU/CX/D3/CX/D2/CU/D3/BA /CE /D3/D0/BA /BD /C6/D3/BA /BE /C5/CP /DD /BE/BC/BC/BFThis is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e1/d2/main.PMC5172406.pdf
3 August 2003 207This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/5c/main.PMC5172407.pdf
"All of the S protein fragments were designed based upon this genomic sequence (http://www.ncbi.nlm.nih.gov, GI: 30275666).",Non-OADS,/arxiv_data1/oa_pdf/dd/5c/main.PMC5172407.pdf
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/51/88/main.PMC5172408.pdf
3 August 2003 This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9c/2b/main.PMC5172409.pdf
Data sources: http://www.moh.gov.cn/zhgl/yqfb/index.htm; http://www.who.int/csr/sars/country/en/.,OADS,/arxiv_data1/oa_pdf/9c/2b/main.PMC5172409.pdf
"SARS Patients, SARS-CoV Iso- lates and Genome Sequencing SARS patients were clinically diagnosed in March 2003 according to World Health Organization (WHO) guidelines (http://www.who.int/csr/sars/guidelines /en/).",Non-OADS,/arxiv_data1/oa_pdf/9c/2b/main.PMC5172409.pdf
"For comparative genomic analyses, 13 other full-length SARS-CoV genome se- quences were downloaded from GenBank (Table 2;http://www.ncbi.nlm.nih.gov).",OADS,/arxiv_data1/oa_pdf/9c/2b/main.PMC5172409.pdf
"Complete Genome Sequences of the SARS-CoV Table 2 Information Summary of the Complete Genome Sequences of the BJ Group and Other 13 Isolates of SARS-CoV* Isolate Genome size (nt) Accession number Modiﬁcation date BJ01 29,725 AY278488.2 1-May-03 BJ02 29,745 AY278487 5-June-03 BJ03 29,740 AY278490 5-June-03 BJ04 29,732 AY279354 29-May-03 GD01 29,757 AY278489 29-May-03 ZJ01 29,715 AY297028.1 19-May-03 TW1 29,729 AY291451.1 14-May-03 CUHK-W1 29,736 AY278554.2 14-May-03 CUHK-Su10 29,736 AY282752.1 7-May-03 Urbani 29,727 AY278741.1 21-Apr-03 HKU-39849 29,742 AY278491.2 18-Apr-03 TOR2 29,751 NC  004718.3 22-May-03 SIN2500 29,711 AY283794.1 9-May-03 SIN2677 29,705 AY283795.1 9-May-03 SIN2679 29,711 AY283796.1 9-May-03 SIN2748 29,706 AY283797.1 9-May-03 SIN2774 29,711 AY283798.1 9-May-03 *Data were retrieved from GenBank: http://www.ncbi.nlm.nih.gov.",Non-OADS,/arxiv_data1/oa_pdf/9c/2b/main.PMC5172409.pdf
"HIV data are from 405 strains, downloaded from http://hiv-web.lanl.gov/.",OADS,/arxiv_data1/oa_pdf/9c/2b/main.PMC5172409.pdf
Substantial research both at cDNA and protein level have been performed on immunochemical fea- tures of human autoantigens (http://www.zoo.uni- heidelberg.de/mol evol/MB/ana base.html).,OADS,/arxiv_data1/oa_pdf/60/c1/main.PMC5172410.pdf
4 November 2003This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/60/c1/main.PMC5172410.pdf
The origin of natural selection of particular nucleotide sequences and their conserva- tion from primitive RNA-based catalysis to eukary- otic chromosome evolution remain to be elucidated (http://manske.virtualave.net/genetik/vorlesung ws 99/teil1-3/rna unddieevolution.h tm; ref.,OADS,/arxiv_data1/oa_pdf/60/c1/main.PMC5172410.pdf
Further advancements in sequence comparison techniques will help to understand whether these functional sites have arisen multiple times during evolution (http://online.itp.ucsb.edu/online/infobio01/higgs1/ pdf/higgs1.pdf; ref.,OADS,/arxiv_data1/oa_pdf/60/c1/main.PMC5172410.pdf
All the DNA sequencings were performed by the Vienna Biocenter oligo team (http://emb1.bcc.univie.ac.at/gem).,OADS,/arxiv_data1/oa_pdf/60/c1/main.PMC5172410.pdf
SÄ uleymano· glu were aligned employing CLUSTALW programme (http://www2.ebi.ac.uk/clustalw/; ref.,Non-OADS,/arxiv_data1/oa_pdf/60/c1/main.PMC5172410.pdf
"Table 1 PCR Primers Used for Generation of RBD-Binding Domains of Human hnRNP A3 Protein Primer Sequence Enco ded fragment 1NA3LIC 50GA CGACGACAAGATGGAGGTAAAACCGCCGCCTGGTCGC 30Full-length hnRNP A3 1CA3LIC 50GAGGAGAAGCCCGGTTTAGAACCTTCTGCTACCATATCC 30RBD1 and RBD2 CT111A3 50GAGGAGAAGCCCGGTTTAAACAGGTCTCTTTGGTTC 30RBD1 CT209A3LIC 50GAGGAGAAGCCCGGTTTACTGCATCTCTTGTTTAGA 30RBD2 Ackno wledgements I thank Dr. Richard Hrabal (Laboratory of NMR Spectroscopy, Institute of Chemical Technology, Prague, Czech Republic; http://www.vscht.cz/nmr) for the hospitality and generous ¯nancial support dur- ing my stay in his laboratory in Prague as a guest re- searcher and for the detailed supervision concerning our joint work on NMR studies of RNA-protein recog- nition and its signi¯cance in the control of stability of hnRNP particles.",Non-OADS,/arxiv_data1/oa_pdf/60/c1/main.PMC5172410.pdf
"Ph.D. Thesis, Medical Faculty, Vi- enna Biocenter, Uiversity of Vienna, Vienna, Austria (http://www.arcs.ac.at/dissdb/rn036425).",Non-OADS,/arxiv_data1/oa_pdf/60/c1/main.PMC5172410.pdf
/BX/CS/CX/D8/D3/D6/CX/CP/D0/CK/CC/CW/D6/CT/CT /C3/CX/D2/CV/CS/D3/D1/D7Ꜽ /D8/D3 /CA/D3/D1/CP/D2/CR/CT/C2/D9/D2 /CH /D9 /BD/B6/B8 /C2/CX/CP/D2 /CF /CP/D2/CV /BD/B8 /BY /D9/CR /CW /D9 /C0/CT /BE/B8 /CP/D2/CS /C0/D9/CP/D2/D1/CX/D2/CV /CH /CP/D2/CV /BD/BD/BU/CT/CX/CY/CX/D2/CV /BZ/CT/D2/D3/D1/CX/CR/D7 /C1/D2/D7/D8/CX/D8/D9/D8/CT/B8 /BV/CW/CX/D2/CT/D7/CT /BT /CR /CP/CS/CT/D1/DD /D3/CU /CB/CR/CX/CT/D2/CR /CT/D7/B8 /BU/CT/CX/CY/CX/D2/CV /BD/BC/BD/BF/BC/BC/B8 /BV/CW/CX/D2/CP/BN /BE/BU/CT/CX/CY/CX/D2/CV /C1/D2/D7/D8/CX/D8/D9/D8/CT /D3/CU/CA /CP/CS/CX/CP/D8/CX/D3/D2 /C5/CT /CS/CX/CR/CX/D2/CT/B8 /BU/CT/CX/CY/CX/D2/CV /BD/BC/BC/BK/BH/BC/B8 /BV/CW/CX/D2/CP/BY/D3/D6 /D7/D3/D1/CT /CW/CX/D7/D8/D3/D6/CX/CR /D6/CT/CP/D7/D3/D2/D7/B8 /D3/D9/D6 /D2/CT/DB/CY/D3/D9/D6/D2/CP/D0 /CX/D7 /D2/CP/D1/CT/CS /CK/BZ/CT/D2/D3/D1/CX/CR/D7/B8 /C8/D6/D3/B9/D8/CT/D3/D1/CX/CR/D7 /B2 /BU/CX/D3/CX/D2/CU/D3/D6/D1/CP/D8/CX/CR/D7Ꜽ/B8 /D3/D6 /CP/D7/DB /CT /CW/CP /DA /CT /D2/CX/CR /CZ/D2/CP/D1/CT/CS /CX/D8 /CX/D2 /D7/CW/D3/D6/D8 /D8/CW/CT/C2/D3/D9/D6/D2/CP/D0 /D3/CU /BZ/C8/BU/BA /BT /CV/D6/D3 /DB/CX/D2/CV /D2 /D9/D1/B9/CQ/CT /D6 /D3/CU /CK/DF/D3/D1/CTꜼ /CP/D2/CS /CK/B9/D3/D1/CX/CR/D7Ꜽ /CW/CP /DA /CT/CP/D4/D4 /CT/CP/D6/CT/CS /CX/D2 /D1/CP/D2 /DD /CS/CX/DA /CT/D6/D7/CT /AC/CT/D0/CS/D7 /D3/CU/CQ/CX/D3/D0/D3/CV/DD /B8 /CT/D7/D4 /CT/CR/CX/CP/D0/D0/DD /CX/D2 /D8/CW/CT /D6/CT/CR/CT/D2 /D8/DD /CT/CP/D6/D7 /D9/D2/CS/CT/D6 /D4/D6/D3/CU/D3/D9/D2/CS /CX/D2/AD/D9/CT/D2/CR/CT/D7 /D3/CU/D8/CW/CT /C0/D9/D1/CP/D2 /BZ/CT/D2/D3/D1/CT /C8/D6/D3 /CY/CT/CR/D8 /CP/D2/CS/D1/CP/D2 /DD /D3/D8/CW/CT/D6 /CV/CT/D2/D3/D1/CT /D4/D6/D3 /CY/CT/CR/D8/D7 /CR/D3/D1/B9/D4/D0/CT/D8/CT/CS /D3/D6 /CX/D2 /D4/D6/D3/CV/D6/CT/D7/D7/BA /CF /CT /CW/CP/CS /CP/D0/B9/D1/D3/D7/D8 /CP/D8/D8/CT/D1/D4/D8/CT/CS /D8/D3 /D6/CT/B9/D2/CP/D1/CT /D8/CW/CX/D7/CY/D3/D9/D6/D2/CP/D0 /CK/BX/DA /CT/D6/B9/D1/D3/D6/CT/B9/D3/D1/CX/CR/D7Ꜽ /D8/D3 /CX/D2/B9/CR/D0/D9/CS/CT /CP/D0/D0 /D8/CW/CT /D2/CT/DB /CR/D3/D1/CT/D6/D7/BA /C0/D3 /DB/B9/CT/DA /CT/D6/B8 /CP/CU/D8/CT/D6 /CP /D7/CT/CR/D3/D2/CS /D8/CW/D3/D9/CV/CW /D8/B8 /DB /CT/CW/CP /DA /CT /CS/CT/CR/CX/CS/CT/CS /D8/D3 /CT/D2 /D8/CT/D6/D8/CP/CX/D2 /D8/CW/CT/D7/CT/CK/CC/CW/D6/CT/CT /C3/CX/D2/CV/CS/D3/D1/D7Ꜽ /AC/D6/D7/D8 /DB/CW/CX/D0/CT /DB /CT/CP/D6/CT /CZ /CT/CT/D4/CX/D2/CV /CP/D2 /CT/DD /CT /D3/D2 /D3/D8/CW/CT/D6/D7/BA/BW/CT/D7/D4/CX/D8/CT /D8/CW/CT /CU/CP/CR/D8 /D8/CW/CP/D8 /D2/D3 /D3/D2/CT /D6/CT/B9/D0/CP/D8/CT/CS /D8/D3 /D8/CW/CT /CY/D3/D9/D6/D2/CP/D0 /DB /CP/D2 /D8/D7 /D8/D3 /CT/DC/B9/CR/D0/D9/CS/CT /CP/D2 /DD /D3/D8/CW/CT/D6 /CT/DC/CX/D7/D8/CX/D2/CV /D3/D6 /D2/CT/DB/D0/DD/CP/D6/D6/CX/DA /CT/CS /CK/B9/D3/D1/CX/CR/D7Ꜽ/B8 /CR/D6/CT/CP/D8/CT/CS /CQ /DD /CT/CX/B9/D8/CW/CT/D6 /D8/D6/D9/CT /CQ/CX/D3/D0/D3/CV/CX/D7/D8/D7 /D3/D6 /D8/CW/CT /CT/D2/B9/D8/D6/CT/D4/D6/CT/D2/CT/D9/D6 /D8 /DD/D4 /CT/D7/B8 /DB/CW/D3 /CP/D6/CT /CT/CX/D8/CW/CT/D6/DB /D3/D6/CZ/CX/D2/CV /D8/D3 /DB /CP/D6/CS /D7/CR/CP/D0/CX/D2/CV /D9/D4 /D8/CW/CT/CX/D6/D3/D4 /CT/D6/CP/D8/CX/D3/D2/D7 /D3/D6 /CT/D2/CY/D3 /DD/CX/D2/CV /CP/CS/DA /CT/D6/D8/CX/D7/CX/D2/CV/D8/CW/CT/CX/D6 /CU/CP /DA /D3/D6/CX/D8/CT /D7/D9/CQ /CY/CT/CR/D8/D7/B8 /D8/CT/CR /CW/D2/CX/D5/D9/CT/D7/D3/D6 /D6/CT/CP/D0/D1/D7/B8 /DB /CT /D6/CT/CP/D0/D0/DD /D7/CW/D3/D9/D0/CS /CQ/CT /CP/D4/B9/D4/D6/D3/D4/D6/CX/CP/D8/CT/D0/DD /CP/D4 /D3/D0/D3/CV/CT/D8/CX/CR /CQ /CT/CR/CP/D9/D7/CT /DB /CT/CP/D6/CT /D7/D9/D7/D4 /CT/CR/D8/CT/CS /CX/D2 /CS/D3/CX/D2/CV /D7/D3 /CP/D2 /DD /DB /CP /DD /BA/C5/CP /DD/CQ /CT/B8 /CY/D9/D7/D8 /D1/CP /DD/CQ /CT/B8 /D3/D2/CT /D3/CU /D3/D9/D6 /CX/D1/B9/D1/CT/CS/CX/CP/D8/CT /D8/CP/D7/CZ/D7 /D6/CX/CV/CW /D8 /CP/CU/D8/CT/D6 /D0/CP/D9/D2/CR /CW/CX/D2/CV/D8/CW/CX/D7 /D2/CT/DB /CY/D3/D9/D6/D2/CP/D0 /CX/D7 /D8/D3 /D7/D3/D1/CT/CW/D3 /DB /AC/D2/CS/CX/D8 /CP /D2/CT/DB /D2/CP/D1/CT /D8/D3 /CP /DA /D3/CX/CS /CR/D3/D2/CU/D9/D7/CX/D3/D2/D7/BA/C6/D3 /D1/CP/D8/D8/CT/D6 /DB/CW/CP/D8/B8 /DB /CT /D1 /D9/D7/D8 /D7/D8/CP/D6/D8/D4/D9/CQ/D0/CX/D7/CW/CX/D2/CV /CP/D2/CS /CQ /CT/CV/CX/D2 /D8/CW/CT /CK/D1/CT/D8/CP/B9/D1/D3/D6/D4/CW/CX/D7/D1Ꜽ /D8/CW/CP/D8 /DB/CX/D0/D0 /D9/D2/CS/D3/D9/CQ/D8/CT/CS/D0/DD/D8/D6/CP/D2/D7/CU/D3/D6/D1 /D3/D9/D6 /D2/CT/DB /CY/D3/D9/D6/D2/CP/D0 /CX/D2 /D8/D3/CP /D1/D3/D6/CT /CX/D2 /D8/CT/CV/D6/CP/D8/CT/CS /D4 /D3 /CS/CX/D9/D1 /CU/D3/D6/CV/CT/D2/D3/D1/CT /CQ/CX/D3/D0/D3/CV/DD /D3 /DA /CT/D6 /D8/CX/D1/CT/BA /BX/DA /CT/D2/DB/CX/D8/CW /D8/CW/CX/D7 /D2/D3/D8/B9/DD /CT/D8 /CP/D4/D4/D6/D3/D4/D6/CX/CP/D8/CT/D0/DD/D2/CP/D1/CT/CS /D4 /D3 /CS/CX/D9/D1/B8 /DB /CT /D7/CR/CX/CT/D2 /D8/CX/D7/D8/D7 /D7/CW/D3/B9/A3/BV/D3/D6/D6/CT/D7/D4 /D3/D2/CS/CX/D2/CV /CP/D9/D8/CW/D3/D6/BA/BX/B9/D1/CP/CX/D0/BM /CY/D9/D2 /DD/D9/BS/CV/CT/D2/D3/D1/CX/CR/D7/BA/D3/D6/CV/BA/CR/D2 /D9/D0/CS /CQ/CT /CP/CQ/D0/CT /D8/D3 /D6/CT/D4 /D3/D6/D8 /D8/CW/CT/CX/D6 /D2/D3 /DA /CT/D0/CS/CX/D7/CR/D3 /DA /CT/D6/CX/CT/D7/B8 /D8/D3 /D4/D6/D3/D4 /D3/D7/CT /D8/CW/CT/CX/D6 /CU/CP/B9/DA /D3/D6/CX/D8/CT /D1/D3 /CS/CT/D0/D7 /CP/D2/CS /CW /DD/D4 /D3/D8/CW/CT/D7/CT/D7/B8 /D8/D3/DA /D3/CX/CR/CT /D8/CW/CT/CX/D6 /D7/CX/D2/CV/D9/D0/CP/D6 /D3/D4/CX/D2/CX/D3/D2/D7/B8 /D8/D3 /CS/CT/B9/CQ/CP/D8/CT /D3/D2 /D8/CW/CT/CX/D6 /CT/D0/CT/CV/CP/D2 /D8 /D8/CW/CT/D3/D6/CT/D1/D7/B8 /D8/D3/D7/CW/CP/D6/CT /D8/CW/CT/CX/D6 /CS/CX/D0/CX/CV/CT/D2 /D8 /CT/DC/D4 /CT/D6/CX/D1/CT/D2 /D8/CP/D0/D8/D6/CX/CR /CZ/D7 /CP/D2/CS /D8/D3 /D7/D9/D1/D1/CP/D6/CX/DE/CT /D8/CW/CT/CX/D6 /CT/DC/B9/D4 /CT/D6/D8/D7/B3 /DA/CX/CT/DB/D7 /D3/D2 /D7/CR/CX/CT/D2 /D8/CX/AC/CR /CP/CS/DA /CP/D2/CR/CT/B9/D1/CT/D2 /D8 /CX/D2 /D8/CW/CT/CX/D6 /CS/CT/CP/D6/D0/DD /D0/D3 /DA /CT/CS /AC/CT/D0/CS/D7/BA/CF /CT /CS/D3 /D2/D3/D8 /CW/CP /DA /CT /CP /D7/D0/CX/CV/CW /D8/CT/D7/D8/CS/D3/D9/CQ/D8 /D8/CW/CP/D8 /DB /CT /CP/D6/CT /CT/D2 /D8/CT/D6/CX/D2/CV /D8/CW/CT/CK/BZ/CT/D2/D3/D1/CX/CR /BX/D6/CPꜼ /DB/CW/CT/D6/CT /CP /C3/D2/D3 /DB/D0/B9/CT/CS/CV/CT /CA/CT/DA /D3/D0/D9/D8/CX/D3/D2 /CX/D7 /CR/D3/D1/CX/D2/CV /D3/D9/D8 /CP/D7/CR/CX/CT/D2 /D8/CX/AC/CR /D3/D2/CT/B8 /D8/CW/CT /BZ/CT/D2/D3/D1/CX/CR /CA/CT/DA /D3/B9/D0/D9/D8/CX/D3/D2/BA /C1/D8/B8 /CX/D2 /D8/D9/D6/D2/B8 /CR/D3/D1/CT/D7 /D3/D9/D8 /D3/CU /CP/D2/C1/D2/CU/D3/D6/D1/CP/D8/CX/D3/D2/CP/D0 /CA/CT/DA /D3/D0/D9/D8/CX/D3/D2/B8 /D8/CW/CT /CX/D2/B9/CU/D3/D6/D1/CP/D8/CX/D3/D2 /CP/CQ /D3/D9/D8 /CV/CT/D2/D3/D1/CT/D7/B8 /D8/CW/CT /D6/CT/DA/B9/D3/D0/D9/D8/CX/D3/D2 /D8/D3 /D9/D2/CS/CT/D6/D7/D8/CP/D2/CS /CV/CT/D2/D3/D1/CT/D7 /CX/D2/D2/CT/DB /DB /CP /DD/D7 /CP/D2/CS /CQ /DD /D2/CT/DB /D7/DD/D2 /D8/CW/CT/D7/CT/D7/BA/BZ/CT/D2/D3/D1/CX/CR /CX/D2/CU/D3/D6/D1/CP/D8/CX/D3/D2 /CX/D7 /CP/CQ /D3/D9/D8 /D8/CW/CT/CQ/CX/D3/D0/D3/CV/DD /D3/CU /CV/CT/D2/D3/D1/CT/D7/B8 /DB/CW/CX/CR /CW /CX/D7 /CQ/CT /B9/CX/D2/CV /CV/CT/D2/CT/D6/CP/D8/CT/CS /CX/D2 /D7/D9/CR /CW /CP /D7/CR/CP/D0/CT /D8/CW/CP/D8/CT/DA /CT/D2 /D8/CW/CT /D7/D8/CP/CZ /CT/CW/D3/D0/CS/CT/D6/D7 /CP/D6/CT /CT/DC/CR/CT/CT/CS/B9/CX/D2/CV/D0/DD /D3 /DA /CT/D6/DB/CW/CT/D0/D1/CT/CS/BA/BZ/CT/D2/D3/D1/CX/CR /CX/D2/CU/D3/D6/D1/CP/D8/CX/D3/D2 /CX/D7 /CP/CQ /D3/D9/D8/D8/CW/CT /D3/D6/CX/CV/CX/D2 /CP/D2/CS /CT/DA /D3/D0/D9/D8/CX/D3/D2 /D3/CU/CV/CT/D2/D3/D1/CT/D7/B8 /D8/CW/CT /CR/D3/D1/D4 /D3/D7/CX/D8/CX/D3/D2/CP/D0 /CS/DD/B9/D2/CP/D1/CX/CR/D7 /D3/CU /CV/CT/D2/D3/D1/CX/CR /CR/D3/D2/D7/D8/CX/D8/D9/CT/D2 /D8/D7 /CX/D2/CP/D0/D0 /D7/D4 /CT/CR/CX/CT/D7 /D3/D2 /CT/CP/D6/D8/CW/B8 /D8/CW/CT /CS/CX/DA /CT/D6/D7/CX/D8 /DD/D3/CU /CP /CV/CT/D2/D3/D1/CT /CX/D2 /CV/CX/DA /CT/D2 /D4 /D3/D4/D9/D0/CP/D8/CX/D3/D2/D7/B8/D8/CW/CT /CX/D2 /D8/D6/CX/CR/CP/D8/CT /CX/D2 /D8/CT/D6/D4/D0/CP /DD /D3/CU /CU/D9/D2/CR/D8/CX/D3/D2/CP/D0/CR/D3/D1/D4 /D3/D2/CT/D2 /D8/D7 /D3/CU /CV/CT/D2/D3/D1/CT/D7/B8 /CP/D2/CS /D7/DD/D7/B9/D8/CT/D1/CP/D8/CX/CR /CX/D2 /D8/CT/D6/D4/D6/CT/D8/CP/D8/CX/D3/D2/D7 /D3/CU /D1/D3/D0/CT/CR/D9/B9/D0/CP/D6 /D4/D6/D3 /CR/CT/D7/D7/CT/D7 /D8/CW/CP/D8 /CZ /CT/CT/D4 /CT/DC/D8/CP/D2 /D8 /D0/CX/CU/CT/D3/CU /CP/D0/D0 /CU/D3/D6/D1/D7 /CP/D0/CX/DA /CT /CU/D3/D6 /D1/CX/D0/D0/CX/D3/D2/D7 /D3/CU/DD /CT/CP/D6/D7/BA /C1/D8 /CX/D7 /DA /CT/D6/DD /CQ/CP/D7/CX/CR/B8 /CR/D3/D2/CR/CT/D6/D2/CX/D2/CV/CP/D0/D0 /D3/D6/CV/CP/D2/CX/D7/D1/D7 /D3/D2 /CT/CP/D6/D8/CW/BA /C1/D8 /CX/D7 /D2/CT/DB/B8/D0/CT/CP/CS/CX/D2/CV /D8/D3 /DB /CP/D6/CS /D8/CW/CT /D8 /DB/CX/D0/CX/CV/CW /D8 /DE/D3/D2/CT/DB/CW/CT/D6/CT /D8/CW/CT /D9/D2/CZ/D2/D3 /DB/D2 /CX/D7 /CX/D2 /D8/CT/D6/D6/D3/CV/CP/D8/CT/CS/CP/D2/CS /D8/D6/CP/D2/D7/D0/CP/D8/CT/CS /CX/D2 /D8/D3 /D8/CW/CT /CZ/D2/D3 /DB/D2/BA/CC/CW/CT /D1/D3/D7/D8 /CX/D1/D4 /D3/D6/D8/CP/D2 /D8 /CV/D3/CP/D0 /D3/CU/D3/D9/D6 /CY/D3/D9/D6/D2/CP/D0 /CX/D7 /D8/D3 /CU/CP/CR/CX/D0/CX/D8/CP/D8/CT /D8/CW/CT/CR/D3/D2 /DA /CT/D6/D7/CX/D3/D2 /D3/CU /CV/CT/D2/D3/D1/CX/CR /CX/D2/CU/D3/D6/D1/CP/D8/CX/D3/D2/CX/D2 /D8/D3 /CQ/CX/D3/D0/D3/CV/CX/CR/CP/D0 /CZ/D2/D3 /DB/D0/CT/CS/CV/CT/B8 /CP /D4/D6/D3/B9/CR/CT/D7/D7 /D8/CW/CP/D8 /D1/CP/CZ /CT/D7 /D7/CR/CX/CT/D2 /D8/CX/AC/CR /CS/CX/D7/CR/D3 /DA/B9/CT/D6/CX/CT/D7 /D9/D2/CS/CT/D6/D7/D8/D3 /D3 /CS /CP/D2/CS /CP/CR/CR/CT/D4/D8/CT/CS /CQ /DD/D7/CR/CX/CT/D2 /D8/CX/D7/D8/D7 /CP/D7 /DB /CT/D0/D0 /CP/D7 /D8/CW/CT /D4/D9/CQ/D0/CX/CR/BA /CF /CT/CW/D3/D4 /CT /D8/CW/CP/D8 /D3/D9/D6 /CY/D3/D9/D6/D2/CP/D0 /D4/D6/D3 /DA/CX/CS/CT/D7 /CP /DA /CT/CW/CX/CR/D0/CT /D8/CW/CP/D8 /CU/CP/CR/CX/D0/CX/D8/CP/D8/CT/D7 /D8/CW/CX/D7 /D4/D6/D3 /CR/CT/D7/D7/BA/BT /D8 /D8/CW/CT /D1/CT/CP/D2 /D8/CX/D1/CT/B8 /DB /CT /CP/D6/CT /CR/CT/D6/D8/CP/CX/D2/D0/DD/DB/CX/D0/D0/CX/D2/CV /D8/D3 /CZ /CT/CT/D4 /CP/D2 /D3/D4 /CT/D2 /D1/CX/D2/CS /CP/CR/B9/CR/CT/D4/D8/CX/D2/CV /D7/D9/CV/CV/CT/D7/D8/CX/D3/D2/D7 /CU/D3/D6 /D1/CP/CZ/CX/D2/CV /D3/D9/D6/C2/D3/D9/D6/D2/CP/D0 /D3/CU /BZ/C8/BU /CP /D9/D2/CX/D5/D9/CT /CP/D2/CS /D7/D9/CR/B9/CR/CT/D7/D7/CU/D9/D0 /D3/D2/CT /D8/CW/CP/D8 /CX/D7 /D4/D9/CQ/D0/CX/D7/CW/CT/CS /CX/D2/BV/CW/CX/D2/CP /DD /CT/D8 /D6/CT/CP/CS /CP/D2/CS /CR/D3/D2 /D8/D6/CX/CQ/D9/D8/CT/CS /CQ /DD/D7/CR/CX/CT/D2 /D8/CX/D7/D8/D7 /CP/D6/D3/D9/D2/CS /D8/CW/CT /DB /D3/D6/D0/CS/BA/BT/D7 /D1 /D9/CR /CW /CP/D7 /DB /CT /CT/D2/CY/D3 /DD /D8/CW/CT /C7/D4 /CT/D2/B9/CX/D2/CV /CB/D3/D2/CV /D3/CU /D8/CW/CT /CU/CP/D1/D3/D9/D7 /BV/CW/CX/D2/CT/D7/CT/D2/D3 /DA /CT/D0/B8 /CA /D3/D1/CP/D2/CR /CT /D3/CU /CC/CW/D6 /CT /CT /C3/CX/D2/CV/B9/CS/D3/D1/D7/B8 /DB /CT /CP/D6/CT /CP/D0/D7/D3 /CU/D3/D2/CS /D3/CU /D8/CW/CT/CT/D5/D9/CP/D0/D0/DD /CU/CP/D1/D3/D9/D7 /C7/D4 /CT/D2/CX/D2/CV /CB/CT/D2 /D8/CT/D2/CR/CT/BM/CK/BW/D3/D1/CP/CX/D2/D7 /D9/D2/CS/CT/D6 /CW/CT /CP/DA/CT/D2/B8 /CP/CU/B9/D8/CT/D6 /CP /D0/D3/D2/CV /D4 /CT/D6/CX/D3 /CS /D3/CU /CS/CX/DA/CX/D7/CX/D3/D2/B8/D8/CT/D2/CS/D7 /D8/D3 /D9/D2/CX/D8/CT/BN /CP/CU/D8/CT/D6 /CP /D0/D3/D2/CV /D4 /CT/B9/D6/CX/D3 /CS /D3/CU /D9/D2/CX/D3/D2/B8 /D8/CT/D2/CS/D7 /D8/D3 /CS/CX/DA/CX/CS/CT/BA/CC/CW/CX/D7 /CW/CP/D7 /CQ /CT /CT/D2 /D7/D3 /D7/CX/D2/CR /CT /CP/D2/D8/CX/D5/D9/CX/D8/DD/BAꜼ/B4/CW /D8/D8/D4/BM/BB/BB/DB/DB/DB/BA/D8/CW/D6/CT/CT/CZ/CX/D2/CV/CS/D3/D1/D7/BA/CR/D3/D1/BB/CR /CW/CP/D4/D8/CT/D6/BA/D4/CW/D4/BR/CR/BP/BD/B5/C1/CU /CT/CP/CR /CW /CK/B9/D3/D1/CX/CR/D7Ꜽ/B8 /D7/D9/CR /CW /CP/D7 /CV/CT/B9/D2/D3/D1/CX/CR/D7 /CP/D2/CS /D4/D6/D3/D8/CT/D3/D1/CX/CR/D7/B8 /CX/D7 /D8/D3 /CS/CX/B9/DA/CX/CS/CT /CS/CX/D7/CR/CX/D4/D0/CX/D2/CT/D7 /D3/CU /CQ/CX/D3/D0/D3/CV/CX/CR/CP/D0 /D7/CR/CX/B9/CT/D2/CR/CT/D7 /CX/D2 /D8/D3 /CT/DA /CT/D6/B9/CX/D2/CR/D6/CT/CP/D7/CX/D2/CV /D2 /D9/D1 /CQ/CT /D6/D3/CU /CK/CZ/CX/D2/CV/CS/D3/D1/D7Ꜽ/B8 /D3/D6 /CT/DA /CT/D6/B9/CS/CT/CR/D6/CT/CP/D7/CX/D2/CV/CP/D1/D3/D9/D2 /D8 /D3/CU /D8/CT/D6/D6/CX/D8/D3/D6/CX/CT/D7/B8 /CU/D3/D6 /CT/CP/CR /CW/CK/CZ/CX/D2/CV/CS/D3/D1/D7Ꜽ/B8 /D8/CW/CT/D6/CT /D1 /D9/D7/D8 /CQ/CT /CT/D0/B9/CT/D1/CT/D2 /D8/D7 /CT/DC/CX/D7/D8/CX/D2/CV /CU/D3/D6 /D9/D2/CX/AC/CR/CP/D8/CX/D3/D2/CP/D2/CS /CP /D8/CX/D1/CT /D8/D3 /D9/D2/CX/D8/CT /D8/CW/CT/D1/BA /C1/CU/CP /CS/CT/CR/CP/CS/CT /CX/D7 /D0/D3/D2/CV /CT/D2/D3/D9/CV/CW /CU/D3/D6/CP/D2 /DD /CU/CP/D7/D8/B9/CT/DA /D3/D0/DA/CX/D2/CV /AC/CT/D0/CS/D7 /D3/CU /CQ/CX/B9/D3/D0/D3/CV/DD /D8/D3 /CR /CW/CP/D2/CV/CT /D8/CW/CT/CX/D6 /CR/D3/D9/D6/D7/CT/D7/D3/D6 /CP/CS/DA /CP/D2/CR/CX/D2/CV /D7/D4 /CT/CT/CS/D7/B8 /DB /CT /D7/CW/CP/D0/D0/D7/CT/CT /D3/D9/D6 /D8/CW/D6/CT/CT /D0/CX/D8/D8/D0/CT /CK/C3/CX/D2/CV/CS/D3/D1/D7Ꜽ/D3/CU /BU/CX/D3/D0/D3/CV/CX/CR/CP/D0 /CB/CR/CX/CT/D2/CR/CT/D7/DG/BZ/CT/D2/D3/D1/CX/CR/D7/B8/C8/D6/D3/D8/CT/D3/D1/CX/CR/D7 /CP/D2/CS /BU/CX/D3/CX/D2/CU/D3/D6/D1/CP/D8/CX/CR/D7/DG/CQ/CT /CR /D3 /D1 /CT /D7 /D9/D2/CX/D8/CT/CS /CX/D2 /D1 /D9/CR /CW /D0/CT/D7/D7 /D3/CU/D8/CW/CT/CX/D6 /CT/D7/D8/CX/D1/CP/D8/CT/CS /CS/D9/CT /D8/CX/D1/CT /CP/D2/CS /CX/D2/D7/D9/CR /CW /CP /DB /CP /DD /DB/CW/CT/D6/CT /D8/CW/CT /BX/D7/D7/CT/D2 /D8/CX/CP/D0/CA/D9/D0/CT/D7 /D3/CU /C4/CX/CU/CT /CP/D6/CT /D0/CT/CP/D6/D2 /D8 /D1/D3/D6/CT /CQ /DD/D7/DD/D7/D8/CT/D1/CP/D8/CX/CR /D1/CT/CP/D2/D7 /CP/D2/CS /D0/CT/D7/D7 /CQ /DD /D8/CW/CT/D3/D0/CS /CU/CP/D7/CW/CX/D3/D2/CT/CS /CS/CX/DA/CX/CS/CT/B9/CP/D2/CS/B9/CR/D3/D2/CR/D9/D6/D7/D8/D6/CP/D8/CT/CV/DD /BA /CF /CT /CW/CP /DA /CT /D8/CW/D6/CT/CT /CK/CZ/CX/D2/CV/B9/CS/D3/D1/D7Ꜽ /D8/D3 /CK/D6/D3/D1/CP/D2/CR/CTꜼ /AC/D6/D7/D8 /CQ/D9/D8 /CW/CP /DA /CT/CP /D0/D3/D8 /D8/D3 /D9/D2/CX/D8/CT /CX/D2 /D8/CW/CT /CU/D9/D8/D9/D6/CT/BA /C7/D9/D6/CT/CS/CX/D8/D3/D6/D7/B8 /CR/D3/D2 /D8/D6/CX/CQ/D9/D8/D3/D6/D7/B8 /D6/CT/CP/CS/CT/D6/D7/B8 /CP/D2/CS/CU/D6/CX/CT/D2/CS/D7 /D7/CW/CP/D0/D0 /CU/D3/D6/D1 /CP /D9/D2/CX/D8/CT/CS /CU/D6/D3/D2 /D8 /D8/D3/CU/D9/D0/AC/D0/D0 /D8/CW/CX/D7 /D8/CP/D7/CZ/BA/BZ/CT/D2/D3/BA/B8 /C8/D6/D3/D8/BA /B2 /BU/CX/D3/CX/D2/CU/D3/BA /CE /D3/D0/BA /BD /C6/D3/BA /BD /BY /CT/CQ/D6/D9/CP/D6/DD /BE/BC/BC/BF /BDThis is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1c/57/main.PMC5172411.pdf
/C1/D2 /DA/CX/D8/CT/CS /BT/D6/D8/CX/CR/D0/CT/CC/CW/CT /BX /C8/D6/D3/D8/CT/CX/D2 /C1/D7 /CP /C5/D9/D0/D8/CX/CU/D9/D2/CR/D8/CX/D3/D2/CP/D0 /C5/CT/D1 /CQ/D6/CP/D2/CT /C8/D6/D3/D8/CT/CX/D2 /D3/CU /CB/BT/CA/CB/B9/BV/D3/CE/C9/CX/D2/CV/CU/CP /CF /D9 /BD/BN/BE/B6/B8 /CH/CX/D0/CX/D2 /CI/CW/CP/D2/CV /BD/B6/B8 /C0/D3/D2/CV /C4/DJ /D9 /BD/B6/B8 /C2/CX/D2/CV /CF /CP/D2/CV /BF/BN/BD/B6/B8 /CG/CX/D1/CX/CP/D3 /C0/CT /BD/B8 /CH /D3/D2/CV /C4/CX/D9 /BG/B8 /BV/CW/CT/D2 /CH /CT /BD/B8 /CF /CT/CX /C4/CX/D2 /BD/B8 /C2/CX/CP/D2/CU/CT/CX/C0/D9 /BD/BN/BF/B8 /C2/CX/CP /C2/CX /BD/B8 /C2/CX/D2/CV /CG/D9 /BD/B8 /C2/CX/CP /CH /CT /BD/BN/BE/B8 /CH /D3/D2/CV/DB/D9 /C0/D9 /BD/B8 /CF /CT/D2/CY/D9/D2 /BV/CW/CT/D2 /BD/B8 /CB/D3/D2/CV/CV/CP/D2/CV /C4/CX /BD/BN/BF/B8 /C2/D9/D2 /CF /CP/D2/CV /BD/B8 /C2/CX/CP/D2 /CF /CP/D2/CV /BD/BN/BE/B8/CB/CW/CT/D2/CV/D0/CX /BU/CX /BH/B8 /CP/D2/CS /C0/D9/CP/D2/D1/CX/D2/CV /CH /CP/D2/CV /BD/BN/BE/AZ/BD/BU/CT/CX/CY/CX/D2/CV /BZ/CT/D2/D3/D1/CX/CR/D7 /C1/D2/D7/D8/CX/D8/D9/D8/CT/B8 /BV/CW/CX/D2/CT/D7/CT /BT /CR /CP/CS/CT/D1/DD /D3/CU /CB/CR/CX/CT/D2/CR /CT/D7/B8 /BU/CT/CX/CY/CX/D2/CV /BD/BC/BD/BF/BC/BC/B8 /BV/CW/CX/D2/CP/BN /BE/C2/CP/D1/CT/D7 /BW/BA /CF/CP/D8/D7/D3/D2/C1/D2/D7/D8/CX/D8/D9/D8/CT /D3/CU /BZ/CT/D2/D3/D1/CT /CB/CR/CX/CT/D2/CR /CT/D7/B8 /CI/CW/CX/CY/CX/CP/D2/CV /BV/CP/D1/D4/D9/D7/B8 /CI/CW/CT/CY/CX/CP/D2/CV /CD/D2/CX/DA/CT/D6/D7/CX/D8/DD/B8 /C0/CP/D2/CV/DE/CW/D3/D9 /BF/BD/BC/BC/BC/BK/B8 /BV/CW/CX/D2/CP/BN /BF/BV/D3/D0 /D0/CT /CV/CT /D3/CU/C4/CX/CU/CT /CB/CR/CX/CT/D2/CR /CT/D7/B8 /C8/CT/CZ/CX/D2/CV /CD/D2/CX/DA/CT/D6/D7/CX/D8/DD/B8 /BU/CT/CX/CY/CX/D2/CV /BD/BC/BC/BK/BJ/BD/B8 /BV/CW/CX/D2/CP/BN /BG/C8/CT/CZ/CX/D2/CV /CD/D2/CX/D3/D2 /C5/CT /CS/CX/CR /CP/D0 /BV/D3/D0 /D0/CT /CV/CT /C0/D3/D7/D4/CX/D8/CP/D0/B8 /BV/CW/CX/D2/CT/D7/CT/BT /CR /CP/CS/CT/D1/DD /D3/CU /C5/CT /CS/CX/CR /CP/D0 /CB/CR/CX/CT/D2/CR /CT/D7/B8 /BU/CT/CX/CY/CX/D2/CV /BD/BC/BC/BJ/BF/BC/B8 /BV/CW/CX/D2/CP/BN /BH/BV/CT/D2/D8/CT/D6 /D3/CU /BW/CX/D7/CT /CP/D7/CT /BV/D3/D2/D8/D6 /D3/D0 /CP/D2/CS /C8/D6 /CT/DA/CT/D2/D8/CX/D3/D2/B8 /BU/CT/CX/CY/CX/D2/CV/BD/BC/BC/BC/BH/BC/B8 /BV/CW/CX/D2/CP/BA/CC/CW/CT /BX /B4/CT/D2 /DA /CT/D0/D3/D4 /CT/B5 /D4/D6/D3/D8/CT/CX/D2 /CX/D7 /D8/CW/CT /D7/D1/CP/D0/D0/CT/D7/D8 /D7/D8/D6/D9/CR/D8/D9/D6/CP/D0 /D4/D6/D3/D8/CT/CX/D2 /CX/D2 /CP/D0/D0 /CR/D3/D6/D3/D2/CP /DA/CX/D6/D9/D7/CT/D7 /CP/D2/CS/CX/D7 /D8/CW/CT /D3/D2/D0/DD /DA/CX/D6/CP/D0 /D7/D8/D6/D9/CR/D8/D9/D6/CP/D0 /D4/D6/D3/D8/CT/CX/D2 /CX/D2 /DB/CW/CX/CR /CW /D2/D3 /DA /CP/D6/CX/CP/D8/CX/D3/D2 /CW/CP/D7 /CQ/CT /CT /D2 /CS/CT/D8/CT/CR/D8/CT/CS/BA /CF /CT/CR/D3/D2/CS/D9/CR/D8/CT/CS /CV/CT/D2/D3/D1/CT /D7/CT/D5/D9/CT/D2/CR/CX/D2/CV /CP/D2/CS /D4/CW /DD/D0/D3/CV/CT/D2/CT/D8/CX/CR /CP/D2/CP/D0/DD/D7/CT/D7 /D3/CU /CB/BT/CA/CB/B9/BV/D3/CE/BA /BU/CP/D7/CT/CS /D3/D2/CV/CT/D2/D3/D1/CT /D7/CT/D5/D9/CT/D2/CR/CX/D2/CV/B8 /DB /CT /D4/D6/CT/CS/CX/CR/D8/CT/CS /D8/CW/CT /BX /D4/D6/D3/D8/CT/CX/D2 /CX/D7 /CP /D8/D6/CP/D2/D7/D1/CT/D1 /CQ/D6/CP/D2/CT /B4/CC/C5/B5 /D4/D6/D3/B9/D8/CT/CX/D2 /CR /CW/CP/D6/CP/CR/D8/CT/D6/CX/DE/CT/CS /CQ /DD /CP /CC/C5 /D6/CT/CV/CX/D3/D2 /DB/CX/D8/CW /D7/D8/D6/D3/D2/CV /CW /DD/CS/D6/D3/D4/CW/D3/CQ/CX/CR/CX/D8 /DD /CP/D2/CS /AB /B9/CW/CT/D0/CX/DC /CR/D3/D2/B9/CU/D3/D6/D1/CP/D8/CX/D3/D2/BA /CF /CT /CX/CS/CT/D2 /D8/CX/AC/CT/CS /CP /D7/CT/CV/D1/CT/D2 /D8 /B4/C6/C0/BE /B9 /C4/B9/BV/DD/D7/B9/BT/B9/CH/B9/BV/DD/D7/B9/BV/DD/D7/B9/C6 /B9/BV/C7/C7/C0/B5 /CX/D2 /D8/CW/CT/CR/CP/D6/CQ /D3 /DC/DD/D0/B9/D8/CT/D6/D1/CX/D2/CP/D0 /D6/CT/CV/CX/D3/D2 /D3/CU /D8/CW/CT /BX /D4/D6/D3/D8/CT/CX/D2 /D8/CW/CP/D8 /CP/D4/D4 /CT/CP/D6/D7 /D8/D3 /CU/D3/D6/D1 /D8/CW/D6/CT/CT /CS/CX/D7/D9/D0/AC/CS/CT /CQ/D3 /D2 /CS /D7/DB/CX/D8/CW /CP/D2/D3/D8/CW/CT/D6 /D7/CT/CV/D1/CT/D2 /D8 /D3/CU /CR/D3/D6/D6/CT/D7/D4 /D3/D2/CS/CX/D2/CV /CR/DD/D7/D8/CT/CX/D2/CT/D7 /CX/D2 /D8/CW/CT /CR/CP/D6/CQ /D3 /DC/DD/D0/B9/D8/CT/D6/D1/CX/D2 /D9/D7 /D3/CU /D8/CW/CT /CB/B4/D7/D4/CX/CZ /CT/B5 /D4/D6/D3/D8/CT/CX/D2/BA /CC/CW/CT/D7/CT /CQ/D3 /D2 /CS /D7 /D4/D3 /CX /D2 /D8 /D8/D3 /CP /D4 /D3/D7/D7/CX/CQ/D0/CT /D7/D8/D6/D9/CR/D8/D9/D6/CP/D0 /CP/D7/D7/D3 /CR/CX/CP/D8/CX/D3/D2 /CQ/CT /D8 /DB /CT/CT/D2 /D8/CW/CT/BX /CP/D2/CS /CB /D4/D6/D3/D8/CT/CX/D2/D7/BA /C7/D9/D6 /D4/CW /DD/D0/D3/CV/CT/D2/CT/D8/CX/CR /CP/D2/CP/D0/DD/D7/CT/D7 /D3/CU /D8/CW/CT /BX /D4/D6/D3/D8/CT/CX/D2 /D7/CT/D5/D9/CT/D2/CR/CT/D7 /CX/D2 /CP/D0/D0 /D4/D9/CQ/B9/D0/CX/D7/CW/CT/CS /CR/D3/D6/D3/D2/CP /DA/CX/D6/D9/D7/CT/D7 /D4/D0/CP/CR/CT /CB/BT/CA/CB/B9/BV/D3/CE /CX/D2 /CP/D2 /CX/D2/CS/CT/D4 /CT/D2/CS/CT/D2 /D8 /CV/D6/D3/D9/D4 /CX/D2 /BV/D3/D6 /D3/D2/CP/DA/CX/D6/CX/CS/CP/CT/CP/D2/CS /D7/D9/CV/CV/CT/D7/D8 /CP /D2/D3/D2/B9/CW /D9/D1/CP/D2 /CP/D2/CX/D1/CP/D0 /D3/D6/CX/CV/CX/D2/BA/C3/CT/DD /DB /D3/D6/CS/D7/BM /CB/BT/CA/CB/B8 /CB/BT/CA/CB/B9/BV/D3/CE/B8 /D8/CW/CT /BX /D4/D6/D3/D8/CT/CX/D2/B8 /CT/D2 /DA /CT/D0/D3/D4 /CT/B8 /CC/C5 /D6/CT/CV/CX/D3/D2/C1/D2 /D8/D6/D3 /CS/D9/CR/D8/CX/D3/D2/CC/CW/CT /CR/D3/D6/D3/D2/CP /DA/CX/D6/D9/D7/CT/D7 /CP/D6/CT /CP /CV/D6/D3/D9/D4 /D3/CU /CT/D2 /DA /CT/D0/D3/D4 /CT/CS /DA/CX/D6/D9/D7/CT/D7/CX/D6/D9/D7/CT/D7/BA /CC/CW/CT /D4/D9/D8/CP/D8/CX/DA /CT /D1/CT/D1 /CQ/D6/CP/D2/D3/D9/D7 /CT/D2 /DA /CT/D0/D3/D4 /CT/D7 /CW/CP /DA /CT /CP/D1/D3/D7/CP/CX/CR /D7/D8/D6/D9/CR/D8/D9/D6/CT/BA /CC/CW/CX/D7 /D7/D8/D6/D9/CR/D8/D9/D6/CT /CX/D7 /CR/D3/D1/D4 /D3/D7/CT/CS /D3/CU /CP/D0/CX/D4/CX/CS /CQ/CX/D0/CP /DD /CT/D6 /D1/CT/D1 /CQ/D6/CP/D2/CT /D8/CW/CP/D8 /CX/D7 /CS/CT/D6/CX/DA /CT/CS /CU/D6/D3/D1 /D8/CW/CT /CT/D2/B9/CS/D3/D4/D0/CP/D7/D1/CX/CR /D6/CT/D8/CX/CR/D9/D0/D9/D1 /B4/BX/CA/B5 /CP/D2/CS /BZ/D3/D0/CV/CX /CR/D3/D1/D4/D0/CT/DC /D3/CU /D8/CW/CT/CW/D3/D7/D8 /CR/CT/D0/D0 /CP/D2/CS /DA/CX/D6/CP/D0 /CV/CT/D2/CT/B9/CT/D2/CR/D3 /CS/CT/CS /D4/D6/D3/D8/CT/CX/D2/D7 /B4/BD /B5/BA/BT/D7 /CP /D7/D1/CP/D0/D0 /D7/D8/D6/D9/CR/D8/D9/D6/CP/D0 /D4/D6/D3/D8/CT/CX/D2/B8 /D8/CW/CT /BX /B4/CT/D2 /DA /CT/D0/D3/D4 /CT/B5/D4/D6/D3/D8/CT/CX/D2 /CX/D7 /D7/D3/B9/D2/CP/D1/CT/CS /CQ /CT/CR/CP/D9/D7/CT /CX/D8 /CW/CP/D7 /CV/CT/D2/CT/D6/CP/D0/D0/DD /CQ/CT /CT /D2 /D6/CT/B9/CV/CP/D6/CS/CT/CS /CP/D7 /D8/CW/CT /D1/CP/CX/D2 /CR/D3/D1/D4 /D3/D2/CT/D2 /D8 /D3/CU /D8/CW/CT /DA/CX/D6/CP/D0 /CT/D2 /DA /CT/D0/D3/D4 /CT/D7/CX/D2/CR/CT /CX/D8/D7 /AC/D6/D7/D8 /CX/CS/CT/D2 /D8/CX/AC/CR/CP/D8/CX/D3/D2 /CX/D2 /CA/C6/BT /DA/CX/D6/D9/D7/CT/D7/BA /C1/D2 /CP/CS/CS/CX/B9/D8/CX/D3/D2 /D8/D3 /D8/CW/CT /D4/CX/DA /D3/D8/CP/D0 /D6/D3/D0/CT /D8/CW/CP/D8 /CX/D8 /D4/D9/D6/D4 /D3/D6/D8/CT/CS/D0/DD /D4/D0/CP /DD/D7 /CX/D2 /D8/CW/CT/CP/D7/D7/CT/D1 /CQ/D0/DD /D3/CU /D8/CW/CT /DA/CX/D6/CP/D0 /CT/D2 /DA /CT/D0/D3/D4 /CT /CP/D2/CS/BB/D3/D6 /D8/CW/CT /CW/D3/D7/D8/B9/CS/CT/D6/CX/DA /CT/CS/D1/CT/D1 /CQ/D6/CP/D2/CT/B8 /D8/CW/CT/D6/CT /CX/D7 /CP/CR/CR/D9/D1 /D9/D0/CP/D8/CX/D2/CV /CT/DA/CX/CS/CT/D2/CR/CT /CU/D6/D3/D1 /D6/CT/B9/D7/CT/CP/D6/CR /CW /D3/D2 /CZ/D2/D3 /DB/D2 /CR/D3/D6/D3/D2/CP /DA/CX/D6/D9/D7/CT/D7 /D8/CW/CP/D8 /D8/CW/CT /CT/DC/D4/D6/CT/D7/D7/CX/D3/D2 /D3/CU/D8/CW/CT /BX /D4/D6/D3/D8/CT/CX/D2 /CP/D0/D7/D3 /D6/CT/D7/D9/D0/D8/D7 /CX/D2 /D8/CW/CT /D4/D6/D3 /CS/D9/CR/D8/CX/D3/D2 /CP/D2/CS /D6/CT/D0/CT/CP/D7/CT/D3/CU /D1/CT/D1 /CQ/D6/CP/D2/CT /DA /CT/D7/CX/CR/D0/CT/D7 /D3/D6 /DA/CX/D6/D9/D7/B9/D0/CX/CZ /CT /D4/CP/D6/D8/CX/CR/D0/CT/D7 /B4/CE/C4/C8/D7/B5/B4/BE /BN /BF /BN /BG /B5/B8 /CX/D2/CS/D9/CR/D8/CX/D3/D2 /D3/CU /CP/D4 /D3/D4/D8/D3/D7/CX/D7 /B4/BF /B5/B8 /CP/D2/CS /D7/DD/D2 /D8/CW/CT/D7/CX/D7 /D3/CU/B6 /CC/CW/CT/D7/CT /CP/D9/D8/CW/D3/D6/D7 /CR/D3/D2 /D8/D6/CX/CQ/D9/D8/CT/CS /CT/D5/D9/CP/D0/D0/DD /D8/D3 /D8/CW/CX/D7/DB /D3/D6/CZ/BA/AZ/BV/D3/D6/D6/CT/D7/D4 /D3/D2/CS/CX/D2/CV /CP/D9/D8/CW/D3/D6/BA/BX/B9/D1/CP/CX/D0/BM /DD /CP/D2/CV/CW/D1/BS/CV/CT/D2/D3/D1/CX/CR/D7/BA/D3/D6/CV/BA/CR/D2 /AB /B9/CX/D2 /D8/CT/D6/CU/CT/D6/D3/D2 /B4/BH /B5/BA /C1/D8/D7 /CX/D2 /DA /D3/D0/DA /CT/D1/CT/D2 /D8 /CX/D2 /CA/C6/BT /D6/CT/D4/D0/CX/CR/CP/D8/CX/D3/D2/CW/CP/D7 /CP/D0/D7/D3 /CQ /CT/CT/D2 /D6/CT/D4 /D3/D6/D8/CT/CS /B4/BI /BN /BJ /B5/BA /C1/D2/CS/D9/CR/CT/CS /D1 /D9/D8/CP/D8/CX/D3/D2 /D3/D6/D6/CT/CR/D3/D1 /CQ/CX/D2/CP/D8/CX/D3/D2 /D3/CU /D8/CW/CT /BX /D4/D6/D3/D8/CT/CX/D2 /D1/CP /DD /D6/CT/D7/D9/D0/D8 /CX/D2 /D0/CT/D8/CW/CP/D0 /D3/D6/D8/CT/D1/D4 /CT/D6/CP/D8/D9/D6/CT/B9/D7/CT/D2/D7/CX/D8/CX/DA /CT /D4/CW/CT/D2/D3/D8 /DD/D4 /CT/D7 /CP/D2/CS /CP/CQ /CT/D6/D6/CP/D2 /D8 /D1/D3/D6/B9/D4/CW/D3/D0/D3/CV/DD /B4/BK /B5/BA/C0/CT/D6/CT/CX/D2 /DB /CT /CT/DC/CP/D1/CX/D2/CT /D8/CW/CT /D6/D3/D0/CT /D3/CU /D8/CW/CT /BX /D4/D6/D3/D8/CT/CX/D2 /CP/D7 /CP/D1 /D9/D0/D8/CX/CU/D9/D2/CR/D8/CX/D3/D2/CP/D0 /D1/CT/D1 /CQ/D6/CP/D2/CT /D4/D6/D3/D8/CT/CX/D2 /CX/D2 /CB/BT/CA/CB/B9/BV/D3/CE/BA /CF /CT/CR/D3/D2/CS/D9/CR/D8/CT/CS /CR/D3/D1/D4/CP/D6/CP/D8/CX/DA /CT /CP/D2/CS /D4/CW /DD/D0/D3/CV/CT/D2/CT/D8/CX/CR /CP/D2/CP/D0/DD/D7/CT/D7 /D3/CU/D8/CW/CT /D7/D8/D6/D9/CR/D8/D9/D6/CT /CP/D2/CS /CU/D9/D2/CR/D8/CX/D3/D2 /D3/CU /D8/CW/CT /BX /D4/D6/D3/D8/CT/CX/D2 /CX/D2 /D7/CX/DC/D8/CT/CT/D2/CV/CT/D2/D3/D1/CT /D7/CT/D5/D9/CT/D2/CR/CT/D7 /D3/CU /CB/BT/CA/CB/B9/BV/D3/CE /D4/D9/CQ/D0/CX/D7/CW/CT/CS /CQ /DD /BU/CT/CX/CY/CX/D2/CV/BZ/CT/D2/D3/D1/CX/CR/D7 /C1/D2/D7/D8/CX/D8/D9/D8/CT /B4/BU/BZ/C1/BN /D6/CT/CU/BA /BL /B5 /CP/D2/CS /D3/D8/CW/CT/D6 /D0/CP/CQ /D3/D6/CP/B9/D8/D3/D6/CX/CT/D7 /B4/BD/BC/B9/BD/BE/B5/B8 /CP/D2/CS /CX/D2 /CV/CT/D2/D3/D1/CT /D7/CT/D5/D9/CT/D2/CR/CT/D7 /D3/CU /CP/D0/D0 /D3/D8/CW/CT/D6/D1/CT/D1 /CQ /CT/D6/D7 /D3/CU /BV/D3/D6 /D3/D2/CP/DA/CX/D6/CX/CS/CP/CT /D4/D9/CQ/D0/CX/D7/CW/CT/CS /CX/D2 /BZ/CT/D2 /CQ/CP/D2/CZ/BA/CA/CT/D7/D9/D0/D8/D7/C1/CS/CT/D2 /D8/CX/AC/CR/CP/D8/CX/D3/D2 /D3/CU /D8/CW/CT /D8/D6/CP/D2/D7/D1/CT/D1 /CQ/D6/CP/D2/CT /D6/CT/B9/CV/CX/D3/D2 /CX/D2 /D8/CW/CT /BX /D4/D6/D3/D8/CT/CX/D2/CF /CT /CX/CS/CT/D2 /D8/CX/AC/CT/CS /CP /CR /CW/CP/D6/CP/CR/D8/CT/D6/CX/D7/D8/CX/CR /D8/D6/CP/D2/D7/D1/CT/D1 /CQ/D6/CP/D2/CT /B4/CC/C5/B5/D6/CT/CV/CX/D3/D2 /CP/D8 /D8/CW/CT /D6/CT/D7/CX/CS/D9/CT /D4 /D3/D7/CX/D8/CX/D3/D2 /BD/BH/B9/BF/BJ /B4/BY/CX/CV/D9/D6/CT /BD/B5/BA /CC/CW/CX/D7/CC/C5 /D6/CT/CV/CX/D3/D2 /CX/D7 /CR/D3/D1/D4 /D3/D7/CT/CS /D3/CU /BE/BF /CP/D1/CX/D2/D3 /CP/CR/CX/CS/D7/B8 /D3 /CR/CR/D9/D4 /DD/CX/D2/CV/BF/BC/B1 /D3/CU /D8/CW/CT /D8/D3/D8/CP/D0 /D7/CX/DE/CT /D3/CU /D8/CW/CT /BX /D4/D6/D3/D8/CT/CX/D2/BA /CC/CW/CT /D4/D6/CT/CS/CX/CR/D8/CT/CS/BZ/CT/D2/D3/BA/B8 /C8/D6/D3/D8/BA /B2 /BU/CX/D3/CX/D2/CU/D3/BA /CE /D3/D0/BA /BD /C6/D3/BA /BE /C5/CP /DD /BE/BC/BC/BF /BD/BF/BDThis is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c7/ae/main.PMC5172412.pdf
3 August 2003 193This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,OADS,/arxiv_data1/oa_pdf/3f/ae/main.PMC5172413.pdf
4 November 2003This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/37/8e/main.PMC5172414.pdf
"Biochemical properties, prediction of secondary structure and ORFs of Anopheles CSP candidates The cDNA sequences of the Anopheles Genome Project stored in GenBank and in the Ensembl Mosquito Genome Browser (ftp://ftp.ensembl.org/ pub/current mosquito/) had been annotated jointly by the privately funded Celera and EBI (http:// www.ensembl.org/Anopheles gam biae/).",OADS,/arxiv_data1/oa_pdf/37/8e/main.PMC5172414.pdf
"length (a.a.) length (a.a.) peptide (kDa) a.a. (%) agCP10968 EAA12703 3R AAAB01008964 127 109 none 12.3 9.5 25.7 agCP11079 EAA12353 3R AAAB01008964 143 127 1-17 14.8 5.4 33.1 agCP11481 EAA12591 3R AAAB01008964 137 123 1-19 14.3 9.4 29.3 agCP11484 EAA12322 3R AAAB01008964 149 127 1-17 14.7 8.6 33.1 agCP11532 EAA12601 3R AAAB01008964 150 117 1-33 12.9 9.8 41.0 agCP11545 EAA12338 3R AAAB01008964 141 126 1-17 14.6 8.6 31.0 agCP11435 EAA12702 3R AAAB01008964 102 137 1-16 15.7 5.0 35.0 agCP12965 EAA05664 3L AAAB01008834 173 137 none 14.1 3.5 23.4 agCP6514 EAA10937 2L AAAB01008960 132 117 1-19 13.0 8.6 25.6 T able 4 Secondary Structure of Anopheles CSP Candidates* P eptide ID Predicted secondory structure (%) Globularity Helix Sheet Loop Class agCP10968 25.70 15.50 58.80 mixed appears not to be globular agCP11079 72.40 0.00 27.60 all-alpha may be globular, but it is not as compact as a domain agCP11481 71.50 0.00 28.50 all-alpha may be globular, but it is not as compact as a domain agCP11484 71.70 1.60 26.80 all-alpha appears as compact, as a globular domain agCP11532 72.70 0.00 27.40 all-alpha appears as compact, as a globular domain agCP11545 68.20 2.40 29.40 all-alpha may be globular, but it is not as compact as a domain agCP11435 75.90 0.00 24.10 all-alpha may be globular, but it is not as compact as a domain agCP12965 13.10 16.80 70.10 mixed appears as compact, as a globular domain agCP6514 10.30 0.00 89.70 mixed appears not to be globular * Prediction server|http://www.sbg.bio.ic.ac.uk/3dpssm.",Non-OADS,/arxiv_data1/oa_pdf/37/8e/main.PMC5172414.pdf
"Pattern search, selection of Anopheles CSP candidates in the whole genome se- quences of A. gambiae The Fasta ¯les of gDNA, cDNA and the accord- ing translated peptide sequences of A. gambiae were downloaded from the Ensembl Mosquito Genome Browser (ftp://ftp.ensembl.org/pub/current mosqui to/).",OADS,/arxiv_data1/oa_pdf/37/8e/main.PMC5172414.pdf
BLAST BLAST was performed at NCBI (http://ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/37/8e/main.PMC5172414.pdf
"The E value is a parameter that describes the number of hits one can \expect"" to see just by chance when searching a database of a particular size.Annotations GENSCAN (http://genes.mit.edu/GENSCAN.html; ref.28;29) and ORF Finder (http://www.",OADS,/arxiv_data1/oa_pdf/37/8e/main.PMC5172414.pdf
The positions of signal peptides were determined on- line (http://www.cbs.dtu.dk/services/SignalP2.0/; ref.,OADS,/arxiv_data1/oa_pdf/37/8e/main.PMC5172414.pdf
"30;31), and ¯nally the secondary struc- ture, in particular the globularity, was predicted (http://maple.bioc.columbia.edu/predictprotein/; ref.32{34).",Non-OADS,/arxiv_data1/oa_pdf/37/8e/main.PMC5172414.pdf
"35) is an elucidated insect chemosensory protein, which was used as a model to predict the 3-D structure ofAnopheles CSP candidates in Swiss-Pdb Viewer (http://us.expasy.org/spdbv/; ref.",Non-OADS,/arxiv_data1/oa_pdf/37/8e/main.PMC5172414.pdf
/BT/D6/D8/CX/CR/D0/CT/BZ/CT/D2/CT /C1/CS/CT/D2 /D8/CX/AC/CR/CP/D8/CX/D3/D2 /CP/D2/CS /BX/DC/D4/D6/CT/D7/D7/CX/D3/D2 /BT/D2/CP/D0/DD/D7/CX/D7 /D3/CU /BK/BI/B8/BD/BF/BI /BX/DC/D4/D6/CT/D7/D7/CT/CS/CB/CT/D5/D9/CT/D2/CR/CT /CC /CP/CV/D7 /B4/BX/CB/CC/B5 /CU/D6/D3/D1 /D8/CW/CT /CA/CX/CR/CT /BZ/CT/D2/D3/D1/CT/CH /CP/D2 /CI/CW/D3/D9 /BD/BN /BE/BN /BF/B8 /C2/CX/CP/CQ/CX/D2 /CC /CP/D2/CV /BE/BN /BH/B8 /C5/CX/CR /CW/CP/CT/D0 /BZ/BA /CF /CP/D0/CZ /CT/D6 /BG/B8 /CG/CX/D9/D5/CX/D2/CV /CI/CW/CP/D2/CV /BE/BN /BH/B8 /C2/D9/D2 /CF /CP/D2/CV /BD/BN /BE/BN /BI/B8 /CB/D3/D2/CV/D2/CX/CP/D2 /C0/D9 /BD/BN /BE/B8/C0/D9/CP /DD /D3/D2/CV /CG/D9 /BD/B8 /CH /CP/CY /D9 /D2 /BW/CT/D2/CV /BE/B8 /C2/CX/CP/D2/CW/CP/CX /BW/D3/D2/CV /BD/B8 /C4/CX/D2 /CH /CT /BD/B8 /C4/CX /C4/CX/D2 /BE/B8 /C2/D9/D2 /C4/CX /BD/B8 /CG/D9/CT/CV/CP/D2/CV /CF /CP/D2/CV /BE/B8 /C0/CP/D3 /CG/D9 /BD/B8 /CH/CX/CQ/CX/D2 /C8 /CP/D2 /BD/B8/CF /CT/CX /C4/CX/D2 /BE/B8 /CF /CT/CX /CC/CX/CP/D2 /BD/B8 /C2/CX/D2/CV /C4/CX/D9 /BD/B8 /C4/CX/D4/CX/D2/CV /CF /CT/CX /BD/BN /BK/B8 /CB/CX/D5/CX /C4/CX/D9 /BD/BN /BE/B8 /C0/D9/CP/D2/D1/CX/D2/CV /CH /CP/D2/CV /BD/BN /BE/BN /BH/B8 /C2/D9/D2 /CH /D9 /BD/BN /BE/BN /BL/B8 /CP/D2/CS /C2/CX/CP/D2/CF /CP/D2/CV /BD/BN /BE/B6/BD/C0/CP/D2/CV/DE/CW/D3/D9 /BZ/CT/D2/D3/D1/CX/CR/D7 /C1/D2/D7/D8/CX/D8/D9/D8/CT/BB/C1/D2/D7/D8/CX/D8/D9/D8/CT /D3/CU /BU/CX/D3/CX/D2/CU/D3/D6/D1/CP/D8/CX/CR/D7 /D3/CU /CI/CW/CT/CY/CX/CP/D2/CV /CD/D2/CX/DA/CT/D6/D7/CX/D8/DD/BB/C3/CT/DD /C4 /CP/CQ /D3/D6 /CP/D8/D3/D6/DD /D3/CU /BU/CX/D3/CX/D2/CU/D3/D6/B9/D1/CP/D8/CX/CR/D7 /D3/CU /CI/CW/CT/CY/CX/CP/D2/CV /C8/D6 /D3/DA/CX/D2/CR /CT/B8 /C0/CP/D2/CV/DE/CW/D3/D9 /BF/BD/BC/BC/BC/BJ/B8 /BV/CW/CX/D2/CP/BN /BE/BU/CT/CX/CY/CX/D2/CV /BZ/CT/D2/D3/D1/CX/CR/D7 /C1/D2/D7/D8/CX/D8/D9/D8/CT/BB/BV/CT/D2/D8/CT/D6 /D3/CU /BZ/CT/D2/D3/D1/CX/CR/D7 /B2/BU/CX/D3/CX/D2/CU/D3/D6/D1/CP/D8/CX/CR/D7/B8 /BV/CW/CX/D2/CT/D7/CT /BT /CR /CP/CS/CT/D1/DD /D3/CU /CB/CR/CX/CT/D2/CR /CT/D7/B8 /BU/CT/CX/CY/CX/D2/CV /BD/BC/BD/BF/BC/BC/B8 /BV/CW/CX/D2/CP/BN /BF/BY /D9/CS/CP/D2 /CD/D2/CX/DA/CT/D6/D7/CX/D8/DD/B8 /CB/CW/CP/D2/CV/CW/CP/CX /BE/BC/BC/BG/BF/BF/B8/BV/CW/CX/D2/CP/BN /BG/CB/D8/CP/D2/CU/D3/D6 /CS /CD/D2/CX/DA/CT/D6/D7/CX/D8/DD/B8 /CB/D8/CP/D2/CU/D3/D6 /CS/B8 /BV/BT /BL/BG/BF/BC/BH/B8 /CD/CB/BT/BN /BH/C1/D2/D7/D8/CX/D8/D9/D8/CT /D3/CU /BZ/CT/D2/CT/D8/CX/CR/D7/B8 /BV/CW/CX/D2/CT/D7/CT /BT /CR /CP/CS/CT/D1/DD /D3/CU /CB/CR/CX/CT/D2/CR /CT/D7/B8/BU/CT/CX/CY/CX/D2/CV /BD/BC/BC/BD/BC/BD/B8 /BV/CW/CX/D2/CP/BN /BI/BV/D3/D0 /D0/CT /CV/CT /D3/CU /C4/CX/CU/CT /CB/CR/CX/CT/D2/CR /CT/D7/B8 /C8/CT/CZ/CX/D2/CV /CD/D2/CX/DA/CT/D6/D7/CX/D8/DD/B8 /BU/CT/CX/CY/CX/D2/CV /BD/BC/BC/BK/BJ/BD/B8 /BV/CW/CX/D2/CP/BN /BJ/C1/D2/D7/D8/CX/D8/D9/D8/CT /D3/CU/CC/CW/CT /D3/D6 /CT/D8/CX/CR /CP/D0 /C8/CW/DD/D7/CX/CR/D7/B8 /BV/CW/CX/D2/CT/D7/CT /BT /CR /CP/CS/CT/D1/DD /D3/CU /CB/CR/CX/CT/D2/CR /CT/D7/B8 /BU/CT/CX/CY/CX/D2/CV /BD/BC/BC/BC/BK/BC/B8 /BV/CW/CX/D2/CP/BN /BK/C6/CT/DC/D9/D7 /BZ/CT/D2/D3/D1/CX/CR/D7/B8 /C5/CT/D2/D0/D3 /C8/CP/D6/CZ/B8/BV/BT /BL/BG/BC/BE/BH/B8 /CD/CB/BT/BN /BL/CD/D2/CX/DA/CT/D6/D7/CX/D8/DD /D3/CU /CF/CP/D7/CW/CX/D2/CV/D8/D3/D2 /BZ/CT/D2/D3/D1/CT /BV/CT/D2/D8/CT/D6/B8 /CB/CT /CP/D8/D8/D0/CT/B8 /CF /BT /BL/BK/BD/BL/BH/B8 /CD/CB/BT/BA/BX/DC/D4/D6/CT/D7/D7/CT/CS /CB/CT/D5/D9/CT/D2/CR/CT /CC /CP/CV /B4/BX/CB/CC/B5 /CP/D2/CP/D0/DD/D7/CX/D7 /CW/CP/D7 /D4/CX/D3/D2/CT/CT/D6/CT/CS /CV/CT/D2/D3/D1/CT/B9/DB/CX/CS/CT /CV/CT/D2/CT /CS/CX/D7/CR/D3 /DA/B9/CT/D6/DD /CP/D2/CS /CT/DC/D4/D6/CT/D7/D7/CX/D3/D2 /D4/D6/D3/AC/D0/CX/D2/CV/BA /C1/D2 /D3/D6/CS/CT/D6 /D8/D3 /CT/D7/D8/CP/CQ/D0/CX/D7/CW /CP /CV/CT/D2/CT /CT/DC/D4/D6/CT/D7/D7/CX/D3/D2 /CX/D2/CS/CT/DC /CX/D2 /D8/CW/CT/D6/CX/CR/CT /CR/D9/D0/D8/CX/DA /CP/D6 /CX/D2/CS/CX/CR /CP/B8 /DB /CT /D7/CT/D5/D9/CT/D2/CR/CT/CS /CP/D2/CS /CP/D2/CP/D0/DD/DE/CT/CS /BK/BI/B8/BD/BF/BI /BX/CB/CC/D7 /CU/D6/D3/D1 /D2/CX/D2/CT /D6/CX/CR/CT /CR/BW/C6/BT/D0/CX/CQ/D6/CP/D6/CX/CT/D7 /CU/D6/D3/D1 /D8/CW/CT /D7/D9/D4 /CT/D6 /CW /DD/CQ/D6/CX/CS /CR/D9/D0/D8/CX/DA /CP/D6 /C4 /CH/C8/BL /CP/D2/CS /CX/D8/D7 /D4/CP/D6/CT/D2 /D8/CP/D0 /CR/D9/D0/D8/CX/DA /CP/D6/D7/BA /CF /CT /CP/D7/B9/D7/CT/D1 /CQ/D0/CT/CS /D8/CW/CT/D7/CT /BX/CB/CC/D7 /CX/D2 /D8/D3 /BD/BF/B8/BE/BF/BE /CR/D3/D2 /D8/CX/CV/D7 /CP/D2/CS /D0/CT/CP /DA /CT /BK/B8/BL/BJ/BI /D7/CX/D2/CV/D0/CT/D8/D3/D2/D7/BA /C7/DA /CT/D6/CP/D0/D0/B8 /BJ/B8/BG/BL/BJ/D7/CT/D5/D9/CT/D2/CR/CT/D7 /DB /CT/D6/CT /CU/D3/D9/D2/CS /D7/CX/D1/CX/D0/CP/D6 /D8/D3 /D8/CW/CT /CT/DC/CX/D7/D8/CX/D2/CV /D7/CT/D5/D9/CT/D2/CR/CT/D7 /CX/D2 /BZ/CT/D2/BU/CP/D2/CZ /CP/D2/CS /BD/BG/B8/BJ/BD/BD /CP/D6/CT/D2/D3 /DA /CT/D0/BA /CC/CW/CT/D7/CT /D7/CT/D5/D9/CT/D2/CR/CT/D7 /CP/D6/CT /CR/D0/CP/D7/D7/CX/AC/CT/CS /CQ /DD /D1/D3/D0/CT/CR/D9/D0/CP/D6 /CU/D9/D2/CR/D8/CX/D3/D2/B8 /CQ/CX/D3/D0/D3/CV/CX/CR/CP/D0 /D4/D6/D3 /CR/CT/D7/D7 /CP/D2/CS/D4/CP/D8/CW /DB /CP /DD/D7 /CP/CR/CR/D3/D6/CS/CX/D2/CV /D8/D3 /D8/CW/CT /BZ/CT/D2/CT /C7/D2 /D8/D3/D0/D3/CV/DD /BA /CF /CT /CR/D3/D1/D4/CP/D6/CT/CS /D3/D9/D6 /D7/CT/D5/D9/CT/D2/CR/CT/CS /BX/CB/CC/D7 /DB/CX/D8/CW/D8/CW/CT /D4/D9/CQ/D0/CX/CR/D0/DD /CP /DA /CP/CX/D0/CP/CQ/D0/CT /BL/BH/B8/BC/BC/BC /BX/CB/CC/D7 /CU/D6/D3/D1 /CY/CP/D4 /D3/D2/CX/CR /CP/B8 /CP/D2/CS /CU/D3/D9/D2/CS /D0/CX/D8/D8/D0/CT /D7/CT/D5/D9/CT/D2/CR/CT /DA /CP/D6/CX/CP/B9/D8/CX/D3/D2/B8 /CS/CT/D7/D4/CX/D8/CT /D8/CW/CT /D0/CP/D6/CV/CT /CS/CX/AB/CT/D6/CT/D2/CR/CT /CQ/CT /D8 /DB /CT/CT/D2 /CV/CT/D2/D3/D1/CT /D7/CT/D5/D9/CT/D2/CR/CT/D7/BA /CF /CT /D8/CW/CT/D2 /CP/D7/D7/CT/D1 /CQ/D0/CT/CS/D8/CW/CT /CR/D3/D1 /CQ/CX/D2/CT/CS /BD/BJ/BF/B8/BC/BC/BC /D6/CX/CR/CT /BX/CB/CC/D7 /CU/D3/D6 /CU/D9/D6/D8/CW/CT/D6 /CP/D2/CP/D0/DD/D7/CX/D7/BA /CD/D7/CX/D2/CV /D8/CW/CT /D4 /D3 /D3/D0/CT/CS /BX/CB/CC/D7/B8 /DB /CT/CR/D3/D1/D4/CP/D6/CT/CS /CV/CT/D2/CT /CT/DC/D4/D6/CT/D7/D7/CX/D3/D2 /CX/D2 /D1/CT/D8/CP/CQ /D3/D0/CX/D7/D1 /D4/CP/D8/CW /DB /CP /DD /CQ/CT /D8 /DB /CT/CT/D2 /D6/CX/CR/CT /CP/D2/CS /BT /D6 /CP/CQ/CX/CS/D3/D4/D7/CX/D7/CP/CR/CR/D3/D6/CS/CX/D2/CV /D8/D3 /C3/BX/BZ/BZ/BA /CF /CT /CU/D9/D6/D8/CW/CT/D6 /D4/D6/D3/AC/D0/CT/CS /CV/CT/D2/CT /CT/DC/D4/D6/CT/D7/D7/CX/D3/D2 /D4/CP/D8/D8/CT/D6/D2/D7 /CX/D2 /CS/CX/AB/CT/D6/CT/D2 /D8 /D8/CX/D7/B9/D7/D9/CT/D7/B8 /CS/CT/DA /CT/D0/D3/D4/D1/CT/D2 /D8/CP/D0 /D7/D8/CP/CV/CT/D7/B8 /CP/D2/CS /CX/D2 /CP /CR/D3/D2/CS/CX/D8/CX/D3/D2/CP/D0 /D7/D8/CT/D6/CX/D0/CT /D1 /D9/D8/CP/D2 /D8/B8 /CP/CU/D8/CT/D6 /CR /CW/CT/CR /CZ/CX/D2/CV /D8/CW/CT/D0/CX/CQ/D6/CP/D6/CX/CT/D7 /CP/D6/CT /CR/D3/D1/D4/CP/D6/CP/CQ/D0/CT /CQ /DD /D1/CT/CP/D2/D7 /D3/CU /D7/CT/D5/D9/CT/D2/CR/CT /CR/D3 /DA /CT/D6/CP/CV/CT/BA /CF /CT /CP/D0/D7/D3 /CX/CS/CT/D2 /D8/CX/AC/CT/CS /D7/D3/D1/CT/D4 /D3/D7/D7/CX/CQ/D0/CT /D0/CX/CQ/D6/CP/D6/DD /D7/D4 /CT/CR/CX/AC/CR /CV/CT/D2/CT/D7 /CP/D2/CS /CP /D2 /D9/D1 /CQ/CT /D6 /D3/CU /CT/D2/DE/DD/D1/CT/D7 /CP/D2/CS /D8/D6/CP/D2/D7/CR/D6/CX/D4/D8/CX/D3/D2 /CU/CP/CR/D8/D3/D6/D7/D8/CW/CP/D8 /CR/D3/D2 /D8/D6/CX/CQ/D9/D8/CT /D8/D3 /D6/CX/CR/CT /CS/CT/DA /CT/D0/D3/D4/D1/CT/D2 /D8/BA/C3/CT/DD /DB /D3/D6/CS/D7/BM /BX/CB/CC/B8 /CT/DC/D4/D6/CT/D7/D7/CX/D3/D2 /D4/D6/D3/AC/D0/CT/C1/D2 /D8/D6/D3 /CS/D9/CR/D8/CX/D3/D2/CA/CX/CR/CT /B4/C7/D6/DD/DE/CP /D7/CP/D8/CX/DA/CP /B5 /CX/D7 /D3/D2/CT /D3/CU /D8/CW/CT /D1/D3/D7/D8 /CX/D1/D4/D3/D6/D8/CP/D2 /D8 /CR/D6/D3/D4/D7/CX/D2 /D8/CW/CT /DB /D3/D6/D0/CS/BA /C1/CS/CT/D2 /D8/CX/CU/DD/CX/D2/CV /D6/CX/CR/CT /CV/CT/D2/CT/D7 /CP/D2/CS /CV/CT/D2/CT /CT/DC/D4/D6/CT/D7/B9/D7/CX/D3/D2 /D4/CP/D8/D8/CT/D6/D2/D7 /CX/D7 /CX/D1/D4/D3/D6/D8/CP/D2 /D8 /CU/D3/D6 /D8/CW/CT /D9/D2/CS/CT/D6/D7/D8/CP/D2/CS/CX/D2/CV /D3/CU/D6/CX/CR/CT /CQ/CX/D3/D0/D3/CV/DD /CP/D7 /DB /CT/D0/D0 /CP/D7 /CU/D3/D6 /D8/CW/CT /D7/D8/D9/CS/DD /D3/CU /D8/D6/CP/CX/D8/D7 /D7/D9/CR /CW /CP/D7/CW/CX/CV/CW /DD/CX/CT/D0/CS/B8 /CS/CX/D7/CT/CP/D7/CT /D6/CT/D7/CX/D7/D8/CP/D2/CR/CT /CP/D2/CS /D7/D8/D6/CT/D7/D7 /D6/CT/D7/CX/D7/D8/CP/D2/CR/CT/BA/CC/CW/CT /D1/D3/D7/D8 /CT/AB/CT/CR/D8/CX/DA /CT /CP/D4/D4/D6/D3/CP/CR /CW /D8/D3 /CX/CS/CT/D2 /D8/CX/CU/DD /D0/CP/D6/CV/CT /D2 /D9/D1 /CQ/CT /D6/D3/CU /CV/CT/D2/CT/D7 /CX/D7 /CT/DC/D4/D6/CT/D7/D7/CT/CS /D7/CT/D5/D9/CT/D2/CR/CT /D8/CP/CV /B4/BX/CB/CC/B5 /D7/CT/D5/D9/CT/D2/CR/B9/CX/D2/CV/B8 /DB/CW/CX/CR /CW /CR/D3/D1/D4/D0/CT/D1/CT/D2 /D8/D7 /CV/CT/D2/D3/D1/CX/CR /BW/C6/BT /D7/CT/D5/D9/CT/D2/CR/CX/D2/CV /CQ /DD/A3/BV/D3/D6/D6/CT/D7/D4 /D3/D2/CS/CX/D2/CV /CP/D9/D8/CW/D3/D6/BA/BX/B9/D1/CP/CX/D0/BM /DB /CP/D2/CV /CY/CX/CP/D2/BS/CV/CT/D2/D3/D1/CX/CR/D7/BA/D3/D6/CV/BA/CR/D2 /CT/DC/D4/D0/CX/CR/CX/D8/D0/DD /CX/CS/CT/D2 /D8/CX/CU/DD/CX/D2/CV /D8/D6/CP/D2/D7/CR/D6/CX/CQ /CT/CS /D6/CT/CV/CX/D3/D2/D7 /B4/BD /BN /BE /B5/BA /BX/CB/CC/D7/CT/D5/D9/CT/D2/CR/CX/D2/CV /CW/CP/D7 /CP/D0/D7/D3 /CQ /CT/CT/D2 /CT/D1/D4/D0/D3 /DD /CT/CS /D8/D3 /CX/CS/CT/D2 /D8/CX/CU/DD /CV/CT/D2/CT/D7/CT/DC/D4/D6/CT/D7/D7/CT/CS /CX/D2 /D4/CP/D6/D8/CX/CR/D9/D0/CP/D6 /D8/CX/D7/D7/D9/CT/D7 /CP/D2/CS /D8/D3 /CX/CS/CT/D2 /D8/CX/CU/DD /CV/CT/D2/CT/D7/D8/CW/CP/D8 /CP/D6/CT /CS/CX/AB/CT/D6/CT/D2 /D8/CX/CP/D0/D0/DD /CT/DC/D4/D6/CT/D7/D7/CT/CS /D9/D2/CS/CT/D6 /DA /CP/D6/CX/D3/D9/D7 /CR/D3/D2/CS/CX/B9/D8/CX/D3/D2/D7 /B4/BD/B8 /BE/B8 /BF/B8 /BG/B5/BA /BV/CP/D6/CT /D1 /D9/D7/D8 /CQ/CT /D8/CP/CZ /CT/D2 /D8/D3 /D9/D7/CT /BX/CB/CC/CU/D6/CT/D5/D9/CT/D2/CR/CX/CT/D7 /D3/D2/D0/DD /CP/D7 /CP /D6/D3/D9/CV/CW /CT/D7/D8/CX/D1/CP/D8/CT/B8 /D2/D3/D8 /CP/D2 /CT/DC/CP/CR/D8/D1/CT/CP/D7/D9/D6/CT/B8 /D3/CU /CV/CT/D2/CT /CT/DC/D4/D6/CT/D7/D7/CX/D3/D2 /D0/CT/DA /CT/D0/D7/BA/CD/D4 /D8/D3 /BW/CT/CR/CT/D1 /CQ/CT /D6 /BE/BC/BC/BD/B8 /D6/CT/D7/CT/CP/D6/CR /CW/CT/D6/D7 /CW/CP /DA /CT /D6/CT/D4/D3/D6/D8/CT/CS/CP/CQ /D3/D9/D8 /BL/BH/B8/BC/BC/BC /D6/CX/CR/CT /BX/CB/CC /D7/CT/D5/D9/CT/D2/CR/CT/D7/B8 /D8/CW/CT /D1/CP /CY/D3/D6/CX/D8 /DD /D3/CU/DB/CW/CX/CR /CW /CP/D6/CT /CU/D6/D3/D1 /C6/CX/D4/D4 /D3/D2/CQ /CP/D6 /CT/B8 /CP /CY/CP/D4 /D3/D2/CX/CR /CP /DA /CP/D6/CX/CT/D8 /DD /B4/BH /B5/BA/C1/D2 /D8/CW/CX/D7 /D4/CP/D4 /CT/D6/B8 /DB /CT /D6/CT/D4/D3/D6/D8 /D8/CW/CT /D7/CT/D5/D9/CT/D2/CR/CX/D2/CV /D3/CU /CP /D8/D3/D8/CP/D0/D3/CU /BK/BI/B8/BD/BF/BI /BX/CB/CC/D7 /CU/D6/D3/D1 /CP /D2/CT/DB /D7/CT/D8 /D3/CU /D6/CX/CR/CT /DA /CP/D6/CX/CT/D8/CX/CT/D7 /CP/D2/CS/CT/D2 /DA/CX/D6/D3/D2/D1/CT/D2 /D8/CP/D0 /CP/D2/CS /CS/CT/DA /CT/D0/D3/D4/D1/CT/D2 /D8/CP/D0 /CR/CX/D6/CR/D9/D1/D7/D8/CP/D2/CR/CT/D7 /D8/CW/CP/D8/BE/BI /BZ/CT/D2/D3/BA/B8 /C8/D6/D3/D8/BA /B2 /BU/CX/D3/CX/D2/CU/D3/BA /CE /D3/D0/BA /BD /C6/D3/BA /BD /BY /CT/CQ/D6/D9/CP/D6/DD /BE/BC/BC/BFThis is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/09/0a/main.PMC5172415.pdf
"During the SARS outbreaks in 2002 and 2003, SARS cases were identiﬁed in 19 countries, and in total 8,605 individuals became infected, of whom 774 died (http://www.who.int/ csr/sars/country/table2003 09 23/en/).",Non-OADS,/arxiv_data1/oa_pdf/4f/07/main.PMC5172416.pdf
"Although thespread of the virus had seemed to be conﬁned byJuly 2003 through rigorous quarantine measures (http://www.who.int/csr/sars/country/table2003 09 23/en/), it may still be circulating in the animal reservoir and it is impossible to say that it will not return ( 8-10).",Non-OADS,/arxiv_data1/oa_pdf/4f/07/main.PMC5172416.pdf
4 November 2003 247This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/4f/07/main.PMC5172416.pdf
Two RT-PCR protocols were then developed by two WHO SARS network laboratories(http://www.who.int/csr/sars/primers/en).,OADS,/arxiv_data1/oa_pdf/4f/07/main.PMC5172416.pdf
"A person will be conﬁrmed to be infected by the SARS-Co V if viral RNA is detected by either the two PCR assays, two aliquots of speci- men, or two sets of primers (http://www.cdc.gov/nci dod/sars/specimen collection  sars2.htm).",Non-OADS,/arxiv_data1/oa_pdf/4f/07/main.PMC5172416.pdf
Seroconversion from negative to positive or a four-fold rise in antibody titer from acute to convalescent serum indicates recent infection (http://www.who.int/csr/sars/diagnostictests/en/).,Non-OADS,/arxiv_data1/oa_pdf/4f/07/main.PMC5172416.pdf
4 November 2003 263This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,OADS,/arxiv_data1/oa_pdf/4b/81/main.PMC5172417.pdf
"patens 82,313 33 Toxoplasma gondii 72,859 34 Lactuca sativa 68,188 35 Populus tremula x Populus tremuloides 65,981 36 Helianthus annuus 59,841 37 Salmo salar 59,420 38 Strongylocentrotus purpuratus (purple urchin) 51,744 * A summary for all ESTs available within the NCBI dbEST database is available from http://www.ncbi.nlm.nih.",OADS,/arxiv_data1/oa_pdf/4b/81/main.PMC5172417.pdf
"trichocarpa x Populus deltoides Salicaceae 6,579 Populus alba x Populus glandulosa Salicaceae 519 Pinus radiata (Monterey pine) Pinaceae 69 Pinus banksiana Pinaceae 46 Pinus patula Pinaceae 23 Pinus elliottii Pinaceae 8 * A summary for all ESTs available within the NCBI dbEST database is available from http://www.ncbi.nlm.nih.",Non-OADS,/arxiv_data1/oa_pdf/4b/81/main.PMC5172417.pdf
"The largest known genomes are currently those of Fritillaria assyriaca (125,000 Mb) and Psilotum nudum (250,000 Mb) (http://www.rbgkew.org.uk; ref.",Non-OADS,/arxiv_data1/oa_pdf/4b/81/main.PMC5172417.pdf
Table 4 Speci¯c Plant EST Databases with Signi¯cant Value and Large Collections of EST Sequences Plan t EST database Websites References B-EST barley database http://pgrc.ipk-gatersleben.de/est/login.php 3 Chlamydomonas resource centre http://www.biology.duke.edu/chlamy genome/ 66 Kazusa EST database http://www.kazusa.or.jp/en/plant/database.html 3 MIPS Sputniks http://mips.gsf.de/proj/sputnik/ 3 NCBI Unigenes http://www.ncbi.nlm.nih.gov/UniGene/ 96 PlantGDB http://www.zmdb.iastate.edu/PlantGDB/ 3 Solanaceae genomics network http://sgn.cornell.edu/ 41 TIGR Plant Gene Indices http://www.tigr.org/tdb/tgi/plant.shtml 94 University Minnesota http://www.ccgb.umn.edu/ 95 ESTs as a current alternative to complete genomes could be applied as the foundation sequence of some genome-scale analyses.,OADS,/arxiv_data1/oa_pdf/4b/81/main.PMC5172417.pdf
"Table 6 Functional Genomics Projects Awarded by NSF in USA in 1999 and 2002 (http://www.nsf.gov) Y ear Title Total Award (USD$) 1999-2002 Tools for Potato Structural and Functional Genomics $5,300,000 1999-2004 Functional Genomics of Maize Centromeres $2,510,000 1999-2002 Functional and Comparative Genomics of Disease Resistance Gene Homologs $2,530,000 1999-2002 Functional Genomics of Hemicellulose Biosynthesis $2,250,000 1999-2002 Genomics of Wood Formation in Loblolly Pine $4,450,000 1999-2002 Functional Genomics of Plant Phosphorylation $2,983,734 2002-2007 Potato Functional Genomics: Application to Analysis of Growth, Development, $7,618,912 Metabolism and Responses to Biotic and Abiotic Stress 2002-2005 Genomics of Loblolly Pine Embryogenesis $1,380,910 2002-2006 Functional Genomics of Host-Virus Interactions $3,363,177 2002-2006 Functional Genomics of Phytophthora-Plant Interactions $1,891,617 2002-2007 Functional Genomics of Hemicellulose Biosynthesis $4,945,077 2002-2005 Transcriptome Responses to Environmental Conditions in Loblolly Pine Roots $1,651,752 2002-2005 Functional genomic analysis of fruit °avor and nutrition pathways $1,159,280 2002-2006 Functional Analyses of Plant Gamete Gene Expression $1,135,486 2002-2007 Functional genomics of root growth and root signaling under drought $4,549,050 References 1.",Non-OADS,/arxiv_data1/oa_pdf/4b/81/main.PMC5172417.pdf
/C1/D2 /DA/CX/D8/CT/CS /BT/D6/D8/CX/CR/D0/CT/CC/CW/CT /CB/D8/D6/D9/CR/D8/D9/D6/CT /BT/D2/CP/D0/DD/D7/CX/D7 /CP/D2/CS /BT/D2 /D8/CX/CV/CT/D2/CX/CR/CX/D8 /DD /CB/D8/D9/CS/DD /D3/CU /D8/CW/CT /C6 /C8/D6/D3/D8/CT/CX/D2 /D3/CU/CB/BT/CA/CB/B9/BV/D3/CE/C2/CX/D2/CV/D5/CX/CP/D2/CV /CF /CP/D2/CV /BD/BN/BE/B6/B8 /C2/CX/CP /C2/CX /BD/B6/B8 /C2/CX/CP /CH /CT /BE/BN/BD/B6/B8 /CG/CX/CP/D3 /D5/CX/CP/D2 /CI/CW/CP/D3 /BD/B6/B8 /C2/CX/CT /CF /CT/D2 /BD/B8 /CF /CT/CX /C4/CX /BD/B8 /C2/CX/CP/D2/CU/CT/CX /C0/D9 /BD/BN/BF/B8 /BW/CP /DB /CT/CX /C4/CX /BD/B8/C5/CX/D2 /CB/D9/D2 /BD/B8 /C0/CP/CX/D4/CP/D2 /CI/CT/D2/CV /BD/B8 /CH /D3/D2/CV/DB/D9 /C0/D9 /BD/B8 /CG/CX/CP/D2/CV /CY/D9/D2 /CC/CX/CP/D2 /BD/BN/BE/B8 /CG/D9/CT/CW/CP/CX /CC /CP/D2 /BD/B8 /C6/CX/D2/CV/DE/CW/CX /CG/D9 /BD/B8 /BV/CW/CP/D2/CV/D5/CX/D2/CV /CI/CT/D2/CV /BD/B8 /C2/CX/CP/D2/CF /CP/D2/CV /BD/BN/BE/B8 /CB/CW/CT/D2/CV/D0/CX /BU/CX /BG/B8 /CP/D2/CS /C0/D9/CP/D2/D1/CX/D2/CV /CH /CP/D2/CV /BD/BN/BE/AZ/BD/BU/CT/CX/CY/CX/D2/CV /BZ/CT/D2/D3/D1/CX/CR/D7 /C1/D2/D7/D8/CX/D8/D9/D8/CT/B8 /BV/CW/CX/D2/CT/D7/CT /BT /CR /CP/CS/CT/D1/DD /D3/CU /CB/CR/CX/CT/D2/CR /CT/D7/B8 /BU/CT/CX/CY/CX/D2/CV /BD/BC/BD/BF/BC/BC/B8 /BV/CW/CX/D2/CP/BN /BE/C2/CP/D1/CT/D7 /BW/BA /CF/CP/D8/D7/D3/D2 /C1/D2/D7/D8/CX/B9/D8/D9/D8/CT /D3/CU /BZ/CT/D2/D3/D1/CT /CB/CR/CX/CT/D2/CR /CT/D7/B8 /CI/CW/CX/CY/CX/CP/D2/CV /BV/CP/D1/D4/D9/D7/B8 /CI/CW/CT/CY/CX/CP/D2/CV /CD/D2/CX/DA/CT/D6/D7/CX/D8/DD /CP/D2/CS /C0/CP/D2/CV/DE/CW/D3/D9 /BZ/CT/D2/D3/D1/CX/CR/D7 /C1/D2/D7/D8/CX/D8/D9/D8/CT/B8 /C0/CP/D2/CV/DE/CW/D3/D9/BF/BD/BC/BC/BC/BK/B8 /BV/CW/CX/D2/CP/BN /BF/BV/D3/D0 /D0/CT /CV/CT /D3/CU /C4/CX/CU/CT /CB/CR/CX/CT/D2/CR /CT/D7/B8 /C8/CT/CZ/CX/D2/CV /CD/D2/CX/DA/CT/D6/D7/CX/D8/DD/B8 /BU/CT/CX/CY/CX/D2/CV /BD/BC/BC/BK/BJ/BD/B8 /BV/CW/CX/D2/CP/BN /BG/BV/CT/D2/D8/CT/D6 /D3/CU /BW/CX/D7/CT /CP/D7/CT/BV/D3/D2/D8/D6 /D3/D0 /CP/D2/CS /C8/D6 /CT/DA/CT/D2/D8/CX/D3/D2/B8 /BU/CT/CX/CY/CX/D2/CV /BD/BC/BC/BC/BH/BC/B8 /BV/CW/CX/D2/CP/BA/CC/CW/CT /BV/D3/D6 /D3/D2/CP/DA/CX/D6/CX/CS/CP/CT /CU/CP/D1/CX/D0/DD /CX/D7 /CR /CW/CP/D6/CP/CR/D8/CT/D6/CX/DE/CT/CS /CQ /DD /CP /D2 /D9/CR/D0/CT/D3 /CR/CP/D4/D7/CX/CS /D8/CW/CP/D8 /CX/D7 /CR/D3/D1/D4 /D3/D7/CT/CS /D3/CU /D8/CW/CT/CV/CT/D2/D3/D1/CT /CA/C6/BT /D1/D3/D0/CT/CR/D9/D0/CT /CX/D2 /CR/D3/D1 /CQ/CX/D2/CP/D8/CX/D3/D2 /DB/CX/D8/CW /D8/CW/CT /D2 /D9/CR/D0/CT/D3/D4/D6/D3/D8/CT/CX/D2 /B4/C6 /D4/D6/D3/D8/CT/CX/D2/B5 /DB/CX/D8/CW/CX/D2/CP /DA/CX/D6/CX/D3/D2/BA /CC/CW/CT /D1/D3/D7/D8 /D7/D8/D6/CX/CZ/CX/D2/CV /D4/CW /DD/D7/CX/D3 /CR /CW/CT/D1/CX/CR/CP/D0 /CU/CT/CP/D8/D9/D6/CT /D3/CU /D8/CW/CT /C6 /D4/D6/D3/D8/CT/CX/D2 /D3/CU /CB/BT/CA/CB/B9/BV/D3/CE/CX/D7 /D8/CW/CP/D8 /CX/D8 /CX/D7 /CP /D8 /DD/D4/CX/CR/CP/D0 /CQ/CP/D7/CX/CR /D4/D6/D3/D8/CT/CX/D2 /DB/CX/D8/CW /CP /CW/CX/CV/CW /D4/D6/CT/CS/CX/CR/D8/CT/CS /D4/C1 /CP/D2/CS /CW/CX/CV/CW /CW /DD/CS/D6/D3/D4/CW/CX/D0/CX/CR/CX/D8 /DD /B8/DB/CW/CX/CR /CW /CX/D7 /CR/D3/D2/D7/CX/D7/D8/CT/D2 /D8 /DB/CX/D8/CW /CX/D8/D7 /CU/D9/D2/CR/D8/CX/D3/D2 /D3/CU /CQ/CX/D2/CS/CX/D2/CV /D8/D3 /D8/CW/CT /D6/CX/CQ /D3/D4/CW/D3/D7/D4/CW/CP/D8/CT /CQ/CP/CR /CZ/CQ /D3/D2/CT /D3/CU/D8/CW/CT /CA/C6/BT /D1/D3/D0/CT/CR/D9/D0/CT/BA /CC/CW/CT /D4/D6/CT/CS/CX/CR/D8/CT/CS /CW/CX/CV/CW /CT/DC/D8/CT/D2 /D8 /D3/CU /D4/CW/D3/D7/D4/CW/D3/D6/DD/D0/CP/D8/CX/D3/D2 /D3/CU /D8/CW/CT /C6 /D4/D6/D3/D8/CT/CX/D2/D3/D2 /D1 /D9/D0/D8/CX/D4/D0/CT /CR/CP/D2/CS/CX/CS/CP/D8/CT /D4/CW/D3/D7/D4/CW/D3/D6/DD/D0/CP/D8/CX/D3/D2 /D7/CX/D8/CT/D7 /CS/CT/D1/D3/D2/D7/D8/D6/CP/D8/CT/D7 /D8/CW/CP/D8 /CX/D8 /DB /D3/D9/D0/CS /CQ/CT /D6/CT/D0/CP/D8/CT/CS/D8/D3 /CX/D1/D4 /D3/D6/D8/CP/D2 /D8 /CU/D9/D2/CR/D8/CX/D3/D2/D7/B8 /D7/D9/CR /CW /CP/D7 /CA/C6/BT/B9/CQ/CX/D2/CS/CX/D2/CV /CP/D2/CS /D0/D3 /CR/CP/D0/CX/DE/CP/D8/CX/D3/D2 /D8/D3 /D8/CW/CT /D2 /D9/CR/D0/CT/D3/D0/D9/D7 /D3/CU/CW/D3/D7/D8 /CR/CT/D0/D0/D7/BA /CB/D9/CQ/D7/CT/D5/D9/CT/D2 /D8 /D7/D8/D9/CS/DD /D7/CW/D3 /DB/D7 /D8/CW/CP/D8 /D8/CW/CT/D6/CT /CX/D7 /CP/D2 /CB/CA/B9/D6/CX/CR /CW /D6/CT/CV/CX/D3/D2 /CX/D2 /D8/CW/CT /C6 /D4/D6/D3/D8/CT/CX/D2/CP/D2/CS /D8/CW/CX/D7 /D6/CT/CV/CX/D3/D2 /D1/CX/CV/CW /D8 /CQ/CT /CX/D2 /DA /D3/D0/DA /CT/CS /CX/D2 /D8/CW/CT /D4/D6/D3/D8/CT/CX/D2/B9/D4/D6/D3/D8/CT/CX/D2 /CX/D2 /D8/CT/D6/CP/CR/D8/CX/D3/D2/BA /CC/CW/CT /CP/CQ/D9/D2/CS/CP/D2 /D8/CP/D2 /D8/CX/CV/CT/D2/CX/CR /D7/CX/D8/CT/D7 /D4/D6/CT/CS/CX/CR/D8/CT/CS /CX/D2 /D8/CW/CT /C6 /D4/D6/D3/D8/CT/CX/D2/B8 /CP/D7 /DB /CT/D0/D0 /CP/D7 /CT/DC/D4 /CT/D6/CX/D1/CT/D2 /D8/CP/D0 /CT/DA/CX/CS/CT/D2/CR/CT /DB/CX/D8/CW/D7/DD/D2 /D8/CW/CT/D7/CX/DE/CT/CS /D4 /D3/D0/DD/D4 /CT/D4/D8/CX/CS/CT/D7/B8 /CX/D2/CS/CX/CR/CP/D8/CT /D8/CW/CP/D8 /D8/CW/CT /C6 /D4/D6/D3/D8/CT/CX/D2 /CX/D7 /D3/D2/CT /D3/CU /D8/CW/CT /D1/CP /CY/D3/D6 /CP/D2 /D8/CX/CV/CT/D2/D7/D3/CU /D8/CW/CT /CB/BT/CA/CB/B9/BV/D3/CE/BA /BV/D3/D1/D4/CP/D6/CT/CS /DB/CX/D8/CW /D3/D8/CW/CT/D6 /DA/CX/D6/CP/D0 /D7/D8/D6/D9/CR/D8/D9/D6/CP/D0 /D4/D6/D3/D8/CT/CX/D2/D7/B8 /D8/CW/CT /D0/D3 /DB /DA /CP/D6/CX/CP/D8/CX/D3/D2/D6/CP/D8/CT /D3/CU /D8/CW/CT /C6 /D4/D6/D3/D8/CT/CX/D2 /DB/CX/D8/CW /D6/CT/CV/CP/D6/CS/D7 /D8/D3 /CX/D8/D7 /D7/CX/DE/CT /D7/D9/CV/CV/CT/D7/D8/D7 /CX/D8/D7 /CX/D1/D4 /D3/D6/D8/CP/D2/CR/CT /D8/D3 /D8/CW/CT /D7/D9/D6/DA/CX/DA /CP/D0/D3/CU /D8/CW/CT /DA/CX/D6/D9/D7/BA/C3/CT/DD /DB /D3/D6/CS/D7/BM /CB/BT/CA/CB/B9/BV/D3/CE/B8 /D2 /D9/CR/D0/CT/D3/D4/D6/D3/D8/CT/CX/D2/B8 /D4/CW/D3/D7/D4/CW/D3/D6/DD/D0/CP/D8/CX/D3/D2/B8 /CB/CA/B9/D6/CX/CR /CW /D6/CT/CV/CX/D3/D2/B8 /CP/D2 /D8/CX/CV/CT/D2/CX/CR /D7/CX/D8/CT/D7/C1/D2 /D8/D6/D3 /CS/D9/CR/D8/CX/D3/D2/C1/D8 /CW/CP/D7 /CQ/CT /CT /D2 /CT/D7/D8/CP/CQ/D0/CX/D7/CW/CT/CS /D8/CW/CP/D8 /CP /DA /CP/D6/CX/CP/D2 /D8 /D3/CU /CR/D3/D6/D3/D2/CP /DA/CX/D6/D9/D7/CT/D7/B8/CB/BT/CA/CB/B9/BV/D3/CE/B8 /CX/D7 /D8/CW/CT /D4/CP/D8/CW/D3/CV/CT/D2 /D3/CU /CB/BT/CA/CB /B4/BD /B5/BA /CC/CW/CT /C6/D4/D6/D3/D8/CT/CX/D2 /B4/D2 /D9/CR/D0/CT/D3/D4/D6/D3/D8/CT/CX/D2/B5 /CX/D7 /D3/D2/CT /D3/CU /D8/CW/CT /D1/CP /CY/D3/D6 /D7/D8/D6/D9/CR/D8/D9/D6/CP/D0/D4/D6/D3/D8/CT/CX/D2/D7 /CX/D2 /CP /DA/CX/D6/CP/D0 /D4/CP/D6/D8/CX/CR/D0/CT/B8 /D4/D0/CP /DD/CX/D2/CV /CP /CR/D6/CX/D8/CX/CR/CP/D0 /D6/D3/D0/CT /CX/D2/D8/CW/CT /D8/D6/CP/D2/D7/CR/D6/CX/D4/D8/CX/D3/D2 /D6/CT/CV/D9/D0/CP/D8/CX/D3/D2 /D3/CU /D8/CW/CT /CV/CT/D2/D3/D1/CX/CR /CA/C6/BT /CP/D2/CS/D3/D8/CW/CT/D6 /DA/CX/D6/CP/D0 /D4/D6/D3/D8/CT/CX/D2/D7 /B4/BE /B5/BA /C1/D8 /D1/CX/CV/CW /D8 /CP/D0/D7/D3 /CQ/CT /CX/D2 /DA /D3/D0/DA /CT/CS/CX/D2 /D8/CW/CT /DA/CX/D6/D9/D0/CT/D2/CR/CT /CP/D2/CS /DA/CX/D6/D9/D7/B9/D7/D4 /CT/CR/CX/AC/CR /D4 /D3/D7/D8/B9/D8/D6/CP/D2/D7/D0/CP/D8/CX/D3/D2/CP/D0/D1/D3 /CS/CX/AC/CR/CP/D8/CX/D3/D2/D7 /B4/BF /B5/BA/C1/D2 /D8/CW/CX/D7 /D4/CP/D4 /CT/D6/B8 /DB /CT /D6/CT/D4 /D3/D6/D8 /D8/CW/CT /D4/D6/CT/CS/CX/CR/D8/CT/CS /D7/D8/D6/D9/CR/D8/D9/D6/CT/B8/D4 /D3/D7/D7/CX/CQ/D0/CT /CU/D9/D2/CR/D8/CX/D3/D2/D7/B8 /CT/DA /D3/D0/D9/D8/CX/D3/D2/B8 /CP/D2/CS /D8/CW/CT /CX/D1/D1 /D9/D2/D3/CP/D7/D7/CP /DD/D3/CU /D8/CW/CT /C6 /D4/D6/D3/D8/CT/CX/D2 /D3/CU /CB/BT/CA/CB/B9/BV/D3/CE /D8/D3 /CR/D3/D2/AC/D6/D1 /D8/CW/CP/D8 /D8/CW/CT /C6/D4/D6/D3/D8/CT/CX/D2 /CX/D7 /D3/D2/CT /D3/CU /D8/CW/CT /D1/CP /CY/D3/D6 /CP/D2 /D8/CX/CV/CT/D2/D7 /DB/CX/D8/CW /D7/DD/D2 /D8/CW/CT/D7/CX/DE/CT/CS/D4 /D3/D0/DD/D4 /CT/D4/D8/CX/CS/CT/D7/BA/B6 /CC/CW/CT/D7/CT /CP/D9/D8/CW/D3/D6/D7 /CR/D3/D2 /D8/D6/CX/CQ/D9/D8/CT/CS /CT/D5/D9/CP/D0/D0/DD /D8/D3 /D8/CW/CX/D7/DB /D3/D6/CZ/BA/AZ/BV/D3/D6/D6/CT/D7/D4 /D3/D2/CS/CX/D2/CV /CP/D9/D8/CW/D3/D6/BA/BX/B9/D1/CP/CX/D0/BM /DD /CP/D2/CV/CW/D1/BS/CV/CT/D2/D3/D1/CX/CR/D7/BA/D3/D6/CV/BA/CR/D2 /CA/CT/D7/D9/D0/D8/D7 /CP/D2/CS /BW/CX/D7/CR/D9/D7/D7/CX/D3/D2/CC/CW/CT /C7/CA/BY /D3/CU /D8/CW/CT /C6 /D4/D6/D3/D8/CT/CX/D2/CC/CW/CT /C7/CA/BY /B4/D3/D4 /CT/D2/B9/D6/CT/CP/CS/CX/D2/CV /CU/D6/CP/D1/CT/B5 /CU/D3/D6 /D8/CW/CT /C6 /D4/D6/D3/D8/CT/CX/D2 /CX/D7 /D0/D3/B9/CR/CP/D8/CT/CS /CP/D8 /D8/CW/CT /BF /BC/CT/D2/CS /B4/D2 /D9/CR/D0/CT/D3/D8/CX/CS/CT /D4 /D3/D7/CX/D8/CX/D3/D2 /BE/BK/B8/BD/BC/BD/B9/BE/BL/B8/BF/BI/BL/B5/D3/CU /D8/CW/CT /CB/BT/CA/CB/B9/BV/D3/CE /CV/CT/D2/D3/D1/CT/BA /CC/CW/CT /C7/CA/BY /CX/D7 /BD/B8/BE/BI/BL /D2 /D9/B9/CR/D0/CT/D3/D8/CX/CS/CT /B4/D2 /D8/B5 /D0/D3/D2/CV/B8 /CP/CR/CR/D3/D9/D2 /D8/CX/D2/CV /CU/D3/D6 /BG/BA/BE/BJ/B1 /D3/CU /D8/CW/CT /D8/D3/D8/CP/D0/CV/CT/D2/D3/D1/CT/BA /C1/D8 /CW/CP/D7 /CP /BZ/BV /CR/D3/D2 /D8/CT/D2 /D8 /D3/CU /BG/BK/BA/BF/BK/B1 /B4/BT/BM /CD/BM /BV/BM /BZ/BP /BF/BD/BA/BI/BC/BM /BE/BC/BA/BC/BE/BM /BE/BI/BA/BF/BE/BM /BE/BE/BA/BC/BI/B5/B8 /DB/CW/CX/CR /CW /CX/D7 /D7/CX/CV/D2/CX/AC/CR/CP/D2 /D8/D0/DD/CW/CX/CV/CW/CT/D6 /D8/CW/CP/D2 /D8/CW/CT /CP /DA /CT/D6/CP/CV/CT /D3/CU /D8/CW/CT /CR/D3/D1/D4/D0/CT/D8/CT /CB/BT/CA/CB/B9/BV/D3/CE/CV/CT/D2/D3/D1/CT /B4/BG/BC/BA/BJ/BI/B1/B5/BA /BT/D2/CS /D8/CW/CT /BZ/BV /CR/D3/D2 /D8/CT/D2 /D8 /CX/D2 /D8/CW/CT /D0/CT/CU/D8 /CW/CP/D0/CU/D2/CT/CP/D6 /D8/CW/CT /BH /BC/CT/D2/CS /B4/BH/BD/BA/BI/BF/B1/B5 /CX/D7 /D3/CQ /DA/CX/D3/D9/D7/D0/DD /CW/CX/CV/CW/CT/D6 /D8/CW/CP/D2 /D8/CW/CP/D8/CX/D2 /D8/CW/CT /D6/CX/CV/CW /D8 /CW/CP/D0/CU /D2/CT/CP/D6 /D8/CW/CT /BF /BC/CT/D2/CS /B4/BG/BG/BA/BI/BK/B1/B5 /B4/BY/CX/CV/D9/D6/CT /BD/B5/BA/BZ/CT/D2/CT/D6/CP/D0 /D4/CW /DD/D7/CX/D3 /CR /CW/CT/D1/CX/CR/CP/D0 /CU/CT/CP/D8/D9/D6/CT/D7 /D3/CU /D8/CW/CT/C6 /D4/D6/D3/D8/CT/CX/D2/CC/CW/CT /C6 /D4/D6/D3/D8/CT/CX/D2 /CX/D7 /CR/D3/D1/D4 /D3/D7/CT/CS /D3/CU /BG/BE/BE /CP/D1/CX/D2/D3 /CP/CR/CX/CS/D7 /B4/CP/BA/CP/BA/B5/DB/CX/D8/CW /CP/D2 /CT/D7/D8/CX/D1/CP/D8/CT/CS /D1/D3/D0/CT/CR/D9/D0/CP/D6 /DB /CT/CX/CV/CW /D8 /D3/CU /BG/BI/BA/BC/BF /C3/BW/B8 /D8/CW/CT/D7/CT/CR/D3/D2/CS /D0/CP/D6/CV/CT/D7/D8 /D3/CU /D8/CW/CT /D7/D8/D6/D9/CR/D8/D9/D6/CP/D0 /DA/CX/D6/CP/D0 /D4/D6/D3/D8/CT/CX/D2/BA /C1/D8 /CW/CP/D7/BZ/CT/D2/D3/BA/B8 /C8/D6/D3/D8/BA /B2 /BU/CX/D3/CX/D2/CU/D3/BA /CE /D3/D0/BA /BD /C6/D3/BA /BE /C5/CP /DD /BE/BC/BC/BF /BD/BG/BHThis is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/02/6d/main.PMC5172421.pdf
4 November 2003 299This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/35/af/main.PMC5172426.pdf
eXtensible Markup Language (XML) XML (http://www.w3c.org/XML/; ref.,OADS,/arxiv_data1/oa_pdf/35/af/main.PMC5172426.pdf
"In life science, many commercial and academic communities are now adopting XML as a stan- dard for their genome biology data management (http://scbi.scu.edu.cn/XML/).",OADS,/arxiv_data1/oa_pdf/35/af/main.PMC5172426.pdf
The web service client is available at http://scbi.scu.edu.cn/webservices/.,OADS,/arxiv_data1/oa_pdf/35/af/main.PMC5172426.pdf
"Apache Axis (Apache eXtensible Interaction Sys- tem, http://ws.apache.org/axis/) is an open-source implementation of the SOAP submission to W3C.",OADS,/arxiv_data1/oa_pdf/35/af/main.PMC5172426.pdf
The information of the GetEn- try server is obtained from the WSDL document (http://xml.nig.ac.jp/wsdl/GetEntry.wsdl; Figures 3 and 4).,OADS,/arxiv_data1/oa_pdf/35/af/main.PMC5172426.pdf
"To transform XML documents into HTML form, an XSL ¯le named \ddbjhtml.xsl"" was designed and is now available at http://scbi.scu.edu.cn/webservices/ ddbjhtml.xsl.More information about XSL can be obtained from W3C website (http://www.w3c.org/Style/XSL/).",OADS,/arxiv_data1/oa_pdf/35/af/main.PMC5172426.pdf
/BU/D6/CX/CT/CU /CA/CT/D4 /D3/D6/D8/BZ/CT/D2/CT /BX/DC/D4/D6/CT/D7/D7/CX/D3/D2 /C8/D6/D3/AC/D0/CX/D2/CV /CX/D2 /C8 /D3/D6/CR/CX/D2/CT /BY /CT/D8/CP/D0 /CC/CW /DD/D1 /D9/D7/CH /CP/D2/CY/CX/D3/D2/CV /BV/CW/CT/D2 /BD/BN/BE/B8 /CB/CW/CT/D2/CV/CQ/CX/D2 /C4/CX /BD/BN/BE/B8 /C4/CX/D2 /CH /CT /BF/B8 /C2/CX/CP/D2/CX/D2/CV /BZ/CT/D2/CV /BE/B8 /CH /CP /CY/D9/D2 /BW/CT/D2/CV /BD/BN/BE/B8 /CP/D2/CS /CB/D3/D2/CV/D2/CX/CP/D2 /C0/D9 /BE/BN/BF/B6/BD/CC/CW/CT /CB/D8/CP/D8/CT /C4 /CP/CQ /D3/D6 /CP/D8/D3/D6/DD /D3/CU /D8/CW/CT /C5/CX/D2/CX/D7/D8/D6/DD /D3/CU /C0/CT /CP/D0/D8/CW /CU/D3/D6 /BY /D3/D6 /CT/D2/D7/CX/CR /CB/CR/CX/CT/D2/CR /CT/B8 /C5/CT /CS/CX/CR /CP/D0 /BV/D3/D0 /D0/CT /CV/CT /D3/CU /CG/CX/B3/CP/D2 /C2/CX/CP/D3/D8/D3/D2/CV/CD/D2/CX/DA/CT/D6/D7/CX/D8/DD/B8 /CG/CX/B3/CP/D2 /BJ/BD/BC/BC/BI/BD/B8 /BV/CW/CX/D2/CP/BN /BE/BU/CT/CX/CY/CX/D2/CV /BZ/CT/D2/D3/D1/CX/CR/D7 /C1/D2/D7/D8/CX/D8/D9/D8/CT/B8 /BU/CT/CX/CY/CX/D2/CV /BD/BC/BD/BF/BC/BC/B8 /BV/CW/CX/D2/CP/BN /BF/C0/CP/D2/CV/DE/CW/D3/D9 /BZ/CT/D2/D3/D1/CX/CR/D7/C1/D2/D7/D8/CX/D8/D9/D8/CT/B8 /C0/CP/D2/CV/DE/CW/D3/D9 /BF/BD/BC/BC/BC/BJ/B8 /BV/CW/CX/D2/CP/BA/CC /D3 /D3/CQ/D8/CP/CX/D2 /CP/D2 /CX/D2/CX/D8/CX/CP/D0 /D3 /DA /CT/D6/DA/CX/CT/DB /D3/CU /CV/CT/D2/CT /CS/CX/DA /CT/D6/D7/CX/D8 /DD /CP/D2/CS /CT/DC/D4/D6/CT/D7/D7/CX/D3/D2 /D4/CP/D8/D8/CT/D6/D2 /CX/D2 /D4/D3 /D6 /CR /CX /D2 /CT/D8/CW /DD/D1 /D9/D7/B8 /BD/BD/B8/BJ/BD/BE /BX/CB/CC/D7 /B4/BX/DC/D4/D6/CT/D7/D7/CT/CS /CB/CT/D5/D9/CT/D2/CR/CT /CC /CP/CV/D7/B5 /CU/D6/D3/D1 /BD/BC/BC/B9/CS/CP /DD/B9/D3/D0/CS /D4 /D3/D6/CR/CX/D2/CT /D8/CW /DD/D1 /D9/D7/B4/BY/CC/CH/B5 /DB /CT/D6/CT /D7/CT/D5/D9/CT/D2/CR/CT/CS /CP/D2/CS /BJ/B8/BC/BJ/BD /CR/D0/CT/CP/D2/CT/CS /BX/CB/CC/D7 /DB /CT/D6/CT /D9/D7/CT/CS /CU/D3/D6 /CV/CT/D2/CT /CT/DC/D4/D6/CT/D7/D7/CX/D3/D2/CP/D2/CP/D0/DD/D7/CX/D7/BA /BV/D0/D9/D7/D8/CT/D6/CT/CS /CQ /DD /D8/CW/CT /C8/C0/CA/BT/C8 /D4/D6/D3/CV/D6/CP/D1/B8 /BL/BH/BL /CR/D3/D2 /D8/CX/CV/D7 /CP/D2/CS /BF/B8/BC/BJ/BG /D7/CX/D2/CV/D0/CT/D8/D7 /DB /CT/D6/CT/D3/CQ/D8/CP/CX/D2/CT/CS/BA /BU/D0/CP/D7/D8 /D7/CT/CP/D6/CR /CW /D7/CW/D3 /DB /CT/CS /D8/CW/CP/D8 /BK/BC/BI /CR/D3/D2 /D8/CX/CV/D7 /CP/D2/CS /BD/B8/BI/BI/BL /D7/CX/D2/CV/D0/CT/D8/D7 /B4/D8/D3/D8/CP/D0/D0/DD /BH/B8/BG/BG/BE/BX/CB/CC/D7/B5 /CW/CP/CS /CW/D3/D1/D3/D0/D3/CV/D9/CT/D7 /CX/D2 /BZ/CT/D2/BU/CP/D2/CZ /CP/D2/CS /BD/B8/BI/BE/BL /BX/CB/CC/D7 /DB /CT/D6/CT /D2/D3 /DA /CT/D0/BA /BT/CR/CR/D3/D6/CS/CX/D2/CV /D8/D3 /D8/CW/CT/BZ/CT/D2/CT /C7/D2 /D8/D3/D0/D3/CV/DD /CR/D0/CP/D7/D7/CX/AC/CR/CP/D8/CX/D3/D2/B8 /BF/BI/BA/BL/BL/B1 /BX/CB/CC/D7 /DB /CT/D6/CT /CR/CP/D8/CP/D0/D3/CV/CT/CS /CX/D2 /D8/D3 /D8/CW/CT /CV/CT/D2/CT /CT/DC/D4/D6/CT/D7/D7/CX/D3/D2/CV/D6/D3/D9/D4/B8 /CX/D2/CS/CX/CR/CP/D8/CX/D2/CV /D8/CW/CP/D8 /CP/D0/D8/CW/D3/D9/CV/CW /D8/CW/CT /CU/D9/D2/CR/D8/CX/D3/D2/CP/D0 /CV/CT/D2/CT /B4/BD/BK/BA/BJ/BK/B1 /CX/D2 /CS/CT/CU/CT/D2/D7/CT /CV/D6/D3/D9/D4/B5 /D3/CU/D8/CW /DD/D1 /D9/D7 /CX/D7 /CT/DC/D4/D6/CT/D7/D7/CT/CS /CX/D2 /CP /CR/CT/D6/D8/CP/CX/D2 /CS/CT/CV/D6/CT/CT/B8 /D8/CW/CT /BD/BC/BC/B9/CS/CP /DD/B9/D3/D0/CS /D4 /D3/D6/CR/CX/D2/CT /D8/CW /DD/D1 /D9/D7 /D7/D8/CX/D0/D0 /CT/DC/CX/D7/D8/D7/CX/D2 /CP /CS/CT/DA /CT/D0/D3/D4/D1/CT/D2 /D8/CP/D0 /D7/D8/CP/CV/CT/BA /BV/D3/D1/D4/CP/D6/CP/D8/CX/DA /CT /CP/D2/CP/D0/DD/D7/CX/D7 /D7/CW/D3 /DB /CT/CS /D8/CW/CP/D8 /D8/CW/CT /CV/CT/D2/CT /CT/DC/D4/D6/CT/D7/D7/CX/D3/D2/D4/CP/D8/D8/CT/D6/D2 /D3/CU /D8/CW/CT /BD/BC/BC/B9/CS/CP /DD/B9/D3/D0/CS /D4 /D3/D6/CR/CX/D2/CT /D8/CW /DD/D1 /D9/D7 /CX/D7 /D7/CX/D1/CX/D0/CP/D6 /D8/D3 /D8/CW/CP/D8 /D3/CU /D8/CW/CT /CW /D9/D1/CP/D2 /CX/D2/CU/CP/D2 /D8/D8/CW /DD/D1 /D9/D7/BA/C3/CT/DD /DB /D3/D6/CS/D7/BM /D4 /D3/D6/CR/CX/D2/CT/B8 /CU/CT/D8/CP/D0 /D8/CW /DD/D1 /D9/D7/B8 /BX/CB/CC/C1/D2 /D8/D6/D3 /CS/D9/CR/D8/CX/D3/D2/CC/CW/CT /D3/D6/CS/CT/D6/CT/CS /CP/D2/CS /D8/CX/D1/CT/D0/DD /CT/DC/D4/D6/CT/D7/D7/CX/D3/D2 /D3/CU /CV/CT/D2/CT/D7 /CX/D7 /CT/D5/D9/CP/D0/D0/DD/CX/D1/D4 /D3/D6/D8/CP/D2 /D8 /D8/D3 /D8/CW/CT /CS/CT/AC/D2/CX/D8/CX/D3/D2 /CP/D2/CS /D8/D3 /D8/CW/CT /CQ/CX/D3/D0/D3/CV/DD /D3/CU /D3/D6/B9/CV/CP/D2/D7/BA /CB/CX/D2/CV/D0/CT/B9/D4/CP/D7/D7/B8 /D4/CP/D6/D8/CX/CP/D0 /D7/CT/D5/D9/CT/D2/CR/CX/D2/CV /D3/CU /CR/D3/D1/D4/D0/CT/D1/CT/D2/B9/D8/CP/D6/DD /BW/C6/BT /B4/CR/BW/C6/BT/B5 /CR/D0/D3/D2/CT/D7 /CU/D6/D3/D1 /D3/D2/CT /D3/D6 /CQ /D3/D8/CW /CT/D2/CS/D7 /D8/D3/CV/CT/D2/CT/D6/CP/D8/CT /CT/DC/D4/D6/CT/D7/D7/CT/CS /D7/CT/D5/D9/CT/D2/CR/CT /D8/CP/CV/D7 /B4/BX/CB/CC/D7/B5 /D4/D6/D3 /DA/CX/CS/CT/D7 /CP/D6/CP/D4/CX/CS /D1/CT/D8/CW/D3 /CS /D3/CU /CV/CT/D2/CT /CS/CX/D7/CR/D3 /DA /CT/D6/DD /D8/CW/CP/D8 /CW/CP/D7 /CQ /CT/CT/D2 /DB/CX/CS/CT/D0/DD/CP/D4/D4/D0/CX/CT/CS /D8/D3 /CW /D9/D1/CP/D2 /CP/D2/CS /D3/D8/CW/CT/D6 /D7/D4 /CT/CR/CX/CT/D7/BA/CC/CW/CT /D8/CW /DD/D1 /D9/D7 /CX/D7 /CP /CQ/CX/D0/D3/CQ /CT/CS /CV/D0/CP/D2/CS /D0/D3 /CR/CP/D8/CT/CS /CX/D2 /D8/CW/CT /CP/D2/B9/D8/CT/D6/CX/D3/D6 /D4/CP/D6/D8 /D3/CU /D8/CW/CT /D7/D9/D4 /CT/D6/CX/D3/D6 /D1/CT/CS/CX/CP/D7/D8/CX/D2 /D9/D1/B8 /D4 /D3/D7/D8/CT/D6/CX/D3/D6 /D8/D3/D8/CW/CT /D7/D8/CT/D6/D2 /D9/D1 /CP/D2/CS /CP/D2 /D8/CT/D6/CX/D3/D6 /D8/D3 /D8/CW/CT /CV/D6/CT/CP/D8 /DA /CT/D7/D7/CT/D0/D7 /CP/D2/CS /D9/D4/B9/D4/CT /D6 /D4/CP/D6/D8 /D3/CU /D8/CW/CT /CW/CT/CP/D6/D8/BA /CC/CW/CT /CV/D0/CP/D2/CS /D6/CT/CP/CR /CW/CT/D7 /CX/D8/D7 /CV/D6/CT/CP/D8/CT/D7/D8/D7/CX/DE/CT /CY/D9/D7/D8 /D4/D6/CX/D3/D6 /D8/D3 /CQ/CX/D6/D8/CW/BA /CC/CW/CT /D8/CW /DD/D1 /D9/D7 /CX/D7 /D8/CW/CT /CR/CT/D2 /D8/D6/CP/D0/D0/DD/D1/D4/CW/D3/CX/CS /D3/D6/CV/CP/D2 /D8/CW/CP/D8 /D4/D6/D3 /DA/CX/CS/CT/D7 /CP /D7/D4 /CT/CR/CX/CP/D0/CX/DE/CT/CS /D1/CX/CR/D6/D3 /CT/D2/B9/DA/CX/D6/D3/D2/D1/CT/D2 /D8 /CU/D3/D6 /D8/CW/CT /D1/CP/D8/D9/D6/CP/D8/CX/D3/D2 /CP/D2/CS /D7/CT/D0/CT/CR/D8/CX/D3/D2 /D3/CU /D8/CW/CT /D1/CP/B9/CY/D3/D6/CX/D8 /DD /D3/CU /CC /D0/DD/D1/D4/CW/D3 /CR/DD/D8/CT/D7/BA /C7/D2/D0/DD /BD/B1/B9/BH/B1 /D3/CU /D8/CW /DD/D1/D3 /CR/DD/D8/CT/D7/CX/D2 /D8/CW/CT /D8/CW /DD/D1 /D9/D7 /D6/CT/CP/CR /CW /D1/CP/D8/D9/D6/CX/D8 /DD /B8 /CP/D2/CS /D1/D3/D7/D8 /D9/D2/CS/CT/D6/CV/D3 /D4/D6/D3/B9/CV/D6/CP/D1/D1/CT/CS /CR/CT/D0/D0 /CS/CT/CP/D8/CW /B4/CP/D4 /D3/D4/D8/D3/D7/CX/D7/B5/BA/C1/D2 /D8/CT/D6/CS/CX/CV/CX/D8/CP/D8/CT/CS /CR/CT/D0/D0/D7 /CP/D2/CS /D1/CP/CR/D6/D3/D4/CW/CP/CV/CT/D7 /CP/D4/D4 /CT/CP/D6 /CX/D2/D8/CW/CT /CU/CT/D8/CP/D0 /D8/CW /DD/D1 /D9/D7 /CP/D8 /CF /CT/CT/CZ /BD/BG /D3/CU /CV/CT/D7/D8/CP/D8/CX/D3/D2/BA /BT /D8 /CF /CT/CT/CZ/BD/BJ/B8 /D8/CW/CT /D8/CW /DD/D1 /D9/D7 /CX/D7 /CU/D9/D0/D0/DD /CS/CX/AB/CT/D6/CT/D2 /D8/CX/CP/D8/CT/CS/B8 /D4/D6/D3 /CS/D9/CR/CX/D2/CV /DA/CX/B9/CP/CQ/D0/CT /D0/DD/D1/D4/CW/D3 /CR/DD/D8/CT/D7 /B4/BD /B5/BA /CC/CW/CT /D9/D2/CX/D5/D9/CT /CR /CW/CP/D6/CP/CR/D8/CT/D6/CX/D7/D8/CX/CR /D3/CU/D8/CW/CT /BD/BC/BC/B9/CS/CP /DD/B9/D3/D0/CS /CU/CT/D8/CP/D0 /D8/CW /DD/D1 /D9/D7 /CX/D7 /D8/CW/CP/D8 /CX/D8 /CX/D7 /CP/D8 /CP /CS/CT/DA /CT/D0/D3/D4/B9/D1/CT/D2 /D8/CP/D0 /D8/D9/D6/D2/CX/D2/CV /D4/D3 /CX /D2 /D8 /CU/D6/D3/D1 /D4/D6/CT/B9/CC /D8/D3 /D4/D6/D3/B9/CC /CR/CT/D0/D0/BA /CC/CW/CT/D6/CT/B9/A3/BV/D3/D6/D6/CT/D7/D4 /D3/D2/CS/CX/D2/CV /CP/D9/D8/CW/D3/D6/BA/BX/B9/D1/CP/CX/D0/BM /CW /D9/D7/D2/BS/CV/CT/D2/D3/D1/CX/CR/D7/BA/D3/D6/CV/BA/CR/D2 /CU/D3/D6/CT/B8 /D0/D3 /CR/CP/D8/CX/D2/CV /CV/CT/D2/CT/D7 /D6/CT/D0/CP/D8/CT/CS /DB/CX/D8/CW /D8/CW /DD/D1 /D9/D7 /CS/CT/DA /CT/D0/D3/D4/D1/CT/D2 /D8/CP/D2/CS /CC /CR/CT/D0/D0 /CS/CX/AB/CT/D6/CT/D2 /D8/CX/CP/D8/CX/D3/D2 /CX/D7 /DB /D3/D6/D8/CW /DD /D3/CU /CX/D2 /DA /CT/D7/D8/CX/CV/CP/D8/CX/D3/D2/BA/CC /D3 /D3/CQ/D8/CP/CX/D2 /CP/D2 /CX/D2/CX/D8/CX/CP/D0 /D3 /DA /CT/D6/DA/CX/CT/DB /D3/CU /CV/CT/D2/CT /CS/CX/DA /CT/D6/D7/CX/D8 /DD /CP/D2/CS/CT/DC/D4/D6/CT/D7/D7/CX/D3/D2 /D4/CP/D8/D8/CT/D6/D2 /CX/D2 /D4 /D3/D6/CR/CX/D2/CT /D8/CW /DD/D1 /D9/D7/B8 /BD/BD/B8/BJ/BD/BE /BX/CB/CC/D7/CU/D6/D3/D1 /CP /BD/BC/BC/B9/CS/CP /DD/B9/D3/D0/CS /D4 /D3/D6/CR/CX/D2/CT /CU/CT/D8/CP/D0 /D8/CW /DD/D1 /D9/D7 /CR/BW/C6/BT /D0/CX/B9/CQ/D6/CP/D6/DD /B8 /D2/CP/D1/CT/CS /BY/CC/CH/B8 /DB /CT/D6/CT /D7/CT/D5/D9/CT/D2/CR/CT/CS /CP/D2/CS /CP/D2/CP/D0/DD/DE/CT/CS/BA/CA/CT/D7/D9/D0/D8/D7/CC/CW/CT /CX/D2/D7/CT/D6/D8 /D7/CX/DE/CT /D3/CU /D8/CW/CT /BY/CC/CH /D0/CX/CQ/D6/CP/D6/DD /DB /CP/D7 /BC/BA/BI/B9/BI /C3/CQ/BA/BD/BD/B8/BJ/BD/BE /CR/D0/D3/D2/CT/D7 /DB /CT/D6/CT /D6/CP/D2/CS/D3/D1/D0/DD /D4/CX/CR /CZ /CT/CS /CP/D2/CS /D7/CT/D5/D9/CT/D2/CR/CT/CS/CU/D6/D3/D1 /D8/CW/CT /BF /BC/CT/D2/CS/BA /BT/CU/D8/CT/D6 /D6/CT/D1/D3 /DA/CX/D2/CV /CP/D0/D0 /D7/CT/D5/D9/CT/D2/CR/CT/D7 /D8/CW/CP/D8/DB /CT/D6/CT /CT/CX/D8/CW/CT/D6 /CR/D3/D2 /D8/CP/D1/CX/D2/CP/D8/CT/CS /D3/D6 /D3/CU /D0/D3 /DB /D5/D9/CP/D0/CX/D8 /DD /B4/C9/BE/BC/BO/BD/BC/BC/CQ/D4/B5/B8 /BJ/B8/BC/BJ/BD /CR/D0/CT/CP/D2/CT/CS /BX/CB/CC /D7/CT/D5/D9/CT/D2/CR/CT/D7 /DB /CT/D6/CT /CP /DA /CP/CX/D0/CP/CQ/D0/CT /CU/D3/D6/CU/D9/D6/D8/CW/CT/D6 /CP/D2/CP/D0/DD/D7/CX/D7/BA /CC/CW/CT /CP /DA /CT/D6/CP/CV/CT /D6/CT/CP/CS/B9/D0/CT/D2/CV/D8/CW /D3/CU /CR/D0/CT/CP/D2/CT/CS/BX/CB/CC/D7 /DB /CP/D7 /BG/BE/BJ /CQ/D4/BA /CC/CW/CT /CR/D0/CT/CP/D2/CT/CS /BX/CB/CC/D7 /DB /CT/D6/CT /CP/D7/D7/CT/D1 /CQ/D0/CT/CS/CX/D2 /D8/D3 /BL/BH/BL /CR/D3/D2 /D8/CX/CV/D7 /CP/D2/CS /BF/B8/BC/BJ/BG /D7/CX/D2/CV/D0/CT/D8/D7 /B4/CR/D0/D9/D7/D8/CT/D6/D7/B5 /CQ /DD /D8/CW/CT/C8/C0/CA/BT/C8 /D4/D6/D3/CV/D6/CP/D1/BA /BU/D0/CP/D7/D8 /D7/CT/CP/D6/CR /CW /D7/CW/D3 /DB /CT/CS /D8/CW/CP/D8 /BE/B8/BF/BG/BH/CR/D0/D9/D7/D8/CT/D6/D7 /B4/BH/B8/BG/BG/BE /BX/CB/CC/D7/B5 /CW/CP/CS /CW/D3/D1/D3/D0/D3/CV/D9/CT/D7 /CX/D2 /BZ/CT/D2/BU/CP/D2/CZ/BA/BT/D1/D3/D2/CV /D8/CW/CT/D1/B8 /BH/B8/BD/BD/BE /B4/BJ/BE/BA/BF/BC/B1/B5 /BX/CB/CC/D7 /CW/CP/CS /CU/D9/D2/CR/D8/CX/D3/D2/CP/D0/CW/D3/D1/D3/D0/D3/CV/D9/CT/D7 /CX/D2 /C6/CA/B8 /CB/DB/CX/D7/D7/C8/D6/D3/D8 /D3/D6 /CW /D9/D1/CP/D2/B8 /CR/CP/D8/D8/D0/CT /CP/D2/CS/D1/D3/D9/D7/CT /CD/D2/CX/CV/CT/D2/CT /CS/CP/D8/CP/CQ/CP/D7/CT/D7/B8 /D6/CT/D4/D6/CT/D7/CT/D2 /D8/CX/D2/CV /BE/B8/BD/BJ/BL /D9/D2/CX/D5/D9/CT/CV/CT/D2/CT/D7/BA /CC/CW/CT /D3/D8/CW/CT/D6 /BD/B8/BI/BE/BL /B4/BE/BF/BA/BC/BG/B1/B5 /BX/CB/CC/D7 /CS/CX/CS /D2/D3/D8 /D7/CW/D3 /DB/CP/D2 /DD /D7/CX/CV/D2/CX/AC/CR/CP/D2 /D8 /CW/D3/D1/D3/D0/D3/CV/DD /D8/D3 /CZ/D2/D3 /DB/D2 /D7/CT/D5/D9/CT/D2/CR/CT/D7 /B4/CC /CP/CQ/D0/CT/CB/BD/B5/BA/BT/D0/D0 /D8/CW/CT /CR/D0/D9/D7/D8/CT/D6/D7 /CP/D2/D2/D3/D8/CP/D8/CT/CS /CX/D2 /BZ/CT/D2/BU/CP/D2/CZ /DB /CT/D6/CT /CR/D0/CP/D7/B9/D7/CX/AC/CT/CS /CX/D2 /D8/D3 /D7/CT/DA /CT/D2 /CV/D6/D3/D9/D4/D7 /CP/CR/CR/D3/D6/CS/CX/D2/CV /D8/D3 /D8/CW/CT/CX/D6 /CU/D9/D2/CR/B9/BZ/CT/D2/D3/BA/B8 /C8/D6/D3/D8/BA /B2 /BU/CX/D3/CX/D2/CU/D3/BA /CE /D3/D0/BA /BD /C6/D3/BA /BE /C5/CP /DD /BE/BC/BC/BF /BD/BJ/BDThis is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/f5/main.PMC5172427.pdf
4 November 2003 279This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,OADS,/arxiv_data1/oa_pdf/67/92/main.PMC5172428.pdf
/BX/CS/CX/D8/D3/D6/CX/CP/D0/CB/CR/CX/CT/D2/CR/CT /CP/D2/CS /CC /CT/CR /CW/D2/D3/D0/D3/CV/DD /C1/D7 /C6/D3/D8 /CB/CX/D1/D4/D0/DD /BX/D5/D9/CP/D0 /D8/D3 /CB/CR/CX/B9/CC /CT/CR /CW/CG/CX/D2/CV/D1/CX/D2 /C4/CX/BZ/D6 /CP/CS/D9/CP/D8/CT /CB/CR/CW/D3 /D3/D0/B8 /BV/CW/CX/D2/CT/D7/CT /BT /CR /CP/CS/CT/D1/DD /D3/CU /CB/CR/CX/CT/D2/CR /CT/D7/B8 /BU/CT/CX/CY/CX/D2/CV /BD/BC/BC/BC/BF/BL/B8 /BV/CW/CX/D2/CP/CC/CW/CT /D8/CT/D6/D1/D7 /CK/D7/CR/CX/CT/D2/CR/CTꜼ /B4/C0/CP/D2 /DD/D9 /C8/CX/D2 /DD/CX/D2/BM /C3 /AM /CT/DC/D9 /AJ /CT /B5 /CP/D2/CS/CK/D8/CT/CR /CW/D2/D3/D0/D3/CV/DDꜼ /B4/C2 /AI /AG/D7/CW /AI /D9 /B5/B8 /CX/D2 /DB /CT/D7/D8/CT/D6/D2 /D0/CP/D2/CV/D9/CP/CV/CT/D7/B8 /CP/D6/CT /D9/D7/D9/B9/CP/D0/D0/DD /D9/D7/CT/CS /D7/CT/D4/CP/D6/CP/D8/CT/D0/DD /DB/CX/D8/CW /CS/CX/AB/CT/D6/CT/D2 /D8 /D1/CT/CP/D2/CX/D2/CV/D7 /D3/D6 /D8/D3/B9/CV/CT/D8/CW/CT/D6 /CP/D7 /CK/D7/CR/CX/CT/D2/CR/CT /CP/D2/CS /D8/CT/CR /CW/D2/D3/D0/D3/CV/DDꜼ/BA /C0/D3 /DB /CT/DA /CT/D6/B8 /D8/CW/CT/DD/CP/D6/CT /D3/CU/D8/CT/D2 /D1/CT/D2 /D8/CX/D3/D2/CT/CS /CP/D7 /CK/C3 /AM /CT/DC/D9 /AJ /CT /C2 /AI /AG/D7/CW /AI /D9 Ꜽ/B8 /D3/D6 /CT/DA /CT/D2 /CP/CQ/CQ/D6/CT/B9/DA/CX/CP/D8/CT/CS /CP/D7 /CK/D7/CR/CX/B9/D8/CT/CR /CW /B4/C3 /AM /CT/CY /AI /AG /B5Ꜽ /CX/D2 /BV/CW/CX/D2/CP /B4/C1/D8 /CX/D7 /D9/D7/CT/CS /CX/D2 /CP/D7/CX/D1/CX/D0/CP/D6 /DB /CP /DD /CX/D2 /C2/CP/D4/CP/D2/B5/BA /C1/D8 /D2/D3/D8 /D3/D2/D0/DD /CR/CP/D9/D7/CT/D7 /CV/D6/CT/CP/D8 /CR/D3/D2/CU/D9/B9/D7/CX/D3/D2 /CX/D2 /CR/D3/D2/CR/CT/D4/D8/D9/CP/D0 /CR/D3/D2 /D8/CT/D2 /D8/B8 /CQ/D9/D8 /CP/D0/D7/D3 /DA /CT/D6/DD /D1/CX/D7/D0/CT/CP/CS/CX/D2/CV/CX/D2 /D4/D6/CP/CR/D8/CX/CR/CT/BA /BV/D3/D2/D7/CR/CX/D3/D9/D7/D0/DD /D3/D6 /D9/D2/CR/D3/D2/D7/CR/CX/D3/D9/D7/D0/DD /B8 /CX/D8 /CT/D5/D9/CP/D8/CT/D7/D8/CT/CR /CW/D2/D3/D0/D3/CV/DD /DB/CX/D8/CW /D7/CR/CX/CT/D2/CR/CT/DG/CS/D3/D2/B3/D8 /DD /D3/D9 /CZ/D2/D3 /DB /D8/CW/CP/D8 /CT/DA /CT/D2/D1/CP/D2 /DD /D4 /D3/D0/CX/D8/CX/CR/CX/CP/D2/D7 /CP/D2/CS /D7/CR /CW/D3/D0/CP/D6/D7 /D6/CT/CV/CP/D6/CS /D7/CR/CX/CT/D2/CR/CT /CP/D7 /CK/D4/D6/D3/B9/CS/D9/CR/D8/CX/DA/CX/D8 /DDꜼ /B4/CF /CT /D7/CW/D3/D9/D0/CS /CZ/D2/D3 /DB /D8/CW/CP/D8 /D7/CR/CX/CT/D2/CR/CT /CX/D8/D7/CT/D0/CU /CX/D7 /D2/D3/D8/CT/D5/D9/CP/D0 /D8/D3 /D4/D6/D3 /CS/D9/CR/D8/CX/DA/CX/D8 /DD /DB/CW/CX/CR /CW /D1 /D9/D7/D8 /CQ/CT /D3/CQ/D8/CP/CX/D2/CT/CS /D8/CW/D6/D3/D9/CV/CW/D8/CT/CR /CW/D2/D3/D0/D3/CV/DD /CP/D7 /DB /CT/D0/D0 /CP/D7 /CP /CR/D3/D1/D4/D0/CT/DC /CP/D2/CS /D7/CT/D6/CX/CP/D0 /D4/D6/D3 /CR/CT/D7/D7 /D8/D3/D1/CP/CZ /CT /CX/D8 /CP /D6/CT/CP/D0/CX/D8 /DD/B5/B8 /CP/D2/CS /D8/CW/CT /D3/D6/CS/CX/D2/CP/D6/CX/CT/D7 /DB /D3/D6/D7/CW/CX/D4 /CX/D8 /CP/D7 /D8/CW/CT/BZ/D3 /CS /D3/CU /CF /CT/CP/D0/D8/CW/BR/C1/D2 /CU/CP/CR/D8/B8 /D7/CR/CX/CT/D2/CR/CT /CP/D2/CS /D8/CT/CR /CW/D2/D3/D0/D3/CV/DD /CP/D6/CT /CR/D0/CT/CP/D6/D0/DD /CS/CX/D7/D8/CX/D2/B9/CV/D9/CX/D7/CW/CP/CQ/D0/CT /CX/D2 /CQ/D3 /D8 /CW /CX/D2 /D8/CT/D2/D7/CX/D3/D2 /CP/D2/CS /CT/DC/D8/CT/D2/D7/CX/D3/D2/BA /CB/CR/CX/CT/D2/CR/CT/CX/D2 /CV/CT/D2/CT/D6/CP/D0 /CX/D7 /D8/CW/CT /CZ/D2/D3 /DB/D0/CT/CS/CV/CT /D7/DD/D7/D8/CT/D1 /DB/CX/D8/CW /D2/CP/D8/D9/D6/CT /CP/D7 /CX/D8/D7/D7/D8/D9/CS/DD/CX/D2/CV /D3/CQ /CY/CT/CR/D8 /B4/D4/D0/D9/D7 /D7/D3 /CR/CX/CT/D8 /DD /CP/D2/CS /CT/DA /CT/D2 /CX/D2/CS/CX/DA/CX/CS/D9/CP/D0/D7/B5/B8/DB/CW/CX/CR /CW /CX/D7 /CP/CR/D5/D9/CX/D6/CT/CS /D8/CW/D6/D3/D9/CV/CW /CT/DC/D4 /CT/D6/CX/D1/CT/D2 /D8/CX/D2/CV/B8 /D6/CT/CP/D7/D3/D2/CX/D2/CV/B8/D4 /CT/D6/CU/CT/CR/D8/CX/D2/CV/B8 /CT/D8/CR/BA /C1/D8 /CP/D0/D7/D3 /CX/D2/CR/D0/D9/CS/CT/D7 /D8/CW/CT /D4/D6/D3 /CR/CT/D7/D7 /CP/D2/CS /CX/D2/B9/D7/D8/CX/D8/D9/D8/CX/D3/D2 /D3/CU /D7/CR/CX/CT/D2 /D8/CX/AC/CR /CP/CR/D8/CX/DA/CX/D8/CX/CT/D7/BA /C0/D3 /DB /CT/DA /CT/D6/B8 /D8/CT/CR /CW/D2/D3/D0/D3/CV/DD/CX/D7 /D8/CW/CT /D8/D3/D8/CP/D0/CX/D8 /DD /CP/D2/CS /DB /D3/D6/CZ/CX/D2/CV /D4/D6/D3 /CR/CT/D7/D7 /D3/CU /CP/D0/D0 /D1/CT/D8/CW/D3 /CS/D7/B8/D4/D6/D3/CV/D6/CP/D1/D7/B8 /D2/D3/D6/D1/D7/B8 /D1/CP/D8/CT/D6/CX/CP/D0/D7/B8 /CT/D8/CR/BA/B8 /CR/D6/CT/CP/D8/CT/CS /CQ /DD /D8/CW/CT /D3/D4/B9/CT/D6/CP/D8/D3/D6/D7 /DB/CW/D3 /CP/D8/D8/CT/D1/D4/D8 /D8/D3 /CR/D3/D2 /D8/D6/D3/D0 /D8/CW/CT /D3/CQ /CY/CT/CR/D8/CX/DA /CT /CT/D2 /DA/CX/D6/D3/D2/B9/D1/CT/D2 /D8 /CP/D2/CS /D8/D3 /D1/CT/CT/D8 /D8/CW/CT /D2/CT/CT/CS/D7 /D3/CU /D0/CX/DA/CX/D2/CV /CP/D2/CS /D4/D6/D3 /CS/D9/CR/B9/D8/CX/D3/D2 /CQ /DD /D9/D7/CX/D2/CV /CZ/D2/D3 /DB/D0/CT/CS/CV/CT/B8 /CT/D7/D4 /CT/CR/CX/CP/D0/D0/DD /D8/CW/CT /CZ/D2/D3 /DB/D0/CT/CS/CV/CT /D3/CU/D7/CR/CX/CT/D2/CR/CT/BA /BX/D8 /DD/D1/D3/D0/D3/CV/CX/CR/CP/D0/D0/DD /B8 /D8/CW/CT /DB /D3/D6/CS /CK/D7/CR/CX/CT/D2/CR/CTꜼ /CT/D1/CT/D6/CV/CT/CS/CX/D2 /D8/CW/CT /BD/BG/D8/CW /CR/CT/D2 /D8/D9/D6/DD /CP/D2/CS /D3/D6/CX/CV/CX/D2/CP/D8/CT/CS /CU/D6/D3/D1 /D8/CW/CT /C4/CP/D8/CX/D2/DB /D3/D6/CS /D7/CR/CX/CT/D2/D8/CX/CP /D8/CW/CP/D8 /D1/CT/CP/D2/D7 /CZ/D2/D3 /DB/D0/CT/CS/CV/CT/BA /C7/D2 /D8/CW/CT /D3/D8/CW/CT/D6/CW/CP/D2/CS/B8 /D8/CW/CT /DB /D3/D6/CS /CK/D8/CT/CR /CW/D2/D3/D0/D3/CV/DDꜼ /CX/D7 /D8/CW/CT /CR/D3/D1/D4 /D3/D9/D2/CS /D3/CU /D8 /DB /D3/BZ/D6/CT/CT/CZ /DB /D3/D6/CS/D7/DG/D8/CT /CR/CW/D2/CT /B4/D7/CZ/CX/D0/D0/B8 /CR/D6/CP/CU/D8/B5 /CP/D2/CS /D0/D3 /CV/D3/D7 /B4/D0/D3/CV/CX/CR/B8/DB /D3/D6/CS/B8 /D7/D4 /CT/CT/CR /CW/B5/B8 /D9/D7/CT/CS /CU/D3/D6 /CS/CT/D7/CR/D6/CX/CQ/CX/D2/CV /CP/D6/D8/CX/CU/CP/CR/D8/D7 /CP/D2/CS /D8/CT/CR /CW/B9/D2/CX/D5/D9/CT/D7 /CX/D2 /D1/CP/CZ/CX/D2/CV /D8/CW/CT/D1/B8 /CP/D2/CS /DB /CP/D7 /CU/D3/D6/D1/CP/D0/D0/DD /CP/CS/CP/D4/D8/CT/CS /CX/D2/BD/BK/BH/BL/BA /C4/CP/D8/CT/D6/B8 /CP/D0/D8/CW/D3/D9/CV/CW /D8/CW/CT /CR/D3/D2/CR/CT/D4/D8/D7 /D3/CU /D8/CW/CT /D8 /DB /D3 /DB /D3/D6/CS/D7/CR /CW/CP/D2/CV/CT/CS /D8/D3 /D7/D3/D1/CT /CT/DC/D8/CT/D2 /D8/B8 /D8/CW/CT/CX/D6 /CQ/CP/D7/CX/CR /D1/CT/CP/D2/CX/D2/CV/D7 /CW/CP /DA /CT/CQ/CT /CT /D2 /D4/D6/CT/D7/CT/D6/DA /CT/CS/BA /CC/CW/CT/D6/CT/CU/D3/D6/CT/B8 /D7/CR/CX/CT/D2/CR/CT /D6/CT/D1/CP/CX/D2/D7 /CX/D2 /D8/CW/CT /CS/D3/B9/D1/CP/CX/D2 /D3/CU /D1/CT/D8/CP/D4/CW /DD/D7/CX/CR/D7 /D7/D9/CR /CW /CP/D7 /CK/C4/CT/CP/D6/D2/CX/D2/CV /B4/CG/D9 /AJ /CT /B5Ꜽ /CP/D2/CS/CK/CF /CP /DD /B4/BW/AI /CP/D3 /B5Ꜽ/B8 /DB/CW/CX/D0/CT /D8/CT/CR /CW/D2/D3/D0/D3/CV/DD /CQ /CT/D0/D3/D2/CV/D7 /D8/D3 /CX/D8/D7 /D3/D4/D4 /D3/D7/B9/CX/D2/CV /CS/D3/D1/CP/CX/D2 /D7/D9/CR /CW /CP/D7 /CK/CB/CZ/CX/D0/D0 /B4/CB/CW /AI /D9 /B5Ꜽ /D3/D6 /CK/CE /CT/D7/D7/CT/D0 /B4/C9 /AI /AG /B5Ꜽ/BA/BX/B9/D1/CP/CX/D0/BM /D0/CX/DC/CX/D2/CV/D1/CX/D2/BS/CV/D7/CR/CP/D7/BA/CP/CR/BA/CR/D2 /C0/CX/D7/D8/D3/D6/CX/CR/CP/D0/D0/DD /B8 /D6/CT/CU/CT/D6/D6/CX/D2/CV /D8/D3 /CQ /D3/D8/CW /CW /D9/D1/CP/D2 /CR/CX/DA/CX/D0/CX/DE/CP/D8/CX/D3/D2/CP/D2/CS /CT/DA /D3/D0/D9/D8/CX/D3/D2/B8 /D7/CR/CX/CT/D2/CR/CT /B4/D6/CT/CU/CT/D6/D7 /D4/D6/CX/D1/CP/D6/CX/D0/DD /D8/D3 /D2/CP/D8/D9/D6/CP/D0 /D7/CR/CX/B9/CT/D2/CR/CT /CX/D2 /D8/CW/CX/D7 /CP/D6/D8/CX/CR/D0/CT/B5 /CP/D2/CS /D8/CT/CR /CW/D2/D3/D0/D3/CV/DD /CW/CP /DA /CT /CS/CT/DA /CT/D0/D3/D4 /CT/CS /CP/D0/B9/D1/D3/D7/D8 /CX/D2/CS/CT/D4 /CT/D2/CS/CT/D2 /D8/D0/DD/DG/D8/CW/CT /D8/D3/D8/CP/D0 /D8/CX/D1/CT /D3/CU /D8/CW/CT/CX/D6 /D1/CP/D6/D6/CX/CP/CV/CT/D3/D6 /CX/D2 /D8/CT/D6/CP/CR/D8/CX/D3/D2 /CX/D7 /D8/D3 /D3 /D7/CW/D3/D6/D8 /D8/D3 /CQ/CT /D8/CP/CZ /CT/D2 /CX/D2 /D8/D3 /CP/CR/CR/D3/D9/D2 /D8/BA/CC /CT/CR /CW/D2/D3/D0/D3/CV/DD /AC/D6/D7/D8 /CP/D4/D4 /CT/CP/D6/CT/CS /CS/D9/D6/CX/D2/CV /D8/CW/CT /D0/CT/D2/CV/D8/CW /DD /CT/DA /D3/D0/D9/B9/D8/CX/D3/D2 /D4/D6/D3 /CR/CT/D7/D7 /CU/D6/D3/D1 /CP/D4 /CT/D7 /D8/D3 /CW /D9/D1/CP/D2/D7/B8 /D7/D9/CR /CW /CP/D7 /D8/D3 /D3/D0 /D1/CP/CZ/CX/D2/CV/CP/D2/CS /AC/D6/CT /CX/CV/D2/CX/D8/CX/D2/CV/BA /C7/D2 /D8/CW/CT /CR/D3/D2 /D8/D6/CP/D6/DD /B8 /D8/CW/CT /D6/CT/CP/D0 /CT/D1/CT/D6/CV/CT/D2/CR/CT/D3/CU /D7/CR/CX/CT/D2/CR/CT /D3/D2/D0/DD /CQ /CT/CV/CP/D2 /CU/D6/D3/D1 /D8/CW/CT /BV/D3/D4 /CT/D6/D2/CX/CR/D9/D7/B9/C6/CT/DB/D8/D3/D2/CA/CT/DA /D3/D0/D9/D8/CX/D3/D2 /CS/D9/D6/CX/D2/CV /D8/CW/CT /BD/BI/D8/CW /CP/D2/CS /BD/BJ/D8/CW /CR/CT/D2 /D8/D9/D6/CX/CT/D7/BA /BX/DA /CT/D2/CX/CU /D3/D2/CT /D8/D6/CP/CR/CT/D7 /CQ/CP/CR /CZ /D8/D3 /D8/CW/CT /CP/D2/CR/CX/CT/D2 /D8 /BZ/D6/CT/CT/CR/CT/B8 /CX/D8/D7 /CW/CX/D7/D8/D3/D6/DD/CX/D7 /D0/CT/D7/D7 /D8/CW/CP/D2 /BF/B8/BC/BC/BC /DD /CT/CP/D6/D7/BA /BY /D3/D6 /CP /D0/D3/D2/CV /D8/CX/D1/CT/B8 /D8/CT/CR /CW/D2/D3/D0/D3/CV/DD/CW/CP/D7 /CP/D0/DB /CP /DD/D7 /CQ/CT /CT /D2 /CP/CR/CR/D3/D1/D4/CP/D2/CX/CT/CS /CQ /DD /CR/D6/CP/CU/D8/D7/D1/CT/D2/B3/D7 /D4/D6/CP/CR/D8/CX/CR/CT/B8/DB/CW/CX/D0/CT /D7/CR/CX/CT/D2/CR/CT /CW/CP/D7 /D4/D6/CX/D1/CP/D6/CX/D0/DD /CQ/CT /CT /D2 /CP/D2 /CK/CT/DC/CR/D0/D9/D7/CX/DA /CT /D6/CX/CV/CW /D8/D7Ꜽ/D3/CU /CP/D6/CX/D7/D8/D3 /CR/D6/CP/D8/CX/CR /D4/CW/CX/D0/D3/D7/D3/D4/CW/CT/D6/D7 /D3/D6 /D4 /CT/D3/D4/D0/CT /DB/CW/D3 /DB /CT/D6/CT /CT/D1/B9/D4/D0/D3 /DD /CT/CS /CQ /DD /D4/D0/D9/D8/D3 /CR/D6/CP/D8/D7 /CU/D6/D3/D1 /D8/CW/CT /CP/D2/CR/CX/CT/D2 /D8 /D8/CX/D1/CT /D8/D3 /D8/CW/CT/C5/CX/CS/CS/D0/CT /BT/CV/CT /CP/D2/CS /CT/DA /CT/D2 /D8/D3 /D8/CW/CT /CT/CP/D6/D0/DD /D4 /CT/D6/CX/D3 /CS /D3/CU /D1/D3 /CS/B9/CT/D6/D2 /D7/CR/CX/CT/D2/CR/CT/BA /C4/D3 /D3/CZ /CT/CS /CQ/CP/CR /CZ /D8/D3 /D8/CW/CT /CQ /CT/CV/CX/D2/D2/CX/D2/CV /D3/CU /D1/D3 /CS/B9/CT/D6/D2 /CP/CV/CT/B8 /D8/CT/CR /CW/D2/D3/D0/D3/CV/DD /CW/CP/CS /CQ/CT /CT /D2 /CS/CT/DA /CT/D0/D3/D4 /CT/CS /CP/D0/D3/D2/CT /DB/CX/D8/CW/B9/D3/D9/D8 /CW/CT/D0/D4 /CU/D6/D3/D1 /D4/D9/D6/CT /D7/CR/CX/CT/D2/CR/CT/BA /CC/CW/CT /CX/D2 /DA /CT/D2 /D8/CX/D3/D2 /D3/CU /D7/D8/CT/CP/D1/CT/D2/CV/CX/D2/CT /D8/CW/CP/D8 /D8/D6/CX/CV/CV/CT/D6/CT/CS /D8/CW/CT /C1/D2/CS/D9/D7/D8/D6/CX/CP/D0 /CA/CT/DA /D3/D0/D9/D8/CX/D3/D2 /DB /CP/D7/CX/D2/CS/CT/CT/CS /D6/CT/D7/D9/D0/D8/CT/CS /CU/D6/D3/D1 /D8/CW/CT /CR/D3/D1/D1/D3/D2 /D7/CT/D2/D7/CT /CP/D2/CS /D4/D6/CP/CR/D8/CX/CR/CP/D0/CT/DC/D4 /CT/D6/CX/CT/D2/CR/CT /D3/CU /CR/D6/CP/CU/D8/D7/D1/CT/D2 /CP/D2/CS /CT/D2/CV/CX/D2/CT/CT/D6/D7/B8 /CQ /CT/D2/CT/AC/D8/CX/D2/CV /D0/CX/D8/B9/D8/D0/CT /CU/D6/D3/D1 /D1/CT/CR /CW/CP/D2/CX/CR/D7 /CP/D2/CS /D8/CW/CT/D6/D1/D3/D0/D3/CV/DD /BA /C1/D8 /DB /CP/D7 /D2/D3/D8 /D9/D2 /D8/CX/D0/D8/CW/CT /BD/BK/BC/BC/D7 /D8/CW/CP/D8 /D8/CT/CR /CW/D2/D3/D0/D3/CV/DD /CW/CP/CS /D4/D6/D3/CV/D6/CT/D7/D7/CT/CS /D8/D3 /D6/CT/D0/DD /D3/D2/D7/CR/CX/CT/D2/CR/CT/BA /CC/CW/CT /D6/CX/D7/CX/D2/CV /D3/CU /CS/DD /CT/B9/D7/DD/D2 /D8/CW/CT/D7/CX/D7 /CX/D2/CS/D9/D7/D8/D6/DD /CX/D2 /BZ/CT/D6/B9/D1/CP/D2 /DD /CX/D2 /D8/CW/CT /BD/BK/BH/BC/D7 /DB /CP/D7 /D8/CW/CT /AC/D6/D7/D8 /CT/DC/CP/D1/D4/D0/CT /D3/CU /CR/D3/D1 /CQ/CX/D2/CX/D2/CV/D7/CR/CX/CT/D2/CR/CT/B8 /D8/CT/CR /CW/D2/D3/D0/D3/CV/DD /B8 /CP/D2/CS /CX/D2/CS/D9/D7/D8/D6/DD /BA/BT/CU/D8/CT/D6 /D8/CW/CT /CF /D3/D6/D0/CS /CF /CP/D6 /C1/C1 /B8 /D8/CW/CT /D6/CT/D0/CP/D8/CX/D3/D2/D7/CW/CX/D4 /CQ/CT /D8 /DB /CT/CT/D2/D7/CR/CX/CT/D2/CR/CT /CP/D2/CS /D8/CT/CR /CW/D2/D3/D0/D3/CV/DD /CW/CP/D7 /CQ /CT/CR/D3/D1/CT /CR/D0/D3/D7/CT/D6 /CP/D2/CS /CR/D0/D3/D7/CT/D6/BM/D7/CR/CX/CT/D2/CR/CT /CS/CT/D7/CX/D6/CT/D7 /D8/CW/CT /D7/D9/D4/D4 /D3/D6/D8 /D3/CU /D8/CT/CR /CW/D2/D3/D0/D3/CV/DD /B8 /DB/CW/CX/D0/CT /D8/CT/CR /CW/B9/D2/D3/D0/D3/CV/DD /D2/CT/CT/CS/D7 /D7/CR/CX/CT/D2/CR/CT /CP/D7 /CX/D8/D7 /D7/D8/CT/D4/D4/CX/D2/CV/B9/D7/D8/D3/D2/CT/B8 /CT/D7/D4 /CT/CR/CX/CP/D0/D0/DD/CQ/CT /D8 /DB /CT/CT/D2 /D8/CW/CT /D7/D3/B9/CR/CP/D0/D0/CT/CS /CK/CQ/CX/CV /D7/CR/CX/CT/D2/CR/CTꜼ /CP/D2/CS /CK/CW/CX/CV/CW /D8/CT/CR /CW/B9/D2/D3/D0/D3/CV/DDꜼ/BA /BT/D7 /CP /D6/CT/D7/D9/D0/D8/B8 /D7/CR/CX/CT/D2/CR/CT /D7/D3/D1/CT/D8/CX/D1/CT/D7 /CX/D7 /D8/CX/D2 /D8/CT/CS /DB/CX/D8/CW/D4 /D3/D0/CX/D8/CX/CR/D7/B8 /D1/CX/D0/CX/D8/CP/D6/DD /B8 /D3/D6 /CR/D3/D1/D1/CT/D6/CR/CT/B8 /CP/D2/CS /D8/CW/CT /D8/D6/CP/D2/D7/CU/D3/D6/D1/CP/B9/D8/CX/D3/D2 /CU/D6/D3/D1 /D7/CR/CX/CT/D2/CR/CT /D8/D3 /D8/CT/CR /CW/D2/D3/D0/D3/CV/DD /CX/D7 /CQ /CT/CR/D3/D1/CX/D2/CV /D1/D3/D6/CT /CP/D2/CS/D1/D3/D6/CT /CS/CX/D6/CT/CR/D8 /CP/D2/CS /CX/D2/D7/D8/CP/D2 /D8/CP/D2/CT/D3/D9/D7/BA /C8 /CP/D6/D8/CX/CR/D9/D0/CP/D6/D0/DD /CX/D2 /D8/CW/CT/AC/CT/D0/CS/D7 /D3/CU /CX/D2/CU/D3/D6/D1/CP/D8/CX/D3/D2 /D8/CT/CR /CW/D2/D3/D0/D3/CV/DD /CP/D2/CS /CV/CT/D2/CT/D8/CX/CR /CT/D2/CV/CX/D2/CT/CT/D6/B9/CX/D2/CV/B8 /D8/CW/CT /CU/D6/D3/D2 /D8/CX/CT/D6 /D3/CU /D7/CR/CX/CT/D2/CR/CT /CP/D2/CS /D8/CT/CR /CW/D2/D3/D0/D3/CV/DD /CW/CP/D7 /CP/D0/D6/CT/CP/CS/DD/CQ /CT/CT/D2 /D7/D3 /D1 /D9/D6/CZ/DD /CX/D2 /D7/D3/D1/CT /D4/D6/D3 /CY/CT/CR/D8/D7 /D8/CW/CP/D8 /D8/CW/CT/D6/CT /CR/D3/D1/CT/D7/D8/CW/CT /D7/D3/B9/CR/CP/D0/D0/CT/CS /CK/CR/D3/CV/D2/CX/D8/CX/DA /CT/B9/D8/CT/CR /CW/D2/CX/CR/CP/D0 /CR/D3/D1/D4/D0/CT/DCꜼ/BA /C6/CT/DA /CT/D6/B9/D8/CW/CT/D0/CT/D7/D7/B8 /D7/CR/CX/CT/D2/CR/CT /CP/D2/CS /D8/CT/CR /CW/D2/D3/D0/D3/CV/DD /CP/D6/CT /CV/CT/D2/CT/D6/CP/D0/D0/DD /D2/D3/D8 /D8/CW/CT/D7/CP/D1/CT /CP/D2/CS /D7/CW/D3/D9/D0/CS /D2/D3/D8 /CQ/CT /CQ/D0/CT/D2/CS/CT/CS /D8/D3/CV/CT/D8/CW/CT/D6/BA/CB/D3 /DB/CW/CP/D8 /D3/D2 /CT/CP/D6/D8/CW /CX/D7 /D8/CW/CT /CS/CX/AB/CT/D6/CT/D2/CR/CT /CQ/CT /D8 /DB /CT/CT/D2 /D7/CR/CX/CT/D2/CR/CT/CP/D2/CS /D8/CT/CR /CW/D2/D3/D0/D3/CV/DD/BR /C1/D8 /CX/D7 /CW/CP/D6/CS /D8/D3 /D1/CP/CZ /CT /CP /CR/D3/D1/D4/D0/CT/D8/CT /D0/CX/D7/D8/B8/BZ/CT/D2/D3/BA/B8 /C8/D6/D3/D8/BA /B2 /BU/CX/D3/CX/D2/CU/D3/BA /CE /D3/D0/BA /BD /C6/D3/BA /BE /C5/CP /DD /BE/BC/BC/BF /BK/BJThis is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a2/66/main.PMC5172429.pdf
Pr ot.Bioinf o. V ol.2No.1e Fbrua ry20 04 43This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c1/c3/main.PMC5172430.pdf
"Researchers have made great advancement on the study of preventing, diagnosing and treat- ing the SARS disease, as well as genomic se- quencing and detection technology of SARS- CoV (http://www.cas.ac.cn/html/Dir/2003/05/03/ 1847.htm; http://tech.sina.com.cn/ae/2003-05-30/ 0740192503.shtml).",Non-OADS,/arxiv_data1/oa_pdf/2d/cf/main.PMC5172431.pdf
"So far, multiplex PCR has been used to detect transgenic products ( 1) and many viruses, such as smallpox virus (http://www.who.int/emc/pdfs/smallpoxenglish.pdf) and newcastle disease virus ( 2{3).",OADS,/arxiv_data1/oa_pdf/2d/cf/main.PMC5172431.pdf
Five primers recommended by World Health Organization (WHO) were used to amplify the fragments by single PCR and multiplex PCR (http://www.who.int/csr/sars/primers/en/print.html).,Non-OADS,/arxiv_data1/oa_pdf/2d/cf/main.PMC5172431.pdf
1 February 2004 55This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2d/cf/main.PMC5172431.pdf
1 February 2004 47This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f8/89/main.PMC5172432.pdf
"Sequence analysis, structure prediction and phylogenetic analysis Sequence analysis and structural prediction were per- formed by searching public databases on the web- site servers of NCBI (http://www.ncbi.nlm.nih.gov/ BLAST/), NetStar (http://www.cbs.dtu.dk/services) and Scan Prosite (http://us.expasy.org/cgi-bin/scan prosite).",OADS,/arxiv_data1/oa_pdf/f8/89/main.PMC5172432.pdf
/C5/CT/D8/CW/D3 /CS/D7/BT /CA/CT/CP/D0/B9/CC/CX/D1/CT /CP/D2/CS /BW/DD/D2/CP/D1/CX/CR /BU/CX/D3/D0/D3/CV/CX/CR/CP/D0 /C1/D2/CU/D3/D6/D1/CP/D8/CX/D3/D2 /CA/CT/D8/D6/CX/CT/DA /CP/D0 /CP/D2/CS/BT/D2/CP/D0/DD/D7/CX/D7 /CB/DD/D7/D8/CT/D1 /B4/BU/C1/CA/BT/CB/B5/C9/CX /CI/CW/D3/D9 /BD/BN /BE/B8 /C0/D3/D2/CV /CI/CW/CP/D2/CV /BD/B8 /C5/CT/CX/DD/CX/D2/CV /BZ/CT/D2/CV /BE/B8 /CP/D2/CS /BV/CW/CT/D2/CV/CV/CP/D2/CV /CI/CW/CP/D2/CV /BD/B6/BD/BW/CT/D4 /CP/D6/D8/D1/CT/D2/D8 /D3/CU /BZ/CT/D2/D3/D1/CX/CR/D7 /CP/D2/CS /C8/D6 /D3/D8/CT /D3/D1/CX/CR/D7/B8 /BU/CT/CX/CY/CX/D2/CV /C1/D2/D7/D8/CX/D8/D9/D8/CT /D3/CU /CA /CP/CS/CX/CP/D8/CX/D3/D2 /C5/CT /CS/CX/CR/CX/D2/CT/B8 /BU/CT/CX/CY/CX/D2/CV /BD/BC/BC/BK/BH/BC/B8 /BV/CW/CX/D2/CP/BN/BE/CC/CW/CT /BV/D3/D0 /D0/CT /CV/CT /D3/CU /BT/D4/D4/D0/CX/CT /CS /CB/CR/CX/CT/D2/CR /CT/B8 /BU/CT/CX/CY/CX/D2/CV /C8/D3/D0/DD/D8/CT /CR/CW/D2/CX/CR /CD/D2/CX/DA/CT/D6/D7/CX/D8/DD/B8 /BU/CT/CX/CY/CX/D2/CV /BD/BC/BC/BC/BE/BE/B8 /BV/CW/CX/D2/CP/CC/CW/CT /CP/CX/D1 /D3/CU /D8/CW/CX/D7 /D7/D8/D9/CS/DD /CX/D7 /D8/D3 /CS/CT/D7/CX/CV/D2 /CP /CQ/CX/D3/D0/D3/CV/CX/CR/CP/D0 /CX/D2/CU/D3/D6/D1/CP/D8/CX/D3/D2 /D6/CT/D8/D6/CX/CT/DA /CP/D0 /CP/D2/CS /CP/D2/CP/D0/DD/D7/CX/D7 /D7/DD/D7/B9/D8/CT/D1 /B4/BU/C1/CA/BT/CB/B5 /CQ/CP/D7/CT/CS /D3/D2 /D8/CW/CT /C1/D2 /D8/CT/D6/D2/CT/D8/BA /CD/D7/CX/D2/CV /D8/CW/CT /D7/D4 /CT/CR/CX/AC/CR /D2/CT/D8 /DB /D3/D6/CZ /D4/D6/D3/D8/D3 /CR/D3/D0/B8 /BU/C1/CA/BT/CB/D7/DD/D7/D8/CT/D1 /CR/D3/D9/D0/CS /D7/CT/D2/CS /CP/D2/CS /D6/CT/CR/CT/CX/DA /CT /CX/D2/CU/D3/D6/D1/CP/D8/CX/D3/D2 /CU/D6/D3/D1 /D8/CW/CT /BX/D2 /D8/D6/CT/DE /D7/CT/CP/D6/CR /CW /CP/D2/CS /D6/CT/D8/D6/CX/CT/DA /CP/D0/D7/DD/D7/D8/CT/D1 /D1/CP/CX/D2 /D8/CP/CX/D2/CT/CS /CQ /DD /C6/CP/D8/CX/D3/D2/CP/D0 /BV/CT/D2 /D8/CT/D6 /CU/D3/D6 /BU/CX/D3/D8/CT/CR /CW/D2/D3/D0/D3/CV/DD /C1/D2/CU/D3/D6/D1/CP/D8/CX/D3/D2 /B4/C6/BV/BU/C1/B5 /CX/D2/CD/CB/BT/BA /CC/CW/CT /D0/CX/D8/CT/D6/CP/D8/D9/D6/CT/D7/B8 /D2 /D9/CR/D0/CT/D3/D8/CX/CS/CT /D7/CT/D5/D9/CT/D2/CR/CT/B8 /D4/D6/D3/D8/CT/CX/D2 /D7/CT/D5/D9/CT/D2/CR/CT/D7/B8 /CP/D2/CS /D3/D8/CW/CT/D6 /D6/CT/D7/D3/D9/D6/CR/CT/D7/CP/CR/CR/D3/D6/CS/CX/D2/CV /D8/D3 /D8/CW/CT /D9/D7/CT/D6/B9/CS/CT/AC/D2/CT/CS /D8/CT/D6/D1 /CR/D3/D9/D0/CS /D8/CW/CT/D2 /CQ/CT /D6/CT/D8/D6/CX/CT/DA /CT/CS /CP/D2/CS /D7/CT/D2 /D8 /D8/D3 /D8/CW/CT /D9/D7/CT/D6/CQ /DD /D4/D3 /D4 /D9/D4 /D1/CT/D7/D7/CP/CV/CT /D3/D6 /CQ /DD /BX/B9/D1/CP/CX/D0 /CX/D2/CU/D3/D6/D1/CX/D2/CV /CP/D9/D8/D3/D1/CP/D8/CX/CR/CP/D0/D0/DD /D9/D7/CX/D2/CV /BU/C1/CA/BT/CB /D7/DD/D7/D8/CT/D1/BA/BT/D0/D0 /D8/CW/CT /CX/D2/CU/D3/D6/D1/CP/D8/CX/D3/D2 /D6/CT/D8/D6/CX/CT/DA/CX/D2/CV /CP/D2/CS /CP/D2/CP/D0/DD/DE/CX/D2/CV /D4/D6/D3 /CR/CT/D7/D7/CT/D7 /CP/D6/CT /CS/D3/D2/CT /CX/D2 /D6/CT/CP/D0/B9/D8/CX/D1/CT/BA /BT/D7/CP /D6/D3/CQ/D9/D7/D8 /D7/DD/D7/D8/CT/D1 /CU/D3/D6 /CX/D2 /D8/CT/D0/D0/CX/CV/CT/D2 /D8/D0/DD /CP/D2/CS /CS/DD/D2/CP/D1/CX/CR/CP/D0/D0/DD /D6/CT/D8/D6/CX/CT/DA/CX/D2/CV /CP/D2/CS /CP/D2/CP/D0/DD/DE/CX/D2/CV /D3/D2 /D8/CW/CT/D9/D7/CT/D6/B9/CS/CT/AC/D2/CT/CS /CX/D2/CU/D3/D6/D1/CP/D8/CX/D3/D2/B8 /CX/D8 /CX/D7 /CQ /CT/D0/CX/CT/DA /CT/CS /D8/CW/CP/D8 /BU/C1/CA/BT/CB /DB /D3/D9/D0/CS /CQ/CT /CT/DC/D8/CT/D2/D7/CX/DA /CT/D0/DD /D9/D7/CT/CS /D8/D3/D6/CT/D8/D6/CX/CT/DA /CT /D7/D4 /CT/CR/CX/AC/CR /CX/D2/CU/D3/D6/D1/CP/D8/CX/D3/D2 /CU/D6/D3/D1 /D0/CP/D6/CV/CT /CP/D1/D3/D9/D2 /D8 /D3/CU /CQ/CX/D3/D0/D3/CV/CX/CR/CP/D0 /CS/CP/D8/CP/CQ/CP/D7/CT/D7 /CX/D2 /D2/D3 /DB /CS/CP /DD/D7/BA/CC/CW/CT /D4/D6/D3/CV/D6/CP/D1 /CX/D7 /CP /DA /CP/CX/D0/CP/CQ/D0/CT /D3/D2 /D6/CT/D5/D9/CT/D7/D8 /CU/D6/D3/D1 /D8/CW/CT /CR/D3/D6/D6/CT/D7/D4 /D3/D2/CS/CX/D2/CV /CP/D9/D8/CW/D3/D6/BA/C3/CT/DD /DB /D3/D6/CS/D7/BM /D6/CT/CP/D0/B9/D8/CX/D1/CT /CX/D2/CU/D3/D6/D1/CP/D8/CX/D3/D2 /D6/CT/D8/D6/CX/CT/DA /CP/D0/B8 /D7/CT/D5/D9/CT/D2/CR/CT /CP/D2/CP/D0/DD/D7/CX/D7/B8 /BX/D2 /D8/D6/CT/DE/B8 /BU/C1/CA/BT/CB/CF/CX/D8/CW /D7/D9/CR/CR/CT/D7/D7/CX/DA /CT/D0/DD /CR/CP/D6/D6/DD/CX/D2/CV /D3/D9/D8 /D8/CW/CT /CW /D9/D1/CP/D2 /CV/CT/D2/D3/D1/CT/D4/D6/D3 /CY/CT/CR/D8 /CP/D2/CS /D1/CP/D2 /DD /D3/D8/CW/CT/D6 /CV/CT/D2/D3/D1/CT /D4/D6/D3 /CY/CT/CR/D8/D7/B8 /D8/CW/CT /D2 /D9/D1 /CQ/CT /D6/D3/CU /CQ/CX/D3/D0/D3/CV/CX/CR/CP/D0 /CS/CP/D8/CP /CP/D2/CS /CX/D2/CU/D3/D6/D1/CP/D8/CX/D3/D2 /D7/CW/CP/D6/D4/D0/DD /CX/D2/CR/D6/CT/CP/D7/CT/CS/B4/BD /B5/BA /CC /D3 /CZ/D2/D3 /DB /D8/CW/CT /D0/CP/D8/CT/D7/D8 /D0/CX/D8/CT/D6/CP/D8/D9/D6/CT/D7 /CP/D2/CS /D8/D3 /AC/D2/CS /D3/D9/D8 /D8/CW/CT/D0/CP/D8/CT/D7/D8 /D6/CT/D0/CP/D8/CT/CS /CW/D3/D1/D3/D0/D3/CV/D3/D9/D7 /D7/CT/D5/D9/CT/D2/CR/CT/D7 /CW/CP /DA /CT /CQ /CT/CT/D2 /DA /CT/D6/DD/CX/D1/D4 /D3/D6/D8/CP/D2 /D8 /CX/D2 /D8/CW/CT /AC/CT/D0/CS /D3/CU /CQ/CX/D3/CX/D2/CU/D3/D6/D1/CP/D8/CX/CR/D7/BA /CA/CT/D7/CT/CP/D6/CR /CW/CT/D6/D7/CP/D0/DB /CP /DD/D7 /CT/D2/CR/D3/D9/D2 /D8/CT/D6 /D7/D3/D1/CT /D9/D2/CU/D3/D6/CT/D7/CT/CT/D2 /D4/D6/D3/CQ/D0/CT/D1/D7 /CX/D2 /D8/CW/CT/CX/D6/D6/CT/D7/CT/CP/D6/CR /CW/BA /BY /D3/D6 /CX/D2/D7/D8/CP/D2/CR/CT/B8 /CQ /CT/CR/CP/D9/D7/CT /CP /D6/CT/D7/CT/CP/D6/CR /CW/CT/D6 /CS/D3 /CT/D7 /D2/D3/D8/D6/CT/D8/D6/CX/CT/DA /CT /D8/CW/CT /D6/CT/D0/CP/D8/CT/CS /D0/CX/D8/CT/D6/CP/D8/D9/D6/CT/D7 /CU/D6/D3/D1 /C5/CT/CS/D0/CX/D2/CT /CS/CP/D8/CP/CQ/CP/D7/CT/CX/D2 /D8/CX/D1/CT/B8 /CW/CT /D1/CX/CV/CW /D8 /AC/D2/CS /D7/D3/D1/CT /D0/CX/D8/CT/D6/CP/D8/D9/D6/CT/D7 /D3/CU /D3/D8/CW/CT/D6/D7 /CP/D0/B9/D6/CT/CP/CS/DD /D4/D9/CQ/D0/CX/D7/CW/CT/CS /CP/D2/CS /D4/D6/D3/D1 /D9/D0/CV/CP/D8/CT/CS /CX/D2 /D8/CW/CT /C5/CT/CS/D0/CX/D2/CT/B8/BZ/CT/D2/BU/CP/D2/CZ /CP/D2/CS /D3/D8/CW/CT/D6 /CS/CP/D8/CP/CQ/CP/D7/CT/D7/BA /C1/D2 /D8/CW/CT /AC/CT/D0/CS /D3/CU /D2/D3 /DA /CT/D0/CV/CT/D2/CT /CR/D0/D3/D2/CX/D2/CV /CP/D2/CS /CU/D9/D2/CR/D8/CX/D3/D2 /D7/D8/D9/CS/CX/CT/D7/B8 /D6/CT/D7/CT/CP/D6/CR /CW/CT/D6/D7 /D4/CT /D6 /B9/CW/CP/D4/D7 /DB/CX/D0/D0 /CU/CP/CR/CT /D8/CW/CT /D7/CP/D1/CT /CT/D1 /CQ/CP/D6/D6/CP/D7/D7/CX/D2/CV /D7/CX/D8/D9/CP/D8/CX/D3/D2 /D8/CW/CP/D8/D8/CW/CT/DD /CS/D3 /D2/D3/D8 /CZ/D2/D3 /DB /DB/CW/CT/D8/CW/CT/D6 /D8/CW/CT/CX/D6 /CR/D3/D2/CR/CT/D6/D2/CT/CS /CV/CT/D2/CT /D7/CT/B9/D5/D9/CT/D2/CR/CT/D7 /D3/D6 /D4/D6/D3/D8/CT/CX/D2 /D7/CT/D5/D9/CT/D2/CR/CT/D7 /CW/CP /DA /CT /CQ /CT/CT/D2 /CP/D4/D4/D0/CX/CT/CS /CU/D3/D6 /CP/D4/CP/D8/CT/D2 /D8 /D3/D6 /D4/D6/D3/D1 /D9/D0/CV/CP/D8/CT/CS /CQ /DD /D3/D8/CW/CT/D6/D7/BA /CC/CW/CT/D6/CT/CU/D3/D6/CT/B8 /CX/D8 /CX/D7 /D2/CT/CR/B9/CT/D7/D7/CP/D6/DD /D8/D3 /CS/CT/D7/CX/CV/D2 /CP/D2 /CX/D2 /D8/CT/D0/D0/CX/CV/CT/D2 /D8 /CP/D2/CS /CS/DD/D2/CP/D1/CX/CR /D7/CT/CP/D6/CR /CW/CX/D2/CV/CT/D2/CV/CX/D2/CT /CU/D3/D6 /CQ/CX/D3/D0/D3/CV/CX/CR/CP/D0 /CX/D2/CU/D3/D6/D1/CP/D8/CX/D3/D2 /D6/CT/D8/D6/CX/CT/DA/CX/D2/CV /D8/D3 /CX/D2/B9/CU/D3/D6/D1 /D6/CT/D7/CT/CP/D6/CR /CW/CT/D6/D7/BA /BT /D8 /D8/CW/CX/D7 /CP/D7/D4 /CT/CR/D8/B8 /D8/CW/CT /C6/CP/D8/CX/D3/D2/CP/D0 /BV/CT/D2 /D8/CT/D6/CU/D3/D6 /BU/CX/D3/D8/CT/CR /CW/D2/D3/D0/D3/CV/DD /C1/D2/CU/D3/D6/D1/CP/D8/CX/D3/D2 /B4/C6/BV/BU/C1/B5 /CW/CP/D7 /D4/D6/D3 /DA/CX/CS/CT/CS/D1/CP/D2 /DD /D6/CT/D0/CP/D8/CT/CS /D6/CT/D7/D3/D9/D6/CR/CT/D7 /D3/CU /CQ/CX/D3/CX/D2/CU/D3/D6/D1/CP/D8/CX/CR/D7 /CP/D2/CS /BX/D2 /D8/D6/CT/DE/B4/CW /D8/D8/D4/BM/BB/BB/DB/DB/DB/BA/D2/CR/CQ/CX/BA/D2/D0/D1/BA/D2/CX/CW/BA/CV/D3 /DA/BB/BW/CP/D8/CP/CQ/CP/D7/CT/BB/CX/D2/CS/CT/DC/BA/CW /D8/D1/D0/B5/B4/BE /B5/B8 /DB/CW/CX/CR /CW /CX/D7 /CP /CU/CP/D1/D3/D9/D7 /D7/CT/CP/D6/CR /CW /CP/D2/CS /D6/CT/D8/D6/CX/CT/DA /CP/D0 /D7/DD/D7/D8/CT/D1/CU/D6/D3/D1 /CS/CP/D8/CP/CQ/CP/D7/CT/D7 /CP/D8 /D8/CW/CT /C6/BV/BU/C1/BA /C1/D8 /CV/D6/CT/CP/D8/D0/DD /D4/D6/D3/D1/D3/D8/CT/D7 /D8/CW/CT/D9/D7/CX/D2/CV /D3/CU /CQ/CX/D3/D0/D3/CV/CX/CR/CP/D0 /CX/D2/CU/D3/D6/D1/CP/D8/CX/D3/D2/BA /CC/CW/CT /BU/D0/CP/D7/D8 /D4/D6/D3/CV/D6/CP/D1 /CX/D7/A3/BV/D3/D6/D6/CT/D7/D4 /D3/D2/CS/CX/D2/CV /CP/D9/D8/CW/D3/D6/BA/BX/B9/D1/CP/CX/D0/BM /DE/CW/CP/D2/CV/CR/CV/BS/D2/CX/CR/BA/CQ/D1/CX/BA/CP/CR/BA/CR/D2 /D3/D2/CT /D3/CU /D8/CW/CT /DB/CX/CS/CT/D0/DD /D9/D7/CT/CS /D7/CT/D5/D9/CT/D2/CR/CT /CW/D3/D1/D3/D0/D3/CV/DD /CP/D2/CP/D0/DD/D7/CX/D7/D8/D3 /D3/D0/D7 /CQ/CP/D7/CT/CS /D3/D2 /D8/CW/CT/D7/CT /CS/CP/D8/CP/CQ/CP/D7/CT/D7 /B4/BF /BN /BG /B5/BA /CD/D7/CT/D6/D7 /D9/D7/D9/CP/D0/D0/DD/CR /CW/D3 /D3/D7/CT /D8/D3 /CR/D3/D2/D2/CT/CR/D8 /CS/CX/D6/CT/CR/D8/D0/DD /D8/D3 /D8/CW/CT /BX/D2 /D8/D6/CT/DE /CF /CT/CQ /CB/CT/D6/DA /CT/D6/CX/D2 /C6/BV/BU/C1 /D8/D3 /D6/CT/D8/D6/CX/CT/DA /CT /D0/CX/D8/CT/D6/CP/D8/D9/D6/CT/D7 /CP/D2/CS /CV/CT/D2/CT /D7/CT/D5/D9/CT/D2/CR/CT/D7/BA/C0/D3 /DB /CT/DA /CT/D6/B8 /CU/D3/D6 /DA /CP/D6/CX/D3/D9/D7 /D6/CT/CP/D7/D3/D2/D7/B8 /D9/D7/CT/D6/D7 /D7/CT/D0/CS/D3/D1 /CR/D3/D2/D2/CT/CR/D8 /D8/D3/C6/BV/BU/C1 /BX/D2 /D8/D6/CT/DE /CF /CT/CQ /CB/CT/D6/DA /CT/D6 /D8/D3 /D6/CT/D8/D6/CX/CT/DA /CT /CS/CP/D8/CP /CT/DA /CT/D6/DD /CS/CP /DD /B8/D7/D3 /CX/D8 /D7/D3/D1/CT/D8/CX/D1/CT/D7 /CR/CP/D9/D7/CT/D7 /D9/D2/CR/D3/D2/D7/CR/CX/D3/D9/D7/D0/DD /D1/CX/D7/D7 /D3/CU /D7/D3/D1/CT /CX/D1/B9/D4 /D3/D6/D8/CP/D2 /D8 /CX/D2/CU/D3/D6/D1/CP/D8/CX/D3/D2/BA /CC /D3 /CP /DA /D3/CX/CS /D7/D9/CR /CW /CX/D2/D7/D8/CP/D2/CR/CT/D7/B8 /D8/CW/CX/D7/D7/D8/D9/CS/DD /DB/CX/D0/D0 /CU/D3 /CR/D9/D7 /D3/D2 /D8/CW/CT /DB /CT/CQ/B9/D4/D6/D3/CV/D6/CP/D1/D1/CX/D2/CV /D8/CT/CR /CW/D2/CX/D5/D9/CT /D8/D3/CS/CT/D7/CX/CV/D2 /CP /BU/CX/D3/D0/D3/CV/CX/CR/CP/D0 /C1/D2/CU/D3/D6/D1/CP/D8/CX/D3/D2 /CA/CT/D8/D6/CX/CT/DA /CP/D0 /CP/D2/CS /BT/D2/CP/D0/DD/B9/D7/CX/D7 /CB/DD/D7/D8/CT/D1 /B4/BU/C1/CA/BT/CB/B5/BA /BT/CR/CR/D3/D6/CS/CX/D2/CV /D8/D3 /D8/CW/CT /D9/D7/CT/D6/B9/CS/CT/AC/D2/CT/CS /D6/CT/B9/D8/D6/CX/CT/DA /CP/D0 /D6/CT/D5/D9/CX/D6/CT/D1/CT/D2 /D8/D7/B8 /BU/C1/CA/BT/CB /CR/D3/D9/D0/CS /CP/D9/D8/D3/D1/CP/D8/CX/CR/CP/D0/D0/DD /D6/CT/B9/D8/D6/CX/CT/DA /CT /D8/CW/CT /D0/CP/D8/CT/D7/D8 /CQ/CX/D3/D0/D3/CV/CX/CR/CP/D0 /CX/D2/CU/D3/D6/D1/CP/D8/CX/D3/D2 /CX/D2 /D8/CW/CT /D6/CT/D0/CP/D8/CT/CS/CS/CP/D8/CP/CQ/CP/D7/CT /D1/CP/CX/D2 /D8/CP/CX/D2/CT/CS /CQ /DD /C6/BV/BU/C1/B8 /CP/D2/CS /CX/D2/CU/D3/D6/D1 /D8/CW/CT /D9/D7/CT/D6/D7/DB/CX/D8/CW /D8/CW/CT /D2/CT/DB /CT/D7/D8 /CX/D2/CU/D3/D6/D1/CP/D8/CX/D3/D2 /CQ /DD /BX/B9/D1/CP/CX/D0 /CX/D2 /CT/CP/CR /CW /CS/CP /DD /BA/CC/CW/CT/D6/CT/CQ /DD /B8 /BU/C1/CA/BT/CB /CR/D3/D9/D0/CS /CU/D9/D6/D8/CW/CT/D7/D8 /D4/D6/D3 /DA/CX/CS/CT /D9/D7/CT/D6/D7 /DB/CX/D8/CW /D8/CW/CT/D7/CT/D6/DA/CX/CR/CT/D7 /D3/CU /D6/CT/CP/D0/B9/D8/CX/D1/CT /D6/CT/D8/D6/CX/CT/DA /CP/D0 /CP/D2/CS /CP/D2/CP/D0/DD/D7/CX/D7/BA/CC/CW/CT /CB/CR /CW/CT/D1/CT /D3/CU /C4/CX/D8/CT/D6/CP/D8/D9/D6/CT/D7/B8 /CP/D2/CS/C6/D9/CR/D0/CT/D3/D8/CX/CS/CT /CB/CT/D5/D9/CT/D2/CR/CT/D7 /CP/D2/CS /C8/D6/D3/B9/D8/CT/CX/D2 /CB/CT/D5/D9/CT/D2/CR/CT/D7 /CA/CT/D8/D6/CX/CT/DA /CP/D0 /BU/CP/D7/CT/CS/D3/D2 /BX/D2 /D8/D6/CT/DE/CC/CW/CT /CP/CX/D1 /D3/CU /CS/CT/D7/CX/CV/D2/CX/D2/CV /BU/C1/CA/BT/CB /CX/D7 /D8/D3 /D1/CP/CZ /CT /CU/D9/D0/D0 /D9/D7/CT /D3/CU /D8/CW/CT/D6/CT/D8/D6/CX/CT/DA /CP/D0 /CU/D9/D2/CR/D8/CX/D3/D2 /D3/CU /BX/D2 /D8/D6/CT/DE /CP/D2/CS /D8/CX/D1/CT/D0/DD /D6/CT/D8/D6/CX/CT/DA /CT /D8/CW/CT/D0/CP/D8/CT/D7/D8 /CX/D2/CU/D3/D6/D1/CP/D8/CX/D3/D2 /D3/CU /D0/CX/D8/CT/D6/CP/D8/D9/D6/CT/D7 /CP/D2/CS /CV/CT/D2/CT /D7/CT/D5/D9/CT/D2/CR/CT/D7/BA/CD/D7/D9/CP/D0/D0/DD /B8 /DB/CW/CT/D2 /DB /CT /D6/CT/D8/D6/CX/CT/DA /CT /CP /CZ /CT/DD/DB /D3/D6/CS /D3/D6 /D8/CT/D6/D1 /CQ /DD /BX/D2/B9/D8/D6/CT/DE /CF /CT/CQ /CB/CT/D6/DA /CT/D6 /CX/D2 /C6/BV/BU/C1/B8 /DB /CT /DB/CX/D0/D0 /AC/D6/D7/D8 /CV/CT/D8 /CP /D7/D9/D1/D1/CP/D6/DD/BJ/BG /BZ/CT/D2/D3/BA/B8 /C8/D6/D3/D8/BA /B2 /BU/CX/D3/CX/D2/CU/D3/BA /CE /D3/D0/BA /BD /C6/D3/BA /BD /BY /CT/CQ/D6/D9/CP/D6/DD /BE/BC/BC/BFThis is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f9/c5/main.PMC5172434.pdf
/C4/CT/D8/D8/CT/D6/BY/CX/D2/CS/CX/D2/CV /CB/CX/CV/D2/CP/D0/D7 /CU/D3/D6 /C8/D0/CP/D2 /D8 /C8/D6/D3/D1/D3/D8/CT/D6/D7/CF /CT/CX/D1/D3/D9 /CI/CW/CT/D2/CV/C1/D2/D7/D8/CX/D8/D9/D8/CT /D3/CU /CC/CW/CT /D3/D6 /CT/D8/CX/CR /CP/D0 /C8/CW/DD/D7/CX/CR/D7/B8 /BV/CW/CX/D2/CT/D7/CT /BT /CR /CP/CS/CT/D1/DD /D3/CU /CB/CR/CX/CT/D2/CR /CT/D7/B8 /BU/CT/CX/CY/CX/D2/CV /BD/BC/BC/BC/BK/BC/B8 /BV/CW/CX/D2/CP/BN /BU/CT/CX/CY/CX/D2/CV /BZ/CT/D2/D3/D1/CX/CR/D7/C1/D2/D7/D8/CX/D8/D9/D8/CT/B8 /BV/CW/CX/D2/CT/D7/CT /BT /CR /CP/CS/CT/D1/DD /D3/CU /CB/CR/CX/CT/D2/CR /CT/D7/B8 /BU/CT/CX/CY/CX/D2/CV /BD/BC/BD/BF/BC/BC/B8 /BV/CW/CX/D2/CP/CC/CW/CT /D7/D8/D6/D3/D2/CV/CT/D7/D8 /D7/CX/CV/D2/CP/D0 /D3/CU /D4/D0/CP/D2 /D8 /D4/D6/D3/D1/D3/D8/CT/D6 /CX/D7 /D7/CT/CP/D6/CR /CW/CT/CS /DB/CX/D8/CW /D8/CW/CT /D1/D3 /CS/CT/D0 /D3/CU /D7/CX/D2/CV/D0/CT /D1/D3/D8/CX/CU/DB/CX/D8/CW /D8 /DB /D3 /D8 /DD/D4 /CT/D7/BA /C1/D8 /D8/D9/D6/D2/D7 /D3/D9/D8 /D8/CW/CP/D8 /D8/CW/CT /CS/D3/D1/CX/D2/CP/D2 /D8 /D8 /DD/D4 /CT /CX/D7 /D8/CW/CT /CC /BT /CC /BT/B9/CQ /D3 /DC/BA /CC/CW/CT/D3/D8/CW/CT/D6 /D8 /DD/D4 /CT /D1/CP /DD /CQ/CT /CR/CP/D0/D0/CT/CS /CC /BT /CC /BT/B9/D0/CT/D7/D7 /D7/CX/CV/D2/CP/D0/B8 /CP/D2/CS /D1/CP /DD /CQ/CT /D9/D7/CT/CS /CX/D2 /CV/CT/D2/CT /AC/D2/CS/CT/D6/D7 /CU/D3/D6/D4/D6/D3/D1/D3/D8/CT/D6 /D6/CT/CR/D3/CV/D2/CX/D8/CX/D3/D2/BA /CF/CW/CX/D0/CT /D8/CW/CT /CC /BT /CC /BT /D7/CX/CV/D2/CP/D0/D7 /CP/D6/CT /DA /CT/D6/DD /CR/D0/D3/D7/CT /CU/D3/D6 /D8/CW/CT /D1/D3/D2/D3 /CR/D3/D8/CP/D2/CS /D8/CW/CT /CS/CX/CR/D3/D8/B8 /D8/CW/CT/CX/D6 /CC /BT /CC /BT/B9/D0/CT/D7/D7 /D7/CX/CV/D2/CP/D0/D7 /CP/D6/CT /D7/CX/CV/D2/CX/AC/CR/CP/D2 /D8/D0/DD /CS/CX/AB/CT/D6/CT/D2 /D8/BA /BT /CV/CT/D2/CT/D6/CP/D0 /CP/D2/CS/AD/CT/DC/CX/CQ/D0/CT /D1 /D9/D0/D8/CX/B9/D1/D3/D8/CX/CU /D1/D3 /CS/CT/D0 /CX/D7 /CP/D0/D7/D3 /D4/D6/D3/D4 /D3/D7/CT/CS /CU/D3/D6 /D4/D6/D3/D1/D3/D8/CT/D6 /CP/D2/CP/D0/DD/D7/CX/D7 /CQ/CP/D7/CT/CS /D3/D2 /CS/DD/D2/CP/D1/CX/CR/D4/D6/D3/CV/D6/CP/D1/D1/CX/D2/CV/BA /BU/DD /CT/DC/D8/CT/D2/CS/CX/D2/CV /D8/CW/CT /BZ/CX/CQ/CQ/D7 /D7/CP/D1/D4/D0/CT/D6 /D8/D3 /D8/CW/CT /CS/DD/D2/CP/D1/CX/CR /D4/D6/D3/CV/D6/CP/D1/D1/CX/D2/CV /CP/D2/CS/CX/D2 /D8/D6/D3 /CS/D9/CR/CX/D2/CV /D8/CT/D1/D4 /CT/D6/CP/D8/D9/D6/CT/B8 /CP/D2 /CTÆ/CR/CX/CT/D2 /D8 /CP/D0/CV/D3/D6/CX/D8/CW/D1 /CX/D7 /CS/CT/DA /CT/D0/D3/D4 /CT/CS /CU/D3/D6 /D7/CT/CP/D6/CR /CW/CX/D2/CV /D7/CX/CV/D2/CP/D0/D7/CX/D2 /D4/D0/CP/D2 /D8 /D4/D6/D3/D1/D3/D8/CT/D6/D7/BA/C1/D2 /D8/D6/D3 /CS/D9/CR/D8/CX/D3/D2/C5/CT/D8/CW/D3 /CS/D7 /CU/D3/D6 /CV/CT/D2/CT /D6/CT/CR/D3/CV/D2/CX/D8/CX/D3/D2 /CP/D6/CT /CQ/CP/D7/CT/CS /D3/D2 /CT/CX/D8/CW/CT/D6/CW/D3/D1/D3/D0/D3/CV/DD /CP/D2/CP/D0/DD/D7/CX/D7/B8 /D3/D2 /CR/D3/D2 /D8/CT/D2 /D8 /D7/CT/CP/D6/CR /CW/B8 /D3/D6 /D3/D2 /D7/CX/CV/D2/CP/D0/D7/CT/CP/D6/CR /CW/BA /CB/CX/CV/D2/CP/D0/D7 /CP/D6/CT /D7/CW/D3/D6/D8 /D7/CT/D5/D9/CT/D2/CR/CT /D7/CT/CV/D1/CT/D2 /D8/D7 /DB/CX/D8/CW /CP/CS/CT/AC/D2/CX/D8/CT /D7/D8/D6/D9/CR/D8/D9/D6/CT/BA /CC/CW/CT /D7/CX/CV/D2/CP/D0 /D7/CT/CP/D6/CR /CW /D8/D6/CX/CT/D7 /D8/D3 /D6/CT/CR/D3/CV/B9/D2/CX/DE/CT /D8/CW/CT /D0/D3 /CR/CP/D8/CX/D3/D2 /CX/D2 /CV/CT/D2/D3/D1/CT /DB/CW/CT/D6/CT /D8/CW/CT /CV/CT/D2/CT /CT/DC/D4/D6/CT/D7/D7/CX/D3/D2/D1/CP/CR /CW/CX/D2/CT/D6/DD /CX/D2 /D8/CT/D6/CP/CR/D8/D7 /DB/CX/D8/CW /D8/CW/CT /D2 /D9/CR/D0/CT/CX/CR /CP/CR/CX/CS/BA /CB/CX/CV/D2/CP/D0/D7 /CP/D7/CQ/CX/D3 /CR /CW/CT/D1/CX/CR/CP/D0 /CQ/CX/D2/CS/CX/D2/CV /D7/CX/D8/CT/D7 /D3/D2 /BW/C6/BT/B8 /D3/D6 /CR/D3/D6/D6/CT/D7/D4/D3/D2/CS/CX/D2/CV/D1/CA/C6/BT /CP/D2/CS /D4/D6/CT/B9/D1/CA/C6/BT /D4/D0/CP /DD /CP /CZ /CT/DD /D6/D3/D0/CT /CX/D2 /D8/D6/CP/D2/D7/CR/D6/CX/D4/B9/D8/CX/D3/D2/B8 /D7/D4/D0/CX/CR/CX/D2/CV /D3/D6 /D8/D6/CP/D2/D7/D0/CP/D8/CX/D3/D2/BA /C8/D6/D3/D1/D3/D8/CT/D6 /CX/D7 /D8/CW/CT /D1/D3/D7/D8 /CX/D1/B9/D4/D3/D6/D8/CP/D2 /D8 /D6/CT/CV/D9/D0/CP/D8/D3/D6/DD /D6/CT/CV/CX/D3/D2 /DB/CW/CX/CR /CW /CR/D3/D2 /D8/D6/D3/D0/D7 /D8/CW/CT /CX/D2/CX/D8/CX/CP/D8/CX/D3/D2/D3/CU /D8/D6/CP/D2/D7/CR/D6/CX/D4/D8/CX/D3/D2/BA /C8/D6/D3/D1/D3/D8/CT/D6 /D4/D6/CT/CS/CX/CR/D8/CX/D3/D2 /CX/D7 /CR/D6/D9/CR/CX/CP/D0 /CU/D3/D6/CV/CT/D2/CT /CP/D2/D2/D3/D8/CP/D8/CX/D3/D2/BA /C1/D2 /CT/D9/CZ /CP/D6/DD /D3/D8/CT/D7/B8 /CP /D4/D6/D3/D1/D3/D8/CT/D6/B8 /CT/D2/CR/D3/D1/B9/D4/CP/D7/D7/CX/D2/CV /CP /CV/CT/D2/CT/B3/D7 /D8/D6/CP/D2/D7/CR/D6/CX/D4/D8/CX/D3/D2 /D7/D8/CP/D6/D8 /D7/CX/D8/CT /B4/CC/CB/CB/B5/B8 /CR/D3/D2/B9/D8/CP/CX/D2/D7 /CP/CV/CV/D6/CT/CV/CP/D8/CT/D7 /D3/CU /D8/D6/CP/D2/D7/CR/D6/CX/D4/D8/CX/D3/D2 /CU/CP/CR/D8/D3/D6 /CQ/CX/D2/CS/CX/D2/CV /D7/CX/D8/CT/D7/B4/CC/BY/BU/CB/D7/B5/BA /CB/CT/DA /CT/D6/CP/D0 /D9/CQ/CX/D5/D9/CX/D8/D3/D9/D7 /CP/D2/CS /CR/CT/D0/D0/B9/D7/D4/CT/CR/CX/AC/CR /D6/CT/CV/D9/B9/D0/CP/D8/D3/D6/DD /CU/CP/CR/D8/D3/D6/D7 /DB /D3/D6/CZ /D8/D3/CV/CT/D8/CW/CT/D6 /D8/D3 /CP/CR /CW/CX/CT/DA /CT /CP /CR/D3/D1 /CQ/CX/D2/CP/D8/D3/B9/D6/CX/CP/D0 /CR/D3/D2 /D8/D6/D3/D0/BA /CC/BY/BU/CB/D7 /CR/CP/D2 /CP/D4/D4 /CT/CP/D6 /CX/D2 /CS/CX/AB/CT/D6/CT/D2 /D8 /CR/D3/D1 /CQ/CX/B9/D2/CP/D8/CX/D3/D2/D7 /D3/D2 /CS/CX/AB/CT/D6/CT/D2 /D8 /D4/D6/D3/D1/D3/D8/CT/D6/D7/BA /CC/CW/CT /D3/D6/CS/CT/D6 /D3/CU /CC/BY/BU/CB/D7/CX/D2 /D4/D6/D3/D1/D3/D8/CT/D6/D7 /DA /CP/D6/CX/CT/D7/B8 /CP/D2/CS /D6/CT/D0/CP/D8/CX/DA /CT /CS/CX/D7/D8/CP/D2/CR/CT/D7 /D3/CU /CC/BY/BU/CB/D7/CX/D2 /DA /CP/D6/CX/D3/D9/D7 /D4/D6/D3/D1/D3/D8/CT/D6/D7 /CS/CX/AB/CT/D6/BA /C8/D6/D3/D1/D3/D8/CT/D6 /CX/D7 /D9/D2/CS/D3/D9/CQ/D8/CT/CS/D0/DD/CT/DC/D8/D6/CT/D1/CT/D0/DD /CR/D3/D1/D4/D0/CT/DC/BA /BXÆ/CR/CX/CT/D2 /D8 /CV/CT/D2/CT /CW /D9/D2 /D8/CX/D2/CV /D9/D7/CX/D2/CV /D4/D6/D3/B9/D1/D3/D8/CT/D6 /D6/CT/CR/D3/CV/D2/CX/D8/CX/D3/D2 /CX/D7 /D7/D8/CX/D0/D0 /CX/D1/D4/D3/D7/D7/CX/CQ/D0/CT/BA /BY /D3/D6 /CT/DC/CP/D1/D4/D0/CT/B8/BZ/CT/D2/CB/CR/CP/D2 /D9/D7/CT/D7 /CP /DA /CT/D6/DD /D7/CX/D1/D4/D0/CX/AC/CT/CS /D1/D3 /CS/CT/D0 /CU/D3/D6 /D4/D6/D3/D1/D3/D8/CT/D6/BM/CP /BD/BH /CQ/D4 /CC /BT /CC /BT/B9/CQ /D3 /DC /DB /CT/CX/CV/CW /D8 /D1/CP/D8/D6/CX/DC /D1/D3 /CS/CT/D0 /B4/CF/C5/C5/B5/B8 /CP/BD/BG/B9/BE/BC /CQ/D4 /CX/D2 /D8/CT/D6/CV/CT/D2/CX/CR/B9/D2 /D9/D0/D0 /D1/D3 /CS/CT/D0 /D3/CU /D7/D4/CP/CR/CT/D6/B8 /CP/D2/CS /D8/CW/CT/D2 /CP/BK /CQ/D4 /CR/CP/D4 /D7/CX/D8/CT /CF/C5/C5 /B4/BD /B5/BA /BT/CQ /D3/D9/D8 /BF/BC/B1 /D3/CU /CT/D9/CZ /CP/D6/DD /D3/D8/CX/CR/D4/D6/D3/D1/D3/D8/CT/D6/D7 /D0/CP/CR /CZ /CP/D2 /CP/D4/D4/CP/D6/CT/D2 /D8 /CC /BT /CC /BT /D7/CX/CV/D2/CP/D0/BA /CC /BT /CC /BT/B9/D0/CT/D7/D7/D4/D6/D3/D1/D3/D8/CT/D6/D7 /CP/D6/CT /D1/D3 /CS/CT/D0/D0/CT/CS /D7/CX/D1/D4/D0/DD /CP/D7 /CX/D2 /D8/CT/D6/CV/CT/D2/CX/CR/B9/D2 /D9/D0/D0 /D6/CT/B9/CV/CX/D3/D2/D7 /D3/CU /BG/BC /CQ/D4 /CX/D2 /D0/CT/D2/CV/D8/CW/BA/CF /CT/CX/CV/CW /D8 /D1/CP/D8/D6/CX/DC /CR/CP/D2 /CQ/CT /D9/D7/CT/CS /D8/D3 /CS/CT/D7/CR/D6/CX/CQ /CT /CP /D7/CX/CV/D2/CP/D0 /CP/D7/D4/CP/D8/D8/CT/D6/D2 /D3/CU /CP /D1 /D9/D0/D8/CX/D4/D0/CT /D7/CT/D5/D9/CT/D2/CR/CT /CP/D0/CX/CV/D2/D1/CT/D2 /D8/B8 /CP/D2/CS /CX/D7 /CV/D3 /D3 /CS/BX/B9/D1/CP/CX/D0/BM /DE/CW/CP/D2/CV/BS/CX/D8/D4/BA/CP/CR/BA/CR/D2 /CU/D3/D6 /D1/D3 /CS/CT/D0/D0/CX/D2/CV /CR/CT/D6/D8/CP/CX/D2 /CC/BY/BU/CB/D7/BA /CC/CW/CX/D7 /D7/CX/D1/D4/D0/CT /D8 /DD/D4/CT /D3/CU/D4/D6/D3/CQ/CP/CQ/CX/D0/CX/D7/D8/CX/CR /D1/D3 /CS/CT/D0/D7 /CU/D3/D6 /D7/CX/CV/D2/CP/D0/D7 /CP/D7/D7/CX/CV/D2/D7 /CP /D4/D6/D3/CQ/CP/CQ/CX/D0/B9/CX/D8 /DD /D8/D3 /CT/CP/CR /CW /D4/D3/D7/CX/D8/CX/D3/D2 /CU/D3/D6 /D7/CX/CV/D2/CP/D0 /D7/CT/D5/D9/CT/D2/CR/CT /D3/CU /D7/D3/D1/CT /AC/DC/CT/CS/D0/CT/D2/CV/D8/CW /D0 /B4/BE /BN /BF /BN /BG /B5/BA /CC/CW/CT /CP/D7/D7/D9/D1/D4/D8/CX/D3/D2 /D3/CU /CX/D2/CS/CT/D4/CT/D2/CS/CT/D2/CR/CT/CQ/CT /D8 /DB /CT/CT/D2 /D4/D3/D7/CX/D8/CX/D3/D2/D7 /CX/D7 /D8/CW/CT /D1/CP/CX/D2 /D0/CX/D1/CX/D8/CP/D8/CX/D3/D2 /D3/CU /CF/C5/C5/D7/BA/BT /D2/CP/D8/D9/D6/CP/D0 /CV/CT/D2/CT/D6/CP/D0/CX/DE/CP/D8/CX/D3/D2 /CX/D7 /CP/D2 /CX/D2/CW/D3/D1/D3/CV/CT/D2/CT/D3/D9/D7 /C5/CP/D6/CZ /D3 /DA/D1/D3 /CS/CT/D0 /CP/D2/CS /CX/D8/D7 /D1/D3 /CS/CX/AC/CR/CP/D8/CX/D3/D2 /CX/D7 /CR/CP/D0/D0/CT/CS /DB/CX/D2/CS/D3 /DB /CT/CS /DB /CT/CX/CV/CW /D8/CP/D6/D6/CP /DD /D1/D3 /CS/CT/D0/B8 /D6/CT/D4/D0/CP/CR/CX/D2/CV /D8/CW/CT /CX/D2/CS/CT/D4/CT/D2/CS/CT/D2 /D8 /D4/D6/D3/CQ/CP/CQ/CX/D0/CX/D8/CX/CT/D7/DB/CX/D8/CW /CR/D3/D2/CS/CX/D8/CX/D3/D2/CP/D0 /D4/D6/D3/CQ/CP/CQ/CX/D0/CX/D8/CX/CT/D7/BA /CC /D3 /D6/CT/D0/CX/CP/CQ/D0/DD /CR/CP/D4/D8/D9/D6/CT /D8/CW/CT/D1/D3/D7/D8 /D7/CX/CV/D2/CX/AC/CR/CP/D2 /D8 /CS/CT/D4/CT/D2/CS/CT/D2/CR/CX/CT/D7 /CQ/CT /D8 /DB /CT/CT/D2 /D4/D3/D7/CX/D8/CX/D3/D2/D7/B8 /D8/CW/CT/D1/CP/DC/CX/D1/CP/D0 /CS/CT/D4/CT/D2/CS/CT/D2/CR/CT /CS/CT/CR/D3/D1/D4/D3/D7/CX/D8/CX/D3/D2 /B4/C5/BW/BW/B5 /D1/D3 /CS/CT/D0/CW/CP/D7 /CQ /CT/CT/D2 /CS/CT/DA /CT/D0/D3/D4/CT/CS /B4/BH /B5/BA /CF /CT /CW/CP /DA /CT /D4/D6/D3/D4 /D3/D7/CT/CS /CP /D7/CX/D1/D4/D0/CT/DB /CP /DD /D8/D3 /CT/D2/CW/CP/D2/CR/CT /D7/CX/CV/D2/CP/D0/D7 /CQ /DD /CR/D0/D9/D7/D8/CT/D6/CX/D2/CV /D7/CX/CV/D2/CP/D0 /D7/CT/D5/D9/CT/D2/CR/CT/D7/B4/BI /B5/BA/CC /D3 /CS/CX/D7/CR/D3 /DA /CT/D6 /D2/D3 /DA /CT/D0 /D1/D3/D8/CX/CU /D7/CX/D8/CT/D7/B8 /D1 /D9/D0/D8/CX/D4/D0/CT /D7/CT/D5/D9/CT/D2/CR/CT/CP/D0/CX/CV/D2/D1/CT/D2 /D8 /D1/CT/D8/CW/D3 /CS/D7 /CP/D6/CT /D9/D7/CT/CU/D9/D0/BA /CB/D3/D1/CT /D7/D8/CP/D8/CX/D7/D8/CX/CR/CP/D0 /D1/CT/D8/CW/B9/D3 /CS/D7/B8 /CT/BA/CV/BA /CT/DC/D4/CT/CR/D8/CP/D8/CX/D3/D2/B9/D1/CP/DC/CX/D1/CX/DE/CP/D8/CX/D3/D2 /B4/BX/C5/B5 /D3/D6 /BZ/CX/CQ/CQ/D7/D7/CP/D1/D4/D0/CX/D2/CV /CP/D0/CV/D3/D6/CX/D8/CW/D1 /CU/D3/D6 /CX/D2/CS/CT/D4/CT/D2/CS/CT/D2 /D8 /CQ/D0/D3 /CR /CZ /D1/D3 /CS/CT/D0/B4/BJ /BN /BK /B5 /D3/D6 /CW/CX/CS/CS/CT/D2 /C5/CP/D6/CZ /D3 /DA /D1/D3 /CS/CT/D0 /B4/BL /B5/B8 /CW/CP /DA /CT /CQ /CT/CT/D2 /CS/CT/B9/DA /CT/D0/D3/D4/CT/CS /CU/D3/D6 /AC/D2/CS/CX/D2/CV /D4/CP/D8/D8/CT/D6/D2/D7 /CX/D2 /D9/D2/CP/D0/CX/CV/D2/CT/CS /D7/CT/D5/D9/CT/D2/CR/CT/D7/B4/D7/CT/CT /D6/CT/DA/CX/CT/DB/D7/B8 /CT/BA/CV/BA /B4/BD/BC/B8 /BD/BD/B8 /BD/BE /B5/B5/BA/CC/CW/CT/D6/CT /CP/D6/CT /BJ/BD /D1/D3/D2/D3 /CR/D3/D8 /CP/D2/CS /BE/BE/BC /CS/CX/CR/D3/D8 /D4/D6/D3/B9/D1/D3/D8/CT/D6 /D7/CT/D5/D9/CT/D2/CR/CT/D7 /CU/D3/D6 /D4/D0/CP/D2 /D8/D7 /CP /DA /CP/CX/D0/CP/CQ/D0/CT /CU/D6/D3/D1 /D8/CW/CT /DB /CT/CQ/B4/CW /D8/D8/D4/BM/BB/BB/DB/DB/DB/BA/D7/D3/CU/D8/CQ /CT/D6/D6/DD /BA/CR/D3/D1/BB/B5/BA /CC/CW/CT /D7/CT/D5/D9/CT/D2/CR/CT/D7 /CP/D6/CT/D8/CP/CZ /CT/D2 /CP/D8 /CJ/A0/BE/BC/BC/B8 /B7/BH/BD/CL /DB/CX/D8/CW /D6/CT/D7/D4/CT/CR/D8 /D8/D3 /D8/CW/CT /CC/CB/CB/BA /CF /CT/D7/CW/CP/D0/D0 /D7/CT/CP/D6/CR /CW /D7/CX/CV/D2/CP/D0/D7 /DB/CX/D8/CW /D8/CW/CT /D7/CX/D1/D4/D0/CT/D7/D8 /D1/D3 /CS/CT/D0 /D3/CU /CP /D7/CX/D2/B9/CV/D0/CT /D1/D3/D8/CX/CU /CX/D2 /CP /D2/D3/CX/D7/CT /CQ/CP/CR /CZ/CV/D6/D3/D9/D2/CS /CU/D3/D6 /CT/CP/CR /CW /D7/CT/D5/D9/CT/D2/CR/CT/BA/CC/CW/CT/D2/B8 /DB /CT /D7/CW/CP/D0/D0 /D4/D6/D3/D4 /D3/D7/CT /CP /AD/CT/DC/CX/CQ/D0/CT /D1 /D9/D0/D8/CX/B9/D1/D3/D8/CX/CU /D1/D3 /CS/CT/D0/D8/D3 /CR/D3/D4/CT /DB/CX/D8/CW /D8/CW/CT /CR/D3/D1/D4/D0/CX/CR/CP/D8/CT/CS /CR/D3/D1 /CQ/CX/D2/CP/D8/CX/D3/D2 /D3/CU /CC/BY/BU/CB/D7/CQ/CP/D7/CT/CS /D3/D2 /CS/DD/D2/CP/D1/CX/CR /D4/D6/D3/CV/D6/CP/D1/D1/CX/D2/CV/BA/CB/CX/D2/CV/D0/CT /C5/D3/D8/CX/CU /C5/D3 /CS/CT/D0/CF /CT /CP/D0/CX/CV/D2 /D8/CW/CT /BJ/BD /D1/D3/D2/D3 /CR/D3/D8 /D7/CT/D5/D9/CT/D2/CR/CT/D7 /CP/CR/CR/D3/D6/CS/CX/D2/CV /D8/D3 /D8/CW/CT/CX/D6/CC/CB/CB/D7/B8 /CP/D2/CS /CR/CP/D0/CR/D9/D0/CP/D8/CT /CQ/CP/D7/CT /CU/D6/CT/D5/D9/CT/D2/CR/CX/CT/D7 /CP/D8 /CT/CP/CR /CW /D4/D3/D7/CX/D8/CX/D3/D2/BA This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/fa/61/main.PMC5172435.pdf
1 February 2004This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,OADS,/arxiv_data1/oa_pdf/37/2f/main.PMC5172436.pdf
"Materials and Methods Sequence data sources The CDS sequences that are available in the pub- lic domain of di®erent species, °y ( Drosophila melalogaster ), mosquito ( Anopheles gambiae ), mouse (Mus muscles ), zebra¯sh (Danio rerio ) and worm (Caenorhabditis elegans ), were downloaded in FASTA format from ftp://ftp.ensembl.org/pub/ in June 2003.",OADS,/arxiv_data1/oa_pdf/37/2f/main.PMC5172436.pdf
"In addition, the data of the silkworm EST-database from our lab containing 81,635 ESTs presently (80,475 entrys of which has been submitted to NCBI, ac- cession number: CK484630-CK565104) and Silk- Base (http://www.ab.a.u-tokyo.ac.jp/silkbase/) con- taining 35,300 ESTs from a variety of di®erent tissues were also used for the analysis of SSRs in this paper.Searching microsatellites EST sequences less than 100 bp in length were not included in the analysis here.",OADS,/arxiv_data1/oa_pdf/37/2f/main.PMC5172436.pdf
1 February 2004This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,OADS,/arxiv_data1/oa_pdf/08/ec/main.PMC5172437.pdf
1 February 2004 1This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,OADS,/arxiv_data1/oa_pdf/c1/ea/main.PMC5172438.pdf
1 February 2004 15This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/de/d2/main.PMC5172439.pdf
2 May 2004 119This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/ce/main.PMC5172440.pdf
The SH2 domain range of each SH2 protein was ¯rstly determined by Motif Scan (http://hits.isb-sib.ch/cgi-bin/PFSCA).,OADS,/arxiv_data1/oa_pdf/63/ce/main.PMC5172440.pdf
This database is available from http://www.proteomics- cams.com/service/database-sh2.htm.,OADS,/arxiv_data1/oa_pdf/63/ce/main.PMC5172440.pdf
Materials and Methods Protein database containing human SH2 domains The CDART Querying was used for search- ing the CDART website in the NCBI Genbank (http://www.ncbi.nlm.nih.gov/BLAST/) for all of the human SH2 proteins.,OADS,/arxiv_data1/oa_pdf/63/ce/main.PMC5172440.pdf
The SMART Querying was used for searching the SMART website (http://smart.embl-heidelberg.de/) for all of the hu- man SH2 proteins.,OADS,/arxiv_data1/oa_pdf/63/ce/main.PMC5172440.pdf
De¯nition of the SH2 domain The SH2 domain ranges of each SH2 protein were de- termined by Motif Scan in http://hits.isb-sib.ch/cgi- bin/PFSCAN.,OADS,/arxiv_data1/oa_pdf/63/ce/main.PMC5172440.pdf
2 May 2004This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/4c/ee/main.PMC5172443.pdf
"Appendix|HMM Software Name Description URL HMMER It pro duces pro¯le hidden Markov models for homolog search in a database.http://hmmer.wustl.edu/ SAM A suite of tools for biological sequence analysis including homology detection, secondary structure prediction and so on.http://www.cse.ucsc.edu/research/compbio/sam.html TMHMM It models and predicts the location and orientation of alpha helices in membrane-spanning proteins.http://www.cbs.dtu.dk/services/TMHMM/ SignalP A signal peptide prediction program.",OADS,/arxiv_data1/oa_pdf/4c/ee/main.PMC5172443.pdf
It was originally developed using arti- ¯cial neural network and later updated to HMMs.http://www.cbs.dtu.dk/services/SignalP/ Phobius It predicts transmembrane regions and signal peptide.http://phobius.cgb.ki.se/ Meta-MEME A motif-based hidden Markov model used for database search for homologs.http://metameme.sdsc.edu/ SATCHMO It aligns sequences and constructs tree using HMMs in situation where se- quence identity is low.http://www.drive5.com/lobster/index.htm COACH It performs pairwise alignment or pro- ¯les of alignments.http://www.drive5.com/lobster HMMSPECTR A protein structure prediction tool.,OADS,/arxiv_data1/oa_pdf/4c/ee/main.PMC5172443.pdf
"http://biology.sdsc.edu/HMM-SPECTR/ HMMSTR A tool to predict the structure (includ- ing secondary, local, supersecondary, and tertiary) of proteins from their se- quences.http://www.bioinfo.rpi.edu/ bystrc/hmmstr/server.php Listed in this table are programs mentioned in this survey that employ HMMs and are freely available for use or download.",OADS,/arxiv_data1/oa_pdf/4c/ee/main.PMC5172443.pdf
2 May 2004 69This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8e/0c/main.PMC5172444.pdf
2 May 2004 97This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/19/65/main.PMC5172445.pdf
2 May 2004 77This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c0/16/main.PMC5172446.pdf
"As a part of Rice Genome Re- search Project of NIAS, Japan, the rice cDNA mi- croarray and proteome databases are now available to the public (http://microarray.rice.dna.a®rc.go.jp and http://gene64.dna.a®rc.go.jp/RPD).",OADS,/arxiv_data1/oa_pdf/c0/16/main.PMC5172446.pdf
"Recently, a high-density rice array is available to the public (http://www.ricearray.org).",Non-OADS,/arxiv_data1/oa_pdf/c0/16/main.PMC5172446.pdf
2 May 2004 123This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/cd/71/main.PMC5172447.pdf
TheExpertProtein Analysis System ( ExPASy ) is a proteomics server of the Swiss Bioinformatic In- stitute (SBI; http://www.isb-sib.ch/) and provides databases and software tools for nearly all aspects of protein analysis.,OADS,/arxiv_data1/oa_pdf/cd/71/main.PMC5172447.pdf
These databases are cross-linked to other information databases such as PRINTS (http://bioinf.man.ac.uk/dbbrowser/PRINTS/; ref.,OADS,/arxiv_data1/oa_pdf/cd/71/main.PMC5172447.pdf
6) and BLOCKS (http://blocks.fhcrc.org; ref.,Non-OADS,/arxiv_data1/oa_pdf/cd/71/main.PMC5172447.pdf
"The journal Frontiers in Biosciences , which is thought as virtual library for protein information, pro-vides a link collection for a wide variety of protein analysis tools (http://www.bioscience.org/urllists/ protdb.htm).",OADS,/arxiv_data1/oa_pdf/cd/71/main.PMC5172447.pdf
"The Reactome project is a collaboration among Cold Spring Harbor Laboratory (http:// www.cshl.org/), the European Bioinformatics Insti- tute (http://www.ebi.ac.uk/), and the Gene Ontology (GO) consortium (http://www.geneontology.org/) to develop a curated resource of core pathways and reac- tions in human biology ( 12).",OADS,/arxiv_data1/oa_pdf/cd/71/main.PMC5172447.pdf
"An Internet resource for visualizing gene splicing from EST data, called spliceNest, is provided at http://splicenest.molgen.mpg.de/.",OADS,/arxiv_data1/oa_pdf/cd/71/main.PMC5172447.pdf
A simi- lar project is hosted by the EMBL-EBI server at http://www.ebi.ac.uk/msd/.,OADS,/arxiv_data1/oa_pdf/cd/71/main.PMC5172447.pdf
The Genomics and Bioinformatics Group of the Weinstein lab at the NIH Laboratory of Molecu- lar Pharmacology o®ers a web site at the URL http://discover.nci.nih.gov useful in genomic and pro- teomic research.,OADS,/arxiv_data1/oa_pdf/cd/71/main.PMC5172447.pdf
"The Bioinformatics and Biocomputing group at the Weizmann Institute of Science, Is- rael, has collected multiple tools and links at http://bioinformatics.weizmann.ac.il/.",OADS,/arxiv_data1/oa_pdf/cd/71/main.PMC5172447.pdf
The NIH Computational Molecular Biology sec- tion can be found at http://molbio.info.nih.gov/ molbio/.,OADS,/arxiv_data1/oa_pdf/cd/71/main.PMC5172447.pdf
"A huge collection of bioinformatic links includ- ing software, journal access, technology resources and providers, institutions and careers, is maintained at http://www.bioinformatik.de/ (the website is avail- able in English language).",OADS,/arxiv_data1/oa_pdf/cd/71/main.PMC5172447.pdf
A resource for links and online protein services can be found at http://www.ch.embnet.org/index.html.,OADS,/arxiv_data1/oa_pdf/cd/71/main.PMC5172447.pdf
"The PeKing University BIOinformatics Server (PKUBIOS) at Beijing, China, is a compre- hensive collection of bioinformatic network services and can be found at http://mdl.ipc.pku.edu.cn/ mirror/mirror.html.",OADS,/arxiv_data1/oa_pdf/cd/71/main.PMC5172447.pdf
The open directory http://dmoz.org/Science/ Biology/Software/ lists a variety of links to software and ongoing projects.,OADS,/arxiv_data1/oa_pdf/cd/71/main.PMC5172447.pdf
The website http://sourceforge.net/ encourages the user to con- tribute to the development of open access soft- ware.,Non-OADS,/arxiv_data1/oa_pdf/cd/71/main.PMC5172447.pdf
Some of the projects encompass the Biomolecule Naming Service (http://openbns.sourceforge.net) with the main pur- pose to quickly and easily convert between di®erentname and identi¯er schemes commonly used for spec- ifying gene and protein sequences.,OADS,/arxiv_data1/oa_pdf/cd/71/main.PMC5172447.pdf
"A huge directory of bioinformatics, genomics, pro- teomics, biotechnology and molecular biology is pro- vided by the Oxford researcher Dr. Jonathan D. Rees at http://www.bioinformatics.vg/index.shtml.",Non-OADS,/arxiv_data1/oa_pdf/cd/71/main.PMC5172447.pdf
Table 1 Internet Links for the Analysis of Genomic and Proteomic Information Name URL Sequence Information: En trez http://www.ncbi.nlm.nih.gov/Entrez/index.html ExPASy http://www.expasy.org Protein analysis tools http://www.bioscience.org/urllists/protdb.htm Reactome http://www.reactome.org GenMAPP http://www.genemapp.org KEGG http://www.genome.jp/kegg/ Genecards http://bioinfo.weizmann.ac.il/cards/index.shtml HPRD http://www.hprd.org Structural Information: BLAST http://www.ncbi.nlm.nih.gov/blast/ SRS http://srs.ebi.ac.uk Prodom http://protein.toulouse.inra.fr/prodom.html 128 Geno.,OADS,/arxiv_data1/oa_pdf/cd/71/main.PMC5172447.pdf
Maurer Table 1Continued Name URL Pfam h ttp://www.sanger.ac.uk/Software/Pfam Mirror sites: http://pfam.wustl.edu; http://www.cgr.ki.se/Pfam SMART http://smart.embl-heidelberg.de A. N. Belozersky Institute http://www.genebee.msu.su/genebee.html spliceNest http://splicenest.molgen.mpg.de/ TAP http://sapiens.wustl.edu/ »zkan/TAP/ Molecular Interactions: PDB http://www.rcsb.org/pdb/; http://www.ebi.ac.uk/msd/ Dali http://www.ebi.ac.uk/dali/ The Holm Group http://ekhidna.biocenter.helsinki.¯:8080/templates/software.html CATH http://www.biochem.ucl.ac.uk/bsm/cath/ SCOP http://scop.mrc-lmb.cam.ac.uk/scop/ 3Dee http://www.compbio.dundee.ac.uk/3Dee HSSP http://www.sander.embl-heidelberg.de/hssp/ Phylogenetic programs http://genome.cs.iastate.edu/supertree/introduction/links.html http://evolution.genetics.washington.edu/phylip/software.html COILS http://www.ch.embnet.org/software/COILS form.html JPRED:TNG h ttp://www.compbio.dundee.ac.uk/ »www-jpred/ Jalview http://www2.ebi.ac.uk/ »michele/jalview/contents.html PredictProtein http://www.embl-heidelberg.de/predictprotein/predictprotein.html GenThreader http://insulin.brunel.ac.uk 3D-PSSM http://www.bmm.icnet.uk COMPOSER http://www-cryst.bioc.cam.ac.uk/ DRAGON http://www.imtech.res.in/pub/pss/dragon/unix/dragon.html WhatIf http://www.cmbi.kun.nl/gv/whatif/ SwissModel http://www.expasy.ch/swissmod/SWISSMODEL.html Biotech Validation Suite http://biotech.embl-heidelberg.de:8400/ or http://biotech.ebi.ac.uk:8400/ Joy http://www-cryst.bioc.cam.ac.uk/cgi-bin/joy.cgi MolTalk http://www.moltalk.org/ BioWeb http://bioweb.uwlax.edu The Sali lab http://salilab.org The Sean Eddy lab http://selab.wustl.edu/cgi-bin/selab.pl?mode=software Visualization Software: Protein Explorer http://www.umass.edu/microbio/rasmol/ Cn3D http://www.ncbi.nih.gov/Structure/CN3D/cn3d.shtml ProteinShop http://proteinshop.lbl.gov//proteinshop-bin/generate.pl?doc=Home Miscellaneous Links: The Genomics and Bioinformatics Grouphttp://discover.nci.nih.gov Ron Shamir's group http://www.cs.tau.ac.il/ »rshamir/ The Society for Neuroscience http://big.sfn.org/NDG/site/ The Canadian Bioinformatics Workshop Serieshttp://www.bioinformatics.ca/links directory/ Pedro M. Coutinho http://www.public.iastate.edu/ »pedro/research tools.h tml The Bioinformatics and Biocom- puting grouphttp://bioinformatics.weizmann.ac.il/ The NIH Computational Molecular Biology sectionhttp://molbio.info.nih.gov/molbio/ Geno.,Non-OADS,/arxiv_data1/oa_pdf/cd/71/main.PMC5172447.pdf
Making Sense of Genomic and Proteomic Information Table 1Continued Name URL bioinformatic links h ttp://www.bioinformatik.de/ links and online protein services http://www.ch.embnet.org/index.html PKUBIOS http://mdl.ipc.pku.edu.cn/mirror/mirror.html open directory http://dmoz.org/Science/Biology/Software/ Dr. Jonathan D. Rees http://www.bioinformatics.vg/index.shtml Je®rey Skolnick's group http://www.bioinformatics.bu®alo.edu/current bu®alo/skolnic k/services.html GMOD: WormBase http://www.wormbase.org FlyBase http://www.°ybase.org MGI http://www.informatics.jax.org SGD http://genome-www.stanford.edu/Saccharomyces/ Gramene http://www.gramene.org RatBase http://rgd.mcw.edu/ EcoCyc http://ecocyc.org TAIR http://www.arabidopsis.org/ Conclusion The presen ted hypertext links may serve as entry level for further information retrieval by following the hypertext links in the documents provided.,Non-OADS,/arxiv_data1/oa_pdf/cd/71/main.PMC5172447.pdf
1 February 2004 59This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,OADS,/arxiv_data1/oa_pdf/3b/e0/main.PMC5172448.pdf
2 May 2004This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/6f/c1/main.PMC5172449.pdf
"Links to completed genomes ( Encephlalitozoon cuniculi, Guillardia theta nucleomorph) can be found at http://www.ncbi.nlm.nih.gov:80/genomes/static/euk g.html; links to additional genomes in progress ( Dictyostelium discoideum, Entamoeba histolytica, Leishmania major ) at http://www.ncbi.nlm.nih.gov:80/genomes/static/EG T.html.",Non-OADS,/arxiv_data1/oa_pdf/6f/c1/main.PMC5172449.pdf
"In contrast, when queried with Rb genes from both human and Ara- bidopisis , tBLASTn (28 ) searches of all completed and partial fungal genomes, and of all other eukary- otic groups available through NCBI-linked BLAST re- sources (http://www.ncbi.nlm.nih.gov:80/BLAST/),return no signi¯cant hits from organisms outside the green plant and animal lineages (author's unpublished results).",OADS,/arxiv_data1/oa_pdf/6f/c1/main.PMC5172449.pdf
2 May 2004 109This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/7a/06/main.PMC5172454.pdf
Chromosome location of the genes ex- pressed in liver regeneration The chromosome location of the 177 genes was ana- lyzed by using BLAST (http://www.ncbi.nlm.nih.gov/ BLAST/) and GENSCAN (http://genes.mit.edu/ GENSCAN.html/) (Table 1).,OADS,/arxiv_data1/oa_pdf/7a/06/main.PMC5172454.pdf
They were searched at http://www.ncbi.nlm.nih.gov/ genomeguide/rat/index.html/ for gene location in chromosome and genes corresponding with WGS (Whole Genome Shotgun).,OADS,/arxiv_data1/oa_pdf/7a/06/main.PMC5172454.pdf
"Compared with known proteins in virtue of BLASTP (http://www.ncbi.nlm.nih.gov/BLAST/), their func- tions and accession numbers were achieved.",OADS,/arxiv_data1/oa_pdf/7a/06/main.PMC5172454.pdf
1 2005 1This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/fe/53/main.PMC5172464.pdf
1 2005This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/48/b8/main.PMC5172465.pdf
The software is available at http://ibi.zju.edu.cn/software/clusterproject/.,OADS,/arxiv_data1/oa_pdf/48/b8/main.PMC5172465.pdf
The data set is publicly available at http://cmgm.stanford.edu/pbrown/sporulation.,OADS,/arxiv_data1/oa_pdf/48/b8/main.PMC5172465.pdf
1 2005 3This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b5/b3/main.PMC5172466.pdf
3 August 2004 143 This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a5/d3/main.PMC5172467.pdf
"To identify this protein spot, the spot was cut from the silver-stained gels, in-gel digested with the trypsinenzyme, and then analyzed on a PerSeptive Voyager-DE MALDI-TOF MS. Peptide ﬁngerprint mass spec-tra generated from MALDI-TOF MS were interpreted and matched to SWISS-PROT database entries us- ing Mascot (http://www.matrixscience.com).",OADS,/arxiv_data1/oa_pdf/a5/d3/main.PMC5172467.pdf
1 2005 47This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c6/ac/main.PMC5172468.pdf
3 August 2004This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,OADS,/arxiv_data1/oa_pdf/2c/f4/main.PMC5172469.pdf
3 August 2004This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,OADS,/arxiv_data1/oa_pdf/dd/be/main.PMC5172470.pdf
"Implementation and Availability Besides our old UNIX code, a very limited ver- sion of the 2D histogram was implemented at the European Bioinformatics Institute (EBI; http:// industry.ebi.ac.uk/openBSA/bsa view ers/) and the National Institute for Standard and Technology (NIST; http://math.nist.gov/»FHunt/GenPatterns/).",OADS,/arxiv_data1/oa_pdf/dd/be/main.PMC5172470.pdf
The source code of SeeDNA is freely available under the GNU General Public License at the au- thors' website (www.itp.ac.cn/»hao/SeeDNA.tar.gz; http://tlife.fudan.edu.cn/SeeDNA.tar.gz).,OADS,/arxiv_data1/oa_pdf/dd/be/main.PMC5172470.pdf
1 2005This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b3/40/main.PMC5172471.pdf
An up-to- date list of references is maintained by Wentian Li (http://www.nslij-genetics.org/gene/; ref.,OADS,/arxiv_data1/oa_pdf/c8/a2/main.PMC5172472.pdf
"And a powerful gene ¯nding program, BGF (Bei- jing Gene Finder), is proposed by Beijing Genomics Institute (http://bgf.genomics.org.cn/).",Non-OADS,/arxiv_data1/oa_pdf/c8/a2/main.PMC5172472.pdf
3 August 2004 167This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c8/a2/main.PMC5172472.pdf
3 August 2004This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,OADS,/arxiv_data1/oa_pdf/db/a4/main.PMC5172473.pdf
1 February 2004This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,OADS,/arxiv_data1/oa_pdf/c2/68/main.PMC5172474.pdf
3 August2004This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/26/89/main.PMC5172475.pdf
1 2005 5This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/fe/71/main.PMC5172476.pdf
The sequences were assembled with Phrap (http://www.phrap.org) in a default setting.,Non-OADS,/arxiv_data1/oa_pdf/fe/71/main.PMC5172476.pdf
Genes of tRNA were de¯ned with tRNAscan-SE 1.2 (http://www.genetics.wustl.edu/eddy/tRNAscan-SE/ ).,OADS,/arxiv_data1/oa_pdf/fe/71/main.PMC5172476.pdf
"In 2005 the number of fully sequenced viral isolates exceeds one hundred (http://www.ncbi.nlm.nih.gov/entrez).SARS-CoV probably originated due to genetic ex- change (recombination) and/or mutations between viruses with different host specificities (5, 6).",Non-OADS,/arxiv_data1/oa_pdf/c3/ef/main.PMC5172477.pdf
1 2005This is an Open Access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c3/ef/main.PMC5172477.pdf
It also encodes for additional 8-9 predicted ORFs whose protein product functions are still under investigation (14; http://www.ncbi.nlm.nih.gov/entrez).,Non-OADS,/arxiv_data1/oa_pdf/c3/ef/main.PMC5172477.pdf
"SP, signal peptide; ED, external domain; TM, trans-membrane domain; and ID, internal domain (http://expasy.org/).",OADS,/arxiv_data1/oa_pdf/c3/ef/main.PMC5172477.pdf
Materials and Methods Dataset Nucleotide sequences of 103 SARS-CoV complete genomes were taken from the PubMed NCBI En- trez database (http://www.ncbi.nlm.nih.gov/entrez) in GenBank and FASTA formats.,OADS,/arxiv_data1/oa_pdf/c3/ef/main.PMC5172477.pdf
Annotation and analysis of the S pro- tein All the S protein sequences (those extracted from annotated isolates and the others we annotated us- ing the publicly available program from PubMed tools for data mining; http://www.ncbi.nlm.nih.gov/ gorf/gorf.html) have been aligned using CLUSTAL X program.,OADS,/arxiv_data1/oa_pdf/c3/ef/main.PMC5172477.pdf
"Supporting Online Material http://www.gpbjournal.org/journal/pdf/GPB3(l)-04.pdf Figures S1-S10, Tables S1-S6 Geno.",Non-OADS,/arxiv_data1/oa_pdf/c3/ef/main.PMC5172477.pdf
Available at: http://store.mintel.com/skincare-ingredient-and-format-trends-us-december-2015.,Non-OADS,/arxiv_data1/oa_pdf/f5/93/gox-4-e1152.PMC5172479.pdf
Personal Care Product Council: Available at: http://www.person- alcarecouncil.org.,Non-OADS,/arxiv_data1/oa_pdf/f5/93/gox-4-e1152.PMC5172479.pdf
Available at: http://www.mintel.com/press-centre/beauty-and-personal-care/one-in-five-us-wom-en-use-a-cleansing-brush-skincare-device  23.,Non-OADS,/arxiv_data1/oa_pdf/f5/93/gox-4-e1152.PMC5172479.pdf
Available at: http://www.accessdata.fda.gov/drugsatfda_docs/ label/2015/206333Orig1s0008)lbl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/54/a1/gox-4-e1155.PMC5172481.pdf
This video is available in the “related videos” section of the full-text article on PRSGlobalOpen.com or available at http://links.lww.,Non-OADS,/arxiv_data1/oa_pdf/d1/30/gox-4-e1166.PMC5172483.pdf
This video is avail- able in the “related videos” section of the full-text article  on PRSGlobalOpen.com or available at http://links.lww.,Non-OADS,/arxiv_data1/oa_pdf/d1/30/gox-4-e1166.PMC5172483.pdf
This video is available in  the “related videos” section of the full-text article on  PRSGlobalOpen.com or available at http://links.lww.,Non-OADS,/arxiv_data1/oa_pdf/d1/30/gox-4-e1166.PMC5172483.pdf
t his  video is available in the “related videos” section of the full-text article on Prsglobalopen.com or available at http://links.lww.com/PRSGO/A311.,Non-OADS,/arxiv_data1/oa_pdf/d1/30/gox-4-e1166.PMC5172483.pdf
this video is available in the “related videos” section of the  full-text article on Prsglobalopen.com or available at http://links.lww.com/PRSGO/A312.,Non-OADS,/arxiv_data1/oa_pdf/d1/30/gox-4-e1166.PMC5172483.pdf
com or available at http://links.lww.com/PRSGO/A310).,Non-OADS,/arxiv_data1/oa_pdf/d1/30/gox-4-e1166.PMC5172483.pdf
Available at: http://www.plasticsurgery.,Non-OADS,/arxiv_data1/oa_pdf/18/eb/gox-4-e1177.PMC5172485.pdf
"(See	 figure,	 Supplemental	digital	 Content	 1,  which shows the optimal treatment of neurotoxin: pattern of injection, http://links.lww.com/PRSGO/A333.)",Non-OADS,/arxiv_data1/oa_pdf/70/1e/gox-4-e1178.PMC5172486.pdf
"(See	figure,	 Supplemental	digital		 Content	 3, which shows  panfacial volumization, http://links.lww.com/PRSGO/A335.",Non-OADS,/arxiv_data1/oa_pdf/70/1e/gox-4-e1178.PMC5172486.pdf
"(See	 figure, 	 Supplemental	digital	 Content	 4, which shows panfacial  volumization, http://links.lww.com/PRSGO/A336.)",Non-OADS,/arxiv_data1/oa_pdf/70/1e/gox-4-e1178.PMC5172486.pdf
"(See	 video,	 Supplemental	digital	 Content 	 5, which demonstrates assessment and injection tear  trough, available in the “Related Videos” section of the full-text article on PRSJournal.com or, for Ovid users, at http://links.lww.com/PRSGO/A337.)",Non-OADS,/arxiv_data1/oa_pdf/70/1e/gox-4-e1178.PMC5172486.pdf
"3) but  has a higher incidence of edema than Restylane because  Video Graphic 1. see video, supplemental digital content 2, which  demonstrates lower face neurotoxin injection, available in the “r e- lated Videos” section of the full-text article on PrsJournal.com  or, for  ovid users, at http://links.lww.com/PRSGO/A334.",Non-OADS,/arxiv_data1/oa_pdf/70/1e/gox-4-e1178.PMC5172486.pdf
"(See	video,	 Supplemental	digital	 Content	 5, which dem- onstrates assessment and injection tear trough, available in the “Related Videos” section of the full-text article on  PRSJournal.com or, for Ovid users, at http://links.lww.com/ PRSGO/A337.)",Non-OADS,/arxiv_data1/oa_pdf/70/1e/gox-4-e1178.PMC5172486.pdf
"(See	 video,	 Supplemental	 digital	 Content	 6, which  demonstrates upper eyelid, eyebrow [ROOF], and tem-poral fossa injection, available in the “Related Videos”  section of the full-text article on PRSJournal.com or,  for Ovid users, at http://links.lww.com/PRSGO/A338.)",Non-OADS,/arxiv_data1/oa_pdf/70/1e/gox-4-e1178.PMC5172486.pdf
"Video Graphic 2. s ee video, supplemental digital c ontent 5,  which demonstrates the assessment and injections to the tear trough,  available in the “r elated Videos” section of the full-text   article on PrsJournal.c om or, for o vid users, at http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/70/1e/gox-4-e1178.PMC5172486.pdf
"(See	 figure,	 Supplemental	 digital	 Content	 7, which  shows facial volumization to correct asymmetries http://links.lww.com/PRSGO/A339.",Non-OADS,/arxiv_data1/oa_pdf/70/1e/gox-4-e1178.PMC5172486.pdf
"(See	 figure,	 Supplemental	digital	 Content	 8, which shows the lasting effect over 2 years:  50-year-old patient Sculptra results after 3 sessions with 2  vials per session, each vial 9 mL total volume [7 mL sterile  water with 2 mL lidocaine 1% with epinephrine] and  6-week treatment sessions’ interval, http://links.lww.com/ Fig.",Non-OADS,/arxiv_data1/oa_pdf/70/1e/gox-4-e1178.PMC5172486.pdf
"Video Graphic 3. see video, supplemental digital content 6, which  demonstrates upper eyelid, eyebrow (rooF), and temporal fossa in- jections, available in the “r elated Videos” section of the full-text ar - ticle on PrsJournal.c om or, for o vid users, at http://links.lww.com/ PRSGO/A338.",Non-OADS,/arxiv_data1/oa_pdf/70/1e/gox-4-e1178.PMC5172486.pdf
"The treatment history: 2 vi- als during first 4 sessions every 6 weeks, then 1 vial  every year for maintenance, http://links.lww.com/ PRSGO/A342.)",Non-OADS,/arxiv_data1/oa_pdf/70/1e/gox-4-e1178.PMC5172486.pdf
"(See	 video, 	 Supplemental	 digital	 Content	 11, which demonstrates  hands Radiesse cannula injection, available in the “Related  Videos” section of the full-text article on PRSJournal.com  or, for Ovid users, at http://links.lww.com/PRSGO/A343.)",Non-OADS,/arxiv_data1/oa_pdf/70/1e/gox-4-e1178.PMC5172486.pdf
"Recommended Reconstitution Volume of PLLA for Nonfacial Rejuvenation area Reconstitution	Volume Needle Hand 9–10 mL volume (8 mL of bacteriostatic water plus 1–2 mL of lidocaine 1%)4326-G needle43 8–10 mL dilution per vial (6 mL SWFI + 2 mL of 1% lidocaine)4425-G needle44 14 mL (5 mL SWFI and 9 mL lidocaine HCl 1%)4725-G needle or cannula47 10 mL (9 mL of bacteriostatic sterile water plus 1 mL 1% lidocaine without epinephrine)6725- or 27-G needle44 Chest/décolleté 10 mL of sterile water4527-G needle45 24 mL (5 mL SWFI and 19 mL lidocaine HCl 1%)4727-G needle47 Buttock 12 mL (5 mL SWFI and 7 mL lidocaine 1%)4725-G needle or cannula47 Video Graphic 4.  s ee video, supplemental digital c ontent 11, which  demonstrates r adiesse cannula injection into the hands, available in  the “r elated Videos” section of the full-text article on PrsJournal.com  or, for o vid users, at http://links.lww.com/PRSGO/A343.Table 7.",Non-OADS,/arxiv_data1/oa_pdf/70/1e/gox-4-e1178.PMC5172486.pdf
Available at: https://d2wirczt3b6wjm.cloudfront.net/News/Statistics/2014/plastic-surgerystatistics-full-report-2014.pdf.,Non-OADS,/arxiv_data1/oa_pdf/70/1e/gox-4-e1178.PMC5172486.pdf
Available at: http://www.allergan.com/assets/pdf/botox_cosmetic_pi.pdf.,Non-OADS,/arxiv_data1/oa_pdf/70/1e/gox-4-e1178.PMC5172486.pdf
Available  at: http://www.galderma.com.au/Portals/4/PIs%20and%20CMIs/April%2016%20uploads/Dysport%20Product%20in-formation%20V2%207%20125U%20%202%20Dec%202015.pdf.,Non-OADS,/arxiv_data1/oa_pdf/70/1e/gox-4-e1178.PMC5172486.pdf
Available at: http://www.xeominaesthetic.com/wp-content/up- loads/XEOMIN-Prescribing-Information.pdf.,Non-OADS,/arxiv_data1/oa_pdf/70/1e/gox-4-e1178.PMC5172486.pdf
Available at: http://www.access- data.fda.gov/cdrh_docs/pdf5/P050052S049a.pdf.,OADS,/arxiv_data1/oa_pdf/70/1e/gox-4-e1178.PMC5172486.pdf
Available at: http://www.radiesse.com/wp-content/uploads/Radiesse-Hands-Instructions-for-Use.pdf.,Non-OADS,/arxiv_data1/oa_pdf/70/1e/gox-4-e1178.PMC5172486.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/16/16/ckw079.PMC5172488.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ea/00/ckw096.PMC5172490.pdf
"Available at: http://hal.archives ouvertes.fr/docs/00/28/39/11/PDF/Les_ travailleurs_syriens_au_Liban.pdf (14 March 2014, date last accessed) 9 Habib RR.",Non-OADS,/arxiv_data1/oa_pdf/ea/00/ckw096.PMC5172490.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ea/00/ckw096.PMC5172490.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium,provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e6/eb/ckw097.PMC5172491.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence(http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2f/0a/ckw115.PMC5172492.pdf
Available at: http://www.statmodel.com/download/GstrucMissingRevision.,OADS,/arxiv_data1/oa_pdf/2f/0a/ckw115.PMC5172492.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/ed/ofw191.PMC5172511.pdf
"Young people and older men had the lowest prevalence of awareness: 56.4% in people aged 15–24 years, 56.2% in men aged 25 –34 years, and 66.0% in men aged 55 –59 years (see Fig.ure 1, Supplemental Digital Content, http://links.lww.com/QAI/A838).Antiretroviral Treatment and Viral Suppression ART coverage was 75.0% (95% CI: 72.0 to 77.8) according to the National Guidelines at the time of the survey, 64.3% (95% CI: 61.5 to 67.0) according to the 2013 WHO guidelines, and 53.1% (95% CI: 50.4 to 55.7) according to a test and treat strategy.",Non-OADS,/arxiv_data1/oa_pdf/8d/7c/qai-73-411.PMC5172512.pdf
Available at: http://www.pubmedcen tral.nih.gov/articlerender.fcgi?,Non-OADS,/arxiv_data1/oa_pdf/8d/7c/qai-73-411.PMC5172512.pdf
Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3433409&tool= pmcentrez&rendertype=abstract.,OADS,/arxiv_data1/oa_pdf/8d/7c/qai-73-411.PMC5172512.pdf
Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4658174&tool= pmcentrez&rendertype=abstract.,OADS,/arxiv_data1/oa_pdf/8d/7c/qai-73-411.PMC5172512.pdf
Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3739051&tool= pmcentrez&rendertype=abstract.,OADS,/arxiv_data1/oa_pdf/8d/7c/qai-73-411.PMC5172512.pdf
Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?,Non-OADS,/arxiv_data1/oa_pdf/8d/7c/qai-73-411.PMC5172512.pdf
Available at: http://www.ncbi.nlm.nih.gov/pubmed/25860192.,Non-OADS,/arxiv_data1/oa_pdf/8d/7c/qai-73-411.PMC5172512.pdf
Available at: http://www.pubmed central.nih.gov/articlerender.,Non-OADS,/arxiv_data1/oa_pdf/8d/7c/qai-73-411.PMC5172512.pdf
Available at: http://www.ncbi.nlm.nih.gov/pubmed/25601912.,Non-OADS,/arxiv_data1/oa_pdf/8d/7c/qai-73-411.PMC5172512.pdf
Available at: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/8d/7c/qai-73-411.PMC5172512.pdf
Available at: http://www.ncbi.nlm.nih.gov/pubmed/26348035.,Non-OADS,/arxiv_data1/oa_pdf/8d/7c/qai-73-411.PMC5172512.pdf
Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?,Non-OADS,/arxiv_data1/oa_pdf/8d/7c/qai-73-411.PMC5172512.pdf
Available at: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/8d/7c/qai-73-411.PMC5172512.pdf
Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3597746&tool= pmcentrez&rendertype=abstract.,OADS,/arxiv_data1/oa_pdf/8d/7c/qai-73-411.PMC5172512.pdf
Available at: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/8d/7c/qai-73-411.PMC5172512.pdf
Available at: http://www.ncbi.nlm.nih.gov/ pubmed/24732815.,Non-OADS,/arxiv_data1/oa_pdf/8d/7c/qai-73-411.PMC5172512.pdf
Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3744613&tool= pmcentrez&rendertype=abstract.,OADS,/arxiv_data1/oa_pdf/8d/7c/qai-73-411.PMC5172512.pdf
Available at: http://www.pubmedcentral.nih.gov/ articlerender.fcgi?artid=4233323&tool=pmcentrez&rendertype=abstract.,OADS,/arxiv_data1/oa_pdf/8d/7c/qai-73-411.PMC5172512.pdf
"Available at: http://www.ncbi.nlm.nih.gov/ pubmed/26280016.Huerga et al J Acquir Immune Deﬁc Syndr /C15Volume 73, Number 4, December 1, 2016 418 |www.jaids.com Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/8d/7c/qai-73-411.PMC5172512.pdf
"Proﬁle likelihood identi ﬁed thresholds of 1.12 mg/L (95% CI from resimulations 0.47 to 1.56 mg/L) for C12h, 0.65 mg/L (95% CI: 0.25 to 1.27) for C24h, and 28 mg $h/L(95% CI: 20.47 to 32.22) for AUC 0-24as the best dichotomized thresholds for predicting virological suppression (see Supple- mental Digital Content, http://links.lww.com/QAI/A819).",Non-OADS,/arxiv_data1/oa_pdf/14/84/qai-73-161.PMC5172513.pdf
Available at: http://www.nejm.,Non-OADS,/arxiv_data1/oa_pdf/14/84/qai-73-161.PMC5172513.pdf
Available at: http://cran.r-project.org/package=survival.,Non-OADS,/arxiv_data1/oa_pdf/14/84/qai-73-161.PMC5172513.pdf
Available at: http://www.R-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/14/84/qai-73-161.PMC5172513.pdf
"Primers were based on a subtype C isolate, Genbank accession no AY772699 (http://www.ncbi.nlm.nih.gov/nuccore/AY772699).",OADS,/arxiv_data1/oa_pdf/49/c1/qai-73-384.PMC5172515.pdf
"Depth of coverage is provided in Table S1, Supplemental Digital Content, http://links.lww.com/QAI/A854.",Non-OADS,/arxiv_data1/oa_pdf/49/c1/qai-73-384.PMC5172515.pdf
Available at: http://www.sahivsoc.org/upload/documents/NDOH_PMTCT.pdf.,Non-OADS,/arxiv_data1/oa_pdf/49/c1/qai-73-384.PMC5172515.pdf
Available at: http://apps.who.,Non-OADS,/arxiv_data1/oa_pdf/49/c1/qai-73-384.PMC5172515.pdf
Available at: http://www.unicef.org/southafrica/survival_devlop_ 343.html.,Non-OADS,/arxiv_data1/oa_pdf/49/c1/qai-73-384.PMC5172515.pdf
Available at: http://www.mrc.ac.za/healthsystems/SAPMTCTE2010.pdf.,Non-OADS,/arxiv_data1/oa_pdf/49/c1/qai-73-384.PMC5172515.pdf
"of these cells (see Figure S3, Supplemental Digital Content, http://links.lww.com/QAI/A845).",Non-OADS,/arxiv_data1/oa_pdf/ae/37/qai-73-245.PMC5172519.pdf
"Four patients proved to be outliers, with estimated lifespans of long-lived infected cells .180 days (see Figure S3, Supplemental Digital Content, http://links.lww.com/QAI/A845).",Non-OADS,/arxiv_data1/oa_pdf/ae/37/qai-73-245.PMC5172519.pdf
"0 3 4 6 0.017 d21,c o r r e s p o n d i n gt oam e d i a nl i f e s p a no f3 2d a y s (IQR: 22 –51), with ;77% of the infected cells at baseline productively infected (see Figure S3, Supplemental DigitalContent, http://links.lww.com/QAI/A845).",Non-OADS,/arxiv_data1/oa_pdf/ae/37/qai-73-245.PMC5172519.pdf
"The resulting estimates were not distinguis hable from those above (median R 0 of 5.3 [IQR: 4.5 –7.0]; see Figure S4, Supplemental Digital Content, http://links.lww.c om/QAI/A845), indicating that the estimate of R 0was robust with respect to variations in d. Similarly, excluding patients w ith viral load undetectable at week 12, whose second phase slope was potentially underestimated by ourﬁts, yielded median R 0to be 5.2 (IQR: 4.7 –6.9) (n = 45), not signiﬁcantly different from the estimate above ( P=0 .",Non-OADS,/arxiv_data1/oa_pdf/ae/37/qai-73-245.PMC5172519.pdf
"We thus estimated the median R 0to be 5.2 (IQR: 4.5 –6.9) (see Figure S5, Supple- mental Digital Content, http://links.lww.com/QAI/A845) (and FIGURE 1.",Non-OADS,/arxiv_data1/oa_pdf/ae/37/qai-73-245.PMC5172519.pdf
"Fits to all the pa-tients analyzed are in Figures,Supplemental Digital Content 1 and Supplemental Digital Content 2, http://links.lww.com/QAI/A845.The resulting best-ﬁt parameter estimates are in Table, Supple- mental Digital Content 6, http://links.lww.com/QAI/A845.Shet et al J Acquir Immune Deﬁc Syndr /C15Volume 73, Number 3, November 1, 2016 248 |www.jaids.com Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/ae/37/qai-73-245.PMC5172519.pdf
"1; also see Table, Supplemental Digital Content 6, http://links.lww.com/QAI/A845).",Non-OADS,/arxiv_data1/oa_pdf/ae/37/qai-73-245.PMC5172519.pdf
Available at http://www.naco.gov.in/NACO/About_NACO/Policy__Guidelines/Policies__Guidelines1/.,Non-OADS,/arxiv_data1/oa_pdf/ae/37/qai-73-245.PMC5172519.pdf
Available from: http://monographs.iarc.fr/ENG/ Monographs/vol100F/index.php.,Non-OADS,/arxiv_data1/oa_pdf/fe/a3/qai-73-332.PMC5172520.pdf
Available at: http://www.aidsinfo.nih.gov/ ContentFiles/AdultandAdolescentGL.pdf.,Non-OADS,/arxiv_data1/oa_pdf/02/87/qai-73-294.PMC5172523.pdf
3 2005This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/cb/01/main.PMC5172528.pdf
"11) as reference sequences to discover SNPs (BGI-RIS, http://rise.genomics.org.cn/ index.jsp).",OADS,/arxiv_data1/oa_pdf/cb/01/main.PMC5172528.pdf
4 2005 201This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/6f/7b/main.PMC5172532.pdf
"Materials We used the human chromosome 22 and collected the upstream (1,000 bp), exon, intron, downstream (1,000 bp), and intergenic regions (1,000 bp) accord- ing to the gene annotation database of the University of Santa Cruz Golden Path human genome sequence (http://genome.cse.ucsc.edu).",OADS,/arxiv_data1/oa_pdf/6f/7b/main.PMC5172532.pdf
"To facilitate the study on this topic, we constructed two databases (DCCP and DICP) containing the known copper- and iron-chelating proteins, which are freely available from the website http://sdbi.sdut.edu.cn/en.",OADS,/arxiv_data1/oa_pdf/9f/b5/main.PMC5172534.pdf
"Although there are some metalloprotein databases relevant to this topic, such as MDB (Metalloprotein Database and Browser, http://metallo.scripps.edu/, last updated on Nov. 20, 2003) and PROMISE (The Prosthetic cen- ters and Metal Ions in Protein Active Sites, http://metallo.scripps.edu/PROMISE/MAIN.html, last updated on Mar.",OADS,/arxiv_data1/oa_pdf/9f/b5/main.PMC5172534.pdf
1 2005This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9f/b5/main.PMC5172534.pdf
"Materials and Methods The construction of DCCP and DICP was based on the well-known web technologies: a fast database management system (MySQL; http://www.mysql.com), a stable web server (Apache; http://www.apache.org), and a powerful web script- ing language (PHP; http://www.php.net) on the ba- sis of an open source operation system|Linux.",OADS,/arxiv_data1/oa_pdf/9f/b5/main.PMC5172534.pdf
Further information can be found at the website http://sdbi.sdut.edu.cn/en.,Non-OADS,/arxiv_data1/oa_pdf/9f/b5/main.PMC5172534.pdf
1 2005 58This is an Open Access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/77/2c/main.PMC5172537.pdf
Tree Visualization accessed at http://geneproject.altervista.org/ and is References available upon request.,OADS,/arxiv_data1/oa_pdf/77/2c/main.PMC5172537.pdf
4 2005This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/fd/38/main.PMC5172539.pdf
2 2005This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/b0/main.PMC5172540.pdf
4 2005 225This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/cf/63/main.PMC5172541.pdf
3 2005This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/95/da/main.PMC5172542.pdf
2 2005 107This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bf/83/main.PMC5172543.pdf
The re- view can be found in the work by Signh and Bru- talg (http://cmgm.stanford.edu/ »brutlag/Papers/ singh00.pdf).,Non-OADS,/arxiv_data1/oa_pdf/bf/83/main.PMC5172543.pdf
DALI and VAST are structural alignment tools that per- form the best (http://cmgm.stanford.edu/ »brutlag/Papers/singh00.pdf).,OADS,/arxiv_data1/oa_pdf/bf/83/main.PMC5172543.pdf
2 2005 61This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a7/8a/main.PMC5172546.pdf
The software package is freely available under the GNU General Public License at http://www.g-language.org/data/cdna/.,OADS,/arxiv_data1/oa_pdf/94/de/main.PMC5172547.pdf
3 2005 179This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/94/de/main.PMC5172547.pdf
"The software package, documentation, and sample output are avail- able at http://www.g-language.org/data/cdna/.",OADS,/arxiv_data1/oa_pdf/94/de/main.PMC5172547.pdf
"For all calculated indices, the strength of consensus is displayed using the GNU- plot graphing utility (http://www.gnuplot.info/).",OADS,/arxiv_data1/oa_pdf/94/de/main.PMC5172547.pdf
The set is graphically displayed using JTreeView software (http://jtreeview.sourceforge.net/) for func- tional classi¯cation and comparative study.,OADS,/arxiv_data1/oa_pdf/94/de/main.PMC5172547.pdf
"The results, including the PWM, graphs of the calculated indices implemented, and the sequence logo output, are supplied as additional data (http://www.g-language.org/data/cdna/Addi- tional data 3.do c).",OADS,/arxiv_data1/oa_pdf/94/de/main.PMC5172547.pdf
The corre- lation coe±cients between all pairs of the PCA axis scores and 126 gene parameters are given in additional data (http://www.g-language.org/data/ cdna/Additional data 1.xls).,OADS,/arxiv_data1/oa_pdf/94/de/main.PMC5172547.pdf
The gener- ated PDB format ¯le of the structure is provided as additional data (http://www.g-language.org/data/ cdna/Additional data 4.p db) that can be directly vi- sualized in 3D with software such as RASMOL.,OADS,/arxiv_data1/oa_pdf/94/de/main.PMC5172547.pdf
4 2005This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f7/70/main.PMC5172548.pdf
2 2005This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d7/74/main.PMC5172550.pdf
A registry has been set up for the assign- ment of miRNA gene names prior to publication (http://www.sanger.ac.uk/Software/Rfam/mirna/; ref.,Non-OADS,/arxiv_data1/oa_pdf/d7/74/main.PMC5172550.pdf
3 2005 189This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/6b/34/main.PMC5172552.pdf
4 2005 213This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/62/b9/main.PMC5172553.pdf
3 2005 169This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/33/main.PMC5172555.pdf
3 2005This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/45/03/main.PMC5172556.pdf
4 2005 197This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d3/55/main.PMC5172557.pdf
2 2005This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/33/main.PMC5172558.pdf
The ¯les of the Pfam MySQL database were downloaded from the Pfam ftp server (ftp://ftp.sanger.ac.uk/pub/databases/Pfam/ database ¯les/) and stored in MySQL DBMS locally.,OADS,/arxiv_data1/oa_pdf/ff/33/main.PMC5172558.pdf
Supporting Online Material http://www.gpbjournal.org/journal/pdf/GPB3(2)-05.pdf Figures S1{S7 106 Geno.,Non-OADS,/arxiv_data1/oa_pdf/ff/33/main.PMC5172558.pdf
3 2005 143This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/12/e7/main.PMC5172559.pdf
3 2005 129This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c4/1b/main.PMC5172560.pdf
2 2005 73This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8d/dd/main.PMC5172590.pdf
The complete rankings of the features are available at http://www.comp.nus.edu.sg/ »ligl/publications/ TIS/feature rankings.htm.,OADS,/arxiv_data1/oa_pdf/8d/dd/main.PMC5172590.pdf
"Description of the Intervention From D ecember 2012, a bundle of measures to improve the PMTCT and Pediatric HIV services were introduced, namely: (1) creation of the One Stop Clinic of Ifakara: a PMTCT and pediatric unit integrated within the Reproductive and ChildHealth Clinic; (2) implementation of electronic medical records; (3) implementation of provider-initiated HIV testing andcounseling (PITC) in the hospital wards; and (4) early infant HIV diagnosis (EID) test locally (See Table, Supplemental Digital Content 1, http://links.lww.com/QAI/A919).",Non-OADS,/arxiv_data1/oa_pdf/2a/aa/qai-73-e67.PMC5172808.pdf
Electronic Medical Records for HIV- Infected Patients The Open Medical Record System (http://openmrs.org/) was adopted to implement an electronic data collectionsystem at our clinic.,Non-OADS,/arxiv_data1/oa_pdf/2a/aa/qai-73-e67.PMC5172808.pdf
"(See Figure, Supplemental Digital Content 2, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/2a/aa/qai-73-e67.PMC5172808.pdf
Available at: http://www.unaids.org/sites/default/ ﬁles/ media_asset/FactSheet_Children_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2a/aa/qai-73-e67.PMC5172808.pdf
Ava ilable at: http://www.unaids.org/ sites/default/ ﬁles/en/media/unaids/contentassets/documents/epidemiology/ 2013/gr2013/UNAIDS_Global_Report_2013_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2a/aa/qai-73-e67.PMC5172808.pdf
Available at: http://www.unaids.org/sites/default/ ﬁles/media_asset/90-90-90_en_0.,Non-OADS,/arxiv_data1/oa_pdf/2a/aa/qai-73-e67.PMC5172808.pdf
Available at: http://www.unaids.org/sites/ default/ ﬁles/country/documents/TZA_narrative_report_2014.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2a/aa/qai-73-e67.PMC5172808.pdf
Available at: http://pmtct.or.tz/wp-content/ uploads/2013/10/tz_guidelines_ccs_optionb_all.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2a/aa/qai-73-e67.PMC5172808.pdf
Available at: http://ihi.eprints.org/823/1/MoHSW.pdf_(53).pdf.,Non-OADS,/arxiv_data1/oa_pdf/2a/aa/qai-73-e67.PMC5172808.pdf
Available at: http://www.dndi.org/images/stories/diseases_portfolio/DNDi_Paediatric_HIV_roundtable.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2a/aa/qai-73-e67.PMC5172808.pdf
Available at: http://www.unaids.org/ sites/default/ ﬁles/media_asset/UNAIDS_Gap_re port_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/08/cb/qai-73-489.PMC5172848.pdf
Available at: http://www.unaids.org/sites/ default/ ﬁles/media_asset/JC2746_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/08/cb/qai-73-489.PMC5172848.pdf
Available at: https://factsconsortium.wordpress.com/facts-001-study.,Non-OADS,/arxiv_data1/oa_pdf/08/cb/qai-73-489.PMC5172848.pdf
Available at: http://www.ipmglobal.org/the-ri ng-study.,Non-OADS,/arxiv_data1/oa_pdf/08/cb/qai-73-489.PMC5172848.pdf
"Available at: http://globenewswire.com/news-release/2003/07/30/299151/43259/en/Medivir-licenses-MIV-150-to-Population-Council.html.Accessed October 18, 2015.",Non-OADS,/arxiv_data1/oa_pdf/08/cb/qai-73-489.PMC5172848.pdf
Available at: http://www.inchem.,Non-OADS,/arxiv_data1/oa_pdf/08/cb/qai-73-489.PMC5172848.pdf
Avail- able at: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProvide rs/ucm166927.htm#.ViVmtj9Bnzs.,Non-OADS,/arxiv_data1/oa_pdf/08/cb/qai-73-489.PMC5172848.pdf
4 2005 247This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3f/42/main.PMC5173181.pdf
Materials and Methods Dataset A set of human GPCR sequences with known coupling specificity was collected from the gpDB database (http://bioinformatics.biol.uoa.gr/gpDB).,OADS,/arxiv_data1/oa_pdf/3f/42/main.PMC5173181.pdf
4 2005This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e4/7a/main.PMC5173237.pdf
"Materials and Methods Sequence data of the rhodopsin-like family In Elrod and Chou ( 6), the accession numbers of 167 GPCR sequences from the December 2000 re- lease of GPCRDB were listed, including 31 acetyl- cholines, 44 adrenoceptors, 38 dopamines, and 54 serotonins (http://www.gpcr.org/7tm/).",OADS,/arxiv_data1/oa_pdf/e4/7a/main.PMC5173237.pdf
4 2005This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/6c/main.PMC5173238.pdf
4 2005 231This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d2/63/main.PMC5173242.pdf
4 2005This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/24/d2/main.PMC5173243.pdf
"pro vided by UniProt (ftp://cn.expasy.org/databases/ uniprot), the length distributions of GPCRs and non- GPCRs were analyzed in this study (Figure 1).",OADS,/arxiv_data1/oa_pdf/24/d2/main.PMC5173243.pdf
J Cell Biol 2016; 214(3):333-45; http://dx.doi.org/10.1083/jcb.201603039 © 2016 Thomas G. McWilliams and Ian G. Ganley.,Non-OADS,/arxiv_data1/oa_pdf/cc/58/kaup-12-12-1234567.PMC5173262.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cc/58/kaup-12-12-1234567.PMC5173262.pdf
"12, 2506 –2507 http://dx.doi.org/10.1080/15548627.2016.1234567",Non-OADS,/arxiv_data1/oa_pdf/cc/58/kaup-12-12-1234567.PMC5173262.pdf
G3 2016; 6:453-62; http://dx.doi.org/10.1534/g3.115.025858 © 2016 Tobias Mourier.,Non-OADS,/arxiv_data1/oa_pdf/95/34/kmge-06-06-1240748.PMC5173269.pdf
"6, e1240748 (4 pages)http://dx.doi.org/10.1080/2159256X.2016.1240748",Non-OADS,/arxiv_data1/oa_pdf/95/34/kmge-06-06-1240748.PMC5173269.pdf
"ORCID Tobias Mourier http://orcid.org/0000-0002-8522-7583 References [1] von Schwedler U, Jack HM, Wabl M. Circular DNA is a product of the immunoglobulin class switch rearrange-ment.",Non-OADS,/arxiv_data1/oa_pdf/95/34/kmge-06-06-1240748.PMC5173269.pdf
"Nature 1990; 345:452-6; PMID:2111465; http://dx.doi.org/10.1038/345452a0 [2] Horowitz H, Haber JE.",OADS,/arxiv_data1/oa_pdf/95/34/kmge-06-06-1240748.PMC5173269.pdf
"Mol Cell Biol 1985; 5:2369-80; PMID:3915542; http://dx.doi.org/10.1128/MCB.5.9.2369 [3] Moller HD, Parsons L, Jorgensen TS, Botstein D, Regenberg B. Extrachromosomal circular DNA iscommon in yeast.",OADS,/arxiv_data1/oa_pdf/95/34/kmge-06-06-1240748.PMC5173269.pdf
"Cell Rep 2015; 11:1749-59; PMID:26051933; http://dx.doi.org/10.1016/j.celrep.2015.05.020 [5] Gresham D, Usaite R, Germann SM, Lisby M, Botstein D, Regenberg B.",OADS,/arxiv_data1/oa_pdf/95/34/kmge-06-06-1240748.PMC5173269.pdf
"Proc Natl Acad Sci U S A 2010; 107:18551-6; PMID:20937885; http://dx.doi.org/ 10.1073/pnas.1014023107 [6] Cohen S, Segal D. Extrachromosomal circular DNA in eukaryotes: possible involvement in the plasticity of tan-dem repeats.",OADS,/arxiv_data1/oa_pdf/95/34/kmge-06-06-1240748.PMC5173269.pdf
"Cytogenetic Genome Res 2009; 124:327-38;PMID:19556784; http://dx.doi.org/10.1159/000218136 [7] Moller HD, Larsen CE, Parsons L, Hansen AJ, Regenberg B, Mourier T. Formation of extrachromosomal circular DNA from long terminal repeats of Retrotransposons in Saccharomyces cerevisiae.",OADS,/arxiv_data1/oa_pdf/95/34/kmge-06-06-1240748.PMC5173269.pdf
G3 2016; 6:453-62; http://dx.doi.org/10.1534/g3.115.025858 [8] Ewing AD.,Non-OADS,/arxiv_data1/oa_pdf/95/34/kmge-06-06-1240748.PMC5173269.pdf
"Mobile DNA 2015; 6:24;PMID:26719777; http://dx.doi.org/10.1186/s13100-015-0055-3 [9] Mourier T, Willerslev E. Large-scale transcriptome data reveals transcriptional activity of ﬁssion yeast LTR retrotransposons.",OADS,/arxiv_data1/oa_pdf/95/34/kmge-06-06-1240748.PMC5173269.pdf
BMC Genomics 2010; 11:167;PMID:20226011; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/95/34/kmge-06-06-1240748.PMC5173269.pdf
"PloS One 2012; 7:e50978; PMID:23226439; http://dx.doi.org/10.1371/journal.pone.0050978 [13] Moller HD, Bojsen RK, Tachibana C, Parsons L, Botstein D, Regenberg B. Genome-wide puri ﬁcation of extrachro- mosomal circular DNA from Eukaryotic cells.",OADS,/arxiv_data1/oa_pdf/95/34/kmge-06-06-1240748.PMC5173269.pdf
"J Vis Exp2016:e54239; PMID:27077531; http://dx.doi.org/10.3791/54239 [14] Libuda DE, Winston F. Ampli ﬁcation of histone genes by circular chromosome formation in Saccharomyces cere-visiae.",Non-OADS,/arxiv_data1/oa_pdf/95/34/kmge-06-06-1240748.PMC5173269.pdf
"Nature 2006; 443:1003-7; PMID:17066037; http://dx.doi.org/10.1038/nature05205 [15] Mieczkowski PA, Lemoine FJ, Petes TD.",OADS,/arxiv_data1/oa_pdf/95/34/kmge-06-06-1240748.PMC5173269.pdf
"Recombination between retrotransposons as a source of chromosomerearrangements in the yeast Saccharomyces cerevisiae.DNA Repair 2006; 5:1010-20; PMID:16798113; http://dx.doi.org/10.1016/j.dnarep.2006.05.027 [16] Farnet CM, Haseltine WA.",OADS,/arxiv_data1/oa_pdf/95/34/kmge-06-06-1240748.PMC5173269.pdf
"J Virol 2006; 80:11920-34; PMID:17005648; http://dx.doi.org/10.1128/JVI.01483-06 [19] Kilzer JM, Stracker T, Beitzel B, Meek K, Weitzman M, Bushman FD.",OADS,/arxiv_data1/oa_pdf/95/34/kmge-06-06-1240748.PMC5173269.pdf
"Virology 2003; 314:460-7; PMID:14517098;http://dx.doi.org/10.1016/S0042-6822(03)00455-0 [20] Telesnitsky A, Goff SP.",Non-OADS,/arxiv_data1/oa_pdf/95/34/kmge-06-06-1240748.PMC5173269.pdf
"Curr Genetics 2016:1-4;PMID:26045103; http://dx.doi.org/10.1007/s00294-016-0592-4 [22] Izsvak Z, Wang J, Singh M, Mager DL, Hurst LD.",OADS,/arxiv_data1/oa_pdf/95/34/kmge-06-06-1240748.PMC5173269.pdf
BioEssays 2016; 38:109-17; PMID:26735931;http://dx.doi.org/10.1002/bies.201500096 [23] Gaubatz JW.,OADS,/arxiv_data1/oa_pdf/95/34/kmge-06-06-1240748.PMC5173269.pdf
"MutationRes 1990; 237:271-92; PMID:2079966; http://dx.doi.org/10.1016/0921-8734(90)90009-G [24] Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W,et al.",OADS,/arxiv_data1/oa_pdf/95/34/kmge-06-06-1240748.PMC5173269.pdf
"Nature 2001; 409:860-921; PMID:11237011; http://dx.doi.org/10.1038/35057062 [25] Batzer MA, Deininger PL.",OADS,/arxiv_data1/oa_pdf/95/34/kmge-06-06-1240748.PMC5173269.pdf
"Nat Rev Genet 2002; 3:370-9;PMID:11988762; http://dx.doi.org/10.1038/nrg798 [26] Deininger PL, Batzer MA.",OADS,/arxiv_data1/oa_pdf/95/34/kmge-06-06-1240748.PMC5173269.pdf
"Mol Genetics Metab 1999; 67:183-93; PMID:10381326;http://dx.doi.org/10.1006/mgme.1999.2864 [27] Ramaprasad A, Mourier T, Naeem R, Malas TB, Moussa E ,P a n i g r a h iA ,V e r m o n tS J ,O t t oT D ,W a s t l i n gJ ,P a i nA .",Non-OADS,/arxiv_data1/oa_pdf/95/34/kmge-06-06-1240748.PMC5173269.pdf
"PloS One 2015; 10:e0124473; PMID:25875305;http://dx.doi.org/10.1371/journal.pone.0124473 [28] Jeffares D, Mourier T, Penny D. The biology of intron gain and loss.",OADS,/arxiv_data1/oa_pdf/95/34/kmge-06-06-1240748.PMC5173269.pdf
"Trends Genetics 2006; 22:16-22; PMID:16290250; http://dx.doi.org/10.10 16/j.tig.2005.10.006 [29] Yates A, Akanni W, Amode MR, Barrell D, Billis K, Carvalho-Silva D, Cummins C, Clapham P, Fitzgerald S,Gil L, et al.",OADS,/arxiv_data1/oa_pdf/95/34/kmge-06-06-1240748.PMC5173269.pdf
"Nucleic Acids Res 2016; 44:D710-6; PMID:26687719; http://dx.doi.org/10.1093/nar/gkv1157 [30] Smedley D, Haider S, Durinck S, Pandini L, Provero P, Allen J, Arnaiz O, Awedh MH, Baldock R, Barbiera G, et al.",OADS,/arxiv_data1/oa_pdf/95/34/kmge-06-06-1240748.PMC5173269.pdf
Nat Genet 2000;24:363-7; PMID:10742098; http://dx.doi.org/10.1038/74184 [32] Brosius J.,OADS,/arxiv_data1/oa_pdf/95/34/kmge-06-06-1240748.PMC5173269.pdf
Trends Genetics 1999; 15:304-5; PMID:10431191; http://dx.doi.org/10.1016/S0168-9525 (99)01783-7 [33] Grzybowska EA.,OADS,/arxiv_data1/oa_pdf/95/34/kmge-06-06-1240748.PMC5173269.pdf
"Biochem Biophys Res Com-mun 2012; 424:1-6; PMID:22732409; http://dx.doi.org/10.1016/j.bbrc.2012.06.092 [34] Usaite R, Patil KR, Grotkjaer T, Nielsen J, Regenberg B.",OADS,/arxiv_data1/oa_pdf/95/34/kmge-06-06-1240748.PMC5173269.pdf
"Appl Environ Microbiol 2006; 72:6194-203;PMID:16957246; http://dx.doi.org/10.1128/AEM.00548-06 [35] Tomasetti C, Vogelstein B.",OADS,/arxiv_data1/oa_pdf/95/34/kmge-06-06-1240748.PMC5173269.pdf
"Science 2015; 347:78-81;PMID:25554788; http://dx.doi.org/10.1126/science.1260825 [36] Prioleau MN, MacAlpine DM.",Non-OADS,/arxiv_data1/oa_pdf/95/34/kmge-06-06-1240748.PMC5173269.pdf
"Genes Dev 2016; 30:1683-97;PMID:27542827; http://dx.doi.org/10.1101/gad.285114.116 [37] Chepelev I, Wei G, Wangsa D, Tang Q, Zhao K. Characteri- zation of genome-wide enhancer-promoter interactionsreveals co-expression of interacting genes and modes ofhigher order chromatin organization.",OADS,/arxiv_data1/oa_pdf/95/34/kmge-06-06-1240748.PMC5173269.pdf
"Cell Res 2012; 22:490-503; PMID:22270183; http://dx.doi.org/10.1038/cr.2012.15 [38] Grewal SI, Moazed D. Heterochromatin and epigenetic control of gene expression.",OADS,/arxiv_data1/oa_pdf/95/34/kmge-06-06-1240748.PMC5173269.pdf
"Science 2003; 301:798-802;PMID:12907790; http://dx.doi.org/10.1126/science.1086887 [39] Lunyak VV, Prefontaine GG, Nunez E, Cramer T, Ju BG, Ohgi KA, Hutt K, Roy R, Garcia-Diaz A, Zhu X, et al.Developmentally regulated activation of a SINE B2 repeatas a domain boundary in organogenesis.",OADS,/arxiv_data1/oa_pdf/95/34/kmge-06-06-1240748.PMC5173269.pdf
"Science 2007;317:248-51; PMID:17626886; http://dx.doi.org/10.1126/ science.1140871 [40] Mazo A, Hodgson JW, Petruk S, Sedkov Y, Brock HW.",OADS,/arxiv_data1/oa_pdf/95/34/kmge-06-06-1240748.PMC5173269.pdf
"J Cell Sci 2007; 120:2755-61;PMID:17690303; http://dx.doi.org/10.1242/jcs.007633 [41] Mourier T, Willerslev E. Does selection against transcrip- tional interference shape retroelement-free regions in mam-malian genomes?",Non-OADS,/arxiv_data1/oa_pdf/95/34/kmge-06-06-1240748.PMC5173269.pdf
"PloS One 2008; 3:e3760; PMID:19018283; http://dx.doi.org/10.137 1/journal.pone.0003760 [42] Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, Pandol ﬁPP.",OADS,/arxiv_data1/oa_pdf/95/34/kmge-06-06-1240748.PMC5173269.pdf
"Nature2010; 465:1033-8; PMID:20577206; http://dx.doi.org/10.1038/nature09144 [43] Sinclair DA, Guarente L. Extrachromosomal rDNA circles –a cause of aging in yeast.",Non-OADS,/arxiv_data1/oa_pdf/95/34/kmge-06-06-1240748.PMC5173269.pdf
Cell 1997; 91:1033-42; PMID:9428525; http://dx.doi.org/10.1016/S0092-8674 (00)80493-6e1240748-4 T. MOURIER,Non-OADS,/arxiv_data1/oa_pdf/95/34/kmge-06-06-1240748.PMC5173269.pdf
"12, 2467 –2483 http://dx.doi.org/10.1080/15548627.2016.1239003",Non-OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"38,40,90The TC RNA ampli ﬁca- tion protocol is available at http://cdr.rfmh.org/pages/ginsber glabpage.html .",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"A list of participating groups and funding canbe found at the website: http://www.rush.edu/ru mc/page-R12394.html .W e thank Arthur Saltzman for his expert technical support; we also wish to thank Eugene Laska, Ph.D., for support in Statistical analyses.",Non-OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
Nat Med 2013; 19:983-97; PMID:23921753; http://dx.doi.org/10.1038/nm.3232[2] Boya P. Lysosomal function and dysfunction: mechanism and dis- ease.,Non-OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Antioxid Redox Signal 2012; 17:766-74; PMID:22098160;http://dx.doi.org/10.1089/ars.2011.4405 [3] Menzies FM, Moreau K, Rubinsztein DC.",Non-OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Curr Opin Cell Biol 2011; 23:190-7; PMID:21087849; http://dx.doi.org/10.1016/j.ceb.2010.10.010 [4] Simonsen A, Cumming RC, Brech A, Isakson P, Schubert DR, Finley KD.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Auto-phagy 2008; 4:176-84; PMID:18059160; http://dx.doi.org/10.4161/auto.5269 [5] Madeo F, Tavernarakis N, Kroemer G. Can autophagy promote lon- gevity?",Non-OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Nat Cell Biol 2010; 12:842-6; PMID:20811357; http://dx.doi.org/10.1038/ncb0910-842 [6] Knuppertz L, Hamann A, Pampaloni F, Stelzer E, Osiewacz HD.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Autophagy 2014; 10:822-34;PMID:24584154; http://dx.doi.org/10.4161/auto.28148 [7] Pietrocola F, Izzo V, Niso-Santano M, Vacchelli E, Galluzzi L, Maiuri MC, Kroemer G. Regulation of autophagy by stress-responsive tran- scription factors.",Non-OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Semin Cancer Biol 2013; 23:310-22;PMID:23726895; http://dx.doi.org/10.1016/j.semcancer.2013.05.008 [8] Yang Z, Klionsky DJ.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Nat Cell Biol 2010; 12:814-22; PMID:20811353; http://dx.doi.org/10.1038/ncb0910-814 [9] Nixon RA, Yang DS, Lee JH.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Autophagy 2008; 4:590- 9; PMID:18497567; http://dx.doi.org/10.4161/auto.6259 [10] Russell RC, Tian Y, Yuan H, Park HW, Chang YY, Kim J, Kim H, Neufeld TP, Dillin A, Guan KL.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Nat Cell Biol 2013; 15:741-50; PMID:23685627; http://dx.doi.org/10.1038/ncb2757 [11] Liang C, Lee JS, Inn KS, Gack MU, Li Q, Roberts EA, Vergne I, Deretic V, Feng P, Akazawa C, et al.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Nat Cell Biol 2008; 10:776-87; PMID:18552835; http://dx.doi.org/10.1038/ncb1740 [12] Bernard A, Klionsky DJ.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Dev Cell 2013; 25:116-7; PMID:23639440; http://dx.doi.org/10.1016/j.devcel.2013.04.004 [13] Nakatogawa H, Ohbayashi S, Sakoh-Nakatogawa M, Kakuta S, Suzuki SW, Kirisako H, Kondo-Kakuta C, Noda NN, Yamamoto H, Ohsumi Y.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"J Biol Chem 2012; 287:28503-7; PMID:22778255; http://dx.doi.org/10.1074/jbc.C112.387514 [14] Nakatogawa H, Ichimura Y, Ohsumi Y. Atg8, a ubiquitin-like protein required for autophagosome formation, mediates membrane tether- ing and hemifusion.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Cell 2007; 130:165-78; PMID:17632063; http://dx.doi.org/10.1016/j.cell.2007.05.021 [15] Wild P, McEwan DG, Dikic I.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"J Cell Sci 2014; 127:3-9; PMID:24345374; http://dx.doi.org/10.1242/jcs.140426 [16] Sancak Y, Peterson TR, Shaul YD, Lindquist RA, Thoreen CC, Bar- Peled L, Sabatini DM.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Science 2008; 320:1496-501; PMID:18497260; http://dx.doi.org/10.1126/science.1157535 [17] Zoncu R, Bar-Peled L, Efeyan A, Wang S, Sancak Y, Sabatini DM.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Science 2011; 334:678-83; PMID:22053050; http://dx.doi.org/10.1126/science.1207056 [18] Kim E, Goraksha-Hicks P, Li L, Neufeld TP, Guan KL.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Nat Cell Biol 2008; 10:935-45; PMID:18604198; http://dx.doi.org/10.1038/ncb1753 [19] Medina DL, Di Paola S, Peluso I, Armani A, De Stefani D, Venditti R, Montefusco S, Scotto-Rosato A, Prezioso C, Forrester A, et al.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
Nat Cell Biol 2015; 17:288-99; PMID:25720963; http://dx.doi.org/10.1038/ncb31142480 M. BORDI ET AL.,OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Science 2011; 332:1429-33;PMID:21617040; http://dx.doi.org/10.1126/science.1204592 [21] Settembre C, Zoncu R, Medina DL, Vetrini F, Erdin S, Huynh T, Fer- ron M, Karsenty G, Vellard MC, Facchinetti V, et al.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"EMBO J 2012; 31:1095-108; PMID:22343943; http://dx.doi.org/10.1038/emboj.2012.32 [22] Palmieri M, Impey S, Kang H, di Ronza A, Pelz C, Sardiello M, Balla- bio A.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Hum Mol Genet 2011; 20:3852-66; PMID:21752829; http://dx.doi.org/10.1093/hmg/ddr306 [23] Webb AE, Brunet A. FOXO transcription factors: key regulators of cellular quality control.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Trends Biochem Sci 2014; 39:159-69; PMID:24630600; http://dx.doi.org/10.1016/j.tibs.2014.02.003 [24] Nixon RA, Yang DS.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Neurobiol Dis 2011; 43:38-45;PMID:21296668; http://dx.doi.org/10.1016/j.nbd.2011.01.021 [25] Lee JH, Yu WH, Kumar A, Lee S, Mohan PS, Peterhoff CM, Wolfe DM, Martinez-Vicente M, Massey AC, Sovak G, et al.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Cell 2010; 141:1146-58; PMID:20541250; http://dx.doi.org/10.1016/j.cell.2010.05.008 [26] Nixon RA, Wegiel J, Kumar A, Yu WH, Peterhoff C, Cataldo A, Cuervo AM.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"J Neuropathol Exp Neurol 2005; 64:113-22; PMID:15751225; http://dx.doi.org/10.1093/jnen/64.2.113 [27] Suzuki K, Terry RD.",Non-OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Acta Neuropathol 1967; 8:276-84; PMID:6039977; http://dx.doi.org/10.1007/BF00688828 [28] Kawai M, Cras P, Richey P, Tabaton M, Lowery DE, Gonzalez-DeW- hitt PA, Greenberg BD, Gambetti P, Perry G. Subcellular localization of amyloid precursor protein in senile plaques of Alzheimer ’s disease.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
Nature 1988; 335:497-8; PMID:3138546; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Biochem Biophys Res Commun 1984; 120:885-90; PMID:6375662; http://dx.doi.org/10.1016/S0006-291X(84)80190-4 [31] Lee JH, McBrayer MK, Wolfe DM, Haslett LJ, Kumar A, Sato Y, Lie PP, Mohan P, Coffey EE, Kompella U, et al.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Cell Rep 2015; 12:1430-44; PMID:26299959; http://dx.doi.org/10.1016/j.celrep.2015.07.050 [32] Yang DS, Stavrides P, Mohan PS, Kaushik S, Kumar A, Ohno M, Schmidt SD, Wesson DW, Bandyopadhyay U, Jiang Y, et al.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Autophagy 2011; 7:788-9; PMID:21464620; http://dx.doi.org/10.4161/auto.7.7.15596 [33] Boland B, Kumar A, Lee S, Platt FM, Wegiel J, Yu WH, Nixon RA.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"J Neurosci 2008; 28:6926-37; PMID:18596167; http://dx.doi.org/10.1523/ JNEUROSCI.0800-08.2008 [34] Pickford F, Masliah E, Britschgi M, Lucin K, Narasimhan R, Jaeger PA, Small S, Spencer B, Rockenstein E, Levine B, et al.",Non-OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"J Neurochem 2015; 133:739-49; PMID:25645581; http://dx.doi.org/10.1111/jnc.13037[36] Lipinski MM, Zheng B, Lu T, Yan Z, Py BF, Ng A, Xavier RJ, Li C, Yankner BA, Scherzer CR, et al.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Neurobiol Dis 2012; 45:751-62;PMID:22079237; http://dx.doi.org/10.1016/j.nbd.2011.10.022 [40] Ginsberg SD, Alldred MJ, Che S. Gene expression levels assessed by CA1 pyramidal neuron and regional hippocampal dissections in Alz-heimer ’s disease.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Neurobiol Dis 2012; 45:99-107; PMID:21821124; http://dx.doi.org/10.1016/j.nbd.2011.07.013 [41] Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Cold Spring Harb Perspect Med2011; 1:a006189; PMID:22229116; http://dx.doi.org/10.1101/ cshperspect.a006189 [42] Jager S, Bucci C, Tanida I, Ueno T, Kominami E, Saftig P, Eskelinen EL.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"J Cell Sci 2004; 117:4837-48; PMID:15340014; http://dx.doi.org/10.1242/jcs.01370 [43] Talaber G, Miklossy G, Oaks Z, Liu Y, Tooze SA, Chudakov DM, Banki K, Perl A. HRES-1/Rab4 promotes the formation of LC3( C) autophagosomes and the accumulation of mitochondria during auto- phagy.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"PLoS One 2014; 9:e84392; PMID:24404161; http://dx.doi.org/ 10.1371/journal.pone.0084392 [44] Ao X, Zou L, Wu Y.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Nat Rev Mol CellBiol 2014; 15:65-74; PMID:24326622; http://dx.doi.org/10.1038/ nrm3716 [46] Cataldo AM, Hamilton DJ, Barnett JL, Paskevich PA, Nixon RA.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Neuron 1995; 14:671-80;PMID:7695914; http://dx.doi.org/10.1016/0896-6273(95)90324-0 [48] Ginsberg SD, Hemby SE, Lee VM, Eberwine JH, Trojanowski JQ.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Ann Neurol 2000; 48:77-87; PMID:10894219;http://dx.doi.org/10.1002/1531-8249(200007)48:1%3c77::AID- ANA12%3e3.0.CO;2-A [49] Maier T, Guell M, Serrano L. Correlation of mRNA and protein in complex biological samples.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
FEBS Lett 2009; 583:3966-73; PMID:19850042; http://dx.doi.org/10.1016/j.febslet.2009.10.036 [50] Nixon RA.,OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"J Cell Sci 2007; 120:4081-91; PMID:18032783; http://dx.doi.org/10.1242/jcs.019265 [51] Lee S, Sato Y, Nixon RA.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"J Neurosci 2010; 31:7817-30; PMID: NOT_FOUND; http://dx.doi.org/10.1523/JNEUROSCI.6412-10.2011 [52] West MJ, Gundersen HJ.",Non-OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"1990; 296:1-22; PMID:2358525; http://dx.doi.org/10.1002/cne.9029 60102 [53] West MJ, Coleman PD, Flood DG, Troncoso JC.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Nat Protoc 2009; 4:44-57; PMID:19131956; http://dx.doi.org/ 10.1038/nprot.2008.211 [56] Settembre C, De Cegli R, Mansueto G, Saha PK, Vetrini F, Visvikis O, Huynh T, Carissimo A, Palmer D, Klisch TJ, et al.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Nat Cell Biol 2013; 15:647-58; PMID:23604321; http://dx.doi.org/10.1038/ncb2718 [57] Martina JA, Diab HI, Lishu L, Jeong AL, Patange S, Raben N, Puer- tollano R. The nutrient-responsive transcription factor TFE3 pro- motes autophagy, lysosomal biogenesis, and clearance of cellulardebris.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Sci Signal 2014; 7:ra9; PMID:24448649; http://dx.doi.org/ 10.1126/scisignal.2004754 [58] Nezich CL, Wang C, Fogel AI, Youle RJ.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"MiT/TFE transcription fac- tors are activated during mitophagy downstream of Parkin and Atg5.J Cell Biol 2015; 210:435-50; PMID:26240184; http://dx.doi.org/ 10.1083/jcb.201501002 [59] Sardiello M, Palmieri M, di Ronza A, Medina DL, Valenza M, Gen- narino VA, Di Malta C, Donaudy F, Embrione V, Polishchuk RS,et al.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Acta Neuropathol Commun 2016; 4:22; PMID:26936765; http://dx.doi.org/10.1186/s40478-016-0292-9 [62] Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Ace- vedo Arozena A, Adachi H, Adams CM, Adams PD, et al.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"doi.org/10.1080/15548627.2015.1100356 [63] Lafay-Chebassier C, Paccalin M, Page G, Barc-Pain S, Perault- Pochat MC, Gil R, Pradier L, Hugon J. MTOR/p70S6k signallingalteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer ’sd i s e a s e .JN e u r o c h e m 2005; 94:215-25; PMID:15953364; http://dx.doi.org/10.1111/j.1471-4159.2005.03187.x [64] Caccamo A, Majumder S, Richardson A, Strong R, Oddo S. Molecu- lar interplay between mammalian target of rapamycin (MTOR), amyloid-beta, and Tau: effects on cognitive impairments.",Non-OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"J BiolChem 2010; 285:13107-20; PMID:20178983; http://dx.doi.org/10.1074/jbc.M110.100420 [65] Xue X, Wang LR, Sato Y, Jiang Y, Berg M, Yang DS, Nixon RA, Liang XJ.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Nano Lett 2014; 14:5110-7; PMID:25115676; http://dx.doi.org/ 10.1021/nl501839q [66] Li X, Alafuzoff I, Soininen H, Winblad B, Pei JJ.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"FEBS J 2005; 272:4211- 20; PMID:16098202; http://dx.doi.org/10.1111/j.1742-4658.2005.04833.x [67] Bhaskar K, Miller M, Chludzinski A, Herrup K, Zagorski M, Lamb BT.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Mol Neurodegener 2009; 4:14;PMID:19291319; http://dx.doi.org/10.1186/1750-1326-4-14[68] Cataldo AM, Barnett JL, Pieroni C, Nixon RA.",Non-OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Brain 2011; 134:258-77; PMID:21186265; http://dx.doi.org/10.1093/brain/awq341 [70] Coffey EE, Beckel JM, Laties AM, Mitchell CH.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Eur J Neurosci 2013; 37:1949-61; PMID:23773064; http://dx.doi.org/10.1111/ejn.12169 [72] McBrayer M, Nixon RA.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Biochem Soc Trans 2013; 41:1495-502; PMID:24256243; http://dx.doi.org/10.1042/ BST20130201 [73] Stoka V, Turk V, Turk B. Lysosomal cathepsins and their regulation in aging and neurodegeneration.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Ageing Res Rev 2016; In press; PMID:27125852; http://dx.doi.org/10.1016/j.arr.2016.04.010 [74] Kroemer G, Marino G, Levine B. Autophagy and the integrated stress response.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Mol Cell 2010; 40:280-93; PMID:20965422; http://dx.doi.org/10.1016/j.molcel.2010.09.023 [75] Kim S, Sato Y, Mohan PS, Peterhoff C, Pensal ﬁni A, Rigoglioso A, Jiang Y, Nixon RA.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Am J Pathol 2004; 164:757-61; PMID:14982829; http://dx.doi.org/10.1016/S0002-9440(10)63163-X [78] Elrick MJ, Yu T, Chung C, Lieberman AP.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Impaired proteolysis underlies autophagic dysfunction in Niemann-Pick type C disease.Hum Mol Genet 2012; 21:4876-87; PMID:22872701; http://dx.doi.org/10.1093/hmg/dds324 [79] Braak H, Braak E. Neuropathological staging of Alzheimer-related changes.",Non-OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Acta Neuropathol 1991; 82:239-59; PMID:1759558; http://dx.doi.org/10.1007/BF00308809 [80] Hyman BT, Trojanowski JQ.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"J Neuropathol Exp Neurol 1997; 56:1095-7; PMID:9329452; http://dx.doi.org/10.1097/00005072-199710000-00002 [81] Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L. The Consortium to Estab- lish a Registry for Alzheimer ’s Disease (CERAD).",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Neurology 1991; 41:479-86; PMID:2011243; http://dx.doi.org/10.1212/WNL.41.4.479 [82] Bennett DA, Wilson RS, Schneider JA, Evans DA, Beckett LA, Aggar- wal NT, Barnes LL, Fox JH, Bach J.",Non-OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Neurology 2002; 59:198-205;PMID:12136057; http://dx.doi.org/10.1212/WNL.59.2.198 [83] Mufson EJ, Ma SY, Cochran EJ, Bennett DA, Beckett LA, Jaffar S, Saragovi HU, Kordower JH.",Non-OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"J Comp Neurol 2000; 427:19-30; PMID:11042589; http://dx.doi.org/10.1002/1096-9861(20001106)427:1%3c19::AID-CNE2%3e3.0.CO;2-A [84] Mufson EJ, Ma SY, Dills J, Cochran EJ, Leurgans S, Wuu J, Bennett DA, Jaffar S, Gilmor ML, Levey AI, Kordower JH.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Loss of basal forebrain P75(NTR) immunoreactivity in subjects withmild cognitive impairment and Alzheimer ’sd i s e a s e .JC o m p Neurol 2002; 443:136-53; PMID:11793352; http://dx.doi.org/ 10.1002/cne.10122 [85] Arvanitakis Z, Grodstein F, Bienias JL, Schneider JA, Wilson RS, Kelly JF, Evans DA, Bennett DA.",Non-OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Neurology 2008; 70:2219-25; PMID:18519870; http://dx.doi.org/10.1212/01.wnl.0000313813.48505.86 [86] Alvarez-Buylla A, Ling CY, Kirn JR. Cresyl violet: a red ﬂuorescent Nissl stain.",Non-OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"J Neurosci Methods 1990; 33:129-33; PMID:2232864; http://dx.doi.org/10.1016/0165-0270(90)90016-9 [87] Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Sc hmid B, et al.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Nat Methods 2012; 9:676-82; PMID:22743772; http://dx.doi.org/10.1038/nmeth.2019 [88] Ginsberg SD, Che S. Expression pro ﬁle analysis within the human hippocampus: comparison of CA1 and CA3 pyramidal neurons.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"J Comp Neurol 2005; 487:107-18; PMID:15861457; http://dx.doi.org/10.1002/cne.20535 [89] Ginsberg SD, Mufson EJ, Alldred MJ, Counts SE, Wuu J, Nixon RA, Che S. Upregulation of select rab GTPases in cholinergic basal fore- brain neurons in mild cognitive impairment and Alzheimer ’s disease.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
J Chem Neuroanat 2011; 42:102-10; PMID:21669283; http://dx.doi.org/10.1016/j.jchemneu.2011.05.012 [90] Ginsberg SD.,OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Methods Mol Biol 2008; 439:147-58;PMID:18370101; http://dx.doi.org/10.1007/978-1-59745-188-8_10 [91] Alldred MJ, Lee SH, Petkova E, Ginsberg SD.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"J Comp Neurol 2015; 523:61-74; PMID:25131634; http://dx.doi.org/10.1002/cne.23663 [92] Alldred MJ, Lee SH, Petkova E, Ginsberg SD.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Brain Struct Funct 2015; 220:2983-96; PMID:25031177; http://dx.doi.org/10.1007/s00429-014-0839-0 [93] Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. Accurate normalization of real-timequantitative RT-PCR data by ge ometric averaging of multiple internal control genes.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Genom e Biol 2002; 3:RESEARCH0034; PMID:12184808; http://dx.doi.org/10.1186/gb-2002-3-7-research 0034 [94] Lipska BK, Peters T, Hyde TM, Halim N, Horowitz C, Mitkus S, Weickert CS, Matsumoto M, Sawa A, Straub RE, et al.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Hum Mol Genet 2006; 15:1245-58;PMID:16510495; http://dx.doi.org/10.1093/hmg/ddl040 [95] Schmidt SD, Jiang Y, Nixon RA, Mathews PM.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"Anal Biochem1985; 150:76-85; PMID:3843705; http://dx.doi.org/10.1016/0003-2697(85)90442-7 [97] Mohan PS, Nixon RA.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"J Neurochem 1995; 64:859-66; PMID:7830080; http://dx.doi.org/10.1046/j.1471-4159.1995.64020859.x [98] Cataldo AM, Thayer CY, Bird ED, Wheelock TR, Nixon RA.",OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
Brain Res 1990; 513:181-92; PMID:2350688; http://dx.doi.org/10.1016/ 0006-8993(90)90456-LAUTOPHAGY 2483,Non-OADS,/arxiv_data1/oa_pdf/9e/a9/kaup-12-12-1239003.PMC5173282.pdf
"2, e1220899 (12 pages)http://dx.doi.org/10.1080/21690731.2016.1220899",Non-OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"J Interferon Cytokine Res 2013; 33:227-238; PMID:23472659; http://dx.doi.org/10.1089/jir.2012.0142 [2] Filipowicz W, Furuichi Y, Sierra JM, Muthukrishnan S, Shatkin AJ, Ochoa S. A protein binding the methylated5 0-terminal sequence, m7GpppN, of eukaryotic messen- ger RNA.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
Curr Opin CellBiol 1998; 10:268-75; PMID:9561852; http://dx.doi.org/ 10.1016/S0955-0674(98)80150-6e1220899-8 K. L. B. BORDEN,OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"J Clin Invest 2007; 117:2638-48;PMID:17786246; http://dx.doi.org/10.1172/JCI32044 [7] Culjkovic-Kraljacic B, Fernando TM, Marullo R, Calvo-Vidal N, Verma A, Yang S, TabbR F, Gaudiano M, Zahreddine H, Goldstein RL, et al.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
Mol Cell2007; 25:635-46; PMID:17349952; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"RNA Biol 2014;11:1019-30; PMID:25531407; http://dx.doi.org/10.4161/15476286.2014.972208 [12] Cohen N, Sharma M, Kentsis A, Perez JM, Strudwick S, Borden KL.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
Embo J 2001; 20:4547-59; PMID:11500381; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"RNA 2005; 11:717-27; PMID:15840819; http://dx.doi.org/10.1261/rna.2340405 [15] Dostie J, Ferraiuolo M, Pause A, Adam SA, Sonenberg N. A novel shuttling protein, 4E-T, mediates the nuclearimport of the mRNA 5 0cap-binding protein, eIF4E.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"Embo J 2000; 19:3142-56; PMID:10856257; http://dx.doi.org/10.1093/emboj/19.12.3142 [16] Lang V, Zanchin NI, Lunsdorf H, Tuite M, McCarthy JE.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"J Cell Biol 2005; 169:245-56; PMID:15837800; http://dx.doi.org/10.1083/jcb.200501019 [18] Culjkovic B, Topisirovic I, Skrabanek L, Ruiz-Gutierrez M, Borden KL.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"J Cell Biol 2006; 175:415-26; PMID:17074885; http://dx.doi.org/10.1083/jcb.200607020 [19] Topisirovic I, Siddiqui N, Lapointe VL, Trost M, Thibault P, Bangeranye C, Pi ~nol-Roma S, Borden KL.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"EMBO J 2009; 28:1087-98; PMID:19262567; http://dx.doi.org/ 10.1038/emboj.2009.53 [20] Culjkovic B, Tan K, Orolicki S, Amri A, Meloche S, Bor- den KL.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"J Cell Biol 2008; 181:51-63; PMID:18391071;http://dx.doi.org/10.1083/jcb.200707018 [21] Keene JD, Lager PJ.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"Chromosome Res 2005; 13:327-37; PMID:15868425; http://dx.doi.org/ 10.1007/s10577-005-0848-1 [22] Keene JD, Tenenbaum SA.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"Mol Cell 2002;9:1161-7; PMID:12086614; http://dx.doi.org/10.1016/S1097-2765(02)00559-2 [23] Blackinton JG, Keene JD.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"Semin Cell Dev Biol 2014; 34:44-54; PMID:24882724; http://dx.doi.org/ 10.1016/j.semcdb.2014.05.014 [24] Culjkovic B, Topisirovic I, Borden KL.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"Cell Cycle 2007; 6:65-9; PMID:17245113; http://dx.doi.org/10.4161/cc.6.1.3688 [25] Kentsis A, Dwyer EC, Perez JM, Sharma M, Chen A, Pan ZQ, Borden KL.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"J Mol Biol 2001; 312:609-23; PMID:11575918; http://dx.doi.org/10.1006/jmbi.2001.5003 [26] Volpon L, Osborne MJ, Capul AA, de la Torre JC, Borden KL.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
Mol Cell Biol 2003; 23:8992-9002; PMID:14645512; http://dx.doi.org/10.1128/ MCB.23.24.8992-9002.2003TRANSLATION e1220899-9,Non-OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"Mol Cell Biol 2005;25:1100-12; PMID:15657436; http://dx.doi.org/10.1128/MCB.25.3.1100-1112.2005 [29] Brunet I, Weinl C, Piper M, Trembleau A, Volovitch M, Harris W, Prochiantz A, Holt C. The transcription factor Engrailed-2 guides retinal axons.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"Nature 2005; 438:94-8;PMID:16267555; http://dx.doi.org/10.1038/nature04110 [30] Nedelec S, Foucher I, Brunet I, Bouillot C, Pro- chiantz A, Trembleau A. Emx2 homeodomain tran-scription factor interacts with eukaryotic translationinitiation factor 4E (eIF4E) in the axons of olfac-tory sensory neurons.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
Proc Natl Acad Sci U S A 2004; 101:10815-20; PMID:15247416; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"Nat Rev Mol Cell Biol2003; 4:814-9; PMID:14570063; http://dx.doi.org/10.1038/nrm1227 [32] Rong L, Livingstone M, Sukarieh R, Petroulakis E, Gingras AC, Crosby K, Smith B, Polakiewicz RD, Pellet- ier J, Ferraiuolo MA, et al.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"Rna 2008;14:1318-27; PMID:18515545; http://dx.doi.org/10.1261/rna.950608 [33] Volpon L, Culjkovic-Kraljacic B, Osborne MJ, Ramteke A, Sun Q, Niesman A, Chook YM, Borden KL.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"J Cell Biol 2000; 148:239-47;PMID:10648556; http://dx.doi.org/10.1083/jcb.148.2.239 [35] Ruggero D, Montanaro L, Ma L, Xu W, Londei P, Cordon-Cardo C, Pandol ﬁPP.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"Nat Med 2004; 10:484-6;PMID:15098029; http://dx.doi.org/10.1038/nm1042 [36] Graff JR, Zimmer SG.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"Clin Exp Metastasis 2003;20:265-73; PMID:12741684; http://dx.doi.org/10.1023/ A:1022943419011 [37] Lazaris-Karatzas A, Montine KS, Sonenberg N. Malig- nant transformation by a eukaryotic initiation factor sub-unit that binds to mRNA 5 0cap.",Non-OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"Nature 1990; 345:544-7; PMID:2348862; http://dx.doi.org/10.1038/345544a0 [38] Truitt ML, Conn CS, Shi Z, Pang X, Tokuyasu T, Coady AM, Seo Y, Barna M, Ruggero D. Differential require-ments for eIF4E dose in normal development and cancer.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"Cell 2015; 162:59-71; PMID:26095252; http://dx.doi.org/ 10.1016/j.cell.2015.05.049[39] Kentsis A, Topisirovic I, Culjkovic B, Shao L, Borden KL.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"RNA 2005; 11:1762-6; PMID:16251386;http://dx.doi.org/10.1261/rna.2238705 [41] Assouline S, Culjkovic B, Cocolakis E, Rousseau C, Beslu N, Amri A, Caplan S, Leber B, Roy DC, Miller WH, Jr,et al.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"Blood 2009; 114:257-60; PMID:19433856; http://dx.doi.org/10.1182/blood-2009- 02-205153 [42] Assouline S, Culjkovic-Kraljacic B, Bergeron J, Caplan S, Cocolakis E, Lambert C, Lau CJ, Zahreddine HA, MillerWH, Jr, Borden KL.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"Gene 1995;163:283-8; PMID:7590282; http://dx.doi.org/10.1016/0378-1119(95)00302-M [44] Wang T, Birsoy K, Hughes NW, Krupczak KM, Post Y, Wei JJ, Lander ES, Sabatini DM.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"Sci- ence 2015; 350:1096-101; PMID:26472758; http://dx.doi.org/10.1126/science.aac7041 [45] Culjkovic-Kraljacic B, Baguet A, Volpon L, Amri A, Borden KL.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"Cell Reports 2012;2:207-15; PMID:22902403; http://dx.doi.org/10.1016/ j.celrep.2012.07.007 [46] Anderson P, Kedersha N, Ivanov P. Stress granules, P- bodies and cancer.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
J BiolChem 1995; 270:21684-8; PMID:7665584; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"Cancer Res 2004; 64:8639-42; PMID:15574771; http://dx.doi.org/10.1158/0008-5472.CAN-04-2677 [49] Wendel HG, De Stanchina E, Fridman JS, Malina A, Ray S, Kogan S, Cordon-Cardo C, Pelletier J, Lowe SW. Sur- vival signalling by Akt and eIF4E in oncogenesis ande1220899-10 K. L. B. BORDEN",Non-OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"Nature 2004; 428:332-7; PMID:15029198; http://dx.doi.org/10.1038/nature02369 [50] Marcotrigiano J, Gingras AC, Sonenberg N, Burley SK.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"Cell 1997;89:951-61; PMID:9200613; http://dx.doi.org/10.1016/S0092-8674(00)80280-9 [51] Marcotrigiano J, Gingras AC, Sonenberg N, Burley SK.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"Mol Cell1999; 3:707-16; http://dx.doi.org/10.1016/S1097-2765(01)80003-4 [52] Mader S, Lee H, Pause A, Sonenberg N. The translation initiation factor eIF-4E binds to a common motif sharedby the translation factor eIF-4 gamma and the transla- tional repressors 4E-binding proteins.",Non-OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"Mol Cell Biol 1995; 15:4990-4997; PMID:7651417; http://dx.doi.org/10.1128/MCB.15.9.4990 [53] Lukhele S, Bah A, Lin H, Sonenberg N, Forman-Kay JD.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"Structure 2013;21:2186-96; PMID:24207126; http://dx.doi.org/10.1016/j.str.2013.08.030 [54] Ptushkina M, von der Haar T, Karim MM, Hughes JM, McCarthy JE.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"Embo J 1999; 18:4068-75; PMID:10406811; http://dx.doi.org/10.1093/emboj/18.14.4068 [55] Ptushkina M, von der Haar T, Vasilescu S, Frank R, Birkenh €ager R, McCarthy JE.",Non-OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"Embo J 1998; 17:4798-808; PMID:9707439; http://dx.doi.org/10.1093/emboj/17.16.4798 [56] von Der Haar T, Ball PD, McCarthy JE.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"J Biol Chem 2000; 275:30551-5; PMID:10887196; http://dx.doi.org/10.1074/jbc.M004565200 [57] Volpon L, Osborne MJ, Topisirovic I, Siddiqui N, Borden KL.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"EMBO J 2006;25:5138-49; PMID:17036047; http://dx.doi.org/10.1038/sj.emboj.7601380 [58] Topisirovic I, Culjkovic B, Cohen N, Perez JM, Skrabanek L, Borden KL.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"Embo J 2003; 22:689-703; PMID:12554669; http://dx.doi.org/10.1093/emboj/cdg069 [59] Niessing D, Blanke S, Jackle H. Bicoid associates with the 5 0-cap-bound complex of caudal mRNA and represses translation.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
Genes Dev 2002; 16:2576-82; PMID:12368268;http://dx.doi.org/10.1101/gad.240002 [60] Tan NG.,OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"FEBS Lett 2003; 554:501-4;PMID:14623119; http://dx.doi.org/10.1016/S0014-5793 (03)01235-3 [61] Michon T, Estevez Y, Walter J, German-Retana S, Le Gall O.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"FEBS J 2006; 273:1312-22; PMID:16519694; http://dx.doi.org/10.1111/j.1742-4658.2006.05156.x [62] Volpon L, Osborne MJ, Zahreddine H, Romeo AA, Borden KL.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"BiochemBiophys Res Commun 2013; 434:614-9; PMID:23583375;http://dx.doi.org/10.1016/j.bbrc.2013.03.125 [63] Yan Y, Svitkin Y, Lee JM, Bisaillon M, Pelletier J. Ribavi- rin is not a functional mimic of the 7-methyl guanosine mRNA cap.",Non-OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"RNA 2005; 11:1238-44; PMID:16043507;http://dx.doi.org/10.1261/rna.2930805 [64] Zahreddine HA, Culjkovic-Kraljacic B, Assouline S, Gendron P, Romeo AA, Morris SJ, Cormack G,Jaquith JB, Cerchietti L, Cocolakis E, et al.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"Nature 2014; 511:90-3; PMID:24870236; http://dx.doi.org/10.1038/ nature13283 [65] Borden KL, Culjkovic-Kraljacic B.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"Leukemia Lym phoma 2010; 51(10):1805- 15; PMID:20629523; http://dx.doi.org/10.3109/10428194.2010.496506 [66] Pettersson F, Yau C, Dobocan MC, Culjkovic-Kraljacic B, Retrouvey H, Puckett R, Flores LM, Krop IE, Rousseau C, Cocolakis E, et al.",Non-OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"Clin Can- cer Res 2011; 17:2874-84; PMID:21415224; http://dx.doi.org/10.1158/1078-0432.CCR-10-2334 [67] Moerke NJ, Aktas H, Chen H, Cantel S, Reibarkh MY, Fahmy A, Gross JD, Degterev A, Yuan J, Chorev M, et al.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"Cell 2007;128:257-67; PMID:17254965; http://dx.doi.org/10.1016/j.cell.2006.11.046 [68] Papadopoulos E, Jenni S, Kabha E, Takrouri KJ, Yi T, Salvi N, Luna RE, Gavathiotis E, Mahalingam P, Artha-nari H, et al.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
Clin Can- cer Res 2011; 17:6582-91; PMID:21831956; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"Cancer2010; 116:4896-901; PMID:20623787; http://dx.doi.org/10.1002/cncr.25281 [71] Joshi S, Platanias LC.",Non-OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"World J Biol Chem 2014; 5:321-33;PMID:25225600;http://dx.doi.org/10.4331/wjbc.v5.i3.321 [72] Joshi S, Platanias LC.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"Nucleic Acids Res 2011; 39:8820- 8832; PMID:21965542; http://dx.doi.org/10.1093/nar/ gkr650 [74] Yedavalli VS, Jeang KT.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"The cap- binding translation initiation factor, eIF4E, binds a pseu- doknot in a viral cap-independent translation element.Structure 2011; 19:868-80; PMID:21645857; http://dx.doi.org/10.1016/j.str.2011.03.013 [76] Martin F, Barends S, Jaeger S, Schaeffer L, Prongidi-Fix L, Eriani G. Cap-assisted internal initiation of translation ofhistone H4.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"Mol Cell 2011; 41:197-209; PMID:21255730;http://dx.doi.org/10.1016/j.molcel.2010.12.019 [77] Feoktistova K, Tuvshintogs E, Do A, Fraser CS.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"MNKs act as a regulatory switch foreIF4E1 and eIF4E3 driven mRNA translation in DLBCL.Nat Commun 2014; 5:5413; PMID:25403230; http://dx.doi.org/10.1038/ncomms6413 [81] Uniacke J, Perera JK, Lachance G, Francisco CB, Lee S. Cancer cells exploit eIF4E2-directed synthesis of hypoxiaresponse proteins to drive tumor progression.",OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"Cancer Res 2014; 74:1379-89; PMID:24408918; http://dx.doi.org/ 10.1158/0008-5472.CAN-13-2278 [82] Lee AS, Kranzusch PJ, Doudna JA, Cate JH.",Non-OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
PMID: 27401559; http://dx.doi.org/10.1101/gad.282418.116.e1220899-12 K. L. B. BORDEN,OADS,/arxiv_data1/oa_pdf/e2/0d/ktrs-04-02-1220899.PMC5173310.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which per- mits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"2, e1244031 (16 pages)http://dx.doi.org/10.1080/21690731.2016.1244031",Non-OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
Proc Natl Acad Sci U S A 1962; 48:2013-8;PMID:13947099; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Proc Natl Acad Sci U SA 1982; 79:2495-9; PMID:6806811; http://dx.doi.org/10.1073/pnas.79.8.2495 [4] Sundquist WI, Klug A. Telomeric DNA dimerizes by formation of guanine tetrads between hairpin loops.Nature 1989; 342:825-9; PMID:2601741; http://dx.doi.org/10.1038/342825a0 [5] Sundquist WI, Heaphy S. Evidence for interstrand quadruplex formation in the dimerization of humanimmunode ﬁciency virus 1 genomic RNA.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Biochemistry 2008;47:1896-909; PMID:18205402; http://dx.doi.org/10.1021/bi701747d [7] Bochman ML, Paeschke K, Zakian VA. DNA secondary structures: stability and function of G-quadruplex struc- tures.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Nat Rev Genet 2012; 13:770-80; PMID:23032257;http://dx.doi.org/10.1038/nrg3296 [8] Mendoza O, Bourdoncle A, Boule JB, Brosh RM, Jr., Mergny JL.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"NucleicAcids Res 2016; 44:1989-2006; PMID:26883636; http://dx.doi.org/10.1093/nar/gkw079 [9] Rhodes D, Lipps HJ.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Nucleic Acids Res 2015; 43:8627-37; PMID:26350216; http://dx.doi.org/10.1093/nar/ gkv862 [10] Murat P, Balasubramanian S. Existence and consequen- ces of G-quadruplex structures in DNA.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Curr OpinGenet Dev 2014; 25:22-9; PMID:24584093; http://dx.doi.org/10.1016/j.gde.2013.10.012 [11] Bugaut A, Balasubramanian S. 5 ’-UTR RNA G-quadru- plexes: translation regulation and targeting.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Nucleic Acids Res 2012; 40:4727-41; PMID:22351747; http://dx.doi.org/10.1093/nar/gks068 [12] Millevoi S, Moine H, Vagner S. G-quadruplexes in RNA biology.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"J Am Chem Soc 2013; 135:5017-28; PMID:23521617; http://dx.doi.org/10.1021/ja310251r [14] Beaudoin JD, Jodoin R, Perreault JP.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"NucleicAcids Res 2014; 42:1209-23; PMID:24121682; http://dx.doi.org/10.1093/nar/gkt904 [15] Huppert JL, Balasubramanian S. Prevalence of quadru- plexes in the human genome.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Nucleic Acids Res 2005; 33:2908-16; PMID:15914667; http://dx.doi.org/10.1093/ nar/gki609 [16] Todd AK, Johnston M, Neidle S. Highly prevalent puta- tive quadruplex sequence motifs in human DNA.Nucleic Acids Res 2005; 33:2901-7; PMID:15914666;http://dx.doi.org/10.1093/nar/gki553 [17] Rodriguez R, Miller KM.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Nat Rev Genet 2014; 15:783-96; PMID:25311424; http://dx.doi.org/10.1038/nrg3796 [18] Chambers VS, Marsico G, Boutell JM, Di Antonio M, Smith GP, Balasubramanian S. High-throughputsequencing of DNA G-quadruplex structures in thehuman genome.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Nat Biotechnol 2015; 33:877-81;PMID:26192317; http://dx.doi.org/10.1038/nbt.3295 [19] Frees S, Menendez C, Crum M, Bagga PS.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Biomolecular concepts 2010;1:197-213; PMID:25961997; http://dx.doi.org/10.1515/bmc.2010.011 [21] Lam EY, Beraldi D, Tannahill D, Balasubramanian S. G- quadruplex structures are stable and detectable in human genomic DNA.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Nucleic Acids Res 2011; 39:6229-37; PMID:21441540; http://dx.doi.org/10.1093/nar/gkr164 [25] Shalaby T, Fiaschetti G, Nagasawa K, Shin-ya K, Baum- gartner M, Grotzer M. G-quadruplexes as potentialtherapeutic targets for embryonal tumors.",Non-OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Molecules2013; 18:12500-37; PMID:24152672; http://dx.doi.org/ 10.3390/molecules181012500 [26] Crees Z, Girard J, Rios Z, Botting GM, Harrington K, Shearrow C, Wojdyla L, Stone AL, Uppada SB, DevitoJT, et al.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Oligonucleotides and G-quadruplex stabilizers:targeting telomeres and telomerase in cancer therapy.Curr Pharm Des 2014; 20:6422-37; PMID:24975605;http://dx.doi.org/10.2174/1381612820666140630100702 [27] Moye AL, Porter KC, Cohen SB, Phan T, Zyner KG, Sasaki N, Lovrecz GO, Beck JL, Bryan TM.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Nat Rev Drug discov 2011; 10:261-75;PMID:21455236; http://dx.doi.org/10.1038/nrd3428 [29] Valton AL, Hassan-Zadeh V, Lema I, Boggetto N, Alberti P, Saintome C, Riou JF, Prioleau MN.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"EMBO J 2014; 33:732-46; PMID:24521668;http://dx.doi.org/10.1002/embj.201387506 [30] Brooks TA, Kendrick S, Hurley L. Making sense of G- quadruplex and i-motif functions in oncogene pro-moters.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"FEBS J 2010; 277:3459-69; PMID:20670278; http://dx.doi.org/10.1111/j.1742-4658.2010.07759.x [31] Morgan RK, Batra H, Gaerig VC, Hockings J, Brooks TA.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Biochimica et biophysicaacta 2016; 1859:235-45; PMID:26597160; http://dx.doi.org/10.1016/j.bbagrm.2015.11.004 [32] Onel B, Carver M, Wu G, Timonina D, Kalarn S, Lar- riva M, Yang D. A New G-Quadruplex with Hairpin Loop Immediately Upstream of the Human BCL2 P1Promoter Modulates Transcription.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Cell Cycle 2012; 11:658-67;PMID:22373526; http://dx.doi.org/10.4161/cc.11.4.19097 [35] Cayrou C, Coulombe P, Vigneron A, Stanojcic S, Ganier O, Peiffer I, Rivals E, Puy A, Laurent-Chabalier S, Desprat R, et al.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Genome Res 2011; 21:1438-49; PMID:21750104; http://dx.doi.org/10.1101/gr.121830.111 [36] Besnard E, Babled A, Lapasset L, Milhavet O, Parrinello H, Dantec C, Marin JM, Lemaitre JM.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Nat Struct Mol Biol 2012; 19:837-44;PMID:22751019; http://dx.doi.org/10.1038/nsmb.2339 [37] Foulk MS, Urban JM, Casella C, Gerbi SA.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Genome Res 2015; 25:725-35; PMID:25695952; http://dx.doi.org/10.1101/gr.183848.114 [38] Zheng KW, Xiao S, Liu JQ, Zhang JY, Hao YH, Tan Z. Co-transcriptional formation of DNA:RNA hybrid G-quadruplex and potential function as constitutional ciselement for transcription control.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Nucleic Acids Res2013; 41:5533-41; PMID:23585281; http://dx.doi.org/10.1093/nar/gkt264 [39] Chen MC, Murat P, Abecassis K, Ferre-D ’Amare AR, Balasubramanian S. Insights into the mechanism of a G-quadruplex-unwinding DEAH-box helicase.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"NucleicAcids Res 2015; 43:2223-31; PMID:25653156; http://dx.doi.org/10.1093/nar/gkv051 [40] Chakraborty P, Grosse F. Human DHX9 helicase pref- erentially unwinds RNA-containing displacement loops(R-loops) and G-quadruplexes.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
DNA repair 2011;10:654-65; PMID:21561811; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Biochemistry 2013; 52:2176-83;PMID:23445442; http://dx.doi.org/10.1021/bi301606u [45] Gros J, Guedin A, Mergny JL, Lacroix L. G-Quadruplex formation interferes with P1 helix formation in theRNA component of telomerase hTERC.",Non-OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Chembiochem2008; 9:2075-9; PMID:18683270; http://dx.doi.org/10.1002/cbic.200800300 [46] Martadinata H, Phan AT.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Nat Chem Biol2007; 3:218-21; PMID:17322877; http://dx.doi.org/10.1038/nchembio864 [48] Beaudoin JD, Perreault JP.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
Nucleic Acids Res 2010; 38:7022-36; PMID:20571090; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"RNA 2014;20:1129-41; PMID:24865610; http://dx.doi.org/10.1261/rna.044578.114 [50] Beaudoin JD, Perreault JP.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Nucleic Acids Res2013; 41:5898-911; PMID:23609544; http://dx.doi.org/10.1093/nar/gkt265 [51] Huppert JL, Bugaut A, Kumari S, Balasubramanian S. G-quadruplexes: the beginning and end of UTRs.Nucleic Acids Res 2008; 36:6260-8; PMID:18832370;http://dx.doi.org/10.1093/nar/gkn511 [52] Thandapani P, Song J, Gandin V, Cai Y, Rouleau SG, Garant JM, Boisvert FM, Yu Z, Perreault JP, TopisirovicI, et al.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
Science 2016; 352:1413-6; PMID:27313038; http://dx.doi.org/10.1126/science.aad9868 [56] Hinnebusch AG.,OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Cell 2009; 136:731-45; PMID:19239892; http://dx.doi.org/10.1016/j.cell.2009.01.042 [58] Jackson RJ, Hellen CU, Pestova TV.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Nat Rev Mol Cell Biol 2010; 11:113-27;PMID:20094052; http://dx.doi.org/10.1038/nrm2838 [59] Holcik M, Sonenberg N. Translational control in stress and apoptosis.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Nat Rev Mol Cell Biol 2005; 6:318-27;PMID:15803138; http://dx.doi.org/10.1038/nrm1618 [60] Koromilas AE, Lazaris-Karatzas A, Sonenberg N. mRNAs containing extensive secondary structure in their 5 ’non-coding region translate ef ﬁciently in cellsoverexpressing initiation factor eIF-4E.",Non-OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Cell 1985; 40:515-26; PMID:2982496; http://dx.doi.org/10.1016/0092-8674(85)90200-4 [62] Komar AA, Hatzoglou M. Cellular IRES-mediated translation: the war of ITAFs in pathophysiologicalstates.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Cell Cycle 2011; 10:229-40; PMID:21220943;http://dx.doi.org/10.4161/cc.10.2.14472 [63] Hellen CU, Sarnow P. Internal ribosome entry sites in eukaryotic mRNA molecules.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Gen Dev 2001; 15:1593-612;PMID:11445534; http://dx.doi.org/10.1101/gad.891101 [64] Arora A, Dutkiewicz M, Scaria V, Hariharan M, Maiti S, Kurreck J. Inhibition of translation in living eukaryotic cells by an RNA G-quadruplex motif.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"RNA 2008; 14:1290-6; PMID:18515550; http://dx.doi.org/10.1261/rna.1001708 [65] Morris MJ, Basu S. An unusually stable G-quadruplex within the 5 ’-UTR of the MT3 matrix metalloproteinase mRNA represses translation in eukaryotic cells.",Non-OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Bio-chemistry 2009; 48:5313-9; PMID:19397366; http://dx.doi.org/10.1021/bi900498z [66] Balkwill GD, Derecka K, Garner TP, Hodgman C, Flint AP, Searle MS. Repression of translation of humanestrogen receptor alpha by G-quadruplex formation.Biochemistry 2009; 48:11487-95; PMID:19860473;http://dx.doi.org/10.1021/bi901420k [67] Shahid R, Bugaut A, Balasubramanian S. The BCL-2 5 ’ untranslated region contains an RNA G-quadruplex-forming motif that modulates protein expression.",Non-OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Nucleic Acids Res 2010; 38:7187-98;PMID:20571083; http://dx.doi.org/10.1093/nar/gkq563 [69] Lammich S, Kamp F, Wagner J, Nuscher B, Zilow S, Lud- wig AK, Willem M, Haass C. Translational repression of the disintegrin and metalloprotease ADAM10 by a stableG-quadruplex secondary structure in its 5 ’-untranslated region.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"J Biol Chem 2011; 286:45063-72; PMID:22065584;http://dx.doi.org/10.1074/jbc.M111.296921 [70] Dai J, Liu ZQ, Wang XQ, Lin J, Yao PF, Huang SL, Ou TM, Tan JH, Li D, Gu LQ, et al.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
Biochemistry 2013; 52:1528-38; PMID:23387555; http://dx.doi.org/ 10.1021/bi301365ge1244031-12 J.,Non-OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Nucleic Acids Res 2015; 43:595-606; PMID:25510493; http://dx.doi.org/10.1093/nar/gku1311 [73] Bhat M, Robichaud N, Hulea L, Sonenberg N, Pelletier J, Topisirovic I.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Nat Rev Drug Discov 2015; 14:261-78; PMID:25743081; http://dx.doi.org/10.1038/nrd4505 [74] Schatz JH, Oricchio E, Wolfe AL, Jiang M, Linkov I, Maragulia J, Shi W, Zhang Z, Rajasekhar VK,Pagano NC, et al.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"J Exp Med 2011;208:1799-807; PMID:21859846; http://dx.doi.org/ 10.1084/jem.20110846 [75] Bordeleau ME, Robert F, Gerard B, Lindqvist L, Chen SM, Wendel HG, Brem B, Greger H, Lowe SW, PorcoJA, Jr., et al.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Nature 2014;513:65-70; PMID:25079319; http://dx.doi.org/10.1038/nature13485 [77] Rubio CA, Weisburd B, Holder ﬁeld M, Arias C, Fang E, DeRisi JL, Fanidi A. Transcriptome-wide characterizationof the eIF4A signature highlights plasticity in translation regulation.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"GenRes 2016; 26:636-48; PMID:26984228; http://dx.doi.org/10.1101/gr.197566.115 [79] Sinvani H, Haimov O, Svitkin Y, Sonenberg N, Tamarkin- Ben-Harush A, Viollet B, Dikstein R. Translational toler-ance of mitochondrial genes to metabolic energy stressinvolves TISU and eIF1-eIF4GI cooperation in start codonselection.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Cell Metab 2015; 21:479-92; PMID:25738462;http://dx.doi.org/10.1016/j.cmet.2015.02.010 [80] Bonnal S, Schaeffer C, Creancier L, Clamens S, Moine H, Prats AC, Vagner S. A single internal ribosome entry site containing a G quartet RNA structure drives ﬁbroblast growth factor 2 gene expression at four alternative transla-tion initiation codons.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"J Biol Chem 2003; 278:39330-6;PMID:12857733; http://dx.doi.org/10.1074/jbc.M305580200 [81] Baird SD, Turcotte M, Korneluk RG, Holcik M. Search- ing for IRES.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"RNA 2006; 12:1755-85; PMID:16957278;http://dx.doi.org/10.1261/rna.157806 [82] Morris MJ, Negishi Y, Pazsint C, Schonhoft JD, Basu S. An RNA G-quadruplex is essential for cap-independenttranslation initiation in human VEGF IRES.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"J Am Chem Soc 2010; 132:17831-9; PMID:21105704; http://dx.doi.org/10.1021/ja106287x [83] Cammas A, Dubrac A, Morel B, Lamaa A, Touriol C, Teulade-Fichou MP, Prats H, Millevoi S. Stabiliza-tion of the G-quadruplex at the VEGF IRESrepresses cap-independent translation.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
RNA Biol 2015; 12:320-9; PMID:2582666 4; http://dx.doi.org/ 10.1080/15476286.2015.1017236 [84] Jackson RJ.,OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Cold Spring Harb Perspect Biol 2013; 5:a011569; http://dx.doi.org/10.1101/cshperspect.a011569 [85] Endoh T, Kawasaki Y, Sugimoto N. Translational halt during elongation caused by G-quadruplex formed bymRNA.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Methods 2013; 64:73-8; PMID:23747335; http://dx.doi.org/10.1016/j.ymeth.2013.05.026 [86] Giedroc DP, Cornish PV.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Virus Res 2009;139:193-208; PMID:18621088; http://dx.doi.org/10.1016/j.virusres.2008.06.008 [87] Doma MK, Parker R. Endonucleolytic cleavage of eukaryotic mRNAs with stalls in translation elongation.Nature 2006; 440:561-4; PMID:16554824; http://dx.doi.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Nat Struct Mole Biol 2009; 16:274-80; PMID:19198590; http://dx.doi.org/10.1038/nsmb.1554 [90] O ’Brien EP, Vendruscolo M, Dobson CM.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Cell 1996; 86:949-59; PMID:8808630; http://dx.doi.org/10.1016/S0092-8674(00)80170-1 [93] Schaeffer C, Bardoni B, Mandel JL, Ehresmann B, Ehresmann C, Moine H. The fragile X mental retar-dation protein binds speci ﬁcally to its mRNA via a purine quartet motif.",Non-OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
Nat Chem Biol 2014; 10:358-64; PMID:24633353; http://dx.doi.org/ 10.1038/nchembio.1479TRANSLATION e1244031-13,OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Gen Dev 1997; 11:2755-66;PMID:9353246; http://dx.doi.org/10.1101/gad.11.21.2755 [99] Arora A, Suess B.",Non-OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"RNABiol 2011; 8:802-5; PMID:21734463; http://dx.doi.org/10.4161/rna.8.5.16038 [100] Decorsiere A, Cayrel A, Vagner S, Millevoi S. Essential role for the interaction between hnRNP H/F and a Gquadruplex in maintaining p53 pre-mRNA 3 ’-end proc- essing and function during DNA damage.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Gen Dev2011; 25:220-5; PMID:21289067; http://dx.doi.org/10.1101/gad.607011 [101] Crenshaw E, Leung BP, Kwok CK, Sharoni M, Olson K, Sebastian NP, Ansaloni S, Schweitzer-Stenner R, Akins MR, Bevilacqua PC, et al.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Carcinogenesis 2011; 32:271-8; PMID:21112961; http://dx.doi.org/10.1093/carcin/bgq253 [104] Subramanian M, Rage F, Tabet R, Flatter E, Mandel JL, Moine H. G-quadruplex RNA structure as a signal for neu- rite mRNA targeting.",Non-OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"EMBO Rep 2011; 12:697-704; PMID:21566646; http://dx.doi.org/10.1038/embor.2011.76 [105] Calabretta S, Richard S. Emerging Roles of Disordered Sequences in RNA-Binding Proteins.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Trends BiochemSci 2015; 40:662-72; PMID:26481498; http://dx.doi.org/10.1016/j.tibs.2015.08.012 [106] Lukong KE, Chang KW, Khandjian EW, Richard S. RNA-binding proteins in human genetic disease.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Mol Cell 2013; 50: 613-23; PMID:23746349; http://dx.doi.org/10.1016/j.molcel.2013.05.021 [108] Castello A, Fischer B, Eichelbaum K, Horos R, Beck- mann BM, Strein C, Davey NE, Humphreys DT, Preiss T, Steinmetz LM, et al.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Cell2012; 149:1393-406; PMID:22658674; http://dx.doi.org/ 10.1016/j.cell.2012.04.031 [109] Hanakahi LA, Sun H, Maizels N. High af ﬁnity interac- tions of nucleolin with G-G-paired rDNA.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"J Biol Chem1999; 274:15908-12; PMID:10336496; http://dx.doi.org/10.1074/jbc.274.22.15908 [110] Darnell JC, Jensen KB, Jin P, Brown V, Warren ST, Dar- nell RB.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Cell2001;107:489-99; PMID:11719189; http://dx.doi.org/10.1016/S0092-8674(01)00566-9 [111] Sissi C, Gatto B, Palumbo M. The evolving world of pro- tein-G-quadruplex recognition: a medicinal chemist ’sp e r - spective.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Biochimie 2011; 93:1219-30; PMID:21549174;http://dx.doi.org/10.1016/j.biochi.2011.04.018 [112] Abdelmohsen K, Tominaga K, Lee EK, Srikantan S, Kang MJ, Kim MM, Selimyan R, Martindale JL, Yang X,Carrier F, et al.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Nucleic Acids Res 2011; 39:8513-30;PMID:21737422; http://dx.doi.org/10.1093/nar/gkr488 [113] Abdelmohsen K, Gorospe M. RNA-binding protein nucleolin in disease.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"RNA Biol 2012; 9:799-808; PMID:22617883; http://dx.doi.org/10.4161/rna.19718 [114] Turner MR, Hardiman O, Benatar M, Brooks BR, Chio A, de Carvalho M, Ince PG, Lin C, Miller RG, Mitsu-moto H, et al.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Lancet Neurol 2013; 12:310-22;PMID:23415570; http://dx.doi.org/10.1016/S1474-4422(13)70036-X [115] DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J, et al.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Neuron2011; 72:245-56; PMID:21944778; http://dx.doi.org/10.1016/j.neuron.2011.09.011 [116] Reddy K, Zamiri B, Stanley SY, Macgregor RB, Jr., Pear- son CE.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"The disease-associated r(GGGGCC)n repeat from the C9orf72 gene forms tract length-dependent uni- and multimolecular RNA G-quadruplex structures.J Biol Chem 2013; 288:9860-6; PMID:23423380; http://dx.doi.org/10.1074/jbc.C113.452532 [117] Haeusler AR, Donnelly CJ, Periz G, Simko EA, Shaw PG, Kim MS, Maragakis NJ, Troncoso JC, Pandey A, SattlerR, et al.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Nature 2014; 507:195-200; PMID:24598541; http://dx.doi.org/10.1038/nature13124 [118] Darnell JC, Klann E. The translation of translational control by FMRP: therapeutic targets for FXS.",Non-OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Nat Neu-rosci 2013; 16:1530-6; PMID:23584741; http://dx.doi.org/10.1038/nn.3379 [119] Colak D, Zaninovic N, Cohen MS, Rosenwaks Z, Yang WY, Gerhardt J, Disney MD, Jaffrey SR. Promoter-bound trinu-cleotide repeat mRNA drives epigenetic silencing in fragile X syndrome.",Non-OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
Science 2014; 343:1002-5; PMID:24578575; http://dx.doi.org/10.1126/science.1245831e1244031-14 J.,OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Nat Rev Neurosci 2015; 16:595-605;PMID:26350240; http://dx.doi.org/10.1038/nrn4001 [121] Blackwell E, Zhang X, Ceman S. Arginines of the RGG box regulate FMRP association with polyribosomes andmRNA.",Non-OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Hum Mol Genet 2010; 19:1314-23; PMID:20064924; http://dx.doi.org/10.1093/hmg/ddq007 [122] Corbin F, Bouillon M, Fortin A, Morin S, Rousseau F, Khandjian EW.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Hum Mol Genet 1997; 6:1465-72;PMID:9285783; http://dx.doi.org/10.1093/hmg/6.9.1465 [123] Brown V, Jin P, Ceman S, Darnell JC, O ’Donnell WT, Tenenbaum SA, Jin X, Feng Y, Wilkinson KD, Keene JD, et al.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Cell 2001; 107:477-87;PMID:11719188; http://dx.doi.org/10.1016/S0092-8674(01)00568-2 [124] Anderson BR, Chopra P, Suhl JA, Warren ST, Bassell GJ.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Nucleic Acids Res 2016; 44(14): 6649-6659; http://dx.doi.org/10.1093/nar/gkw593 [125] Blice-Baum AC, Mihailescu MR. Biophysical char- acterization of G-quadruplex forming FMR1 mRNAand of its interactions with different fragile X men-tal retardation protein is oforms.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"RNA 2014; 20:103- 14; PMID:24249225; http://dx.doi.org/10.1261/rna.041442.113 [126] Lu R, Wang H, Liang Z, Ku L, O ’Donnell WT, Li W, Warren ST, Feng Y.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Hum Mol Genet 2005; 14:835-44; PMID:15703194; http://dx.doi.org/10.1093/hmg/ddi077 [128] Zhang Y, Gaetano CM, Williams KR, Bassell GJ, Mihai- lescu MR. FMRP interacts with G-quadruplex structuresin the 3 ’-UTR of its dendritic target Shank1 mRNA.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"RNA Biol 2014; 11:1364-74; PMID:25692235; http://dx.doi.org/10.1080/15476286.2014.996464 [129] Napoli I, Mercaldo V, Boyl PP, Eleuteri B, Zalfa F, De Rubeis S, Di Marino D, Mohr E, Massimi M, Falconi M, et al.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP.Cell 2008; 134:1042-54; PMID:18805096; http://dx.doi.org/10.1016/j.cell.2008.07.031 [130] Simone R, Fratta P, Neidle S, Parkinson GN, Isaacs AM.",Non-OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"FEBS Lett 2015; 589:1653-68; PMID:25979174; http://dx.doi.org/ 10.1016/j.febslet.2015.05.003[131] Bechara EG, Didiot MC, Melko M, Davidovic L, Bensaid M, Martin P, Castets M, Pognonec P, Khandjian EW,Moine H, et al.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Structure-function studies of FMRP RGG peptide recognition of an RNA duplex-quadruplex junction.Nat Struct Mol Biol 2011; 18:796-804; PMID:21642970;http://dx.doi.org/10.1038/nsmb.2064 [133] Vasilyev N, Polonskaia A, Darnell JC, Darnell RB, Patel DJ, Serganov A.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Cell2011; 146:247-61; PMID:21784246; http://dx.doi.org/10.1016/j.cell.2011.06.013 [135] Chen E, Sharma MR, Shi X, Agrawal RK, Joseph S. Fragile X mental retardation protein regulates trans- lation by binding directly to the ribosome.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Mol Cell2014; 54:407-17; PMID:24746697; http://dx.doi.org/10.1016/j.molcel.2014.03.023 [136] Taha MS, Nouri K, Milroy LG, Moll JM, Herrmann C, Brunsveld L, Piekorz RP, Ahmadian MR. Subcellularfractionation and localization studies reveal a directinteraction of the fragile X mental retardation protein (FMRP) with nucleolin.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
J Biol Chem2005; 280:38117-20; PMID:16150737; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Methods Mol Biol 2015;1259:125-35; PMID:25579584; http://dx.doi.org/10.1007/978-1-4939-2214-7_9 [139] Creacy SD, Routh ED, Iwamoto F, Nagamine Y, Akman SA, Vaughn JP.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"J BiolChem 2008; 283:34626-34; PMID:18842585; http://dx.doi.org/10.1074/jbc.M806277200 [140] Chalupnikova K, Lattmann S, Selak N, Iwamoto F, Fujiki Y, Nagamine Y.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Nucleic Acids Res 2012; 40:4110-24;PMID:22238380; http://dx.doi.org/10.1093/nar/gkr1306 [142] Heddi B, Cheong VV, Martadinata H, Phan AT.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Nucleic AcidsRes 2011; 39:9390-404; PMID:21846770; http://dx.doi.org/10.1093/nar/gkr630 [145] Sexton AN, Collins K. The 5 ’guanosine tracts of human telomerase RNA are recognized by the G-quadruplexbinding domain of the RNA helicase DHX36 and func-tion to increase RNA accumulation.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Mol Cell Biol 2011;31:736-43; PMID:21149580; http://dx.doi.org/10.1128/MCB.01033-10 [146] Booy EP, Howard R, Marushchak O, Ariyo EO, Meier M, Novakowski SK, Deo SR, Dzananovic E, Stetefeld J, McKenna SA.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"The RNA helicase RHAU (DHX36) sup- presses expression of the transcription factor PITX1.Nucleic Acids Res 2014; 42:3346-61; PMID:24369427;http://dx.doi.org/10.1093/nar/gkt1340 [147] Chau BN, Cheng EH, Kerr DA, Hardwick JM.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Mol Cell 2000; 6:31-40; PMID:10949025; http://dx.doi.org/10.1016/S1097-2765(05)00021-3 [148] Paydas S, Tanriverdi K, Yavuz S, Disel U, Sahin B, Bur- gut R. Survivin and aven: two distinct antiapoptotic sig-nals in acute leukemias.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Leukemia Res 2006; 30:1019-25; PMID:16388850; http://dx.doi.org/10.1016/j.leukres.2005.11.001 [150] Tome JM, Ozer A, Pagano JM, Gheba D, Schroth GP, Lis JT.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Nat methods 2014; 11:683-8; PMID:24809628; http://dx.doi.org/10.1038/nmeth.2970 [151] Moore MJ, Zhang C, Gantman EC, Mele A, Darnell JC, Darnell RB.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Nature protocols 2014; 9:263-93; PMID:24407355;http://dx.doi.org/10.1038/nprot.2014.012 [152] Deigan KE, Li TW, Mathews DH, Weeks KM.",Non-OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Nature methods 2014; 11:959-65; PMID:25028896; http://dx.doi.org/10.1038/nmeth.3029 [154] Xu W, Bolduc F, Hong N, Perreault JP.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Mol Plant Pathol 2012; 13: 666-76; PMID:22243942; http://dx.doi.org/10.1111/j.1364-3703.2011.00776.x [155] Didiot MC, Tian Z, Schaeffer C, Subramanian M, Man- del JL, Moine H. The G-quartet containing FMRP bind-ing site in FMR1 mRNA is a potent exonic splicingenhancer.",Non-OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Nucleic Acids Res 2008; 36:4902-12;PMID:18653529; http://dx.doi.org/10.1093/nar/gkn472 [156] Bidzinska J, Cimino-Reale G, Zaffaroni N, Folini M. G-quadruplex structures in the human genome asnovel therapeutic targets.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Molecules 2013; 18:12368-95;PMID:24108400; http://dx.do i.org/10.3390/molecules 181012368 [157] Bugaut A, Rodriguez R, Kumari S, Hsu ST, Balasubra- manian S. Small molecule-mediated inhibition of trans-lation by targeting a native RNA G-quadruplex.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Nucleic Acids Res 2014;42:8719-31; PMID:24939896; http://dx.doi.org/10.1093/nar/gku526 [159] Morris MJ, Wingate KL, Silwal J, Leeper TC, Basu S. The porphyrin TmPyP4 unfolds the extremelystable G-quadruplex in MT3-MMP mRNA and alle-viates its repressive effect to enhance translation ineukaryotic cells.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
"Nucleic Acids Res 2012; 40:4137-45; PMID:22266651; http://dx.doi.org/10.1093/nar/gkr1308 [160] Faudale M, Cogoi S, Xodo LE.",OADS,/arxiv_data1/oa_pdf/f0/05/ktrs-04-02-1244031.PMC5173311.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/37/d6/main.PMC5173312.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.11.046 2049-0801/ ©2016 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/37/d6/main.PMC5173312.pdf
available at https://tools.thermo ﬁsher.com/content/sfs/ manuals/purelink_genomic_man.pdf .,Non-OADS,/arxiv_data1/oa_pdf/37/d6/main.PMC5173312.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Reproductive age ContraceptionFertileFertility preservationUnplanned pregnancyGynecologic oncology 1.,Non-OADS,/arxiv_data1/oa_pdf/94/30/main.PMC5173313.pdf
http://dx.doi.org/10.1016/j.gore.2016.11.006 2352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/94/30/main.PMC5173313.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/94/30/main.PMC5173313.pdf
http://seer.cancer.gov/faststats/selections.php?#Output .,Non-OADS,/arxiv_data1/oa_pdf/94/30/main.PMC5173313.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/01/64/main.PMC5173315.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.11.010 2049-0801/ ©2016 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.,Non-OADS,/arxiv_data1/oa_pdf/01/64/main.PMC5173315.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).Annals of Medicine and Surgery 13 (2017) 13 e19,Non-OADS,/arxiv_data1/oa_pdf/01/64/main.PMC5173315.pdf
Health facilities Korean J Thorac Cardiovasc Surg 2016;49 Suppl 1:S28-36 □ BASIC RESEARCH □ https://doi.or g/10.5090/k jtcs.2016.49.S1.S28,Non-OADS,/arxiv_data1/oa_pdf/4a/78/kjtcv-49suppl.issue-028.PMC5173331.pdf
"Although  deaths from neurovascular disease significantly de- creased from 70.1 to 48.2 deaths per 100 000 pop-ulations between 2004 and 2014, it still remains the Korean J Thorac Cardiovasc Surg 2016;49 Suppl 1:S44-52 □ BASIC RESEARCH □ https://doi.or g/10.5090/k jtcs.2016.49.S1.S44",Non-OADS,/arxiv_data1/oa_pdf/da/66/kjtcv-49suppl.issue-044.PMC5173332.pdf
Avaiable from: http://www.index.go.kr/potal/main/EachDtlPage Detail.,OADS,/arxiv_data1/oa_pdf/da/66/kjtcv-49suppl.issue-044.PMC5173332.pdf
Available from: http://ko-sis.kr/statisticsList/statisticsList_01List.jsp?vwcd=MT_ZTITLE& parentId=D#SubCont.,OADS,/arxiv_data1/oa_pdf/da/66/kjtcv-49suppl.issue-044.PMC5173332.pdf
"However, in 2014, a 4.2% decrease in mortality from neurovascular  disease and a 4.4% increase in mortality from CVD  brought about an unprecedented change in the order Korean J Thorac Cardiovasc Surg 2016;49 Suppl 1:S60-67 □ BASIC RESEARCH □ https://doi.or g/10.5090/k jtcs.2016.49.S1.S60",Non-OADS,/arxiv_data1/oa_pdf/82/cd/kjtcv-49suppl.issue-060.PMC5173333.pdf
Avail-able from: http://kostat.go.kr/smart/news/file_dn.jsp?aSeq= 347102&ord=1.,Non-OADS,/arxiv_data1/oa_pdf/82/cd/kjtcv-49suppl.issue-060.PMC5173333.pdf
Available from: http://kostat.go.kr/portal/korea/kor_nw/2/ 6/2/index.board?bmode=read&aSeq=348539&pageNo= &rowNum=10&amSeq=&sTarget=&sTxt=.,OADS,/arxiv_data1/oa_pdf/82/cd/kjtcv-49suppl.issue-060.PMC5173333.pdf
Available from: http://www.cdc.go.kr/CDC/contents/CdcKrContentView.,Non-OADS,/arxiv_data1/oa_pdf/82/cd/kjtcv-49suppl.issue-060.PMC5173333.pdf
Available from: http://kosis.kr/statisticsList/statisticsList_01List.jsp?,OADS,/arxiv_data1/oa_pdf/82/cd/kjtcv-49suppl.issue-060.PMC5173333.pdf
Heart sur-Korean J Thorac Cardiovasc Surg 2016;49 Suppl 1:S20-27 □ BASIC RESEARCH □ https://doi.or g/10.5090/k jtcs.2016.49.S1.S20,Non-OADS,/arxiv_data1/oa_pdf/ae/7e/kjtcv-49suppl.issue-020.PMC5173334.pdf
Health services needs and demand Korean J Thorac Cardiovasc Surg 2016;49 Suppl 1:S37-43 □ BASIC RESEARCH □ https://doi.or g/10.5090/k jtcs.2016.49.S1.S37,Non-OADS,/arxiv_data1/oa_pdf/b5/04/kjtcv-49suppl.issue-037.PMC5173335.pdf
Available from: http://www.ktcvs.,Non-OADS,/arxiv_data1/oa_pdf/b5/04/kjtcv-49suppl.issue-037.PMC5173335.pdf
"In the same period, Korean J Thorac Cardiovasc Surg 2016;49 Suppl 1:S1-13 □ BASIC RESEARCH □ https://doi.or g/10.5090/k jtcs.2016.49.S1.S1",Non-OADS,/arxiv_data1/oa_pdf/65/33/kjtcv-49suppl.issue-001.PMC5173336.pdf
"In particular, because cardiovascular surgery  is a field that integrates advanced techniques and Korean J Thorac Cardiovasc Surg 2016;49 Suppl 1:S14-19 □ BASIC RESEARCH □ https://doi.or g/10.5090/k jtcs.2016.49.S1.S14",Non-OADS,/arxiv_data1/oa_pdf/87/2d/kjtcv-49suppl.issue-014.PMC5173337.pdf
For Korean J Thorac Cardiovasc Surg 2016;49 Suppl 1:S53-59 □ BASIC RESEARCH □ https://doi.or g/10.5090/k jtcs.2016.49.S1.S53,Non-OADS,/arxiv_data1/oa_pdf/30/06/kjtcv-49suppl.issue-053.PMC5173338.pdf
Available from: http://m.bokuennews.com/news/article.html?no= 89105.5.,Non-OADS,/arxiv_data1/oa_pdf/30/06/kjtcv-49suppl.issue-053.PMC5173338.pdf
Available from: http://www.docdocdoc.co.kr/ news/newsview.php?newscd=2015122800013.,Non-OADS,/arxiv_data1/oa_pdf/30/06/kjtcv-49suppl.issue-053.PMC5173338.pdf
Available from: http://www.lexisnexis.com/ hottopics/njcode/.,Non-OADS,/arxiv_data1/oa_pdf/30/06/kjtcv-49suppl.issue-053.PMC5173338.pdf
Available from: http://msa.maryland.gov/megafile/msa/speccol/sc5300/ sc5339/000113/001000/ 001906/unrestricted/20061903e.pdf.,OADS,/arxiv_data1/oa_pdf/30/06/kjtcv-49suppl.issue-053.PMC5173338.pdf
Available from: http://www.waikatodhb.health.,Non-OADS,/arxiv_data1/oa_pdf/30/06/kjtcv-49suppl.issue-053.PMC5173338.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/c9/1e/1349-7235-55-3235.PMC5173488.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/c9/1e/1349-7235-55-3235.PMC5173488.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/e1/17/1349-7235-55-3239.PMC5173489.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/e1/17/1349-7235-55-3239.PMC5173489.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/69/48/1349-7235-55-3247.PMC5173490.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/69/48/1349-7235-55-3247.PMC5173490.pdf
"https://catalog.hardydiagnostics.com/cp_prod/product/324764-pertussis-antibody-eia-48-tests-per-kit-by-denka-seiken-research-use-only-antisera) at Showa Medical Science Corporation (Tokyo,Japan).",Non-OADS,/arxiv_data1/oa_pdf/ac/0d/1349-7235-55-3257.PMC5173491.pdf
Available from: http://www.cdc.gov/nchs/data/ahcd/namcs_summary/2012_namcs_web_tables.pdf 2.Morrell DC.,OADS,/arxiv_data1/oa_pdf/ac/0d/1349-7235-55-3257.PMC5173491.pdf
"Available from: http://www.junte ndo.ac.jp/english/department/med/ general_medicine/ 4.Irwin RS, Baumann MH, Bolser DC, et al; American College ofChest Physicians (ACCP).",Non-OADS,/arxiv_data1/oa_pdf/ac/0d/1349-7235-55-3257.PMC5173491.pdf
"Avail-able from: http://www.cdc.gov/vaccines/hcp/vis/vis-statements/tdap.html 14.Althouse BM, Scarpino SV .",Non-OADS,/arxiv_data1/oa_pdf/ac/0d/1349-7235-55-3257.PMC5173491.pdf
"Intern Med 55: 3257-3263, 2016 DOI: 10.2169/internalmedicine.55.6973 3263from: http://www.who.int/immunization/documents/WHO_IVB_IS BN9789241599337/en/ 26.The Japanese Respiratory Society.",Non-OADS,/arxiv_data1/oa_pdf/ac/0d/1349-7235-55-3257.PMC5173491.pdf
"Available from: http://www.jrs.or.jp/modules/guidelines/index.php?content_id=57 27.de Melker HE, Versteegh FG, Conyn-Van Spaendonck MA, et al.",Non-OADS,/arxiv_data1/oa_pdf/ac/0d/1349-7235-55-3257.PMC5173491.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/ac/0d/1349-7235-55-3257.PMC5173491.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/ac/0d/1349-7235-55-3257.PMC5173491.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/90/db/1349-7235-55-3265.PMC5173492.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/90/db/1349-7235-55-3265.PMC5173492.pdf
"To view the details of this license, please visi t (https://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/1b/94/1349-7235-55-3273.PMC5173493.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/1b/94/1349-7235-55-3273.PMC5173493.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/6b/c6/1349-7235-55-3279.PMC5173494.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/6b/c6/1349-7235-55-3279.PMC5173494.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/c2/50/1349-7235-55-3285.PMC5173495.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/8d/59/1349-7235-55-3291.PMC5173496.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/8d/59/1349-7235-55-3291.PMC5173496.pdf
In: Endotext(http://www.thyroidmanager.org).,Non-OADS,/arxiv_data1/oa_pdf/6c/93/1349-7235-55-3295.PMC5173497.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/6c/93/1349-7235-55-3295.PMC5173497.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/6c/93/1349-7235-55-3295.PMC5173497.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/75/7f/1349-7235-55-3301.PMC5173498.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/75/7f/1349-7235-55-3301.PMC5173498.pdf
http://wwwhourei.mhlw.go.jp/cgi-bin/t_docframe.cgi?MODE=tsuchi&DMODE=CONTENTS&SMODE=NORMAL&KEYWORD=&EFSNO=942.1998 (in Japanese).,OADS,/arxiv_data1/oa_pdf/b6/12/1349-7235-55-3309.PMC5173499.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/b6/12/1349-7235-55-3309.PMC5173499.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/b6/12/1349-7235-55-3309.PMC5173499.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/f4/0a/1349-7235-55-3315.PMC5173500.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/f4/0a/1349-7235-55-3315.PMC5173500.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/de/8f/1349-7235-55-3321.PMC5173501.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/de/8f/1349-7235-55-3321.PMC5173501.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/70/12/1349-7235-55-3325.PMC5173502.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/70/12/1349-7235-55-3325.PMC5173502.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/36/7a/1349-7235-55-3331.PMC5173503.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/36/7a/1349-7235-55-3331.PMC5173503.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/4c/f9/1349-7235-55-3337.PMC5173504.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/4c/f9/1349-7235-55-3337.PMC5173504.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/2d/53/1349-7235-55-3341.PMC5173505.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/2d/53/1349-7235-55-3341.PMC5173505.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/ed/bd/1349-7235-55-3347.PMC5173506.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/ed/bd/1349-7235-55-3347.PMC5173506.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/1a/95/1349-7235-55-3351.PMC5173507.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/1a/95/1349-7235-55-3351.PMC5173507.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/e2/08/1349-7235-55-3357.PMC5173508.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/e2/08/1349-7235-55-3357.PMC5173508.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/59/49/1349-7235-55-3361.PMC5173509.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/59/49/1349-7235-55-3361.PMC5173509.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/96/dc/1349-7235-55-3365.PMC5173510.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/96/dc/1349-7235-55-3365.PMC5173510.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/b7/fc/1349-7235-55-3369.PMC5173511.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/b7/fc/1349-7235-55-3369.PMC5173511.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/61/1f/1349-7235-55-3375.PMC5173512.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/61/1f/1349-7235-55-3375.PMC5173512.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/7a/0f/1349-7235-55-3383.PMC5173513.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/7a/0f/1349-7235-55-3383.PMC5173513.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/79/75/1349-7235-55-3387.PMC5173514.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/79/75/1349-7235-55-3387.PMC5173514.pdf
Available from: http://www.who.int/malaria/publications/world_malaria_report_2014/report/en/ 2.Guidelines for the treatment of malaria.,Non-OADS,/arxiv_data1/oa_pdf/e5/1c/1349-7235-55-3393.PMC5173515.pdf
"Available from: http://www.who.int/malaria/publications/atoz/9789241549127/en 3.Idro R, Jenkins NE, Newton CR.",Non-OADS,/arxiv_data1/oa_pdf/e5/1c/1349-7235-55-3393.PMC5173515.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/e5/1c/1349-7235-55-3393.PMC5173515.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/e5/1c/1349-7235-55-3393.PMC5173515.pdf
Available from: http://www.mhlw.go.jp/shingi/2010/05/dl/s0519-6j_08.pdf (in Japanese).,Non-OADS,/arxiv_data1/oa_pdf/58/45/1349-7235-55-3399.PMC5173516.pdf
"Available from: http://idsc.nih.go.jp/iasr/30/349/de3491.html 4.Trujillo MH, Castillo A, Espana J, Manzo A, Zerpa R. Impact of intensive care management on the prognosis of tetanus.",Non-OADS,/arxiv_data1/oa_pdf/58/45/1349-7235-55-3399.PMC5173516.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/58/45/1349-7235-55-3399.PMC5173516.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/58/45/1349-7235-55-3399.PMC5173516.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/a3/aa/1349-7235-55-3403.PMC5173517.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/a3/aa/1349-7235-55-3403.PMC5173517.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/d1/06/1349-7235-55-3405.PMC5173518.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/d1/06/1349-7235-55-3405.PMC5173518.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/f5/e2/1349-7235-55-3407.PMC5173519.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/f5/e2/1349-7235-55-3407.PMC5173519.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/d6/13/1349-7235-55-3409.PMC5173520.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/d6/13/1349-7235-55-3409.PMC5173520.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/75/4b/1349-7235-55-3411.PMC5173521.pdf
⡥2016 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/75/4b/1349-7235-55-3411.PMC5173521.pdf
"92, Karimkhan Zand Avenue, Hafte Tir Square, Tehran, Iran Drug Saf - Case Rep (2017) 4:1 https://doi.org/10.1007/s40800-016-0042-8",Non-OADS,/arxiv_data1/oa_pdf/af/a9/40800_2016_Article_42.PMC5174011.pdf
"In this case, teicoplanin was used instead of vancomycin according to the Summary of Product Characteristics(available at http://www.sanoﬁ.com.au ).",Non-OADS,/arxiv_data1/oa_pdf/af/a9/40800_2016_Article_42.PMC5174011.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/af/a9/40800_2016_Article_42.PMC5174011.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits noncommercial re-use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/2b/2f/rjw214.PMC5174156.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a9/c3/rjw201.PMC5174157.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits noncommercial re-use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/a8/06/rjw215.PMC5174158.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/ae/evw214.PMC5174731.pdf
"2014 ,http://www.helsinki.ﬁ/science/metapop/ research/mcgenome2_downloads.html ; last accessed February 2015) were propagated to their predicted orthologs inM.",Non-OADS,/arxiv_data1/oa_pdf/90/ae/evw214.PMC5174731.pdf
Supplementary Material Supplementary tables S1–S9 andﬁgures S1–S4 are available atGenome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/90/ae/evw214.PMC5174731.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/ae/evw215.PMC5174732.pdf
transcriptome; these proteins were identiﬁed by comparing their predicted open-reading frame sequences to those of ex- isting proteins in the UNIPROT database ( http://www.uniprot.,OADS,/arxiv_data1/oa_pdf/da/ae/evw215.PMC5174732.pdf
"All ﬁnal annotations were further summarized in GO SLIM ( http://geneontology.org/page/go- slim-and-subset-guide ; last accessed September 19, 2016).",OADS,/arxiv_data1/oa_pdf/da/ae/evw215.PMC5174732.pdf
http://www.nature.com/ nature/journal/v453/n7198/suppinfo/nature06967_S1.html .,Non-OADS,/arxiv_data1/oa_pdf/da/ae/evw215.PMC5174732.pdf
Available from: http://www.repeatmasker.org/ .,Non-OADS,/arxiv_data1/oa_pdf/da/ae/evw215.PMC5174732.pdf
Available from: http://www.repeatmasker.org/ .,Non-OADS,/arxiv_data1/oa_pdf/da/ae/evw215.PMC5174732.pdf
Available from: http://www.nature.com/nclimate/journal/v3/n11/abs/ nclimate1989.html-supplementary-information .Rapid Evolutionary Rates and Unique Genomic Signatures Discovered in Salpa thompsoni GBE Genome Biol.,OADS,/arxiv_data1/oa_pdf/da/ae/evw215.PMC5174732.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d6/57/evw216.PMC5174733.pdf
Supplementary Material Supplementary ﬁgures S1–S7 andtables S1–S8 are available atGenome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/d6/57/evw216.PMC5174733.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ad/61/evw217.PMC5174734.pdf
"Materials and Methods Cell Culture P. bilix cells were cultured in the seawater-based URO medium (http://mcc.nies.go.jp/02medium.html#uro ; last accessed September 12, 2016) containing 10% of the YT medium (http://mcc.nies.go.jp/02medium.html#YT ; last accessed September 12, 2016) at 20/C14C as described in Yabuki et al.",OADS,/arxiv_data1/oa_pdf/ad/61/evw217.PMC5174734.pdf
Supplementary Material Supplementary table S1 andﬁgures S1–S3 a r ea v a i l a b l ea t Genome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/ad/61/evw217.PMC5174734.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ec/42/evw221.PMC5174735.pdf
Supplementary Material Supplementary ﬁgures S1–S5 andtables S1–S9 are available atGenome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/ec/42/evw221.PMC5174735.pdf
Available from: https://sourceforge.net/projects/ evidentialgene/ .,OADS,/arxiv_data1/oa_pdf/ec/42/evw221.PMC5174735.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/21/ed/evw222.PMC5174736.pdf
"Adaptors and low quality reads were trimmed using Scythe (https://github.com/vsbuffalo/scythe )a n dS i c k l e( https:// github.com/najoshi/sickle ), respectively, and assembled using SPAdes ( Bankevich et al.",Non-OADS,/arxiv_data1/oa_pdf/21/ed/evw222.PMC5174736.pdf
Trees were graphed using FigTree ( http://tree.bio.ed.ac.uk/ software/ﬁgtree/ ).,OADS,/arxiv_data1/oa_pdf/21/ed/evw222.PMC5174736.pdf
Supplementary Material Supplementary ﬁgures S1–S7 andtables S1–S3 are available atGenome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/21/ed/evw222.PMC5174736.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/66/bb/evw224.PMC5174737.pdf
"2014 )o ft h e Nomascus leuco- genys genome library (CHORI 271, http://bacpac.chori.org/li- brary.php?id=228 ; last accessed September 21, 2016) that was also used for the gibbon genome assembly (Nleu1.0).",OADS,/arxiv_data1/oa_pdf/66/bb/evw224.PMC5174737.pdf
"A glycerol stock of CHORI271-458C4 was obtained fromBACPAC Resources ( http://bacpac.chori.org/ ; last accessed September 21, 2016).",Non-OADS,/arxiv_data1/oa_pdf/66/bb/evw224.PMC5174737.pdf
"2011 ) and the alignments were visualized in Geneious version 5.6.5 ( http://www.geneious.com ;l a s t accessed September 21, 2016) ( Kearse et al.",OADS,/arxiv_data1/oa_pdf/66/bb/evw224.PMC5174737.pdf
Supplementary Material Supplementary ﬁgures S1–S6 andtables S1–S4 are available atGenome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/66/bb/evw224.PMC5174737.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1a/05/evw225.PMC5174738.pdf
"For gene prediction, it was applied the prediction programs Glimmer GeneMark and Prodigal ( http://prodigal.ornl.gov/ ; last accessed July 1, 2016) including a correction routine forstart codon from the multiple alignment of “n” similar pro-teins identiﬁed by BLASP against NR database ( http://www.",OADS,/arxiv_data1/oa_pdf/1a/05/evw225.PMC5174738.pdf
"Brieﬂy, the deep sequencing libraries ﬁles were quality checked with FASTQC tool ( http://www.bio- informatics.babraham.ac.uk/projects/fastqc/ ; last accessed July 29, 2016) and further trimmed with Fastx_toolkit ( http://han- nonlab.cshl.edu/fastx_toolkit/index.html ; last accessed July 29, 2016).",Non-OADS,/arxiv_data1/oa_pdf/1a/05/evw225.PMC5174738.pdf
"The re- sulting mapping ﬁles were treated with SAMtools program (http://samtools.sourceforge.net/ ; last accessed July 29, 2016), only mapping reads with map quality (mapQ) above30 were kept.",OADS,/arxiv_data1/oa_pdf/1a/05/evw225.PMC5174738.pdf
"The Genome Analysis Toolkit—GATK (https://software.broad institute.org/gatk/ ; last accessed July 29, 2016) was used to call the variants using default parame-ters.",OADS,/arxiv_data1/oa_pdf/1a/05/evw225.PMC5174738.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/b5/evw227.PMC5174739.pdf
Supplementary Material Supplementary ﬁgures S1–S7 and tables S1–S5 are available atGenome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/bf/b5/evw227.PMC5174739.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/18/evw228.PMC5174740.pdf
"Number of DNA-Binding Targets The number of DNA-binding targets for each TF was calcu- lated from wgEncodeRegTfbsClusteredV3 database, found at http://genome.ucsc.edu/cgi-bin/hgTrackUi?db=hg19&g=wgE ncodeRegTfbsClusteredV3 .",OADS,/arxiv_data1/oa_pdf/14/18/evw228.PMC5174740.pdf
Supplementary Material Supplementary table S1 andﬁgures S1 andS2are available at Genome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/14/18/evw228.PMC5174740.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/de/92/evw229.PMC5174741.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8a/48/evw233.PMC5174742.pdf
Supplementary Material Supplementary Figures S1–S2 and Tables S1–S3 are available atGenome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/8a/48/evw233.PMC5174742.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e9/7c/evw237.PMC5174743.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c4/de/evw240.PMC5174744.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b8/7a/evw242.PMC5174745.pdf
"To ensure that our results do not reﬂect discovery errors in 1 kGP, we man-ually checked individual samples for misalignments inIntegrated Genome Browser ( http://bioviz.org/igb/index.html ) and found no apparent errors ( supplementary ﬁg.",OADS,/arxiv_data1/oa_pdf/b8/7a/evw242.PMC5174745.pdf
"Methods Samples and Detection of Nonsense (Stop-Gain or Loss- of-Function) Single Nucleotide Variants We used 1000 Genomes Phase 3 dataset (1-kGP dataset, http://www.1000genomes.org/anno uncements/initial-phase- 3-variant-list-and-phased-genotypes-2014-06-24 ), which in- volve resequencing data from 2,504 samples across 26global populations (1000 Genomes Project Consortium et al.2015) for all our analyses.",OADS,/arxiv_data1/oa_pdf/b8/7a/evw242.PMC5174745.pdf
"We obtained integrated haplotype homozygosity scores (iHS), FSTand nucleotide diver- sity (pi) values for CEU, CHB and YRI from 1000 Genomes Selection Browser 1.0 database ( http://hsb.upf.edu ,l a s t accessed December 2015).",OADS,/arxiv_data1/oa_pdf/b8/7a/evw242.PMC5174745.pdf
2014 ) to get the CADD- based C-scores that gives the deleteriousness of the single nucleotide variants of the 1000 Genome Phase 3 dataset (http://cadd.gs.washington.edu/download ).,Non-OADS,/arxiv_data1/oa_pdf/b8/7a/evw242.PMC5174745.pdf
"For expression quantitative trait loci analysis, we searched rs12746538, one SNP linked with Huxian haplogroup, in the GTEx database ( http://www.gtexportal.org/home/ )(The GTEx Consortium 2015 ).",OADS,/arxiv_data1/oa_pdf/b8/7a/evw242.PMC5174745.pdf
All codes used in this study have been provided in our website: http://gokcumenlab.org/data-and-codes/ .,OADS,/arxiv_data1/oa_pdf/b8/7a/evw242.PMC5174745.pdf
Supplementary Material Supplementary ﬁgures S1–S6 andtable S1–S4 are available at Genome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/b8/7a/evw242.PMC5174745.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Neven B, Magerus-Chatinet A, Florkin B, et al .",Non-OADS,/arxiv_data1/oa_pdf/52/1e/bcr-2016-216758.PMC5174767.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/REFERENCES 1 Hummelshein E. Uber Schnentransplantation am Ague.,Non-OADS,/arxiv_data1/oa_pdf/ee/21/bcr-2016-216722.PMC5174768.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 van den Hoogen FH, Spronk PE, Boerbooms AM, et al .",Non-OADS,/arxiv_data1/oa_pdf/a4/31/bcr-2016-217418.PMC5174774.pdf
doi:10.1136/esmoopen-2016- 000110 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/esmoopen-2016-000110).,Non-OADS,/arxiv_data1/oa_pdf/6d/e2/esmoopen-2016-000110.PMC5174787.pdf
Received 4 October 2016 Revised 16 October 2016 Accepted 22 October 2016 Find more ESMO Clinical Practice Guidelines under: http://www.esmo.,Non-OADS,/arxiv_data1/oa_pdf/6d/e2/esmoopen-2016-000110.PMC5174787.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/6d/e2/esmoopen-2016-000110.PMC5174787.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/4e/0a/bmjqir.u209520.w4033.PMC5174790.pdf
Clinical guideline[CG101] Published date: June 2010 Accessed at https://www.nice.org.uk/guidance/CG101/chapter/1-Guidance#management-of-exacerbations-of-copd 13/10/2016 4 Helliar S. BMJ Quality Improvement Reports 2016; 5:u209520.w4033.,Non-OADS,/arxiv_data1/oa_pdf/4e/0a/bmjqir.u209520.w4033.PMC5174790.pdf
To view these filesplease visit the journal (http://dx.doi.org/10.1136/ rmdopen-2016-000325).,OADS,/arxiv_data1/oa_pdf/82/51/rmdopen-2016-000325.PMC5174791.pdf
"Competing interests All authors have completed the Unified Competing Interest form at http://www.icmje.org/coi_disclosure.pdf (available on requestfrom the corresponding author) and declare: EAH has received research funding from Pfizer, UCB, Roche, MSD and AbbVie for the submitted work, honoraria as a speaker from Pfizer, UCB, Roche, and AbbVie, honoraria fordevelopment of educational material from Pfizer, and has been on advisory board for Pfizer that might have an interest on the submitted work in the previous 3 years.",Non-OADS,/arxiv_data1/oa_pdf/82/51/rmdopen-2016-000325.PMC5174791.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ esmoopen-2016-000107).,Non-OADS,/arxiv_data1/oa_pdf/2f/72/esmoopen-2016-000107.PMC5174792.pdf
"Table 1 Overview of ESMO career development opportunities for young oncologists (for updated information, please refer to http://www.esmo.org ESMO activity Required LanguageOptimal age and experience Held inRoom and boardincludedTravel grantavailable Length ESMO membership* Proof of status English Anyone NA NA NA 1 year ESMO Translational Research,Clinical Research, PalliativeCare, European integration andGeorges Mathe translationalresearch fellowshipsApplication form, photograph, description of research projectproposal+ timeline, motivation letter,including project goals, acceptanceletter from mentor at host facility andrecommendation letter from theapplicant ’s department headEnglish Young oncologistsunder the ageof 40Various times No No Varies ESMO ESO Masterclass CV, letter of motivation for attending and letter of recommendation and apresentation caseEnglish 30 –40 and 2 – 3 years ofoncologyMarch Yes No 5 days ESMO Academy †‡ Application form English Anyone August Yes Yes 3 days ESMO Examination Application form English (currently) and otherlanguages currentlyin considerationOncologists nearing end oftrainingSeptember/ October duringESMOCongressNA NA 2.5 hours The ESMO ESO course on medical oncology for medicalstudentsCV, letter of motivation for attending and letter of recommendationEnglish Fourth-year and fifth-yearmedicalstudentsJuly Yes Yes 5 days The ESMO Preceptorships Online application, CV and PPT presentationEnglish Experience in medicaloncologyVarious times Yes Yes 2 –3d a y s All activities except the ESMO membership, Masterclasses and Examination are exclusive for ESMO members.",Non-OADS,/arxiv_data1/oa_pdf/2f/72/esmoopen-2016-000107.PMC5174792.pdf
More information is available at http://www.eso.net/ events-2.html.,Non-OADS,/arxiv_data1/oa_pdf/2f/72/esmoopen-2016-000107.PMC5174792.pdf
"Diabetes Atlas [article online], 2015. http://www.idf.org/diabetesatlas (accessed 11-04 2015).",Non-OADS,/arxiv_data1/oa_pdf/08/94/bmjdrc-2016-000266.PMC5174793.pdf
"Nanopass® 34G [article online], 2015. http://www.terumo-europe.",Non-OADS,/arxiv_data1/oa_pdf/08/94/bmjdrc-2016-000266.PMC5174793.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d6/7d/openhrt-2016-000421.PMC5174794.pdf
To view please visit the journal (http://dx.doi.org/10.1136/lupus-2016- 000183).,Non-OADS,/arxiv_data1/oa_pdf/06/d0/lupus-2016-000183.PMC5174796.pdf
"R: A Language and Environment for Statistical Computing [program], Vienna, Austria, 2015.http://www.R-project.org/).",Non-OADS,/arxiv_data1/oa_pdf/06/d0/lupus-2016-000183.PMC5174796.pdf
"Funding The work was supported by the following NIH (http://www.nih.gov) grants: R01 AR052300 (LAC), K24 AR02175 (LAC), P60 AR053308 (LAC), R01 AI097134 (AHS), UCSF-CTSI KL2 RR024130 (SAC), UCSF-CTSI UL1 TR000004 (SAC) and K23 AR063126 (SAC); Alliance for Lupus Research (http://www.lupusresearch.org, LAC); Mary Kirkland Scholar Award (http:// www.hss.edu/mary-kirkland-scholar-program.asp, LAC); RheumatologyResearch Foundation (AM), the Irene Perstein Award (https://medschool.ucsf.",Non-OADS,/arxiv_data1/oa_pdf/06/d0/lupus-2016-000183.PMC5174796.pdf
"edu/school-medicine-irene-perstein-award/, SAC), and the Russell/Engleman Rheumatology Research Center (https://russellenglemancenter.ucsf.edu/, RRN, JN, LAC and SAC).",Non-OADS,/arxiv_data1/oa_pdf/06/d0/lupus-2016-000183.PMC5174796.pdf
Data sharing statement Methylation data for the study participants are available at https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?,Non-OADS,/arxiv_data1/oa_pdf/06/d0/lupus-2016-000183.PMC5174796.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ vetreco-2015-000162).,Non-OADS,/arxiv_data1/oa_pdf/e8/e3/vetreco-2015-000162.PMC5174797.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ esmoopen-2016-000129).,Non-OADS,/arxiv_data1/oa_pdf/b2/d2/esmoopen-2016-000129.PMC5174799.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ esmoopen-2016-000084).,Non-OADS,/arxiv_data1/oa_pdf/ae/6f/esmoopen-2016-000084.PMC5174801.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ esmoopen-2016-000109).,Non-OADS,/arxiv_data1/oa_pdf/c1/76/esmoopen-2016-000109.PMC5174803.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ esmoopen-2016-000133).,Non-OADS,/arxiv_data1/oa_pdf/35/29/esmoopen-2016-000133.PMC5174804.pdf
See: http://creativecommons.org/licenses/ by-nc/4.0/Click here to listen to the Podcast Winkler F. ESMO Open 2016; 1:e000133.,Non-OADS,/arxiv_data1/oa_pdf/35/29/esmoopen-2016-000133.PMC5174804.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/fd/b0/bmjqir.u215856.w7316.PMC5174805.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/17/59/bmjqir.u217936.w7106.PMC5174806.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/f7/75/bmjqir.u209049.w6736.PMC5174808.pdf
Available from: http://www.health.govt.nz/ new-zealand-health-system/my-dhb/south-canterbury-dhb/ population-south-canterbury-dhb.,Non-OADS,/arxiv_data1/oa_pdf/f7/75/bmjqir.u209049.w6736.PMC5174808.pdf
2015 [accessed 10 Oct 2016] Available from: http://www.TeAra.govt.nz/en/south-canterbury-region/page-13.,Non-OADS,/arxiv_data1/oa_pdf/f7/75/bmjqir.u209049.w6736.PMC5174808.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/4b/fa/bmjqir.u212920.w5661.PMC5174810.pdf
Available from: http://www.jointcommission.org/assets/1/18/Root_Causes_by_Event_Type_2004-2015.pdf 2.,OADS,/arxiv_data1/oa_pdf/4b/fa/bmjqir.u212920.w5661.PMC5174810.pdf
Available from: http://www.jointcommission.org/assets/1/6/2007_annual_report.pdf 3.,OADS,/arxiv_data1/oa_pdf/4b/fa/bmjqir.u212920.w5661.PMC5174810.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/bd/50/bmjgast-2016-000104.PMC5174812.pdf
http://www-dep.iarc.fr/ NORDCAN/DK/frame.asp 2.,Non-OADS,/arxiv_data1/oa_pdf/70/6e/bmjgast-2016-000120.PMC5174813.pdf
2007. https://www.cancer.,Non-OADS,/arxiv_data1/oa_pdf/70/6e/bmjgast-2016-000120.PMC5174813.pdf
"https://www.melanoma.org/ understand-melanoma/what-is-melanoma/ocular-melanoma/ocular-melanoma-treatment 11 Zimmerman LE, McLean IW.",Non-OADS,/arxiv_data1/oa_pdf/79/94/bcr-2016-217503.PMC5174817.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/cd/ee/openhrt-2016-000535.PMC5174824.pdf
Competing interests All authors have completed the ICMJE form for disclosure of potential conflicts at http://www.icmje.org/coi_disclosure.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e7/bf/bmjdrc-2016-000303.PMC5174825.pdf
https://www.diabetes.org.uk/Documents/Position%20statements/Diabetes%20UK%20Facts%20and%20Stats_Dec%202015.pdf (accessed 20 Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/e7/bf/bmjdrc-2016-000303.PMC5174825.pdf
2016. http://www.ons.gov.uk/ peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/datasets/cancerregistrationstatisticscancerregistrationstatisticsengland (accessed 13 Oct 2016).,Non-OADS,/arxiv_data1/oa_pdf/e7/bf/bmjdrc-2016-000303.PMC5174825.pdf
https://www.nice.org.uk/guidance/ng28/chapter/1-Recommendations (accessed 3 May 2016).,Non-OADS,/arxiv_data1/oa_pdf/e7/bf/bmjdrc-2016-000303.PMC5174825.pdf
2013. http://www.takeda.us/products/default.aspx (accessed 14 Sep 2016).,OADS,/arxiv_data1/oa_pdf/e7/bf/bmjdrc-2016-000303.PMC5174825.pdf
Available at:  http://www.acr.org/~/media/ACR/Documents/PDF/Quali- tySafety/Resources/BIRADS/MammoGuidance.pdf.,Non-OADS,/arxiv_data1/oa_pdf/87/ac/NCI-1-1.PMC5175017.pdf
Available at http://www.iasj.net/ iasj?func=fulltext&aId=5108.,Non-OADS,/arxiv_data1/oa_pdf/b4/5e/NCI-1-19.PMC5175019.pdf
Available at: http://www.saglik.gov.tr/TR/belge/1-570/ evde-bakim-hizmetleri-sunumu-hakkinda-yonetmelik.html.,Non-OADS,/arxiv_data1/oa_pdf/85/3a/NCI-1-166.PMC5175036.pdf
Available at: http://www.saglik.gov.tr/TR/belge/1-12133/saglik-bakanliginca-sunu- lan-evde-saglik-hizmetlerinin-u-.html.,Non-OADS,/arxiv_data1/oa_pdf/85/3a/NCI-1-166.PMC5175036.pdf
"Global burden of neurological disorders estimates and projec-tions, Available at: http://www.who.int/mental_health/neurol-ogy/ neu rology/ chapter_2_ neuro_disorders_ public_h_ chal-lenges.pdf.",OADS,/arxiv_data1/oa_pdf/85/3a/NCI-1-166.PMC5175036.pdf
"Avail-able at: http://www.diyanet.gov.tr/dinisleriyuksekkurulu/sayfa - lar/organnakli.aspx Accessed August 06, 2013.Kose et al., Knowledge levels of and attitudes to organ donation and transplantation among university students 25",Non-OADS,/arxiv_data1/oa_pdf/76/4c/NCI-2-19.PMC5175046.pdf
Available at: http://www.tuik.gov.tr/PreT abloArama.do?metod=search&araT ype=vt.,Non-OADS,/arxiv_data1/oa_pdf/01/11/NCI-2-33.PMC5175048.pdf
http://www.uptodate.com/con-tents/neurosyphilis.,Non-OADS,/arxiv_data1/oa_pdf/79/cd/NCI-2-66.PMC5175054.pdf
"TÜİK, Adrese Dayalı Nüfus Kayıt Sistemi (ADNKS) Sonuçları, 2008-2013 http://www.tuik.gov.tr (Erişim tarihi: 20.10.2014).with cancer can be prevented.",Non-OADS,/arxiv_data1/oa_pdf/d9/00/NCI-2-73.PMC5175057.pdf
(Erişim T arihi: 10.12.2014) 9. http://www.hasuder.org/anasayfa/index.php/yayinlar/hasud- er-yayinlari (Erişim T arihi: 10.12.2014) 10.,Non-OADS,/arxiv_data1/oa_pdf/d9/00/NCI-2-73.PMC5175057.pdf
CrossRef 11. http://www.cancer.org/research/cancerfactsstatistics/cancer - factsfigures2014/index (Erişim T arihi: 10.12.2014) 12. http://www.cancer.org/acs/groups/cid/documents/ webcontent/003115-pdf.pdf (Erişim T arihi: 10.12.2014) 13. http://www.who.int/mediacentre/factsheets/fs297/en/  (Erişim T arihi: 10.12.2014) 14.,Non-OADS,/arxiv_data1/oa_pdf/d9/00/NCI-2-73.PMC5175057.pdf
20. http://kanser.gov.tr/Dosya/tarama/kolorektal_kanser_tara - ma_programi.pdf (Erişim T arihi: 20.01.2015).,Non-OADS,/arxiv_data1/oa_pdf/d9/00/NCI-2-73.PMC5175057.pdf
Available at http://www.cdc.gov/vhf/ebola/hcp/casedefinition.,Non-OADS,/arxiv_data1/oa_pdf/07/ac/NCI-2-81.PMC5175058.pdf
Available from:http://www.usatoday.com/story/news/ nation/2014/10/13/ebola-nurse-who/17182599/  21.,Non-OADS,/arxiv_data1/oa_pdf/07/ac/NCI-2-81.PMC5175058.pdf
http://www.cdc.gov/vhf/ebola/hcp/clinician-in- formation-us-healthcare-settings.html#investigational-vaccines.,Non-OADS,/arxiv_data1/oa_pdf/07/ac/NCI-2-81.PMC5175058.pdf
Available from: http://www.nytimes.com/interactive/2014/07/31/world/africa/ebola-viru-,Non-OADS,/arxiv_data1/oa_pdf/07/ac/NCI-2-81.PMC5175058.pdf
"Siegel JD, Rhinehart E, Jackson M, Chiarello L, and the Health- care Infection Control Practices Advisory Committee, 2007 Guideline for Isolation Precautions: Preventing Transmission of  Infectious Agents in Healthcare Settings http://www.cdc.gov/ ncidod/dhqp/pdf/isolation2007.pdfNorth Clin Istanbul – NCI 86",Non-OADS,/arxiv_data1/oa_pdf/07/ac/NCI-2-81.PMC5175058.pdf
http://www.who.int/mediacentre/fact- sheets/fs138/en.,Non-OADS,/arxiv_data1/oa_pdf/e8/d1/NCI-3-34.PMC5175075.pdf
4. http://www.cdc.gov/drugresistance/ adresinden 12.10.2014  tarihinde erişilmiştir.5.,Non-OADS,/arxiv_data1/oa_pdf/71/4b/NCI-2-107.PMC5175087.pdf
http://www.who.int/mediacentre/news/releases/2014/amr- report/en adresinden 12/10/2014 tarihinde erişilmiştir.,Non-OADS,/arxiv_data1/oa_pdf/71/4b/NCI-2-107.PMC5175087.pdf
Adolescent fertility rate (births per 1000 women ages  15-19);http://data.worldbank.org/indicator/SP .ADO.,OADS,/arxiv_data1/oa_pdf/14/cd/NCI-2-122.PMC5175089.pdf
"T ürkiye İstatistik Kurumu, İstatistiklerle Çocuk, 2013; http://www.tuik.gov.tr/PreHaberBultenleri.do?id=16054.",Non-OADS,/arxiv_data1/oa_pdf/14/cd/NCI-2-122.PMC5175089.pdf
Available from: http://www.who.int/mediacentre/fact- sheets/20090804_figure1.jpg?ua=1.,Non-OADS,/arxiv_data1/oa_pdf/14/cd/NCI-2-122.PMC5175089.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3d/5d/fnw249.PMC5175184.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Richard B Presland, PhD, Department  of Oral Health Sciences, School of Dentistry, University of  Washington, 1959 NE Pacific St, Box 357475, Seattle, WA  98195, United States.",Non-OADS,/arxiv_data1/oa_pdf/90/0e/WJT-6-608.PMC5175218.pdf
"In the last decade many molecular biomarkers have  been identified that correlate with cGVHD onset and/or  progression, and some might have applications clinically in  the near future.REVIEW 608 December 24, 2016 |Volume 6 |Issue 4| WJT|www.wjgnet.comBiology of chronic graft- vs-host disease: Immune  mechanisms and progress in biomarker discoveryWorld J Transplant   2016 December 24; 6(4): 608-619 ISSN 2220-3230 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5500/wjt.v6.i4.608World Journal of  Transplantation WJT",Non-OADS,/arxiv_data1/oa_pdf/90/0e/WJT-6-608.PMC5175218.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/90/0e/WJT-6-608.PMC5175218.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Unsolicited manuscript Correspondence to: Aparna Dalal, MD, Assistant Professor,   Department of Anesthesiology, Icahn School of Medicine, Mount  Sinai 1428 Madison Avenue, New York, NY 10029,  United States.",Non-OADS,/arxiv_data1/oa_pdf/cb/4c/WJT-6-620.PMC5175219.pdf
"Key words: Drug eluting stents; Cangrelor; Stent thro -REVIEW 620 December 24, 2016 |Volume 6 |Issue 4| WJT|www.wjgnet.comOrgan transplantation and drug eluting stents: Perioperative  challengesWorld J Transplant   2016 December 24; 6(4): 620-631 ISSN 2220-3230 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5500/wjt.v6.i4.620World Journal of  Transplantation WJT",Non-OADS,/arxiv_data1/oa_pdf/cb/4c/WJT-6-620.PMC5175219.pdf
World J Transplant  2016; 6(4): 620-631   Available from: URL: http://www.wjgnet.com/2220-3230/full/ v6/i4/620.htm   DOI: http://dx.doi.org/ 10.5500 /wjt.v6.i4.620 INTRODUCTION Percutaneous coronary intervention (PCI) is presently  the most frequent revascularization procedure used for  treating coronary artery disease (CAD).,Non-OADS,/arxiv_data1/oa_pdf/cb/4c/WJT-6-620.PMC5175219.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/cb/4c/WJT-6-620.PMC5175219.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Maurizio Salvadori, MD, Department  of Renal Transplantation, Careggi University Hospital, viale  Pieraccini 18, 50139 Florence,  Italy.",Non-OADS,/arxiv_data1/oa_pdf/e7/7a/WJT-6-632.PMC5175220.pdf
"A distinction should be made  between kidney d iseases with complement overactivation REVIEW 632 December 24, 2016 |Volume 6 |Issue 4| WJT|www.wjgnet.comComplement related kidney diseases: Recurrence after  transplantationWorld J Transplant   2016 December 24; 6(4): 632-645 ISSN 2220-3230 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5500/wjt.v6.i4.632World Journal of  Transplantation WJT",Non-OADS,/arxiv_data1/oa_pdf/e7/7a/WJT-6-632.PMC5175220.pdf
"World J Transplant  2016; 6(4):  632-645  Available from: URL: http://www.wjgnet.com/2220-3230/ full/v6/i4/632.htm   DOI: http://dx.doi.org/ 10.5500 /wjt.v6.i4.632 INTRODUCTION The aim of this review is to highlight the relevance of  recurrent diseases after kidney transplantation and,  in particular, to discuss the frequency and severity  of recurrence of two groups of renal diseases strictly  related to each other: C3 glomerulopathy (C3G) and  thrombotic microangiopathy (TMA).",Non-OADS,/arxiv_data1/oa_pdf/e7/7a/WJT-6-632.PMC5175220.pdf
Available from: URL: https://www.emmes.com/ study/ped.,Non-OADS,/arxiv_data1/oa_pdf/e7/7a/WJT-6-632.PMC5175220.pdf
"Available from: URL: http://www.usrds.org/adr.htm 17   Australia and New Zealand Dialysis and Transplant Registry: the 29th  Annual Report, 2006.",Non-OADS,/arxiv_data1/oa_pdf/e7/7a/WJT-6-632.PMC5175220.pdf
Available from: URL: http://www.anzdata.org.,Non-OADS,/arxiv_data1/oa_pdf/e7/7a/WJT-6-632.PMC5175220.pdf
"Available from:  URL: https://www.clinicaltrials.gov/ct2/show/NCT02093533 NLM  Identifier: NCT02093533 130  Midtvedt K , Bitter J, Dørje C, Bjørneklett R, Holdaas H. Belatacept  as immunosuppression in patient with recurrence of hemolytic uremic  syndrome after renal transplantation.",Non-OADS,/arxiv_data1/oa_pdf/e7/7a/WJT-6-632.PMC5175220.pdf
"Available from: URL:  https://www.clinicaltrials.gov/ct2/show/NCT00838513 NLM  Identifier: NCT00838513  136  Zuber J , Fakhouri F, Roumenina LT, Loirat C, Frémeaux-Bacchi V .",Non-OADS,/arxiv_data1/oa_pdf/e7/7a/WJT-6-632.PMC5175220.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/e7/7a/WJT-6-632.PMC5175220.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Unsolicited manuscript Correspondence to:  Aparna Dalal, MD, Department of  Anesthesiology, Icahn School of Medicine at Mount Sinai, 1428  Madison Ave, New York, NY 10029,  United States.",Non-OADS,/arxiv_data1/oa_pdf/20/ff/WJT-6-646.PMC5175221.pdf
"This article  reviews the anesth etic considerations for management MINIREVIEWS 646 December 24, 2016 |Volume 6 |Issue 4| WJT|www.wjgnet.comFace transplantation: Anesthetic challengesWorld J Transplant   2016 December 24; 6(4): 646-649 ISSN 2220-3230 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5500/wjt.v6.i4.646World Journal of  Transplantation WJT",Non-OADS,/arxiv_data1/oa_pdf/20/ff/WJT-6-646.PMC5175221.pdf
Available from: URL: http://edition.cnn.,Non-OADS,/arxiv_data1/oa_pdf/20/ff/WJT-6-646.PMC5175221.pdf
Available  from: URL: https://optn.transplant.hrsa.gov/governance/about-the- optn/final-rule/ 7 United Network of Organ Sharing.,Non-OADS,/arxiv_data1/oa_pdf/20/ff/WJT-6-646.PMC5175221.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/20/ff/WJT-6-646.PMC5175221.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Beatrice P Concepcion, MD, Assistant  Professor  of Medicine,  Department of Medicine, Division of  Nephrology and Hypertension, Vanderbilt University Medical  Center, 1161 21st Avenue South, MCN S-3223, Nashville, TN  37232, United States.",Non-OADS,/arxiv_data1/oa_pdf/5c/5c/WJT-6-650.PMC5175222.pdf
"Published by Baishideng Publishing  Group Inc. All rights reserved.MINIREVIEWS 650 December 24, 2016 |Volume 6 |Issue 4 | WJT|www.wjgnet.comOlder candidates for kidney transplantation: Who to refer  and what to expect?World J Transplant   2016 December 24; 6(4): 650-657 ISSN 2220-3230 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5500/wjt.v6.i4.650World Journal of  Transplantation WJT",Non-OADS,/arxiv_data1/oa_pdf/5c/5c/WJT-6-650.PMC5175222.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/5c/5c/WJT-6-650.PMC5175222.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited Manuscript Correspondence to: Andrew G Bostom, MD, MS, Associate  Professor  of Medicine,  Research Physician, Division of  Hypertension and Kidney Diseases, Department of Medicine,  Rhode Island Hospital, 593 Eddy Street, Providence, RI 02903,  United States.",Non-OADS,/arxiv_data1/oa_pdf/24/b3/WJT-6-658.PMC5175223.pdf
Potential nicotinamide treatment  applications in chronic kidney transplant recipientsWorld J Transplant   2016 December 24; 6(4): 658-664 ISSN 2220-3230 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5500/wjt.v6.i4.658World Journal of  Transplantation WJT,Non-OADS,/arxiv_data1/oa_pdf/24/b3/WJT-6-658.PMC5175223.pdf
World J Transplant   2016; 6(4): 658-664  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/24/b3/WJT-6-658.PMC5175223.pdf
"com/2220-3230/full/v6/i4/658.htm   DOI: http://dx.doi.org/ 10.5500 / wjt.v6.i4.658 NON-MELANOMA SKIN CANCER IN  GENERAL AND KIDNEY TRANSPLANT  RECIPIENT POPULATIONS Updated United States incidence estimates for non- melanoma cutaneous carcinoma, or skin cancer (NMSC)  in the Medicare fee-for-service population indicate a  pronounced rise of 100% for the entire two decade  period from 1992 to 2012, and a sustained 6-year 2006  to 2012 elevation in NMSC rates of 35%[1].",Non-OADS,/arxiv_data1/oa_pdf/24/b3/WJT-6-658.PMC5175223.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/24/b3/WJT-6-658.PMC5175223.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: William J Hogan, MBBCh, MRCPI,  Division of Hematology, Department of Medicine, Mayo Clinic,  200 First Street SW, Rochester, MN 55905,  United States.",Non-OADS,/arxiv_data1/oa_pdf/56/fa/WJT-6-665.PMC5175224.pdf
"WoWorld J Transplant  2016; 6(4):  665-674  Available from: URL: http://www.wjgnet.com/2220-3230/ full/v6/i4/665.htm   DOI: http://dx.doi.org/ 10.5500 /wjt.v6.i4.665 INTRODUCTION Hematopoietic stem-cell transplantation (HSCT) is MINIREVIEWS 665 December 24, 2016 |Volume 6 |Issue 4| WJT|www.wjgnet.comOverview of the progress on haploidentical hematopoietic  transplantationWorld J Transplant   2016 December 24; 6(4): 665-674 ISSN 2220-3230 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5500/wjt.v6.i4.665World Journal of  Transplantation WJT",Non-OADS,/arxiv_data1/oa_pdf/56/fa/WJT-6-665.PMC5175224.pdf
"Available from: URL:  https://clinicaltrials.gov/ct2/show/NCT0222098 5 NLM Identifier:  NCT02220985 40 Hoffmann P , Ermann J, Edinger M, Fathman CG, Strober S. Donor- type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft- versus-host disease after allogeneic bone marrow transplantation.",Non-OADS,/arxiv_data1/oa_pdf/56/fa/WJT-6-665.PMC5175224.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/56/fa/WJT-6-665.PMC5175224.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Taner Demirer, MD, FACP, Professor of  Medicine and Hematology/Oncology,  Department of Hematology,  Ankara University Medical School, Cebeci Hospital, 06220 Ankara,  Turkey.",Non-OADS,/arxiv_data1/oa_pdf/b9/63/WJT-6-675.PMC5175225.pdf
"Core tip: Some refractory metastatic solid tumors  including renal, ovarian and even colon cancers may  respond well to allogeneic hematopoietic stem cell  transplantation (allo-HSCT) with reduced intensity MINIREVIEWS 675 December 24, 2016 |Volume 6 |Issue 4| WJT|www.wjgnet.comReview of allogeneic hematopoietic stem cell  transplantation with reduced intensity conditioning in solid  tumors excluding breast cancerWorld J Transplant   2016 December 24; 6(4): 675-681 ISSN 2220-3230 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5500/wjt.v6.i4.675World Journal of  Transplantation WJT",Non-OADS,/arxiv_data1/oa_pdf/b9/63/WJT-6-675.PMC5175225.pdf
World J Transplant  2016; 6(4): 675-681  Available  from: URL: http://www.wjgnet.com/2220-3230/full/v6/i4/675.,Non-OADS,/arxiv_data1/oa_pdf/b9/63/WJT-6-675.PMC5175225.pdf
htm  DOI: http://dx.doi.org/ 10.5500 /wjt.v6.i4.675 INTRODUCTION Allogeneic hematopoietic stem cell transplantation (allo- HSCT) is primarily used in patients with relapsed or  high-risk hematologic malignancies and the efficacy of  this treatment has been substantially demonstrated.,Non-OADS,/arxiv_data1/oa_pdf/b9/63/WJT-6-675.PMC5175225.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/b9/63/WJT-6-675.PMC5175225.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Ahmed Halawa, Consultant Transplant  Surgeon,  Sheffield Teaching Hospital, Herries Road, Sheffield  S5 7AU, United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/96/21/WJT-6-682.PMC5175226.pdf
"We provide  in this article a comprehensive review of the current  evidence on the true incidence, the mechanism of damage  induced by CIN and available preventive measures to  counteract the possible effect induced by CIN.MINIREVIEWS 682 December 24, 2016 |Volume 6 |Issue 4| WJT|www.wjgnet.com“Contrast nephropathy” in renal transplantation: Is it real?World J Transplant   2016 December 24; 6(4): 682-688 ISSN 2220-3230 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5500/wjt.v6.i4.682World Journal of  Transplantation WJT",Non-OADS,/arxiv_data1/oa_pdf/96/21/WJT-6-682.PMC5175226.pdf
World J Transplant  2016; 6(4):  682-688  Available from: URL: http://www.wjgnet.com/2220-3230/ full/v6/i4/682.htm   DOI: http://dx.doi.org/ 10.5500 /wjt.v6.i4.682 INTRODUCTION Perioperative transplant complications are reported  to involve about 15%-20% of the kidney transplant  recipients.,Non-OADS,/arxiv_data1/oa_pdf/96/21/WJT-6-682.PMC5175226.pdf
Available  from: URL: http://www.imaginis.com/ct-scan/information-about- intravenous-and-oral-contrast-used-in-ct-1 36 Radiologyinfo.org for patients.,Non-OADS,/arxiv_data1/oa_pdf/96/21/WJT-6-682.PMC5175226.pdf
"Available from: URL: http://www.stockport.nhs.uk/ P- Reviewer : Hu XP, Sheashaa HA, Tanaka A    S- Editor : Ji FF     L- Editor : A    E- Editor : Lu YJ    Abbas FM  et al.",Non-OADS,/arxiv_data1/oa_pdf/96/21/WJT-6-682.PMC5175226.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/96/21/WJT-6-682.PMC5175226.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript  source:  Invited  manuscript Correspondence to: Sofia Santos, MD, Department of  Nephrology and Kidney Transplantation, Centro Hospitalar do  Porto, Largo Prof. Abel Salazar, 4099-001 Porto,  Portugal.",Non-OADS,/arxiv_data1/oa_pdf/79/8a/WJT-6-689.PMC5175227.pdf
"RESULTS One year after transplantation there were no differences ORIGINAL ARTICLE 689 December 24, 2016 |Volume 6 |Issue 4| WJT|www.wjgnet.comImpact of preformed donor-specific antibodies against HLA  class Ⅰ on kidney graft outcomes: Comparative analysis of  exclusively anti-Cw vs anti-A and/or -B antibodiesWorld J Transplant   2016 December 24; 6(4): 689-696 ISSN 2220-3230 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5500/wjt.v6.i4.689World Journal of  Transplantation WJT Retrospective Cohort Study",Non-OADS,/arxiv_data1/oa_pdf/79/8a/WJT-6-689.PMC5175227.pdf
wjgnet.com/2220-3230/full/v6/i4/689.htm   DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/79/8a/WJT-6-689.PMC5175227.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/79/8a/WJT-6-689.PMC5175227.pdf
"See: http://creativecommons.org/ licenses/by ­ nc/4.0/ Manuscript   source:   Invited   manuscript Correspondence to: Maria Aurora Posadas Salas, MD,   Department of Medicine, Medical University of South Carolina, 96 Jonathan Lucas St., Charleston, SC 29425,  United States.",Non-OADS,/arxiv_data1/oa_pdf/fa/84/WJT-6-697.PMC5175228.pdf
"After  multivariate analysis, which controlled for confounders,  FK use was a strong predictor for lower acute rejection ORIGINAL ARTICLE 697 December 24, 2016 |Volume 6 |Issue 4| WJT|www.wjgnet.comTacrolimus confers lower acute rejection rates and better  renal allograft survival compared to cyclosporineWorld J Transplant   2016 December 24; 6(4): 697-702 ISSN 2220-3230 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5500/wjt.v6.i4.697World Journal of  Transplantation WJT Retrospective Study",Non-OADS,/arxiv_data1/oa_pdf/fa/84/WJT-6-697.PMC5175228.pdf
wjgnet.com/2220 ­ 3230/full/v6/i4/697.htm   DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fa/84/WJT-6-697.PMC5175228.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/fa/84/WJT-6-697.PMC5175228.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Vincent Karam, PhD, Centre Hépatobiliaire,  Assistance Publique-Hôpitaux de Paris, Université Paris-Sud, Hôpital  Paul Brousse, 12-14, Avenue Paul Vaillant Couturier, B.P.",Non-OADS,/arxiv_data1/oa_pdf/35/67/WJT-6-703.PMC5175229.pdf
"Logistic regression analysis was used  to explore associations between hist ological, clinical and ORIGINAL ARTICLE 703 December 24, 2016 |Volume 6 |Issue 4| WJT|www.wjgnet.comQuality of life 10 years after liver transplantation: The  impact of graft histologyWorld J Transplant   2016 December 24; 6(4): 703-711 ISSN 2220-3230 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5500/wjt.v6.i4.703World Journal of  Transplantation WJT Retrospective Study",Non-OADS,/arxiv_data1/oa_pdf/35/67/WJT-6-703.PMC5175229.pdf
"World J Transplant  2016; 6(4): 703-711  Available from: URL:  http://www.wjgnet.com/2220-3230/full/v6/i4/703.htm   DOI:  http://dx.doi.org/ 10.5500 /wjt.v6.i4.703 INTRODUCTION The goal of liver transplantation (LT) is to ameliorate not  only survival, but also quality of life (QOL) while minimizing  the effects of disease and costs of care.",Non-OADS,/arxiv_data1/oa_pdf/35/67/WJT-6-703.PMC5175229.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/35/67/WJT-6-703.PMC5175229.pdf
"See: http://creativecommons.org/ licenses/by ­ nc/4.0/ Manuscript   source:   Invited   manuscript Correspondence to: Vasant Sumethkul, MD, Division of  Nephrology, Department of Medicine, Faculty of Medicine,  Ramathibodi Hospital, Mahidol University, Bangkok 10400,  Thailand.",Non-OADS,/arxiv_data1/oa_pdf/ff/67/WJT-6-712.PMC5175230.pdf
"Significant ORIGINAL ARTICLE 712 December 24, 2016 |Volume 6 |Issue 4| WJT|www.wjgnet.comStabilization of estimated glomerular filtration rate in kidney  transplantation from deceased donors with acute kidney injuriesWorld J Transplant   2016 December 24; 6(4): 712-718 ISSN 2220-3230 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5500/wjt.v6.i4.712World Journal of  Transplantation WJT Retrospective Study",Non-OADS,/arxiv_data1/oa_pdf/ff/67/WJT-6-712.PMC5175230.pdf
World J Transplant  2016; 6(4): 712­718   Available from: URL: http://www.wjgnet.com/2220 ­ 3230/full/v6/ i4/712.htm   DOI: http://dx.doi.org/ 10.5500 /wjt.v6.i4.712 INTRODUCTION An increasing tendency to perform kidney transplant (KT) from deceased donors other than standard  criteria donor (SCD) is the result of disparity between  the number of patient being in the waiting list for  transplantation and utilized donor pool[1].,Non-OADS,/arxiv_data1/oa_pdf/ff/67/WJT-6-712.PMC5175230.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/ff/67/WJT-6-712.PMC5175230.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Guo-Sheng Wu, MD, PhD, Division of  Gastrointestinal Surgery, Xijing Hospital of Digestive Diseases,  the Fourth Military Medical University, #127 Changle West Rd, Xi’an 710032, Shaanxi Province,  China.",Non-OADS,/arxiv_data1/oa_pdf/5c/ac/WJT-6-719.PMC5175231.pdf
"Multivariate analysis identified  a liver-free graft and high level of panel r eactive antibody ORIGINAL ARTICLE 719 December 24, 2016 |Volume 6 |Issue 4| WJT|www.wjgnet.comAcute antibody-mediated rejection after intestinal  transplantationWorld J Transplant   2016 December 24; 6(4): 719-728 ISSN 2220-3230 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5500/wjt.v6.i4.719World Journal of  Transplantation WJT Retrospective Study",Non-OADS,/arxiv_data1/oa_pdf/5c/ac/WJT-6-719.PMC5175231.pdf
World J Transplant  2016; 6(4): 719-728   Available from: URL: http://www.wjgnet.com/2220-3230/full/v6/ i4/719.htm   DOI: http://dx.doi.org/ 10.5500 /wjt.v6.i4.719 INTRODUCTION Intestinal transplantation (ITx) has increasingly become a  viable option for most patients with irreversible intestinal  failure.,Non-OADS,/arxiv_data1/oa_pdf/5c/ac/WJT-6-719.PMC5175231.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/5c/ac/WJT-6-719.PMC5175231.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Bibhuti Das, MD, Deptartment of Pediatrics,  Children’s Medical Cente, University of Texas Southwestern  Medical Center, 1935 Medical District Dr, Dallas, TX 75235,  United States.",Non-OADS,/arxiv_data1/oa_pdf/69/0a/WJT-6-729.PMC5175232.pdf
"In the EBV seropositive group, PTLD was diagnosed in  15% (3/20) of patients with high EBV vs 4.2% (3/71) of  patients with low or undetectable EBV load ( P = 0.14)  whereas in EBV naïve patients 8.3% (1/12) of those with ORIGINAL ARTICLE 729 December 24, 2016 |Volume 6 |Issue 4 | WJT|www.wjgnet.comPersistent Epstein-Barr viral load in Epstein-Barr viral naïve  pediatric heart transplant recipients: Risk of late-onset post- transplant lymphoproliferative diseaseWorld J Transplant   2016 December 24; 6(4): 729-735 ISSN 2220-3230 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5500/wjt.v6.i4.729World Journal of  Transplantation WJT Observational Study",Non-OADS,/arxiv_data1/oa_pdf/69/0a/WJT-6-729.PMC5175232.pdf
World J Transplant  2016; 6(4): 729-735  Available from: URL:  http://www.wjgnet.com/2220-3230/full/v6/i4/729.htm   DOI: http:// dx.doi.org/ 10.5500 /wjt.v6.i4.729 INTRODUCTION Post-transplant lymphoproliferative disorder (PTLD) is  the most common malignancy occurring in 3.5%-9% of pediatric HT recipients[1-4].,Non-OADS,/arxiv_data1/oa_pdf/69/0a/WJT-6-729.PMC5175232.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/69/0a/WJT-6-729.PMC5175232.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Concetta De Pasquale, MD, PhD,  Vascular Surgery and Organ Transplant Unit, Department of  Medical, Surgery Sciences and Advanced Technologies “GF Ingrassia,” University of Catania, Via Santa Sofia, 84, 95123  Catania, Italy.",Non-OADS,/arxiv_data1/oa_pdf/88/37/WJT-6-736.PMC5175233.pdf
"CONCLUSION The biopsychosocial illness model provides a conceptual ORIGINAL ARTICLE 736 December 24, 2016 |Volume 6 |Issue 4| WJT|www.wjgnet.comPsychological perspective of medication adherence in  transplantationWorld J Transplant   2016 December 24; 6(4): 736-742 ISSN 2220-3230 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5500/wjt.v6.i4.736World Journal of  Transplantation WJT Observational Study",Non-OADS,/arxiv_data1/oa_pdf/88/37/WJT-6-736.PMC5175233.pdf
World J Transplant   2016; 6(4): 736-742  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/88/37/WJT-6-736.PMC5175233.pdf
com/2220-3230/full/v6/i4/736.htm   DOI: http://dx.doi.org/ 10.5500 / wjt.v6.i4.736 Introduct Ion The theme of therapeutic adherence (TA) plays a central  role in research on education and health promotion[1].,Non-OADS,/arxiv_data1/oa_pdf/88/37/WJT-6-736.PMC5175233.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/88/37/WJT-6-736.PMC5175233.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript   source:   Invited   manuscript Correspondence to: Chutwichai Tovikkai, MD, PhD, MRCS,  FRCST , Clinical Effectiveness Unit, the Royal College of Surgeons  of England, 35-43 Lincoln’s Inn Fields, London WC2A 3PE,  United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/d3/c7/WJT-6-743.PMC5175234.pdf
"METHODS A linked United Kingdom Liver Transplant Audit - Hospital  Episode Statistics database of patients who received a first  adult liver transplant between 1997 and 2010 in England ORIGINAL ARTICLE 743 December 24, 2016 |Volume 6 |Issue 4 | WJT|www.wjgnet.comTime spent in hospital after liver transplantation: Effects of  primary liver disease and comorbidityWorld J Transplant   2016 December 24; 6(4): 743-750 ISSN 2220-3230 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5500/wjt.v6.i4.743World Journal of  Transplantation WJT Observational Study",Non-OADS,/arxiv_data1/oa_pdf/d3/c7/WJT-6-743.PMC5175234.pdf
World J Transplant   2016; 6(4): 743-750  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/d3/c7/WJT-6-743.PMC5175234.pdf
com/2220-3230/full/v6/i4/743.htm   DOI: http://dx.doi.org/ 10.5500 / wjt.v6.i4.743 INTRODUCTION The short-term and long-term survival after liver transplantation has been improving over the last few  decades.,Non-OADS,/arxiv_data1/oa_pdf/d3/c7/WJT-6-743.PMC5175234.pdf
Available from: URL: http://www.hscic.,Non-OADS,/arxiv_data1/oa_pdf/d3/c7/WJT-6-743.PMC5175234.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/d3/c7/WJT-6-743.PMC5175234.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript  source:  Invited  manuscript Correspondence to: Lars Grosse-Wortmann, MD,  Labatt  Family Heart Centre, the Hospital for Sick Children, Department  of Paediatrics, University of Toronto, 555 University Avenue,  Toronto, ON M5G 1X8,  Canada.",Non-OADS,/arxiv_data1/oa_pdf/5e/60/WJT-6-751.PMC5175235.pdf
"Biventricular  volumes, ejection fractions (EFs), T2-weighted signal  intensities, native T1 times, extracellular volumes (ECVs)  and presence of late gadolinium enhancement (LGE) were  compared between patients and controls and between ORIGINAL ARTICLE 751 December 24, 2016 |Volume 6 |Issue 4| WJT|www.wjgnet.comMagnetic resonance imaging of the transplanted pediatric  heart as a potential predictor of rejectionWorld J Transplant   2016 December 24; 6(4): 751-758 ISSN 2220-3230 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5500/wjt.v6.i4.751World Journal of  Transplantation WJT Prospective Study",Non-OADS,/arxiv_data1/oa_pdf/5e/60/WJT-6-751.PMC5175235.pdf
World J Transplant   2016; 6(4): 751-758  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/5e/60/WJT-6-751.PMC5175235.pdf
com/2220-3230/full/v6/i4/751.htm   DOI: http://dx.doi.org/ 10.5500 / wjt.v6.i4.751 INTRODUCTION Acute cellular rejection (ACR) is an immune-mediated  process leading to allograft damage and decreased graft  survival.,Non-OADS,/arxiv_data1/oa_pdf/5e/60/WJT-6-751.PMC5175235.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/5e/60/WJT-6-751.PMC5175235.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Ahmed Halawa, Consultant Transplant  Surgeon, Department of Transplantation, Sheffield Teaching  Hospitals, Herries Road, Sheffield S5 7AU,  United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/d2/75/WJT-6-759.PMC5175236.pdf
"CONCLUSION   Transplant recipients at low immunological risk (pri - mary transplant, low panel reactive antibodies) are EVIDENCE-BASED MEDICINE 759 December 24, 2016 |Volume 6 |Issue 4| WJT|www.wjgnet.comCorticosteroid minimization in renal transplantation: Careful  patient selection enables feasibilityWorld J Transplant   2016 December 24; 6(4): 759-766 ISSN 2220-3230 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5500/wjt.v6.i4.759World Journal of  Transplantation WJT",Non-OADS,/arxiv_data1/oa_pdf/d2/75/WJT-6-759.PMC5175236.pdf
World J Transplant  2016; 6(4): 759-766   Available from: URL: http://www.wjgnet.com/2220-3230/full/ v6/i4/759.htm   DOI: http://dx.doi.org/ 10.5500 /wjt.v6.i4.759 INTRODUCTION  Corticosteroids (CS) have been ubiquitously included  in immunosuppressive regimens since the early days  of renal transplantation (Tx).,Non-OADS,/arxiv_data1/oa_pdf/d2/75/WJT-6-759.PMC5175236.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/d2/75/WJT-6-759.PMC5175236.pdf
"Conflict-of-interest statement:  Part of the manuscript was  published elsewhere (http://researchpub.org/journal/npwt/ archives-vol1-no2.html) in 2014, but was retracted by the author.",Non-OADS,/arxiv_data1/oa_pdf/41/c3/WJT-6-767.PMC5175237.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Badri Man Shrestha, MD, FRCS, FACS,   Sheffield Kidney Institute, Sheffield Teaching Hospitals NHS  Trust, Herries Road, Sheffield S5 7AU,  United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/41/c3/WJT-6-767.PMC5175237.pdf
"Because of the lack of robust  evidence on the safety and efficacy of NPWT in KT  patients, prospective multicentre studies recruiting large  number of patients is recommended to examine the role SYSTEMATIC REVIEWS 767 December 24, 2016 |Volume 6 |Issue 4| WJT|www.wjgnet.comSystematic review of the negative pressure wound therapy  in kidney transplant recipientsWorld J Transplant   2016 December 24; 6(4): 767-773 ISSN 2220-3230 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5500/wjt.v6.i4.767World Journal of  Transplantation WJT",Non-OADS,/arxiv_data1/oa_pdf/41/c3/WJT-6-767.PMC5175237.pdf
World J Transplant   2016; 6(4): 767-773  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/41/c3/WJT-6-767.PMC5175237.pdf
"com/2220-3230/full/v6/i4/767.htm   DOI: http://dx.doi.org/ 10.5500 / wjt.v6.i4.767 INTRODUCTION Kidney transplantation (KT) represents the best treat­ ment modality for patients with end ­stage renal disease,  providing the best outcomes for survival, quality of life and cost ­effectiveness [1].",Non-OADS,/arxiv_data1/oa_pdf/41/c3/WJT-6-767.PMC5175237.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/41/c3/WJT-6-767.PMC5175237.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Tania Janaudis-Ferreira, PhD, School  of Physical and Occupational Therapy, McGill University, 3630  Promenade Sir-William-Osler, Montreal, QC H3G1Y5,  Canada.",Non-OADS,/arxiv_data1/oa_pdf/6e/0f/WJT-6-774.PMC5175238.pdf
"These SYSTEMATIC REVIEWS 774 December 24, 2016 |Volume 6 |Issue 4| WJT|www.wjgnet.comOutcomes in randomized controlled trials of exercise  interventions in solid organ transplantWorld J Transplant   2016 December 24; 6(4): 774-789 ISSN 2220-3230 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5500/wjt.v6.i4.774World Journal of  Transplantation WJT",Non-OADS,/arxiv_data1/oa_pdf/6e/0f/WJT-6-774.PMC5175238.pdf
"World J Transplant  2016; 6(4): 774-789   Available from: URL: http://www.wjgnet.com/2220-3230/full/v6/ i4/774.htm   DOI: http://dx.doi.org/ 10.5500 /wjt.v6.i4.774 INTRODUCTION As the acute morbidity and mortality associated with  solid organ transplantation continues to improve,  interventions that improve quality of life and long- term health outcomes are needed.",Non-OADS,/arxiv_data1/oa_pdf/6e/0f/WJT-6-774.PMC5175238.pdf
Available from: URL: http://www.comet-initiative.org/ 12 World Health Organization .,Non-OADS,/arxiv_data1/oa_pdf/6e/0f/WJT-6-774.PMC5175238.pdf
"World Health Organisation,  2002 Available from: URL: http://www.who.int/classifications/icf/en/ 13 Gilchrist LS , Galantino ML, Wampler M, Marchese VG, Morris GS,  Ness KK.",Non-OADS,/arxiv_data1/oa_pdf/6e/0f/WJT-6-774.PMC5175238.pdf
"A vailable from: URL: http://xueshu.baidu.com/ s?wd=paperuri:(15d7def06167aa5c5228841b35d7d3a7)&filter=sc_long_si gn&sc_ks_para=q%3DComparison+of +T argeted+Lower+ Extremity+Stre ngthening+and+ Usual+Care+Progressive+Ambulation+in+Subjects+Post- Liver+Transplant%3A+A+Randomized+Controlled+Trial &tn=SE_baiduxueshu_c1gjeupa&ie=utf-8&sc_us=11096312547240  331258 29 Hermann TS , Dall CH, Christensen SB, Goetze JP, Prescott E,  Gustafsson F. Effect of high intensity exercise on peak oxygen uptake  and endothelial function in long-term heart transplant recipients.",Non-OADS,/arxiv_data1/oa_pdf/6e/0f/WJT-6-774.PMC5175238.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/6e/0f/WJT-6-774.PMC5175238.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Wisit Cheungpasitporn, MD, Assistant  Professor , Division of Nephrology and Hypertension, Department  of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN  55905, United States.",Non-OADS,/arxiv_data1/oa_pdf/5f/89/WJT-6-790.PMC5175239.pdf
"Although calcium  based stones are the most common kidney stones after META-ANALYSIS 790 December 24, 2016 |Volume 6 |Issue 4| WJT|www.wjgnet.comIncidence of kidney stones in kidney transplant recipients: A  systematic review and meta-analysisWorld J Transplant   2016 December 24; 6(4): 790-797 ISSN 2220-3230 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5500/wjt.v6.i4.790World Journal of  Transplantation WJT",Non-OADS,/arxiv_data1/oa_pdf/5f/89/WJT-6-790.PMC5175239.pdf
"World J Transplant  2016; 6(4):  790-797  Available from: URL: http://www.wjgnet.com/2220-3230/ full/v6/i4/790.htm   DOI: http://dx.doi.org/ 10.5500 /wjt.v6.i4.790 INTRODUCTION Kidney stones are one of the most common metabolic  disorders and urological problems with a prevalence  of 7.2%-7.7% in the adult population, and a ten- year recurrence rate of ≥ 30%[1-4].",Non-OADS,/arxiv_data1/oa_pdf/5f/89/WJT-6-790.PMC5175239.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/5f/89/WJT-6-790.PMC5175239.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Zenichi Morise, MD, PhD, FACS, AGAF,   Department of Surgery, Fujita Health University School of  Medicine, 1-98 Kutsukakecho, Toyoake 470-1192,  Japan.",Non-OADS,/arxiv_data1/oa_pdf/14/c1/WJG-22-10267.PMC5175240.pdf
"Published by Baishideng Publishing  Group Inc. All rights reserved.EDITORIALSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i47.10267 10267 December 21, 2016 |Volume 22 |Issue 47 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 21; 22(47): 10267-10274  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/14/c1/WJG-22-10267.PMC5175240.pdf
World J Gastroenterol  2016; 22(47): 10267-10274   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v22/i47/10267.htm   DOI: http://dx.doi.org/10.3748/wjg.v22.,Non-OADS,/arxiv_data1/oa_pdf/14/c1/WJG-22-10267.PMC5175240.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   7",Non-OADS,/arxiv_data1/oa_pdf/14/c1/WJG-22-10267.PMC5175240.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Benedicte Y De Winter, Professor,  MD, PhD, Laboratory of Experimental Medicine and Pediatrics,  Division of Gastroenterology, University of Antwerp, Universi - teitsplein 1, 2610 Antwerpen,  Belgium.",Non-OADS,/arxiv_data1/oa_pdf/73/04/WJG-22-10275.PMC5175241.pdf
"REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i47.10275 10275 December 21, 2016 |Volume 22 |Issue 47 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 21; 22(47): 10275-10286  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/73/04/WJG-22-10275.PMC5175241.pdf
"World J Gastroenterol  2016; 22(47): 10275-10286  Available  from: URL: http://www.wjgnet.com/1007-9327/full/v22/ i47/10275.htm   DOI: http://dx.doi.org/10.3748/wjg.v22.i47.10275 INTRODUCTION Abdominal pain is a key feature of two major  gastrointestinal disorders, inflammatory bowel  diseases (IBD) and irritable bowel syndrome (IBS).",Non-OADS,/arxiv_data1/oa_pdf/73/04/WJG-22-10275.PMC5175241.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   7",Non-OADS,/arxiv_data1/oa_pdf/73/04/WJG-22-10275.PMC5175241.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Tomohide Hori, PhD, MD, FACS,  Department of Gastrointestinal and General Surgery, Tenriyoro - dusoudanjyo Hospital, 200 Mishima-cho, Tenri 632-8552,  Japan.",Non-OADS,/arxiv_data1/oa_pdf/9c/d2/WJG-22-10287.PMC5175242.pdf
"REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i47.10287 10287 December 21, 2016 |Volume 22 |Issue 47 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 21; 22(47): 10287-10303  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/9c/d2/WJG-22-10287.PMC5175242.pdf
World J  Gastroenterol  2016; 22(47): 10287-10303  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i47/10287.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i47.10287 INTRODUCTION Pure laparoscopic surgery (PLS) has been adopted  in various fields.,Non-OADS,/arxiv_data1/oa_pdf/9c/d2/WJG-22-10287.PMC5175242.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   7",Non-OADS,/arxiv_data1/oa_pdf/9c/d2/WJG-22-10287.PMC5175242.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Nikhil Pai, MD FAAP FRCPC, Assistant  Professor,  Department of Pediatrics, Division of Pediatric  Gastroenterology, McMaster Children’s Hospital, McMaster  University, Hamilton, 1280 Main Street West, HSC 3A21,  Ontario L8N 3Z5, Canada.",Non-OADS,/arxiv_data1/oa_pdf/2c/89/WJG-22-10304.PMC5175243.pdf
"Published by Baishideng Publishing  Group Inc. All rights reserved.MINIREVIEWSSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i47.10304 10304 December 21, 2016 |Volume 22 |Issue 47 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 21; 22(47): 10304-10315  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/2c/89/WJG-22-10304.PMC5175243.pdf
World J  Gastroenterol  2016; 22(47): 10304-10315  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i47/10304.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i47.10304 INTRODUCTION   Fecal microbial transplant (FMT) has garnered in­ creasing attention over the past decade for its role  in the treatment of recurrent Clostridium difficile   (C. difficile ) infection (RCDI).,Non-OADS,/arxiv_data1/oa_pdf/2c/89/WJG-22-10304.PMC5175243.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   7",Non-OADS,/arxiv_data1/oa_pdf/2c/89/WJG-22-10304.PMC5175243.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Dr. Simon R Bramhall,  Department of  Surgery, the Wye Valley NHS Trust, Vaughan Building/Ruckhall  La, Hereford HR1 2ER,  United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/be/66/WJG-22-10316.PMC5175244.pdf
"World J Gastroenterol  2016; 22(47): 10316-10324  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v22/i47/10316.htm    DOI: http://dx.doi.org/10.3748/wjg.v22.i47.10316MINIREVIEWSSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i47.10316 10316 December 21, 2016 |Volume 22 |Issue 47 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 21; 22(47): 10316-10324  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/be/66/WJG-22-10316.PMC5175244.pdf
"Available from:  URL: http://www.nice.org.uk/guidance/IPG496/chapter/1- Recommendations 60 Duits LC , Phoa KN, Curvers WL, Ten Kate FJ, Meijer GA,  Seldenrijk CA, Offerhaus GJ, Visser M, Meijer SL, Krishnadath  KK, Tijssen JG, Mallant-Hent RC, Bergman JJ.",Non-OADS,/arxiv_data1/oa_pdf/be/66/WJG-22-10316.PMC5175244.pdf
Available from:  URL: http://www.emedmd.com 77 Barrett’s Oesophagus.,Non-OADS,/arxiv_data1/oa_pdf/be/66/WJG-22-10316.PMC5175244.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   7",Non-OADS,/arxiv_data1/oa_pdf/be/66/WJG-22-10316.PMC5175244.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Orsolya Galamb, PhD,  2nd Department of  Internal Medicine, Semmelweis University, Szentkirályi str 46,  H-1088 Budapest, Hungary.",Non-OADS,/arxiv_data1/oa_pdf/00/e2/WJG-22-10325.PMC5175245.pdf
"Among the differentially methylated age- related genes, secreted frizzled related protein 1  (SFRP1 ) promoter methylation was further investigated  in colonic tissue from 8 healthy adults, 19 nor mal Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i47.10325 10325 December 21, 2016 |Volume 22 |Issue 47 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 21; 22(47): 10325-10340  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/00/e2/WJG-22-10325.PMC5175245.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   7",Non-OADS,/arxiv_data1/oa_pdf/00/e2/WJG-22-10325.PMC5175245.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Dr. Runu Chakravarty,  ICMR Virus  Unit, Kolkata, ID and BG Hospital Campus, GB 4, Kolkata  700010, India.",Non-OADS,/arxiv_data1/oa_pdf/56/e3/WJG-22-10341.PMC5175246.pdf
"Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i47.10341 10341 December 21, 2016 |Volume 22 |Issue 47 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 21; 22(47): 10341-10352  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/56/e3/WJG-22-10341.PMC5175246.pdf
World J Gastroenterol  2016; 22(47): 10341-10352   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v22/i47/10341.htm   DOI: http://dx.doi.org/10.3748/wjg.v22.,Non-OADS,/arxiv_data1/oa_pdf/56/e3/WJG-22-10341.PMC5175246.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   7",Non-OADS,/arxiv_data1/oa_pdf/56/e3/WJG-22-10341.PMC5175246.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Fu-Chen Huang, MD, Associate  Professor,  Department of Pediatrics, Kaohsiung Chang Gung  Memorial Hospital and Chang Gung University College of  Medicine, 123, Ta-pei Road, Niao-sung District, Kaohsiung 833,  Taiwan.",Non-OADS,/arxiv_data1/oa_pdf/c9/59/WJG-22-10353.PMC5175247.pdf
"Thus, active vitamin D  may enhance autophagy but suppress inflammatory IL- 1β expression in Salmonella -infected IECs.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i47.10353 10353 December 21, 2016 |Volume 22 |Issue 47 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 21; 22(47): 10353-10363  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/c9/59/WJG-22-10353.PMC5175247.pdf
World J Gastroenterol  2016; 22(47): 10353-10363   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v22/i47/10353.htm   DOI: http://dx.doi.org/10.3748/wjg.v22.,Non-OADS,/arxiv_data1/oa_pdf/c9/59/WJG-22-10353.PMC5175247.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   7",Non-OADS,/arxiv_data1/oa_pdf/c9/59/WJG-22-10353.PMC5175247.pdf
"see: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Wei-Dong Gao, MD, Associate  professor,  Department of general surgery, Fudan University  affiliated zhongshan Hospital, No.",Non-OADS,/arxiv_data1/oa_pdf/b2/c8/WJG-22-10364.PMC5175248.pdf
"MTT and Transwell experiments  indicated that the proliferation rate and invasive ability  of stable overexpressed gastric cancer cells was faster  than in cells transfected with Lv-NC and blank control Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i47.10364 10364 December 21, 2016 |Volume 22 |Issue 47 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 21; 22(47): 10364-10370  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/b2/c8/WJG-22-10364.PMC5175248.pdf
World J Gastroenterol  2016; 22(47): 10364-10370   available from: URL: http://www.wjgnet.com/1007-9327/full/ v22/i47/10364.htm   DOI: http://dx.doi.org/10.3748/wjg.v22.,Non-OADS,/arxiv_data1/oa_pdf/b2/c8/WJG-22-10364.PMC5175248.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   7",Non-OADS,/arxiv_data1/oa_pdf/b2/c8/WJG-22-10364.PMC5175248.pdf
"Narrowing of a  gastric sleeve includes: inability to pass a 9.6 mm   gastroscope due to stenosis or sharp angulation or  spiral hindering its passage.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i47.10371 10371 December 21, 2016 |Volume 22 |Issue 47 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 21; 22(47): 10371-10379  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/1f/c2/WJG-22-10371.PMC5175249.pdf
"World J  Gastroenterol  2016; 22(47): 10371-10379  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i47/10371.htm  DOI:  http://dx.doi.org/10.3748/wjg.v22.i47.10371 INTRODUCTION Obesity is a leading predisposing factor internationally  for multiple chronic diseases[1] including hyperchole­ sterolemia, type 2 diabetes mellitus, hypertension,  osteoarthritis, asthma, and decreased health status.",Non-OADS,/arxiv_data1/oa_pdf/1f/c2/WJG-22-10371.PMC5175249.pdf
"WHO/NHD/99/13, 1999: 1-52 Available from:  URL: http://www.who.int/nutrition/publications/emergencies/  WHO_NHD_99.13/en/ 24 Shah HN , Bal BS, Finelli FC, Koch TR.",Non-OADS,/arxiv_data1/oa_pdf/1f/c2/WJG-22-10371.PMC5175249.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   7",Non-OADS,/arxiv_data1/oa_pdf/1f/c2/WJG-22-10371.PMC5175249.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/Manuscript source:  Unsolicited manuscript Correspondence to: Eran Israeli, MD, MHA, Head,  IBD  Unit, Institute of Gastroenterology and Liver Diseases, Hadassah- Hebrew University Medical Center, POB 12000, Jerusalem  91120, Israel.",Non-OADS,/arxiv_data1/oa_pdf/89/c8/WJG-22-10380.PMC5175250.pdf
"Multivariate analysis for  the prediction of abdominal surgery was calculated via  Generalized Linear Models.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i47.10380 10380 December 21, 2016 |Volume 22 |Issue 47 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 21; 22(47): 10380-10387  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/89/c8/WJG-22-10380.PMC5175250.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   7",Non-OADS,/arxiv_data1/oa_pdf/89/c8/WJG-22-10380.PMC5175250.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Liang Chen, Professor,  Wenzhou  Medical University, Ouhai District, Wenzhou 325000, Zhejiang  Province, China.",Non-OADS,/arxiv_data1/oa_pdf/f9/6f/WJG-22-10388.PMC5175251.pdf
"Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i47.10388 10388 December 21, 2016 |Volume 22 |Issue 47 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 21; 22(47): 10388-10397  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/f9/6f/WJG-22-10388.PMC5175251.pdf
"World J Gastroenterol  2016; 22(47): 10388 ­10397  Available from:  URL: http://www.wjgnet.com/1007 ­9327/full/v22/i47/10388.htm    DOI: http://dx.doi.org/10.3748/wjg.v22.i47.10388 INTRODUCTION Viral hepatitis, including hepatitis A, B, C, D and E,  causing acute or chronic liver diseases, represents  severe threats to public health worldwide.",Non-OADS,/arxiv_data1/oa_pdf/f9/6f/WJG-22-10388.PMC5175251.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   7",Non-OADS,/arxiv_data1/oa_pdf/f9/6f/WJG-22-10388.PMC5175251.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Roman Schumann, MD, Professor  of Anesthesiology,  Department of Anesthesiology and  Perioperative Medicine,  Tufts Medical Center, 800 Washington  Street, Boston, MA 02111,  United States.",Non-OADS,/arxiv_data1/oa_pdf/fa/82/WJG-22-10398.PMC5175252.pdf
"rschumann@tuftmedicalcenter.o rg Telephone:  +1-617-6366044 Fax:  +1-617-6368384 Received:  August 19, 2016 Peer-review started:  August 19, 2016 First decision:  October 20, 2016 Revised:  November 3, 2016 Accepted:  November 28, 2016 Article in press:  November 28, 2016 Published online: December 21, 2016Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i47.10398 10398 December 21, 2016 |Volume 22 |Issue 47 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 21; 22(47): 10398-10405  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/fa/82/WJG-22-10398.PMC5175252.pdf
World J Gastroenterol  2016; 22(47):  10398-10405  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/fa/82/WJG-22-10398.PMC5175252.pdf
com/1007-9327/full/v22/i47/10398.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fa/82/WJG-22-10398.PMC5175252.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   7",Non-OADS,/arxiv_data1/oa_pdf/fa/82/WJG-22-10398.PMC5175252.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Ghassan El-Haddad, MD,  Department  of Interventional Radiology, H Lee Moffitt Cancer Center and  Research Institute, 12902 Magnolia Drive, Tampa, FL 33612,  United States.",Non-OADS,/arxiv_data1/oa_pdf/1c/4d/WJG-22-10406.PMC5175253.pdf
"Patients were Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i47.10406 10406 December 21, 2016 |Volume 22 |Issue 47 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 21; 22(47): 10406-10414  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/1c/4d/WJG-22-10406.PMC5175253.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   7",Non-OADS,/arxiv_data1/oa_pdf/1c/4d/WJG-22-10406.PMC5175253.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Ke-Zhou Li, PhD,  Department of  Pancreatic Surgery, West China Hospital of Sichuan University,  37 Guoxuexiang, Chengdu 610041, Sichuan Province,  China.",Non-OADS,/arxiv_data1/oa_pdf/c1/f6/WJG-22-10415.PMC5175254.pdf
"The  original Frey’s procedure resulted in significantly better Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i47.10415 10415 December 21, 2016 |Volume 22 |Issue 47 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 21; 22(47): 10415-10423  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/c1/f6/WJG-22-10415.PMC5175254.pdf
"World J  Gastroenterol  2016; 22(47): 10415 ­10423  Available from: URL:  http://www.wjgnet.com/1007 ­9327/full/v22/i47/10415.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i47.10415 INTRODUCTION Chronic pancreatitis (CP) is an inflammatory disease  of the pancreas characterized by abdominal pain,  repeated episodes of acute pancreatitis and fibrotic  destruction of the organ, resulting in endocrine and  exocrine insufficiency[1].",Non-OADS,/arxiv_data1/oa_pdf/c1/f6/WJG-22-10415.PMC5175254.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   7",Non-OADS,/arxiv_data1/oa_pdf/c1/f6/WJG-22-10415.PMC5175254.pdf
"Here we present the short-term outcomes  and evaluate the safety and feasibility of this new  technique.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i47.10424 10424 December 21, 2016 |Volume 22 |Issue 47 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 21; 22(47): 10424-10431  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/33/a2/WJG-22-10424.PMC5175255.pdf
"World J  Gastroenterol 2016; 22(47): 10424-10431  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i47/10424.htm  DOI:  http://dx.doi.org/10.3748/wjg.v22.i47.10424 INTRODUCTION Pancreatoduodenectomy is considered as the standard  approach for the resection of duodenal tumors[1,2].",Non-OADS,/arxiv_data1/oa_pdf/33/a2/WJG-22-10424.PMC5175255.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   7",Non-OADS,/arxiv_data1/oa_pdf/33/a2/WJG-22-10424.PMC5175255.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Marta Maia Bosca-Watts, PhD, MD,  Inflammatory Bowel Disease Unit, Digestive Disease Department,  University of Valencia, University Clinic Hospital of Valencia,  Avda.",Non-OADS,/arxiv_data1/oa_pdf/1c/11/WJG-22-10432.PMC5175256.pdf
"METHODS We conducted an observational, prospective and multi-Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i47.10432 10432 December 21, 2016 |Volume 22 |Issue 47 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 21; 22(47): 10432-10439  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/1c/11/WJG-22-10432.PMC5175256.pdf
Available from: URL: http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/1c/11/WJG-22-10432.PMC5175256.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   7",Non-OADS,/arxiv_data1/oa_pdf/1c/11/WJG-22-10432.PMC5175256.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Mitsushige Sugimoto, MD, PhD,  Division of Digestive Endoscopy, Shiga University of Medical  Science Hospital, Seta Tsukinowa-cho, Otsu, Shiga 520-2192,  Japan.",Non-OADS,/arxiv_data1/oa_pdf/22/0d/WJG-22-10440.PMC5175257.pdf
"METHODS One hundred eights patients who received hemodialysis  and 13 non-hemodialysis H. pylori -negative controls Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i47.10440 10440 December 21, 2016 |Volume 22 |Issue 47 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 21; 22(47): 10440-10449  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/22/0d/WJG-22-10440.PMC5175257.pdf
"World J  Gastroenterol  2016; 22(47): 10440-10449  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i47/10440.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i47.10440 INTRODUCTION The number of end-stage kidney disease patients  receiving hemodialysis is more than 1.1 million world - wide, and the size of this population is expanding at  a rate of 7% per year with the progress in medical  and hemodialysis machine technique[1].",Non-OADS,/arxiv_data1/oa_pdf/22/0d/WJG-22-10440.PMC5175257.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   7",Non-OADS,/arxiv_data1/oa_pdf/22/0d/WJG-22-10440.PMC5175257.pdf
"The  proportions of direct and indirect costs were similar Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i47.10450 10450 December 21, 2016 |Volume 22 |Issue 47 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 21; 22(47): 10450-10460  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/42/55/WJG-22-10450.PMC5175258.pdf
World J Gastroenterol 2016; 22(47):  10450-10460  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/42/55/WJG-22-10450.PMC5175258.pdf
com/1007-9327/full/v22/i47/10450.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/42/55/WJG-22-10450.PMC5175258.pdf
Available from: URL: http://www.stats.gov.,OADS,/arxiv_data1/oa_pdf/42/55/WJG-22-10450.PMC5175258.pdf
Available from: URL: http://www.nhfpc.gov.cn/zwgkzt/tjnj/ list.shtml 37 The People’s Bank of China .,Non-OADS,/arxiv_data1/oa_pdf/42/55/WJG-22-10450.PMC5175258.pdf
Available from: URL:  http://srh.bankofchina.com/search/whpj/ search.jsp 38 Academy of Managed Care Pharmacy .,Non-OADS,/arxiv_data1/oa_pdf/42/55/WJG-22-10450.PMC5175258.pdf
Available from: URL: http://www.amcp.,Non-OADS,/arxiv_data1/oa_pdf/42/55/WJG-22-10450.PMC5175258.pdf
"Available from: URL:  https://www.nice.org.uk/article/pmg9/chapter/Foreword 40 Onukwugha E , McRae J, Kravetz A, Varga S, Khairnar R, Mullins  CD.",Non-OADS,/arxiv_data1/oa_pdf/42/55/WJG-22-10450.PMC5175258.pdf
Available from:  URL: http://health.costhelper.com/colonoscopy.html 57 Private Healthcare UK .,Non-OADS,/arxiv_data1/oa_pdf/42/55/WJG-22-10450.PMC5175258.pdf
"Available  from: URL: http://www.privatehealth.co.uk/hospitaltreatment/  whatdoesitcost/colonoscopy/ 58 Nellesen D , Yee K, Chawla A, Lewis BE, Carson RT.",Non-OADS,/arxiv_data1/oa_pdf/42/55/WJG-22-10450.PMC5175258.pdf
Available from: URL: http://data.bls.,OADS,/arxiv_data1/oa_pdf/42/55/WJG-22-10450.PMC5175258.pdf
"Available from: URL: http://www.ons.gov.uk/ons/ rel/ashe/annual-survey-of-hours-and-earnings/2012-provisional- results/index.html 62 Maxion-Bergemann S , Thielecke F, Abel F, Bergemann R.  Costs of irritable bowel syndrome in the UK and US.",Non-OADS,/arxiv_data1/oa_pdf/42/55/WJG-22-10450.PMC5175258.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   7",Non-OADS,/arxiv_data1/oa_pdf/42/55/WJG-22-10450.PMC5175258.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Giuseppe Mamone, MD,  Department  of Diagnostic and Therapeutic Services, IRCCS ISMETT  (Mediterranean Institute for Transplantation and Advanced  Specialized Therapies), via Tricomi 5, 90127 Palermo,  Italy.",Non-OADS,/arxiv_data1/oa_pdf/7f/86/WJG-22-10461.PMC5175259.pdf
"The present case suggests that a young patient  with giant FNH should be managed conservatively CASE REPORT 10461 December 21, 2016 |Volume 22 |Issue 47 | WJG|www.wjgnet.comSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i47.10461World J Gastroenterol   2016 December 21; 22(47): 10461-10464  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/7f/86/WJG-22-10461.PMC5175259.pdf
World J Gastroenterol  2016;  22(47): 10461-10464  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/7f/86/WJG-22-10461.PMC5175259.pdf
com/1007-9327/full/v22/i47/10461.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7f/86/WJG-22-10461.PMC5175259.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   7",Non-OADS,/arxiv_data1/oa_pdf/7f/86/WJG-22-10461.PMC5175259.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Unsolicited manuscript Correspondence to: Maartje M van de Meeberg, MD,   Department of Gastroenterology and Hepatology, Jeroen Bosch  Hospital, Henri Dunantstraat 1, 5200 ME ’s-Hertogenbosch,  The Netherlands.",Non-OADS,/arxiv_data1/oa_pdf/49/d3/WJG-22-10465.PMC5175260.pdf
"maartjevdm@gmail.co m Telephone:  +31-73-5532000 Fax:  +31-73-5538804CASE REPORT 10465 December 21, 2016 |Volume 22 |Issue 47 | WJG|www.wjgnet.comSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i47.10465World J Gastroenterol   2016 December 21; 22(47): 10465-10470  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/49/d3/WJG-22-10465.PMC5175260.pdf
World J Gastroenterol  2016; 22(47): 10465-10470  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v22/i47/10465.htm    DOI: http://dx.doi.org/10.3748/wjg.v22.i47.10465 INTRODUCTION Hepatosplenic T-cell lymphoma (HSTCL) is a rare  subtype (1%) of peripheral T-cell non-Hodgkin  lymphomas[1].,Non-OADS,/arxiv_data1/oa_pdf/49/d3/WJG-22-10465.PMC5175260.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   7",Non-OADS,/arxiv_data1/oa_pdf/49/d3/WJG-22-10465.PMC5175260.pdf
"Key words:  Azathioprine; Granulomatous inflammation;  Prednisolone; Gastric sarcoidosis; Helicobacter pyloriSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i47.10471 10471 December 21, 2016 |Volume 22 |Issue 47 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 December 21; 22(47): 10471-10476 ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/37/b3/WJG-22-10471.PMC5175261.pdf
World J Gastroenterol  2016; 22(47): 10471-10476   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v22/i47/10471.htm   DOI: http://dx.doi.org/10.3748/wjg.v22.,Non-OADS,/arxiv_data1/oa_pdf/37/b3/WJG-22-10471.PMC5175261.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   7",Non-OADS,/arxiv_data1/oa_pdf/37/b3/WJG-22-10471.PMC5175261.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/   © The Author(s) 2016",Non-OADS,/arxiv_data1/oa_pdf/7d/39/srep39234.PMC5175264.pdf
The set of features were then used to predict RAG1 levels using non-linear support vector regression (SVR) (35) implemented by the R package e1071SVM function (https://cran.r-project.org/web/packages/e1071/vignettes/ svmdoc.pdf ) withradial basis function (rbf) kernel and default parameters.,OADS,/arxiv_data1/oa_pdf/91/fc/gkw633.PMC5175335.pdf
These peaks were thenclusteredaccordingtotheabovematrixbyhierarchicalclusteringusing pheatmap R(https://cran.rproject.org/web/ packages/pheatmap/pheatmap.pdf )withEuclidiandistance andcompletelinkage.Anon-parametricWilcoxon-testwasused to compare the RAG1 levels in two clusters of peaks (Figure5B).,OADS,/arxiv_data1/oa_pdf/91/fc/gkw633.PMC5175335.pdf
NIS Elements 3.0 software (Nikon) was used foracquisition and Fiji ( http://fiji.sc ) for analysis.,OADS,/arxiv_data1/oa_pdf/45/c5/gkw664.PMC5175341.pdf
Numbers of FISH dots were quantified counting all cells positive for staining.Colocalizationwasscoredincellnucleipositiveforboth fluorescent signals when they overlapped while using thesamecontrastadjustmentsthroughoutallimages.Scor- ing was performed by direct optical observation using Fiji(http://fiji.sc ).Foreachanalysisimagesfromatleasttwoin- dependentreplicas werecombined.,OADS,/arxiv_data1/oa_pdf/45/c5/gkw664.PMC5175341.pdf
(A) Bioinformatic RNA structure prediction using RNAfold webserver ( http://rna.tbi.univie.ac.at/cgi-bin/RNAfold.cgi ).,OADS,/arxiv_data1/oa_pdf/45/c5/gkw664.PMC5175341.pdf
"(1997–2016)NationalInstitutesofHealth,Bethesda, Maryland, http://imagej.nih.gov/ij/ .",Non-OADS,/arxiv_data1/oa_pdf/1d/ef/gkw673.PMC5175343.pdf
"The code for performing all the analyses in this paper is available at http://sweb.uky.edu/ ~cwa236/ NanoStringDiff/ .The NanoString nCounter data, referred to as the Horbinski data, are available at Gene Expression Omnibus under accession number GSE80821.",OADS,/arxiv_data1/oa_pdf/b5/58/gkw677.PMC5175344.pdf
EXCAVATOR2 is freely available athttp://sourceforge.net/projects/excavator2tool/ .,OADS,/arxiv_data1/oa_pdf/cb/7e/gkw695.PMC5175347.pdf
The new methodological advances have beenincludedinanewversionofthetoolthatisfreelyavail- able athttp://sourceforge.net/projects/excavator2tool/ .,Non-OADS,/arxiv_data1/oa_pdf/cb/7e/gkw695.PMC5175347.pdf
EXCAVATOR2 is freely available at http://sourceforge.net/projects/excavator2tool/ .,OADS,/arxiv_data1/oa_pdf/cb/7e/gkw695.PMC5175347.pdf
"9864NucleicAcidsResearch,2016,Vol.44,No.20 tRNA8fMet-CAT, tRNA12Val-CAC, tRNA37Asn-GTTand tRNA31Asp-GTC(Supplementary Figure S2A-E) (the tRNAnomenclatureusedisinaccordancewithGtRNAdb: http://gtrnadb.ucsc.edu and the reads have been plotted as per million).",OADS,/arxiv_data1/oa_pdf/b5/b2/gkw781.PMC5175351.pdf
"thesize their corresponding RNAs, taking the highly con- servedregionsoftheInt2sequencein ChtopmRNAamong 100 vertebrates into account (UCSC Genome browser; http://genome.ucsc.edu/ ) (Supplementary Figure S6B and S6C).",OADS,/arxiv_data1/oa_pdf/98/33/gkw831.PMC5175361.pdf
"To predict the secondary structure of the Int2-1-2-2 region, we used the RNAfold webserver ( http://rna.tbi.",OADS,/arxiv_data1/oa_pdf/98/33/gkw831.PMC5175361.pdf
"Conformational and environmental analysis AverageDNAconformation,DNAconformationalfluctu- ationsandiondistributionsaroundtheprotein /DNAcom- plexes during the MD simulations were analyzed with the Curves+ program ( 23) and the Canal and Canion utilities (https://bisi.ibcp.fr/tools/curves plus/).Inadditiontointra- bp, inter-bp and bp-axis parameters Curves+ can calculate groove geometries and the overall bend of a helical axis.",OADS,/arxiv_data1/oa_pdf/02/7c/gkw841.PMC5175364.pdf
G ECKO3 is available online at http://bio.informatik.uni- jena.de/software/gecko3/ .,OADS,/arxiv_data1/oa_pdf/af/e9/gkw843.PMC5175365.pdf
"In addition, we supply apythonscripttopreparefullGenBankfilesforall-versus-all blasting ( 29), clustering the results with TransClust ( 30) (http://transclust.mmci.uni-saarland.de/ )andtransforming theoutputto theG ECKO3input format.",OADS,/arxiv_data1/oa_pdf/af/e9/gkw843.PMC5175365.pdf
"The STRING database ( 36)(http://string-db.org/ ) clusters proteins into orthologous groups, namely manually cu- rated‘clustersoforthologousgroups’(COG)( 37)and‘non- supervised orthologous groups’ (NOG).",OADS,/arxiv_data1/oa_pdf/af/e9/gkw843.PMC5175365.pdf
The dataset is available in the G ECKO3inputformatfrom http://bio.informatik.uni-jena.,OADS,/arxiv_data1/oa_pdf/af/e9/gkw843.PMC5175365.pdf
"The bacteriophage RB69 DNApol is one of the most studied at the structural and functional levels, and there are currently 122 entries in the protein data bank(http://www.rcsb.org/pdb/results/results.do?outformat= &qrid=C9789076&tabtoshow=Current )(30,36–40).",OADS,/arxiv_data1/oa_pdf/a5/dd/gkw875.PMC5175367.pdf
"For human DNApol /H9254and/H9280, the model of the 3D-structure was built using‘Swiss-Modelworkspace’( http://swissmodel.expasy.org/ ).AllthestructureswerevisualizedandthepicturesgeneratedusingPyMolDelanoSoftware.",OADS,/arxiv_data1/oa_pdf/a5/dd/gkw875.PMC5175367.pdf
"For (i), we wrote a Python script (avail-able athttps://github.com/flosopher/floscripts/blob/master/ genutils/InsertPrimerDesigner.py )thatdesignsthetwoout- ward facing MIP primers for each site while attempting tokeep the melting temperatures of both as similar as pos- sible (Supplementary Figure S4).",OADS,/arxiv_data1/oa_pdf/17/51/gkw930.PMC5175372.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/64/cb/10.1177_2325967116673560.PMC5175415.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/fb/91/10.1177_2325967116673797.PMC5175416.pdf
http://www.ors.org/Transactions/58/ 0846.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fb/91/10.1177_2325967116673797.PMC5175416.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/b8/1d/10.1177_2325967116673579.PMC5175417.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits anynoncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.BRAIN CONNECTIVITY Volume 6, Number 10, 2016 Mary Ann Liebert, Inc.DOI: 10.1089/brain.2016.0454 735",Non-OADS,/arxiv_data1/oa_pdf/6f/94/brain.2016.0454.PMC5175424.pdf
"http://arxiv.org/ abs/1601.03236 van Dijk KRA, Sabuncu MR, Buckner RL.",Non-OADS,/arxiv_data1/oa_pdf/6f/94/brain.2016.0454.PMC5175424.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.TISSUE ENGINEERING: Part A Volume 22, Numbers 23 and 24, 2016 Mary Ann Liebert, Inc.DOI: 10.1089/ten.tea.2016.0189 1367",Non-OADS,/arxiv_data1/oa_pdf/10/bc/ten.tea.2016.0189.PMC5175426.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, dis-tribution, and reproduction in any medium, provided the original author(s) and the source are credited.AIDS RESEARCH AND HUMAN RETROVIRUSES Volume 32, Number 12, 2016Mary Ann Liebert, Inc.DOI: 10.1089/aid.2016.0182 1187",Non-OADS,/arxiv_data1/oa_pdf/0d/c8/aid.2016.0182.PMC5175433.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.AIDS RESEARCH AND HUMAN RETROVIRUSES Volume 32, Number 12, 2016Mary Ann Liebert, Inc.DOI: 10.1089/aid.2015.0349 1180",Non-OADS,/arxiv_data1/oa_pdf/38/cd/aid.2015.0349.PMC5175434.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, distribution, and reproductio n in any medium, provided the original author(s) and the source are credited.",Non-OADS,/arxiv_data1/oa_pdf/17/92/adt.2016.742.PMC5175440.pdf
MATERIALS AND METHODS ClinicalTrials.gov and HTML Contents ClinicalTrials.gov is a registry and results database of both publicly and privately supported clinical studies of human participants around the world (https://clinicaltrials.gov).,OADS,/arxiv_data1/oa_pdf/17/92/adt.2016.742.PMC5175440.pdf
J Am Med Inform Assoc 2016; DOI: http://dx.doi.org/10.1093/jamia/ocw003.,OADS,/arxiv_data1/oa_pdf/17/92/adt.2016.742.PMC5175440.pdf
"http://dx.doi.org/10.18383/j.tom.2015.00151 ), errors were discovered in Table 2 .",Non-OADS,/arxiv_data1/oa_pdf/48/58/tom238.PMC5175480.pdf
"Published by Grapho Publications, LLC This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/48/58/tom238.PMC5175480.pdf
ISSN 2379-1381 http://dx.doi.org/10.18383/j.tom.2016.00262 238 TOMOGRAPHY.ORG | VOLUME 2 NUMBER 3 |SEPTEMBER 2016,Non-OADS,/arxiv_data1/oa_pdf/48/58/tom238.PMC5175480.pdf
"© European Crohn’s and Colitis Organisation (ECCO) 2016.118Journal of Crohn's and Colitis , 2017, 118–127 doi:10.1093/ecco-jcc/jjw127 Advance Access publication July 5, 2016 Review Article This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b7/59/jjw127.PMC5175491.pdf
"84Journal of Crohn's and Colitis , 2017, 84–91 doi:10.1093/ecco-jcc/jjw132 Advance Access publication July 27, 2016 Original Article This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0b/75/jjw132.PMC5175492.pdf
"© European Crohn’s and Colitis Organisation (ECCO) 2016.35Journal of Crohn's and Colitis , 2017, 35–46 doi:10.1093/ecco-jcc/jjw133 Advance Access publication July 20, 2016 Original Article This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/32/46/jjw133.PMC5175493.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious DiseasesThis is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.11.010,Non-OADS,/arxiv_data1/oa_pdf/0d/26/main.PMC5175988.pdf
massiliensis ’strain Marseille-P2828Tare available online ( http://www.mediterranee-infection.com/ article.php?laref=256&titre=urms-database ).,Non-OADS,/arxiv_data1/oa_pdf/0d/26/main.PMC5175988.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,15,4 6 –48 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/0d/26/main.PMC5175988.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,15,4 6 –48 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/0d/26/main.PMC5175988.pdf
This is an open access article under the CCBY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/44/b3/main.PMC5175989.pdf
1936-5233/17http://dx.doi.org/10.1016/j.tranon.2016.11.007,OADS,/arxiv_data1/oa_pdf/44/b3/main.PMC5175989.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Social marketing MilkSegmented regressionMass communicationPaid advertisingProgram evaluation 1.,Non-OADS,/arxiv_data1/oa_pdf/d4/a8/main.PMC5175990.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.11.017 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/a8/main.PMC5175990.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d4/a8/main.PMC5175990.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/d4/a8/main.PMC5175990.pdf
http://dx.doi.org/10.1016/j.ypmed.2004.02.013 .,OADS,/arxiv_data1/oa_pdf/d4/a8/main.PMC5175990.pdf
http://dx.doi.org/10.4278/ajhp.,Non-OADS,/arxiv_data1/oa_pdf/d4/a8/main.PMC5175990.pdf
http://dx.doi.org/10.1177/1090198106290621 .,Non-OADS,/arxiv_data1/oa_pdf/d4/a8/main.PMC5175990.pdf
http://dx.doi.org/10.1006/pmed.1998.0570 .,Non-OADS,/arxiv_data1/oa_pdf/d4/a8/main.PMC5175990.pdf
http://www.ers.usda.gov/data- products/dairy-data.aspx (Accessed 17 June 2014).,Non-OADS,/arxiv_data1/oa_pdf/d4/a8/main.PMC5175990.pdf
Dietary Guidelines of Americans (http://www.health.gov/dietaryguidelines/ 2010.asp.,Non-OADS,/arxiv_data1/oa_pdf/d4/a8/main.PMC5175990.pdf
(http://health.gov/ dietaryguidelines/2015/guidelines/.,Non-OADS,/arxiv_data1/oa_pdf/d4/a8/main.PMC5175990.pdf
http://dx.doi.org/10.1046/j.1365-2710.2002.00430.x .,OADS,/arxiv_data1/oa_pdf/d4/a8/main.PMC5175990.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Uterine serous carcinoma Trastuzumab-emtansineHER2/neu 1.,Non-OADS,/arxiv_data1/oa_pdf/ba/94/main.PMC5175991.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gore.2016.12.003 2352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ba/94/main.PMC5175991.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ba/94/main.PMC5175991.pdf
"NIH Clinical Trials, d. Evaluation of carboplatin/paclitaxel with or without trastuzumab (Herceptin) in uterine serous cancer http://clinicaltrials.gov/ct2/show/NCT01367002 .",Non-OADS,/arxiv_data1/oa_pdf/ba/94/main.PMC5175991.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Magnetic resonance imaging Fluid-attenuated inversion recovery Multiple sclerosisAutomated lesion segmentationInter-rater variabilityDice coef ﬁcient 1.,Non-OADS,/arxiv_data1/oa_pdf/53/bd/main.PMC5175993.pdf
http://dx.doi.org/10.1016/j.nicl.2016.11.020 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/53/bd/main.PMC5175993.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/53/bd/main.PMC5175993.pdf
"At the same time, Schmidt and co-workers ( Schmidt et al., 2012 ) released the lesion segmentation toolbox (LST) ( http://www.applied-statistics.de/lst.htm ) which runs under the Statistical Parametric Mapping (SPM8) software package (http://www.",OADS,/arxiv_data1/oa_pdf/53/bd/main.PMC5175993.pdf
Automated lesion detection was performed with the former and lat- est lesion segmentation toolbox (LST) ( http://www.applied-statistics.,OADS,/arxiv_data1/oa_pdf/53/bd/main.PMC5175993.pdf
"7–10 See Clinical PerspectiveOriginal Article Circ Heart Fail is available at http://circheartfailure.ahajournals.org DOI: 10.1161/CIRCHEARTFAILURE.116.003662One-Year Outcomes After Transcatheter Insertion of an  Interatrial Shunt Device for the Management of Heart  Failure With Preserved Ejection Fraction David M. Kaye, MD, PhD; Gerd Hasenfuß, MD; Petr Neuzil, MD; Martijn C. Post, MD;   Robert Doughty, MD; Jean-Noël Trochu, MD, PhD; Adam Kolodziej, MD;   Ralf Westenfeld, MD; Martin Penicka, MD; Mark Rosenberg, MD, PhD; Antony Walton, MD;   David Muller, MD; Darren Walters, MD; Jorg Hausleiter, MD; Philip Raake, MD;   Mark C. Petrie, MD; Martin Bergmann, MD, PhD; Guillaume Jondeau, MD; Ted Feldman, MD;   Dirk J. van Veldhuisen, MD; Piotr Ponikowski, MD, PhD; Frank E. Silvestry, MD;   Dan Burkhoff, MD, PhD; Christopher Hayward, MD Background—Heart failure with preserved ejection fraction has a complex pathophysiology and remains a therapeutic  challenge.",Non-OADS,/arxiv_data1/oa_pdf/a2/ba/hhf-9-e003662.PMC5175994.pdf
Clinical Trial Registration—URL: https://www.clinicaltrials.gov .,Non-OADS,/arxiv_data1/oa_pdf/a2/ba/hhf-9-e003662.PMC5175994.pdf
The Data Supplement is available at http://circheartfailure.ahajournals.org/lookup/suppl/doi:10.1161/CIRCHEARTFAILURE.116.003662/-/DC1.,OADS,/arxiv_data1/oa_pdf/a2/ba/hhf-9-e003662.PMC5175994.pdf
"Lars-Petter Granana,b aDepartment of pain management and research, Oslo university hospital, Oslo, Norway bFaculty of Health and Social Sciences, University College of Southeast Norway, Drammen, Norway E-mail address: lpgranan@gmail.com (L.P.Granan) http://dx.doi.org/10.1097/j.pain.0000000000000735 This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/17/f7/jop-158-179.PMC5175995.pdf
http://dx.doi.org/10.1097/j.pain.0000000000000733 110 K.E.,Non-OADS,/arxiv_data1/oa_pdf/5f/01/jop-158-110.PMC5175996.pdf
"Of the 9665 people responding to both the baseline and the 3-year questionnaires, 9% (n 5831) did not consent to medical record review and 6% (n 5548) had ,5 years of medical record data available, leaving 8286 participants eligible for inclusion in this study (Supplementary Figure S1, available online at http://links.lww.com/PAIN/A352).",Non-OADS,/arxiv_data1/oa_pdf/5f/01/jop-158-110.PMC5175996.pdf
"Incomplete responders (either baseline-only responders or baseline and 3-year responders without 5 years of medical record data) showed generally small differences from the study population on all baseline variables assessed (Supplementary Table S1, available online at http://links.lww.com/PAIN/A352).",OADS,/arxiv_data1/oa_pdf/5f/01/jop-158-110.PMC5175996.pdf
Supplemental Digital Content Supplemental Digital Content associated with this article can be found online at http://links.lww.com/PAIN/A352.,Non-OADS,/arxiv_data1/oa_pdf/5f/01/jop-158-110.PMC5175996.pdf
Available at: http://www.hscic.gov.,Non-OADS,/arxiv_data1/oa_pdf/5f/01/jop-158-110.PMC5175996.pdf
Available at: http://www.ons.,Non-OADS,/arxiv_data1/oa_pdf/5f/01/jop-158-110.PMC5175996.pdf
http://dx.doi.org/10.1097/j.pain.0000000000000732 96 G.T.,Non-OADS,/arxiv_data1/oa_pdf/75/fc/jop-158-096.PMC5175998.pdf
Clinical Trial Registration —URL: http://www.clinicaltrials.gov .,Non-OADS,/arxiv_data1/oa_pdf/93/b2/str-48-145.PMC5176000.pdf
The online-only Data Supplement is available with this article at http://stroke.ahajournals.org/lookup/suppl/doi:10.1161/STROKEAHA.,OADS,/arxiv_data1/oa_pdf/93/b2/str-48-145.PMC5176000.pdf
Stroke is available at http://stroke.ahajournals.org DOI: 10.1161/STROKEAHA.116.014250,Non-OADS,/arxiv_data1/oa_pdf/93/b2/str-48-145.PMC5176000.pdf
The protocol and written informed consent  procedure are published (http://www.clinicaltrials.gov .,Non-OADS,/arxiv_data1/oa_pdf/93/b2/str-48-145.PMC5176000.pdf
"Validity of the method was examined through measures of agreement (95% limits of agreement, standard error of measurement, and Lin ’s concordance correlationReceived: 30 October 2016 Revised: 25 November 2016 Accepted: 9 December 2016 Heliyon 2 (2016) e00216 http://dx.doi.org/10.1016/j.heliyon.2016.e00216 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
"Based on “Out-of-Africa ” hypothesis, the first entry of modern humans into the southern part of East Asiaoccurred about 18,000 –60,000 years ago from Africa, followed by a great Article No~e00216 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00216 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
"Using retrospectively collected panoramic radiographs, the purpose of the present study was to evaluate validity of the southern Chinese reference dataset for Article No~e00216 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00216 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
Article No~e00216 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00216 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
Article No~e00216 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00216 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
Article No~e00216 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00216 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
Article No~e00216 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00216 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
Estimation of Article No~e00216 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00216 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
Article No~e00216 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00216 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
Article No~e00216 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00216 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
Article No~e00216 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00216 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
Article No~e00216 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00216 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
"On the other hand, the economic reform in China in recent decades has also Article No~e00216 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00216 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
Article No~e00216 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00216 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
Article No~e00216 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00216 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
Article No~e00216 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00216 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
Article No~e00216 17 http://dx.doi.org/10.1016/j.heliyon.2016.e00216 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
Article No~e00216 18 http://dx.doi.org/10.1016/j.heliyon.2016.e00216 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
Version = 1.6.4 http://CRAN.R-project.org/package=psych .,Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
"Accessed at September 28th, 2016 http://www.stats.gov.cn/tjsj/ndsj/ 2015/indexeh.htm .",OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
Article No~e00216 19 http://dx.doi.org/10.1016/j.heliyon.2016.e00216 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
Article No~e00216 20 http://dx.doi.org/10.1016/j.heliyon.2016.e00216 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5b/00/main.PMC5176030.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Kinetic modeling Basal forebrainAcetylcholinesteraseN-[ 11C]-Methylpiperidin-4-yl propionate PETPrimary progressive aphasia 1.,Non-OADS,/arxiv_data1/oa_pdf/b7/2a/main.PMC5176031.pdf
http://dx.doi.org/10.1016/j.nicl.2016.11.027 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b7/2a/main.PMC5176031.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/2a/main.PMC5176031.pdf
http://dx.doi.org/10.1006/nimg.2000.0582 .,OADS,/arxiv_data1/oa_pdf/b7/2a/main.PMC5176031.pdf
http://dx.doi.org/10.1093/brain/awv024 .,Non-OADS,/arxiv_data1/oa_pdf/b7/2a/main.PMC5176031.pdf
http://dx.doi.org/10.1212/01.wnl.0000242626.69666.e2 .,Non-OADS,/arxiv_data1/oa_pdf/b7/2a/main.PMC5176031.pdf
http://dx.doi.org/10.1093/brain/ aw1025 .,Non-OADS,/arxiv_data1/oa_pdf/b7/2a/main.PMC5176031.pdf
http://dx.doi.org/10.1001/archneur.,Non-OADS,/arxiv_data1/oa_pdf/b7/2a/main.PMC5176031.pdf
http://dx.doi.org/10.1016/S1474-4422(12)70320-4 .,OADS,/arxiv_data1/oa_pdf/b7/2a/main.PMC5176031.pdf
http://dx.doi.org/10.1016/j.cortex.2011.06.021 .,OADS,/arxiv_data1/oa_pdf/b7/2a/main.PMC5176031.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/b7/2a/main.PMC5176031.pdf
6:88 –97.http://dx.doi.org/10.1038/nrneurol.2009.216 .,OADS,/arxiv_data1/oa_pdf/b7/2a/main.PMC5176031.pdf
http://dx.doi.org/10.1007/s00415-014-7439-z .,Non-OADS,/arxiv_data1/oa_pdf/b7/2a/main.PMC5176031.pdf
Brain http://dx.doi.org/10.1093/brain/ aww067 .,Non-OADS,/arxiv_data1/oa_pdf/b7/2a/main.PMC5176031.pdf
http://dx.doi.org/10.1212/01.,Non-OADS,/arxiv_data1/oa_pdf/b7/2a/main.PMC5176031.pdf
http://dx.doi.org/10.1093/brain/awq120 .,Non-OADS,/arxiv_data1/oa_pdf/b7/2a/main.PMC5176031.pdf
http://dx.doi.org/10.1007/s00401-009-0547-7 .,Non-OADS,/arxiv_data1/oa_pdf/b7/2a/main.PMC5176031.pdf
http://dx.doi.org/10.1007/s00401-002- 0621-x .,Non-OADS,/arxiv_data1/oa_pdf/b7/2a/main.PMC5176031.pdf
http://dx.doi.org/10.1016/j.nicl.2014.11.015 .,OADS,/arxiv_data1/oa_pdf/b7/2a/main.PMC5176031.pdf
http://dx.doi.org/10.1159/000113034 .,Non-OADS,/arxiv_data1/oa_pdf/b7/2a/main.PMC5176031.pdf
http://dx.doi.org/10.1212/ WNL.52.4.691 .,Non-OADS,/arxiv_data1/oa_pdf/b7/2a/main.PMC5176031.pdf
http://dx.doi.org/10.1007/s00415-015-7738-z .,Non-OADS,/arxiv_data1/oa_pdf/b7/2a/main.PMC5176031.pdf
Psychiatry 15:84 –87.http://dx.doi.org/10.1097/01.JGP.0000231744.69631.33 .,Non-OADS,/arxiv_data1/oa_pdf/b7/2a/main.PMC5176031.pdf
http://dx.doi.org/10.1002/ cne.23415 .,Non-OADS,/arxiv_data1/oa_pdf/b7/2a/main.PMC5176031.pdf
15. http://dx.doi.org/10.4088/PCC.12r01412 .,Non-OADS,/arxiv_data1/oa_pdf/b7/2a/main.PMC5176031.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/b7/2a/main.PMC5176031.pdf
http://dx.doi.org/ 10.1016/j.neurobiolaging.2011.03.006 .,OADS,/arxiv_data1/oa_pdf/b7/2a/main.PMC5176031.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/b7/2a/main.PMC5176031.pdf
http://dx.doi.org/10.1016/j.cortex.2016.07.,OADS,/arxiv_data1/oa_pdf/b7/2a/main.PMC5176031.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b7/2a/main.PMC5176031.pdf
http://dx.doi.org/10.1093/ brain/awh589 .,Non-OADS,/arxiv_data1/oa_pdf/b7/2a/main.PMC5176031.pdf
http://dx.doi.org/10.1006/nimg.2001.0978 .,OADS,/arxiv_data1/oa_pdf/b7/2a/main.PMC5176031.pdf
8:16. http://dx.doi.org/10.1186/ s13195-016-0185-y .,Non-OADS,/arxiv_data1/oa_pdf/b7/2a/main.PMC5176031.pdf
http://dx.doi.org/10.1016/j.bbr.2010.02.025 .,OADS,/arxiv_data1/oa_pdf/b7/2a/main.PMC5176031.pdf
http://dx.doi.org/10.1159/000087343 .,Non-OADS,/arxiv_data1/oa_pdf/b7/2a/main.PMC5176031.pdf
http://dx.doi.org/10.1097/WNF.0000000000000089 .,Non-OADS,/arxiv_data1/oa_pdf/b7/2a/main.PMC5176031.pdf
http://dx.doi.org/10.1016/j.neuroimage.2008.05.055 .279 J. Schaeverbeke et al.,OADS,/arxiv_data1/oa_pdf/b7/2a/main.PMC5176031.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/4.0/HIV-1 patient sepsis risk of surgical diseases T Feng et al 6 Emerging Microbes and Infections",Non-OADS,/arxiv_data1/oa_pdf/5d/ef/emi201559a.PMC5176082.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/B.",Non-OADS,/arxiv_data1/oa_pdf/c7/b8/emi201554a.PMC5176084.pdf
Available at http://www.who.int/mediacentre/factsheets/fs117/en/ (accessed 20 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/ee/fa/emi201557a.PMC5176085.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Epidemic survey of dengue fever in Guangzhou, 2014 L Yang et al.",Non-OADS,/arxiv_data1/oa_pdf/ee/fa/emi201557a.PMC5176085.pdf
Please read the full license for further details at - http:// creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary information of this article can be found on the Emerging Microbes & Infections ’ website (http://www.nature.com/emi).Disease threat to European biodiversity revealed D Ercan et al 6 Emerging Microbes and Infections,Non-OADS,/arxiv_data1/oa_pdf/6f/82/emi201552a.PMC5176086.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ rThe Author(s) 2017Population genetics from 1966 to 2016 BC h a r l e s w o r t ha n dDC h a r l e s w o r t h 9 Heredity",Non-OADS,/arxiv_data1/oa_pdf/27/cd/hdy201655a.PMC5176116.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org /licenses/by-nc-nd/4.0/ ).Keywords: Wilms' tumor of ovaryImmature teratoma 1.,Non-OADS,/arxiv_data1/oa_pdf/eb/7c/main.PMC5176123.pdf
http://dx.doi.org/10.1016/j.gore.2016.12.004 2352-5789/© 2016 Emory University School of Medicine; Department of Gynecology and Obstetrics.,Non-OADS,/arxiv_data1/oa_pdf/eb/7c/main.PMC5176123.pdf
This is an open access art icle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/7c/main.PMC5176123.pdf
http://dx.doi.org/10.1016/j.mmcr.2016.11.003 Received 10 November 2016; Received in revised form 23 November 2016; Accepted 24 November 2016⁎Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/bd/3e/main.PMC5176124.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bd/3e/main.PMC5176124.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/77/e3/main.PMC5176126.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.11.001 2049-0801/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/77/e3/main.PMC5176126.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/00/main.PMC5176128.pdf
"All  three  cases  had  tumors related  to  the  ﬂexor  tendons  within  the  carpal  tunnel:  a  giant  cell tumor  of  tendon  sheath  [1],  a  synovial  mass  [3],  and  a  ﬁbroma  of http://dx.doi.org/10.1016/j.ijscr.2016.11.051 2210-2612/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/ed/00/main.PMC5176128.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c6/a3/main.PMC5176130.pdf
"The C-terminal region of YAP, rich in serine, threonine and acidic amino acids, acts as a strong transcription activationContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/bbrepBiochemistry and Biophysics Reports http://dx.doi.org/10.1016/j.bbrep.2016.02.015 2405-5808/ &2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/c6/a3/main.PMC5176130.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: YAP, yes-associated protein; TAD, transcriptional activation do- main; hYAP:, human YAP; aa:, Amino acid; mYAP:, mouse YAP; WT, wild-type; Con,control; EV, empty vector nCorrespondence to: Mechanobiology Institute, T-Lab, National University of Singapore, #10-01 5A Engineering Drive 1, 117411, Singapore.",Non-OADS,/arxiv_data1/oa_pdf/c6/a3/main.PMC5176130.pdf
"Interestingly, C-terminal homology between Yorkie and YAP is low, although Yorkie and TAZ do harbour a coiled-coil motif in their putative TAD (predicted using COILS: http://embnet.vital-it.ch/software/COILS_form.html ) via other amino acids e.g., I-I-L-L-E in TAZ.",Non-OADS,/arxiv_data1/oa_pdf/c6/a3/main.PMC5176130.pdf
Appendix A. Transparency Document Transparency Document associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.bbrep.2016.02.015 .,Non-OADS,/arxiv_data1/oa_pdf/c6/a3/main.PMC5176130.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Black band disease Genome announcement Coral reefsStappia indicaNitratireductor aquibiodomus Speci ﬁcations Organism/cell line/tissueStappia indica; Nitratireductor aquibiodomus Strain EBBD 17.2, EBB 35.1, SBBC 49 Sequencer or array typeIllumina Hiseq 2000 Data format Assembled Experimental factorsCoral reef affected Experimental featuresWhole genome shotgun sequencing followed by genome assembly and a brief gene description Consent N/ASample source locationSanta Marta, Colombia 1.",Non-OADS,/arxiv_data1/oa_pdf/80/94/main.PMC5176132.pdf
Direct link to deposited data EBBD 17.2 ( Stappia indica ):https://www.ncbi.nlm.nih.gov/ bioproject/328867 EBB 35.1 ( Nitratireductor aquibiodomus ):https://www.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/80/94/main.PMC5176132.pdf
nih.gov/bioproject/PRJNA327597SBBC 49 ( Stappia indica ):https://www.ncbi.nlm.nih.gov/ bioproject/PRJNA328866 2.,Non-OADS,/arxiv_data1/oa_pdf/80/94/main.PMC5176132.pdf
http://dx.doi.org/10.1016/j.gdata.2016.12.008 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/80/94/main.PMC5176132.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/80/94/main.PMC5176132.pdf
"Fass, Sickle: a sliding-window, adaptive, quality-based trimming tool for FastQ ﬁles (Version 1.33) [Software]Available at https://github.com/najoshi/ sickle 2011.",Non-OADS,/arxiv_data1/oa_pdf/80/94/main.PMC5176132.pdf
2016; 18(7):790-802; PMID: 27295554; http://dx.doi.org/10.1038/ncb3371.,Non-OADS,/arxiv_data1/oa_pdf/df/d5/kccy-15-23-1216927.PMC5176149.pdf
"23, 3149 –3150 http://dx.doi.org/10.1080/15384101.2016.1216927",Non-OADS,/arxiv_data1/oa_pdf/df/d5/kccy-15-23-1216927.PMC5176149.pdf
Nat Immunol2010; 11:889-96; PMID:20856220; http://dx.doi.org/10.1038/ni.,Non-OADS,/arxiv_data1/oa_pdf/df/d5/kccy-15-23-1216927.PMC5176149.pdf
"Cancer Cell 2013; 23:277-86; PMID:23518347;http://dx.doi.org/10.1016/j.ccr.2013.02.013 [3] Lewis CE, Harney AS, Pollard JW.",OADS,/arxiv_data1/oa_pdf/df/d5/kccy-15-23-1216927.PMC5176149.pdf
"Cancer Cell 2016; 30:18-25;PMID:27411586; http://dx.doi.org/10.1016/j.ccell.2016.05.017 [4] Squadrito ML, Pucci F, Magri L, Moi D, Gil ﬁllan GD, Ranghetti A, Casazza A, Mazzone M, Lyle R, Naldini L, et al.",Non-OADS,/arxiv_data1/oa_pdf/df/d5/kccy-15-23-1216927.PMC5176149.pdf
"miR-511-3p modulates genetic programs of tumor-associated macrophages.Cell Rep 2012; 1:141-54; PMID:22832163; http://dx.doi.org/ 10.1016/j.celrep.2011.12.005 [5] Baer C, Squadrito ML, Laoui D, Thompson D, Hansen SK, Kiialainen A, Hoves S, Ries CH, Ooi CH, De Palma M. Suppression of micro-RNA activity ampli ﬁes IFN-gamma-induced macrophage activation and promotes anti-tumour immunity.",OADS,/arxiv_data1/oa_pdf/df/d5/kccy-15-23-1216927.PMC5176149.pdf
"Nat Cell Biol 2016; 18:790-802; PMID:27295554; http://dx.doi.org/10.1038/ncb3371 [6] Su JL, Chen PS, Johansson G, Kuo ML.",OADS,/arxiv_data1/oa_pdf/df/d5/kccy-15-23-1216927.PMC5176149.pdf
"MicroRNA 2012; 1:34-9; PMID:25048088; http://dx.doi.org/10.2174/2211536611201010034 [7] De Palma M, Hanahan D. The biology of personalized cancer medi- cine: facing individual complexities underlying hallmark capabilities.Mol Oncol 2012; 6:111-27; PMID:22360993; http://dx.doi.org/ 10.1016/j.molonc.2012.01.011 Figure 1.",OADS,/arxiv_data1/oa_pdf/df/d5/kccy-15-23-1216927.PMC5176149.pdf
Nat Cell Biol 2016; 18(5):5 27-39; PMID: 27043084; http://dx.doi.org/10.1038/ncb3335 © 2016 Kuo-Hui Su and Chengkai Dai.,OADS,/arxiv_data1/oa_pdf/24/a0/kccy-15-23-1220714.PMC5176174.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/24/a0/kccy-15-23-1220714.PMC5176174.pdf
"23, 3155 –3156 http://dx.doi.org/10.1080/15384101.2016.1220714",Non-OADS,/arxiv_data1/oa_pdf/24/a0/kccy-15-23-1220714.PMC5176174.pdf
"Genes Dev 2008; 22:1427-38; PMID:18519635; http://dx.doi.org/10.1101/gad.1657108 [2] Vihervaara A, Sistonen L. HSF1 at a glance.",Non-OADS,/arxiv_data1/oa_pdf/24/a0/kccy-15-23-1220714.PMC5176174.pdf
"J Cell Sci 2014; 127:261-6; PMID:24421309; http://dx.doi.org/10.1242/jcs.132605 [3] Sengupta S, Peterson TR, Sabatini DM.",OADS,/arxiv_data1/oa_pdf/24/a0/kccy-15-23-1220714.PMC5176174.pdf
"Mol Cell 2010;40:310-22; PMID:20965424; http://dx.doi.org/10.1016/j.molcel.2010.09.026 [4] Su KH, Cao J, Tang Z, Dai S, He Y, Sampson SB, Benjamin IJ, Dai C. HSF1 critically attunes proteotoxic stress sensing by mTORC1 tocombat stress and promote growth.",OADS,/arxiv_data1/oa_pdf/24/a0/kccy-15-23-1220714.PMC5176174.pdf
Nat Cell Biol 2016; 18:527-39;PMID:27043084; http://dx.doi.org/10.1038/ncb3335 [5] Davis RJ.,OADS,/arxiv_data1/oa_pdf/24/a0/kccy-15-23-1220714.PMC5176174.pdf
"Cell 2000; 103:239-52; PMID:11057897; http://dx.doi.org/10.1016/S0092-8674(00)00116-1 [6] Tang Z, Dai S, He Y, Doty RA, Shultz LD, Sampson SB, Dai C. MEK guards proteome stability and inhibits tumor-suppressive amyloido-genesis via HSF1.",OADS,/arxiv_data1/oa_pdf/24/a0/kccy-15-23-1220714.PMC5176174.pdf
"Cell 2015; 160:729-44; PMID:25679764; http://dx.doi.org/10.1016/j.cell.2015.01.028 [7] Dai C, Sampson SB.",OADS,/arxiv_data1/oa_pdf/24/a0/kccy-15-23-1220714.PMC5176174.pdf
Trends Cell Biol 2016; 26:17-28; PMID:26597576; http://dx.doi.org/10.1016/j.tcb.2015.10.011 Figure 1.,OADS,/arxiv_data1/oa_pdf/24/a0/kccy-15-23-1220714.PMC5176174.pdf
Available at: http://www.cdc.gov/lyme/(accessed 13 September 2014).,Non-OADS,/arxiv_data1/oa_pdf/4b/fd/emi201531a.PMC5176177.pdf
Available at: http://www.cdc.gov/lyme/postLDS/index.html(accessed 13 September 2014).,OADS,/arxiv_data1/oa_pdf/4b/fd/emi201531a.PMC5176177.pdf
Available at: http://dtp.nci.nih.gov/branches/dscb/repo_open.html (accessed 15 March 2015).,Non-OADS,/arxiv_data1/oa_pdf/4b/fd/emi201531a.PMC5176177.pdf
Available at: http://dtp.nci.nih.gov/branches/dscb/ mechanistic_explanation.html (accessed 11 January 2015).,OADS,/arxiv_data1/oa_pdf/4b/fd/emi201531a.PMC5176177.pdf
Available at: http://dtp.nci.nih.gov/branches/dscb/natprod_explanation2.html (accessed 11 January 2015).,OADS,/arxiv_data1/oa_pdf/4b/fd/emi201531a.PMC5176177.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/New compounds active against stationary phase Borrelia burgdorferi J Feng et al 15 Emerging Microbes and Infections",Non-OADS,/arxiv_data1/oa_pdf/4b/fd/emi201531a.PMC5176177.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Translational Medicine: Bench to Bedside 2 Clinical and Translational Gastroenterology",Non-OADS,/arxiv_data1/oa_pdf/1d/67/ctg201535a.PMC5176315.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Translational Medicine: Bench to Bedside 2 Clinical and Translational Gastroenterology",Non-OADS,/arxiv_data1/oa_pdf/17/77/ctg201511a.PMC5176317.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ac/87/main.PMC5176330.pdf
THIS IS AN OPEN ACCESS ARTICLE UNDER THE CC BY-NC-ND LICENSE ( http://creativecommons.o rg/licenses/by-nc-nd/4.0/ ).ISSN 0735-1097 http://dx.doi.org/10.1016/j.jacc.2016.10.020,Non-OADS,/arxiv_data1/oa_pdf/ac/87/main.PMC5176330.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1f/99/nihms835284.PMC5176333.pdf
Supplementary data to this article can be found online at http://dx.doi.org/10.1016/j.mito.,OADS,/arxiv_data1/oa_pdf/1f/99/nihms835284.PMC5176333.pdf
http://dx.doi.org/ 10.1177/0898264313509277 .,Non-OADS,/arxiv_data1/oa_pdf/1f/99/nihms835284.PMC5176333.pdf
http://dx.doi.org/10.3233/ JAD-2010-100351 .,Non-OADS,/arxiv_data1/oa_pdf/1f/99/nihms835284.PMC5176333.pdf
http://dx.doi.org/10.1016/j.mrfmmm.2007.06.002 .,OADS,/arxiv_data1/oa_pdf/1f/99/nihms835284.PMC5176333.pdf
http://dx.doi.org/10.1001/archneur.,Non-OADS,/arxiv_data1/oa_pdf/1f/99/nihms835284.PMC5176333.pdf
http://dx.doi.org/10.1007/s12035-012-8300-y .,Non-OADS,/arxiv_data1/oa_pdf/1f/99/nihms835284.PMC5176333.pdf
http://dx.doi.org/10.1093/hmg/ddn401 .,Non-OADS,/arxiv_data1/oa_pdf/1f/99/nihms835284.PMC5176333.pdf
http://dx.doi.org/10.3233/JAD-140384 .,Non-OADS,/arxiv_data1/oa_pdf/1f/99/nihms835284.PMC5176333.pdf
http://dx.doi.org/10.1002/ana.23955 .,Non-OADS,/arxiv_data1/oa_pdf/1f/99/nihms835284.PMC5176333.pdf
http://dx.doi.org/10.1080/15257771003730128 .,Non-OADS,/arxiv_data1/oa_pdf/1f/99/nihms835284.PMC5176333.pdf
http://dx.doi.org/ 10.1016/j.bbadis.2013.09.010 .,OADS,/arxiv_data1/oa_pdf/1f/99/nihms835284.PMC5176333.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/12/e1601796/DC1 Supplementary Materials and Methods Supplementary Texttable S1.,Non-OADS,/arxiv_data1/oa_pdf/a0/32/1601796.PMC5176347.pdf
"CASM, v0.1.0 (2015); https://github.com/prisms-center/CASMcode.37.",OADS,/arxiv_data1/oa_pdf/a0/32/1601796.PMC5176347.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/12/e1601282/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/10/36/1601282.PMC5176348.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/12/e1601530/DC1 fig.,Non-OADS,/arxiv_data1/oa_pdf/bd/13/1601530.PMC5176349.pdf
"C. Mass, D. Ovens, WRF model physics: Progress, problems, and perhaps some solutions, the 11th WRF Users ’Workshop, 21 –25 June, NCAR Center Green Campus, http://www2.mmm.ucar.edu/wrf/users/workshops/WS2010/presentations/session 4/4- 1_WRFworkshop2010Final.pdf (2010) [accessed December 2015].",Non-OADS,/arxiv_data1/oa_pdf/bd/13/1601530.PMC5176349.pdf
"This article is available under a Creative Commons License 4.0 (Attribution-Non-Commercial), as described at http://creativecommons.org/licenses/by-nc/4.0eISSN: 1529-7268 http://www.biolreprod.orgISSN: 0006-3363 1 Article 81",Non-OADS,/arxiv_data1/oa_pdf/5b/c9/i0006-3363-95-4-81.PMC5176362.pdf
"This article is available under a Creative Commons License 4.0 (Attribution-Non-Commercial), as described at http://creativecommons.org/licenses/by-nc/4.0eISSN: 1529-7268 http://www.biolreprod.orgISSN: 0006-3363 1 Article 85",Non-OADS,/arxiv_data1/oa_pdf/50/11/i0006-3363-95-4-85.PMC5176363.pdf
http://www.worthington-biochem.com/ tissuedissociation/Reproductive.html.,Non-OADS,/arxiv_data1/oa_pdf/50/11/i0006-3363-95-4-85.PMC5176363.pdf
"This article is available under a Creative Commons License 4.0 (Attribution-Non-Commercial), as described at http://creativecommons.org/licenses/by-nc/4.0eISSN: 1529-7268 http://www.biolreprod.orgISSN: 0006-3363 1 Article 90",Non-OADS,/arxiv_data1/oa_pdf/49/c2/i0006-3363-95-4-90.PMC5176364.pdf
"S1 https://doi.org/10.3345/kjp.2016.59.11.S1Korean J Pediatr 2016;59(Suppl 1):S1-4 A nonsense PAX6  mutation in a family with  con genital aniridia  Kyoung Hee Han, MD1, Hye Jin Lee, MD2, Il-Soo Ha, MD, PhD3, Hee Gyung Kang, MD3,4, Hae Il Cheong, MD, PhD3,4,5 Departments of 1Pediatrics and 2Ophthalmology, Jeju National University School of Medicine, Jeju, 3Department of Pediatrics, Seoul National University Children’s  Hospital, Seoul, 4Research Coordination Center for Rare Diseases, Seoul National University Hospital, Seoul, 5Kidney Research Institute, Medical Research Center,  Seoul National University College of Medicine, Seoul, Korea Congenital aniridia is a rare ocular malformation that presents with severe hypoplasia of the iris and  various ocular manifestations.",Non-OADS,/arxiv_data1/oa_pdf/00/1f/kjped-59-S1.PMC5177687.pdf
"In the current study, we conducted mutational analysis of the PAX6  gene in familial  cases of autosomal dominant congenital aniridia and found premature termination of  PAX6 protein translation.Corresponding author: Hae Il Cheong, MD Department of Pediatrics, Seoul National University  Children's Hospital, 101 Daehak-ro, Jongno-gu,  Seoul 03080, Korea Tel: +82-2-2072-2810 Fax: +82-2-743-3455 E-mail: cheonghi@snu.ac.kr Received: 22 December, 2015 Revised: 11 April, 2016 Accepted: 18 April, 2016 Copyright © 2016 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Korean J PediatrCase report Korean J Pediatr 2016;59(Suppl 1):S1-4 https://doi.org/10.3345/kjp.2016.59.11.S1 pISSN 1738-1061•eISSN 2092-7258",Non-OADS,/arxiv_data1/oa_pdf/00/1f/kjped-59-S1.PMC5177687.pdf
"https://doi.org/10.3345/kjp.2016.59.11.S1Han KH, et al.",OADS,/arxiv_data1/oa_pdf/00/1f/kjped-59-S1.PMC5177687.pdf
S3 https://doi.org/10.3345/kjp.2016.59.11.S1Korean J Pediatr 2016;59(Suppl 1):S1-4 Discussion It is known that almost all patients with aniridia have muta - tions in the PAX6  gene.,Non-OADS,/arxiv_data1/oa_pdf/00/1f/kjped-59-S1.PMC5177687.pdf
"https://doi.org/10.3345/kjp.2016.59.11.S1Han KH, et al.",OADS,/arxiv_data1/oa_pdf/00/1f/kjped-59-S1.PMC5177687.pdf
"https://doi.org/10.3345/kjp.2016.59.11.S10Kim YS, et al.",OADS,/arxiv_data1/oa_pdf/ce/3e/kjped-59-S10.PMC5177688.pdf
"She was born at 38 weeks of gestational age by vaginal delivery and her Corresponding author: Baik-Lin Eun, MD, PhD Department of Pediatrics, Korea University Guro  Hospital, 148 Gurodong-ro, Guro-gu, Seoul 08308,  Korea Tel: +82-2-2626-1229 Fax: +82-2-2626-1249 E-mail: bleun@korea.ac.kr Received: 28 August, 2014 Revised: 26 September, 2014 Accepted: 20 October, 2014 Copyright © 2016 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Korean J PediatrCase report Korean J Pediatr 2016;59(Suppl 1):S10-13 https://doi.org/10.3345/kjp.2016.59.11.S10 pISSN 1738-1061•eISSN 2092-7258",Non-OADS,/arxiv_data1/oa_pdf/ce/3e/kjped-59-S10.PMC5177688.pdf
"S11 https://doi.org/10.3345/kjp.2016.59.11.S10Korean J Pediatr 2016;59(Suppl 1):S10-13 weight was 2,090 g (<3rd percentile).",OADS,/arxiv_data1/oa_pdf/ce/3e/kjped-59-S10.PMC5177688.pdf
"https://doi.org/10.3345/kjp.2016.59.11.S10Kim YS, et al.",OADS,/arxiv_data1/oa_pdf/ce/3e/kjped-59-S10.PMC5177688.pdf
S13 https://doi.org/10.3345/kjp.2016.59.11.S10Korean J Pediatr 2016;59(Suppl 1):S10-13 tia.,OADS,/arxiv_data1/oa_pdf/ce/3e/kjped-59-S10.PMC5177688.pdf
"S103 https://doi.org/10.3345/kjp.2016.59.11.S103Korean J Pediatr 2016;59(Suppl 1):S103-106 A novel mutation of CLCNKB  in a Korean pa­ tient of mixed phenotype of Bartter ­Gitelman  syndrome Hee-Won Cho, MD1, Sang Taek Lee, MD1, Heeyeon Cho, MD1, Hae Il Cheong, MD2 1Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 2Department of Pediatrics, Seoul National University  Children’s Hospital, Seoul, Korea  Bartter syndrome (BS) is an inherited renal tubular disorder characterized by low or normal blood  pressure, hypokalemic metabolic alkalosis, and hyperreninemic hyperaldosteronism.",Non-OADS,/arxiv_data1/oa_pdf/ac/17/kjped-59-S103.PMC5177689.pdf
"In other Corresponding author: Heeyeon Cho, MD  Department of Pediatrics, Samsung Medical Center,  Sungkyunkwan University School of Medicine, 81  Irwon-ro, Gangnam-gu, Seoul 06351, Korea Tel: +82-2-3410-3539  Fax: +82-2-3410-0043 E-mail: choheeyeon@gmail.com Received: 25 November, 2015 Revised: 11 January, 2016 Accepted: 27 January, 2016 Copyright © 2016 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Korean J PediatrCase report Korean J Pediatr 2016;59(Suppl 1):S103­106 https://doi.org/10.3345/kjp.2016.59.11.S103 pISSN 1738-1061•eISSN 2092-7258",Non-OADS,/arxiv_data1/oa_pdf/ac/17/kjped-59-S103.PMC5177689.pdf
"https://doi.org/10.3345/kjp.2016.59.11.S103Cho HW, et al.",OADS,/arxiv_data1/oa_pdf/ac/17/kjped-59-S103.PMC5177689.pdf
"S105 https://doi.org/10.3345/kjp.2016.59.11.S103Korean J Pediatr 2016;59(Suppl 1):S103-106 Discussion According to the related defective genes, inherited renal tubular  disorders associated with impaired renal conversion of salt,  calcium, and magnesium are classified as BS, GS, isolated renal  magnesium loss or FHHNC, and these disorders exhibit a broad  spectrum of clinical pictures, often overlapping one another3).",Non-OADS,/arxiv_data1/oa_pdf/ac/17/kjped-59-S103.PMC5177689.pdf
"https://doi.org/10.3345/kjp.2016.59.11.S103Cho HW, et al.",OADS,/arxiv_data1/oa_pdf/ac/17/kjped-59-S103.PMC5177689.pdf
"S107 https://doi.org/10.3345/kjp.2016.59.11.S107Korean J Pediatr 2016;59(Suppl 1):S107-111 Unusual malignant neoplasms of ovary in  child ren: two cases report   Ali Ghribi, MD, Aicha Bouden, MD, Manef Gasmi, MD, Mourad Hamzaoui Department of Pediatric Surgery, Children’s Hospital, Tunis El Manar University, Tunis, Tunisia Sex cord tumors with annular tubules are known to originate from the sex cord of embryonic gonads  that synthesize Sertoli cells, Leydig cells, granulosa cells, and theca cells of the ovarian stroma,  while ovarian small cell carcinoma of the hypercalcemic type is a type of neuroendocrine tumor.",Non-OADS,/arxiv_data1/oa_pdf/d3/fc/kjped-59-S107.PMC5177690.pdf
"At laparotomy, Corresponding author: Ali Ghribi, MD Department of Pediatric Surgery, Children’s Hospi - tal of Tunis, Tunis El Manar University, Bab Saadoun  1007 Tunis, Tunisia Tel: +216-7156810 Fax: +216-71562810  E-mail: ali_ghribi_2007@yahoo.fr Received: 17 May, 2014 Revised: 13 October, 2014 Accepted: 7 November, 2014 Copyright © 2016 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Korean J PediatrCase report Korean J Pediatr 2016;59(Suppl 1):S107-111 https://doi.org/10.3345/kjp.2016.59.11.S107 pISSN 1738-1061•eISSN 2092-7258",Non-OADS,/arxiv_data1/oa_pdf/d3/fc/kjped-59-S107.PMC5177690.pdf
"https://doi.org/10.3345/kjp.2016.59.11.S107Ghribi A, et al.",OADS,/arxiv_data1/oa_pdf/d3/fc/kjped-59-S107.PMC5177690.pdf
S109 https://doi.org/10.3345/kjp.2016.59.11.S107Korean J Pediatr 2016;59(Suppl 1):S107-111 quent laboratory tests revealed hypercalcemia (2.95 mmol/L).,Non-OADS,/arxiv_data1/oa_pdf/d3/fc/kjped-59-S107.PMC5177690.pdf
"https://doi.org/10.3345/kjp.2016.59.11.S107Ghribi A, et al.",OADS,/arxiv_data1/oa_pdf/d3/fc/kjped-59-S107.PMC5177690.pdf
S111 https://doi.org/10.3345/kjp.2016.59.11.S107Korean J Pediatr 2016;59(Suppl 1):S107-111 calcemic type: a case report.,Non-OADS,/arxiv_data1/oa_pdf/d3/fc/kjped-59-S107.PMC5177690.pdf
"https://doi.org/10.3345/kjp.2016.59.11.S112Lee MJ, et al.",OADS,/arxiv_data1/oa_pdf/cd/68/kjped-59-S112.PMC5177691.pdf
"Physical examination revealed hypertelorism, low set posteriorly  rotated ears, micrognathia, thick lips, and short neck with excess nuchal skin, shield chest, Corresponding author: Hwa Jin Cho, MD Department of Pediatrics, Chonnam National Uni - versity Hospital, 42 Jebong-ro, Dong-gu, Gwangju  61469, Korea Tel: +82-62-220-6646 Fax: +82-62-222-6103 E-mail: chhj98@gmail.com Received: 9 July, 2014 Revised: 1 September, 2014 Accepted: 22 September, 2014 Copyright © 2016 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Korean J PediatrCase report Korean J Pediatr 2016;59(Suppl 1):S112­115 https://doi.org/10.3345/kjp.2016.59.11.S112 pISSN 1738-1061•eISSN 2092-7258",Non-OADS,/arxiv_data1/oa_pdf/cd/68/kjped-59-S112.PMC5177691.pdf
S113 https://doi.org/10.3345/kjp.2016.59.11.S112Korean J Pediatr 2016;59(Suppl 1):S112-115 and mild mental retardation.,Non-OADS,/arxiv_data1/oa_pdf/cd/68/kjped-59-S112.PMC5177691.pdf
"https://doi.org/10.3345/kjp.2016.59.11.S112Lee MJ, et al.",OADS,/arxiv_data1/oa_pdf/cd/68/kjped-59-S112.PMC5177691.pdf
S115 https://doi.org/10.3345/kjp.2016.59.11.S112Korean J Pediatr 2016;59(Suppl 1):S112-115 References  1.,Non-OADS,/arxiv_data1/oa_pdf/cd/68/kjped-59-S112.PMC5177691.pdf
"https://doi.org/10.3345/kjp.2016.59.11.S116Park JS, et al.",OADS,/arxiv_data1/oa_pdf/f8/8d/kjped-59-S116.PMC5177692.pdf
"Corresponding author: Chan-Hoo Park, MD Department of Pediatrics, Gyeongsang National  Unviersity School of Medicine, 15 Jinju-daero  816beon-gil, Jinju 52727, Korea Tel: +82-55-750-8161 Fax: +82-55-752-9889 E-mail: aroma@gnu.ac.kr Received: 21 August, 2014 Revised: 15 September, 2014 Accepted: 25 September, 2014 Copyright © 2016 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Korean J PediatrCase report Korean J Pediatr 2016;59(Suppl 1):S116-120 https://doi.org/10.3345/kjp.2016.59.11.S116 pISSN 1738-1061•eISSN 2092-7258",Non-OADS,/arxiv_data1/oa_pdf/f8/8d/kjped-59-S116.PMC5177692.pdf
"S117 https://doi.org/10.3345/kjp.2016.59.11.S116Korean J Pediatr 2016;59(Suppl 1):S116-120 Recently, we examined a baby with diazoxide unresponsive  CHI with a novel mutation in the ABCC8  gene and would like to  report our case in this paper.",Non-OADS,/arxiv_data1/oa_pdf/f8/8d/kjped-59-S116.PMC5177692.pdf
"https://doi.org/10.3345/kjp.2016.59.11.S116Park JS, et al.",OADS,/arxiv_data1/oa_pdf/f8/8d/kjped-59-S116.PMC5177692.pdf
"S119 https://doi.org/10.3345/kjp.2016.59.11.S116Korean J Pediatr 2016;59(Suppl 1):S116-120 laboratory findings, the variation seems to be a rea  son of her CHI.",Non-OADS,/arxiv_data1/oa_pdf/f8/8d/kjped-59-S116.PMC5177692.pdf
The  alteration was neither identified in the polymorphism and muta ­ tion database until now (http://www.ncbi.nlm.nih.gov/snp).,OADS,/arxiv_data1/oa_pdf/f8/8d/kjped-59-S116.PMC5177692.pdf
"https://doi.org/10.3345/kjp.2016.59.11.S116Park JS, et al.",OADS,/arxiv_data1/oa_pdf/f8/8d/kjped-59-S116.PMC5177692.pdf
"S121 https://doi.org/10.3345/kjp.2016.59.11.S121Korean J Pediatr 2016;59(Suppl 1):S121-124 Concomitant occurrence of Turner syndrome  and growth hormone deficiency  Jung Yu, MD, Ha Young Shin, MD, Chong Guk Lee, MD, Jae Hyun Kim, MD Department of Pediatrics, Inje University Ilsan Paik Hospital, Goyang, Korea Turner syndrome (TS) is a genetic disorder in phenotypic females that has characteristic physical  features and presents as partial or complete absence of the second sex chromosome.",Non-OADS,/arxiv_data1/oa_pdf/40/04/kjped-59-S121.PMC5177693.pdf
"A diagnosis of GHD is made through a comprehensive Corresponding author: Jae Hyun Kim, MD Department of Pediatrics, Inje University Ilsan Paik  Hospital, Inje University College of Medicine, 170  Juhwa-ro, Ilsanseo-gu, Goyang 10380, Korea Tel: +82-31-910-7942 Fax: +82-31-910-7108 E-mail: pedendo@paik.ac.kr Received: 13 September, 2014 Revised: 30 October, 2014 Accepted: 31 October, 2014 Copyright © 2016 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Korean J PediatrCase report Korean J Pediatr 2016;59(Suppl 1):S121-124 https://doi.org/10.3345/kjp.2016.59.11.S121 pISSN 1738-1061•eISSN 2092-7258",Non-OADS,/arxiv_data1/oa_pdf/40/04/kjped-59-S121.PMC5177693.pdf
"https://doi.org/10.3345/kjp.2016.59.11.S121Yu J, et al.",OADS,/arxiv_data1/oa_pdf/40/04/kjped-59-S121.PMC5177693.pdf
"S123 https://doi.org/10.3345/kjp.2016.59.11.S121Korean J Pediatr 2016;59(Suppl 1):S121-124 not have any head trauma, seizure, or infections in the central  nervous system.",Non-OADS,/arxiv_data1/oa_pdf/40/04/kjped-59-S121.PMC5177693.pdf
"https://doi.org/10.3345/kjp.2016.59.11.S121Yu J, et al.",OADS,/arxiv_data1/oa_pdf/40/04/kjped-59-S121.PMC5177693.pdf
"S125 https://doi.org/10.3345/kjp.2016.59.11.S125Korean J Pediatr 2016;59(Suppl 1):S125-128 A pediatric case of idiopathic Harlequin syn­ drome  Ju Young Kim, MD, Moon Souk Lee, MD, Seung Yeon Kim, MD, Hyun Jung Kim, MD, Soo Jin Lee, MD, PhD, Chur Woo You, MD, PhD,  Jon Soo Kim, MD, Ju Hyung Kang, MD, PhD Department of Pediatrics, Eulji University Hospital, Daejeon, Korea Harlequin syndrome, which is a rare disorder caused by dysfunction of the autonomic system,  manifests as asymmetric facial flushing and sweating in response to heat, exercise, or emotional  factors.",Non-OADS,/arxiv_data1/oa_pdf/4e/f9/kjped-59-S125.PMC5177694.pdf
"Case report A 6­year­old boy visited the pediatric outpatient clinic, complaining of unilateral hemi ­ facial flushing and sweating occurring within minutes during or after physical exercise Corresponding author: Ju Hyung Kang, MD, PhD Department of Pediatrics, Eulji University Hospital,  95 Dunsanseo-ro, Seo-gu, Daejeon 35233, Korea Tel: +82-42-611-3360 Fax: +82-42-259-1111 E-mail:kjh@eulji.ac.kr Received: 10 June, 2015 Revised: 20 August, 2015 Accepted: 22 September, 2015 Copyright © 2016 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Korean J PediatrCase report Korean J Pediatr 2016;59(Suppl 1):S125­128 https://doi.org/10.3345/kjp.2016.59.11.S125 pISSN 1738-1061•eISSN 2092-7258",Non-OADS,/arxiv_data1/oa_pdf/4e/f9/kjped-59-S125.PMC5177694.pdf
"https://doi.org/10.3345/kjp.2016.59.11.S125Kim JY, et al.",OADS,/arxiv_data1/oa_pdf/4e/f9/kjped-59-S125.PMC5177694.pdf
"S127 https://doi.org/10.3345/kjp.2016.59.11.S125Korean J Pediatr 2016;59(Suppl 1):S125-128 Discussion Classically, HS is defined as unilateral facial flushing and  sweating with normal ocular sympathetic innervation, but it has  been gradually considered a spectrum of partial dysautonomias  affecting sudomotor, pupillary, and vasomotor responses in the  facial or facio­brachial region5).",Non-OADS,/arxiv_data1/oa_pdf/4e/f9/kjped-59-S125.PMC5177694.pdf
"https://doi.org/10.3345/kjp.2016.59.11.S125Kim JY, et al.",OADS,/arxiv_data1/oa_pdf/4e/f9/kjped-59-S125.PMC5177694.pdf
"S129 https://doi.org/10.3345/kjp.2016.59.11.S129Korean J Pediatr 2016;59(Suppl 1):S129-132 Ictal sinus pause and myoclonic seizure in a  child  Hye Ryun Kim, MD, Gun-Ha Kim, MD, PhD, So-Hee Eun, MD, PhD, Baik-Lin Eun, MD, PhD, Jung Hye Byeon, MD, PhD Department of Pediatrics, Korea University College of Medicine, Seoul, Korea Ictal tachycardia and bradycardia are common arrhythmias; however, ictal sinus pause and asystole are  rare.",Non-OADS,/arxiv_data1/oa_pdf/2f/63/kjped-59-S129.PMC5177695.pdf
"Routine sleep electroencephalography (EEG) was normal, but she experienced 1 Corresponding author: Jung Hye Byeon, MD, PhD Department of Pediatrics, Korea University College  of Medicine, 73 Inchon-ro, Seongbuk-gu, Seoul  02841, Korea  Tel: +82-2-920-5090 Fax: +82-2-922-7476 E-mail: byeonagnes@naver.com Received: 22 June, 2015 Revised: 3 November, 2015 Accepted: 5 November, 2015 Copyright © 2016 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Korean J PediatrCase report Korean J Pediatr 2016;59(Suppl 1):S129-132 https://doi.org/10.3345/kjp.2016.59.11.S129 pISSN 1738-1061•eISSN 2092-7258",Non-OADS,/arxiv_data1/oa_pdf/2f/63/kjped-59-S129.PMC5177695.pdf
"https://doi.org/10.3345/kjp.2016.59.11.S129Kim HR, et al.",OADS,/arxiv_data1/oa_pdf/2f/63/kjped-59-S129.PMC5177695.pdf
S131 https://doi.org/10.3345/kjp.2016.59.11.S129Korean J Pediatr 2016;59(Suppl 1):S129-132 did not perform EEG or 24-hour Holter ECG monitoring.,OADS,/arxiv_data1/oa_pdf/2f/63/kjped-59-S129.PMC5177695.pdf
"https://doi.org/10.3345/kjp.2016.59.11.S129Kim HR, et al.",OADS,/arxiv_data1/oa_pdf/2f/63/kjped-59-S129.PMC5177695.pdf
